*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 5 2blt_c00 BETA-LACTAMASE (E.C.3.5.2.6) (CEPHALuser 1 5 # 1 A 64 SER A 149 SER^? 11.10 N9 ADE A 500 A 67 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 150 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 272 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 315 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 22.64 52.16 22.71 22.26 54.50 22.75 188.74 152.31 25.78 189.32 151.10 23.76 coo 24.52 49.51 18.06 22.40 54.53 19.78 182.91 155.29 23.54 184.46 151.31 19.55 coo 26.30 59.17 19.56 25.19 56.85 20.60 190.70 148.50 17.91 191.29 151.03 18.92 coo 32.44 54.38 20.44 31.35 55.74 21.42 188.90 156.57 17.91 187.92 156.12 16.11 coo 30.06 51.26 24.63 26.98 53.93 22.55 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 5 2blt_c00 BETA-LACTAMASE (E.C.3.5.2.6) (CEPHALuser 2 5 # 2 A 64 SER B 149 SER^? 19.92 O4 CIT A1102 A 67 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 150 TYR B 84 TYR^? 19.29 O4 CIT A1102 A 272 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 315 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 22.64 52.16 22.71 22.26 54.50 22.75 184.89 121.99 12.52 183.61 123.38 14.10 coo 24.52 49.51 18.06 22.40 54.53 19.78 181.66 123.79 6.82 179.82 128.66 10.46 coo 26.30 59.17 19.56 25.19 56.85 20.60 180.02 126.93 17.73 179.63 124.28 16.92 coo 32.44 54.38 20.44 31.35 55.74 21.42 174.85 121.76 12.80 173.53 120.38 11.97 coo 30.06 51.26 24.63 26.98 53.93 22.55 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 5 2blt_c00 BETA-LACTAMASE (E.C.3.5.2.6) (CEPHALuser 3 5 # 3 A 64 SER C 149 SER^? 14.30 O1 GOL C1901 A 67 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 150 TYR C 84 TYR^? 9.85 O1 GOL C1901 A 272 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 315 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 22.64 52.16 22.71 22.26 54.50 22.75 163.58 128.93 46.04 161.38 129.11 45.07 coo 24.52 49.51 18.06 22.40 54.53 19.78 165.62 124.17 41.44 160.89 126.43 37.84 coo 26.30 59.17 19.56 25.19 56.85 20.60 155.65 129.37 42.44 156.62 127.68 44.43 coo 32.44 54.38 20.44 31.35 55.74 21.42 157.18 120.22 44.20 157.97 118.54 45.19 coo 30.06 51.26 24.63 26.98 53.93 22.55 161.58 122.48 47.40 160.49 120.58 53.33 2blt_c00 source 2blt BETA-LACTAMASE (E.C.3.5.2.6) (CEPHALOSPORINASE: 3 hits 2blt_c00 naa= 5 ULMN 5 2blt_c01 BETA-LACTAMASE (E.C.3.5.2.6) (CEPHALuser 1 5 # 1 B 64 SER A 149 SER^? 11.10 N9 ADE A 500 B 67 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 150 TYR A 84 TYR^? 7.34 N9 ADE A 500 B 272 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 315 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 0.59 3.85 22.95 0.96 1.52 22.81 188.74 152.31 25.78 189.32 151.10 23.76 coo -1.21 6.51 18.37 0.85 1.47 19.55 182.91 155.29 23.54 184.46 151.31 19.55 coo -2.99 -3.23 19.81 -1.97 -0.94 20.95 190.70 148.50 17.91 191.29 151.03 18.92 coo -9.29 1.42 20.60 -8.18 0.08 21.73 188.90 156.57 17.91 187.92 156.12 16.11 coo -6.85 4.65 24.88 -3.65 1.92 22.65 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 5 2blt_c01 BETA-LACTAMASE (E.C.3.5.2.6) (CEPHALuser 2 5 # 2 B 64 SER B 149 SER^? 19.92 O4 CIT A1102 B 67 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 150 TYR B 84 TYR^? 19.29 O4 CIT A1102 B 272 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 315 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 0.59 3.85 22.95 0.96 1.52 22.81 184.89 121.99 12.52 183.61 123.38 14.10 coo -1.21 6.51 18.37 0.85 1.47 19.55 181.66 123.79 6.82 179.82 128.66 10.46 coo -2.99 -3.23 19.81 -1.97 -0.94 20.95 180.02 126.93 17.73 179.63 124.28 16.92 coo -9.29 1.42 20.60 -8.18 0.08 21.73 174.85 121.76 12.80 173.53 120.38 11.97 coo -6.85 4.65 24.88 -3.65 1.92 22.65 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 5 2blt_c01 BETA-LACTAMASE (E.C.3.5.2.6) (CEPHALuser 3 5 # 3 B 64 SER C 149 SER^? 14.30 O1 GOL C1901 B 67 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 150 TYR C 84 TYR^? 9.85 O1 GOL C1901 B 272 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 315 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 0.59 3.85 22.95 0.96 1.52 22.81 163.58 128.93 46.04 161.38 129.11 45.07 coo -1.21 6.51 18.37 0.85 1.47 19.55 165.62 124.17 41.44 160.89 126.43 37.84 coo -2.99 -3.23 19.81 -1.97 -0.94 20.95 155.65 129.37 42.44 156.62 127.68 44.43 coo -9.29 1.42 20.60 -8.18 0.08 21.73 157.18 120.22 44.20 157.97 118.54 45.19 coo -6.85 4.65 24.88 -3.65 1.92 22.65 161.58 122.48 47.40 160.49 120.58 53.33 2blt_c01 source 2blt BETA-LACTAMASE (E.C.3.5.2.6) (CEPHALOSPORINASE: 3 hits 2blt_c01 naa= 5 ULMN 4 1aq0_c00 1,3-1,4-BETA-GLUCANASE user 1 4 # 1 A 232 GLU B 196 GLU~? 29.77 O4 CIT A1102 A 280 GLU B 192 GLU~? 33.56 O4 CIT A1102 A 283 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 288 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 5.76 85.47 37.35 6.76 85.56 39.24 190.49 111.97 5.68 191.95 113.07 4.61 coo 4.25 95.66 42.75 4.18 93.57 42.69 188.59 108.97 -3.25 189.65 108.47 -5.00 coo 9.66 95.18 46.95 8.19 90.97 44.00 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 13.49 92.75 43.16 12.39 91.15 42.33 180.61 109.47 2.81 182.18 108.21 3.48 1aq0_c00 source 1aq0 1,3-1,4-BETA-GLUCANASE : 1 hits 1aq0_c00 naa= 4 ULMN 4 1bs0_c00 8-AMINO-7-OXONANOATE SYNTHASE user 1 4 # 1 A 133 HIS A 187 HIS~? 25.73 N9 ADE A 500 A 175 GLU A 184 GLU~? 18.03 N9 ADE A 500 A 204 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 236 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 7.06 3.02 44.15 5.29 1.89 44.11 179.01 171.47 26.59 179.51 173.49 26.31 coo 5.26 3.96 48.13 7.21 3.45 47.51 180.48 167.65 23.03 180.45 166.67 21.17 coo 1.26 2.66 46.42 2.28 1.24 45.18 184.84 171.88 24.93 186.38 173.28 25.14 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 183.60 164.07 35.65 183.22 158.61 36.42 1bs0_c00 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 1 hits 1bs0_c00 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP A 130 ASP~? 27.60 C8 ADE A 500 M 206 SER B 79 SER.? 11.49 O4 CIT A1102 M 210 ARG A 101 ARG.? 15.15 C8 ADE A 500 M 214 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 188.71 136.74 34.61 188.50 136.01 36.57 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 172.67 140.46 12.34 174.10 141.88 13.69 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 173.48 146.74 16.27 172.57 144.92 18.53 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 2 4 # 2 A 61 ASP B 130 ASP~? 26.83 N6 ADE A 500 M 206 SER A 79 SER.? 7.17 O4 CIT A1102 M 210 ARG B 101 ARG.? -6.88 O4 CIT A1102s M 214 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 200.55 129.62 17.17 202.64 129.41 16.98 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 179.20 144.60 7.13 179.51 142.21 7.02 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 179.40 137.94 3.82 182.23 139.06 3.56 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 174.18 134.78 4.77 172.12 135.04 4.40 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 2 hits 1c17_c11 naa= 4 ULMN 4 1cqj_c00 SUCCINYL-COA SYNTHETASE BETA CHAIN user 1 4 # 1 A 208 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 109 TYR C 131 TYR.? 29.32 C8 ADE A 500 B 197 GLU C 135 GLU.? 26.33 O1 GOL C1901 coo 42.05 62.45 76.31 40.18 63.04 75.45 157.18 120.22 44.20 157.97 118.54 45.19 coo 37.14 61.56 73.28 37.00 63.65 73.26 153.36 123.09 43.85 154.03 121.98 42.20 coo 50.22 35.25 75.17 48.69 37.57 74.89 168.57 146.54 37.64 168.87 149.06 36.42 coo 45.03 37.30 75.10 44.89 38.23 76.98 168.08 142.51 43.72 166.57 142.98 45.14 ULMN 4 1cqj_c00 SUCCINYL-COA SYNTHETASE BETA CHAIN user 2 4 # 2 A 208 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 246 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 109 TYR C 131 TYR.? 29.32 C8 ADE A 500 B 197 GLU C 135 GLU.? 26.33 O1 GOL C1901 coo 42.05 62.45 76.31 40.18 63.04 75.45 157.18 120.22 44.20 157.97 118.54 45.19 coo 37.14 61.56 73.28 37.00 63.65 73.26 157.21 117.94 38.21 157.48 118.99 40.00 coo 50.22 35.25 75.17 48.69 37.57 74.89 168.57 146.54 37.64 168.87 149.06 36.42 coo 45.03 37.30 75.10 44.89 38.23 76.98 168.08 142.51 43.72 166.57 142.98 45.14 1cqj_c00 source 1cqj SUCCINYL-COA SYNTHETASE BETA CHAIN : 2 hits 1cqj_c00 naa= 4 ULMN 4 1cqj_c01 SUCCINYL-COA SYNTHETASE BETA CHAIN user 1 4 # 1 D 208 GLU C 44 GLU.? 9.57 O3 GOL C1901 D 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 E 109 TYR C 131 TYR.? 29.32 C8 ADE A 500 E 197 GLU C 135 GLU.? 26.33 O1 GOL C1901 coo -2.91 18.30 76.21 -1.08 17.82 77.32 157.18 120.22 44.20 157.97 118.54 45.19 coo 2.87 18.34 77.03 2.47 16.92 78.50 153.36 123.09 43.85 154.03 121.98 42.20 coo -1.67 35.94 53.83 -0.91 34.37 56.05 168.57 146.54 37.64 168.87 149.06 36.42 coo 1.76 35.71 58.20 0.46 36.19 59.80 168.08 142.51 43.72 166.57 142.98 45.14 ULMN 4 1cqj_c01 SUCCINYL-COA SYNTHETASE BETA CHAIN user 2 4 # 2 D 208 GLU C 44 GLU.? 9.57 O3 GOL C1901 D 246 HIS C 176 HIS^? 7.29 C1 GOL C1901 E 109 TYR C 131 TYR.? 29.32 C8 ADE A 500 E 197 GLU C 135 GLU.? 26.33 O1 GOL C1901 coo -2.91 18.30 76.21 -1.08 17.82 77.32 157.18 120.22 44.20 157.97 118.54 45.19 coo 2.87 18.34 77.03 2.47 16.92 78.50 157.21 117.94 38.21 157.48 118.99 40.00 coo -1.67 35.94 53.83 -0.91 34.37 56.05 168.57 146.54 37.64 168.87 149.06 36.42 coo 1.76 35.71 58.20 0.46 36.19 59.80 168.08 142.51 43.72 166.57 142.98 45.14 1cqj_c01 source 1cqj SUCCINYL-COA SYNTHETASE BETA CHAIN : 2 hits 1cqj_c01 naa= 4 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 1 4 # 1 A 92 TYR A 83 TYR^? 11.70 N6 ADE A 500 A 112 PHE A 157 PHE.? 18.76 C8 ADE A 500 A 178 PHE A 161 PHE^? 14.06 C8 ADE A 500 A 333 TRP A 37 TRP~? 16.06 N6 ADE A 500 coo 36.26 31.30 22.39 35.67 33.02 24.49 192.51 141.71 13.59 192.79 138.96 13.21 coo 45.52 35.08 26.96 42.72 35.07 26.70 197.65 139.50 24.25 197.70 140.07 21.50 coo 43.67 42.67 22.02 43.98 41.21 24.38 192.43 145.24 24.85 189.68 145.10 25.32 coo 37.80 27.73 29.78 38.27 31.62 30.15 199.31 139.07 11.62 196.71 138.80 14.55 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 2 4 # 2 A 92 TYR B 83 TYR^? 20.46 C8 ADE A 500 A 112 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 178 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 333 TRP B 37 TRP~? 24.65 C8 ADE A 500 coo 36.26 31.30 22.39 35.67 33.02 24.49 179.54 132.93 23.44 180.82 135.06 24.75 coo 45.52 35.08 26.96 42.72 35.07 26.70 189.45 127.38 26.40 186.79 128.09 26.89 coo 43.67 42.67 22.02 43.98 41.21 24.38 187.70 125.47 18.98 188.18 126.81 16.59 coo 37.80 27.73 29.78 38.27 31.62 30.15 179.47 132.20 30.73 182.06 132.56 27.80 ULMN 4 1di1_c00 ARISTOLOCHENE SYNTHASE user 3 4 # 3 A 92 TYR C 83 TYR^? 12.44 O1 GOL C1901 A 112 PHE C 157 PHE~? 20.21 O1 GOL C1901 A 178 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 333 TRP C 37 TRP~? 16.35 O1 GOL C1901 coo 36.26 31.30 22.39 35.67 33.02 24.49 149.52 133.95 39.18 148.57 136.34 38.09 coo 45.52 35.08 26.96 42.72 35.07 26.70 154.00 141.12 47.59 151.92 139.65 46.43 coo 43.67 42.67 22.02 43.98 41.21 24.38 159.14 135.31 45.76 161.07 134.95 43.76 coo 37.80 27.73 29.78 38.27 31.62 30.15 143.63 136.83 42.73 147.30 137.68 41.60 1di1_c00 source 1di1 ARISTOLOCHENE SYNTHASE : 3 hits 1di1_c00 naa= 4 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 1 4 # 1 B 92 TYR A 83 TYR^? 11.70 N6 ADE A 500 B 112 PHE A 157 PHE.? 18.76 C8 ADE A 500 B 178 PHE A 161 PHE^? 14.06 C8 ADE A 500 B 333 TRP A 37 TRP~? 16.06 N6 ADE A 500 coo 99.56 54.98 23.15 101.17 54.32 25.32 192.51 141.71 13.59 192.79 138.96 13.21 coo 95.53 46.26 28.54 97.54 48.18 28.09 197.65 139.50 24.25 197.70 140.07 21.50 coo 102.10 41.65 23.98 100.86 42.71 26.26 192.43 145.24 24.85 189.68 145.10 25.32 coo 96.01 57.16 30.39 98.35 54.06 31.01 199.31 139.07 11.62 196.71 138.80 14.55 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 2 4 # 2 B 92 TYR B 83 TYR^? 20.46 C8 ADE A 500 B 112 PHE B 157 PHE.? 26.46 N7 ADE A 500 B 178 PHE B 161 PHE^? 22.57 O4 CIT A1102 B 333 TRP B 37 TRP~? 24.65 C8 ADE A 500 coo 99.56 54.98 23.15 101.17 54.32 25.32 179.54 132.93 23.44 180.82 135.06 24.75 coo 95.53 46.26 28.54 97.54 48.18 28.09 189.45 127.38 26.40 186.79 128.09 26.89 coo 102.10 41.65 23.98 100.86 42.71 26.26 187.70 125.47 18.98 188.18 126.81 16.59 coo 96.01 57.16 30.39 98.35 54.06 31.01 179.47 132.20 30.73 182.06 132.56 27.80 ULMN 4 1di1_c01 ARISTOLOCHENE SYNTHASE user 3 4 # 3 B 92 TYR C 83 TYR^? 12.44 O1 GOL C1901 B 112 PHE C 157 PHE~? 20.21 O1 GOL C1901 B 178 PHE C 161 PHE^? 16.85 O1 GOL C1901 B 333 TRP C 37 TRP~? 16.35 O1 GOL C1901 coo 99.56 54.98 23.15 101.17 54.32 25.32 149.52 133.95 39.18 148.57 136.34 38.09 coo 95.53 46.26 28.54 97.54 48.18 28.09 154.00 141.12 47.59 151.92 139.65 46.43 coo 102.10 41.65 23.98 100.86 42.71 26.26 159.14 135.31 45.76 161.07 134.95 43.76 coo 96.01 57.16 30.39 98.35 54.06 31.01 143.63 136.83 42.73 147.30 137.68 41.60 1di1_c01 source 1di1 ARISTOLOCHENE SYNTHASE : 3 hits 1di1_c01 naa= 4 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 1 4 # 1 A1020 THR A 51 THR^? 8.68 N6 ADE A 500 A1034 TYR A 83 TYR^? 11.70 N6 ADE A 500 A1100 THR A 80 THR^? 4.30 N6 ADE A 500 B3294 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 40.94 131.25 89.60 39.24 130.12 90.27 189.89 142.39 7.18 190.42 141.55 9.05 coo 35.38 132.08 89.27 36.78 129.74 88.76 192.51 141.71 13.59 192.79 138.96 13.21 coo 43.56 124.16 89.51 42.17 124.73 91.05 182.84 145.31 7.97 182.66 147.39 7.73 coo 33.89 125.64 85.55 35.54 126.95 85.33 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 2 4 # 2 A1020 THR B 51 THR^? 19.74 C8 ADE A 500 A1034 TYR B 83 TYR^? 20.46 C8 ADE A 500 A1100 THR B 80 THR^? 11.53 O1 CIT A1102 B3294 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 40.94 131.25 89.60 39.24 130.12 90.27 174.04 136.47 22.40 175.88 136.63 23.40 coo 35.38 132.08 89.27 36.78 129.74 88.76 179.54 132.93 23.44 180.82 135.06 24.75 coo 43.56 124.16 89.51 42.17 124.73 91.05 173.05 137.67 14.86 171.74 136.22 13.94 coo 33.89 125.64 85.55 35.54 126.95 85.33 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 4 1djo_c00 GLUTAMINASE-ASPARAGINASE user 3 4 # 3 A1020 THR C 51 THR^? 10.18 O1 GOL C1901 A1034 TYR C 83 TYR^? 12.44 O1 GOL C1901 A1100 THR C 80 THR^? 5.30 O1 GOL C1901 B3294 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 40.94 131.25 89.60 39.24 130.12 90.27 146.36 130.30 34.58 146.96 132.15 35.42 coo 35.38 132.08 89.27 36.78 129.74 88.76 149.52 133.95 39.18 148.57 136.34 38.09 coo 43.56 124.16 89.51 42.17 124.73 91.05 151.58 126.43 30.18 151.60 124.76 31.56 coo 33.89 125.64 85.55 35.54 126.95 85.33 157.34 129.59 37.15 157.60 127.69 38.11 1djo_c00 source 1djo GLUTAMINASE-ASPARAGINASE : 3 hits 1djo_c00 naa= 4 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 1 4 # 1 A1294 GLU A 165 GLU^? 4.52 C8 ADE A 500 B3020 THR A 51 THR^? 8.68 N6 ADE A 500 B3034 TYR A 83 TYR^? 11.70 N6 ADE A 500 B3100 THR A 80 THR^? 4.30 N6 ADE A 500 coo 42.18 93.40 84.96 40.44 92.19 85.03 185.43 146.45 17.17 186.00 148.48 17.29 coo 35.69 87.89 89.88 37.41 89.09 90.33 189.89 142.39 7.18 190.42 141.55 9.05 coo 40.98 87.08 88.86 39.63 89.46 88.41 192.51 141.71 13.59 192.79 138.96 13.21 coo 33.09 94.86 90.18 34.63 94.22 91.55 182.84 145.31 7.97 182.66 147.39 7.73 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 2 4 # 2 A1294 GLU B 165 GLU^? 13.88 O4 CIT A1102 B3020 THR B 51 THR^? 19.74 C8 ADE A 500 B3034 TYR B 83 TYR^? 20.46 C8 ADE A 500 B3100 THR B 80 THR^? 11.53 O1 CIT A1102 coo 42.18 93.40 84.96 40.44 92.19 85.03 180.17 131.30 14.36 179.09 129.62 13.64 coo 35.69 87.89 89.88 37.41 89.09 90.33 174.04 136.47 22.40 175.88 136.63 23.40 coo 40.98 87.08 88.86 39.63 89.46 88.41 179.54 132.93 23.44 180.82 135.06 24.75 coo 33.09 94.86 90.18 34.63 94.22 91.55 173.05 137.67 14.86 171.74 136.22 13.94 ULMN 4 1djo_c01 GLUTAMINASE-ASPARAGINASE user 3 4 # 3 A1294 GLU C 165 GLU^? 7.74 O1 GOL C1901 B3020 THR C 51 THR^? 10.18 O1 GOL C1901 B3034 TYR C 83 TYR^? 12.44 O1 GOL C1901 B3100 THR C 80 THR^? 5.30 O1 GOL C1901 coo 42.18 93.40 84.96 40.44 92.19 85.03 157.34 129.59 37.15 157.60 127.69 38.11 coo 35.69 87.89 89.88 37.41 89.09 90.33 146.36 130.30 34.58 146.96 132.15 35.42 coo 40.98 87.08 88.86 39.63 89.46 88.41 149.52 133.95 39.18 148.57 136.34 38.09 coo 33.09 94.86 90.18 34.63 94.22 91.55 151.58 126.43 30.18 151.60 124.76 31.56 1djo_c01 source 1djo GLUTAMINASE-ASPARAGINASE : 3 hits 1djo_c01 naa= 4 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 1 4 # 1 A 132 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 136 ARG B 43 ARG.? 18.57 O1 CIT A1102 A 275 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 435 GLU B 174 GLU~? 9.44 O1 CIT A1102 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 174.85 121.76 12.80 173.53 120.38 11.97 coo -4.99 57.22 1.82 -7.93 56.43 2.21 169.37 120.65 13.94 167.07 120.51 11.92 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 169.82 131.15 6.22 168.64 132.89 5.97 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 163.25 129.94 5.84 161.93 130.97 4.55 ULMN 4 1dl2_c00 CLASS I ALPHA-1,2-MANNOSIDASE user 2 4 # 2 A 132 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 136 ARG C 43 ARG.? 5.25 O3 GOL C1901 A 275 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 435 GLU C 174 GLU~? 13.54 O2 GOL C1901 coo -6.23 53.40 -2.33 -7.38 55.09 -1.77 157.18 120.22 44.20 157.97 118.54 45.19 coo -4.99 57.22 1.82 -7.93 56.43 2.21 154.24 116.29 44.96 152.24 116.07 42.61 coo -12.63 61.87 -10.13 -11.95 60.35 -8.79 157.90 117.18 31.56 156.68 116.62 29.91 coo -13.69 65.25 -3.58 -13.46 63.85 -2.01 154.24 111.69 31.90 154.05 110.16 30.47 1dl2_c00 source 1dl2 CLASS I ALPHA-1,2-MANNOSIDASE : 2 hits 1dl2_c00 naa= 4 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 1 4 # 1 A 1 THR A 87 THR.? 16.32 N9 ADE A 500 A 33 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 45 GLY A 109 GLY^? 18.96 C8 ADE A 500 A 124 SER A 90 SER.? 14.48 N3 ADE A 500 coo 20.60 80.81 78.25 19.93 81.48 80.23 199.26 148.57 23.25 200.05 148.42 21.27 coo 24.21 79.63 86.31 23.19 81.94 80.55 192.52 142.86 28.75 192.00 138.78 32.31 coo 20.39 75.93 87.86 19.67 76.00 88.35 194.47 140.38 26.65 193.77 140.12 26.60 coo 15.73 80.26 75.45 17.95 80.97 75.03 199.47 153.71 22.16 199.01 152.90 19.92 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 2 4 # 2 A 1 THR A 87 THR.? 16.32 N9 ADE A 500 A 33 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 45 GLY A 111 GLY^? 16.58 C8 ADE A 500 A 124 SER A 90 SER.? 14.48 N3 ADE A 500 coo 20.60 80.81 78.25 19.93 81.48 80.23 199.26 148.57 23.25 200.05 148.42 21.27 coo 24.21 79.63 86.31 23.19 81.94 80.55 192.52 142.86 28.75 192.00 138.78 32.31 coo 20.39 75.93 87.86 19.67 76.00 88.35 191.04 146.32 28.35 190.54 145.86 28.86 coo 15.73 80.26 75.45 17.95 80.97 75.03 199.47 153.71 22.16 199.01 152.90 19.92 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 3 4 # 3 A 1 THR B 87 THR.? 28.94 O4 CIT A1102 A 33 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 45 GLY B 109 GLY^? 25.56 N7 ADE A 500 A 124 SER B 90 SER.? 26.90 O4 CIT A1102 coo 20.60 80.81 78.25 19.93 81.48 80.23 184.52 120.26 23.93 182.79 120.64 25.15 coo 24.21 79.63 86.31 23.19 81.94 80.55 192.36 125.68 19.31 197.51 127.46 19.90 coo 20.39 75.93 87.86 19.67 76.00 88.35 191.39 127.14 22.65 191.56 127.78 22.18 coo 15.73 80.26 75.45 17.95 80.97 75.03 181.23 117.12 21.89 179.24 118.41 21.27 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 4 4 # 4 A 1 THR B 87 THR.? 28.94 O4 CIT A1102 A 33 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 45 GLY B 111 GLY^? 24.48 O4 CIT A1102 A 124 SER B 90 SER.? 26.90 O4 CIT A1102 coo 20.60 80.81 78.25 19.93 81.48 80.23 184.52 120.26 23.93 182.79 120.64 25.15 coo 24.21 79.63 86.31 23.19 81.94 80.55 192.36 125.68 19.31 197.51 127.46 19.90 coo 20.39 75.93 87.86 19.67 76.00 88.35 190.52 123.97 16.51 191.16 124.37 16.16 coo 15.73 80.26 75.45 17.95 80.97 75.03 181.23 117.12 21.89 179.24 118.41 21.27 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 5 4 # 5 A 1 THR C 87 THR.? 16.92 O3 GOL C1901 A 33 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 45 GLY C 109 GLY^? 21.15 O1 GOL C1901 A 124 SER C 90 SER.? 14.02 O3 GOL C1901 coo 20.60 80.81 78.25 19.93 81.48 80.23 154.44 133.19 51.68 152.52 132.26 51.51 coo 24.21 79.63 86.31 23.19 81.94 80.55 161.71 139.26 46.53 163.20 144.39 46.83 coo 20.39 75.93 87.86 19.67 76.00 88.35 158.25 140.78 46.12 158.62 140.96 45.46 coo 15.73 80.26 75.45 17.95 80.97 75.03 155.07 128.53 53.12 154.12 126.92 51.57 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 6 4 # 6 A 1 THR C 87 THR.? 16.92 O3 GOL C1901 A 33 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 45 GLY C 111 GLY^? 19.92 O1 GOL C1901 A 124 SER C 90 SER.? 14.02 O3 GOL C1901 coo 20.60 80.81 78.25 19.93 81.48 80.23 154.44 133.19 51.68 152.52 132.26 51.51 coo 24.21 79.63 86.31 23.19 81.94 80.55 161.71 139.26 46.53 163.20 144.39 46.83 coo 20.39 75.93 87.86 19.67 76.00 88.35 163.15 135.76 46.71 163.71 136.22 46.30 coo 15.73 80.26 75.45 17.95 80.97 75.03 155.07 128.53 53.12 154.12 126.92 51.57 1doo_c04 source 1doo HEAT SHOCK LOCUS U : 6 hits 1doo_c04 naa= 4 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 1 4 # 1 B 1 THR A 87 THR.? 16.32 N9 ADE A 500 B 33 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 45 GLY A 109 GLY^? 18.96 C8 ADE A 500 B 124 SER A 90 SER.? 14.48 N3 ADE A 500 coo 26.69 108.13 78.57 25.70 107.69 80.43 199.26 148.57 23.25 200.05 148.42 21.27 coo 30.17 110.91 86.31 27.32 111.03 80.63 192.52 142.86 28.75 192.00 138.78 32.31 coo 31.73 106.00 88.02 31.34 105.46 88.62 194.47 140.38 26.65 193.77 140.12 26.60 coo 24.65 103.43 76.04 24.59 105.78 75.60 199.47 153.71 22.16 199.01 152.90 19.92 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 2 4 # 2 B 1 THR A 87 THR.? 16.32 N9 ADE A 500 B 33 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 45 GLY A 111 GLY^? 16.58 C8 ADE A 500 B 124 SER A 90 SER.? 14.48 N3 ADE A 500 coo 26.69 108.13 78.57 25.70 107.69 80.43 199.26 148.57 23.25 200.05 148.42 21.27 coo 30.17 110.91 86.31 27.32 111.03 80.63 192.52 142.86 28.75 192.00 138.78 32.31 coo 31.73 106.00 88.02 31.34 105.46 88.62 191.04 146.32 28.35 190.54 145.86 28.86 coo 24.65 103.43 76.04 24.59 105.78 75.60 199.47 153.71 22.16 199.01 152.90 19.92 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 3 4 # 3 B 1 THR B 87 THR.? 28.94 O4 CIT A1102 B 33 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 45 GLY B 109 GLY^? 25.56 N7 ADE A 500 B 124 SER B 90 SER.? 26.90 O4 CIT A1102 coo 26.69 108.13 78.57 25.70 107.69 80.43 184.52 120.26 23.93 182.79 120.64 25.15 coo 30.17 110.91 86.31 27.32 111.03 80.63 192.36 125.68 19.31 197.51 127.46 19.90 coo 31.73 106.00 88.02 31.34 105.46 88.62 191.39 127.14 22.65 191.56 127.78 22.18 coo 24.65 103.43 76.04 24.59 105.78 75.60 181.23 117.12 21.89 179.24 118.41 21.27 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 4 4 # 4 B 1 THR B 87 THR.? 28.94 O4 CIT A1102 B 33 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 45 GLY B 111 GLY^? 24.48 O4 CIT A1102 B 124 SER B 90 SER.? 26.90 O4 CIT A1102 coo 26.69 108.13 78.57 25.70 107.69 80.43 184.52 120.26 23.93 182.79 120.64 25.15 coo 30.17 110.91 86.31 27.32 111.03 80.63 192.36 125.68 19.31 197.51 127.46 19.90 coo 31.73 106.00 88.02 31.34 105.46 88.62 190.52 123.97 16.51 191.16 124.37 16.16 coo 24.65 103.43 76.04 24.59 105.78 75.60 181.23 117.12 21.89 179.24 118.41 21.27 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 5 4 # 5 B 1 THR C 87 THR.? 16.92 O3 GOL C1901 B 33 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 45 GLY C 109 GLY^? 21.15 O1 GOL C1901 B 124 SER C 90 SER.? 14.02 O3 GOL C1901 coo 26.69 108.13 78.57 25.70 107.69 80.43 154.44 133.19 51.68 152.52 132.26 51.51 coo 30.17 110.91 86.31 27.32 111.03 80.63 161.71 139.26 46.53 163.20 144.39 46.83 coo 31.73 106.00 88.02 31.34 105.46 88.62 158.25 140.78 46.12 158.62 140.96 45.46 coo 24.65 103.43 76.04 24.59 105.78 75.60 155.07 128.53 53.12 154.12 126.92 51.57 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 6 4 # 6 B 1 THR C 87 THR.? 16.92 O3 GOL C1901 B 33 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 45 GLY C 111 GLY^? 19.92 O1 GOL C1901 B 124 SER C 90 SER.? 14.02 O3 GOL C1901 coo 26.69 108.13 78.57 25.70 107.69 80.43 154.44 133.19 51.68 152.52 132.26 51.51 coo 30.17 110.91 86.31 27.32 111.03 80.63 161.71 139.26 46.53 163.20 144.39 46.83 coo 31.73 106.00 88.02 31.34 105.46 88.62 163.15 135.76 46.71 163.71 136.22 46.30 coo 24.65 103.43 76.04 24.59 105.78 75.60 155.07 128.53 53.12 154.12 126.92 51.57 1doo_c05 source 1doo HEAT SHOCK LOCUS U : 6 hits 1doo_c05 naa= 4 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 1 4 # 1 C 1 THR A 87 THR.? 16.32 N9 ADE A 500 C 33 LYS A 110 LYS.? 23.26 C8 ADE A 500 C 45 GLY A 109 GLY^? 18.96 C8 ADE A 500 C 124 SER A 90 SER.? 14.48 N3 ADE A 500 coo -5.30 26.59 199.66 -4.98 26.05 197.57 199.26 148.57 23.25 200.05 148.42 21.27 coo -4.62 30.60 191.94 -3.32 28.83 197.07 192.52 142.86 28.75 192.00 138.78 32.31 coo -9.57 29.11 189.94 -9.84 28.44 189.46 194.47 140.38 26.65 193.77 140.12 26.60 coo -8.31 23.03 202.48 -6.18 24.15 202.80 199.47 153.71 22.16 199.01 152.90 19.92 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 2 4 # 2 C 1 THR A 87 THR.? 16.32 N9 ADE A 500 C 33 LYS A 110 LYS.? 23.26 C8 ADE A 500 C 45 GLY A 111 GLY^? 16.58 C8 ADE A 500 C 124 SER A 90 SER.? 14.48 N3 ADE A 500 coo -5.30 26.59 199.66 -4.98 26.05 197.57 199.26 148.57 23.25 200.05 148.42 21.27 coo -4.62 30.60 191.94 -3.32 28.83 197.07 192.52 142.86 28.75 192.00 138.78 32.31 coo -9.57 29.11 189.94 -9.84 28.44 189.46 191.04 146.32 28.35 190.54 145.86 28.86 coo -8.31 23.03 202.48 -6.18 24.15 202.80 199.47 153.71 22.16 199.01 152.90 19.92 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 3 4 # 3 C 1 THR B 87 THR.? 28.94 O4 CIT A1102 C 33 LYS B 110 LYS.? 26.40 N7 ADE A 500 C 45 GLY B 109 GLY^? 25.56 N7 ADE A 500 C 124 SER B 90 SER.? 26.90 O4 CIT A1102 coo -5.30 26.59 199.66 -4.98 26.05 197.57 184.52 120.26 23.93 182.79 120.64 25.15 coo -4.62 30.60 191.94 -3.32 28.83 197.07 192.36 125.68 19.31 197.51 127.46 19.90 coo -9.57 29.11 189.94 -9.84 28.44 189.46 191.39 127.14 22.65 191.56 127.78 22.18 coo -8.31 23.03 202.48 -6.18 24.15 202.80 181.23 117.12 21.89 179.24 118.41 21.27 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 4 4 # 4 C 1 THR B 87 THR.? 28.94 O4 CIT A1102 C 33 LYS B 110 LYS.? 26.40 N7 ADE A 500 C 45 GLY B 111 GLY^? 24.48 O4 CIT A1102 C 124 SER B 90 SER.? 26.90 O4 CIT A1102 coo -5.30 26.59 199.66 -4.98 26.05 197.57 184.52 120.26 23.93 182.79 120.64 25.15 coo -4.62 30.60 191.94 -3.32 28.83 197.07 192.36 125.68 19.31 197.51 127.46 19.90 coo -9.57 29.11 189.94 -9.84 28.44 189.46 190.52 123.97 16.51 191.16 124.37 16.16 coo -8.31 23.03 202.48 -6.18 24.15 202.80 181.23 117.12 21.89 179.24 118.41 21.27 1doo_c06 source 1doo HEAT SHOCK LOCUS U : 4 hits 1doo_c06 naa= 4 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 1 4 # 1 D 1 THR A 87 THR.? 16.32 N9 ADE A 500 D 33 LYS A 110 LYS.? 23.26 C8 ADE A 500 D 45 GLY A 109 GLY^? 18.96 C8 ADE A 500 D 124 SER A 90 SER.? 14.48 N3 ADE A 500 coo 21.09 18.28 199.42 20.72 17.74 197.38 199.26 148.57 23.25 200.05 148.42 21.27 coo 25.54 20.08 191.91 24.21 17.77 197.54 192.52 142.86 28.75 192.00 138.78 32.31 coo 21.95 23.77 189.96 21.30 23.70 189.39 194.47 140.38 26.65 193.77 140.12 26.60 coo 16.26 18.98 201.87 18.32 18.00 202.67 199.47 153.71 22.16 199.01 152.90 19.92 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 2 4 # 2 D 1 THR A 87 THR.? 16.32 N9 ADE A 500 D 33 LYS A 110 LYS.? 23.26 C8 ADE A 500 D 45 GLY A 111 GLY^? 16.58 C8 ADE A 500 D 124 SER A 90 SER.? 14.48 N3 ADE A 500 coo 21.09 18.28 199.42 20.72 17.74 197.38 199.26 148.57 23.25 200.05 148.42 21.27 coo 25.54 20.08 191.91 24.21 17.77 197.54 192.52 142.86 28.75 192.00 138.78 32.31 coo 21.95 23.77 189.96 21.30 23.70 189.39 191.04 146.32 28.35 190.54 145.86 28.86 coo 16.26 18.98 201.87 18.32 18.00 202.67 199.47 153.71 22.16 199.01 152.90 19.92 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 3 4 # 3 D 1 THR B 87 THR.? 28.94 O4 CIT A1102 D 33 LYS B 110 LYS.? 26.40 N7 ADE A 500 D 45 GLY B 109 GLY^? 25.56 N7 ADE A 500 D 124 SER B 90 SER.? 26.90 O4 CIT A1102 coo 21.09 18.28 199.42 20.72 17.74 197.38 184.52 120.26 23.93 182.79 120.64 25.15 coo 25.54 20.08 191.91 24.21 17.77 197.54 192.36 125.68 19.31 197.51 127.46 19.90 coo 21.95 23.77 189.96 21.30 23.70 189.39 191.39 127.14 22.65 191.56 127.78 22.18 coo 16.26 18.98 201.87 18.32 18.00 202.67 181.23 117.12 21.89 179.24 118.41 21.27 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 4 4 # 4 D 1 THR B 87 THR.? 28.94 O4 CIT A1102 D 33 LYS B 110 LYS.? 26.40 N7 ADE A 500 D 45 GLY B 111 GLY^? 24.48 O4 CIT A1102 D 124 SER B 90 SER.? 26.90 O4 CIT A1102 coo 21.09 18.28 199.42 20.72 17.74 197.38 184.52 120.26 23.93 182.79 120.64 25.15 coo 25.54 20.08 191.91 24.21 17.77 197.54 192.36 125.68 19.31 197.51 127.46 19.90 coo 21.95 23.77 189.96 21.30 23.70 189.39 190.52 123.97 16.51 191.16 124.37 16.16 coo 16.26 18.98 201.87 18.32 18.00 202.67 181.23 117.12 21.89 179.24 118.41 21.27 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 5 4 # 5 D 1 THR C 87 THR.? 16.92 O3 GOL C1901 D 33 LYS C 110 LYS.? 26.32 O1 GOL C1901 D 45 GLY C 109 GLY^? 21.15 O1 GOL C1901 D 124 SER C 90 SER.? 14.02 O3 GOL C1901 coo 21.09 18.28 199.42 20.72 17.74 197.38 154.44 133.19 51.68 152.52 132.26 51.51 coo 25.54 20.08 191.91 24.21 17.77 197.54 161.71 139.26 46.53 163.20 144.39 46.83 coo 21.95 23.77 189.96 21.30 23.70 189.39 158.25 140.78 46.12 158.62 140.96 45.46 coo 16.26 18.98 201.87 18.32 18.00 202.67 155.07 128.53 53.12 154.12 126.92 51.57 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 6 4 # 6 D 1 THR C 87 THR.? 16.92 O3 GOL C1901 D 33 LYS C 110 LYS.? 26.32 O1 GOL C1901 D 45 GLY C 111 GLY^? 19.92 O1 GOL C1901 D 124 SER C 90 SER.? 14.02 O3 GOL C1901 coo 21.09 18.28 199.42 20.72 17.74 197.38 154.44 133.19 51.68 152.52 132.26 51.51 coo 25.54 20.08 191.91 24.21 17.77 197.54 161.71 139.26 46.53 163.20 144.39 46.83 coo 21.95 23.77 189.96 21.30 23.70 189.39 163.15 135.76 46.71 163.71 136.22 46.30 coo 16.26 18.98 201.87 18.32 18.00 202.67 155.07 128.53 53.12 154.12 126.92 51.57 1doo_c07 source 1doo HEAT SHOCK LOCUS U : 6 hits 1doo_c07 naa= 4 ULMN 4 1dub_c00 2-ENOYL-COA HYDRATASE user 1 4 # 1 A 98 ALA B 201 ALA.? 25.06 C2 CIT A1102 A 141 GLY B 181 GLY.? 26.00 C2 CIT A1102 A 144 GLU B 182 GLU~? 29.98 C2 CIT A1102 A 164 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 58.27 102.60 178.19 59.43 101.66 178.07 179.08 113.99 8.58 179.23 113.12 7.33 coo 59.27 103.88 173.55 59.11 104.69 173.45 175.27 110.79 5.61 175.43 111.53 5.31 coo 61.78 103.61 169.93 62.63 102.26 171.29 180.61 109.47 2.81 182.18 108.21 3.48 coo 65.46 104.88 175.81 64.47 105.72 174.12 174.79 115.83 -0.09 173.37 117.02 0.92 1dub_c00 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c00 naa= 4 ULMN 4 1f6d_c03 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 4 # 1 D 95 ASP A 130 ASP~? 27.60 C8 ADE A 500 D 117 GLU A 156 GLU.? 23.41 C8 ADE A 500 D 131 GLU A 135 GLU.? 23.34 C8 ADE A 500 D 213 HIS A 104 HIS^? 8.41 C8 ADE A 500 coo 60.45 59.04 95.56 60.08 59.57 97.62 188.71 136.74 34.61 188.50 136.01 36.57 coo 53.51 54.68 98.43 54.65 55.64 99.96 196.65 137.08 28.97 194.78 136.94 30.01 coo 62.34 62.21 97.48 63.80 63.61 98.07 187.40 140.84 33.48 189.24 139.81 33.69 coo 57.94 68.02 108.20 56.70 67.43 106.62 183.15 146.13 20.69 182.60 148.09 20.18 1f6d_c03 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 1 hits 1f6d_c03 naa= 4 ULMN 4 1ghs_c00 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1user 1 4 # 1 A 231 GLU B 196 GLU~? 29.77 O4 CIT A1102 A 279 GLU B 192 GLU~? 33.56 O4 CIT A1102 A 282 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 288 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 56.45 0.46 86.18 56.87 -0.85 87.80 190.49 111.97 5.68 191.95 113.07 4.61 coo 47.04 -1.91 92.33 48.79 -2.81 91.49 188.59 108.97 -3.25 189.65 108.47 -5.00 coo 49.98 -4.05 98.00 52.40 -3.58 93.17 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 54.40 -0.12 97.85 55.58 0.51 96.24 180.61 109.47 2.81 182.18 108.21 3.48 1ghs_c00 source 1ghs 1,3-BETA-GLUCANASE (E.C.3.2.1.39) (1,3-BETA-D-: 1 hits 1ghs_c00 naa= 4 ULMN 4 1hzd_c00 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 A 141 ALA C 201 ALA~? 18.41 O3 GOL C1901 A 186 GLY C 181 GLY~? 19.59 O3 GOL C1901 A 189 GLU C 184 GLU~? 18.70 O3 GOL C1901 A 209 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 37.84 0.78 41.05 36.64 1.72 41.12 164.63 119.64 49.73 165.82 118.76 49.44 coo 35.09 -2.80 36.98 35.21 -3.54 37.30 165.66 113.75 50.03 166.23 113.72 49.40 coo 31.14 -3.99 35.34 30.92 -2.18 36.39 168.68 112.73 44.51 166.86 112.61 43.45 coo 29.51 -1.57 42.43 30.35 -3.27 41.49 170.51 115.98 53.19 171.23 115.96 55.18 1hzd_c00 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 1 hits 1hzd_c00 naa= 4 ULMN 4 1hzd_c01 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 B 141 ALA C 201 ALA~? 18.41 O3 GOL C1901 B 186 GLY C 181 GLY~? 19.59 O3 GOL C1901 B 189 GLU C 184 GLU~? 18.70 O3 GOL C1901 B 209 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -8.13 -16.22 36.72 -8.40 -15.53 35.38 164.63 119.64 49.73 165.82 118.76 49.44 coo -1.96 -15.64 35.87 -1.68 -16.38 36.08 165.66 113.75 50.03 166.23 113.72 49.40 coo 1.43 -14.98 33.07 -0.42 -14.67 32.13 168.68 112.73 44.51 166.86 112.61 43.45 coo -4.08 -18.59 28.97 -2.63 -18.97 30.46 170.51 115.98 53.19 171.23 115.96 55.18 1hzd_c01 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 1 hits 1hzd_c01 naa= 4 ULMN 4 1hzd_c02 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 C 141 ALA C 201 ALA~? 18.41 O3 GOL C1901 C 186 GLY C 181 GLY~? 19.59 O3 GOL C1901 C 189 GLU C 184 GLU~? 18.70 O3 GOL C1901 C 209 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 24.08 -22.10 -0.34 24.67 -20.69 -0.31 164.63 119.64 49.73 165.82 118.76 49.44 coo 21.75 -21.33 5.24 22.01 -22.00 5.60 165.66 113.75 50.03 166.23 113.72 49.40 coo 21.57 -18.82 8.95 22.63 -17.75 7.49 168.68 112.73 44.51 166.86 112.61 43.45 coo 28.83 -17.90 5.95 27.84 -19.51 6.89 170.51 115.98 53.19 171.23 115.96 55.18 1hzd_c02 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 1 hits 1hzd_c02 naa= 4 ULMN 4 1hzd_c04 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 E 141 ALA C 201 ALA~? 18.41 O3 GOL C1901 E 186 GLY C 181 GLY~? 19.59 O3 GOL C1901 E 189 GLU C 184 GLU~? 18.70 O3 GOL C1901 E 209 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 2.89 21.88 40.63 4.19 21.12 40.89 164.63 119.64 49.73 165.82 118.76 49.44 coo 2.61 20.08 34.75 2.44 20.78 34.37 165.66 113.75 50.03 166.23 113.72 49.40 coo 4.93 18.46 31.25 6.09 18.34 33.00 168.68 112.73 44.51 166.86 112.61 43.45 coo 10.22 22.22 35.51 8.60 22.81 34.29 170.51 115.98 53.19 171.23 115.96 55.18 1hzd_c04 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 1 hits 1hzd_c04 naa= 4 ULMN 4 1hzd_c05 AU-BINDING PROTEIN-ENOYL-COA HYDRATAuser 1 4 # 1 F 141 ALA C 201 ALA~? 18.41 O3 GOL C1901 F 186 GLY C 181 GLY~? 19.59 O3 GOL C1901 F 189 GLU C 184 GLU~? 18.70 O3 GOL C1901 F 209 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 35.74 16.95 4.24 35.51 15.47 3.99 164.63 119.64 49.73 165.82 118.76 49.44 coo 30.48 17.59 7.15 30.10 18.21 6.83 165.66 113.75 50.03 166.23 113.72 49.40 coo 26.45 15.67 7.87 27.70 14.18 7.03 168.68 112.73 44.51 166.86 112.61 43.45 coo 28.20 13.18 0.91 27.61 14.93 1.92 170.51 115.98 53.19 171.23 115.96 55.18 1hzd_c05 source 1hzd AU-BINDING PROTEIN-ENOYL-COA HYDRATASE : 1 hits 1hzd_c05 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU A 156 GLU.? 23.41 C8 ADE A 500 A 485 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 488 GLU A 135 GLU.? 23.34 C8 ADE A 500 A 603 LYS A 132 LYS~? 32.58 C8 ADE A 500 coo -7.79 3.39 10.29 -9.01 4.74 9.32 196.65 137.08 28.97 194.78 136.94 30.01 coo -9.44 10.08 8.58 -11.94 6.98 8.10 192.52 142.86 28.75 192.00 138.78 32.31 coo -13.30 11.40 4.76 -13.95 9.40 5.16 187.40 140.84 33.48 189.24 139.81 33.69 coo -21.26 6.97 3.81 -20.43 4.23 9.21 183.55 135.22 37.19 185.46 129.22 37.94 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 1 hits 1jxa_c01 naa= 4 ULMN 4 1ltq_c00 POLYNUCLEOTIDE KINASE user 1 4 # 1 A 15 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 35 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 126 ARG A 108 ARG^? 21.78 N7 ADE A 500 A 165 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 25.71 11.82 52.50 25.05 7.88 50.17 192.52 142.86 28.75 192.00 138.78 32.31 coo 23.50 1.36 54.56 23.86 1.61 52.50 203.27 140.75 25.55 204.24 138.86 25.61 coo 33.89 4.42 51.79 30.99 5.09 51.05 195.17 135.76 22.50 193.88 133.29 23.81 coo 42.34 11.15 22.32 43.58 12.11 23.75 169.82 131.15 6.22 168.64 132.89 5.97 1ltq_c00 source 1ltq POLYNUCLEOTIDE KINASE : 1 hits 1ltq_c00 naa= 4 ULMN 4 1moq_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 481 GLU A 192 GLU~? 30.91 N9 ADE A 500 485 LYS A 193 LYS~? 24.54 N9 ADE A 500 488 GLU A 196 GLU~? 25.56 N9 ADE A 500 603 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo 24.49 18.95 6.71 25.16 18.17 4.85 184.22 167.29 40.11 184.97 165.39 40.74 coo 21.77 13.74 4.55 26.03 15.07 4.05 183.60 164.07 35.65 183.22 158.61 36.42 coo 22.93 13.34 0.22 24.67 14.21 1.12 187.60 160.31 36.10 186.31 159.33 37.47 coo 31.74 12.46 -4.74 33.15 13.34 0.17 179.30 153.63 32.06 174.52 149.85 32.01 1moq_c00 source 1moq GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 1 hits 1moq_c00 naa= 4 ULMN 4 1oh9_c00 ACETYLGLUTAMATE KINASE user 1 4 # 1 A 8 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 11 GLY B 93 GLY^? 21.08 O4 CIT A1102 A 45 GLY B 45 GLY.? 23.68 O4 CIT A1102 A 217 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 23.95 20.41 42.64 25.99 15.22 44.13 175.75 125.08 4.60 173.18 124.12 -0.61 coo 21.78 10.35 42.81 21.85 10.58 42.04 180.85 120.89 14.39 181.25 120.12 13.99 coo 27.49 8.11 39.28 26.75 8.17 38.90 177.24 119.43 17.85 177.04 120.22 17.68 coo 29.45 15.15 50.79 25.80 14.13 47.92 173.15 113.94 5.34 166.89 113.91 6.31 1oh9_c00 source 1oh9 ACETYLGLUTAMATE KINASE : 1 hits 1oh9_c00 naa= 4 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 151 VAL B 166 VAL^? 10.79 O4 CIT A1102 A 194 GLY B 170 GLY.? 8.41 O1 CIT A1102 A 417 ILE C 92 ILE^? 17.23 O3 GOL C1901 A 457 ALA C 148 ALA^? 16.55 C1 GOL C1901 coo 60.43 93.31 8.03 62.16 94.30 8.93 178.33 136.80 13.13 178.76 138.88 13.62 coo 59.34 89.99 13.88 59.24 89.18 13.73 170.68 137.70 10.86 170.48 137.43 10.11 coo 39.61 128.90 22.54 40.04 128.24 23.80 160.86 126.32 51.15 162.05 125.86 51.80 coo 43.27 124.32 20.47 43.79 125.29 21.53 164.43 125.46 44.79 165.16 124.81 45.94 ULMN 4 1pix_c00 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 151 VAL B 167 VAL^? 7.72 O4 CIT A1102 A 194 GLY B 170 GLY.? 8.41 O1 CIT A1102 A 417 ILE C 92 ILE^? 17.23 O3 GOL C1901 A 457 ALA C 148 ALA^? 16.55 C1 GOL C1901 coo 60.43 93.31 8.03 62.16 94.30 8.93 175.73 136.30 10.41 174.85 134.33 10.25 coo 59.34 89.99 13.88 59.24 89.18 13.73 170.68 137.70 10.86 170.48 137.43 10.11 coo 39.61 128.90 22.54 40.04 128.24 23.80 160.86 126.32 51.15 162.05 125.86 51.80 coo 43.27 124.32 20.47 43.79 125.29 21.53 164.43 125.46 44.79 165.16 124.81 45.94 1pix_c00 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 2 hits 1pix_c00 naa= 4 ULMN 4 1pix_c01 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 B 151 VAL B 166 VAL^? 10.79 O4 CIT A1102 B 194 GLY B 170 GLY.? 8.41 O1 CIT A1102 B 417 ILE C 92 ILE^? 17.23 O3 GOL C1901 B 457 ALA C 148 ALA^? 16.55 C1 GOL C1901 coo 52.95 126.71 13.21 51.34 125.24 13.19 178.33 136.80 13.13 178.76 138.88 13.62 coo 50.40 126.23 20.48 50.46 127.00 20.75 170.68 137.70 10.86 170.48 137.43 10.11 coo 68.38 85.45 19.33 67.41 85.52 20.41 160.86 126.32 51.15 162.05 125.86 51.80 coo 65.50 91.13 17.77 64.65 89.88 18.00 164.43 125.46 44.79 165.16 124.81 45.94 1pix_c01 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 1 hits 1pix_c01 naa= 4 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 457 ALA A 198 ALA~? 22.51 N9 ADE A 500 A 458 ALA A 194 ALA~? 24.12 N9 ADE A 500 B 193 ALA A 201 ALA~? 17.12 N9 ADE A 500 B 194 GLY A 181 GLY~? 18.98 N9 ADE A 500 coo 43.27 124.32 20.47 43.79 125.29 21.53 189.84 163.90 29.97 190.40 165.13 30.64 coo 39.57 123.53 20.89 38.42 124.25 20.20 184.86 165.44 32.34 184.45 166.79 31.77 coo 47.95 129.15 20.31 47.81 128.95 18.79 189.52 162.53 24.76 188.43 163.45 25.31 coo 50.40 126.23 20.48 50.46 127.00 20.75 187.72 167.74 23.06 186.98 167.48 23.15 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 457 ALA A 198 ALA~? 22.51 N9 ADE A 500 A 458 ALA A 195 ALA~? 27.08 N9 ADE A 500 B 193 ALA A 201 ALA~? 17.12 N9 ADE A 500 B 194 GLY A 181 GLY~? 18.98 N9 ADE A 500 coo 43.27 124.32 20.47 43.79 125.29 21.53 189.84 163.90 29.97 190.40 165.13 30.64 coo 39.57 123.53 20.89 38.42 124.25 20.20 188.15 166.18 34.05 188.29 166.96 35.33 coo 47.95 129.15 20.31 47.81 128.95 18.79 189.52 162.53 24.76 188.43 163.45 25.31 coo 50.40 126.23 20.48 50.46 127.00 20.75 187.72 167.74 23.06 186.98 167.48 23.15 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 457 ALA A 201 ALA~? 17.12 N9 ADE A 500 A 458 ALA A 198 ALA~? 22.51 N9 ADE A 500 B 193 ALA A 148 ALA^? 13.14 N9 ADE A 500 B 194 GLY A 93 GLY^? 10.42 N9 ADE A 500 coo 43.27 124.32 20.47 43.79 125.29 21.53 189.52 162.53 24.76 188.43 163.45 25.31 coo 39.57 123.53 20.89 38.42 124.25 20.20 189.84 163.90 29.97 190.40 165.13 30.64 coo 47.95 129.15 20.31 47.81 128.95 18.79 186.54 155.13 24.52 186.93 156.34 25.35 coo 50.40 126.23 20.48 50.46 127.00 20.75 191.16 154.66 21.80 191.10 155.17 22.59 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 457 ALA B 11 ALA.? 26.08 O4 CIT A1102 A 458 ALA B 12 ALA.? 30.70 O4 CIT A1102 B 193 ALA B 9 ALA.? 25.11 N6 ADE A 500 B 194 GLY B 134 GLY~? 24.07 N6 ADE A 500 coo 43.27 124.32 20.47 43.79 125.29 21.53 196.30 121.74 7.22 195.68 122.25 8.51 coo 39.57 123.53 20.89 38.42 124.25 20.20 196.42 117.97 7.74 197.73 117.26 8.08 coo 47.95 129.15 20.31 47.81 128.95 18.79 197.54 127.53 5.34 198.69 127.54 6.34 coo 50.40 126.23 20.48 50.46 127.00 20.75 199.49 129.07 9.64 199.41 129.13 10.41 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 457 ALA B 198 ALA.? 29.73 O4 CIT A1102 A 458 ALA B 195 ALA~? 32.61 O4 CIT A1102 B 193 ALA B 201 ALA.? 25.06 C2 CIT A1102 B 194 GLY B 181 GLY.? 26.00 C2 CIT A1102 coo 43.27 124.32 20.47 43.79 125.29 21.53 183.32 111.00 7.40 183.44 109.49 7.28 coo 39.57 123.53 20.89 38.42 124.25 20.20 185.78 108.35 3.71 186.55 107.14 3.21 coo 47.95 129.15 20.31 47.81 128.95 18.79 179.08 113.99 8.58 179.23 113.12 7.33 coo 50.40 126.23 20.48 50.46 127.00 20.75 175.27 110.79 5.61 175.43 111.53 5.31 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 457 ALA B 201 ALA.? 25.06 C2 CIT A1102 A 458 ALA B 198 ALA.? 29.73 O4 CIT A1102 B 193 ALA B 148 ALA^? 20.27 O4 CIT A1102 B 194 GLY B 93 GLY^? 21.08 O4 CIT A1102 coo 43.27 124.32 20.47 43.79 125.29 21.53 179.08 113.99 8.58 179.23 113.12 7.33 coo 39.57 123.53 20.89 38.42 124.25 20.20 183.32 111.00 7.40 183.44 109.49 7.28 coo 47.95 129.15 20.31 47.81 128.95 18.79 182.64 121.34 9.52 182.83 119.91 9.05 coo 50.40 126.23 20.48 50.46 127.00 20.75 180.85 120.89 14.39 181.25 120.12 13.99 ULMN 4 1pix_c02 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 457 ALA C 201 ALA~? 18.41 O3 GOL C1901 A 458 ALA C 198 ALA~? 24.12 O3 GOL C1901 B 193 ALA C 148 ALA^? 16.55 C1 GOL C1901 B 194 GLY C 93 GLY^? 13.18 O3 GOL C1901 coo 43.27 124.32 20.47 43.79 125.29 21.53 164.63 119.64 49.73 165.82 118.76 49.44 coo 39.57 123.53 20.89 38.42 124.25 20.20 168.86 120.30 53.31 169.26 119.70 54.63 coo 47.95 129.15 20.31 47.81 128.95 18.79 164.43 125.46 44.79 165.16 124.81 45.94 coo 50.40 126.23 20.48 50.46 127.00 20.75 159.81 125.78 46.83 160.54 125.64 47.42 1pix_c02 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 7 hits 1pix_c02 naa= 4 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 1 4 # 1 A 193 ALA A 148 ALA^? 13.14 N9 ADE A 500 A 194 GLY A 93 GLY^? 10.42 N9 ADE A 500 B 457 ALA A 201 ALA~? 17.12 N9 ADE A 500 B 458 ALA A 198 ALA~? 22.51 N9 ADE A 500 coo 61.89 87.20 13.50 62.59 88.00 12.38 186.54 155.13 24.52 186.93 156.34 25.35 coo 59.34 89.99 13.88 59.24 89.18 13.73 191.16 154.66 21.80 191.10 155.17 22.59 coo 65.50 91.13 17.77 64.65 89.88 18.00 189.52 162.53 24.76 188.43 163.45 25.31 coo 68.56 91.15 20.03 69.95 90.68 19.64 189.84 163.90 29.97 190.40 165.13 30.64 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 2 4 # 2 A 193 ALA A 201 ALA~? 17.12 N9 ADE A 500 A 194 GLY A 181 GLY~? 18.98 N9 ADE A 500 B 457 ALA A 198 ALA~? 22.51 N9 ADE A 500 B 458 ALA A 194 ALA~? 24.12 N9 ADE A 500 coo 61.89 87.20 13.50 62.59 88.00 12.38 189.52 162.53 24.76 188.43 163.45 25.31 coo 59.34 89.99 13.88 59.24 89.18 13.73 187.72 167.74 23.06 186.98 167.48 23.15 coo 65.50 91.13 17.77 64.65 89.88 18.00 189.84 163.90 29.97 190.40 165.13 30.64 coo 68.56 91.15 20.03 69.95 90.68 19.64 184.86 165.44 32.34 184.45 166.79 31.77 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 3 4 # 3 A 193 ALA A 201 ALA~? 17.12 N9 ADE A 500 A 194 GLY A 181 GLY~? 18.98 N9 ADE A 500 B 457 ALA A 198 ALA~? 22.51 N9 ADE A 500 B 458 ALA A 195 ALA~? 27.08 N9 ADE A 500 coo 61.89 87.20 13.50 62.59 88.00 12.38 189.52 162.53 24.76 188.43 163.45 25.31 coo 59.34 89.99 13.88 59.24 89.18 13.73 187.72 167.74 23.06 186.98 167.48 23.15 coo 65.50 91.13 17.77 64.65 89.88 18.00 189.84 163.90 29.97 190.40 165.13 30.64 coo 68.56 91.15 20.03 69.95 90.68 19.64 188.15 166.18 34.05 188.29 166.96 35.33 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 4 4 # 4 A 193 ALA B 9 ALA.? 25.11 N6 ADE A 500 A 194 GLY B 134 GLY~? 24.07 N6 ADE A 500 B 457 ALA B 11 ALA.? 26.08 O4 CIT A1102 B 458 ALA B 12 ALA.? 30.70 O4 CIT A1102 coo 61.89 87.20 13.50 62.59 88.00 12.38 197.54 127.53 5.34 198.69 127.54 6.34 coo 59.34 89.99 13.88 59.24 89.18 13.73 199.49 129.07 9.64 199.41 129.13 10.41 coo 65.50 91.13 17.77 64.65 89.88 18.00 196.30 121.74 7.22 195.68 122.25 8.51 coo 68.56 91.15 20.03 69.95 90.68 19.64 196.42 117.97 7.74 197.73 117.26 8.08 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 5 4 # 5 A 193 ALA B 148 ALA^? 20.27 O4 CIT A1102 A 194 GLY B 93 GLY^? 21.08 O4 CIT A1102 B 457 ALA B 201 ALA.? 25.06 C2 CIT A1102 B 458 ALA B 198 ALA.? 29.73 O4 CIT A1102 coo 61.89 87.20 13.50 62.59 88.00 12.38 182.64 121.34 9.52 182.83 119.91 9.05 coo 59.34 89.99 13.88 59.24 89.18 13.73 180.85 120.89 14.39 181.25 120.12 13.99 coo 65.50 91.13 17.77 64.65 89.88 18.00 179.08 113.99 8.58 179.23 113.12 7.33 coo 68.56 91.15 20.03 69.95 90.68 19.64 183.32 111.00 7.40 183.44 109.49 7.28 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 6 4 # 6 A 193 ALA B 201 ALA.? 25.06 C2 CIT A1102 A 194 GLY B 181 GLY.? 26.00 C2 CIT A1102 B 457 ALA B 198 ALA.? 29.73 O4 CIT A1102 B 458 ALA B 195 ALA~? 32.61 O4 CIT A1102 coo 61.89 87.20 13.50 62.59 88.00 12.38 179.08 113.99 8.58 179.23 113.12 7.33 coo 59.34 89.99 13.88 59.24 89.18 13.73 175.27 110.79 5.61 175.43 111.53 5.31 coo 65.50 91.13 17.77 64.65 89.88 18.00 183.32 111.00 7.40 183.44 109.49 7.28 coo 68.56 91.15 20.03 69.95 90.68 19.64 185.78 108.35 3.71 186.55 107.14 3.21 ULMN 4 1pix_c03 GLUTACONYL-COA DECARBOXYLASE A SUBUNuser 7 4 # 7 A 193 ALA C 148 ALA^? 16.55 C1 GOL C1901 A 194 GLY C 93 GLY^? 13.18 O3 GOL C1901 B 457 ALA C 201 ALA~? 18.41 O3 GOL C1901 B 458 ALA C 198 ALA~? 24.12 O3 GOL C1901 coo 61.89 87.20 13.50 62.59 88.00 12.38 164.43 125.46 44.79 165.16 124.81 45.94 coo 59.34 89.99 13.88 59.24 89.18 13.73 159.81 125.78 46.83 160.54 125.64 47.42 coo 65.50 91.13 17.77 64.65 89.88 18.00 164.63 119.64 49.73 165.82 118.76 49.44 coo 68.56 91.15 20.03 69.95 90.68 19.64 168.86 120.30 53.31 169.26 119.70 54.63 1pix_c03 source 1pix GLUTACONYL-COA DECARBOXYLASE A SUBUNIT : 7 hits 1pix_c03 naa= 4 ULMN 4 1ptd_c01 PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHuser 1 4 # 1 32 HIS B 176 HIS^? 13.79 O1 CIT A1102 69 ARG B 43 ARG.? 18.57 O1 CIT A1102 82 HIS B 42 HIS.? 18.79 O1 CIT A1102 274 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 17.95 33.65 102.53 17.45 31.62 102.61 171.08 125.47 9.27 172.48 124.18 10.15 coo 21.40 29.87 95.89 20.75 29.43 98.86 169.37 120.65 13.94 167.07 120.51 11.92 coo 13.78 26.89 97.17 14.10 26.88 99.25 174.27 123.90 17.18 173.55 124.80 15.43 coo 13.65 36.01 104.94 14.62 34.25 104.47 169.82 131.15 6.22 168.64 132.89 5.97 1ptd_c01 source 1ptd PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C : 1 hits 1ptd_c01 naa= 4 ULMN 4 1qi9_c02 VANADIUM BROMOPEROXIDASE user 1 4 # 1 A 341 LYS C 180 LYS.? 20.00 O3 GOL C1901 A 411 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 418 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 486 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 104.35 34.37 32.90 100.82 36.32 29.09 163.89 112.64 46.86 163.54 106.47 45.76 coo 97.41 36.75 31.83 96.89 36.64 29.80 160.20 116.89 49.36 158.52 117.92 48.65 coo 96.54 35.93 21.66 94.52 36.26 22.15 153.36 123.09 43.85 154.03 121.98 42.20 coo 101.56 40.73 24.87 100.70 39.23 26.07 160.37 121.38 41.43 159.84 123.37 41.06 1qi9_c02 source 1qi9 VANADIUM BROMOPEROXIDASE : 1 hits 1qi9_c02 naa= 4 ULMN 4 1qi9_c03 VANADIUM BROMOPEROXIDASE user 1 4 # 1 B 341 LYS C 180 LYS.? 20.00 O3 GOL C1901 B 411 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 418 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 486 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 86.35 -0.78 12.68 84.14 3.90 10.48 163.89 112.64 46.86 163.54 106.47 45.76 coo 86.78 4.06 6.95 85.81 5.85 7.39 160.20 116.89 49.36 158.52 117.92 48.65 coo 81.39 11.93 10.46 82.24 12.93 8.84 153.36 123.09 43.85 154.03 121.98 42.20 coo 78.14 5.23 9.11 80.26 5.28 9.20 160.37 121.38 41.43 159.84 123.37 41.06 ULMN 4 1qi9_c03 VANADIUM BROMOPEROXIDASE user 2 4 # 2 B 341 LYS C 180 LYS.? 20.00 O3 GOL C1901 B 411 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 418 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 486 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 86.35 -0.78 12.68 84.14 3.90 10.48 163.89 112.64 46.86 163.54 106.47 45.76 coo 86.78 4.06 6.95 85.81 5.85 7.39 160.20 116.89 49.36 158.52 117.92 48.65 coo 81.39 11.93 10.46 82.24 12.93 8.84 157.21 117.94 38.21 157.48 118.99 40.00 coo 78.14 5.23 9.11 80.26 5.28 9.20 160.37 121.38 41.43 159.84 123.37 41.06 1qi9_c03 source 1qi9 VANADIUM BROMOPEROXIDASE : 2 hits 1qi9_c03 naa= 4 ULMN 4 1ro7_c00 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 4 # 1 A 129 ARG A 43 ARG.? 7.62 C2 ADE A 500 A 156 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 162 TYR A 83 TYR^? 11.70 N6 ADE A 500 A 188 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 13.26 -3.59 9.83 13.09 -6.11 8.08 190.33 158.90 11.08 189.17 159.63 8.34 coo 24.49 1.42 8.60 23.51 -0.13 10.72 190.70 148.50 17.91 191.29 151.03 18.92 coo 29.93 -1.69 13.68 27.68 -2.80 12.45 192.51 141.71 13.59 192.79 138.96 13.21 coo 18.14 -0.38 8.50 17.55 -1.78 9.95 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 4 1ro7_c00 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 4 # 2 A 129 ARG A 43 ARG.? 7.62 C2 ADE A 500 A 156 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 162 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 188 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 13.26 -3.59 9.83 13.09 -6.11 8.08 190.33 158.90 11.08 189.17 159.63 8.34 coo 24.49 1.42 8.60 23.51 -0.13 10.72 190.70 148.50 17.91 191.29 151.03 18.92 coo 29.93 -1.69 13.68 27.68 -2.80 12.45 185.14 149.36 25.84 186.22 148.61 23.38 coo 18.14 -0.38 8.50 17.55 -1.78 9.95 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 4 1ro7_c00 ALPHA-2,3/8-SIALYLTRANSFERASE user 3 4 # 3 A 129 ARG B 43 ARG.? 18.57 O1 CIT A1102 A 156 TYR B 84 TYR^? 19.29 O4 CIT A1102 A 162 TYR B 83 TYR^? 20.46 C8 ADE A 500 A 188 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 13.26 -3.59 9.83 13.09 -6.11 8.08 169.37 120.65 13.94 167.07 120.51 11.92 coo 24.49 1.42 8.60 23.51 -0.13 10.72 180.02 126.93 17.73 179.63 124.28 16.92 coo 29.93 -1.69 13.68 27.68 -2.80 12.45 179.54 132.93 23.44 180.82 135.06 24.75 coo 18.14 -0.38 8.50 17.55 -1.78 9.95 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 4 1ro7_c00 ALPHA-2,3/8-SIALYLTRANSFERASE user 4 4 # 4 A 129 ARG B 43 ARG.? 18.57 O1 CIT A1102 A 156 TYR B 84 TYR^? 19.29 O4 CIT A1102 A 162 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 188 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 13.26 -3.59 9.83 13.09 -6.11 8.08 169.37 120.65 13.94 167.07 120.51 11.92 coo 24.49 1.42 8.60 23.51 -0.13 10.72 180.02 126.93 17.73 179.63 124.28 16.92 coo 29.93 -1.69 13.68 27.68 -2.80 12.45 186.72 125.72 10.79 185.00 126.80 12.71 coo 18.14 -0.38 8.50 17.55 -1.78 9.95 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 4 1ro7_c00 ALPHA-2,3/8-SIALYLTRANSFERASE user 5 4 # 5 A 129 ARG C 43 ARG.? 5.25 O3 GOL C1901 A 156 TYR C 84 TYR^? 9.85 O1 GOL C1901 A 162 TYR C 83 TYR^? 12.44 O1 GOL C1901 A 188 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 13.26 -3.59 9.83 13.09 -6.11 8.08 154.24 116.29 44.96 152.24 116.07 42.61 coo 24.49 1.42 8.60 23.51 -0.13 10.72 155.65 129.37 42.44 156.62 127.68 44.43 coo 29.93 -1.69 13.68 27.68 -2.80 12.45 149.52 133.95 39.18 148.57 136.34 38.09 coo 18.14 -0.38 8.50 17.55 -1.78 9.95 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 4 1ro7_c00 ALPHA-2,3/8-SIALYLTRANSFERASE user 6 4 # 6 A 129 ARG C 43 ARG.? 5.25 O3 GOL C1901 A 156 TYR C 84 TYR^? 9.85 O1 GOL C1901 A 162 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 188 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 13.26 -3.59 9.83 13.09 -6.11 8.08 154.24 116.29 44.96 152.24 116.07 42.61 coo 24.49 1.42 8.60 23.51 -0.13 10.72 155.65 129.37 42.44 156.62 127.68 44.43 coo 29.93 -1.69 13.68 27.68 -2.80 12.45 165.10 130.81 41.92 162.37 130.83 41.35 coo 18.14 -0.38 8.50 17.55 -1.78 9.95 153.36 123.09 43.85 154.03 121.98 42.20 1ro7_c00 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 6 hits 1ro7_c00 naa= 4 ULMN 4 1ro7_c02 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 4 # 1 C 129 ARG A 43 ARG.? 7.62 C2 ADE A 500 C 156 TYR A 84 TYR^? 7.34 N9 ADE A 500 C 162 TYR A 83 TYR^? 11.70 N6 ADE A 500 C 188 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo -21.93 -12.96 3.85 -20.61 -15.55 2.86 190.33 158.90 11.08 189.17 159.63 8.34 coo -26.79 -5.72 -5.03 -24.66 -5.47 -3.25 190.70 148.50 17.91 191.29 151.03 18.92 coo -21.39 -0.36 -7.59 -20.89 -2.89 -6.49 192.51 141.71 13.59 192.79 138.96 13.21 coo -25.74 -10.27 -0.74 -23.71 -9.75 -0.67 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 4 1ro7_c02 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 4 # 2 C 129 ARG A 43 ARG.? 7.62 C2 ADE A 500 C 156 TYR A 84 TYR^? 7.34 N9 ADE A 500 C 162 TYR A 113 TYR^? 11.47 C8 ADE A 500 C 188 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo -21.93 -12.96 3.85 -20.61 -15.55 2.86 190.33 158.90 11.08 189.17 159.63 8.34 coo -26.79 -5.72 -5.03 -24.66 -5.47 -3.25 190.70 148.50 17.91 191.29 151.03 18.92 coo -21.39 -0.36 -7.59 -20.89 -2.89 -6.49 185.14 149.36 25.84 186.22 148.61 23.38 coo -25.74 -10.27 -0.74 -23.71 -9.75 -0.67 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 4 1ro7_c02 ALPHA-2,3/8-SIALYLTRANSFERASE user 3 4 # 3 C 129 ARG B 43 ARG.? 18.57 O1 CIT A1102 C 156 TYR B 84 TYR^? 19.29 O4 CIT A1102 C 162 TYR B 83 TYR^? 20.46 C8 ADE A 500 C 188 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo -21.93 -12.96 3.85 -20.61 -15.55 2.86 169.37 120.65 13.94 167.07 120.51 11.92 coo -26.79 -5.72 -5.03 -24.66 -5.47 -3.25 180.02 126.93 17.73 179.63 124.28 16.92 coo -21.39 -0.36 -7.59 -20.89 -2.89 -6.49 179.54 132.93 23.44 180.82 135.06 24.75 coo -25.74 -10.27 -0.74 -23.71 -9.75 -0.67 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 4 1ro7_c02 ALPHA-2,3/8-SIALYLTRANSFERASE user 4 4 # 4 C 129 ARG B 43 ARG.? 18.57 O1 CIT A1102 C 156 TYR B 84 TYR^? 19.29 O4 CIT A1102 C 162 TYR B 113 TYR^? 17.81 O4 CIT A1102 C 188 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo -21.93 -12.96 3.85 -20.61 -15.55 2.86 169.37 120.65 13.94 167.07 120.51 11.92 coo -26.79 -5.72 -5.03 -24.66 -5.47 -3.25 180.02 126.93 17.73 179.63 124.28 16.92 coo -21.39 -0.36 -7.59 -20.89 -2.89 -6.49 186.72 125.72 10.79 185.00 126.80 12.71 coo -25.74 -10.27 -0.74 -23.71 -9.75 -0.67 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 4 1ro7_c02 ALPHA-2,3/8-SIALYLTRANSFERASE user 5 4 # 5 C 129 ARG C 43 ARG.? 5.25 O3 GOL C1901 C 156 TYR C 84 TYR^? 9.85 O1 GOL C1901 C 162 TYR C 113 TYR^? 15.28 O1 GOL C1901 C 188 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo -21.93 -12.96 3.85 -20.61 -15.55 2.86 154.24 116.29 44.96 152.24 116.07 42.61 coo -26.79 -5.72 -5.03 -24.66 -5.47 -3.25 155.65 129.37 42.44 156.62 127.68 44.43 coo -21.39 -0.36 -7.59 -20.89 -2.89 -6.49 165.10 130.81 41.92 162.37 130.83 41.35 coo -25.74 -10.27 -0.74 -23.71 -9.75 -0.67 153.36 123.09 43.85 154.03 121.98 42.20 1ro7_c02 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 5 hits 1ro7_c02 naa= 4 ULMN 4 2plc_c01 PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHuser 1 4 # 1 45 HIS A 176 HIS^? 6.39 N3 ADE A 500 84 ARG A 43 ARG.? 7.62 C2 ADE A 500 93 HIS A 42 HIS.? -4.20 N3 ADE A 500s 278 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo 31.87 31.30 28.72 31.86 29.46 29.73 184.39 157.95 13.11 185.86 157.96 14.60 coo 24.84 27.81 28.65 27.85 27.30 28.97 190.33 158.90 11.08 189.17 159.63 8.34 coo 27.02 27.68 36.08 29.06 27.20 35.96 191.47 153.75 14.17 189.52 154.05 13.44 coo 35.36 34.87 31.53 34.51 32.98 31.23 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 4 2plc_c01 PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHuser 2 4 # 2 45 HIS B 176 HIS^? 13.79 O1 CIT A1102 84 ARG B 43 ARG.? 18.57 O1 CIT A1102 93 HIS B 42 HIS.? 18.79 O1 CIT A1102 278 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 31.87 31.30 28.72 31.86 29.46 29.73 171.08 125.47 9.27 172.48 124.18 10.15 coo 24.84 27.81 28.65 27.85 27.30 28.97 169.37 120.65 13.94 167.07 120.51 11.92 coo 27.02 27.68 36.08 29.06 27.20 35.96 174.27 123.90 17.18 173.55 124.80 15.43 coo 35.36 34.87 31.53 34.51 32.98 31.23 169.82 131.15 6.22 168.64 132.89 5.97 2plc_c01 source 2plc PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE C : 2 hits 2plc_c01 naa= 4 ULMN 4 2rnf_c00 RIBONUCLEASE 4 user 1 4 # 1 A 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 40 LYS A 41 LYS^? 15.86 N3 ADE A 500 A 116 HIS A 202 HIS.? 13.56 N3 ADE A 500 A 117 PHE A 178 PHE^? 9.61 N3 ADE A 500 coo 12.34 -0.45 10.80 13.53 1.19 11.34 185.28 156.61 18.37 185.56 154.55 18.68 coo 18.50 3.53 20.10 16.17 2.61 14.41 197.56 153.42 13.51 201.64 156.08 17.41 coo 14.70 6.01 5.61 14.27 7.69 6.78 190.73 163.86 19.83 191.04 162.27 18.50 coo 10.36 3.58 9.83 7.87 3.59 11.03 187.30 161.92 16.41 189.15 160.05 15.37 ULMN 4 2rnf_c00 RIBONUCLEASE 4 user 2 4 # 2 A 12 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 40 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 116 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 117 PHE C 178 PHE^? 10.90 O3 GOL C1901 coo 12.34 -0.45 10.80 13.53 1.19 11.34 160.37 121.38 41.43 159.84 123.37 41.06 coo 18.50 3.53 20.10 16.17 2.61 14.41 149.18 124.89 48.07 150.57 125.16 54.16 coo 14.70 6.01 5.61 14.27 7.69 6.78 160.20 116.89 49.36 158.52 117.92 48.65 coo 10.36 3.58 9.83 7.87 3.59 11.03 159.27 115.44 43.88 157.53 113.30 44.32 ULMN 4 2rnf_c00 RIBONUCLEASE 4 user 3 4 # 3 A 12 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 40 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 116 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 117 PHE C 178 PHE^? 10.90 O3 GOL C1901 coo 12.34 -0.45 10.80 13.53 1.19 11.34 160.20 116.89 49.36 158.52 117.92 48.65 coo 18.50 3.53 20.10 16.17 2.61 14.41 149.18 124.89 48.07 150.57 125.16 54.16 coo 14.70 6.01 5.61 14.27 7.69 6.78 160.37 121.38 41.43 159.84 123.37 41.06 coo 10.36 3.58 9.83 7.87 3.59 11.03 159.27 115.44 43.88 157.53 113.30 44.32 2rnf_c00 source 2rnf RIBONUCLEASE 4 : 3 hits 2rnf_c00 naa= 4 ULMN 4 2rnf_c01 RIBONUCLEASE 4 user 1 4 # 1 B 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 40 LYS A 41 LYS^? 15.86 N3 ADE A 500 B 116 HIS A 202 HIS.? 13.56 N3 ADE A 500 B 117 PHE A 178 PHE^? 9.61 N3 ADE A 500 coo -6.35 21.42 14.69 -6.06 23.46 15.04 185.28 156.61 18.37 185.56 154.55 18.68 coo -10.61 31.45 9.72 -8.75 26.69 13.45 197.56 153.42 13.51 201.64 156.08 17.41 coo -0.95 25.22 19.68 -0.68 26.73 18.24 190.73 163.86 19.83 191.04 162.27 18.50 coo -2.03 21.85 14.13 -1.38 20.31 11.90 187.30 161.92 16.41 189.15 160.05 15.37 ULMN 4 2rnf_c01 RIBONUCLEASE 4 user 2 4 # 2 B 12 HIS A 202 HIS.? 13.56 N3 ADE A 500 B 40 LYS A 41 LYS^? 15.86 N3 ADE A 500 B 116 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 117 PHE A 178 PHE^? 9.61 N3 ADE A 500 coo -6.35 21.42 14.69 -6.06 23.46 15.04 190.73 163.86 19.83 191.04 162.27 18.50 coo -10.61 31.45 9.72 -8.75 26.69 13.45 197.56 153.42 13.51 201.64 156.08 17.41 coo -0.95 25.22 19.68 -0.68 26.73 18.24 185.28 156.61 18.37 185.56 154.55 18.68 coo -2.03 21.85 14.13 -1.38 20.31 11.90 187.30 161.92 16.41 189.15 160.05 15.37 ULMN 4 2rnf_c01 RIBONUCLEASE 4 user 3 4 # 3 B 12 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 40 LYS C 41 LYS^? 15.03 O3 GOL C1901 B 116 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 117 PHE C 178 PHE^? 10.90 O3 GOL C1901 coo -6.35 21.42 14.69 -6.06 23.46 15.04 160.20 116.89 49.36 158.52 117.92 48.65 coo -10.61 31.45 9.72 -8.75 26.69 13.45 149.18 124.89 48.07 150.57 125.16 54.16 coo -0.95 25.22 19.68 -0.68 26.73 18.24 160.37 121.38 41.43 159.84 123.37 41.06 coo -2.03 21.85 14.13 -1.38 20.31 11.90 159.27 115.44 43.88 157.53 113.30 44.32 2rnf_c01 source 2rnf RIBONUCLEASE 4 : 3 hits 2rnf_c01 naa= 4 ULMN 4 2tpl_c02 TYROSINE PHENOL-LYASE user 1 4 # 1 A 71 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 123 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 214 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 381 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo -18.26 14.59 1.38 -20.32 13.94 3.12 165.10 130.81 41.92 162.37 130.83 41.35 coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 189.45 127.38 26.40 186.79 128.09 26.89 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 190.60 123.10 30.08 190.26 121.25 31.09 coo -28.50 -18.89 13.52 -29.04 -16.11 14.56 195.17 135.76 22.50 193.88 133.29 23.81 2tpl_c02 source 2tpl TYROSINE PHENOL-LYASE : 1 hits 2tpl_c02 naa= 4 ULMN 4 2tpl_c03 TYROSINE PHENOL-LYASE user 1 4 # 1 B 71 TYR C 113 TYR^? 15.28 O1 GOL C1901 B 123 PHE B 157 PHE.? 26.46 N7 ADE A 500 B 214 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 381 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo -20.85 -10.53 13.88 -22.65 -9.60 11.98 165.10 130.81 41.92 162.37 130.83 41.35 coo -26.81 18.98 9.83 -25.06 17.93 7.94 189.45 127.38 26.40 186.79 128.09 26.89 coo -26.88 17.61 16.89 -26.08 17.11 15.00 190.60 123.10 30.08 190.26 121.25 31.09 coo -23.89 24.28 2.03 -24.86 21.74 0.63 195.17 135.76 22.50 193.88 133.29 23.81 2tpl_c03 source 2tpl TYROSINE PHENOL-LYASE : 1 hits 2tpl_c03 naa= 4 ULMN 4 5rsa_c00 RIBONUCLEASE A user 1 4 # 1 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 41 LYS A 41 LYS^? 15.86 N3 ADE A 500 119 HIS A 202 HIS.? 13.56 N3 ADE A 500 120 PHE A 178 PHE^? 9.61 N3 ADE A 500 coo 28.18 18.67 11.43 28.83 17.39 9.89 185.28 156.61 18.37 185.56 154.55 18.68 coo 25.33 8.32 6.30 27.86 13.90 7.82 197.56 153.42 13.51 201.64 156.08 17.41 coo 33.68 19.99 5.35 34.98 18.36 5.19 190.73 163.86 19.83 191.04 162.27 18.50 coo 32.59 18.19 11.79 33.96 17.55 14.10 187.30 161.92 16.41 189.15 160.05 15.37 ULMN 4 5rsa_c00 RIBONUCLEASE A user 2 4 # 2 12 HIS C 202 HIS.? 13.21 O3 GOL C1901 41 LYS C 41 LYS^? 15.03 O3 GOL C1901 119 HIS C 96 HIS^? 9.69 C1 GOL C1901 120 PHE C 178 PHE^? 10.90 O3 GOL C1901 coo 28.18 18.67 11.43 28.83 17.39 9.89 160.20 116.89 49.36 158.52 117.92 48.65 coo 25.33 8.32 6.30 27.86 13.90 7.82 149.18 124.89 48.07 150.57 125.16 54.16 coo 33.68 19.99 5.35 34.98 18.36 5.19 160.37 121.38 41.43 159.84 123.37 41.06 coo 32.59 18.19 11.79 33.96 17.55 14.10 159.27 115.44 43.88 157.53 113.30 44.32 5rsa_c00 source 5rsa RIBONUCLEASE A : 2 hits 5rsa_c00 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 100 ARG B 101 ARG.? -6.88 O4 CIT A1102s A 116 GLN A 78 GLN.? -2.82 O3 CIT A1102s coo 32.24 20.09 5.34 30.38 19.04 5.27 185.72 140.93 6.30 184.35 140.00 4.99 coo 26.40 25.34 6.28 26.15 22.33 7.25 179.40 137.94 3.82 182.23 139.06 3.56 coo 26.74 21.94 13.78 27.57 20.97 12.08 174.92 143.73 3.06 173.78 141.94 2.87 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 100 ARG A 101 ARG.? 15.15 C8 ADE A 500 A 116 GLN B 78 GLN.? 11.42 O5 CIT A1102 coo 32.24 20.09 5.34 30.38 19.04 5.27 173.93 140.35 20.11 173.24 142.10 19.12 coo 26.40 25.34 6.28 26.15 22.33 7.25 173.48 146.74 16.27 172.57 144.92 18.53 coo 26.74 21.94 13.78 27.57 20.97 12.08 169.82 145.33 10.20 170.62 147.30 10.35 12as_c00 source 12as ASPARAGINE SYNTHETASE : 2 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 100 ARG B 101 ARG.? -6.88 O4 CIT A1102s B 116 GLN A 78 GLN.? -2.82 O3 CIT A1102s coo 32.18 48.37 12.48 33.96 49.46 12.97 185.72 140.93 6.30 184.35 140.00 4.99 coo 39.04 43.25 11.37 38.30 45.35 13.56 179.40 137.94 3.82 182.23 139.06 3.56 coo 37.43 42.63 19.41 36.76 44.08 17.97 174.92 143.73 3.06 173.78 141.94 2.87 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP B 52 ASP^? 16.07 C8 ADE A 500 B 100 ARG A 101 ARG.? 15.15 C8 ADE A 500 B 116 GLN B 78 GLN.? 11.42 O5 CIT A1102 coo 32.18 48.37 12.48 33.96 49.46 12.97 173.93 140.35 20.11 173.24 142.10 19.12 coo 39.04 43.25 11.37 38.30 45.35 13.56 173.48 146.74 16.27 172.57 144.92 18.53 coo 37.43 42.63 19.41 36.76 44.08 17.97 169.82 145.33 10.20 170.62 147.30 10.35 12as_c01 source 12as ASPARAGINE SYNTHETASE : 2 hits 12as_c01 naa= 3 ULMN 3 1a05_c00 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 140 TYR C 117 TYR.? 21.72 O1 GOL C1901 B 190 LYS C 123 LYS^? 25.30 O1 GOL C1901 B 222 ASP B 36 ASP~? 28.48 O1 GOL C1901 coo 7.17 16.59 41.26 8.01 19.20 40.73 173.67 123.08 36.58 172.76 125.64 35.98 coo 13.38 20.00 35.06 11.43 22.49 39.53 174.37 128.14 41.95 175.88 130.01 36.96 coo 9.76 26.58 38.10 11.63 25.78 38.76 178.67 130.13 34.24 179.32 129.31 36.04 1a05_c00 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c00 naa= 3 ULMN 3 1a05_c01 3-ISOPROPYLMALATE DEHYDROGENASE user 1 3 # 1 A 190 LYS C 123 LYS^? 25.30 O1 GOL C1901 A 222 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 140 TYR C 117 TYR.? 21.72 O1 GOL C1901 coo -4.61 20.12 30.34 -2.74 22.65 25.95 174.37 128.14 41.95 175.88 130.01 36.96 coo -1.04 26.60 27.37 -2.94 25.93 26.69 178.67 130.13 34.24 179.32 129.31 36.04 coo 1.51 16.60 24.17 0.82 19.23 24.79 173.67 123.08 36.58 172.76 125.64 35.98 1a05_c01 source 1a05 3-ISOPROPYLMALATE DEHYDROGENASE : 1 hits 1a05_c01 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 187 HIS~? 25.73 N9 ADE A 500 A 102 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 193 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo 25.57 41.22 61.68 24.18 39.98 62.50 179.01 171.47 26.59 179.51 173.49 26.31 coo 22.33 45.48 59.73 23.35 43.67 60.06 184.84 171.88 24.93 186.38 173.28 25.14 coo 22.57 32.23 64.13 21.98 32.82 64.22 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 193 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo 25.57 41.22 61.68 24.18 39.98 62.50 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 22.33 45.48 59.73 23.35 43.67 60.06 174.65 109.33 0.17 174.41 107.27 0.58 coo 22.57 32.23 64.13 21.98 32.82 64.22 184.36 119.52 -4.81 184.70 120.30 -4.67 1a0j_c12 source 1a0j TRYPSIN : 2 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 187 HIS~? 25.73 N9 ADE A 500 B 102 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 193 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo 44.08 45.58 52.81 45.86 46.55 52.85 179.01 171.47 26.59 179.51 173.49 26.31 coo 43.04 44.75 47.18 43.31 45.51 49.13 184.84 171.88 24.93 186.38 173.28 25.14 coo 50.46 51.91 56.90 50.65 51.62 56.14 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 193 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo 44.08 45.58 52.81 45.86 46.55 52.85 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 43.04 44.75 47.18 43.31 45.51 49.13 174.65 109.33 0.17 174.41 107.27 0.58 coo 50.46 51.91 56.90 50.65 51.62 56.14 184.36 119.52 -4.81 184.70 120.30 -4.67 1a0j_c13 source 1a0j TRYPSIN : 2 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 187 HIS~? 25.73 N9 ADE A 500 C 102 ASP A 183 ASP~? 24.76 N9 ADE A 500 C 193 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo 34.37 41.18 73.21 34.04 43.09 73.87 179.01 171.47 26.59 179.51 173.49 26.31 coo 34.89 38.34 78.12 35.11 39.59 76.42 184.84 171.88 24.93 186.38 173.28 25.14 coo 35.43 51.03 72.12 35.20 50.72 72.87 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 C 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 C 193 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo 34.37 41.18 73.21 34.04 43.09 73.87 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 34.89 38.34 78.12 35.11 39.59 76.42 174.65 109.33 0.17 174.41 107.27 0.58 coo 35.43 51.03 72.12 35.20 50.72 72.87 184.36 119.52 -4.81 184.70 120.30 -4.67 1a0j_c14 source 1a0j TRYPSIN : 2 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 187 HIS~? 25.73 N9 ADE A 500 D 102 ASP A 183 ASP~? 24.76 N9 ADE A 500 D 193 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo 8.19 15.01 95.72 7.78 16.53 97.01 179.01 171.47 26.59 179.51 173.49 26.31 coo 13.53 16.28 93.98 11.45 16.21 94.40 184.84 171.88 24.93 186.38 173.28 25.14 coo 1.80 21.25 100.04 2.61 21.42 100.18 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 D 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 D 193 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo 8.19 15.01 95.72 7.78 16.53 97.01 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 13.53 16.28 93.98 11.45 16.21 94.40 174.65 109.33 0.17 174.41 107.27 0.58 coo 1.80 21.25 100.04 2.61 21.42 100.18 184.36 119.52 -4.81 184.70 120.30 -4.67 1a0j_c15 source 1a0j TRYPSIN : 2 hits 1a0j_c15 naa= 3 ULMN 3 1a41_c01 TOPOISOMERASE I user 1 3 # 1 223 ARG A 43 ARG.? 7.62 C2 ADE A 500 265 HIS A 96 HIS^? 6.77 N9 ADE A 500 274 TYR A 83 TYR^? 11.70 N6 ADE A 500 coo -15.18 55.46 8.55 -14.82 52.98 10.38 190.33 158.90 11.08 189.17 159.63 8.34 coo -14.48 45.59 11.18 -14.02 47.49 10.42 185.28 156.61 18.37 185.56 154.55 18.68 coo 0.94 52.26 9.16 1.95 54.78 9.91 192.51 141.71 13.59 192.79 138.96 13.21 ULMN 3 1a41_c01 TOPOISOMERASE I user 2 3 # 2 223 ARG A 43 ARG.? 7.62 C2 ADE A 500 265 HIS A 202 HIS.? 13.56 N3 ADE A 500 274 TYR A 113 TYR^? 11.47 C8 ADE A 500 coo -15.18 55.46 8.55 -14.82 52.98 10.38 190.33 158.90 11.08 189.17 159.63 8.34 coo -14.48 45.59 11.18 -14.02 47.49 10.42 190.73 163.86 19.83 191.04 162.27 18.50 coo 0.94 52.26 9.16 1.95 54.78 9.91 185.14 149.36 25.84 186.22 148.61 23.38 1a41_c01 source 1a41 TOPOISOMERASE I : 2 hits 1a41_c01 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 40 LYS A 180 LYS~? 18.96 N3 ADE A 500 B 114 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 185.28 156.61 18.37 185.56 154.55 18.68 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 185.07 167.50 20.34 181.31 169.96 15.85 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 40 LYS A 180 LYS~? 18.96 N3 ADE A 500 B 114 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 184.39 157.95 13.11 185.86 157.96 14.60 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 185.07 167.50 20.34 181.31 169.96 15.85 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 3 3 # 3 B 13 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 40 LYS B 180 LYS.? 22.96 O1 CIT A1102 B 114 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 176.50 123.51 9.48 177.50 124.87 10.72 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 173.15 113.94 5.34 166.89 113.91 6.31 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 4 3 # 4 B 13 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 40 LYS B 180 LYS.? 22.96 O1 CIT A1102 B 114 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 171.08 125.47 9.27 172.48 124.18 10.15 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 173.15 113.94 5.34 166.89 113.91 6.31 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 5 3 # 5 B 13 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 40 LYS C 180 LYS.? 20.00 O3 GOL C1901 B 114 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 160.37 121.38 41.43 159.84 123.37 41.06 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 163.89 112.64 46.86 163.54 106.47 45.76 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 6 3 # 6 B 13 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 40 LYS C 180 LYS.? 20.00 O3 GOL C1901 B 114 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 1.80 -13.66 41.28 2.01 -11.61 41.71 157.21 117.94 38.21 157.48 118.99 40.00 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 163.89 112.64 46.86 163.54 106.47 45.76 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 153.36 123.09 43.85 154.03 121.98 42.20 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 6 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 96 HIS^? 6.77 N9 ADE A 500 E 40 LYS A 180 LYS~? 18.96 N3 ADE A 500 E 114 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 185.28 156.61 18.37 185.56 154.55 18.68 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 185.07 167.50 20.34 181.31 169.96 15.85 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS A 176 HIS^? 6.39 N3 ADE A 500 E 40 LYS A 180 LYS~? 18.96 N3 ADE A 500 E 114 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 184.39 157.95 13.11 185.86 157.96 14.60 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 185.07 167.50 20.34 181.31 169.96 15.85 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 3 3 # 3 E 13 HIS B 96 HIS^? 15.42 O4 CIT A1102 E 40 LYS B 180 LYS.? 22.96 O1 CIT A1102 E 114 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 176.50 123.51 9.48 177.50 124.87 10.72 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 173.15 113.94 5.34 166.89 113.91 6.31 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 4 3 # 4 E 13 HIS B 176 HIS^? 13.79 O1 CIT A1102 E 40 LYS B 180 LYS.? 22.96 O1 CIT A1102 E 114 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 171.08 125.47 9.27 172.48 124.18 10.15 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 173.15 113.94 5.34 166.89 113.91 6.31 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 5 3 # 5 E 13 HIS C 96 HIS^? 9.69 C1 GOL C1901 E 40 LYS C 41 LYS^? 15.03 O3 GOL C1901 E 114 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 160.37 121.38 41.43 159.84 123.37 41.06 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 149.18 124.89 48.07 150.57 125.16 54.16 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 160.20 116.89 49.36 158.52 117.92 48.65 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 6 3 # 6 E 13 HIS C 96 HIS^? 9.69 C1 GOL C1901 E 40 LYS C 180 LYS.? 20.00 O3 GOL C1901 E 114 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 160.37 121.38 41.43 159.84 123.37 41.06 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 163.89 112.64 46.86 163.54 106.47 45.76 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 7 3 # 7 E 13 HIS C 176 HIS^? 7.29 C1 GOL C1901 E 40 LYS C 180 LYS.? 20.00 O3 GOL C1901 E 114 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 22.66 18.80 -11.81 23.81 19.26 -10.13 157.21 117.94 38.21 157.48 118.99 40.00 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 163.89 112.64 46.86 163.54 106.47 45.76 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 153.36 123.09 43.85 154.03 121.98 42.20 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 7 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 60 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 175 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo 46.10 28.27 19.27 45.48 26.99 20.84 185.43 146.45 17.17 186.00 148.48 17.29 coo 56.42 28.06 12.93 55.01 27.92 14.50 185.72 140.93 6.30 184.35 140.00 4.99 coo 45.02 22.04 15.38 46.16 24.00 13.76 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 60 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 175 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 46.10 28.27 19.27 45.48 26.99 20.84 180.17 131.30 14.36 179.09 129.62 13.64 coo 56.42 28.06 12.93 55.01 27.92 14.50 173.93 140.35 20.11 173.24 142.10 19.12 coo 45.02 22.04 15.38 46.16 24.00 13.76 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 60 ASP C 52 ASP^? 12.06 O1 GOL C1901 A 175 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 46.10 28.27 19.27 45.48 26.99 20.84 157.34 129.59 37.15 157.60 127.69 38.11 coo 56.42 28.06 12.93 55.01 27.92 14.50 147.21 130.59 30.19 147.01 130.37 28.08 coo 45.02 22.04 15.38 46.16 24.00 13.76 155.65 129.37 42.44 156.62 127.68 44.43 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 3 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 125 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 156 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 190.70 148.50 17.91 191.29 151.03 18.92 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 191.47 153.75 14.17 189.52 154.05 13.44 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 125 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 156 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 190.70 148.50 17.91 191.29 151.03 18.92 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 183.15 146.13 20.69 182.60 148.09 20.18 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 3 3 # 3 A 115 TYR B 47 TYR^? 27.62 O4 CIT A1102 A 125 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 156 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 177.82 122.79 24.63 178.10 120.27 25.77 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 174.27 123.90 17.18 173.55 124.80 15.43 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 4 3 # 4 A 115 TYR B 84 TYR^? 19.29 O4 CIT A1102 A 125 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 156 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 180.02 126.93 17.73 179.63 124.28 16.92 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 174.27 123.90 17.18 173.55 124.80 15.43 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 5 3 # 5 A 115 TYR B 84 TYR^? 19.29 O4 CIT A1102 A 125 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 156 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 180.02 126.93 17.73 179.63 124.28 16.92 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 183.49 131.36 11.56 181.98 130.36 10.51 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 6 3 # 6 A 115 TYR C 47 TYR^? 13.41 O3 GOL C1901 A 125 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 156 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 149.80 129.36 48.45 149.55 129.08 51.21 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 153.36 123.09 43.85 154.03 121.98 42.20 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 7 3 # 7 A 115 TYR C 84 TYR^? 9.85 O1 GOL C1901 A 125 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 156 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 155.65 129.37 42.44 156.62 127.68 44.43 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 153.36 123.09 43.85 154.03 121.98 42.20 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 8 3 # 8 A 115 TYR C 84 TYR^? 9.85 O1 GOL C1901 A 125 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 156 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 155.65 129.37 42.44 156.62 127.68 44.43 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 161.39 131.07 36.65 161.63 129.00 36.89 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 165.62 124.17 41.44 160.89 126.43 37.84 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 8 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 84 TYR^? 7.34 N9 ADE A 500 B 125 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 156 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 190.70 148.50 17.91 191.29 151.03 18.92 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 191.47 153.75 14.17 189.52 154.05 13.44 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR A 84 TYR^? 7.34 N9 ADE A 500 B 125 HIS A 104 HIS^? 8.41 C8 ADE A 500 B 156 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 190.70 148.50 17.91 191.29 151.03 18.92 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 183.15 146.13 20.69 182.60 148.09 20.18 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 3 3 # 3 B 115 TYR B 84 TYR^? 19.29 O4 CIT A1102 B 125 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 156 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 180.02 126.93 17.73 179.63 124.28 16.92 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 174.27 123.90 17.18 173.55 124.80 15.43 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 4 3 # 4 B 115 TYR B 84 TYR^? 19.29 O4 CIT A1102 B 125 HIS B 104 HIS^? 12.85 O4 CIT A1102 B 156 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 180.02 126.93 17.73 179.63 124.28 16.92 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 183.49 131.36 11.56 181.98 130.36 10.51 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 5 3 # 5 B 115 TYR C 84 TYR^? 9.85 O1 GOL C1901 B 125 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 156 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 155.65 129.37 42.44 156.62 127.68 44.43 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 153.36 123.09 43.85 154.03 121.98 42.20 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 6 3 # 6 B 115 TYR C 84 TYR^? 9.85 O1 GOL C1901 B 125 HIS C 104 HIS^? 12.14 O1 GOL C1901 B 156 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 155.65 129.37 42.44 156.62 127.68 44.43 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 161.39 131.07 36.65 161.63 129.00 36.89 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 165.62 124.17 41.44 160.89 126.43 37.84 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 6 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 84 TYR^? 7.34 N9 ADE A 500 C 125 HIS A 104 HIS^? 8.41 C8 ADE A 500 C 156 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 190.70 148.50 17.91 191.29 151.03 18.92 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 183.15 146.13 20.69 182.60 148.09 20.18 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR B 47 TYR^? 27.62 O4 CIT A1102 C 125 HIS B 42 HIS.? 18.79 O1 CIT A1102 C 156 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 177.82 122.79 24.63 178.10 120.27 25.77 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 174.27 123.90 17.18 173.55 124.80 15.43 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 3 3 # 3 C 115 TYR B 84 TYR^? 19.29 O4 CIT A1102 C 125 HIS B 42 HIS.? 18.79 O1 CIT A1102 C 156 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 180.02 126.93 17.73 179.63 124.28 16.92 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 174.27 123.90 17.18 173.55 124.80 15.43 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 4 3 # 4 C 115 TYR B 84 TYR^? 19.29 O4 CIT A1102 C 125 HIS B 104 HIS^? 12.85 O4 CIT A1102 C 156 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 180.02 126.93 17.73 179.63 124.28 16.92 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 183.49 131.36 11.56 181.98 130.36 10.51 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 5 3 # 5 C 115 TYR C 47 TYR^? 13.41 O3 GOL C1901 C 125 HIS C 42 HIS.? 5.32 O3 GOL C1901 C 156 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 149.80 129.36 48.45 149.55 129.08 51.21 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 153.36 123.09 43.85 154.03 121.98 42.20 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 6 3 # 6 C 115 TYR C 84 TYR^? 9.85 O1 GOL C1901 C 125 HIS C 42 HIS.? 5.32 O3 GOL C1901 C 156 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 155.65 129.37 42.44 156.62 127.68 44.43 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 153.36 123.09 43.85 154.03 121.98 42.20 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 7 3 # 7 C 115 TYR C 84 TYR^? 9.85 O1 GOL C1901 C 125 HIS C 104 HIS^? 12.14 O1 GOL C1901 C 156 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 155.65 129.37 42.44 156.62 127.68 44.43 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 161.39 131.07 36.65 161.63 129.00 36.89 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 165.62 124.17 41.44 160.89 126.43 37.84 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 7 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 84 TYR^? 7.34 N9 ADE A 500 D 125 HIS A 42 HIS.? -4.20 N3 ADE A 500s D 156 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 54.10 1.42 85.16 54.14 4.17 85.62 190.70 148.50 17.91 191.29 151.03 18.92 coo 61.27 5.43 85.32 62.73 6.38 86.49 191.47 153.75 14.17 189.52 154.05 13.44 coo 60.28 4.62 76.00 58.35 6.41 80.65 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR A 84 TYR^? 7.34 N9 ADE A 500 D 125 HIS A 104 HIS^? 8.41 C8 ADE A 500 D 156 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 54.10 1.42 85.16 54.14 4.17 85.62 190.70 148.50 17.91 191.29 151.03 18.92 coo 61.27 5.43 85.32 62.73 6.38 86.49 183.15 146.13 20.69 182.60 148.09 20.18 coo 60.28 4.62 76.00 58.35 6.41 80.65 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR B 84 TYR^? 19.29 O4 CIT A1102 D 125 HIS B 42 HIS.? 18.79 O1 CIT A1102 D 156 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 54.10 1.42 85.16 54.14 4.17 85.62 180.02 126.93 17.73 179.63 124.28 16.92 coo 61.27 5.43 85.32 62.73 6.38 86.49 174.27 123.90 17.18 173.55 124.80 15.43 coo 60.28 4.62 76.00 58.35 6.41 80.65 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR B 84 TYR^? 19.29 O4 CIT A1102 D 125 HIS B 104 HIS^? 12.85 O4 CIT A1102 D 156 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 54.10 1.42 85.16 54.14 4.17 85.62 180.02 126.93 17.73 179.63 124.28 16.92 coo 61.27 5.43 85.32 62.73 6.38 86.49 183.49 131.36 11.56 181.98 130.36 10.51 coo 60.28 4.62 76.00 58.35 6.41 80.65 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 5 3 # 5 D 115 TYR C 84 TYR^? 9.85 O1 GOL C1901 D 125 HIS C 42 HIS.? 5.32 O3 GOL C1901 D 156 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 54.10 1.42 85.16 54.14 4.17 85.62 155.65 129.37 42.44 156.62 127.68 44.43 coo 61.27 5.43 85.32 62.73 6.38 86.49 153.36 123.09 43.85 154.03 121.98 42.20 coo 60.28 4.62 76.00 58.35 6.41 80.65 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 6 3 # 6 D 115 TYR C 84 TYR^? 9.85 O1 GOL C1901 D 125 HIS C 104 HIS^? 12.14 O1 GOL C1901 D 156 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 54.10 1.42 85.16 54.14 4.17 85.62 155.65 129.37 42.44 156.62 127.68 44.43 coo 61.27 5.43 85.32 62.73 6.38 86.49 161.39 131.07 36.65 161.63 129.00 36.89 coo 60.28 4.62 76.00 58.35 6.41 80.65 165.62 124.17 41.44 160.89 126.43 37.84 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 6 hits 1a79_c03 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG B 43 ARG.? 18.57 O1 CIT A1102 78 HIS B 42 HIS.? 18.79 O1 CIT A1102 122 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 48.32 72.26 30.89 48.69 69.28 31.53 169.37 120.65 13.94 167.07 120.51 11.92 coo 53.63 68.24 34.99 53.08 69.10 33.16 174.27 123.90 17.18 173.55 124.80 15.43 coo 75.01 61.87 32.93 75.34 59.26 31.96 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG B 43 ARG.? 18.57 O1 CIT A1102 78 HIS B 176 HIS^? 13.79 O1 CIT A1102 122 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 48.32 72.26 30.89 48.69 69.28 31.53 169.37 120.65 13.94 167.07 120.51 11.92 coo 53.63 68.24 34.99 53.08 69.10 33.16 171.08 125.47 9.27 172.48 124.18 10.15 coo 75.01 61.87 32.93 75.34 59.26 31.96 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG C 43 ARG.? 5.25 O3 GOL C1901 78 HIS C 176 HIS^? 7.29 C1 GOL C1901 122 TYR C 56 TYR.? 18.89 O2 GOL C1901 coo 48.32 72.26 30.89 48.69 69.28 31.53 154.24 116.29 44.96 152.24 116.07 42.61 coo 53.63 68.24 34.99 53.08 69.10 33.16 157.21 117.94 38.21 157.48 118.99 40.00 coo 75.01 61.87 32.93 75.34 59.26 31.96 147.08 126.92 19.41 145.08 128.68 18.52 1ab4_c00 source 1ab4 GYRASE A : 3 hits 1ab4_c00 naa= 3 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 1 3 # 1 22 ASN A 98 ASN^? 5.64 N9 ADE A 500 63 ARG A 101 ARG.? 15.15 C8 ADE A 500 255 ARG A 76 ARG^? 12.51 N1 ADE A 500 coo 42.10 13.02 11.14 41.85 11.12 10.23 179.72 154.52 15.51 181.63 154.42 14.60 coo 44.36 11.24 3.39 41.81 12.78 4.00 173.48 146.74 16.27 172.57 144.92 18.53 coo 38.40 3.83 10.26 40.02 6.30 9.25 176.90 153.44 4.90 177.24 156.32 3.96 ULMN 3 1aj0_c00 DIHYDROPTEROATE SYNTHASE user 2 3 # 2 22 ASN A 100 ASN.? 10.86 N7 ADE A 500 63 ARG A 101 ARG.? 15.15 C8 ADE A 500 255 ARG A 76 ARG^? 12.51 N1 ADE A 500 coo 42.10 13.02 11.14 41.85 11.12 10.23 175.81 151.36 12.66 175.13 152.21 10.81 coo 44.36 11.24 3.39 41.81 12.78 4.00 173.48 146.74 16.27 172.57 144.92 18.53 coo 38.40 3.83 10.26 40.02 6.30 9.25 176.90 153.44 4.90 177.24 156.32 3.96 1aj0_c00 source 1aj0 DIHYDROPTEROATE SYNTHASE : 2 hits 1aj0_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP B 158 ASP.? 34.51 N7 ADE A 500 214 ASP C 175 ASP.? 10.66 O1 GOL C1901 289 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo -0.62 65.95 29.97 0.31 67.47 31.05 190.60 123.10 30.08 190.26 121.25 31.09 coo 26.86 59.76 46.36 25.42 58.23 45.92 157.90 117.18 31.56 156.68 116.62 29.91 coo 9.42 68.07 30.27 7.35 68.27 30.10 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP C 119 ASP.? 26.31 O1 GOL C1901 214 ASP B 130 ASP~? 26.83 N6 ADE A 500 289 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo -0.62 65.95 29.97 0.31 67.47 31.05 178.03 118.40 36.14 177.70 120.46 36.31 coo 26.86 59.76 46.36 25.42 58.23 45.92 200.55 129.62 17.17 202.64 129.41 16.98 coo 9.42 68.07 30.27 7.35 68.27 30.10 181.93 115.70 26.33 180.57 117.33 26.20 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP B 89 ASP.? 31.34 O4 CIT A1102 204 GLU B 25 GLU.? 28.27 O1 GOL C1901 289 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo -0.62 65.95 29.97 0.31 67.47 31.05 181.93 115.70 26.33 180.57 117.33 26.20 coo 4.34 62.44 32.05 4.22 64.48 32.53 179.49 113.39 31.74 177.60 113.83 30.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP C 119 ASP.? 26.31 O1 GOL C1901 204 GLU B 25 GLU.? 28.27 O1 GOL C1901 289 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo -0.62 65.95 29.97 0.31 67.47 31.05 178.03 118.40 36.14 177.70 120.46 36.31 coo 4.34 62.44 32.05 4.22 64.48 32.53 179.49 113.39 31.74 177.60 113.83 30.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 181.93 115.70 26.33 180.57 117.33 26.20 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP B 130 ASP~? 26.83 N6 ADE A 500 227 GLU A 156 GLU.? 23.41 C8 ADE A 500 289 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo -0.62 65.95 29.97 0.31 67.47 31.05 200.55 129.62 17.17 202.64 129.41 16.98 coo 3.96 55.76 41.24 4.83 57.69 41.17 196.65 137.08 28.97 194.78 136.94 30.01 coo 9.42 68.07 30.27 7.35 68.27 30.10 203.35 139.46 11.01 205.31 139.04 11.69 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c06 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 42 HIS.? -4.20 N3 ADE A 500s 254 LYS A 49 LYS^? 10.58 N6 ADE A 500 333 ARG A 53 ARG^? 5.21 N6 ADE A 500 coo 28.11 -1.15 8.51 29.21 0.63 8.34 191.47 153.75 14.17 189.52 154.05 13.44 coo 26.09 4.87 14.60 27.89 3.33 10.26 193.06 146.52 10.07 195.03 144.09 6.09 coo 37.35 7.47 11.84 34.90 6.11 10.60 184.38 147.77 2.51 183.90 149.96 4.60 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS B 42 HIS.? 18.79 O1 CIT A1102 254 LYS B 49 LYS^? 24.07 O1 GOL C1901 333 ARG C 101 ARG.? 18.11 O1 GOL C1901 coo 28.11 -1.15 8.51 29.21 0.63 8.34 174.27 123.90 17.18 173.55 124.80 15.43 coo 26.09 4.87 14.60 27.89 3.33 10.26 174.03 130.60 22.66 171.30 132.48 26.53 coo 37.35 7.47 11.84 34.90 6.11 10.60 163.77 126.78 27.00 165.49 129.29 26.85 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 3 3 # 3 232 HIS B 202 HIS.? 28.80 C2 CIT A1102 254 LYS B 94 LYS^? 27.17 C2 CIT A1102 333 ARG B 43 ARG.? 18.57 O1 CIT A1102 coo 28.11 -1.15 8.51 29.21 0.63 8.34 175.03 109.49 9.82 173.45 108.46 10.74 coo 26.09 4.87 14.60 27.89 3.33 10.26 179.28 118.69 11.71 177.59 112.91 13.79 coo 37.35 7.47 11.84 34.90 6.11 10.60 169.37 120.65 13.94 167.07 120.51 11.92 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 3 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 124 SER^? 19.87 C8 ADE A 500 A 292 ASP C 130 ASP.? 30.92 O1 GOL C1901 A 322 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 36.34 32.23 39.60 36.43 34.62 39.93 182.61 151.80 32.41 184.93 152.05 33.02 coo 19.73 19.18 41.39 21.50 18.65 40.34 167.73 145.95 43.64 168.62 147.66 44.50 coo 41.69 45.14 46.60 41.78 47.19 46.18 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 164 SER^? 10.66 N7 ADE A 500 A 292 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 322 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 36.34 32.23 39.60 36.43 34.62 39.93 187.50 142.03 16.61 188.23 139.96 15.55 coo 19.73 19.18 41.39 21.50 18.65 40.34 178.67 130.13 34.24 179.32 129.31 36.04 coo 41.69 45.14 46.60 41.78 47.19 46.18 184.39 157.95 13.11 185.86 157.96 14.60 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 149 SER^? 19.92 O4 CIT A1102 A 292 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 322 HIS B 202 HIS.? 28.80 C2 CIT A1102 coo 36.34 32.23 39.60 36.43 34.62 39.93 184.89 121.99 12.52 183.61 123.38 14.10 coo 19.73 19.18 41.39 21.50 18.65 40.34 185.72 140.93 6.30 184.35 140.00 4.99 coo 41.69 45.14 46.60 41.78 47.19 46.18 175.03 109.49 9.82 173.45 108.46 10.74 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER B 149 SER^? 19.92 O4 CIT A1102 A 292 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 322 HIS B 202 HIS.? 28.80 C2 CIT A1102 coo 36.34 32.23 39.60 36.43 34.62 39.93 184.89 121.99 12.52 183.61 123.38 14.10 coo 19.73 19.18 41.39 21.50 18.65 40.34 173.93 140.35 20.11 173.24 142.10 19.12 coo 41.69 45.14 46.60 41.78 47.19 46.18 175.03 109.49 9.82 173.45 108.46 10.74 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER B 164 SER^? 16.78 N7 ADE A 500 A 292 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 322 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo 36.34 32.23 39.60 36.43 34.62 39.93 181.99 133.83 18.01 182.11 135.27 19.93 coo 19.73 19.18 41.39 21.50 18.65 40.34 203.35 139.46 11.01 205.31 139.04 11.69 coo 41.69 45.14 46.60 41.78 47.19 46.18 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER C 124 SER^? 23.11 O1 GOL C1901 A 292 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 322 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 36.34 32.23 39.60 36.43 34.62 39.93 172.32 130.73 43.72 171.22 130.88 45.88 coo 19.73 19.18 41.39 21.50 18.65 40.34 188.71 136.74 34.61 188.50 136.01 36.57 coo 41.69 45.14 46.60 41.78 47.19 46.18 160.37 121.38 41.43 159.84 123.37 41.06 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 6 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 164 SER^? 10.66 N7 ADE A 500 B 292 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 322 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 35.42 71.28 22.94 36.24 69.06 22.37 187.50 142.03 16.61 188.23 139.96 15.55 coo 24.74 78.07 5.59 24.32 79.03 7.46 178.67 130.13 34.24 179.32 129.31 36.04 coo 48.81 64.16 26.34 49.30 62.16 26.73 184.39 157.95 13.11 185.86 157.96 14.60 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 164 SER^? 10.66 N7 ADE A 500 B 292 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 322 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 35.42 71.28 22.94 36.24 69.06 22.37 187.50 142.03 16.61 188.23 139.96 15.55 coo 24.74 78.07 5.59 24.32 79.03 7.46 190.60 123.10 30.08 190.26 121.25 31.09 coo 48.81 64.16 26.34 49.30 62.16 26.73 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 90 SER.? 26.90 O4 CIT A1102 B 292 ASP B 130 ASP~? 26.83 N6 ADE A 500 B 322 HIS B 202 HIS.? 28.80 C2 CIT A1102 coo 35.42 71.28 22.94 36.24 69.06 22.37 181.23 117.12 21.89 179.24 118.41 21.27 coo 24.74 78.07 5.59 24.32 79.03 7.46 200.55 129.62 17.17 202.64 129.41 16.98 coo 48.81 64.16 26.34 49.30 62.16 26.73 175.03 109.49 9.82 173.45 108.46 10.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER B 149 SER^? 19.92 O4 CIT A1102 B 292 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 322 HIS B 202 HIS.? 28.80 C2 CIT A1102 coo 35.42 71.28 22.94 36.24 69.06 22.37 184.89 121.99 12.52 183.61 123.38 14.10 coo 24.74 78.07 5.59 24.32 79.03 7.46 185.72 140.93 6.30 184.35 140.00 4.99 coo 48.81 64.16 26.34 49.30 62.16 26.73 175.03 109.49 9.82 173.45 108.46 10.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER B 164 SER^? 16.78 N7 ADE A 500 B 292 ASP A 36 ASP~? 21.71 N6 ADE A 500 B 322 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo 35.42 71.28 22.94 36.24 69.06 22.37 181.99 133.83 18.01 182.11 135.27 19.93 coo 24.74 78.07 5.59 24.32 79.03 7.46 203.35 139.46 11.01 205.31 139.04 11.69 coo 48.81 64.16 26.34 49.30 62.16 26.73 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER C 79 SER.? 11.88 O1 GOL C1901 B 292 ASP B 172 ASP~? 8.81 O1 CIT A1102 B 322 HIS C 176 HIS^? 7.29 C1 GOL C1901 coo 35.42 71.28 22.94 36.24 69.06 22.37 152.54 126.39 26.52 151.63 128.65 26.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 166.30 133.15 8.87 164.29 132.56 8.69 coo 48.81 64.16 26.34 49.30 62.16 26.73 157.21 117.94 38.21 157.48 118.99 40.00 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER C 124 SER^? 23.11 O1 GOL C1901 B 292 ASP A 130 ASP~? 27.60 C8 ADE A 500 B 322 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 35.42 71.28 22.94 36.24 69.06 22.37 172.32 130.73 43.72 171.22 130.88 45.88 coo 24.74 78.07 5.59 24.32 79.03 7.46 188.71 136.74 34.61 188.50 136.01 36.57 coo 48.81 64.16 26.34 49.30 62.16 26.73 160.37 121.38 41.43 159.84 123.37 41.06 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 7 hits 1aql_c03 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE C 125 PHE^? 20.22 O1 GOL C1901 A 223 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 265 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 39.74 52.86 65.74 41.15 55.14 66.52 169.98 133.58 40.46 167.86 132.27 39.18 coo 30.70 47.50 67.53 29.83 49.47 67.39 178.67 130.13 34.24 179.32 129.31 36.04 coo 19.99 54.53 64.11 20.55 58.78 68.33 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE C 125 PHE^? 20.22 O1 GOL C1901 A 223 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 265 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 39.74 52.86 65.74 41.15 55.14 66.52 169.98 133.58 40.46 167.86 132.27 39.18 coo 30.70 47.50 67.53 29.83 49.47 67.39 178.67 130.13 34.24 179.32 129.31 36.04 coo 19.99 54.53 64.11 20.55 58.78 68.33 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE C 146 PHE^? 16.71 C1 GOL C1901 A 223 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 265 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 39.74 52.86 65.74 41.15 55.14 66.52 167.22 118.61 41.10 166.40 115.95 40.88 coo 30.70 47.50 67.53 29.83 49.47 67.39 178.03 118.40 36.14 177.70 120.46 36.31 coo 19.99 54.53 64.11 20.55 58.78 68.33 174.17 121.55 22.91 175.90 116.24 24.75 1ax4_c04 source 1ax4 TRYPTOPHANASE : 3 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE C 125 PHE^? 20.22 O1 GOL C1901 B 223 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 265 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 7.48 54.94 99.62 7.67 52.27 100.42 169.98 133.58 40.46 167.86 132.27 39.18 coo 10.43 61.66 91.81 9.80 60.04 90.61 178.67 130.13 34.24 179.32 129.31 36.04 coo 5.43 58.06 80.08 8.57 53.00 79.37 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE C 125 PHE^? 20.22 O1 GOL C1901 B 223 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 265 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 7.48 54.94 99.62 7.67 52.27 100.42 169.98 133.58 40.46 167.86 132.27 39.18 coo 10.43 61.66 91.81 9.80 60.04 90.61 178.67 130.13 34.24 179.32 129.31 36.04 coo 5.43 58.06 80.08 8.57 53.00 79.37 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE C 146 PHE^? 16.71 C1 GOL C1901 B 223 ASP C 119 ASP.? 26.31 O1 GOL C1901 B 265 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 7.48 54.94 99.62 7.67 52.27 100.42 167.22 118.61 41.10 166.40 115.95 40.88 coo 10.43 61.66 91.81 9.80 60.04 90.61 178.03 118.40 36.14 177.70 120.46 36.31 coo 5.43 58.06 80.08 8.57 53.00 79.37 174.17 121.55 22.91 175.90 116.24 24.75 1ax4_c05 source 1ax4 TRYPTOPHANASE : 3 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE C 125 PHE^? 20.22 O1 GOL C1901 C 223 ASP B 36 ASP~? 28.48 O1 GOL C1901 C 265 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -6.55 73.45 23.60 -6.77 71.48 21.66 169.98 133.58 40.46 167.86 132.27 39.18 coo -9.52 75.74 33.62 -8.85 73.74 33.93 178.67 130.13 34.24 179.32 129.31 36.04 coo -4.44 67.20 42.32 -7.50 62.41 40.49 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE C 125 PHE^? 20.22 O1 GOL C1901 C 223 ASP B 36 ASP~? 28.48 O1 GOL C1901 C 265 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -6.55 73.45 23.60 -6.77 71.48 21.66 169.98 133.58 40.46 167.86 132.27 39.18 coo -9.52 75.74 33.62 -8.85 73.74 33.93 178.67 130.13 34.24 179.32 129.31 36.04 coo -4.44 67.20 42.32 -7.50 62.41 40.49 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE C 146 PHE^? 16.71 C1 GOL C1901 C 223 ASP C 119 ASP.? 26.31 O1 GOL C1901 C 265 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -6.55 73.45 23.60 -6.77 71.48 21.66 167.22 118.61 41.10 166.40 115.95 40.88 coo -9.52 75.74 33.62 -8.85 73.74 33.93 178.03 118.40 36.14 177.70 120.46 36.31 coo -4.44 67.20 42.32 -7.50 62.41 40.49 174.17 121.55 22.91 175.90 116.24 24.75 1ax4_c06 source 1ax4 TRYPTOPHANASE : 3 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE C 125 PHE^? 20.22 O1 GOL C1901 D 223 ASP B 36 ASP~? 28.48 O1 GOL C1901 D 265 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -38.60 55.38 52.70 -40.06 57.72 53.04 169.98 133.58 40.46 167.86 132.27 39.18 coo -29.46 51.67 48.51 -28.63 53.31 49.56 178.67 130.13 34.24 179.32 129.31 36.04 coo -18.87 56.53 54.79 -19.47 62.22 53.03 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE C 125 PHE^? 20.22 O1 GOL C1901 D 223 ASP B 36 ASP~? 28.48 O1 GOL C1901 D 265 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -38.60 55.38 52.70 -40.06 57.72 53.04 169.98 133.58 40.46 167.86 132.27 39.18 coo -29.46 51.67 48.51 -28.63 53.31 49.56 178.67 130.13 34.24 179.32 129.31 36.04 coo -18.87 56.53 54.79 -19.47 62.22 53.03 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE C 146 PHE^? 16.71 C1 GOL C1901 D 223 ASP C 119 ASP.? 26.31 O1 GOL C1901 D 265 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -38.60 55.38 52.70 -40.06 57.72 53.04 167.22 118.61 41.10 166.40 115.95 40.88 coo -29.46 51.67 48.51 -28.63 53.31 49.56 178.03 118.40 36.14 177.70 120.46 36.31 coo -18.87 56.53 54.79 -19.47 62.22 53.03 174.17 121.55 22.91 175.90 116.24 24.75 1ax4_c07 source 1ax4 TRYPTOPHANASE : 3 hits 1ax4_c07 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 171 ARG A 43 ARG.? 7.62 C2 ADE A 500 A 190 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 22.59 2.26 43.22 21.17 3.47 42.27 183.15 146.13 20.69 182.60 148.09 20.18 coo 13.63 3.81 28.83 14.49 2.91 31.59 190.33 158.90 11.08 189.17 159.63 8.34 coo 24.97 7.47 37.69 21.24 10.69 35.89 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 171 ARG A 101 ARG.? 15.15 C8 ADE A 500 A 190 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 22.59 2.26 43.22 21.17 3.47 42.27 184.39 157.95 13.11 185.86 157.96 14.60 coo 13.63 3.81 28.83 14.49 2.91 31.59 173.48 146.74 16.27 172.57 144.92 18.53 coo 24.97 7.47 37.69 21.24 10.69 35.89 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 3 3 # 3 A 85 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 171 ARG B 108 ARG^? 25.54 C8 ADE A 500 A 190 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 22.59 2.26 43.22 21.17 3.47 42.27 174.27 123.90 17.18 173.55 124.80 15.43 coo 13.63 3.81 28.83 14.49 2.91 31.59 188.64 131.77 26.61 189.85 131.11 29.36 coo 24.97 7.47 37.69 21.24 10.69 35.89 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 4 3 # 4 A 85 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 171 ARG B 43 ARG.? 18.57 O1 CIT A1102 A 190 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 22.59 2.26 43.22 21.17 3.47 42.27 183.49 131.36 11.56 181.98 130.36 10.51 coo 13.63 3.81 28.83 14.49 2.91 31.59 169.37 120.65 13.94 167.07 120.51 11.92 coo 24.97 7.47 37.69 21.24 10.69 35.89 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 5 3 # 5 A 85 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 171 ARG B 101 ARG.? -6.88 O4 CIT A1102s A 190 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 22.59 2.26 43.22 21.17 3.47 42.27 171.08 125.47 9.27 172.48 124.18 10.15 coo 13.63 3.81 28.83 14.49 2.91 31.59 179.40 137.94 3.82 182.23 139.06 3.56 coo 24.97 7.47 37.69 21.24 10.69 35.89 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 6 3 # 6 A 85 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 171 ARG C 43 ARG.? 5.25 O3 GOL C1901 A 190 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 22.59 2.26 43.22 21.17 3.47 42.27 161.39 131.07 36.65 161.63 129.00 36.89 coo 13.63 3.81 28.83 14.49 2.91 31.59 154.24 116.29 44.96 152.24 116.07 42.61 coo 24.97 7.47 37.69 21.24 10.69 35.89 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 7 3 # 7 A 85 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 171 ARG C 101 ARG.? 18.11 O1 GOL C1901 A 190 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 22.59 2.26 43.22 21.17 3.47 42.27 157.21 117.94 38.21 157.48 118.99 40.00 coo 13.63 3.81 28.83 14.49 2.91 31.59 163.77 126.78 27.00 165.49 129.29 26.85 coo 24.97 7.47 37.69 21.24 10.69 35.89 163.30 119.33 38.22 166.56 114.68 36.90 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 7 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 104 HIS^? 8.41 C8 ADE A 500 B 171 ARG A 43 ARG.? 7.62 C2 ADE A 500 B 190 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 183.15 146.13 20.69 182.60 148.09 20.18 coo 2.83 4.83 10.84 1.96 4.32 7.97 190.33 158.90 11.08 189.17 159.63 8.34 coo -8.96 9.04 2.88 -5.39 12.11 5.08 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 171 ARG A 101 ARG.? 15.15 C8 ADE A 500 B 190 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 184.39 157.95 13.11 185.86 157.96 14.60 coo 2.83 4.83 10.84 1.96 4.32 7.97 173.48 146.74 16.27 172.57 144.92 18.53 coo -8.96 9.04 2.88 -5.39 12.11 5.08 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 3 3 # 3 B 85 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 171 ARG B 108 ARG^? 25.54 C8 ADE A 500 B 190 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 174.27 123.90 17.18 173.55 124.80 15.43 coo 2.83 4.83 10.84 1.96 4.32 7.97 188.64 131.77 26.61 189.85 131.11 29.36 coo -8.96 9.04 2.88 -5.39 12.11 5.08 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 4 3 # 4 B 85 HIS B 104 HIS^? 12.85 O4 CIT A1102 B 171 ARG B 43 ARG.? 18.57 O1 CIT A1102 B 190 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 183.49 131.36 11.56 181.98 130.36 10.51 coo 2.83 4.83 10.84 1.96 4.32 7.97 169.37 120.65 13.94 167.07 120.51 11.92 coo -8.96 9.04 2.88 -5.39 12.11 5.08 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 5 3 # 5 B 85 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 171 ARG B 101 ARG.? -6.88 O4 CIT A1102s B 190 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 171.08 125.47 9.27 172.48 124.18 10.15 coo 2.83 4.83 10.84 1.96 4.32 7.97 179.40 137.94 3.82 182.23 139.06 3.56 coo -8.96 9.04 2.88 -5.39 12.11 5.08 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 6 3 # 6 B 85 HIS C 104 HIS^? 12.14 O1 GOL C1901 B 171 ARG C 43 ARG.? 5.25 O3 GOL C1901 B 190 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 161.39 131.07 36.65 161.63 129.00 36.89 coo 2.83 4.83 10.84 1.96 4.32 7.97 154.24 116.29 44.96 152.24 116.07 42.61 coo -8.96 9.04 2.88 -5.39 12.11 5.08 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 7 3 # 7 B 85 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 171 ARG C 101 ARG.? 18.11 O1 GOL C1901 B 190 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 157.21 117.94 38.21 157.48 118.99 40.00 coo 2.83 4.83 10.84 1.96 4.32 7.97 163.77 126.78 27.00 165.49 129.29 26.85 coo -8.96 9.04 2.88 -5.39 12.11 5.08 163.30 119.33 38.22 166.56 114.68 36.90 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 7 hits 1azy_c01 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 58 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 92 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 12.70 27.74 1.76 10.77 27.11 1.24 191.47 153.75 14.17 189.52 154.05 13.44 coo 11.38 23.30 3.20 9.27 23.34 3.13 188.90 156.57 17.91 187.92 156.12 16.11 coo 2.67 19.36 1.56 3.51 21.24 1.94 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 A 40 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 58 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 92 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 12.70 27.74 1.76 10.77 27.11 1.24 183.15 146.13 20.69 182.60 148.09 20.18 coo 11.38 23.30 3.20 9.27 23.34 3.13 185.43 146.45 17.17 186.00 148.48 17.29 coo 2.67 19.36 1.56 3.51 21.24 1.94 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 3 3 # 3 A 40 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 58 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 92 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 12.70 27.74 1.76 10.77 27.11 1.24 183.49 131.36 11.56 181.98 130.36 10.51 coo 11.38 23.30 3.20 9.27 23.34 3.13 180.17 131.30 14.36 179.09 129.62 13.64 coo 2.67 19.36 1.56 3.51 21.24 1.94 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 4 3 # 4 A 40 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 58 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 92 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 12.70 27.74 1.76 10.77 27.11 1.24 161.39 131.07 36.65 161.63 129.00 36.89 coo 11.38 23.30 3.20 9.27 23.34 3.13 157.34 129.59 37.15 157.60 127.69 38.11 coo 2.67 19.36 1.56 3.51 21.24 1.94 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 5 3 # 5 A 40 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 58 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 92 HIS C 176 HIS^? 7.29 C1 GOL C1901 coo 12.70 27.74 1.76 10.77 27.11 1.24 161.39 131.07 36.65 161.63 129.00 36.89 coo 11.38 23.30 3.20 9.27 23.34 3.13 157.34 129.59 37.15 157.60 127.69 38.11 coo 2.67 19.36 1.56 3.51 21.24 1.94 157.21 117.94 38.21 157.48 118.99 40.00 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 5 hits 1b2m_c00 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 58 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 92 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 10.74 36.24 16.20 9.81 34.52 16.97 191.47 153.75 14.17 189.52 154.05 13.44 coo 5.02 36.40 17.74 5.55 34.41 17.37 188.90 156.57 17.91 187.92 156.12 16.11 coo 0.68 29.04 20.43 2.46 29.56 19.46 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 B 40 HIS A 104 HIS^? 8.41 C8 ADE A 500 B 58 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 92 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 10.74 36.24 16.20 9.81 34.52 16.97 183.15 146.13 20.69 182.60 148.09 20.18 coo 5.02 36.40 17.74 5.55 34.41 17.37 185.43 146.45 17.17 186.00 148.48 17.29 coo 0.68 29.04 20.43 2.46 29.56 19.46 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 3 3 # 3 B 40 HIS B 104 HIS^? 12.85 O4 CIT A1102 B 58 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 92 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 10.74 36.24 16.20 9.81 34.52 16.97 183.49 131.36 11.56 181.98 130.36 10.51 coo 5.02 36.40 17.74 5.55 34.41 17.37 180.17 131.30 14.36 179.09 129.62 13.64 coo 0.68 29.04 20.43 2.46 29.56 19.46 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 4 3 # 4 B 40 HIS C 104 HIS^? 12.14 O1 GOL C1901 B 58 GLU C 165 GLU^? 7.74 O1 GOL C1901 B 92 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 10.74 36.24 16.20 9.81 34.52 16.97 161.39 131.07 36.65 161.63 129.00 36.89 coo 5.02 36.40 17.74 5.55 34.41 17.37 157.34 129.59 37.15 157.60 127.69 38.11 coo 0.68 29.04 20.43 2.46 29.56 19.46 153.36 123.09 43.85 154.03 121.98 42.20 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 4 hits 1b2m_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 182 GLU B 156 GLU.? 24.53 N7 ADE A 500 A 286 ASN B 159 ASN.? 34.53 O4 CIT A1102 coo 26.03 44.66 108.90 25.67 42.61 108.82 190.60 123.10 30.08 190.26 121.25 31.09 coo 18.06 44.02 105.38 18.08 45.37 107.03 194.44 129.17 25.88 194.48 130.18 24.03 coo 25.47 38.28 112.06 27.26 39.30 111.54 190.73 119.78 25.86 192.60 118.87 26.28 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 182 GLU B 25 GLU.? 28.27 O1 GOL C1901 A 286 ASN B 35 ASN~? 25.18 O1 GOL C1901 coo 26.03 44.66 108.90 25.67 42.61 108.82 178.03 118.40 36.14 177.70 120.46 36.31 coo 18.06 44.02 105.38 18.08 45.37 107.03 179.49 113.39 31.74 177.60 113.83 30.87 coo 25.47 38.28 112.06 27.26 39.30 111.54 176.57 125.33 34.40 176.61 123.22 34.34 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 2 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 182 GLU B 156 GLU.? 24.53 N7 ADE A 500 B 286 ASN B 159 ASN.? 34.53 O4 CIT A1102 coo 13.82 69.26 132.27 11.87 70.14 132.51 190.60 123.10 30.08 190.26 121.25 31.09 coo 8.74 63.05 136.42 9.87 62.19 134.79 194.44 129.17 25.88 194.48 130.18 24.03 coo 8.26 72.60 129.22 10.14 73.45 129.80 190.73 119.78 25.86 192.60 118.87 26.28 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 1 hits 1b57_c01 naa= 3 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU B 14 GLU.? 33.67 O4 CIT A1102 B 88 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 89 HIS A 187 HIS~? 25.73 N9 ADE A 500 coo 44.53 38.98 5.35 43.53 40.60 6.22 196.57 114.78 10.83 198.67 114.78 11.14 coo 58.74 13.49 55.78 58.72 14.38 57.67 184.84 171.88 24.93 186.38 173.28 25.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 179.01 171.47 26.59 179.51 173.49 26.31 ULMN 3 1b66_c00 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU C 14 GLU.? 32.06 O1 GOL C1901 B 88 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 89 HIS B 187 HIS~? 26.45 C2 CIT A1102 coo 44.53 38.98 5.35 43.53 40.60 6.22 173.34 134.38 54.29 174.51 136.04 54.85 coo 58.74 13.49 55.78 58.72 14.38 57.67 174.65 109.33 0.17 174.41 107.27 0.58 coo 60.89 12.20 60.42 60.43 13.81 61.68 176.75 112.07 -5.75 176.32 110.31 -6.80 1b66_c00 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 2 hits 1b66_c00 naa= 3 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 1 3 # 1 A 133 GLU B 14 GLU.? 33.67 O4 CIT A1102 B 88 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 89 HIS A 187 HIS~? 25.73 N9 ADE A 500 coo 44.53 38.98 5.35 43.53 40.60 6.22 196.57 114.78 10.83 198.67 114.78 11.14 coo 58.74 13.49 55.78 58.72 14.38 57.67 184.84 171.88 24.93 186.38 173.28 25.14 coo 60.89 12.20 60.42 60.43 13.81 61.68 179.01 171.47 26.59 179.51 173.49 26.31 ULMN 3 1b66_c02 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASEuser 2 3 # 2 A 133 GLU C 14 GLU.? 32.06 O1 GOL C1901 B 88 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 89 HIS B 187 HIS~? 26.45 C2 CIT A1102 coo 44.53 38.98 5.35 43.53 40.60 6.22 173.34 134.38 54.29 174.51 136.04 54.85 coo 58.74 13.49 55.78 58.72 14.38 57.67 174.65 109.33 0.17 174.41 107.27 0.58 coo 60.89 12.20 60.42 60.43 13.81 61.68 176.75 112.07 -5.75 176.32 110.31 -6.80 1b66_c02 source 1b66 6-PYRUVOYL TETRAHYDROPTERIN SYNTHASE : 2 hits 1b66_c02 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 18 PHE~? 23.25 N9 ADE A 500 A 159 ASP A 89 ASP.? 18.10 N3 ADE A 500 A 188 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 13.91 34.58 14.67 12.95 36.00 12.47 201.55 150.80 30.31 200.89 148.25 31.29 coo 20.97 28.40 16.26 20.19 30.15 15.34 203.02 151.24 21.31 203.43 152.46 19.71 coo 22.55 41.65 15.60 18.92 37.20 14.63 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 18 PHE~? 23.25 N9 ADE A 500 A 159 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 188 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 13.91 34.58 14.67 12.95 36.00 12.47 201.55 150.80 30.31 200.89 148.25 31.29 coo 20.97 28.40 16.26 20.19 30.15 15.34 203.27 140.75 25.55 204.24 138.86 25.61 coo 22.55 41.65 15.60 18.92 37.20 14.63 192.52 142.86 28.75 192.00 138.78 32.31 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 2 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 101 ARG.? 15.15 C8 ADE A 500 A 141 THR B 80 THR^? 11.53 O1 CIT A1102 A 235 ASP A 172 ASP~? 9.43 N1 ADE A 500 coo 6.21 93.81 36.58 4.58 96.33 37.17 173.48 146.74 16.27 172.57 144.92 18.53 coo 6.80 92.87 28.33 4.91 92.74 27.40 173.05 137.67 14.86 171.74 136.22 13.94 coo 12.98 90.36 47.57 11.26 89.62 46.62 180.59 154.59 5.93 180.83 155.75 4.19 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 101 ARG.? 15.15 C8 ADE A 500 A 141 THR B 80 THR^? 11.53 O1 CIT A1102 A 235 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo 6.21 93.81 36.58 4.58 96.33 37.17 173.48 146.74 16.27 172.57 144.92 18.53 coo 6.80 92.87 28.33 4.91 92.74 27.40 173.05 137.67 14.86 171.74 136.22 13.94 coo 12.98 90.36 47.57 11.26 89.62 46.62 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG B 101 ARG.? -6.88 O4 CIT A1102s A 141 THR A 80 THR^? 4.30 N6 ADE A 500 A 235 ASP B 172 ASP~? 8.81 O1 CIT A1102 coo 6.21 93.81 36.58 4.58 96.33 37.17 179.40 137.94 3.82 182.23 139.06 3.56 coo 6.80 92.87 28.33 4.91 92.74 27.40 182.84 145.31 7.97 182.66 147.39 7.73 coo 12.98 90.36 47.57 11.26 89.62 46.62 166.30 133.15 8.87 164.29 132.56 8.69 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 101 ARG.? -6.88 O4 CIT A1102s A 141 THR A 80 THR^? 4.30 N6 ADE A 500 A 235 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 6.21 93.81 36.58 4.58 96.33 37.17 179.40 137.94 3.82 182.23 139.06 3.56 coo 6.80 92.87 28.33 4.91 92.74 27.40 182.84 145.31 7.97 182.66 147.39 7.73 coo 12.98 90.36 47.57 11.26 89.62 46.62 169.82 131.15 6.22 168.64 132.89 5.97 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 101 ARG.? 15.15 C8 ADE A 500 D 141 THR B 80 THR^? 11.53 O1 CIT A1102 D 235 ASP A 172 ASP~? 9.43 N1 ADE A 500 coo -8.33 92.80 100.06 -7.71 95.33 98.44 173.48 146.74 16.27 172.57 144.92 18.53 coo -9.24 93.49 108.77 -7.37 94.21 109.61 173.05 137.67 14.86 171.74 136.22 13.94 coo -14.64 87.74 89.51 -12.89 87.43 90.65 180.59 154.59 5.93 180.83 155.75 4.19 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 101 ARG.? 15.15 C8 ADE A 500 D 141 THR B 80 THR^? 11.53 O1 CIT A1102 D 235 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo -8.33 92.80 100.06 -7.71 95.33 98.44 173.48 146.74 16.27 172.57 144.92 18.53 coo -9.24 93.49 108.77 -7.37 94.21 109.61 173.05 137.67 14.86 171.74 136.22 13.94 coo -14.64 87.74 89.51 -12.89 87.43 90.65 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG B 101 ARG.? -6.88 O4 CIT A1102s D 141 THR A 80 THR^? 4.30 N6 ADE A 500 D 235 ASP B 172 ASP~? 8.81 O1 CIT A1102 coo -8.33 92.80 100.06 -7.71 95.33 98.44 179.40 137.94 3.82 182.23 139.06 3.56 coo -9.24 93.49 108.77 -7.37 94.21 109.61 182.84 145.31 7.97 182.66 147.39 7.73 coo -14.64 87.74 89.51 -12.89 87.43 90.65 166.30 133.15 8.87 164.29 132.56 8.69 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 101 ARG.? -6.88 O4 CIT A1102s D 141 THR A 80 THR^? 4.30 N6 ADE A 500 D 235 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo -8.33 92.80 100.06 -7.71 95.33 98.44 179.40 137.94 3.82 182.23 139.06 3.56 coo -9.24 93.49 108.77 -7.37 94.21 109.61 182.84 145.31 7.97 182.66 147.39 7.73 coo -14.64 87.74 89.51 -12.89 87.43 90.65 169.82 131.15 6.22 168.64 132.89 5.97 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 101 ARG.? 15.15 C8 ADE A 500 C 141 THR B 80 THR^? 11.53 O1 CIT A1102 C 235 ASP A 172 ASP~? 9.43 N1 ADE A 500 coo -5.79 67.26 36.83 -4.57 64.58 37.74 173.48 146.74 16.27 172.57 144.92 18.53 coo -6.81 68.31 28.28 -4.82 68.47 27.57 173.05 137.67 14.86 171.74 136.22 13.94 coo -13.01 70.96 47.58 -11.44 71.65 46.34 180.59 154.59 5.93 180.83 155.75 4.19 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 101 ARG.? 15.15 C8 ADE A 500 C 141 THR B 80 THR^? 11.53 O1 CIT A1102 C 235 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo -5.79 67.26 36.83 -4.57 64.58 37.74 173.48 146.74 16.27 172.57 144.92 18.53 coo -6.81 68.31 28.28 -4.82 68.47 27.57 173.05 137.67 14.86 171.74 136.22 13.94 coo -13.01 70.96 47.58 -11.44 71.65 46.34 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG B 101 ARG.? -6.88 O4 CIT A1102s C 141 THR A 57 THR^? 9.14 O3 CIT A1102 C 235 ASP B 172 ASP~? 8.81 O1 CIT A1102 coo -5.79 67.26 36.83 -4.57 64.58 37.74 179.40 137.94 3.82 182.23 139.06 3.56 coo -6.81 68.31 28.28 -4.82 68.47 27.57 175.37 146.55 -0.38 175.84 147.29 -2.36 coo -13.01 70.96 47.58 -11.44 71.65 46.34 166.30 133.15 8.87 164.29 132.56 8.69 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 101 ARG.? -6.88 O4 CIT A1102s C 141 THR A 80 THR^? 4.30 N6 ADE A 500 C 235 ASP B 172 ASP~? 8.81 O1 CIT A1102 coo -5.79 67.26 36.83 -4.57 64.58 37.74 179.40 137.94 3.82 182.23 139.06 3.56 coo -6.81 68.31 28.28 -4.82 68.47 27.57 182.84 145.31 7.97 182.66 147.39 7.73 coo -13.01 70.96 47.58 -11.44 71.65 46.34 166.30 133.15 8.87 164.29 132.56 8.69 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG B 101 ARG.? -6.88 O4 CIT A1102s C 141 THR A 80 THR^? 4.30 N6 ADE A 500 C 235 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo -5.79 67.26 36.83 -4.57 64.58 37.74 179.40 137.94 3.82 182.23 139.06 3.56 coo -6.81 68.31 28.28 -4.82 68.47 27.57 182.84 145.31 7.97 182.66 147.39 7.73 coo -13.01 70.96 47.58 -11.44 71.65 46.34 169.82 131.15 6.22 168.64 132.89 5.97 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 5 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 101 ARG.? 15.15 C8 ADE A 500 B 141 THR B 80 THR^? 11.53 O1 CIT A1102 B 235 ASP A 172 ASP~? 9.43 N1 ADE A 500 coo 8.13 67.41 100.27 7.18 68.35 97.45 173.48 146.74 16.27 172.57 144.92 18.53 coo 8.28 67.78 108.81 6.22 67.65 109.43 173.05 137.67 14.86 171.74 136.22 13.94 coo 14.55 73.52 89.47 12.81 73.95 90.56 180.59 154.59 5.93 180.83 155.75 4.19 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 101 ARG.? 15.15 C8 ADE A 500 B 141 THR B 80 THR^? 11.53 O1 CIT A1102 B 235 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo 8.13 67.41 100.27 7.18 68.35 97.45 173.48 146.74 16.27 172.57 144.92 18.53 coo 8.28 67.78 108.81 6.22 67.65 109.43 173.05 137.67 14.86 171.74 136.22 13.94 coo 14.55 73.52 89.47 12.81 73.95 90.56 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG B 101 ARG.? -6.88 O4 CIT A1102s B 141 THR A 80 THR^? 4.30 N6 ADE A 500 B 235 ASP B 172 ASP~? 8.81 O1 CIT A1102 coo 8.13 67.41 100.27 7.18 68.35 97.45 179.40 137.94 3.82 182.23 139.06 3.56 coo 8.28 67.78 108.81 6.22 67.65 109.43 182.84 145.31 7.97 182.66 147.39 7.73 coo 14.55 73.52 89.47 12.81 73.95 90.56 166.30 133.15 8.87 164.29 132.56 8.69 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 3 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 175 ASP.? 10.98 C4 ADE A 500 16 HIS A 176 HIS^? 6.39 N3 ADE A 500 67 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 178.57 156.37 9.84 177.44 156.14 8.05 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 184.39 157.95 13.11 185.86 157.96 14.60 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 183 ASP~? 24.76 N9 ADE A 500 16 HIS A 187 HIS~? 25.73 N9 ADE A 500 67 GLY A 143 GLY.? 12.19 C8 ADE A 500 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 184.84 171.88 24.93 186.38 173.28 25.14 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 179.01 171.47 26.59 179.51 173.49 26.31 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 174.93 153.96 17.89 174.52 154.02 18.66 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP B 175 ASP.? 4.91 O1 CIT A1102 16 HIS B 176 HIS^? 13.79 O1 CIT A1102 67 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 169.82 131.15 6.22 168.64 132.89 5.97 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 171.08 125.47 9.27 172.48 124.18 10.15 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 184.36 119.52 -4.81 184.70 120.30 -4.67 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP B 183 ASP~? 28.98 C2 CIT A1102 16 HIS B 187 HIS~? 26.45 C2 CIT A1102 67 GLY B 143 GLY.? 6.99 O4 CIT A1102 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 174.65 109.33 0.17 174.41 107.27 0.58 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 177.58 131.25 1.88 178.27 131.09 1.31 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP C 175 ASP.? 10.66 O1 GOL C1901 16 HIS C 176 HIS^? 7.29 C1 GOL C1901 67 GLY C 120 GLY.? 26.00 O1 GOL C1901 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 157.90 117.18 31.56 156.68 116.62 29.91 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 157.21 117.94 38.21 157.48 118.99 40.00 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 176.82 118.68 40.70 176.80 119.24 40.18 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP C 183 ASP~? 25.06 O3 GOL C1901 16 HIS C 187 HIS~? 27.79 O3 GOL C1901 67 GLY C 143 GLY.? 14.90 O1 GOL C1901 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 169.34 110.13 50.56 169.06 109.63 52.58 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 174.78 109.74 44.68 175.79 108.53 43.31 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 165.52 121.63 31.71 166.35 121.80 31.83 1be1_c02 source 1be1 GLUTAMATE MUTASE : 6 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP B 89 ASP.? 31.34 O4 CIT A1102 435 GLU B 25 GLU.? 28.27 O1 GOL C1901 510 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 88.62 69.90 41.16 89.05 70.67 43.04 181.93 115.70 26.33 180.57 117.33 26.20 coo 89.52 76.11 40.17 89.01 75.16 41.97 179.49 113.39 31.74 177.60 113.83 30.87 coo 84.89 77.60 46.67 85.63 75.79 46.03 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP C 119 ASP.? 26.31 O1 GOL C1901 435 GLU B 25 GLU.? 28.27 O1 GOL C1901 510 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 88.62 69.90 41.16 89.05 70.67 43.04 178.03 118.40 36.14 177.70 120.46 36.31 coo 89.52 76.11 40.17 89.01 75.16 41.97 179.49 113.39 31.74 177.60 113.83 30.87 coo 84.89 77.60 46.67 85.63 75.79 46.03 181.93 115.70 26.33 180.57 117.33 26.20 1bf2_c00 source 1bf2 ISOAMYLASE : 2 hits 1bf2_c00 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 44 GLU.? 5.64 N9 ADE A 500 70 HIS A 42 HIS.? -4.20 N3 ADE A 500s 281 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 188.90 156.57 17.91 187.92 156.12 16.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 191.47 153.75 14.17 189.52 154.05 13.44 coo 100.93 36.73 156.02 100.47 38.42 157.18 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU A 44 GLU.? 5.64 N9 ADE A 500 70 HIS A 42 HIS.? -4.20 N3 ADE A 500s 281 HIS B 96 HIS^? 15.42 O4 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 188.90 156.57 17.91 187.92 156.12 16.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 191.47 153.75 14.17 189.52 154.05 13.44 coo 100.93 36.73 156.02 100.47 38.42 157.18 176.50 123.51 9.48 177.50 124.87 10.72 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 3 3 # 3 28 GLU A 44 GLU.? 5.64 N9 ADE A 500 70 HIS A 42 HIS.? -4.20 N3 ADE A 500s 281 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 188.90 156.57 17.91 187.92 156.12 16.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 191.47 153.75 14.17 189.52 154.05 13.44 coo 100.93 36.73 156.02 100.47 38.42 157.18 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 4 3 # 4 28 GLU A 44 GLU.? 5.64 N9 ADE A 500 70 HIS A 96 HIS^? 6.77 N9 ADE A 500 281 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 188.90 156.57 17.91 187.92 156.12 16.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 185.28 156.61 18.37 185.56 154.55 18.68 coo 100.93 36.73 156.02 100.47 38.42 157.18 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 5 3 # 5 28 GLU A 44 GLU.? 5.64 N9 ADE A 500 70 HIS A 96 HIS^? 6.77 N9 ADE A 500 281 HIS B 96 HIS^? 15.42 O4 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 188.90 156.57 17.91 187.92 156.12 16.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 185.28 156.61 18.37 185.56 154.55 18.68 coo 100.93 36.73 156.02 100.47 38.42 157.18 176.50 123.51 9.48 177.50 124.87 10.72 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 6 3 # 6 28 GLU A 44 GLU.? 5.64 N9 ADE A 500 70 HIS A 96 HIS^? 6.77 N9 ADE A 500 281 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 188.90 156.57 17.91 187.92 156.12 16.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 185.28 156.61 18.37 185.56 154.55 18.68 coo 100.93 36.73 156.02 100.47 38.42 157.18 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 7 3 # 7 28 GLU A 44 GLU.? 5.64 N9 ADE A 500 70 HIS A 176 HIS^? 6.39 N3 ADE A 500 281 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 188.90 156.57 17.91 187.92 156.12 16.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 184.39 157.95 13.11 185.86 157.96 14.60 coo 100.93 36.73 156.02 100.47 38.42 157.18 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 8 3 # 8 28 GLU A 44 GLU.? 5.64 N9 ADE A 500 70 HIS A 176 HIS^? 6.39 N3 ADE A 500 281 HIS B 96 HIS^? 15.42 O4 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 188.90 156.57 17.91 187.92 156.12 16.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 184.39 157.95 13.11 185.86 157.96 14.60 coo 100.93 36.73 156.02 100.47 38.42 157.18 176.50 123.51 9.48 177.50 124.87 10.72 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 9 3 # 9 28 GLU A 44 GLU.? 5.64 N9 ADE A 500 70 HIS A 176 HIS^? 6.39 N3 ADE A 500 281 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 188.90 156.57 17.91 187.92 156.12 16.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 184.39 157.95 13.11 185.86 157.96 14.60 coo 100.93 36.73 156.02 100.47 38.42 157.18 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 10 3 # 10 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 42 HIS.? 18.79 O1 CIT A1102 281 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 174.27 123.90 17.18 173.55 124.80 15.43 coo 100.93 36.73 156.02 100.47 38.42 157.18 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 11 3 # 11 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 42 HIS.? 18.79 O1 CIT A1102 281 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 174.27 123.90 17.18 173.55 124.80 15.43 coo 100.93 36.73 156.02 100.47 38.42 157.18 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 12 3 # 12 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 42 HIS.? 18.79 O1 CIT A1102 281 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 174.27 123.90 17.18 173.55 124.80 15.43 coo 100.93 36.73 156.02 100.47 38.42 157.18 184.39 157.95 13.11 185.86 157.96 14.60 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 13 3 # 13 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 42 HIS.? 18.79 O1 CIT A1102 281 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 174.27 123.90 17.18 173.55 124.80 15.43 coo 100.93 36.73 156.02 100.47 38.42 157.18 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 14 3 # 14 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 96 HIS^? 15.42 O4 CIT A1102 281 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 176.50 123.51 9.48 177.50 124.87 10.72 coo 100.93 36.73 156.02 100.47 38.42 157.18 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 15 3 # 15 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 96 HIS^? 15.42 O4 CIT A1102 281 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 176.50 123.51 9.48 177.50 124.87 10.72 coo 100.93 36.73 156.02 100.47 38.42 157.18 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 16 3 # 16 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 96 HIS^? 15.42 O4 CIT A1102 281 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 176.50 123.51 9.48 177.50 124.87 10.72 coo 100.93 36.73 156.02 100.47 38.42 157.18 184.39 157.95 13.11 185.86 157.96 14.60 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 17 3 # 17 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 176 HIS^? 13.79 O1 CIT A1102 281 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 171.08 125.47 9.27 172.48 124.18 10.15 coo 100.93 36.73 156.02 100.47 38.42 157.18 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 18 3 # 18 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 176 HIS^? 13.79 O1 CIT A1102 281 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 171.08 125.47 9.27 172.48 124.18 10.15 coo 100.93 36.73 156.02 100.47 38.42 157.18 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 19 3 # 19 28 GLU B 44 GLU.? 19.02 O1 CIT A1102 70 HIS B 176 HIS^? 13.79 O1 CIT A1102 281 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 66.09 46.17 155.81 66.77 48.19 155.70 174.85 121.76 12.80 173.53 120.38 11.97 coo 69.05 50.55 157.03 68.00 52.29 156.51 171.08 125.47 9.27 172.48 124.18 10.15 coo 100.93 36.73 156.02 100.47 38.42 157.18 184.39 157.95 13.11 185.86 157.96 14.60 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 20 3 # 20 28 GLU B 165 GLU^? 13.88 O4 CIT A1102 70 HIS B 104 HIS^? 12.85 O4 CIT A1102 281 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 66.09 46.17 155.81 66.77 48.19 155.70 180.17 131.30 14.36 179.09 129.62 13.64 coo 69.05 50.55 157.03 68.00 52.29 156.51 183.49 131.36 11.56 181.98 130.36 10.51 coo 100.93 36.73 156.02 100.47 38.42 157.18 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 21 3 # 21 28 GLU C 44 GLU.? 9.57 O3 GOL C1901 70 HIS C 96 HIS^? 9.69 C1 GOL C1901 281 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 157.18 120.22 44.20 157.97 118.54 45.19 coo 69.05 50.55 157.03 68.00 52.29 156.51 160.37 121.38 41.43 159.84 123.37 41.06 coo 100.93 36.73 156.02 100.47 38.42 157.18 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 22 3 # 22 28 GLU C 44 GLU.? 9.57 O3 GOL C1901 70 HIS C 176 HIS^? 7.29 C1 GOL C1901 281 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 157.18 120.22 44.20 157.97 118.54 45.19 coo 69.05 50.55 157.03 68.00 52.29 156.51 157.21 117.94 38.21 157.48 118.99 40.00 coo 100.93 36.73 156.02 100.47 38.42 157.18 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 23 3 # 23 28 GLU C 165 GLU^? 7.74 O1 GOL C1901 70 HIS C 104 HIS^? 12.14 O1 GOL C1901 281 HIS B 104 HIS^? 12.85 O4 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 157.34 129.59 37.15 157.60 127.69 38.11 coo 69.05 50.55 157.03 68.00 52.29 156.51 161.39 131.07 36.65 161.63 129.00 36.89 coo 100.93 36.73 156.02 100.47 38.42 157.18 183.49 131.36 11.56 181.98 130.36 10.51 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 24 3 # 24 28 GLU C 184 GLU~? 18.70 O3 GOL C1901 70 HIS C 187 HIS~? 27.79 O3 GOL C1901 281 HIS B 202 HIS.? 28.80 C2 CIT A1102 coo 66.09 46.17 155.81 66.77 48.19 155.70 168.68 112.73 44.51 166.86 112.61 43.45 coo 69.05 50.55 157.03 68.00 52.29 156.51 174.78 109.74 44.68 175.79 108.53 43.31 coo 100.93 36.73 156.02 100.47 38.42 157.18 175.03 109.49 9.82 173.45 108.46 10.74 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 24 hits 1bfd_c00 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 76 ARG^? 12.51 N1 ADE A 500 A 451 GLU A 61 GLU^? 16.24 O5 CIT A1102 A 540 GLU A 59 GLU^? 13.22 O6 CIT A1102 coo 79.04 80.20 80.81 79.58 81.40 83.63 176.90 153.44 4.90 177.24 156.32 3.96 coo 81.34 87.29 87.22 82.36 86.09 88.61 165.65 155.89 5.11 164.98 153.86 5.06 coo 79.94 80.46 88.84 81.11 81.36 87.27 169.62 150.86 -1.29 170.91 152.08 -2.44 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG B 108 ARG^? 25.54 C8 ADE A 500 A 451 GLU A 156 GLU.? 23.41 C8 ADE A 500 A 540 GLU B 156 GLU.? 24.53 N7 ADE A 500 coo 79.04 80.20 80.81 79.58 81.40 83.63 188.64 131.77 26.61 189.85 131.11 29.36 coo 81.34 87.29 87.22 82.36 86.09 88.61 196.65 137.08 28.97 194.78 136.94 30.01 coo 79.94 80.46 88.84 81.11 81.36 87.27 194.44 129.17 25.88 194.48 130.18 24.03 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG C 76 ARG^? 12.29 O2 GOL C1901 A 451 GLU C 61 GLU^? 23.56 O1 GOL C1901 A 540 GLU C 59 GLU^? 20.19 O2 GOL C1901 coo 79.04 80.20 80.81 79.58 81.40 83.63 153.02 116.91 26.58 154.63 114.54 27.70 coo 81.34 87.29 87.22 82.36 86.09 88.61 160.74 113.36 18.70 162.31 114.29 17.61 coo 79.94 80.46 88.84 81.11 81.36 87.27 152.75 116.35 16.84 151.33 114.88 17.42 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c04 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 43 ARG.? 7.62 C2 ADE A 500 183 LYS A 49 LYS^? 10.58 N6 ADE A 500 317 ARG A 101 ARG.? 15.15 C8 ADE A 500 coo 76.57 109.19 73.41 73.86 110.26 72.16 190.33 158.90 11.08 189.17 159.63 8.34 coo 82.09 117.51 66.37 80.60 114.32 71.44 193.06 146.52 10.07 195.03 144.09 6.09 coo 65.21 120.62 58.76 63.62 123.14 59.66 173.48 146.74 16.27 172.57 144.92 18.53 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG C 101 ARG.? 18.11 O1 GOL C1901 183 LYS B 49 LYS^? 24.07 O1 GOL C1901 317 ARG B 76 ARG^? 5.63 O1 CIT A1102 coo 76.57 109.19 73.41 73.86 110.26 72.16 163.77 126.78 27.00 165.49 129.29 26.85 coo 82.09 117.51 66.37 80.60 114.32 71.44 174.03 130.60 22.66 171.30 132.48 26.53 coo 65.21 120.62 58.76 63.62 123.14 59.66 166.15 136.82 7.45 164.99 134.62 5.65 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 2 hits 1bib_c00 naa= 3 ULMN 3 1bol_c00 RIBONUCLEASE RH user 1 3 # 1 A 46 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 105 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 109 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 191.47 153.75 14.17 189.52 154.05 13.44 coo 43.60 31.12 0.44 42.42 31.86 -1.18 188.90 156.57 17.91 187.92 156.12 16.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 184.39 157.95 13.11 185.86 157.96 14.60 ULMN 3 1bol_c00 RIBONUCLEASE RH user 2 3 # 2 A 46 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 105 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 109 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 184.39 157.95 13.11 185.86 157.96 14.60 coo 43.60 31.12 0.44 42.42 31.86 -1.18 188.90 156.57 17.91 187.92 156.12 16.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1bol_c00 RIBONUCLEASE RH user 3 3 # 3 A 46 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 105 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 109 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 184.39 157.95 13.11 185.86 157.96 14.60 coo 43.60 31.12 0.44 42.42 31.86 -1.18 188.90 156.57 17.91 187.92 156.12 16.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 1bol_c00 RIBONUCLEASE RH user 4 3 # 4 A 46 HIS A 202 HIS.? 13.56 N3 ADE A 500 A 105 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 109 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 190.73 163.86 19.83 191.04 162.27 18.50 coo 43.60 31.12 0.44 42.42 31.86 -1.18 188.90 156.57 17.91 187.92 156.12 16.11 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 184.39 157.95 13.11 185.86 157.96 14.60 ULMN 3 1bol_c00 RIBONUCLEASE RH user 5 3 # 5 A 46 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 105 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 109 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 174.27 123.90 17.18 173.55 124.80 15.43 coo 43.60 31.12 0.44 42.42 31.86 -1.18 174.85 121.76 12.80 173.53 120.38 11.97 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1bol_c00 RIBONUCLEASE RH user 6 3 # 6 A 46 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 105 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 109 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 171.08 125.47 9.27 172.48 124.18 10.15 coo 43.60 31.12 0.44 42.42 31.86 -1.18 174.85 121.76 12.80 173.53 120.38 11.97 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1bol_c00 RIBONUCLEASE RH user 7 3 # 7 A 46 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 105 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 109 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 153.36 123.09 43.85 154.03 121.98 42.20 coo 43.60 31.12 0.44 42.42 31.86 -1.18 157.18 120.22 44.20 157.97 118.54 45.19 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 160.37 121.38 41.43 159.84 123.37 41.06 ULMN 3 1bol_c00 RIBONUCLEASE RH user 8 3 # 8 A 46 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 105 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 109 HIS C 176 HIS^? 7.29 C1 GOL C1901 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 153.36 123.09 43.85 154.03 121.98 42.20 coo 43.60 31.12 0.44 42.42 31.86 -1.18 157.18 120.22 44.20 157.97 118.54 45.19 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 157.21 117.94 38.21 157.48 118.99 40.00 ULMN 3 1bol_c00 RIBONUCLEASE RH user 9 3 # 9 A 46 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 105 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 109 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 153.36 123.09 43.85 154.03 121.98 42.20 coo 43.60 31.12 0.44 42.42 31.86 -1.18 157.18 120.22 44.20 157.97 118.54 45.19 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 160.20 116.89 49.36 158.52 117.92 48.65 ULMN 3 1bol_c00 RIBONUCLEASE RH user 10 3 # 10 A 46 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 105 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 109 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 160.37 121.38 41.43 159.84 123.37 41.06 coo 43.60 31.12 0.44 42.42 31.86 -1.18 157.18 120.22 44.20 157.97 118.54 45.19 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1bol_c00 RIBONUCLEASE RH user 11 3 # 11 A 46 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 105 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 109 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 160.37 121.38 41.43 159.84 123.37 41.06 coo 43.60 31.12 0.44 42.42 31.86 -1.18 157.18 120.22 44.20 157.97 118.54 45.19 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 160.20 116.89 49.36 158.52 117.92 48.65 ULMN 3 1bol_c00 RIBONUCLEASE RH user 12 3 # 12 A 46 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 105 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 109 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 157.21 117.94 38.21 157.48 118.99 40.00 coo 43.60 31.12 0.44 42.42 31.86 -1.18 157.18 120.22 44.20 157.97 118.54 45.19 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1bol_c00 RIBONUCLEASE RH user 13 3 # 13 A 46 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 105 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 109 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 160.20 116.89 49.36 158.52 117.92 48.65 coo 43.60 31.12 0.44 42.42 31.86 -1.18 157.18 120.22 44.20 157.97 118.54 45.19 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1bol_c00 RIBONUCLEASE RH user 14 3 # 14 A 46 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 105 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 109 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 160.20 116.89 49.36 158.52 117.92 48.65 coo 43.60 31.12 0.44 42.42 31.86 -1.18 157.18 120.22 44.20 157.97 118.54 45.19 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 160.37 121.38 41.43 159.84 123.37 41.06 1bol_c00 source 1bol RIBONUCLEASE RH : 14 hits 1bol_c00 naa= 3 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 1 3 # 1 A 53 SER A 90 SER.? 14.48 N3 ADE A 500 A 54 PRO A 22 PRO.? 21.17 N9 ADE A 500 A 96 ASP A 89 ASP.? 18.10 N3 ADE A 500 coo -9.03 45.15 44.45 -7.51 43.26 44.28 199.47 153.71 22.16 199.01 152.90 19.92 coo -12.82 46.62 43.11 -11.69 44.75 42.79 201.29 157.70 25.73 202.08 156.48 27.42 coo -5.86 47.39 44.34 -4.55 46.60 42.83 203.02 151.24 21.31 203.43 152.46 19.71 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 2 3 # 2 A 53 SER A 90 SER.? 14.48 N3 ADE A 500 A 54 PRO A 91 PRO.? 16.98 N9 ADE A 500 A 96 ASP A 89 ASP.? 18.10 N3 ADE A 500 coo -9.03 45.15 44.45 -7.51 43.26 44.28 199.47 153.71 22.16 199.01 152.90 19.92 coo -12.82 46.62 43.11 -11.69 44.75 42.79 198.24 153.78 26.33 197.53 152.80 24.46 coo -5.86 47.39 44.34 -4.55 46.60 42.83 203.02 151.24 21.31 203.43 152.46 19.71 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 3 3 # 3 A 53 SER B 90 SER.? 26.90 O4 CIT A1102 A 54 PRO B 91 PRO.? 28.48 O4 CIT A1102 A 96 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo -9.03 45.15 44.45 -7.51 43.26 44.28 181.23 117.12 21.89 179.24 118.41 21.27 coo -12.82 46.62 43.11 -11.69 44.75 42.79 184.64 115.58 19.71 183.74 117.57 20.07 coo -5.86 47.39 44.34 -4.55 46.60 42.83 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 4 3 # 4 A 53 SER C 90 SER.? 14.02 O3 GOL C1901 A 54 PRO C 22 PRO.? 21.63 O3 GOL C1901 A 96 ASP C 89 ASP.? 17.67 O3 GOL C1901 coo -9.03 45.15 44.45 -7.51 43.26 44.28 155.07 128.53 53.12 154.12 126.92 51.57 coo -12.82 46.62 43.11 -11.69 44.75 42.79 157.54 126.86 58.24 158.07 128.84 59.10 coo -5.86 47.39 44.34 -4.55 46.60 42.83 152.15 130.32 56.35 151.16 130.16 54.50 ULMN 3 1boo_c00 N-4 CYTOSINE-SPECIFIC METHYLTRANSFERuser 5 3 # 5 A 53 SER C 90 SER.? 14.02 O3 GOL C1901 A 54 PRO C 91 PRO.? 18.52 O3 GOL C1901 A 96 ASP C 89 ASP.? 17.67 O3 GOL C1901 coo -9.03 45.15 44.45 -7.51 43.26 44.28 155.07 128.53 53.12 154.12 126.92 51.57 coo -12.82 46.62 43.11 -11.69 44.75 42.79 159.10 129.56 54.34 157.88 129.83 52.51 coo -5.86 47.39 44.34 -4.55 46.60 42.83 152.15 130.32 56.35 151.16 130.16 54.50 1boo_c00 source 1boo N-4 CYTOSINE-SPECIFIC METHYLTRANSFERASE PVU II: 5 hits 1boo_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 120 GLY.? 22.88 N9 ADE A 500 48 HIS A 187 HIS~? 25.73 N9 ADE A 500 99 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 12.38 5.55 24.25 13.27 5.59 24.39 174.96 162.20 29.93 174.67 161.48 29.96 coo 18.80 12.68 24.53 17.69 13.54 26.08 179.01 171.47 26.59 179.51 173.49 26.31 coo 17.07 18.51 26.62 16.67 17.07 28.09 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY B 120 GLY.? 21.76 O7 CIT A1102 48 HIS B 187 HIS~? 26.45 C2 CIT A1102 99 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 12.38 5.55 24.25 13.27 5.59 24.39 184.36 119.52 -4.81 184.70 120.30 -4.67 coo 18.80 12.68 24.53 17.69 13.54 26.08 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 17.07 18.51 26.62 16.67 17.07 28.09 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY C 120 GLY.? 26.00 O1 GOL C1901 48 HIS C 187 HIS~? 27.79 O3 GOL C1901 99 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 12.38 5.55 24.25 13.27 5.59 24.39 176.82 118.68 40.70 176.80 119.24 40.18 coo 18.80 12.68 24.53 17.69 13.54 26.08 174.78 109.74 44.68 175.79 108.53 43.31 coo 17.07 18.51 26.62 16.67 17.07 28.09 169.34 110.13 50.56 169.06 109.63 52.58 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 3 hits 1bp2_c00 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 168 ARG A 43 ARG.? 7.62 C2 ADE A 500 A 187 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 62.47 12.00 59.65 61.76 10.14 60.31 183.15 146.13 20.69 182.60 148.09 20.18 coo 55.10 8.37 73.00 55.48 9.59 70.20 190.33 158.90 11.08 189.17 159.63 8.34 coo 66.76 10.09 66.23 61.80 8.06 65.82 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 168 ARG A 101 ARG.? 15.15 C8 ADE A 500 A 187 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 62.47 12.00 59.65 61.76 10.14 60.31 184.39 157.95 13.11 185.86 157.96 14.60 coo 55.10 8.37 73.00 55.48 9.59 70.20 173.48 146.74 16.27 172.57 144.92 18.53 coo 66.76 10.09 66.23 61.80 8.06 65.82 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 A 82 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 168 ARG B 53 ARG^? 12.50 O1 CIT A1102 A 187 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 62.47 12.00 59.65 61.76 10.14 60.31 174.27 123.90 17.18 173.55 124.80 15.43 coo 55.10 8.37 73.00 55.48 9.59 70.20 166.97 137.64 16.68 167.60 135.18 14.95 coo 66.76 10.09 66.23 61.80 8.06 65.82 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 3 # 4 A 82 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 168 ARG C 101 ARG.? 18.11 O1 GOL C1901 A 187 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 62.47 12.00 59.65 61.76 10.14 60.31 174.27 123.90 17.18 173.55 124.80 15.43 coo 55.10 8.37 73.00 55.48 9.59 70.20 163.77 126.78 27.00 165.49 129.29 26.85 coo 66.76 10.09 66.23 61.80 8.06 65.82 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 5 3 # 5 A 82 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 168 ARG C 101 ARG.? 18.11 O1 GOL C1901 A 187 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 62.47 12.00 59.65 61.76 10.14 60.31 174.27 123.90 17.18 173.55 124.80 15.43 coo 55.10 8.37 73.00 55.48 9.59 70.20 163.77 126.78 27.00 165.49 129.29 26.85 coo 66.76 10.09 66.23 61.80 8.06 65.82 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 6 3 # 6 A 82 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 168 ARG B 101 ARG.? -6.88 O4 CIT A1102s A 187 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 62.47 12.00 59.65 61.76 10.14 60.31 171.08 125.47 9.27 172.48 124.18 10.15 coo 55.10 8.37 73.00 55.48 9.59 70.20 179.40 137.94 3.82 182.23 139.06 3.56 coo 66.76 10.09 66.23 61.80 8.06 65.82 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 7 3 # 7 A 82 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 168 ARG C 53 ARG^? 4.89 O2 GOL C1901 A 187 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 62.47 12.00 59.65 61.76 10.14 60.31 153.36 123.09 43.85 154.03 121.98 42.20 coo 55.10 8.37 73.00 55.48 9.59 70.20 146.33 122.48 29.52 148.17 121.33 31.67 coo 66.76 10.09 66.23 61.80 8.06 65.82 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 8 3 # 8 A 82 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 168 ARG C 101 ARG.? 18.11 O1 GOL C1901 A 187 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 62.47 12.00 59.65 61.76 10.14 60.31 157.21 117.94 38.21 157.48 118.99 40.00 coo 55.10 8.37 73.00 55.48 9.59 70.20 163.77 126.78 27.00 165.49 129.29 26.85 coo 66.76 10.09 66.23 61.80 8.06 65.82 163.30 119.33 38.22 166.56 114.68 36.90 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 8 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 42 HIS.? -4.20 N3 ADE A 500s B1168 ARG A 53 ARG^? 5.21 N6 ADE A 500 B1187 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 35.03 5.72 103.61 36.82 5.00 102.79 191.47 153.75 14.17 189.52 154.05 13.44 coo 41.91 5.48 91.85 40.59 6.81 94.28 184.38 147.77 2.51 183.90 149.96 4.60 coo 32.93 -0.12 99.60 37.71 2.39 99.23 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 B1082 HIS A 96 HIS^? 6.77 N9 ADE A 500 B1168 ARG A 101 ARG.? 15.15 C8 ADE A 500 B1187 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 35.03 5.72 103.61 36.82 5.00 102.79 185.28 156.61 18.37 185.56 154.55 18.68 coo 41.91 5.48 91.85 40.59 6.81 94.28 173.48 146.74 16.27 172.57 144.92 18.53 coo 32.93 -0.12 99.60 37.71 2.39 99.23 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 3 3 # 3 B1082 HIS A 176 HIS^? 6.39 N3 ADE A 500 B1168 ARG A 76 ARG^? 12.51 N1 ADE A 500 B1187 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 35.03 5.72 103.61 36.82 5.00 102.79 184.39 157.95 13.11 185.86 157.96 14.60 coo 41.91 5.48 91.85 40.59 6.81 94.28 176.90 153.44 4.90 177.24 156.32 3.96 coo 32.93 -0.12 99.60 37.71 2.39 99.23 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 4 3 # 4 B1082 HIS B 42 HIS.? 18.79 O1 CIT A1102 B1168 ARG B 53 ARG^? 12.50 O1 CIT A1102 B1187 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 35.03 5.72 103.61 36.82 5.00 102.79 174.27 123.90 17.18 173.55 124.80 15.43 coo 41.91 5.48 91.85 40.59 6.81 94.28 166.97 137.64 16.68 167.60 135.18 14.95 coo 32.93 -0.12 99.60 37.71 2.39 99.23 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 5 3 # 5 B1082 HIS B 42 HIS.? 18.79 O1 CIT A1102 B1168 ARG C 101 ARG.? 18.11 O1 GOL C1901 B1187 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 35.03 5.72 103.61 36.82 5.00 102.79 174.27 123.90 17.18 173.55 124.80 15.43 coo 41.91 5.48 91.85 40.59 6.81 94.28 163.77 126.78 27.00 165.49 129.29 26.85 coo 32.93 -0.12 99.60 37.71 2.39 99.23 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 6 3 # 6 B1082 HIS B 42 HIS.? 18.79 O1 CIT A1102 B1168 ARG C 101 ARG.? 18.11 O1 GOL C1901 B1187 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 35.03 5.72 103.61 36.82 5.00 102.79 174.27 123.90 17.18 173.55 124.80 15.43 coo 41.91 5.48 91.85 40.59 6.81 94.28 163.77 126.78 27.00 165.49 129.29 26.85 coo 32.93 -0.12 99.60 37.71 2.39 99.23 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 7 3 # 7 B1082 HIS B 202 HIS.? 28.80 C2 CIT A1102 B1168 ARG B 43 ARG.? 18.57 O1 CIT A1102 B1187 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 35.03 5.72 103.61 36.82 5.00 102.79 175.03 109.49 9.82 173.45 108.46 10.74 coo 41.91 5.48 91.85 40.59 6.81 94.28 169.37 120.65 13.94 167.07 120.51 11.92 coo 32.93 -0.12 99.60 37.71 2.39 99.23 173.15 113.94 5.34 166.89 113.91 6.31 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 7 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 48 PHE^? 4.82 C2 ADE A 500 A 205 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 236 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 4.14 2.10 36.34 6.69 3.08 36.92 192.28 150.01 12.11 192.07 151.51 9.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 180.59 154.59 5.93 180.83 155.75 4.19 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 129 PHE.? 20.13 C8 ADE A 500 A 205 ASP B 130 ASP~? 26.83 N6 ADE A 500 A 236 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 4.14 2.10 36.34 6.69 3.08 36.92 188.97 135.38 27.69 188.93 135.61 24.90 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 200.55 129.62 17.17 202.64 129.41 16.98 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 157 PHE.? 18.76 C8 ADE A 500 A 205 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 236 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 4.14 2.10 36.34 6.69 3.08 36.92 197.65 139.50 24.25 197.70 140.07 21.50 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 188.71 136.74 34.61 188.50 136.01 36.57 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 173 PHE~? 4.60 C2 ADE A 500 A 205 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 236 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 4.14 2.10 36.34 6.69 3.08 36.92 186.20 157.44 8.21 188.39 156.08 9.40 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 185.72 140.93 6.30 184.35 140.00 4.99 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE B 48 PHE^? 19.83 O1 CIT A1102 A 205 ASP B 172 ASP~? 8.81 O1 CIT A1102 A 236 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 4.14 2.10 36.34 6.69 3.08 36.92 174.23 127.42 20.06 171.47 127.09 19.71 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 166.30 133.15 8.87 164.29 132.56 8.69 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE B 129 PHE.? 19.08 N7 ADE A 500 A 205 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 236 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 4.14 2.10 36.34 6.69 3.08 36.92 195.26 133.73 19.36 192.72 134.81 19.79 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 188.71 136.74 34.61 188.50 136.01 36.57 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 205 ASP B 130 ASP~? 26.83 N6 ADE A 500 A 236 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 4.14 2.10 36.34 6.69 3.08 36.92 189.45 127.38 26.40 186.79 128.09 26.89 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 200.55 129.62 17.17 202.64 129.41 16.98 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 205 ASP B 89 ASP.? 31.34 O4 CIT A1102 A 236 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo 4.14 2.10 36.34 6.69 3.08 36.92 187.70 125.47 18.98 188.18 126.81 16.59 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 181.93 115.70 26.33 180.57 117.33 26.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 186.73 109.97 17.12 190.68 107.86 12.58 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 205 ASP B 89 ASP.? 31.34 O4 CIT A1102 A 236 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 4.14 2.10 36.34 6.69 3.08 36.92 187.70 125.47 18.98 188.18 126.81 16.59 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 181.93 115.70 26.33 180.57 117.33 26.20 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE B 173 PHE~? 14.11 O1 CIT A1102 A 205 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 236 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 4.14 2.10 36.34 6.69 3.08 36.92 165.53 127.89 11.96 166.03 128.02 14.71 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 173.93 140.35 20.11 173.24 142.10 19.12 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE C 48 PHE^? -4.71 O3 GOL C1901s A 205 ASP C 172 ASP~? 9.22 O2 GOL C1901 A 236 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 4.14 2.10 36.34 6.69 3.08 36.92 150.16 125.74 41.77 148.90 123.30 41.28 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 153.21 116.81 30.64 152.37 114.88 30.62 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 163.30 119.33 38.22 166.56 114.68 36.90 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE C 157 PHE~? 20.21 O1 GOL C1901 A 205 ASP C 130 ASP.? 30.92 O1 GOL C1901 A 236 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 4.14 2.10 36.34 6.69 3.08 36.92 154.00 141.12 47.59 151.92 139.65 46.43 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 167.73 145.95 43.64 168.62 147.66 44.50 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 13 3 # 13 A 109 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 205 ASP C 89 ASP.? 17.67 O3 GOL C1901 A 236 LYS C 20 LYS~? 29.81 O3 GOL C1901 coo 4.14 2.10 36.34 6.69 3.08 36.92 159.14 135.31 45.76 161.07 134.95 43.76 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 152.15 130.32 56.35 151.16 130.16 54.50 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 163.54 128.31 58.75 169.18 130.90 60.17 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 14 3 # 14 A 109 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 205 ASP C 89 ASP.? 17.67 O3 GOL C1901 A 236 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo 4.14 2.10 36.34 6.69 3.08 36.92 159.14 135.31 45.76 161.07 134.95 43.76 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 152.15 130.32 56.35 151.16 130.16 54.50 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 15 3 # 15 A 109 PHE C 173 PHE~? 4.81 C3 GOL C1901 A 205 ASP C 52 ASP^? 12.06 O1 GOL C1901 A 236 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 4.14 2.10 36.34 6.69 3.08 36.92 151.21 115.28 36.33 149.30 116.99 37.50 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 147.21 130.59 30.19 147.01 130.37 28.08 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 147.41 128.03 39.92 142.61 128.90 38.51 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 15 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 107 GLN^? 13.61 N7 ADE A 500 A 91 LEU A 106 LEU^? 16.14 C8 ADE A 500 A 133 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 43.58 43.67 66.73 42.32 42.78 68.15 189.72 137.73 19.03 190.31 137.91 17.01 coo 38.58 45.09 70.44 38.28 45.21 72.59 187.46 139.66 24.32 189.25 139.66 25.53 coo 44.05 36.87 70.65 43.15 38.64 69.97 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 107 GLN^? 13.61 N7 ADE A 500 A 91 LEU A 162 LEU^? 13.88 C8 ADE A 500 A 133 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 43.58 43.67 66.73 42.32 42.78 68.15 189.72 137.73 19.03 190.31 137.91 17.01 coo 38.58 45.09 70.44 38.28 45.21 72.59 194.06 141.28 20.24 193.66 140.74 18.18 coo 44.05 36.87 70.65 43.15 38.64 69.97 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 112 GLN^? 20.81 C8 ADE A 500 A 91 LEU A 152 LEU.? 20.43 C8 ADE A 500 A 133 GLU A 14 GLU.? 28.29 N9 ADE A 500 coo 43.58 43.67 66.73 42.32 42.78 68.15 187.82 149.99 31.85 188.55 150.31 33.84 coo 38.58 45.09 70.44 38.28 45.21 72.59 193.51 146.45 31.67 191.70 147.29 32.52 coo 44.05 36.87 70.65 43.15 38.64 69.97 191.26 153.03 39.37 191.20 151.63 40.96 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN A 112 GLN^? 20.81 C8 ADE A 500 A 91 LEU A 152 LEU.? 20.43 C8 ADE A 500 A 133 GLU A 135 GLU.? 23.34 C8 ADE A 500 coo 43.58 43.67 66.73 42.32 42.78 68.15 187.82 149.99 31.85 188.55 150.31 33.84 coo 38.58 45.09 70.44 38.28 45.21 72.59 193.51 146.45 31.67 191.70 147.29 32.52 coo 44.05 36.87 70.65 43.15 38.64 69.97 187.40 140.84 33.48 189.24 139.81 33.69 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 31 GLN~? 27.26 O1 GOL C1901 A 91 LEU B 30 LEU~? 31.26 O4 CIT A1102 A 133 GLU B 25 GLU.? 28.27 O1 GOL C1901 coo 43.58 43.67 66.73 42.32 42.78 68.15 179.81 120.64 33.63 178.29 120.34 32.19 coo 38.58 45.09 70.44 38.28 45.21 72.59 184.70 122.72 29.40 186.23 123.32 28.00 coo 44.05 36.87 70.65 43.15 38.64 69.97 179.49 113.39 31.74 177.60 113.83 30.87 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 112 GLN^? 26.54 O4 CIT A1102 A 91 LEU B 152 LEU.? 28.12 O4 CIT A1102 A 133 GLU B 14 GLU.? 33.67 O4 CIT A1102 coo 43.58 43.67 66.73 42.32 42.78 68.15 191.75 121.43 11.28 193.26 119.92 11.27 coo 38.58 45.09 70.44 38.28 45.21 72.59 192.92 121.31 17.92 193.54 120.71 15.94 coo 44.05 36.87 70.65 43.15 38.64 69.97 196.57 114.78 10.83 198.67 114.78 11.14 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN B 112 GLN^? 26.54 O4 CIT A1102 A 91 LEU B 152 LEU.? 28.12 O4 CIT A1102 A 133 GLU B 135 GLU.? 25.67 N6 ADE A 500 coo 43.58 43.67 66.73 42.32 42.78 68.15 191.75 121.43 11.28 193.26 119.92 11.27 coo 38.58 45.09 70.44 38.28 45.21 72.59 192.92 121.31 17.92 193.54 120.71 15.94 coo 44.05 36.87 70.65 43.15 38.64 69.97 197.88 127.79 14.29 197.78 127.39 16.36 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN C 31 GLN~? 19.36 O3 GOL C1901 A 91 LEU C 30 LEU~? 20.29 O1 GOL C1901 A 133 GLU C 25 GLU.? 20.39 O3 GOL C1901 coo 43.58 43.67 66.73 42.32 42.78 68.15 145.05 134.00 54.89 144.43 132.11 54.12 coo 38.58 45.09 70.44 38.28 45.21 72.59 149.67 136.76 51.63 151.47 137.62 50.77 coo 44.05 36.87 70.65 43.15 38.64 69.97 147.09 130.00 59.71 146.72 128.39 58.35 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN C 107 GLN^? 15.17 O1 GOL C1901 A 91 LEU C 106 LEU^? 18.98 O1 GOL C1901 A 133 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 43.58 43.67 66.73 42.32 42.78 68.15 154.42 138.86 37.89 152.43 138.24 37.46 coo 38.58 45.09 70.44 38.28 45.21 72.59 160.44 139.04 39.12 160.48 139.99 41.05 coo 44.05 36.87 70.65 43.15 38.64 69.97 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN C 107 GLN^? 15.17 O1 GOL C1901 A 91 LEU C 162 LEU^? 15.28 O1 GOL C1901 A 133 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 43.58 43.67 66.73 42.32 42.78 68.15 154.42 138.86 37.89 152.43 138.24 37.46 coo 38.58 45.09 70.44 38.28 45.21 72.59 153.66 137.34 43.51 152.39 136.80 41.85 coo 44.05 36.87 70.65 43.15 38.64 69.97 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 11 3 # 11 A 50 GLN C 112 GLN^? 24.26 O1 GOL C1901 A 91 LEU C 152 LEU.? 23.68 O1 GOL C1901 A 133 GLU C 14 GLU.? 32.06 O1 GOL C1901 coo 43.58 43.67 66.73 42.32 42.78 68.15 168.50 133.03 46.93 169.91 133.74 48.35 coo 38.58 45.09 70.44 38.28 45.21 72.59 164.23 137.51 50.25 166.14 136.71 49.71 coo 44.05 36.87 70.65 43.15 38.64 69.97 173.34 134.38 54.29 174.51 136.04 54.85 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 11 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 107 GLN^? 13.61 N7 ADE A 500 B 591 LEU A 106 LEU^? 16.14 C8 ADE A 500 B 633 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 88.06 44.34 57.19 89.06 45.53 55.74 189.72 137.73 19.03 190.31 137.91 17.01 coo 86.70 48.66 52.61 87.15 48.69 50.51 187.46 139.66 24.32 189.25 139.66 25.53 coo 95.42 44.52 54.43 93.46 45.31 54.70 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 107 GLN^? 13.61 N7 ADE A 500 B 591 LEU A 162 LEU^? 13.88 C8 ADE A 500 B 633 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 88.06 44.34 57.19 89.06 45.53 55.74 189.72 137.73 19.03 190.31 137.91 17.01 coo 86.70 48.66 52.61 87.15 48.69 50.51 194.06 141.28 20.24 193.66 140.74 18.18 coo 95.42 44.52 54.43 93.46 45.31 54.70 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN A 112 GLN^? 20.81 C8 ADE A 500 B 591 LEU A 152 LEU.? 20.43 C8 ADE A 500 B 633 GLU A 14 GLU.? 28.29 N9 ADE A 500 coo 88.06 44.34 57.19 89.06 45.53 55.74 187.82 149.99 31.85 188.55 150.31 33.84 coo 86.70 48.66 52.61 87.15 48.69 50.51 193.51 146.45 31.67 191.70 147.29 32.52 coo 95.42 44.52 54.43 93.46 45.31 54.70 191.26 153.03 39.37 191.20 151.63 40.96 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN A 112 GLN^? 20.81 C8 ADE A 500 B 591 LEU A 152 LEU.? 20.43 C8 ADE A 500 B 633 GLU A 135 GLU.? 23.34 C8 ADE A 500 coo 88.06 44.34 57.19 89.06 45.53 55.74 187.82 149.99 31.85 188.55 150.31 33.84 coo 86.70 48.66 52.61 87.15 48.69 50.51 193.51 146.45 31.67 191.70 147.29 32.52 coo 95.42 44.52 54.43 93.46 45.31 54.70 187.40 140.84 33.48 189.24 139.81 33.69 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 5 3 # 5 B 550 GLN B 31 GLN~? 27.26 O1 GOL C1901 B 591 LEU B 30 LEU~? 31.26 O4 CIT A1102 B 633 GLU B 25 GLU.? 28.27 O1 GOL C1901 coo 88.06 44.34 57.19 89.06 45.53 55.74 179.81 120.64 33.63 178.29 120.34 32.19 coo 86.70 48.66 52.61 87.15 48.69 50.51 184.70 122.72 29.40 186.23 123.32 28.00 coo 95.42 44.52 54.43 93.46 45.31 54.70 179.49 113.39 31.74 177.60 113.83 30.87 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 6 3 # 6 B 550 GLN B 112 GLN^? 26.54 O4 CIT A1102 B 591 LEU B 152 LEU.? 28.12 O4 CIT A1102 B 633 GLU B 14 GLU.? 33.67 O4 CIT A1102 coo 88.06 44.34 57.19 89.06 45.53 55.74 191.75 121.43 11.28 193.26 119.92 11.27 coo 86.70 48.66 52.61 87.15 48.69 50.51 192.92 121.31 17.92 193.54 120.71 15.94 coo 95.42 44.52 54.43 93.46 45.31 54.70 196.57 114.78 10.83 198.67 114.78 11.14 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 7 3 # 7 B 550 GLN B 112 GLN^? 26.54 O4 CIT A1102 B 591 LEU B 152 LEU.? 28.12 O4 CIT A1102 B 633 GLU B 135 GLU.? 25.67 N6 ADE A 500 coo 88.06 44.34 57.19 89.06 45.53 55.74 191.75 121.43 11.28 193.26 119.92 11.27 coo 86.70 48.66 52.61 87.15 48.69 50.51 192.92 121.31 17.92 193.54 120.71 15.94 coo 95.42 44.52 54.43 93.46 45.31 54.70 197.88 127.79 14.29 197.78 127.39 16.36 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 8 3 # 8 B 550 GLN C 31 GLN~? 19.36 O3 GOL C1901 B 591 LEU C 30 LEU~? 20.29 O1 GOL C1901 B 633 GLU C 25 GLU.? 20.39 O3 GOL C1901 coo 88.06 44.34 57.19 89.06 45.53 55.74 145.05 134.00 54.89 144.43 132.11 54.12 coo 86.70 48.66 52.61 87.15 48.69 50.51 149.67 136.76 51.63 151.47 137.62 50.77 coo 95.42 44.52 54.43 93.46 45.31 54.70 147.09 130.00 59.71 146.72 128.39 58.35 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 9 3 # 9 B 550 GLN C 107 GLN^? 15.17 O1 GOL C1901 B 591 LEU C 106 LEU^? 18.98 O1 GOL C1901 B 633 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 88.06 44.34 57.19 89.06 45.53 55.74 154.42 138.86 37.89 152.43 138.24 37.46 coo 86.70 48.66 52.61 87.15 48.69 50.51 160.44 139.04 39.12 160.48 139.99 41.05 coo 95.42 44.52 54.43 93.46 45.31 54.70 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 10 3 # 10 B 550 GLN C 107 GLN^? 15.17 O1 GOL C1901 B 591 LEU C 162 LEU^? 15.28 O1 GOL C1901 B 633 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 88.06 44.34 57.19 89.06 45.53 55.74 154.42 138.86 37.89 152.43 138.24 37.46 coo 86.70 48.66 52.61 87.15 48.69 50.51 153.66 137.34 43.51 152.39 136.80 41.85 coo 95.42 44.52 54.43 93.46 45.31 54.70 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 11 3 # 11 B 550 GLN C 112 GLN^? 24.26 O1 GOL C1901 B 591 LEU C 152 LEU.? 23.68 O1 GOL C1901 B 633 GLU C 14 GLU.? 32.06 O1 GOL C1901 coo 88.06 44.34 57.19 89.06 45.53 55.74 168.50 133.03 46.93 169.91 133.74 48.35 coo 86.70 48.66 52.61 87.15 48.69 50.51 164.23 137.51 50.25 166.14 136.71 49.71 coo 95.42 44.52 54.43 93.46 45.31 54.70 173.34 134.38 54.29 174.51 136.04 54.85 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 11 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 107 GLN^? 13.61 N7 ADE A 500 C1091 LEU A 106 LEU^? 16.14 C8 ADE A 500 C1133 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 68.29 34.44 43.03 66.67 34.74 44.37 189.72 137.73 19.03 190.31 137.91 17.01 coo 65.83 38.95 47.05 65.46 38.90 49.20 187.46 139.66 24.32 189.25 139.66 25.53 coo 63.14 29.39 46.25 63.84 31.31 45.74 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 107 GLN^? 13.61 N7 ADE A 500 C1091 LEU A 162 LEU^? 13.88 C8 ADE A 500 C1133 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 68.29 34.44 43.03 66.67 34.74 44.37 189.72 137.73 19.03 190.31 137.91 17.01 coo 65.83 38.95 47.05 65.46 38.90 49.20 194.06 141.28 20.24 193.66 140.74 18.18 coo 63.14 29.39 46.25 63.84 31.31 45.74 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN A 112 GLN^? 20.81 C8 ADE A 500 C1091 LEU A 152 LEU.? 20.43 C8 ADE A 500 C1133 GLU A 14 GLU.? 28.29 N9 ADE A 500 coo 68.29 34.44 43.03 66.67 34.74 44.37 187.82 149.99 31.85 188.55 150.31 33.84 coo 65.83 38.95 47.05 65.46 38.90 49.20 193.51 146.45 31.67 191.70 147.29 32.52 coo 63.14 29.39 46.25 63.84 31.31 45.74 191.26 153.03 39.37 191.20 151.63 40.96 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN A 112 GLN^? 20.81 C8 ADE A 500 C1091 LEU A 152 LEU.? 20.43 C8 ADE A 500 C1133 GLU A 135 GLU.? 23.34 C8 ADE A 500 coo 68.29 34.44 43.03 66.67 34.74 44.37 187.82 149.99 31.85 188.55 150.31 33.84 coo 65.83 38.95 47.05 65.46 38.90 49.20 193.51 146.45 31.67 191.70 147.29 32.52 coo 63.14 29.39 46.25 63.84 31.31 45.74 187.40 140.84 33.48 189.24 139.81 33.69 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 5 3 # 5 C1050 GLN B 31 GLN~? 27.26 O1 GOL C1901 C1091 LEU B 30 LEU~? 31.26 O4 CIT A1102 C1133 GLU B 25 GLU.? 28.27 O1 GOL C1901 coo 68.29 34.44 43.03 66.67 34.74 44.37 179.81 120.64 33.63 178.29 120.34 32.19 coo 65.83 38.95 47.05 65.46 38.90 49.20 184.70 122.72 29.40 186.23 123.32 28.00 coo 63.14 29.39 46.25 63.84 31.31 45.74 179.49 113.39 31.74 177.60 113.83 30.87 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 6 3 # 6 C1050 GLN B 112 GLN^? 26.54 O4 CIT A1102 C1091 LEU B 152 LEU.? 28.12 O4 CIT A1102 C1133 GLU B 14 GLU.? 33.67 O4 CIT A1102 coo 68.29 34.44 43.03 66.67 34.74 44.37 191.75 121.43 11.28 193.26 119.92 11.27 coo 65.83 38.95 47.05 65.46 38.90 49.20 192.92 121.31 17.92 193.54 120.71 15.94 coo 63.14 29.39 46.25 63.84 31.31 45.74 196.57 114.78 10.83 198.67 114.78 11.14 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 7 3 # 7 C1050 GLN B 112 GLN^? 26.54 O4 CIT A1102 C1091 LEU B 152 LEU.? 28.12 O4 CIT A1102 C1133 GLU B 135 GLU.? 25.67 N6 ADE A 500 coo 68.29 34.44 43.03 66.67 34.74 44.37 191.75 121.43 11.28 193.26 119.92 11.27 coo 65.83 38.95 47.05 65.46 38.90 49.20 192.92 121.31 17.92 193.54 120.71 15.94 coo 63.14 29.39 46.25 63.84 31.31 45.74 197.88 127.79 14.29 197.78 127.39 16.36 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 8 3 # 8 C1050 GLN C 31 GLN~? 19.36 O3 GOL C1901 C1091 LEU C 30 LEU~? 20.29 O1 GOL C1901 C1133 GLU C 25 GLU.? 20.39 O3 GOL C1901 coo 68.29 34.44 43.03 66.67 34.74 44.37 145.05 134.00 54.89 144.43 132.11 54.12 coo 65.83 38.95 47.05 65.46 38.90 49.20 149.67 136.76 51.63 151.47 137.62 50.77 coo 63.14 29.39 46.25 63.84 31.31 45.74 147.09 130.00 59.71 146.72 128.39 58.35 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 9 3 # 9 C1050 GLN C 107 GLN^? 15.17 O1 GOL C1901 C1091 LEU C 106 LEU^? 18.98 O1 GOL C1901 C1133 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 68.29 34.44 43.03 66.67 34.74 44.37 154.42 138.86 37.89 152.43 138.24 37.46 coo 65.83 38.95 47.05 65.46 38.90 49.20 160.44 139.04 39.12 160.48 139.99 41.05 coo 63.14 29.39 46.25 63.84 31.31 45.74 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 10 3 # 10 C1050 GLN C 107 GLN^? 15.17 O1 GOL C1901 C1091 LEU C 162 LEU^? 15.28 O1 GOL C1901 C1133 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 68.29 34.44 43.03 66.67 34.74 44.37 154.42 138.86 37.89 152.43 138.24 37.46 coo 65.83 38.95 47.05 65.46 38.90 49.20 153.66 137.34 43.51 152.39 136.80 41.85 coo 63.14 29.39 46.25 63.84 31.31 45.74 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 11 3 # 11 C1050 GLN C 112 GLN^? 24.26 O1 GOL C1901 C1091 LEU C 152 LEU.? 23.68 O1 GOL C1901 C1133 GLU C 14 GLU.? 32.06 O1 GOL C1901 coo 68.29 34.44 43.03 66.67 34.74 44.37 168.50 133.03 46.93 169.91 133.74 48.35 coo 65.83 38.95 47.05 65.46 38.90 49.20 164.23 137.51 50.25 166.14 136.71 49.71 coo 63.14 29.39 46.25 63.84 31.31 45.74 173.34 134.38 54.29 174.51 136.04 54.85 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 11 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 107 GLN^? 13.61 N7 ADE A 500 A 91 LEU A 106 LEU^? 16.14 C8 ADE A 500 A 133 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 38.23 53.34 67.59 38.84 53.87 69.56 189.72 137.73 19.03 190.31 137.91 17.01 coo 35.40 53.22 73.30 35.37 54.87 74.74 187.46 139.66 24.32 189.25 139.66 25.53 coo 45.08 56.04 70.60 43.15 55.19 70.77 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 107 GLN^? 13.61 N7 ADE A 500 A 91 LEU A 162 LEU^? 13.88 C8 ADE A 500 A 133 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 38.23 53.34 67.59 38.84 53.87 69.56 189.72 137.73 19.03 190.31 137.91 17.01 coo 35.40 53.22 73.30 35.37 54.87 74.74 194.06 141.28 20.24 193.66 140.74 18.18 coo 45.08 56.04 70.60 43.15 55.19 70.77 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN A 112 GLN^? 20.81 C8 ADE A 500 A 91 LEU A 152 LEU.? 20.43 C8 ADE A 500 A 133 GLU A 14 GLU.? 28.29 N9 ADE A 500 coo 38.23 53.34 67.59 38.84 53.87 69.56 187.82 149.99 31.85 188.55 150.31 33.84 coo 35.40 53.22 73.30 35.37 54.87 74.74 193.51 146.45 31.67 191.70 147.29 32.52 coo 45.08 56.04 70.60 43.15 55.19 70.77 191.26 153.03 39.37 191.20 151.63 40.96 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN A 112 GLN^? 20.81 C8 ADE A 500 A 91 LEU A 152 LEU.? 20.43 C8 ADE A 500 A 133 GLU A 135 GLU.? 23.34 C8 ADE A 500 coo 38.23 53.34 67.59 38.84 53.87 69.56 187.82 149.99 31.85 188.55 150.31 33.84 coo 35.40 53.22 73.30 35.37 54.87 74.74 193.51 146.45 31.67 191.70 147.29 32.52 coo 45.08 56.04 70.60 43.15 55.19 70.77 187.40 140.84 33.48 189.24 139.81 33.69 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 5 3 # 5 A 50 GLN B 31 GLN~? 27.26 O1 GOL C1901 A 91 LEU B 30 LEU~? 31.26 O4 CIT A1102 A 133 GLU B 25 GLU.? 28.27 O1 GOL C1901 coo 38.23 53.34 67.59 38.84 53.87 69.56 179.81 120.64 33.63 178.29 120.34 32.19 coo 35.40 53.22 73.30 35.37 54.87 74.74 184.70 122.72 29.40 186.23 123.32 28.00 coo 45.08 56.04 70.60 43.15 55.19 70.77 179.49 113.39 31.74 177.60 113.83 30.87 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 6 3 # 6 A 50 GLN B 107 GLN^? 17.47 N7 ADE A 500 A 91 LEU B 106 LEU^? 19.55 N7 ADE A 500 A 133 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 38.23 53.34 67.59 38.84 53.87 69.56 186.39 134.92 21.23 184.61 135.48 22.22 coo 35.40 53.22 73.30 35.37 54.87 74.74 190.09 132.39 17.09 191.23 130.92 18.21 coo 45.08 56.04 70.60 43.15 55.19 70.77 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 7 3 # 7 A 50 GLN B 107 GLN^? 17.47 N7 ADE A 500 A 91 LEU B 162 LEU^? 22.55 N7 ADE A 500 A 133 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 38.23 53.34 67.59 38.84 53.87 69.56 186.39 134.92 21.23 184.61 135.48 22.22 coo 35.40 53.22 73.30 35.37 54.87 74.74 185.36 129.41 23.16 183.75 130.83 23.34 coo 45.08 56.04 70.60 43.15 55.19 70.77 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 8 3 # 8 A 50 GLN B 112 GLN^? 26.54 O4 CIT A1102 A 91 LEU B 152 LEU.? 28.12 O4 CIT A1102 A 133 GLU B 14 GLU.? 33.67 O4 CIT A1102 coo 38.23 53.34 67.59 38.84 53.87 69.56 191.75 121.43 11.28 193.26 119.92 11.27 coo 35.40 53.22 73.30 35.37 54.87 74.74 192.92 121.31 17.92 193.54 120.71 15.94 coo 45.08 56.04 70.60 43.15 55.19 70.77 196.57 114.78 10.83 198.67 114.78 11.14 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 9 3 # 9 A 50 GLN B 112 GLN^? 26.54 O4 CIT A1102 A 91 LEU B 152 LEU.? 28.12 O4 CIT A1102 A 133 GLU B 135 GLU.? 25.67 N6 ADE A 500 coo 38.23 53.34 67.59 38.84 53.87 69.56 191.75 121.43 11.28 193.26 119.92 11.27 coo 35.40 53.22 73.30 35.37 54.87 74.74 192.92 121.31 17.92 193.54 120.71 15.94 coo 45.08 56.04 70.60 43.15 55.19 70.77 197.88 127.79 14.29 197.78 127.39 16.36 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 10 3 # 10 A 50 GLN C 31 GLN~? 19.36 O3 GOL C1901 A 91 LEU C 30 LEU~? 20.29 O1 GOL C1901 A 133 GLU C 25 GLU.? 20.39 O3 GOL C1901 coo 38.23 53.34 67.59 38.84 53.87 69.56 145.05 134.00 54.89 144.43 132.11 54.12 coo 35.40 53.22 73.30 35.37 54.87 74.74 149.67 136.76 51.63 151.47 137.62 50.77 coo 45.08 56.04 70.60 43.15 55.19 70.77 147.09 130.00 59.71 146.72 128.39 58.35 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 11 3 # 11 A 50 GLN C 107 GLN^? 15.17 O1 GOL C1901 A 91 LEU C 106 LEU^? 18.98 O1 GOL C1901 A 133 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 38.23 53.34 67.59 38.84 53.87 69.56 154.42 138.86 37.89 152.43 138.24 37.46 coo 35.40 53.22 73.30 35.37 54.87 74.74 160.44 139.04 39.12 160.48 139.99 41.05 coo 45.08 56.04 70.60 43.15 55.19 70.77 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 12 3 # 12 A 50 GLN C 107 GLN^? 15.17 O1 GOL C1901 A 91 LEU C 162 LEU^? 15.28 O1 GOL C1901 A 133 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 38.23 53.34 67.59 38.84 53.87 69.56 154.42 138.86 37.89 152.43 138.24 37.46 coo 35.40 53.22 73.30 35.37 54.87 74.74 153.66 137.34 43.51 152.39 136.80 41.85 coo 45.08 56.04 70.60 43.15 55.19 70.77 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 13 3 # 13 A 50 GLN C 112 GLN^? 24.26 O1 GOL C1901 A 91 LEU C 152 LEU.? 23.68 O1 GOL C1901 A 133 GLU C 14 GLU.? 32.06 O1 GOL C1901 coo 38.23 53.34 67.59 38.84 53.87 69.56 168.50 133.03 46.93 169.91 133.74 48.35 coo 35.40 53.22 73.30 35.37 54.87 74.74 164.23 137.51 50.25 166.14 136.71 49.71 coo 45.08 56.04 70.60 43.15 55.19 70.77 173.34 134.38 54.29 174.51 136.04 54.85 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 13 hits 1bsj_c00 naa= 3 ULMN 3 1c82_c02 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 408 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 480 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 191.47 153.75 14.17 189.52 154.05 13.44 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 190.70 148.50 17.91 191.29 151.03 18.92 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1c82_c02 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 408 TYR B 84 TYR^? 19.29 O4 CIT A1102 A 480 ARG B 101 ARG.? -6.88 O4 CIT A1102s coo 13.02 -18.02 35.24 12.75 -16.25 34.15 174.27 123.90 17.18 173.55 124.80 15.43 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 180.02 126.93 17.73 179.63 124.28 16.92 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 179.40 137.94 3.82 182.23 139.06 3.56 ULMN 3 1c82_c02 HYALURONATE LYASE user 3 3 # 3 A 399 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 408 TYR C 84 TYR^? 9.85 O1 GOL C1901 A 480 ARG C 101 ARG.? 18.11 O1 GOL C1901 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 153.36 123.09 43.85 154.03 121.98 42.20 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 155.65 129.37 42.44 156.62 127.68 44.43 coo -6.46 -13.31 26.85 -4.21 -11.25 27.13 163.77 126.78 27.00 165.49 129.29 26.85 1c82_c02 source 1c82 HYALURONATE LYASE : 3 hits 1c82_c02 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 16 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 67 GLY A 143 GLY.? 12.19 C8 ADE A 500 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 178.57 156.37 9.84 177.44 156.14 8.05 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 184.39 157.95 13.11 185.86 157.96 14.60 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 174.93 153.96 17.89 174.52 154.02 18.66 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 16 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 67 GLY A 170 GLY.? 7.13 N6 ADE A 500 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 178.57 156.37 9.84 177.44 156.14 8.05 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 184.39 157.95 13.11 185.86 157.96 14.60 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 179.43 148.38 7.40 178.96 149.01 7.51 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 16 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 67 GLY B 143 GLY.? 6.99 O4 CIT A1102 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 169.82 131.15 6.22 168.64 132.89 5.97 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 171.08 125.47 9.27 172.48 124.18 10.15 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 177.58 131.25 1.88 178.27 131.09 1.31 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 16 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 67 GLY B 170 GLY.? 8.41 O1 CIT A1102 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 169.82 131.15 6.22 168.64 132.89 5.97 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 171.08 125.47 9.27 172.48 124.18 10.15 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 170.68 137.70 10.86 170.48 137.43 10.11 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 16 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 67 GLY C 143 GLY.? 14.90 O1 GOL C1901 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 157.90 117.18 31.56 156.68 116.62 29.91 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 157.21 117.94 38.21 157.48 118.99 40.00 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 165.52 121.63 31.71 166.35 121.80 31.83 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 6 3 # 6 A 14 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 16 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 67 GLY C 144 GLY.? 16.29 O1 GOL C1901 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 157.90 117.18 31.56 156.68 116.62 29.91 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 157.21 117.94 38.21 157.48 118.99 40.00 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 167.03 118.92 33.88 166.95 119.67 34.15 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 7 3 # 7 A 14 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 16 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 67 GLY C 170 GLY.? 8.58 O1 GOL C1901 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 157.90 117.18 31.56 156.68 116.62 29.91 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 157.21 117.94 38.21 157.48 118.99 40.00 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 153.24 122.95 28.19 153.77 122.36 28.10 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 7 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 175 ASP.? 10.98 C4 ADE A 500 C 16 HIS A 176 HIS^? 6.39 N3 ADE A 500 C 67 GLY A 143 GLY.? 12.19 C8 ADE A 500 coo 10.04 44.27 88.44 9.47 42.32 89.03 178.57 156.37 9.84 177.44 156.14 8.05 coo 6.38 39.80 88.71 6.88 38.89 86.87 184.39 157.95 13.11 185.86 157.96 14.60 coo 17.63 42.50 89.25 18.11 42.29 88.64 174.93 153.96 17.89 174.52 154.02 18.66 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 175 ASP.? 10.98 C4 ADE A 500 C 16 HIS A 176 HIS^? 6.39 N3 ADE A 500 C 67 GLY A 170 GLY.? 7.13 N6 ADE A 500 coo 10.04 44.27 88.44 9.47 42.32 89.03 178.57 156.37 9.84 177.44 156.14 8.05 coo 6.38 39.80 88.71 6.88 38.89 86.87 184.39 157.95 13.11 185.86 157.96 14.60 coo 17.63 42.50 89.25 18.11 42.29 88.64 179.43 148.38 7.40 178.96 149.01 7.51 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP B 175 ASP.? 4.91 O1 CIT A1102 C 16 HIS B 176 HIS^? 13.79 O1 CIT A1102 C 67 GLY B 143 GLY.? 6.99 O4 CIT A1102 coo 10.04 44.27 88.44 9.47 42.32 89.03 169.82 131.15 6.22 168.64 132.89 5.97 coo 6.38 39.80 88.71 6.88 38.89 86.87 171.08 125.47 9.27 172.48 124.18 10.15 coo 17.63 42.50 89.25 18.11 42.29 88.64 177.58 131.25 1.88 178.27 131.09 1.31 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP B 175 ASP.? 4.91 O1 CIT A1102 C 16 HIS B 176 HIS^? 13.79 O1 CIT A1102 C 67 GLY B 170 GLY.? 8.41 O1 CIT A1102 coo 10.04 44.27 88.44 9.47 42.32 89.03 169.82 131.15 6.22 168.64 132.89 5.97 coo 6.38 39.80 88.71 6.88 38.89 86.87 171.08 125.47 9.27 172.48 124.18 10.15 coo 17.63 42.50 89.25 18.11 42.29 88.64 170.68 137.70 10.86 170.48 137.43 10.11 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP C 175 ASP.? 10.66 O1 GOL C1901 C 16 HIS C 176 HIS^? 7.29 C1 GOL C1901 C 67 GLY C 143 GLY.? 14.90 O1 GOL C1901 coo 10.04 44.27 88.44 9.47 42.32 89.03 157.90 117.18 31.56 156.68 116.62 29.91 coo 6.38 39.80 88.71 6.88 38.89 86.87 157.21 117.94 38.21 157.48 118.99 40.00 coo 17.63 42.50 89.25 18.11 42.29 88.64 165.52 121.63 31.71 166.35 121.80 31.83 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP C 175 ASP.? 10.66 O1 GOL C1901 C 16 HIS C 176 HIS^? 7.29 C1 GOL C1901 C 67 GLY C 144 GLY.? 16.29 O1 GOL C1901 coo 10.04 44.27 88.44 9.47 42.32 89.03 157.90 117.18 31.56 156.68 116.62 29.91 coo 6.38 39.80 88.71 6.88 38.89 86.87 157.21 117.94 38.21 157.48 118.99 40.00 coo 17.63 42.50 89.25 18.11 42.29 88.64 167.03 118.92 33.88 166.95 119.67 34.15 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 7 3 # 7 C 14 ASP C 175 ASP.? 10.66 O1 GOL C1901 C 16 HIS C 176 HIS^? 7.29 C1 GOL C1901 C 67 GLY C 170 GLY.? 8.58 O1 GOL C1901 coo 10.04 44.27 88.44 9.47 42.32 89.03 157.90 117.18 31.56 156.68 116.62 29.91 coo 6.38 39.80 88.71 6.88 38.89 86.87 157.21 117.94 38.21 157.48 118.99 40.00 coo 17.63 42.50 89.25 18.11 42.29 88.64 153.24 122.95 28.19 153.77 122.36 28.10 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 7 hits 1cb7_c07 naa= 3 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 1 3 # 1 183 GLU C 155 GLU~? 32.67 O1 GOL C1901 324 ASN C 154 ASN~? 23.43 O1 GOL C1901 397 GLU C 156 GLU~? 24.55 O1 GOL C1901 coo 39.31 34.78 85.95 38.51 34.50 84.04 159.66 146.89 54.14 160.20 148.86 54.76 coo 43.16 34.25 82.88 42.98 32.71 84.39 160.52 142.23 50.24 158.78 141.09 49.77 coo 42.23 29.47 82.87 40.46 30.21 83.67 157.99 144.71 47.12 158.90 144.92 45.19 ULMN 3 1cbg_c00 CYANOGENIC BETA-GLUCOSIDASE user 2 3 # 2 183 GLU C 156 GLU~? 24.55 O1 GOL C1901 324 ASN C 154 ASN~? 23.43 O1 GOL C1901 397 GLU C 155 GLU~? 32.67 O1 GOL C1901 coo 39.31 34.78 85.95 38.51 34.50 84.04 157.99 144.71 47.12 158.90 144.92 45.19 coo 43.16 34.25 82.88 42.98 32.71 84.39 160.52 142.23 50.24 158.78 141.09 49.77 coo 42.23 29.47 82.87 40.46 30.21 83.67 159.66 146.89 54.14 160.20 148.86 54.76 1cbg_c00 source 1cbg CYANOGENIC BETA-GLUCOSIDASE : 2 hits 1cbg_c00 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 36 ASP~? 21.71 N6 ADE A 500 264 GLU A 156 GLU.? 23.41 C8 ADE A 500 328 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo 45.62 80.42 43.69 45.65 82.01 45.07 203.35 139.46 11.01 205.31 139.04 11.69 coo 59.69 92.71 39.85 58.53 92.03 41.47 196.65 137.08 28.97 194.78 136.94 30.01 coo 45.39 90.72 40.63 45.07 89.14 41.90 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 36 ASP~? 28.48 O1 GOL C1901 264 GLU B 156 GLU.? 24.53 N7 ADE A 500 328 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo 45.62 80.42 43.69 45.65 82.01 45.07 178.67 130.13 34.24 179.32 129.31 36.04 coo 59.69 92.71 39.85 58.53 92.03 41.47 194.44 129.17 25.88 194.48 130.18 24.03 coo 45.39 90.72 40.63 45.07 89.14 41.90 188.71 136.74 34.61 188.50 136.01 36.57 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 2 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP B 89 ASP.? 31.34 O4 CIT A1102 257 GLU B 25 GLU.? 28.27 O1 GOL C1901 328 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 45.62 80.42 43.69 45.65 82.01 45.07 181.93 115.70 26.33 180.57 117.33 26.20 coo 48.97 85.16 40.39 47.18 86.25 40.47 179.49 113.39 31.74 177.60 113.83 30.87 coo 45.39 90.72 40.63 45.07 89.14 41.90 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP C 119 ASP.? 26.31 O1 GOL C1901 257 GLU B 25 GLU.? 28.27 O1 GOL C1901 328 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 45.62 80.42 43.69 45.65 82.01 45.07 178.03 118.40 36.14 177.70 120.46 36.31 coo 48.97 85.16 40.39 47.18 86.25 40.47 179.49 113.39 31.74 177.60 113.83 30.87 coo 45.39 90.72 40.63 45.07 89.14 41.90 181.93 115.70 26.33 180.57 117.33 26.20 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 2 hits 1cdg_c04 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS B 202 HIS.? 28.80 C2 CIT A1102 A 262 GLU B 182 GLU~? 29.98 C2 CIT A1102 A 358 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 26.19 60.87 43.98 27.48 59.27 43.30 175.03 109.49 9.82 173.45 108.46 10.74 coo 27.13 54.07 50.45 26.96 54.19 48.35 180.61 109.47 2.81 182.18 108.21 3.48 coo 27.06 50.43 44.36 27.99 52.27 44.74 174.79 115.83 -0.09 173.37 117.02 0.92 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 1 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS B 202 HIS.? 28.80 C2 CIT A1102 B 262 GLU B 182 GLU~? 29.98 C2 CIT A1102 B 358 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 44.98 77.01 48.39 44.42 78.67 47.18 175.03 109.49 9.82 173.45 108.46 10.74 coo 41.60 83.57 54.16 42.46 83.24 52.25 180.61 109.47 2.81 182.18 108.21 3.48 coo 44.05 87.61 48.73 43.15 85.67 48.52 174.79 115.83 -0.09 173.37 117.02 0.92 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 1 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 45 GLY.? 10.73 N9 ADE A 500 A 228 SER A 90 SER.? 14.48 N3 ADE A 500 A 549 ASP A 89 ASP.? 18.10 N3 ADE A 500 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 194.65 155.46 18.65 194.04 154.92 18.22 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 199.47 153.71 22.16 199.01 152.90 19.92 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 203.02 151.24 21.31 203.43 152.46 19.71 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 170 GLY.? 7.13 N6 ADE A 500 A 228 SER A 54 SER.? 4.61 O3 CIT A1102 A 549 ASP A 52 ASP^? 9.33 O4 CIT A1102 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 179.43 148.38 7.40 178.96 149.01 7.51 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 180.68 142.57 2.59 178.38 141.86 2.59 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 185.72 140.93 6.30 184.35 140.00 4.99 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 45 GLY.? 23.68 O4 CIT A1102 A 228 SER B 90 SER.? 26.90 O4 CIT A1102 A 549 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 177.24 119.43 17.85 177.04 120.22 17.68 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 181.23 117.12 21.89 179.24 118.41 21.27 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 46 GLY.? 23.93 O4 CIT A1102 A 228 SER B 90 SER.? 26.90 O4 CIT A1102 A 549 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 179.08 121.64 20.30 178.23 121.42 20.36 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 181.23 117.12 21.89 179.24 118.41 21.27 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY B 170 GLY.? 8.41 O1 CIT A1102 A 228 SER B 54 SER.? 13.70 O5 CIT A1102 A 549 ASP B 52 ASP^? 16.07 C8 ADE A 500 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 170.68 137.70 10.86 170.48 137.43 10.11 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 170.01 143.15 16.19 170.47 144.95 14.66 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 173.93 140.35 20.11 173.24 142.10 19.12 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY C 45 GLY.? 11.06 O3 GOL C1901 A 228 SER C 90 SER.? 14.02 O3 GOL C1901 A 549 ASP C 89 ASP.? 17.67 O3 GOL C1901 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 155.66 124.22 48.62 155.39 124.25 47.85 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 155.07 128.53 53.12 154.12 126.92 51.57 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 152.15 130.32 56.35 151.16 130.16 54.50 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 A 198 GLY C 46 GLY.? 11.75 O3 GOL C1901 A 228 SER C 90 SER.? 14.02 O3 GOL C1901 A 549 ASP C 89 ASP.? 17.67 O3 GOL C1901 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 154.15 127.64 48.04 153.68 126.93 48.08 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 155.07 128.53 53.12 154.12 126.92 51.57 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 152.15 130.32 56.35 151.16 130.16 54.50 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 A 198 GLY C 170 GLY.? 8.58 O1 GOL C1901 A 228 SER C 54 SER.? 14.46 O1 GOL C1901 A 549 ASP C 52 ASP^? 12.06 O1 GOL C1901 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 153.24 122.95 28.19 153.77 122.36 28.10 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 147.47 126.83 25.21 148.44 127.11 23.04 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 147.21 130.59 30.19 147.01 130.37 28.08 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 8 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 45 GLY.? 10.73 N9 ADE A 500 B1228 SER A 90 SER.? 14.48 N3 ADE A 500 B1549 ASP A 89 ASP.? 18.10 N3 ADE A 500 coo 126.34 72.75 125.66 125.95 73.27 126.11 194.65 155.46 18.65 194.04 154.92 18.22 coo 131.65 74.68 129.41 130.31 72.73 128.82 199.47 153.71 22.16 199.01 152.90 19.92 coo 134.72 69.43 130.42 133.03 70.65 130.08 203.02 151.24 21.31 203.43 152.46 19.71 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 170 GLY.? 7.13 N6 ADE A 500 B1228 SER A 54 SER.? 4.61 O3 CIT A1102 B1549 ASP A 52 ASP^? 9.33 O4 CIT A1102 coo 126.34 72.75 125.66 125.95 73.27 126.11 179.43 148.38 7.40 178.96 149.01 7.51 coo 131.65 74.68 129.41 130.31 72.73 128.82 180.68 142.57 2.59 178.38 141.86 2.59 coo 134.72 69.43 130.42 133.03 70.65 130.08 185.72 140.93 6.30 184.35 140.00 4.99 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY B 45 GLY.? 23.68 O4 CIT A1102 B1228 SER B 90 SER.? 26.90 O4 CIT A1102 B1549 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 126.34 72.75 125.66 125.95 73.27 126.11 177.24 119.43 17.85 177.04 120.22 17.68 coo 131.65 74.68 129.41 130.31 72.73 128.82 181.23 117.12 21.89 179.24 118.41 21.27 coo 134.72 69.43 130.42 133.03 70.65 130.08 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 46 GLY.? 23.93 O4 CIT A1102 B1228 SER B 90 SER.? 26.90 O4 CIT A1102 B1549 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 126.34 72.75 125.66 125.95 73.27 126.11 179.08 121.64 20.30 178.23 121.42 20.36 coo 131.65 74.68 129.41 130.31 72.73 128.82 181.23 117.12 21.89 179.24 118.41 21.27 coo 134.72 69.43 130.42 133.03 70.65 130.08 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 170 GLY.? 8.41 O1 CIT A1102 B1228 SER B 54 SER.? 13.70 O5 CIT A1102 B1549 ASP B 52 ASP^? 16.07 C8 ADE A 500 coo 126.34 72.75 125.66 125.95 73.27 126.11 170.68 137.70 10.86 170.48 137.43 10.11 coo 131.65 74.68 129.41 130.31 72.73 128.82 170.01 143.15 16.19 170.47 144.95 14.66 coo 134.72 69.43 130.42 133.03 70.65 130.08 173.93 140.35 20.11 173.24 142.10 19.12 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY C 45 GLY.? 11.06 O3 GOL C1901 B1228 SER C 90 SER.? 14.02 O3 GOL C1901 B1549 ASP C 89 ASP.? 17.67 O3 GOL C1901 coo 126.34 72.75 125.66 125.95 73.27 126.11 155.66 124.22 48.62 155.39 124.25 47.85 coo 131.65 74.68 129.41 130.31 72.73 128.82 155.07 128.53 53.12 154.12 126.92 51.57 coo 134.72 69.43 130.42 133.03 70.65 130.08 152.15 130.32 56.35 151.16 130.16 54.50 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 B1198 GLY C 46 GLY.? 11.75 O3 GOL C1901 B1228 SER C 90 SER.? 14.02 O3 GOL C1901 B1549 ASP C 89 ASP.? 17.67 O3 GOL C1901 coo 126.34 72.75 125.66 125.95 73.27 126.11 154.15 127.64 48.04 153.68 126.93 48.08 coo 131.65 74.68 129.41 130.31 72.73 128.82 155.07 128.53 53.12 154.12 126.92 51.57 coo 134.72 69.43 130.42 133.03 70.65 130.08 152.15 130.32 56.35 151.16 130.16 54.50 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 B1198 GLY C 170 GLY.? 8.58 O1 GOL C1901 B1228 SER C 54 SER.? 14.46 O1 GOL C1901 B1549 ASP C 52 ASP^? 12.06 O1 GOL C1901 coo 126.34 72.75 125.66 125.95 73.27 126.11 153.24 122.95 28.19 153.77 122.36 28.10 coo 131.65 74.68 129.41 130.31 72.73 128.82 147.47 126.83 25.21 148.44 127.11 23.04 coo 134.72 69.43 130.42 133.03 70.65 130.08 147.21 130.59 30.19 147.01 130.37 28.08 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 8 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 89 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 120 SER A 149 SER^? 11.10 N9 ADE A 500 coo -24.35 9.53 67.64 -25.07 11.29 68.60 185.43 146.45 17.17 186.00 148.48 17.29 coo -31.18 6.91 75.60 -32.39 8.51 74.91 188.90 156.57 17.91 187.92 156.12 16.11 coo -34.73 8.57 68.21 -33.63 9.08 70.28 188.74 152.31 25.78 189.32 151.10 23.76 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 89 GLU A 50 GLU^? -3.91 N6 ADE A 500s A 120 SER A 79 SER.? 7.17 O4 CIT A1102 coo -24.35 9.53 67.64 -25.07 11.29 68.60 185.43 146.45 17.17 186.00 148.48 17.29 coo -31.18 6.91 75.60 -32.39 8.51 74.91 187.90 146.65 6.60 187.00 148.18 5.47 coo -34.73 8.57 68.21 -33.63 9.08 70.28 179.20 144.60 7.13 179.51 142.21 7.02 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 89 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 120 SER B 149 SER^? 19.92 O4 CIT A1102 coo -24.35 9.53 67.64 -25.07 11.29 68.60 180.17 131.30 14.36 179.09 129.62 13.64 coo -31.18 6.91 75.60 -32.39 8.51 74.91 174.85 121.76 12.80 173.53 120.38 11.97 coo -34.73 8.57 68.21 -33.63 9.08 70.28 184.89 121.99 12.52 183.61 123.38 14.10 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 89 GLU B 50 GLU^? 15.33 O1 CIT A1102 A 120 SER B 79 SER.? 11.49 O4 CIT A1102 coo -24.35 9.53 67.64 -25.07 11.29 68.60 180.17 131.30 14.36 179.09 129.62 13.64 coo -31.18 6.91 75.60 -32.39 8.51 74.91 171.15 134.64 18.99 169.39 134.49 17.85 coo -34.73 8.57 68.21 -33.63 9.08 70.28 172.67 140.46 12.34 174.10 141.88 13.69 ULMN 3 1cns_c00 CHITINASE user 5 3 # 5 A 67 GLU C 156 GLU~? 24.55 O1 GOL C1901 A 89 GLU C 135 GLU.? 26.33 O1 GOL C1901 A 120 SER C 137 SER.? 22.99 O1 GOL C1901 coo -24.35 9.53 67.64 -25.07 11.29 68.60 157.99 144.71 47.12 158.90 144.92 45.19 coo -31.18 6.91 75.60 -32.39 8.51 74.91 168.08 142.51 43.72 166.57 142.98 45.14 coo -34.73 8.57 68.21 -33.63 9.08 70.28 163.55 140.21 37.15 163.65 142.66 37.22 ULMN 3 1cns_c00 CHITINASE user 6 3 # 6 A 67 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 89 GLU C 50 GLU^? -3.82 O2 GOL C1901s A 120 SER C 79 SER.? 11.88 O1 GOL C1901 coo -24.35 9.53 67.64 -25.07 11.29 68.60 157.34 129.59 37.15 157.60 127.69 38.11 coo -31.18 6.91 75.60 -32.39 8.51 74.91 147.72 125.56 34.28 147.67 123.54 33.74 coo -34.73 8.57 68.21 -33.63 9.08 70.28 152.54 126.39 26.52 151.63 128.65 26.08 1cns_c00 source 1cns CHITINASE : 6 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 156 GLU.? 23.41 C8 ADE A 500 B 89 GLU A 135 GLU.? 23.34 C8 ADE A 500 B 120 SER A 137 SER.? 19.19 C8 ADE A 500 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 196.65 137.08 28.97 194.78 136.94 30.01 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 187.40 140.84 33.48 189.24 139.81 33.69 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 184.43 139.00 26.42 183.74 136.66 26.44 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 89 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 120 SER A 149 SER^? 11.10 N9 ADE A 500 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 185.43 146.45 17.17 186.00 148.48 17.29 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 188.90 156.57 17.91 187.92 156.12 16.11 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 188.74 152.31 25.78 189.32 151.10 23.76 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 89 GLU A 50 GLU^? -3.91 N6 ADE A 500s B 120 SER A 79 SER.? 7.17 O4 CIT A1102 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 185.43 146.45 17.17 186.00 148.48 17.29 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 187.90 146.65 6.60 187.00 148.18 5.47 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 179.20 144.60 7.13 179.51 142.21 7.02 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 89 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 120 SER B 149 SER^? 19.92 O4 CIT A1102 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 174.85 121.76 12.80 173.53 120.38 11.97 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 180.17 131.30 14.36 179.09 129.62 13.64 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 184.89 121.99 12.52 183.61 123.38 14.10 ULMN 3 1cns_c01 CHITINASE user 5 3 # 5 B 67 GLU B 135 GLU.? 25.67 N6 ADE A 500 B 89 GLU B 14 GLU.? 33.67 O4 CIT A1102 B 120 SER B 124 SER^? 23.63 O4 CIT A1102 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 197.88 127.79 14.29 197.78 127.39 16.36 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 196.57 114.78 10.83 198.67 114.78 11.14 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 191.23 122.78 5.73 191.55 121.05 7.41 ULMN 3 1cns_c01 CHITINASE user 6 3 # 6 B 67 GLU B 156 GLU.? 24.53 N7 ADE A 500 B 89 GLU B 135 GLU.? 25.67 N6 ADE A 500 B 120 SER B 137 SER.? 16.00 N6 ADE A 500 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 194.44 129.17 25.88 194.48 130.18 24.03 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 197.88 127.79 14.29 197.78 127.39 16.36 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 192.22 133.71 14.40 193.34 135.87 14.56 ULMN 3 1cns_c01 CHITINASE user 7 3 # 7 B 67 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 89 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 120 SER B 149 SER^? 19.92 O4 CIT A1102 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 180.17 131.30 14.36 179.09 129.62 13.64 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 174.85 121.76 12.80 173.53 120.38 11.97 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 184.89 121.99 12.52 183.61 123.38 14.10 ULMN 3 1cns_c01 CHITINASE user 8 3 # 8 B 67 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 89 GLU B 50 GLU^? 15.33 O1 CIT A1102 B 120 SER B 79 SER.? 11.49 O4 CIT A1102 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 180.17 131.30 14.36 179.09 129.62 13.64 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 171.15 134.64 18.99 169.39 134.49 17.85 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 172.67 140.46 12.34 174.10 141.88 13.69 ULMN 3 1cns_c01 CHITINASE user 9 3 # 9 B 67 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 89 GLU C 165 GLU^? 7.74 O1 GOL C1901 B 120 SER C 149 SER^? 14.30 O1 GOL C1901 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 157.18 120.22 44.20 157.97 118.54 45.19 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 157.34 129.59 37.15 157.60 127.69 38.11 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 163.58 128.93 46.04 161.38 129.11 45.07 ULMN 3 1cns_c01 CHITINASE user 10 3 # 10 B 67 GLU C 156 GLU~? 24.55 O1 GOL C1901 B 89 GLU C 135 GLU.? 26.33 O1 GOL C1901 B 120 SER C 137 SER.? 22.99 O1 GOL C1901 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 157.99 144.71 47.12 158.90 144.92 45.19 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 168.08 142.51 43.72 166.57 142.98 45.14 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 163.55 140.21 37.15 163.65 142.66 37.22 ULMN 3 1cns_c01 CHITINASE user 11 3 # 11 B 67 GLU C 165 GLU^? 7.74 O1 GOL C1901 B 89 GLU C 50 GLU^? -3.82 O2 GOL C1901s B 120 SER C 79 SER.? 11.88 O1 GOL C1901 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 157.34 129.59 37.15 157.60 127.69 38.11 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 147.72 125.56 34.28 147.67 123.54 33.74 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 152.54 126.39 26.52 151.63 128.65 26.08 1cns_c01 source 1cns CHITINASE : 11 hits 1cns_c01 naa= 3 ULMN 3 1coy_c00 CHOLESTEROL OXIDASE (E.C.1.1.3.6) COuser 1 3 # 1 361 GLU C 165 GLU^? 7.74 O1 GOL C1901 447 HIS C 96 HIS^? 9.69 C1 GOL C1901 485 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo -7.99 19.51 30.67 -8.74 17.98 29.42 157.34 129.59 37.15 157.60 127.69 38.11 coo -15.81 17.12 25.99 -13.91 16.92 26.88 160.37 121.38 41.43 159.84 123.37 41.06 coo -13.17 13.85 30.36 -11.76 15.41 30.53 160.68 120.91 34.68 159.00 120.62 33.38 1coy_c00 source 1coy CHOLESTEROL OXIDASE (E.C.1.1.3.6) COMPLEX WITH: 1 hits 1coy_c00 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 131 TYR~? 27.02 C8 ADE A 500 A 173 ASP B 36 ASP~? 28.48 O1 GOL C1901 C 48 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 182.79 134.12 33.10 182.43 131.46 33.83 coo 24.35 4.55 25.11 25.94 3.23 25.53 178.67 130.13 34.24 179.32 129.31 36.04 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 131 TYR~? 20.61 N6 ADE A 500 A 173 ASP A 36 ASP~? 21.71 N6 ADE A 500 C 48 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 200.50 135.01 13.30 202.41 136.93 13.95 coo 24.35 4.55 25.11 25.94 3.23 25.53 203.35 139.46 11.01 205.31 139.04 11.69 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 195.17 135.76 22.50 193.88 133.29 23.81 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 108 ARG^? 21.78 N7 ADE A 500 C 101 TYR B 131 TYR~? 20.61 N6 ADE A 500 C 173 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 32.27 5.62 48.15 31.93 6.48 51.06 195.17 135.76 22.50 193.88 133.29 23.81 coo 29.64 3.64 57.39 31.22 5.14 55.65 200.50 135.01 13.30 202.41 136.93 13.95 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 108 ARG^? 25.54 C8 ADE A 500 C 101 TYR A 131 TYR~? 27.02 C8 ADE A 500 C 173 ASP B 36 ASP~? 28.48 O1 GOL C1901 coo 32.27 5.62 48.15 31.93 6.48 51.06 188.64 131.77 26.61 189.85 131.11 29.36 coo 29.64 3.64 57.39 31.22 5.14 55.65 182.79 134.12 33.10 182.43 131.46 33.83 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 178.67 130.13 34.24 179.32 129.31 36.04 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 108 ARG^? 21.78 N7 ADE A 500 D 101 TYR B 131 TYR~? 20.61 N6 ADE A 500 D 173 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 69.08 8.58 32.60 69.70 10.81 30.58 195.17 135.76 22.50 193.88 133.29 23.81 coo 71.77 11.86 24.26 70.23 12.22 26.56 200.50 135.01 13.30 202.41 136.93 13.95 coo 71.60 6.14 19.25 70.26 6.87 20.69 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 108 ARG^? 25.54 C8 ADE A 500 D 101 TYR A 131 TYR~? 27.02 C8 ADE A 500 D 173 ASP B 36 ASP~? 28.48 O1 GOL C1901 coo 69.08 8.58 32.60 69.70 10.81 30.58 188.64 131.77 26.61 189.85 131.11 29.36 coo 71.77 11.86 24.26 70.23 12.22 26.56 182.79 134.12 33.10 182.43 131.46 33.83 coo 71.60 6.14 19.25 70.26 6.87 20.69 178.67 130.13 34.24 179.32 129.31 36.04 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 131 TYR~? 27.02 C8 ADE A 500 B 173 ASP B 36 ASP~? 28.48 O1 GOL C1901 D 48 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 182.79 134.12 33.10 182.43 131.46 33.83 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 178.67 130.13 34.24 179.32 129.31 36.04 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 131 TYR~? 20.61 N6 ADE A 500 B 173 ASP A 36 ASP~? 21.71 N6 ADE A 500 D 48 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 200.50 135.01 13.30 202.41 136.93 13.95 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 203.35 139.46 11.01 205.31 139.04 11.69 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 195.17 135.76 22.50 193.88 133.29 23.81 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP C 119 ASP.? 26.31 O1 GOL C1901 315 GLU B 25 GLU.? 28.27 O1 GOL C1901 390 TYR B 47 TYR^? 27.62 O4 CIT A1102 coo 32.46 99.13 19.34 30.94 100.38 20.07 178.03 118.40 36.14 177.70 120.46 36.31 coo 32.04 94.22 18.23 30.57 94.75 16.88 179.49 113.39 31.74 177.60 113.83 30.87 coo 21.10 94.74 18.36 23.09 96.71 18.59 177.82 122.79 24.63 178.10 120.27 25.77 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 1 hits 1ctn_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 56 ILE A 40 ILE^? 9.89 C2 ADE A 500 A 82 TYR A 47 TYR^? 13.72 N3 ADE A 500 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 203.35 139.46 11.01 205.31 139.04 11.69 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 197.81 151.14 9.65 197.15 150.81 8.29 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 198.66 149.45 16.16 201.00 150.74 16.95 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 56 ILE B 40 ILE^? 23.00 O1 GOL C1901 A 82 TYR B 47 TYR^? 27.62 O4 CIT A1102 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 178.67 130.13 34.24 179.32 129.31 36.04 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 171.49 124.80 24.57 171.02 124.74 25.19 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 177.82 122.79 24.63 178.10 120.27 25.77 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP C 36 ASP~? 21.70 O1 GOL C1901 A 56 ILE C 40 ILE^? 8.63 O3 GOL C1901 A 82 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 140.93 137.00 45.78 140.14 138.07 47.46 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 145.73 124.81 45.15 144.64 124.39 45.92 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 149.80 129.36 48.45 149.55 129.08 51.21 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 3 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 36 ASP~? 21.71 N6 ADE A 500 B 56 ILE A 40 ILE^? 9.89 C2 ADE A 500 B 82 TYR A 47 TYR^? 13.72 N3 ADE A 500 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 203.35 139.46 11.01 205.31 139.04 11.69 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 197.81 151.14 9.65 197.15 150.81 8.29 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 198.66 149.45 16.16 201.00 150.74 16.95 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 56 ILE B 40 ILE^? 23.00 O1 GOL C1901 B 82 TYR B 47 TYR^? 27.62 O4 CIT A1102 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 178.67 130.13 34.24 179.32 129.31 36.04 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 171.49 124.80 24.57 171.02 124.74 25.19 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 177.82 122.79 24.63 178.10 120.27 25.77 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP C 36 ASP~? 21.70 O1 GOL C1901 B 56 ILE C 40 ILE^? 8.63 O3 GOL C1901 B 82 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 140.93 137.00 45.78 140.14 138.07 47.46 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 145.73 124.81 45.15 144.64 124.39 45.92 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 149.80 129.36 48.45 149.55 129.08 51.21 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 3 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 243 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 272 LYS A 62 LYS^? 14.90 N3 ADE A 500 coo 2.03 68.31 21.46 0.66 68.36 23.90 185.14 149.36 25.84 186.22 148.61 23.38 coo 16.93 55.67 9.65 17.16 54.23 11.19 180.59 154.59 5.93 180.83 155.75 4.19 coo 14.13 45.79 13.40 14.25 49.41 18.30 170.54 158.67 6.99 175.63 160.94 7.57 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 243 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 272 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo 2.03 68.31 21.46 0.66 68.36 23.90 185.14 149.36 25.84 186.22 148.61 23.38 coo 16.93 55.67 9.65 17.16 54.23 11.19 178.67 130.13 34.24 179.32 129.31 36.04 coo 14.13 45.79 13.40 14.25 49.41 18.30 174.37 128.14 41.95 175.88 130.01 36.96 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR A 131 TYR~? 27.02 C8 ADE A 500 A 243 ASP B 130 ASP~? 26.83 N6 ADE A 500 A 272 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 2.03 68.31 21.46 0.66 68.36 23.90 182.79 134.12 33.10 182.43 131.46 33.83 coo 16.93 55.67 9.65 17.16 54.23 11.19 200.55 129.62 17.17 202.64 129.41 16.98 coo 14.13 45.79 13.40 14.25 49.41 18.30 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR A 131 TYR~? 27.02 C8 ADE A 500 A 243 ASP C 130 ASP.? 30.92 O1 GOL C1901 A 272 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 2.03 68.31 21.46 0.66 68.36 23.90 182.79 134.12 33.10 182.43 131.46 33.83 coo 16.93 55.67 9.65 17.16 54.23 11.19 167.73 145.95 43.64 168.62 147.66 44.50 coo 14.13 45.79 13.40 14.25 49.41 18.30 161.71 139.26 46.53 163.20 144.39 46.83 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 5 3 # 5 A 173 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 243 ASP B 172 ASP~? 8.81 O1 CIT A1102 A 272 LYS B 62 LYS^? 8.83 O2 CIT A1102 coo 2.03 68.31 21.46 0.66 68.36 23.90 186.72 125.72 10.79 185.00 126.80 12.71 coo 16.93 55.67 9.65 17.16 54.23 11.19 166.30 133.15 8.87 164.29 132.56 8.69 coo 14.13 45.79 13.40 14.25 49.41 18.30 165.33 135.53 -1.27 161.40 132.35 2.38 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 6 3 # 6 A 173 TYR B 131 TYR~? 20.61 N6 ADE A 500 A 243 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 272 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 2.03 68.31 21.46 0.66 68.36 23.90 200.50 135.01 13.30 202.41 136.93 13.95 coo 16.93 55.67 9.65 17.16 54.23 11.19 188.71 136.74 34.61 188.50 136.01 36.57 coo 14.13 45.79 13.40 14.25 49.41 18.30 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 7 3 # 7 A 173 TYR C 84 TYR^? 9.85 O1 GOL C1901 A 243 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 272 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 2.03 68.31 21.46 0.66 68.36 23.90 155.65 129.37 42.44 156.62 127.68 44.43 coo 16.93 55.67 9.65 17.16 54.23 11.19 178.67 130.13 34.24 179.32 129.31 36.04 coo 14.13 45.79 13.40 14.25 49.41 18.30 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 8 3 # 8 A 173 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 243 ASP C 172 ASP~? 9.22 O2 GOL C1901 A 272 LYS C 62 LYS^? 15.99 O2 GOL C1901 coo 2.03 68.31 21.46 0.66 68.36 23.90 165.10 130.81 41.92 162.37 130.83 41.35 coo 16.93 55.67 9.65 17.16 54.23 11.19 153.21 116.81 30.64 152.37 114.88 30.62 coo 14.13 45.79 13.40 14.25 49.41 18.30 160.07 111.06 24.23 156.23 109.52 28.21 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 9 3 # 9 A 173 TYR C 131 TYR.? 29.32 C8 ADE A 500 A 243 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 272 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 2.03 68.31 21.46 0.66 68.36 23.90 168.57 146.54 37.64 168.87 149.06 36.42 coo 16.93 55.67 9.65 17.16 54.23 11.19 188.71 136.74 34.61 188.50 136.01 36.57 coo 14.13 45.79 13.40 14.25 49.41 18.30 192.52 142.86 28.75 192.00 138.78 32.31 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 9 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 177 GLU A 184 GLU~? 18.03 N9 ADE A 500 A 201 LEU A 179 LEU.? 15.79 N9 ADE A 500 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 180.69 158.10 18.36 176.95 162.62 18.15 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 180.48 167.65 23.03 180.45 166.67 21.17 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 184.39 163.22 22.10 184.20 164.27 23.98 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 177 GLU A 182 GLU~? 24.67 N9 ADE A 500 A 201 LEU A 185 LEU~? 20.19 N9 ADE A 500 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 185.07 167.50 20.34 181.31 169.96 15.85 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 187.83 168.13 29.26 189.30 168.72 30.65 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 184.18 165.92 27.88 184.62 163.92 28.49 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 A 145 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 177 GLU C 184 GLU~? 18.70 O3 GOL C1901 A 201 LEU C 179 LEU.? 17.41 O3 GOL C1901 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 161.58 122.48 47.40 160.49 120.58 53.33 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 168.68 112.73 44.51 166.86 112.61 43.45 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 165.23 116.77 45.20 167.34 116.76 45.58 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 A 145 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 177 GLU C 184 GLU~? 18.70 O3 GOL C1901 A 201 LEU C 179 LEU.? 17.41 O3 GOL C1901 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 163.30 119.33 38.22 166.56 114.68 36.90 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 168.68 112.73 44.51 166.86 112.61 43.45 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 165.23 116.77 45.20 167.34 116.76 45.58 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 4 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 177 GLU A 184 GLU~? 18.03 N9 ADE A 500 B 201 LEU A 179 LEU.? 15.79 N9 ADE A 500 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 180.69 158.10 18.36 176.95 162.62 18.15 coo 27.00 6.35 51.01 26.30 4.53 50.18 180.48 167.65 23.03 180.45 166.67 21.17 coo 23.74 1.68 49.50 22.87 -0.24 49.97 184.39 163.22 22.10 184.20 164.27 23.98 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS A 180 LYS~? 18.96 N3 ADE A 500 B 177 GLU A 182 GLU~? 24.67 N9 ADE A 500 B 201 LEU A 185 LEU~? 20.19 N9 ADE A 500 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 185.07 167.50 20.34 181.31 169.96 15.85 coo 27.00 6.35 51.01 26.30 4.53 50.18 187.83 168.13 29.26 189.30 168.72 30.65 coo 23.74 1.68 49.50 22.87 -0.24 49.97 184.18 165.92 27.88 184.62 163.92 28.49 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 3 3 # 3 B 145 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 177 GLU B 184 GLU~? 19.18 C2 CIT A1102 B 201 LEU B 179 LEU.? 19.82 C2 CIT A1102 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 175.75 125.08 4.60 173.18 124.12 -0.61 coo 27.00 6.35 51.01 26.30 4.53 50.18 174.79 115.83 -0.09 173.37 117.02 0.92 coo 23.74 1.68 49.50 22.87 -0.24 49.97 175.42 117.47 3.45 176.95 116.74 4.78 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 4 3 # 4 B 145 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 177 GLU C 184 GLU~? 18.70 O3 GOL C1901 B 201 LEU C 179 LEU.? 17.41 O3 GOL C1901 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 161.58 122.48 47.40 160.49 120.58 53.33 coo 27.00 6.35 51.01 26.30 4.53 50.18 168.68 112.73 44.51 166.86 112.61 43.45 coo 23.74 1.68 49.50 22.87 -0.24 49.97 165.23 116.77 45.20 167.34 116.76 45.58 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 5 3 # 5 B 145 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 177 GLU C 184 GLU~? 18.70 O3 GOL C1901 B 201 LEU C 179 LEU.? 17.41 O3 GOL C1901 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 163.30 119.33 38.22 166.56 114.68 36.90 coo 27.00 6.35 51.01 26.30 4.53 50.18 168.68 112.73 44.51 166.86 112.61 43.45 coo 23.74 1.68 49.50 22.87 -0.24 49.97 165.23 116.77 45.20 167.34 116.76 45.58 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 6 3 # 6 B 145 LYS C 193 LYS~? 28.43 O1 GOL C1901 B 177 GLU C 182 GLU~? 26.37 O3 GOL C1901 B 201 LEU C 185 LEU~? 22.40 O3 GOL C1901 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 177.05 121.15 50.66 176.96 126.15 48.94 coo 27.00 6.35 51.01 26.30 4.53 50.18 170.51 115.98 53.19 171.23 115.96 55.18 coo 23.74 1.68 49.50 22.87 -0.24 49.97 170.83 116.75 48.61 170.51 118.87 48.39 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 7 3 # 7 B 145 LYS C 193 LYS~? 28.43 O1 GOL C1901 B 177 GLU C 182 GLU~? 26.37 O3 GOL C1901 B 201 LEU C 197 LEU~? 23.74 C1 GOL C1901 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 177.05 121.15 50.66 176.96 126.15 48.94 coo 27.00 6.35 51.01 26.30 4.53 50.18 170.51 115.98 53.19 171.23 115.96 55.18 coo 23.74 1.68 49.50 22.87 -0.24 49.97 171.31 122.49 49.83 172.36 123.89 48.55 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 7 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 51 THR^? 8.68 N6 ADE A 500 A 156 TYR A 83 TYR^? 11.70 N6 ADE A 500 A 160 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 10.50 56.87 17.73 11.24 57.93 19.43 189.89 142.39 7.18 190.42 141.55 9.05 coo 11.64 63.07 23.95 11.76 62.47 21.20 192.51 141.71 13.59 192.79 138.96 13.21 coo 5.78 61.30 21.65 8.04 62.89 17.54 193.06 146.52 10.07 195.03 144.09 6.09 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 1 hits 1db3_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 63 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 89 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo 49.66 36.74 42.37 48.88 35.30 43.64 184.39 157.95 13.11 185.86 157.96 14.60 coo 49.93 35.76 35.94 51.58 36.96 35.47 185.28 156.61 18.37 185.56 154.55 18.68 coo 46.15 35.33 47.12 47.46 33.99 46.29 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 63 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 89 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 49.66 36.74 42.37 48.88 35.30 43.64 171.08 125.47 9.27 172.48 124.18 10.15 coo 49.93 35.76 35.94 51.58 36.96 35.47 176.50 123.51 9.48 177.50 124.87 10.72 coo 46.15 35.33 47.12 47.46 33.99 46.29 169.82 131.15 6.22 168.64 132.89 5.97 ULMN 3 1dco_c00 DCOH user 3 3 # 3 A 62 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 63 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 89 ASP C 175 ASP.? 10.66 O1 GOL C1901 coo 49.66 36.74 42.37 48.88 35.30 43.64 157.21 117.94 38.21 157.48 118.99 40.00 coo 49.93 35.76 35.94 51.58 36.96 35.47 160.37 121.38 41.43 159.84 123.37 41.06 coo 46.15 35.33 47.12 47.46 33.99 46.29 157.90 117.18 31.56 156.68 116.62 29.91 1dco_c00 source 1dco DCOH : 3 hits 1dco_c00 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 96 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 137 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 1.83 2.95 4.76 1.26 0.98 4.81 191.47 153.75 14.17 189.52 154.05 13.44 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 188.90 156.57 17.91 187.92 156.12 16.11 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 2 3 # 2 A 50 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 96 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 137 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 1.83 2.95 4.76 1.26 0.98 4.81 183.15 146.13 20.69 182.60 148.09 20.18 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 185.43 146.45 17.17 186.00 148.48 17.29 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 3 3 # 3 A 50 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 96 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 137 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 1.83 2.95 4.76 1.26 0.98 4.81 183.15 146.13 20.69 182.60 148.09 20.18 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 185.43 146.45 17.17 186.00 148.48 17.29 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 4 3 # 4 A 50 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 96 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 137 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 1.83 2.95 4.76 1.26 0.98 4.81 184.39 157.95 13.11 185.86 157.96 14.60 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 188.90 156.57 17.91 187.92 156.12 16.11 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 5 3 # 5 A 50 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 96 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 137 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 1.83 2.95 4.76 1.26 0.98 4.81 183.49 131.36 11.56 181.98 130.36 10.51 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 180.17 131.30 14.36 179.09 129.62 13.64 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 6 3 # 6 A 50 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 96 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 137 HIS B 96 HIS^? 15.42 O4 CIT A1102 coo 1.83 2.95 4.76 1.26 0.98 4.81 183.49 131.36 11.56 181.98 130.36 10.51 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 180.17 131.30 14.36 179.09 129.62 13.64 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 176.50 123.51 9.48 177.50 124.87 10.72 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 7 3 # 7 A 50 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 96 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 137 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo 1.83 2.95 4.76 1.26 0.98 4.81 153.36 123.09 43.85 154.03 121.98 42.20 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 157.18 120.22 44.20 157.97 118.54 45.19 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 160.20 116.89 49.36 158.52 117.92 48.65 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 8 3 # 8 A 50 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 96 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 137 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 1.83 2.95 4.76 1.26 0.98 4.81 161.39 131.07 36.65 161.63 129.00 36.89 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 157.34 129.59 37.15 157.60 127.69 38.11 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 9 3 # 9 A 50 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 96 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 137 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 1.83 2.95 4.76 1.26 0.98 4.81 161.39 131.07 36.65 161.63 129.00 36.89 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 157.34 129.59 37.15 157.60 127.69 38.11 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 160.37 121.38 41.43 159.84 123.37 41.06 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 10 3 # 10 A 50 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 96 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 137 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo 1.83 2.95 4.76 1.26 0.98 4.81 157.21 117.94 38.21 157.48 118.99 40.00 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 157.18 120.22 44.20 157.97 118.54 45.19 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 160.20 116.89 49.36 158.52 117.92 48.65 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 10 hits 1de3_c00 naa= 3 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 1 3 # 1 A 236 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 270 HIS A 187 HIS~? 25.73 N9 ADE A 500 A 302 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 31.95 29.75 57.34 28.52 26.19 61.27 182.07 169.10 30.10 186.87 173.28 30.86 coo 33.21 25.89 58.06 33.02 25.68 60.13 179.01 171.47 26.59 179.51 173.49 26.31 coo 28.85 22.90 58.20 30.22 22.78 59.84 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1de6_c00 L-RHAMNOSE ISOMERASE user 2 3 # 2 A 236 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 270 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 302 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 31.95 29.75 57.34 28.52 26.19 61.27 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 33.21 25.89 58.06 33.02 25.68 60.13 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 28.85 22.90 58.20 30.22 22.78 59.84 174.65 109.33 0.17 174.41 107.27 0.58 1de6_c00 source 1de6 L-RHAMNOSE ISOMERASE : 2 hits 1de6_c00 naa= 3 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 1 3 # 1 B 236 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 270 HIS A 187 HIS~? 25.73 N9 ADE A 500 B 302 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 38.57 31.68 38.20 37.57 30.37 32.27 182.07 169.10 30.10 186.87 173.28 30.86 coo 35.21 33.33 36.56 35.91 33.91 34.66 179.01 171.47 26.59 179.51 173.49 26.31 coo 33.27 29.36 33.58 33.68 31.25 32.69 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1de6_c01 L-RHAMNOSE ISOMERASE user 2 3 # 2 B 236 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 270 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 302 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 38.57 31.68 38.20 37.57 30.37 32.27 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 35.21 33.33 36.56 35.91 33.91 34.66 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 33.27 29.36 33.58 33.68 31.25 32.69 174.65 109.33 0.17 174.41 107.27 0.58 1de6_c01 source 1de6 L-RHAMNOSE ISOMERASE : 2 hits 1de6_c01 naa= 3 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 1 3 # 1 C 236 LYS A 186 LYS~? 28.00 N9 ADE A 500 C 270 HIS A 187 HIS~? 25.73 N9 ADE A 500 C 302 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 14.14 13.22 49.33 13.72 16.13 54.74 182.07 169.10 30.10 186.87 173.28 30.86 coo 12.62 17.05 49.17 11.38 17.06 50.85 179.01 171.47 26.59 179.51 173.49 26.31 coo 15.59 19.87 52.59 13.47 19.78 52.76 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1de6_c02 L-RHAMNOSE ISOMERASE user 2 3 # 2 C 236 LYS B 186 LYS~? 32.32 C2 CIT A1102 C 270 HIS B 187 HIS~? 26.45 C2 CIT A1102 C 302 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 14.14 13.22 49.33 13.72 16.13 54.74 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 12.62 17.05 49.17 11.38 17.06 50.85 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 15.59 19.87 52.59 13.47 19.78 52.76 174.65 109.33 0.17 174.41 107.27 0.58 1de6_c02 source 1de6 L-RHAMNOSE ISOMERASE : 2 hits 1de6_c02 naa= 3 ULMN 3 1de6_c03 L-RHAMNOSE ISOMERASE user 1 3 # 1 D 236 LYS A 186 LYS~? 28.00 N9 ADE A 500 D 270 HIS A 187 HIS~? 25.73 N9 ADE A 500 D 302 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 22.81 12.92 30.93 27.72 14.83 27.49 182.07 169.10 30.10 186.87 173.28 30.86 coo 26.34 11.31 32.03 27.15 10.82 30.17 179.01 171.47 26.59 179.51 173.49 26.31 coo 29.89 15.23 31.62 30.32 13.38 30.56 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1de6_c03 L-RHAMNOSE ISOMERASE user 2 3 # 2 D 236 LYS B 186 LYS~? 32.32 C2 CIT A1102 D 270 HIS B 187 HIS~? 26.45 C2 CIT A1102 D 302 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 22.81 12.92 30.93 27.72 14.83 27.49 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 26.34 11.31 32.03 27.15 10.82 30.17 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 29.89 15.23 31.62 30.32 13.38 30.56 174.65 109.33 0.17 174.41 107.27 0.58 1de6_c03 source 1de6 L-RHAMNOSE ISOMERASE : 2 hits 1de6_c03 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 61 GLU^? 16.24 O5 CIT A1102 A 226 THR A 177 THR^? 11.99 N9 ADE A 500 A 229 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 9.66 102.78 70.07 9.79 101.18 71.42 165.65 155.89 5.11 164.98 153.86 5.06 coo 7.24 97.46 49.60 8.11 95.69 48.80 182.36 161.43 14.75 180.27 161.91 14.59 coo 10.53 97.56 43.71 9.33 93.71 47.17 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU C 59 GLU^? 20.19 O2 GOL C1901 A 226 THR B 177 THR^? 12.64 C2 CIT A1102 A 229 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 9.66 102.78 70.07 9.79 101.18 71.42 152.75 116.35 16.84 151.33 114.88 17.42 coo 7.24 97.46 49.60 8.11 95.69 48.80 170.76 123.10 5.75 170.51 123.79 3.70 coo 10.53 97.56 43.71 9.33 93.71 47.17 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU C 135 GLU.? 26.33 O1 GOL C1901 A 226 THR B 51 THR^? 19.74 C8 ADE A 500 A 229 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 9.66 102.78 70.07 9.79 101.18 71.42 168.08 142.51 43.72 166.57 142.98 45.14 coo 7.24 97.46 49.60 8.11 95.69 48.80 174.04 136.47 22.40 175.88 136.63 23.40 coo 10.53 97.56 43.71 9.33 93.71 47.17 174.03 130.60 22.66 171.30 132.48 26.53 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 61 GLU^? 16.24 O5 CIT A1102 B 226 THR A 177 THR^? 11.99 N9 ADE A 500 B 229 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 15.90 87.61 49.61 13.92 86.96 49.36 165.65 155.89 5.11 164.98 153.86 5.06 coo 20.74 95.78 68.68 19.29 96.84 69.83 182.36 161.43 14.75 180.27 161.91 14.59 coo 22.32 101.61 71.64 17.89 98.63 71.55 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU C 59 GLU^? 20.19 O2 GOL C1901 B 226 THR B 177 THR^? 12.64 C2 CIT A1102 B 229 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 15.90 87.61 49.61 13.92 86.96 49.36 152.75 116.35 16.84 151.33 114.88 17.42 coo 20.74 95.78 68.68 19.29 96.84 69.83 170.76 123.10 5.75 170.51 123.79 3.70 coo 22.32 101.61 71.64 17.89 98.63 71.55 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU C 135 GLU.? 26.33 O1 GOL C1901 B 226 THR B 51 THR^? 19.74 C8 ADE A 500 B 229 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 15.90 87.61 49.61 13.92 86.96 49.36 168.08 142.51 43.72 166.57 142.98 45.14 coo 20.74 95.78 68.68 19.29 96.84 69.83 174.04 136.47 22.40 175.88 136.63 23.40 coo 22.32 101.61 71.64 17.89 98.63 71.55 174.03 130.60 22.66 171.30 132.48 26.53 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 61 GLU^? 16.24 O5 CIT A1102 C 226 THR A 177 THR^? 11.99 N9 ADE A 500 C 229 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 5.43 40.40 61.63 4.27 41.99 60.90 165.65 155.89 5.11 164.98 153.86 5.06 coo 22.16 45.88 73.63 23.23 47.70 73.25 182.36 161.43 14.75 180.27 161.91 14.59 coo 28.90 45.91 73.55 25.22 49.72 72.97 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU C 59 GLU^? 20.19 O2 GOL C1901 C 226 THR B 177 THR^? 12.64 C2 CIT A1102 C 229 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 5.43 40.40 61.63 4.27 41.99 60.90 152.75 116.35 16.84 151.33 114.88 17.42 coo 22.16 45.88 73.63 23.23 47.70 73.25 170.76 123.10 5.75 170.51 123.79 3.70 coo 28.90 45.91 73.55 25.22 49.72 72.97 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU C 135 GLU.? 26.33 O1 GOL C1901 C 226 THR B 51 THR^? 19.74 C8 ADE A 500 C 229 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 5.43 40.40 61.63 4.27 41.99 60.90 168.08 142.51 43.72 166.57 142.98 45.14 coo 22.16 45.88 73.63 23.23 47.70 73.25 174.04 136.47 22.40 175.88 136.63 23.40 coo 28.90 45.91 73.55 25.22 49.72 72.97 174.03 130.60 22.66 171.30 132.48 26.53 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 61 GLU^? 16.24 O5 CIT A1102 D 226 THR A 177 THR^? 11.99 N9 ADE A 500 D 229 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 26.07 55.89 66.14 25.33 56.50 68.01 165.65 155.89 5.11 164.98 153.86 5.06 coo 11.79 47.62 52.67 10.10 46.51 53.39 182.36 161.43 14.75 180.27 161.91 14.59 coo 10.05 41.79 49.80 7.94 44.71 53.76 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU C 59 GLU^? 20.19 O2 GOL C1901 D 226 THR B 177 THR^? 12.64 C2 CIT A1102 D 229 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 26.07 55.89 66.14 25.33 56.50 68.01 152.75 116.35 16.84 151.33 114.88 17.42 coo 11.79 47.62 52.67 10.10 46.51 53.39 170.76 123.10 5.75 170.51 123.79 3.70 coo 10.05 41.79 49.80 7.94 44.71 53.76 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU C 135 GLU.? 26.33 O1 GOL C1901 D 226 THR B 51 THR^? 19.74 C8 ADE A 500 D 229 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 26.07 55.89 66.14 25.33 56.50 68.01 168.08 142.51 43.72 166.57 142.98 45.14 coo 11.79 47.62 52.67 10.10 46.51 53.39 174.04 136.47 22.40 175.88 136.63 23.40 coo 10.05 41.79 49.80 7.94 44.71 53.76 174.03 130.60 22.66 171.30 132.48 26.53 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c07 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 200 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 229 LYS A 62 LYS^? 14.90 N3 ADE A 500 coo 1.13 77.49 40.64 0.62 75.57 39.98 183.15 146.13 20.69 182.60 148.09 20.18 coo 0.84 91.24 49.01 2.91 91.61 49.23 180.59 154.59 5.93 180.83 155.75 4.19 coo 10.53 97.56 43.71 9.33 93.71 47.17 170.54 158.67 6.99 175.63 160.94 7.57 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 200 ASP C 172 ASP~? 9.22 O2 GOL C1901 A 229 LYS C 62 LYS^? 15.99 O2 GOL C1901 coo 1.13 77.49 40.64 0.62 75.57 39.98 153.36 123.09 43.85 154.03 121.98 42.20 coo 0.84 91.24 49.01 2.91 91.61 49.23 153.21 116.81 30.64 152.37 114.88 30.62 coo 10.53 97.56 43.71 9.33 93.71 47.17 160.07 111.06 24.23 156.23 109.52 28.21 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 123 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 200 ASP C 172 ASP~? 9.22 O2 GOL C1901 A 229 LYS C 62 LYS^? 15.99 O2 GOL C1901 coo 1.13 77.49 40.64 0.62 75.57 39.98 161.39 131.07 36.65 161.63 129.00 36.89 coo 0.84 91.24 49.01 2.91 91.61 49.23 153.21 116.81 30.64 152.37 114.88 30.62 coo 10.53 97.56 43.71 9.33 93.71 47.17 160.07 111.06 24.23 156.23 109.52 28.21 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 104 HIS^? 8.41 C8 ADE A 500 B 200 ASP A 172 ASP~? 9.43 N1 ADE A 500 B 229 LYS A 62 LYS^? 14.90 N3 ADE A 500 coo 9.24 94.26 88.22 8.02 94.07 89.92 183.15 146.13 20.69 182.60 148.09 20.18 coo 17.54 90.31 75.01 17.17 92.01 73.80 180.59 154.59 5.93 180.83 155.75 4.19 coo 22.32 101.61 71.64 17.89 98.63 71.55 170.54 158.67 6.99 175.63 160.94 7.57 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 200 ASP C 172 ASP~? 9.22 O2 GOL C1901 B 229 LYS C 62 LYS^? 15.99 O2 GOL C1901 coo 9.24 94.26 88.22 8.02 94.07 89.92 153.36 123.09 43.85 154.03 121.98 42.20 coo 17.54 90.31 75.01 17.17 92.01 73.80 153.21 116.81 30.64 152.37 114.88 30.62 coo 22.32 101.61 71.64 17.89 98.63 71.55 160.07 111.06 24.23 156.23 109.52 28.21 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 123 HIS C 104 HIS^? 12.14 O1 GOL C1901 B 200 ASP C 172 ASP~? 9.22 O2 GOL C1901 B 229 LYS C 62 LYS^? 15.99 O2 GOL C1901 coo 9.24 94.26 88.22 8.02 94.07 89.92 161.39 131.07 36.65 161.63 129.00 36.89 coo 17.54 90.31 75.01 17.17 92.01 73.80 153.21 116.81 30.64 152.37 114.88 30.62 coo 22.32 101.61 71.64 17.89 98.63 71.55 160.07 111.06 24.23 156.23 109.52 28.21 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 104 HIS^? 8.41 C8 ADE A 500 C 200 ASP A 172 ASP~? 9.43 N1 ADE A 500 C 229 LYS A 62 LYS^? 14.90 N3 ADE A 500 coo 26.77 65.84 83.49 27.06 67.76 84.27 183.15 146.13 20.69 182.60 148.09 20.18 coo 19.52 52.01 79.59 20.28 51.65 77.65 180.59 154.59 5.93 180.83 155.75 4.19 coo 28.90 45.91 73.55 25.22 49.72 72.97 170.54 158.67 6.99 175.63 160.94 7.57 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS C 42 HIS.? 5.32 O3 GOL C1901 C 200 ASP C 172 ASP~? 9.22 O2 GOL C1901 C 229 LYS C 62 LYS^? 15.99 O2 GOL C1901 coo 26.77 65.84 83.49 27.06 67.76 84.27 153.36 123.09 43.85 154.03 121.98 42.20 coo 19.52 52.01 79.59 20.28 51.65 77.65 153.21 116.81 30.64 152.37 114.88 30.62 coo 28.90 45.91 73.55 25.22 49.72 72.97 160.07 111.06 24.23 156.23 109.52 28.21 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 123 HIS C 104 HIS^? 12.14 O1 GOL C1901 C 200 ASP C 172 ASP~? 9.22 O2 GOL C1901 C 229 LYS C 62 LYS^? 15.99 O2 GOL C1901 coo 26.77 65.84 83.49 27.06 67.76 84.27 161.39 131.07 36.65 161.63 129.00 36.89 coo 19.52 52.01 79.59 20.28 51.65 77.65 153.21 116.81 30.64 152.37 114.88 30.62 coo 28.90 45.91 73.55 25.22 49.72 72.97 160.07 111.06 24.23 156.23 109.52 28.21 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 104 HIS^? 8.41 C8 ADE A 500 D 200 ASP A 172 ASP~? 9.43 N1 ADE A 500 D 229 LYS A 62 LYS^? 14.90 N3 ADE A 500 coo -10.90 48.74 53.41 -12.98 48.90 53.67 183.15 146.13 20.69 182.60 148.09 20.18 coo 4.60 52.95 52.50 5.57 51.29 53.40 180.59 154.59 5.93 180.83 155.75 4.19 coo 10.05 41.79 49.80 7.94 44.71 53.76 170.54 158.67 6.99 175.63 160.94 7.57 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS C 42 HIS.? 5.32 O3 GOL C1901 D 200 ASP C 172 ASP~? 9.22 O2 GOL C1901 D 229 LYS C 62 LYS^? 15.99 O2 GOL C1901 coo -10.90 48.74 53.41 -12.98 48.90 53.67 153.36 123.09 43.85 154.03 121.98 42.20 coo 4.60 52.95 52.50 5.57 51.29 53.40 153.21 116.81 30.64 152.37 114.88 30.62 coo 10.05 41.79 49.80 7.94 44.71 53.76 160.07 111.06 24.23 156.23 109.52 28.21 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 123 HIS C 104 HIS^? 12.14 O1 GOL C1901 D 200 ASP C 172 ASP~? 9.22 O2 GOL C1901 D 229 LYS C 62 LYS^? 15.99 O2 GOL C1901 coo -10.90 48.74 53.41 -12.98 48.90 53.67 161.39 131.07 36.65 161.63 129.00 36.89 coo 4.60 52.95 52.50 5.57 51.29 53.40 153.21 116.81 30.64 152.37 114.88 30.62 coo 10.05 41.79 49.80 7.94 44.71 53.76 160.07 111.06 24.23 156.23 109.52 28.21 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 131 TYR~? 27.02 C8 ADE A 500 A 138 ARG B 108 ARG^? 25.54 C8 ADE A 500 A 161 LYS A 132 LYS~? 32.58 C8 ADE A 500 coo 29.03 88.95 86.80 28.09 90.57 84.75 182.79 134.12 33.10 182.43 131.46 33.83 coo 23.31 93.18 82.88 23.00 93.71 79.86 188.64 131.77 26.61 189.85 131.11 29.36 coo 33.83 91.15 88.62 31.07 91.06 83.02 183.55 135.22 37.19 185.46 129.22 37.94 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 131 TYR~? 27.02 C8 ADE A 500 B 138 ARG B 108 ARG^? 25.54 C8 ADE A 500 B 161 LYS A 132 LYS~? 32.58 C8 ADE A 500 coo 4.62 122.69 99.88 5.46 122.82 97.24 182.79 134.12 33.10 182.43 131.46 33.83 coo 10.44 122.27 94.08 11.02 123.87 91.53 188.64 131.77 26.61 189.85 131.11 29.36 coo -0.17 119.75 99.65 2.51 123.83 95.70 183.55 135.22 37.19 185.46 129.22 37.94 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 1 hits 1dhp_c01 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 150 LYS A 41 LYS^? 15.86 N3 ADE A 500 186 ASN A 159 ASN.? 24.44 N9 ADE A 500 coo 32.88 50.55 24.33 31.89 51.78 26.65 198.66 149.45 16.16 201.00 150.74 16.95 coo 27.04 52.42 22.30 26.88 49.99 27.00 197.56 153.42 13.51 201.64 156.08 17.41 coo 36.98 50.30 37.29 35.85 50.29 35.50 201.43 144.98 28.36 202.11 144.65 30.37 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 84 TYR^? 7.34 N9 ADE A 500 150 LYS A 49 LYS^? 10.58 N6 ADE A 500 186 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 32.88 50.55 24.33 31.89 51.78 26.65 190.70 148.50 17.91 191.29 151.03 18.92 coo 27.04 52.42 22.30 26.88 49.99 27.00 193.06 146.52 10.07 195.03 144.09 6.09 coo 36.98 50.30 37.29 35.85 50.29 35.50 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR A 113 TYR^? 11.47 C8 ADE A 500 150 LYS A 126 LYS^? 24.40 C8 ADE A 500 186 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 32.88 50.55 24.33 31.89 51.78 26.65 185.14 149.36 25.84 186.22 148.61 23.38 coo 27.04 52.42 22.30 26.88 49.99 27.00 186.22 145.69 31.90 189.62 146.93 37.05 coo 36.98 50.30 37.29 35.85 50.29 35.50 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR A 117 TYR.? 18.31 C8 ADE A 500 150 LYS A 123 LYS^? 21.83 C8 ADE A 500 186 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 32.88 50.55 24.33 31.89 51.78 26.65 174.51 155.83 27.46 174.88 153.07 27.26 coo 27.04 52.42 22.30 26.88 49.99 27.00 179.30 153.63 32.06 174.52 149.85 32.01 coo 36.98 50.30 37.29 35.85 50.29 35.50 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 5 3 # 5 146 TYR A 117 TYR.? 18.31 C8 ADE A 500 150 LYS A 123 LYS^? 21.83 C8 ADE A 500 186 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 32.88 50.55 24.33 31.89 51.78 26.65 174.51 155.83 27.46 174.88 153.07 27.26 coo 27.04 52.42 22.30 26.88 49.99 27.00 179.30 153.63 32.06 174.52 149.85 32.01 coo 36.98 50.30 37.29 35.85 50.29 35.50 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 6 3 # 6 146 TYR B 113 TYR^? 17.81 O4 CIT A1102 150 LYS B 126 LYS^? 29.75 O4 CIT A1102 186 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo 32.88 50.55 24.33 31.89 51.78 26.65 186.72 125.72 10.79 185.00 126.80 12.71 coo 27.04 52.42 22.30 26.88 49.99 27.00 193.73 125.48 11.85 197.51 120.83 13.59 coo 36.98 50.30 37.29 35.85 50.29 35.50 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 7 3 # 7 146 TYR B 117 TYR.? 15.40 O4 CIT A1102 150 LYS B 123 LYS.? 21.18 O4 CIT A1102 186 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo 32.88 50.55 24.33 31.89 51.78 26.65 184.92 125.90 -1.64 186.19 127.72 0.06 coo 27.04 52.42 22.30 26.88 49.99 27.00 190.30 123.24 2.08 193.85 127.78 -0.15 coo 36.98 50.30 37.29 35.85 50.29 35.50 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 8 3 # 8 146 TYR B 117 TYR.? 15.40 O4 CIT A1102 150 LYS B 123 LYS.? 21.18 O4 CIT A1102 186 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 32.88 50.55 24.33 31.89 51.78 26.65 184.92 125.90 -1.64 186.19 127.72 0.06 coo 27.04 52.42 22.30 26.88 49.99 27.00 190.30 123.24 2.08 193.85 127.78 -0.15 coo 36.98 50.30 37.29 35.85 50.29 35.50 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 9 3 # 9 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 150 LYS C 41 LYS^? 15.03 O3 GOL C1901 186 ASN C 159 ASN.? 26.35 O1 GOL C1901 coo 32.88 50.55 24.33 31.89 51.78 26.65 149.80 129.36 48.45 149.55 129.08 51.21 coo 27.04 52.42 22.30 26.88 49.99 27.00 149.18 124.89 48.07 150.57 125.16 54.16 coo 36.98 50.30 37.29 35.85 50.29 35.50 157.28 138.82 54.17 158.01 140.31 55.50 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 10 3 # 10 146 TYR C 113 TYR^? 15.28 O1 GOL C1901 150 LYS C 126 LYS^? 28.06 O1 GOL C1901 186 ASN B 35 ASN~? 25.18 O1 GOL C1901 coo 32.88 50.55 24.33 31.89 51.78 26.65 165.10 130.81 41.92 162.37 130.83 41.35 coo 27.04 52.42 22.30 26.88 49.99 27.00 168.56 136.65 44.17 170.62 139.01 49.65 coo 36.98 50.30 37.29 35.85 50.29 35.50 176.57 125.33 34.40 176.61 123.22 34.34 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 11 3 # 11 146 TYR C 113 TYR^? 15.28 O1 GOL C1901 150 LYS C 126 LYS^? 28.06 O1 GOL C1901 186 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 32.88 50.55 24.33 31.89 51.78 26.65 165.10 130.81 41.92 162.37 130.83 41.35 coo 27.04 52.42 22.30 26.88 49.99 27.00 168.56 136.65 44.17 170.62 139.01 49.65 coo 36.98 50.30 37.29 35.85 50.29 35.50 160.68 120.91 34.68 159.00 120.62 33.38 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 12 3 # 12 146 TYR C 117 TYR.? 21.72 O1 GOL C1901 150 LYS C 123 LYS^? 25.30 O1 GOL C1901 186 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 32.88 50.55 24.33 31.89 51.78 26.65 173.67 123.08 36.58 172.76 125.64 35.98 coo 27.04 52.42 22.30 26.88 49.99 27.00 174.37 128.14 41.95 175.88 130.01 36.96 coo 36.98 50.30 37.29 35.85 50.29 35.50 160.68 120.91 34.68 159.00 120.62 33.38 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 13 3 # 13 146 TYR C 117 TYR.? 21.72 O1 GOL C1901 150 LYS C 123 LYS^? 25.30 O1 GOL C1901 186 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 32.88 50.55 24.33 31.89 51.78 26.65 173.67 123.08 36.58 172.76 125.64 35.98 coo 27.04 52.42 22.30 26.88 49.99 27.00 174.37 128.14 41.95 175.88 130.01 36.96 coo 36.98 50.30 37.29 35.85 50.29 35.50 160.54 121.61 29.05 159.70 119.87 28.12 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 13 hits 1dhr_c00 naa= 3 ULMN 3 1do8_c00 MALIC ENZYME user 1 3 # 1 A 112 TYR A 83 TYR^? 11.70 N6 ADE A 500 A 183 LYS A 49 LYS^? 10.58 N6 ADE A 500 A 278 ASP A 52 ASP^? 9.33 O4 CIT A1102 coo 19.43 18.53 42.32 17.66 18.80 40.15 192.51 141.71 13.59 192.79 138.96 13.21 coo 21.92 15.80 36.19 17.64 19.44 36.35 193.06 146.52 10.07 195.03 144.09 6.09 coo 15.46 19.03 31.40 15.01 18.25 33.31 185.72 140.93 6.30 184.35 140.00 4.99 ULMN 3 1do8_c00 MALIC ENZYME user 2 3 # 2 A 112 TYR B 83 TYR^? 20.46 C8 ADE A 500 A 183 LYS B 49 LYS^? 24.07 O1 GOL C1901 A 278 ASP B 52 ASP^? 16.07 C8 ADE A 500 coo 19.43 18.53 42.32 17.66 18.80 40.15 179.54 132.93 23.44 180.82 135.06 24.75 coo 21.92 15.80 36.19 17.64 19.44 36.35 174.03 130.60 22.66 171.30 132.48 26.53 coo 15.46 19.03 31.40 15.01 18.25 33.31 173.93 140.35 20.11 173.24 142.10 19.12 ULMN 3 1do8_c00 MALIC ENZYME user 3 3 # 3 A 112 TYR C 83 TYR^? 12.44 O1 GOL C1901 A 183 LYS C 49 LYS^? 10.29 O2 GOL C1901 A 278 ASP C 52 ASP^? 12.06 O1 GOL C1901 coo 19.43 18.53 42.32 17.66 18.80 40.15 149.52 133.95 39.18 148.57 136.34 38.09 coo 21.92 15.80 36.19 17.64 19.44 36.35 147.41 128.03 39.92 142.61 128.90 38.51 coo 15.46 19.03 31.40 15.01 18.25 33.31 147.21 130.59 30.19 147.01 130.37 28.08 1do8_c00 source 1do8 MALIC ENZYME : 3 hits 1do8_c00 naa= 3 ULMN 3 1do8_c01 MALIC ENZYME user 1 3 # 1 B 112 TYR A 83 TYR^? 11.70 N6 ADE A 500 B 183 LYS A 49 LYS^? 10.58 N6 ADE A 500 B 278 ASP A 52 ASP^? 9.33 O4 CIT A1102 coo 58.62 15.99 58.34 60.98 14.60 58.93 192.51 141.71 13.59 192.79 138.96 13.21 coo 60.11 10.60 53.63 62.59 10.74 58.67 193.06 146.52 10.07 195.03 144.09 6.09 coo 66.50 7.32 58.45 66.26 9.42 58.23 185.72 140.93 6.30 184.35 140.00 4.99 ULMN 3 1do8_c01 MALIC ENZYME user 2 3 # 2 B 112 TYR B 83 TYR^? 20.46 C8 ADE A 500 B 183 LYS B 49 LYS^? 24.07 O1 GOL C1901 B 278 ASP B 52 ASP^? 16.07 C8 ADE A 500 coo 58.62 15.99 58.34 60.98 14.60 58.93 179.54 132.93 23.44 180.82 135.06 24.75 coo 60.11 10.60 53.63 62.59 10.74 58.67 174.03 130.60 22.66 171.30 132.48 26.53 coo 66.50 7.32 58.45 66.26 9.42 58.23 173.93 140.35 20.11 173.24 142.10 19.12 ULMN 3 1do8_c01 MALIC ENZYME user 3 3 # 3 B 112 TYR C 83 TYR^? 12.44 O1 GOL C1901 B 183 LYS C 49 LYS^? 10.29 O2 GOL C1901 B 278 ASP C 52 ASP^? 12.06 O1 GOL C1901 coo 58.62 15.99 58.34 60.98 14.60 58.93 149.52 133.95 39.18 148.57 136.34 38.09 coo 60.11 10.60 53.63 62.59 10.74 58.67 147.41 128.03 39.92 142.61 128.90 38.51 coo 66.50 7.32 58.45 66.26 9.42 58.23 147.21 130.59 30.19 147.01 130.37 28.08 1do8_c01 source 1do8 MALIC ENZYME : 3 hits 1do8_c01 naa= 3 ULMN 3 1do8_c02 MALIC ENZYME user 1 3 # 1 C 112 TYR A 83 TYR^? 11.70 N6 ADE A 500 C 183 LYS A 49 LYS^? 10.58 N6 ADE A 500 C 278 ASP A 52 ASP^? 9.33 O4 CIT A1102 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 192.51 141.71 13.59 192.79 138.96 13.21 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 193.06 146.52 10.07 195.03 144.09 6.09 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 185.72 140.93 6.30 184.35 140.00 4.99 ULMN 3 1do8_c02 MALIC ENZYME user 2 3 # 2 C 112 TYR B 83 TYR^? 20.46 C8 ADE A 500 C 183 LYS B 49 LYS^? 24.07 O1 GOL C1901 C 278 ASP B 52 ASP^? 16.07 C8 ADE A 500 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 179.54 132.93 23.44 180.82 135.06 24.75 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 174.03 130.60 22.66 171.30 132.48 26.53 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 173.93 140.35 20.11 173.24 142.10 19.12 ULMN 3 1do8_c02 MALIC ENZYME user 3 3 # 3 C 112 TYR C 83 TYR^? 12.44 O1 GOL C1901 C 183 LYS C 49 LYS^? 10.29 O2 GOL C1901 C 278 ASP C 52 ASP^? 12.06 O1 GOL C1901 coo 76.02 -16.57 8.89 78.24 -15.17 9.87 149.52 133.95 39.18 148.57 136.34 38.09 coo 74.18 -11.17 13.22 79.08 -11.19 10.47 147.41 128.03 39.92 142.61 128.90 38.51 coo 82.27 -7.93 13.54 81.93 -10.04 13.72 147.21 130.59 30.19 147.01 130.37 28.08 1do8_c02 source 1do8 MALIC ENZYME : 3 hits 1do8_c02 naa= 3 ULMN 3 1do8_c03 MALIC ENZYME user 1 3 # 1 D 112 TYR A 83 TYR^? 11.70 N6 ADE A 500 D 183 LYS A 49 LYS^? 10.58 N6 ADE A 500 D 278 ASP A 52 ASP^? 9.33 O4 CIT A1102 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 192.51 141.71 13.59 192.79 138.96 13.21 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 193.06 146.52 10.07 195.03 144.09 6.09 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 185.72 140.93 6.30 184.35 140.00 4.99 ULMN 3 1do8_c03 MALIC ENZYME user 2 3 # 2 D 112 TYR B 83 TYR^? 20.46 C8 ADE A 500 D 183 LYS B 49 LYS^? 24.07 O1 GOL C1901 D 278 ASP B 52 ASP^? 16.07 C8 ADE A 500 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 179.54 132.93 23.44 180.82 135.06 24.75 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 174.03 130.60 22.66 171.30 132.48 26.53 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 173.93 140.35 20.11 173.24 142.10 19.12 ULMN 3 1do8_c03 MALIC ENZYME user 3 3 # 3 D 112 TYR C 83 TYR^? 12.44 O1 GOL C1901 D 183 LYS C 49 LYS^? 10.29 O2 GOL C1901 D 278 ASP C 52 ASP^? 12.06 O1 GOL C1901 coo 35.64 -19.32 -3.24 32.92 -19.55 -2.64 149.52 133.95 39.18 148.57 136.34 38.09 coo 33.51 -16.63 3.10 30.11 -20.23 0.26 147.41 128.03 39.92 142.61 128.90 38.51 coo 25.62 -19.94 2.86 26.44 -19.16 1.09 147.21 130.59 30.19 147.01 130.37 28.08 1do8_c03 source 1do8 MALIC ENZYME : 3 hits 1do8_c03 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 187 HIS~? 25.73 N9 ADE A 500 E 102 ASP A 183 ASP~? 24.76 N9 ADE A 500 E 193 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo 11.39 26.86 25.95 9.85 26.64 27.36 179.01 171.47 26.59 179.51 173.49 26.31 coo 10.90 32.83 25.96 10.83 30.68 25.98 184.84 171.88 24.93 186.38 173.28 25.14 coo 4.57 20.60 30.29 4.74 21.36 30.66 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 E 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 E 193 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo 11.39 26.86 25.95 9.85 26.64 27.36 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 10.90 32.83 25.96 10.83 30.68 25.98 174.65 109.33 0.17 174.41 107.27 0.58 coo 4.57 20.60 30.29 4.74 21.36 30.66 184.36 119.52 -4.81 184.70 120.30 -4.67 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 2 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY B 181 GLY.? 26.00 C2 CIT A1102 B 144 GLU B 182 GLU~? 29.98 C2 CIT A1102 B 164 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 88.87 114.43 152.30 88.45 115.15 152.32 175.27 110.79 5.61 175.43 111.53 5.31 coo 85.20 111.99 152.05 86.60 110.89 150.91 180.61 109.47 2.81 182.18 108.21 3.48 coo 88.14 113.46 145.73 86.79 113.92 147.30 174.79 115.83 -0.09 173.37 117.02 0.92 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c13 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY B 181 GLY.? 26.00 C2 CIT A1102 F 144 GLU B 182 GLU~? 29.98 C2 CIT A1102 F 164 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 57.12 70.68 155.10 57.52 69.95 155.02 175.27 110.79 5.61 175.43 111.53 5.31 coo 60.62 73.13 154.21 59.05 74.26 153.35 180.61 109.47 2.81 182.18 108.21 3.48 coo 56.75 71.71 148.46 58.44 71.01 149.54 174.79 115.83 -0.09 173.37 117.02 0.92 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c17 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 20 LYS~? 27.72 N9 ADE A 500 A 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 277 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 198.50 157.87 31.43 197.45 157.77 37.73 coo 13.06 30.79 51.73 11.40 35.76 53.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS A 41 LYS^? 15.86 N3 ADE A 500 A 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 277 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 197.56 153.42 13.51 201.64 156.08 17.41 coo 13.06 30.79 51.73 11.40 35.76 53.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 A 131 LYS A 41 LYS^? 15.86 N3 ADE A 500 A 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 277 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 197.56 153.42 13.51 201.64 156.08 17.41 coo 13.06 30.79 51.73 11.40 35.76 53.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 A 131 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 215 LYS A 41 LYS^? 15.86 N3 ADE A 500 A 277 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.06 30.79 51.73 11.40 35.76 53.48 197.56 153.42 13.51 201.64 156.08 17.41 coo 13.04 31.88 60.72 10.57 35.34 57.49 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 A 131 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 215 LYS A 123 LYS^? 21.83 C8 ADE A 500 A 277 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.30 153.63 32.06 174.52 149.85 32.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 A 131 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 215 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 277 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.06 30.79 51.73 11.40 35.76 53.48 186.22 145.69 31.90 189.62 146.93 37.05 coo 13.04 31.88 60.72 10.57 35.34 57.49 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 A 131 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 215 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 277 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.06 30.79 51.73 11.40 35.76 53.48 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.04 31.88 60.72 10.57 35.34 57.49 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 A 131 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 215 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 277 LYS A 186 LYS~? 28.00 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.06 30.79 51.73 11.40 35.76 53.48 183.60 164.07 35.65 183.22 158.61 36.42 coo 13.04 31.88 60.72 10.57 35.34 57.49 182.07 169.10 30.10 186.87 173.28 30.86 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 A 131 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 215 LYS A 123 LYS^? 21.83 C8 ADE A 500 A 277 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 180.69 158.10 18.36 176.95 162.62 18.15 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.30 153.63 32.06 174.52 149.85 32.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 A 131 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 215 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 277 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 180.69 158.10 18.36 176.95 162.62 18.15 coo 13.06 30.79 51.73 11.40 35.76 53.48 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.04 31.88 60.72 10.57 35.34 57.49 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 A 131 LYS A 123 LYS^? 21.83 C8 ADE A 500 A 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 277 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 179.30 153.63 32.06 174.52 149.85 32.01 coo 13.06 30.79 51.73 11.40 35.76 53.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 A 131 LYS A 123 LYS^? 21.83 C8 ADE A 500 A 215 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 277 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 179.30 153.63 32.06 174.52 149.85 32.01 coo 13.06 30.79 51.73 11.40 35.76 53.48 180.69 158.10 18.36 176.95 162.62 18.15 coo 13.04 31.88 60.72 10.57 35.34 57.49 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 A 131 LYS A 123 LYS^? 21.83 C8 ADE A 500 A 215 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 277 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 179.30 153.63 32.06 174.52 149.85 32.01 coo 13.06 30.79 51.73 11.40 35.76 53.48 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.04 31.88 60.72 10.57 35.34 57.49 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 A 131 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 277 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 186.22 145.69 31.90 189.62 146.93 37.05 coo 13.06 30.79 51.73 11.40 35.76 53.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 A 131 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 215 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 277 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 186.22 145.69 31.90 189.62 146.93 37.05 coo 13.06 30.79 51.73 11.40 35.76 53.48 182.91 155.29 23.54 184.46 151.31 19.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 A 131 LYS A 132 LYS~? 32.58 C8 ADE A 500 A 215 LYS C 123 LYS^? 25.30 O1 GOL C1901 A 277 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 183.55 135.22 37.19 185.46 129.22 37.94 coo 13.06 30.79 51.73 11.40 35.76 53.48 174.37 128.14 41.95 175.88 130.01 36.96 coo 13.04 31.88 60.72 10.57 35.34 57.49 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 A 131 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 215 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 277 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 182.91 155.29 23.54 184.46 151.31 19.55 coo 13.06 30.79 51.73 11.40 35.76 53.48 186.22 145.69 31.90 189.62 146.93 37.05 coo 13.04 31.88 60.72 10.57 35.34 57.49 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 A 131 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 215 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 277 LYS A 186 LYS~? 28.00 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 182.91 155.29 23.54 184.46 151.31 19.55 coo 13.06 30.79 51.73 11.40 35.76 53.48 185.07 167.50 20.34 181.31 169.96 15.85 coo 13.04 31.88 60.72 10.57 35.34 57.49 182.07 169.10 30.10 186.87 173.28 30.86 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 A 131 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 215 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 277 LYS A 186 LYS~? 28.00 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 182.91 155.29 23.54 184.46 151.31 19.55 coo 13.06 30.79 51.73 11.40 35.76 53.48 183.60 164.07 35.65 183.22 158.61 36.42 coo 13.04 31.88 60.72 10.57 35.34 57.49 182.07 169.10 30.10 186.87 173.28 30.86 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 A 131 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 215 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 277 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 185.07 167.50 20.34 181.31 169.96 15.85 coo 13.06 30.79 51.73 11.40 35.76 53.48 182.91 155.29 23.54 184.46 151.31 19.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 179.30 153.63 32.06 174.52 149.85 32.01 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 A 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 277 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 22 3 # 22 A 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 277 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 23 3 # 23 A 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 215 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 277 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 180.69 158.10 18.36 176.95 162.62 18.15 coo 13.04 31.88 60.72 10.57 35.34 57.49 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 24 3 # 24 A 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 215 LYS A 123 LYS^? 21.83 C8 ADE A 500 A 277 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.30 153.63 32.06 174.52 149.85 32.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 25 3 # 25 A 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 215 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 277 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 182.91 155.29 23.54 184.46 151.31 19.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 26 3 # 26 A 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 215 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 277 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.06 30.79 51.73 11.40 35.76 53.48 182.91 155.29 23.54 184.46 151.31 19.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 179.30 153.63 32.06 174.52 149.85 32.01 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 27 3 # 27 A 131 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 277 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 183.60 164.07 35.65 183.22 158.61 36.42 coo 13.06 30.79 51.73 11.40 35.76 53.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 28 3 # 28 A 131 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 277 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 183.60 164.07 35.65 183.22 158.61 36.42 coo 13.06 30.79 51.73 11.40 35.76 53.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 13.04 31.88 60.72 10.57 35.34 57.49 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 29 3 # 29 A 131 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 215 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 277 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 183.60 164.07 35.65 183.22 158.61 36.42 coo 13.06 30.79 51.73 11.40 35.76 53.48 182.91 155.29 23.54 184.46 151.31 19.55 coo 13.04 31.88 60.72 10.57 35.34 57.49 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 30 3 # 30 A 131 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 215 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 277 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 183.60 164.07 35.65 183.22 158.61 36.42 coo 13.06 30.79 51.73 11.40 35.76 53.48 185.07 167.50 20.34 181.31 169.96 15.85 coo 13.04 31.88 60.72 10.57 35.34 57.49 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 31 3 # 31 A 131 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 215 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 277 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 183.60 164.07 35.65 183.22 158.61 36.42 coo 13.06 30.79 51.73 11.40 35.76 53.48 185.07 167.50 20.34 181.31 169.96 15.85 coo 13.04 31.88 60.72 10.57 35.34 57.49 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 32 3 # 32 A 131 LYS B 20 LYS~? 34.92 O4 CIT A1102 A 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 277 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 186.73 109.97 17.12 190.68 107.86 12.58 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.04 31.88 60.72 10.57 35.34 57.49 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 33 3 # 33 A 131 LYS B 20 LYS~? 34.92 O4 CIT A1102 A 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 277 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 186.73 109.97 17.12 190.68 107.86 12.58 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.04 31.88 60.72 10.57 35.34 57.49 173.15 113.94 5.34 166.89 113.91 6.31 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 34 3 # 34 A 131 LYS B 41 LYS^? 27.96 O1 GOL C1901 A 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 277 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 174.17 121.55 22.91 175.90 116.24 24.75 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.04 31.88 60.72 10.57 35.34 57.49 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 35 3 # 35 A 131 LYS B 41 LYS^? 27.96 O1 GOL C1901 A 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 277 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 174.17 121.55 22.91 175.90 116.24 24.75 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.04 31.88 60.72 10.57 35.34 57.49 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 36 3 # 36 A 131 LYS B 41 LYS^? 27.96 O1 GOL C1901 A 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 277 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 174.17 121.55 22.91 175.90 116.24 24.75 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.04 31.88 60.72 10.57 35.34 57.49 173.15 113.94 5.34 166.89 113.91 6.31 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 37 3 # 37 A 131 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 215 LYS B 41 LYS^? 27.96 O1 GOL C1901 A 277 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.06 30.79 51.73 11.40 35.76 53.48 174.17 121.55 22.91 175.90 116.24 24.75 coo 13.04 31.88 60.72 10.57 35.34 57.49 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 38 3 # 38 A 131 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 215 LYS B 123 LYS.? 21.18 O4 CIT A1102 A 277 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.06 30.79 51.73 11.40 35.76 53.48 190.30 123.24 2.08 193.85 127.78 -0.15 coo 13.04 31.88 60.72 10.57 35.34 57.49 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 39 3 # 39 A 131 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 215 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 277 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.06 30.79 51.73 11.40 35.76 53.48 193.73 125.48 11.85 197.51 120.83 13.59 coo 13.04 31.88 60.72 10.57 35.34 57.49 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 40 3 # 40 A 131 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 215 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 277 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.06 30.79 51.73 11.40 35.76 53.48 193.73 125.48 11.85 197.51 120.83 13.59 coo 13.04 31.88 60.72 10.57 35.34 57.49 190.30 123.24 2.08 193.85 127.78 -0.15 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 41 3 # 41 A 131 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 215 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 277 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.06 30.79 51.73 11.40 35.76 53.48 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 13.04 31.88 60.72 10.57 35.34 57.49 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 42 3 # 42 A 131 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 215 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 277 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 175.75 125.08 4.60 173.18 124.12 -0.61 coo 13.06 30.79 51.73 11.40 35.76 53.48 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 13.04 31.88 60.72 10.57 35.34 57.49 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 43 3 # 43 A 131 LYS B 123 LYS.? 21.18 O4 CIT A1102 A 215 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 277 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 190.30 123.24 2.08 193.85 127.78 -0.15 coo 13.06 30.79 51.73 11.40 35.76 53.48 175.75 125.08 4.60 173.18 124.12 -0.61 coo 13.04 31.88 60.72 10.57 35.34 57.49 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 44 3 # 44 A 131 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 215 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 277 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 193.73 125.48 11.85 197.51 120.83 13.59 coo 13.06 30.79 51.73 11.40 35.76 53.48 181.66 123.79 6.82 179.82 128.66 10.46 coo 13.04 31.88 60.72 10.57 35.34 57.49 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 45 3 # 45 A 131 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 215 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 277 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 181.66 123.79 6.82 179.82 128.66 10.46 coo 13.06 30.79 51.73 11.40 35.76 53.48 193.73 125.48 11.85 197.51 120.83 13.59 coo 13.04 31.88 60.72 10.57 35.34 57.49 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 46 3 # 46 A 131 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 215 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 277 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 181.66 123.79 6.82 179.82 128.66 10.46 coo 13.06 30.79 51.73 11.40 35.76 53.48 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 13.04 31.88 60.72 10.57 35.34 57.49 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 47 3 # 47 A 131 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 277 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.28 118.69 11.71 177.59 112.91 13.79 coo 13.04 31.88 60.72 10.57 35.34 57.49 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 48 3 # 48 A 131 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 215 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 277 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 13.06 30.79 51.73 11.40 35.76 53.48 175.75 125.08 4.60 173.18 124.12 -0.61 coo 13.04 31.88 60.72 10.57 35.34 57.49 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 49 3 # 49 A 131 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 215 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 277 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 13.06 30.79 51.73 11.40 35.76 53.48 181.66 123.79 6.82 179.82 128.66 10.46 coo 13.04 31.88 60.72 10.57 35.34 57.49 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 50 3 # 50 A 131 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 215 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 277 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 13.06 30.79 51.73 11.40 35.76 53.48 181.66 123.79 6.82 179.82 128.66 10.46 coo 13.04 31.88 60.72 10.57 35.34 57.49 190.30 123.24 2.08 193.85 127.78 -0.15 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 51 3 # 51 A 131 LYS B 193 LYS~? 27.56 O4 CIT A1102 A 215 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 277 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 0.50 24.09 51.68 1.51 29.34 52.35 188.45 111.50 0.09 191.63 115.50 2.10 coo 13.06 30.79 51.73 11.40 35.76 53.48 181.66 123.79 6.82 179.82 128.66 10.46 coo 13.04 31.88 60.72 10.57 35.34 57.49 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 52 3 # 52 A 131 LYS C 20 LYS~? 29.81 O3 GOL C1901 A 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 277 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 163.54 128.31 58.75 169.18 130.90 60.17 coo 13.06 30.79 51.73 11.40 35.76 53.48 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.04 31.88 60.72 10.57 35.34 57.49 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 53 3 # 53 A 131 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 277 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 149.18 124.89 48.07 150.57 125.16 54.16 coo 13.06 30.79 51.73 11.40 35.76 53.48 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.04 31.88 60.72 10.57 35.34 57.49 163.30 119.33 38.22 166.56 114.68 36.90 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 54 3 # 54 A 131 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 277 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 149.18 124.89 48.07 150.57 125.16 54.16 coo 13.06 30.79 51.73 11.40 35.76 53.48 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.04 31.88 60.72 10.57 35.34 57.49 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 55 3 # 55 A 131 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 277 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 149.18 124.89 48.07 150.57 125.16 54.16 coo 13.06 30.79 51.73 11.40 35.76 53.48 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.04 31.88 60.72 10.57 35.34 57.49 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 56 3 # 56 A 131 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 215 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 277 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.06 30.79 51.73 11.40 35.76 53.48 149.18 124.89 48.07 150.57 125.16 54.16 coo 13.04 31.88 60.72 10.57 35.34 57.49 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 57 3 # 57 A 131 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 215 LYS C 123 LYS^? 25.30 O1 GOL C1901 A 277 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.06 30.79 51.73 11.40 35.76 53.48 174.37 128.14 41.95 175.88 130.01 36.96 coo 13.04 31.88 60.72 10.57 35.34 57.49 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 58 3 # 58 A 131 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 215 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 277 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.06 30.79 51.73 11.40 35.76 53.48 168.56 136.65 44.17 170.62 139.01 49.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 161.71 139.26 46.53 163.20 144.39 46.83 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 59 3 # 59 A 131 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 215 LYS C 186 LYS~? 29.69 O3 GOL C1901 A 277 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.06 30.79 51.73 11.40 35.76 53.48 174.37 114.14 48.91 174.42 112.17 55.03 coo 13.04 31.88 60.72 10.57 35.34 57.49 177.05 121.15 50.66 176.96 126.15 48.94 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 60 3 # 60 A 131 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 215 LYS C 193 LYS~? 28.43 O1 GOL C1901 A 277 LYS C 186 LYS~? 29.69 O3 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.06 30.79 51.73 11.40 35.76 53.48 177.05 121.15 50.66 176.96 126.15 48.94 coo 13.04 31.88 60.72 10.57 35.34 57.49 174.37 114.14 48.91 174.42 112.17 55.03 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 61 3 # 61 A 131 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 215 LYS C 123 LYS^? 25.30 O1 GOL C1901 A 277 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 163.30 119.33 38.22 166.56 114.68 36.90 coo 13.06 30.79 51.73 11.40 35.76 53.48 174.37 128.14 41.95 175.88 130.01 36.96 coo 13.04 31.88 60.72 10.57 35.34 57.49 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 62 3 # 62 A 131 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 277 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 168.56 136.65 44.17 170.62 139.01 49.65 coo 13.06 30.79 51.73 11.40 35.76 53.48 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.04 31.88 60.72 10.57 35.34 57.49 163.30 119.33 38.22 166.56 114.68 36.90 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 63 3 # 63 A 131 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 215 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 277 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 168.56 136.65 44.17 170.62 139.01 49.65 coo 13.06 30.79 51.73 11.40 35.76 53.48 165.62 124.17 41.44 160.89 126.43 37.84 coo 13.04 31.88 60.72 10.57 35.34 57.49 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 64 3 # 64 A 131 LYS C 132 LYS.? 31.57 C8 ADE A 500 A 215 LYS A 123 LYS^? 21.83 C8 ADE A 500 A 277 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 0.50 24.09 51.68 1.51 29.34 52.35 171.68 147.74 40.36 169.69 153.78 40.28 coo 13.06 30.79 51.73 11.40 35.76 53.48 179.30 153.63 32.06 174.52 149.85 32.01 coo 13.04 31.88 60.72 10.57 35.34 57.49 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 65 3 # 65 A 131 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 215 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 277 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 165.62 124.17 41.44 160.89 126.43 37.84 coo 13.06 30.79 51.73 11.40 35.76 53.48 168.56 136.65 44.17 170.62 139.01 49.65 coo 13.04 31.88 60.72 10.57 35.34 57.49 161.71 139.26 46.53 163.20 144.39 46.83 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 66 3 # 66 A 131 LYS C 186 LYS~? 29.69 O3 GOL C1901 A 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 277 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 174.37 114.14 48.91 174.42 112.17 55.03 coo 13.06 30.79 51.73 11.40 35.76 53.48 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.04 31.88 60.72 10.57 35.34 57.49 163.30 119.33 38.22 166.56 114.68 36.90 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 67 3 # 67 A 131 LYS C 186 LYS~? 29.69 O3 GOL C1901 A 215 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 277 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 174.37 114.14 48.91 174.42 112.17 55.03 coo 13.06 30.79 51.73 11.40 35.76 53.48 165.62 124.17 41.44 160.89 126.43 37.84 coo 13.04 31.88 60.72 10.57 35.34 57.49 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 68 3 # 68 A 131 LYS C 186 LYS~? 29.69 O3 GOL C1901 A 215 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 277 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 174.37 114.14 48.91 174.42 112.17 55.03 coo 13.06 30.79 51.73 11.40 35.76 53.48 165.62 124.17 41.44 160.89 126.43 37.84 coo 13.04 31.88 60.72 10.57 35.34 57.49 174.37 128.14 41.95 175.88 130.01 36.96 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 69 3 # 69 A 131 LYS C 193 LYS~? 28.43 O1 GOL C1901 A 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 277 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 177.05 121.15 50.66 176.96 126.15 48.94 coo 13.06 30.79 51.73 11.40 35.76 53.48 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.04 31.88 60.72 10.57 35.34 57.49 163.30 119.33 38.22 166.56 114.68 36.90 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 70 3 # 70 A 131 LYS C 193 LYS~? 28.43 O1 GOL C1901 A 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 277 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 177.05 121.15 50.66 176.96 126.15 48.94 coo 13.06 30.79 51.73 11.40 35.76 53.48 161.58 122.48 47.40 160.49 120.58 53.33 coo 13.04 31.88 60.72 10.57 35.34 57.49 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 71 3 # 71 A 131 LYS C 193 LYS~? 28.43 O1 GOL C1901 A 215 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 277 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 177.05 121.15 50.66 176.96 126.15 48.94 coo 13.06 30.79 51.73 11.40 35.76 53.48 165.62 124.17 41.44 160.89 126.43 37.84 coo 13.04 31.88 60.72 10.57 35.34 57.49 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 72 3 # 72 A 131 LYS C 193 LYS~? 28.43 O1 GOL C1901 A 215 LYS C 180 LYS.? 20.00 O3 GOL C1901 A 277 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 177.05 121.15 50.66 176.96 126.15 48.94 coo 13.06 30.79 51.73 11.40 35.76 53.48 163.89 112.64 46.86 163.54 106.47 45.76 coo 13.04 31.88 60.72 10.57 35.34 57.49 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 73 3 # 73 A 131 LYS C 193 LYS~? 28.43 O1 GOL C1901 A 215 LYS C 180 LYS.? 20.00 O3 GOL C1901 A 277 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 0.50 24.09 51.68 1.51 29.34 52.35 177.05 121.15 50.66 176.96 126.15 48.94 coo 13.06 30.79 51.73 11.40 35.76 53.48 163.89 112.64 46.86 163.54 106.47 45.76 coo 13.04 31.88 60.72 10.57 35.34 57.49 163.30 119.33 38.22 166.56 114.68 36.90 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 73 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 20 LYS~? 27.72 N9 ADE A 500 B 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 277 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 198.50 157.87 31.43 197.45 157.77 37.73 coo 17.88 38.77 19.81 16.38 34.23 17.24 189.82 158.18 22.25 194.56 162.25 23.07 coo 20.33 37.78 11.20 16.77 34.53 13.47 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS A 41 LYS^? 15.86 N3 ADE A 500 B 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 277 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 197.56 153.42 13.51 201.64 156.08 17.41 coo 17.88 38.77 19.81 16.38 34.23 17.24 189.82 158.18 22.25 194.56 162.25 23.07 coo 20.33 37.78 11.20 16.77 34.53 13.47 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 3 3 # 3 B 131 LYS A 41 LYS^? 15.86 N3 ADE A 500 B 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 277 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 197.56 153.42 13.51 201.64 156.08 17.41 coo 17.88 38.77 19.81 16.38 34.23 17.24 189.82 158.18 22.25 194.56 162.25 23.07 coo 20.33 37.78 11.20 16.77 34.53 13.47 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 4 3 # 4 B 131 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 215 LYS A 41 LYS^? 15.86 N3 ADE A 500 B 277 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 189.82 158.18 22.25 194.56 162.25 23.07 coo 17.88 38.77 19.81 16.38 34.23 17.24 197.56 153.42 13.51 201.64 156.08 17.41 coo 20.33 37.78 11.20 16.77 34.53 13.47 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 5 3 # 5 B 131 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 215 LYS A 123 LYS^? 21.83 C8 ADE A 500 B 277 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 189.82 158.18 22.25 194.56 162.25 23.07 coo 17.88 38.77 19.81 16.38 34.23 17.24 179.30 153.63 32.06 174.52 149.85 32.01 coo 20.33 37.78 11.20 16.77 34.53 13.47 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 6 3 # 6 B 131 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 215 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 277 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 189.82 158.18 22.25 194.56 162.25 23.07 coo 17.88 38.77 19.81 16.38 34.23 17.24 182.07 169.10 30.10 186.87 173.28 30.86 coo 20.33 37.78 11.20 16.77 34.53 13.47 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 7 3 # 7 B 131 LYS A 123 LYS^? 21.83 C8 ADE A 500 B 215 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 277 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 179.30 153.63 32.06 174.52 149.85 32.01 coo 17.88 38.77 19.81 16.38 34.23 17.24 180.69 158.10 18.36 176.95 162.62 18.15 coo 20.33 37.78 11.20 16.77 34.53 13.47 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 8 3 # 8 B 131 LYS A 123 LYS^? 21.83 C8 ADE A 500 B 215 LYS A 193 LYS~? 24.54 N9 ADE A 500 B 277 LYS A 186 LYS~? 28.00 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 179.30 153.63 32.06 174.52 149.85 32.01 coo 17.88 38.77 19.81 16.38 34.23 17.24 183.60 164.07 35.65 183.22 158.61 36.42 coo 20.33 37.78 11.20 16.77 34.53 13.47 182.07 169.10 30.10 186.87 173.28 30.86 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 9 3 # 9 B 131 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 215 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 277 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 186.22 145.69 31.90 189.62 146.93 37.05 coo 17.88 38.77 19.81 16.38 34.23 17.24 182.91 155.29 23.54 184.46 151.31 19.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 10 3 # 10 B 131 LYS A 132 LYS~? 32.58 C8 ADE A 500 B 215 LYS C 123 LYS^? 25.30 O1 GOL C1901 B 277 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 183.55 135.22 37.19 185.46 129.22 37.94 coo 17.88 38.77 19.81 16.38 34.23 17.24 174.37 128.14 41.95 175.88 130.01 36.96 coo 20.33 37.78 11.20 16.77 34.53 13.47 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 11 3 # 11 B 131 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 215 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 277 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 182.91 155.29 23.54 184.46 151.31 19.55 coo 17.88 38.77 19.81 16.38 34.23 17.24 186.22 145.69 31.90 189.62 146.93 37.05 coo 20.33 37.78 11.20 16.77 34.53 13.47 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 12 3 # 12 B 131 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 215 LYS A 180 LYS~? 18.96 N3 ADE A 500 B 277 LYS A 186 LYS~? 28.00 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 182.91 155.29 23.54 184.46 151.31 19.55 coo 17.88 38.77 19.81 16.38 34.23 17.24 185.07 167.50 20.34 181.31 169.96 15.85 coo 20.33 37.78 11.20 16.77 34.53 13.47 182.07 169.10 30.10 186.87 173.28 30.86 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 13 3 # 13 B 131 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 215 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 277 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 182.91 155.29 23.54 184.46 151.31 19.55 coo 17.88 38.77 19.81 16.38 34.23 17.24 182.07 169.10 30.10 186.87 173.28 30.86 coo 20.33 37.78 11.20 16.77 34.53 13.47 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 14 3 # 14 B 131 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 215 LYS A 193 LYS~? 24.54 N9 ADE A 500 B 277 LYS A 186 LYS~? 28.00 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 182.91 155.29 23.54 184.46 151.31 19.55 coo 17.88 38.77 19.81 16.38 34.23 17.24 183.60 164.07 35.65 183.22 158.61 36.42 coo 20.33 37.78 11.20 16.77 34.53 13.47 182.07 169.10 30.10 186.87 173.28 30.86 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 15 3 # 15 B 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 277 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 182.07 169.10 30.10 186.87 173.28 30.86 coo 17.88 38.77 19.81 16.38 34.23 17.24 189.82 158.18 22.25 194.56 162.25 23.07 coo 20.33 37.78 11.20 16.77 34.53 13.47 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 16 3 # 16 B 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 215 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 277 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 182.07 169.10 30.10 186.87 173.28 30.86 coo 17.88 38.77 19.81 16.38 34.23 17.24 189.82 158.18 22.25 194.56 162.25 23.07 coo 20.33 37.78 11.20 16.77 34.53 13.47 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 17 3 # 17 B 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 215 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 277 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 182.07 169.10 30.10 186.87 173.28 30.86 coo 17.88 38.77 19.81 16.38 34.23 17.24 182.91 155.29 23.54 184.46 151.31 19.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 18 3 # 18 B 131 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 215 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 277 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 182.07 169.10 30.10 186.87 173.28 30.86 coo 17.88 38.77 19.81 16.38 34.23 17.24 182.91 155.29 23.54 184.46 151.31 19.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 179.30 153.63 32.06 174.52 149.85 32.01 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 19 3 # 19 B 131 LYS A 193 LYS~? 24.54 N9 ADE A 500 B 215 LYS A 123 LYS^? 21.83 C8 ADE A 500 B 277 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 183.60 164.07 35.65 183.22 158.61 36.42 coo 17.88 38.77 19.81 16.38 34.23 17.24 179.30 153.63 32.06 174.52 149.85 32.01 coo 20.33 37.78 11.20 16.77 34.53 13.47 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 20 3 # 20 B 131 LYS A 193 LYS~? 24.54 N9 ADE A 500 B 215 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 277 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 183.60 164.07 35.65 183.22 158.61 36.42 coo 17.88 38.77 19.81 16.38 34.23 17.24 182.91 155.29 23.54 184.46 151.31 19.55 coo 20.33 37.78 11.20 16.77 34.53 13.47 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 21 3 # 21 B 131 LYS B 20 LYS~? 34.92 O4 CIT A1102 B 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 277 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 186.73 109.97 17.12 190.68 107.86 12.58 coo 17.88 38.77 19.81 16.38 34.23 17.24 179.28 118.69 11.71 177.59 112.91 13.79 coo 20.33 37.78 11.20 16.77 34.53 13.47 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 22 3 # 22 B 131 LYS B 20 LYS~? 34.92 O4 CIT A1102 B 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 277 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 186.73 109.97 17.12 190.68 107.86 12.58 coo 17.88 38.77 19.81 16.38 34.23 17.24 179.28 118.69 11.71 177.59 112.91 13.79 coo 20.33 37.78 11.20 16.77 34.53 13.47 173.15 113.94 5.34 166.89 113.91 6.31 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 23 3 # 23 B 131 LYS B 41 LYS^? 27.96 O1 GOL C1901 B 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 277 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 174.17 121.55 22.91 175.90 116.24 24.75 coo 17.88 38.77 19.81 16.38 34.23 17.24 179.28 118.69 11.71 177.59 112.91 13.79 coo 20.33 37.78 11.20 16.77 34.53 13.47 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 24 3 # 24 B 131 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 215 LYS B 41 LYS^? 27.96 O1 GOL C1901 B 277 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 179.28 118.69 11.71 177.59 112.91 13.79 coo 17.88 38.77 19.81 16.38 34.23 17.24 174.17 121.55 22.91 175.90 116.24 24.75 coo 20.33 37.78 11.20 16.77 34.53 13.47 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 25 3 # 25 B 131 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 215 LYS B 123 LYS.? 21.18 O4 CIT A1102 B 277 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 179.28 118.69 11.71 177.59 112.91 13.79 coo 17.88 38.77 19.81 16.38 34.23 17.24 190.30 123.24 2.08 193.85 127.78 -0.15 coo 20.33 37.78 11.20 16.77 34.53 13.47 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 26 3 # 26 B 131 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 215 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 277 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 179.28 118.69 11.71 177.59 112.91 13.79 coo 17.88 38.77 19.81 16.38 34.23 17.24 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 20.33 37.78 11.20 16.77 34.53 13.47 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 27 3 # 27 B 131 LYS B 123 LYS.? 21.18 O4 CIT A1102 B 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 277 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 190.30 123.24 2.08 193.85 127.78 -0.15 coo 17.88 38.77 19.81 16.38 34.23 17.24 179.28 118.69 11.71 177.59 112.91 13.79 coo 20.33 37.78 11.20 16.77 34.53 13.47 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 28 3 # 28 B 131 LYS B 123 LYS.? 21.18 O4 CIT A1102 B 215 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 277 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 190.30 123.24 2.08 193.85 127.78 -0.15 coo 17.88 38.77 19.81 16.38 34.23 17.24 175.75 125.08 4.60 173.18 124.12 -0.61 coo 20.33 37.78 11.20 16.77 34.53 13.47 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 29 3 # 29 B 131 LYS B 123 LYS.? 21.18 O4 CIT A1102 B 215 LYS B 193 LYS~? 27.56 O4 CIT A1102 B 277 LYS B 186 LYS~? 32.32 C2 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 190.30 123.24 2.08 193.85 127.78 -0.15 coo 17.88 38.77 19.81 16.38 34.23 17.24 188.45 111.50 0.09 191.63 115.50 2.10 coo 20.33 37.78 11.20 16.77 34.53 13.47 180.39 111.43 -2.06 180.17 105.09 -1.71 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 30 3 # 30 B 131 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 215 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 277 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 193.73 125.48 11.85 197.51 120.83 13.59 coo 17.88 38.77 19.81 16.38 34.23 17.24 181.66 123.79 6.82 179.82 128.66 10.46 coo 20.33 37.78 11.20 16.77 34.53 13.47 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 31 3 # 31 B 131 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 215 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 277 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 181.66 123.79 6.82 179.82 128.66 10.46 coo 17.88 38.77 19.81 16.38 34.23 17.24 193.73 125.48 11.85 197.51 120.83 13.59 coo 20.33 37.78 11.20 16.77 34.53 13.47 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 32 3 # 32 B 131 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 215 LYS B 180 LYS.? 22.96 O1 CIT A1102 B 277 LYS B 186 LYS~? 32.32 C2 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 181.66 123.79 6.82 179.82 128.66 10.46 coo 17.88 38.77 19.81 16.38 34.23 17.24 173.15 113.94 5.34 166.89 113.91 6.31 coo 20.33 37.78 11.20 16.77 34.53 13.47 180.39 111.43 -2.06 180.17 105.09 -1.71 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 33 3 # 33 B 131 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 215 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 277 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 181.66 123.79 6.82 179.82 128.66 10.46 coo 17.88 38.77 19.81 16.38 34.23 17.24 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 20.33 37.78 11.20 16.77 34.53 13.47 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 34 3 # 34 B 131 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 215 LYS B 193 LYS~? 27.56 O4 CIT A1102 B 277 LYS B 186 LYS~? 32.32 C2 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 181.66 123.79 6.82 179.82 128.66 10.46 coo 17.88 38.77 19.81 16.38 34.23 17.24 188.45 111.50 0.09 191.63 115.50 2.10 coo 20.33 37.78 11.20 16.77 34.53 13.47 180.39 111.43 -2.06 180.17 105.09 -1.71 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 35 3 # 35 B 131 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 277 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 17.88 38.77 19.81 16.38 34.23 17.24 179.28 118.69 11.71 177.59 112.91 13.79 coo 20.33 37.78 11.20 16.77 34.53 13.47 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 36 3 # 36 B 131 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 215 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 277 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 17.88 38.77 19.81 16.38 34.23 17.24 179.28 118.69 11.71 177.59 112.91 13.79 coo 20.33 37.78 11.20 16.77 34.53 13.47 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 37 3 # 37 B 131 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 215 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 277 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 17.88 38.77 19.81 16.38 34.23 17.24 181.66 123.79 6.82 179.82 128.66 10.46 coo 20.33 37.78 11.20 16.77 34.53 13.47 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 38 3 # 38 B 131 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 215 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 277 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 17.88 38.77 19.81 16.38 34.23 17.24 181.66 123.79 6.82 179.82 128.66 10.46 coo 20.33 37.78 11.20 16.77 34.53 13.47 190.30 123.24 2.08 193.85 127.78 -0.15 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 39 3 # 39 B 131 LYS B 193 LYS~? 27.56 O4 CIT A1102 B 215 LYS B 123 LYS.? 21.18 O4 CIT A1102 B 277 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 188.45 111.50 0.09 191.63 115.50 2.10 coo 17.88 38.77 19.81 16.38 34.23 17.24 190.30 123.24 2.08 193.85 127.78 -0.15 coo 20.33 37.78 11.20 16.77 34.53 13.47 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 40 3 # 40 B 131 LYS B 193 LYS~? 27.56 O4 CIT A1102 B 215 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 277 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 6.78 45.91 16.15 7.82 40.81 15.84 188.45 111.50 0.09 191.63 115.50 2.10 coo 17.88 38.77 19.81 16.38 34.23 17.24 181.66 123.79 6.82 179.82 128.66 10.46 coo 20.33 37.78 11.20 16.77 34.53 13.47 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 41 3 # 41 B 131 LYS C 20 LYS~? 29.81 O3 GOL C1901 B 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 277 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 163.54 128.31 58.75 169.18 130.90 60.17 coo 17.88 38.77 19.81 16.38 34.23 17.24 161.58 122.48 47.40 160.49 120.58 53.33 coo 20.33 37.78 11.20 16.77 34.53 13.47 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 42 3 # 42 B 131 LYS C 41 LYS^? 15.03 O3 GOL C1901 B 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 277 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 149.18 124.89 48.07 150.57 125.16 54.16 coo 17.88 38.77 19.81 16.38 34.23 17.24 161.58 122.48 47.40 160.49 120.58 53.33 coo 20.33 37.78 11.20 16.77 34.53 13.47 163.30 119.33 38.22 166.56 114.68 36.90 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 43 3 # 43 B 131 LYS C 41 LYS^? 15.03 O3 GOL C1901 B 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 277 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 149.18 124.89 48.07 150.57 125.16 54.16 coo 17.88 38.77 19.81 16.38 34.23 17.24 161.58 122.48 47.40 160.49 120.58 53.33 coo 20.33 37.78 11.20 16.77 34.53 13.47 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 44 3 # 44 B 131 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 215 LYS C 41 LYS^? 15.03 O3 GOL C1901 B 277 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 161.58 122.48 47.40 160.49 120.58 53.33 coo 17.88 38.77 19.81 16.38 34.23 17.24 149.18 124.89 48.07 150.57 125.16 54.16 coo 20.33 37.78 11.20 16.77 34.53 13.47 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 45 3 # 45 B 131 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 215 LYS C 123 LYS^? 25.30 O1 GOL C1901 B 277 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 161.58 122.48 47.40 160.49 120.58 53.33 coo 17.88 38.77 19.81 16.38 34.23 17.24 174.37 128.14 41.95 175.88 130.01 36.96 coo 20.33 37.78 11.20 16.77 34.53 13.47 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 46 3 # 46 B 131 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 215 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 277 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 161.58 122.48 47.40 160.49 120.58 53.33 coo 17.88 38.77 19.81 16.38 34.23 17.24 174.37 114.14 48.91 174.42 112.17 55.03 coo 20.33 37.78 11.20 16.77 34.53 13.47 177.05 121.15 50.66 176.96 126.15 48.94 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 47 3 # 47 B 131 LYS C 123 LYS^? 25.30 O1 GOL C1901 B 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 277 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 174.37 128.14 41.95 175.88 130.01 36.96 coo 17.88 38.77 19.81 16.38 34.23 17.24 161.58 122.48 47.40 160.49 120.58 53.33 coo 20.33 37.78 11.20 16.77 34.53 13.47 163.30 119.33 38.22 166.56 114.68 36.90 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 48 3 # 48 B 131 LYS C 123 LYS^? 25.30 O1 GOL C1901 B 215 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 277 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 174.37 128.14 41.95 175.88 130.01 36.96 coo 17.88 38.77 19.81 16.38 34.23 17.24 163.30 119.33 38.22 166.56 114.68 36.90 coo 20.33 37.78 11.20 16.77 34.53 13.47 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 49 3 # 49 B 131 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 215 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 277 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 168.56 136.65 44.17 170.62 139.01 49.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 165.62 124.17 41.44 160.89 126.43 37.84 coo 20.33 37.78 11.20 16.77 34.53 13.47 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 50 3 # 50 B 131 LYS C 132 LYS.? 31.57 C8 ADE A 500 B 215 LYS A 123 LYS^? 21.83 C8 ADE A 500 B 277 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 6.78 45.91 16.15 7.82 40.81 15.84 171.68 147.74 40.36 169.69 153.78 40.28 coo 17.88 38.77 19.81 16.38 34.23 17.24 179.30 153.63 32.06 174.52 149.85 32.01 coo 20.33 37.78 11.20 16.77 34.53 13.47 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 51 3 # 51 B 131 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 215 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 277 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 165.62 124.17 41.44 160.89 126.43 37.84 coo 17.88 38.77 19.81 16.38 34.23 17.24 168.56 136.65 44.17 170.62 139.01 49.65 coo 20.33 37.78 11.20 16.77 34.53 13.47 161.71 139.26 46.53 163.20 144.39 46.83 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 52 3 # 52 B 131 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 215 LYS C 180 LYS.? 20.00 O3 GOL C1901 B 277 LYS C 186 LYS~? 29.69 O3 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 165.62 124.17 41.44 160.89 126.43 37.84 coo 17.88 38.77 19.81 16.38 34.23 17.24 163.89 112.64 46.86 163.54 106.47 45.76 coo 20.33 37.78 11.20 16.77 34.53 13.47 174.37 114.14 48.91 174.42 112.17 55.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 53 3 # 53 B 131 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 215 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 277 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 165.62 124.17 41.44 160.89 126.43 37.84 coo 17.88 38.77 19.81 16.38 34.23 17.24 174.37 114.14 48.91 174.42 112.17 55.03 coo 20.33 37.78 11.20 16.77 34.53 13.47 177.05 121.15 50.66 176.96 126.15 48.94 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 54 3 # 54 B 131 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 215 LYS C 193 LYS~? 28.43 O1 GOL C1901 B 277 LYS C 186 LYS~? 29.69 O3 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 165.62 124.17 41.44 160.89 126.43 37.84 coo 17.88 38.77 19.81 16.38 34.23 17.24 177.05 121.15 50.66 176.96 126.15 48.94 coo 20.33 37.78 11.20 16.77 34.53 13.47 174.37 114.14 48.91 174.42 112.17 55.03 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 55 3 # 55 B 131 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 277 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 174.37 114.14 48.91 174.42 112.17 55.03 coo 17.88 38.77 19.81 16.38 34.23 17.24 161.58 122.48 47.40 160.49 120.58 53.33 coo 20.33 37.78 11.20 16.77 34.53 13.47 163.30 119.33 38.22 166.56 114.68 36.90 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 56 3 # 56 B 131 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 215 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 277 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 174.37 114.14 48.91 174.42 112.17 55.03 coo 17.88 38.77 19.81 16.38 34.23 17.24 161.58 122.48 47.40 160.49 120.58 53.33 coo 20.33 37.78 11.20 16.77 34.53 13.47 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 57 3 # 57 B 131 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 215 LYS C 123 LYS^? 25.30 O1 GOL C1901 B 277 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 174.37 114.14 48.91 174.42 112.17 55.03 coo 17.88 38.77 19.81 16.38 34.23 17.24 174.37 128.14 41.95 175.88 130.01 36.96 coo 20.33 37.78 11.20 16.77 34.53 13.47 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 58 3 # 58 B 131 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 215 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 277 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 174.37 114.14 48.91 174.42 112.17 55.03 coo 17.88 38.77 19.81 16.38 34.23 17.24 165.62 124.17 41.44 160.89 126.43 37.84 coo 20.33 37.78 11.20 16.77 34.53 13.47 161.58 122.48 47.40 160.49 120.58 53.33 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 59 3 # 59 B 131 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 215 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 277 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 174.37 114.14 48.91 174.42 112.17 55.03 coo 17.88 38.77 19.81 16.38 34.23 17.24 165.62 124.17 41.44 160.89 126.43 37.84 coo 20.33 37.78 11.20 16.77 34.53 13.47 174.37 128.14 41.95 175.88 130.01 36.96 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 60 3 # 60 B 131 LYS C 193 LYS~? 28.43 O1 GOL C1901 B 215 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 277 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 6.78 45.91 16.15 7.82 40.81 15.84 177.05 121.15 50.66 176.96 126.15 48.94 coo 17.88 38.77 19.81 16.38 34.23 17.24 165.62 124.17 41.44 160.89 126.43 37.84 coo 20.33 37.78 11.20 16.77 34.53 13.47 161.58 122.48 47.40 160.49 120.58 53.33 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 60 hits 1e19_c01 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 43 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 65 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 20.15 22.08 34.36 20.84 20.10 34.21 184.39 157.95 13.11 185.86 157.96 14.60 coo 19.55 18.91 30.27 18.21 18.65 31.84 185.28 156.61 18.37 185.56 154.55 18.68 coo 10.90 21.31 28.81 12.14 22.15 30.31 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 43 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 65 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 20.15 22.08 34.36 20.84 20.10 34.21 171.08 125.47 9.27 172.48 124.18 10.15 coo 19.55 18.91 30.27 18.21 18.65 31.84 176.50 123.51 9.48 177.50 124.87 10.72 coo 10.90 21.31 28.81 12.14 22.15 30.31 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 43 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 65 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 20.15 22.08 34.36 20.84 20.10 34.21 157.21 117.94 38.21 157.48 118.99 40.00 coo 19.55 18.91 30.27 18.21 18.65 31.84 160.37 121.38 41.43 159.84 123.37 41.06 coo 10.90 21.31 28.81 12.14 22.15 30.31 157.34 129.59 37.15 157.60 127.69 38.11 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 3 hits 1e7l_c01 naa= 3 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 1 3 # 1 A 205 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 207 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 366 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 192.52 142.86 28.75 192.00 138.78 32.31 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 186.22 145.69 31.90 189.62 146.93 37.05 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 2 3 # 2 A 205 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 207 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 366 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 186.22 145.69 31.90 189.62 146.93 37.05 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 192.52 142.86 28.75 192.00 138.78 32.31 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 3 3 # 3 A 205 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 207 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 366 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 192.36 125.68 19.31 197.51 127.46 19.90 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 193.73 125.48 11.85 197.51 120.83 13.59 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 4 3 # 4 A 205 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 207 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 366 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 193.73 125.48 11.85 197.51 120.83 13.59 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 192.36 125.68 19.31 197.51 127.46 19.90 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 5 3 # 5 A 205 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 207 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 366 ASP C 130 ASP.? 30.92 O1 GOL C1901 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 161.71 139.26 46.53 163.20 144.39 46.83 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 168.56 136.65 44.17 170.62 139.01 49.65 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 167.73 145.95 43.64 168.62 147.66 44.50 ULMN 3 1ec9_c04 GLUCARATE DEHYDRATASE user 6 3 # 6 A 205 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 207 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 366 ASP C 130 ASP.? 30.92 O1 GOL C1901 coo -15.19 -26.42 1.17 -15.94 -21.72 -3.01 168.56 136.65 44.17 170.62 139.01 49.65 coo -20.91 -23.36 1.14 -20.26 -20.07 -2.33 161.71 139.26 46.53 163.20 144.39 46.83 coo -13.66 -24.10 -6.32 -13.27 -22.99 -4.55 167.73 145.95 43.64 168.62 147.66 44.50 1ec9_c04 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c04 naa= 3 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 1 3 # 1 B 205 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 207 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 366 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 192.52 142.86 28.75 192.00 138.78 32.31 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 186.22 145.69 31.90 189.62 146.93 37.05 coo -11.13 25.71 4.86 -10.82 24.43 3.24 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 2 3 # 2 B 205 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 207 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 366 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 186.22 145.69 31.90 189.62 146.93 37.05 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 192.52 142.86 28.75 192.00 138.78 32.31 coo -11.13 25.71 4.86 -10.82 24.43 3.24 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 3 3 # 3 B 205 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 207 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 366 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 192.36 125.68 19.31 197.51 127.46 19.90 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 193.73 125.48 11.85 197.51 120.83 13.59 coo -11.13 25.71 4.86 -10.82 24.43 3.24 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 4 3 # 4 B 205 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 207 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 366 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 193.73 125.48 11.85 197.51 120.83 13.59 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 192.36 125.68 19.31 197.51 127.46 19.90 coo -11.13 25.71 4.86 -10.82 24.43 3.24 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 5 3 # 5 B 205 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 207 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 366 ASP C 130 ASP.? 30.92 O1 GOL C1901 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 161.71 139.26 46.53 163.20 144.39 46.83 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 168.56 136.65 44.17 170.62 139.01 49.65 coo -11.13 25.71 4.86 -10.82 24.43 3.24 167.73 145.95 43.64 168.62 147.66 44.50 ULMN 3 1ec9_c05 GLUCARATE DEHYDRATASE user 6 3 # 6 B 205 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 207 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 366 ASP C 130 ASP.? 30.92 O1 GOL C1901 coo -11.45 28.09 -2.93 -13.20 23.63 1.17 168.56 136.65 44.17 170.62 139.01 49.65 coo -17.50 25.66 -3.58 -17.49 22.55 -0.15 161.71 139.26 46.53 163.20 144.39 46.83 coo -11.13 25.71 4.86 -10.82 24.43 3.24 167.73 145.95 43.64 168.62 147.66 44.50 1ec9_c05 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c05 naa= 3 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 1 3 # 1 C 205 LYS A 110 LYS.? 23.26 C8 ADE A 500 C 207 LYS A 126 LYS^? 24.40 C8 ADE A 500 C 366 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 192.52 142.86 28.75 192.00 138.78 32.31 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 186.22 145.69 31.90 189.62 146.93 37.05 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 2 3 # 2 C 205 LYS A 126 LYS^? 24.40 C8 ADE A 500 C 207 LYS A 110 LYS.? 23.26 C8 ADE A 500 C 366 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 186.22 145.69 31.90 189.62 146.93 37.05 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 192.52 142.86 28.75 192.00 138.78 32.31 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 3 3 # 3 C 205 LYS B 110 LYS.? 26.40 N7 ADE A 500 C 207 LYS B 126 LYS^? 29.75 O4 CIT A1102 C 366 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 192.36 125.68 19.31 197.51 127.46 19.90 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 193.73 125.48 11.85 197.51 120.83 13.59 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 4 3 # 4 C 205 LYS B 126 LYS^? 29.75 O4 CIT A1102 C 207 LYS B 110 LYS.? 26.40 N7 ADE A 500 C 366 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 193.73 125.48 11.85 197.51 120.83 13.59 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 192.36 125.68 19.31 197.51 127.46 19.90 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 5 3 # 5 C 205 LYS C 110 LYS.? 26.32 O1 GOL C1901 C 207 LYS C 126 LYS^? 28.06 O1 GOL C1901 C 366 ASP C 130 ASP.? 30.92 O1 GOL C1901 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 161.71 139.26 46.53 163.20 144.39 46.83 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 168.56 136.65 44.17 170.62 139.01 49.65 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 167.73 145.95 43.64 168.62 147.66 44.50 ULMN 3 1ec9_c06 GLUCARATE DEHYDRATASE user 6 3 # 6 C 205 LYS C 126 LYS^? 28.06 O1 GOL C1901 C 207 LYS C 110 LYS.? 26.32 O1 GOL C1901 C 366 ASP C 130 ASP.? 30.92 O1 GOL C1901 coo 15.57 11.65 -23.50 16.31 5.98 -20.68 168.56 136.65 44.17 170.62 139.01 49.65 coo 21.27 10.43 -20.58 20.77 6.00 -18.91 161.71 139.26 46.53 163.20 144.39 46.83 coo 14.28 3.88 -24.50 13.85 4.89 -22.78 167.73 145.95 43.64 168.62 147.66 44.50 1ec9_c06 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c06 naa= 3 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 1 3 # 1 D 205 LYS A 110 LYS.? 23.26 C8 ADE A 500 D 207 LYS A 126 LYS^? 24.40 C8 ADE A 500 D 366 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 192.52 142.86 28.75 192.00 138.78 32.31 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 186.22 145.69 31.90 189.62 146.93 37.05 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 2 3 # 2 D 205 LYS A 126 LYS^? 24.40 C8 ADE A 500 D 207 LYS A 110 LYS.? 23.26 C8 ADE A 500 D 366 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 186.22 145.69 31.90 189.62 146.93 37.05 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 192.52 142.86 28.75 192.00 138.78 32.31 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 3 3 # 3 D 205 LYS B 110 LYS.? 26.40 N7 ADE A 500 D 207 LYS B 126 LYS^? 29.75 O4 CIT A1102 D 366 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 192.36 125.68 19.31 197.51 127.46 19.90 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 193.73 125.48 11.85 197.51 120.83 13.59 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 4 3 # 4 D 205 LYS B 126 LYS^? 29.75 O4 CIT A1102 D 207 LYS B 110 LYS.? 26.40 N7 ADE A 500 D 366 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 193.73 125.48 11.85 197.51 120.83 13.59 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 192.36 125.68 19.31 197.51 127.46 19.90 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 5 3 # 5 D 205 LYS C 110 LYS.? 26.32 O1 GOL C1901 D 207 LYS C 126 LYS^? 28.06 O1 GOL C1901 D 366 ASP C 130 ASP.? 30.92 O1 GOL C1901 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 161.71 139.26 46.53 163.20 144.39 46.83 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 168.56 136.65 44.17 170.62 139.01 49.65 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 167.73 145.95 43.64 168.62 147.66 44.50 ULMN 3 1ec9_c07 GLUCARATE DEHYDRATASE user 6 3 # 6 D 205 LYS C 126 LYS^? 28.06 O1 GOL C1901 D 207 LYS C 110 LYS.? 26.32 O1 GOL C1901 D 366 ASP C 130 ASP.? 30.92 O1 GOL C1901 coo 11.00 -13.38 25.10 13.14 -7.87 22.68 168.56 136.65 44.17 170.62 139.01 49.65 coo 17.14 -12.99 22.96 17.50 -8.64 21.08 161.71 139.26 46.53 163.20 144.39 46.83 coo 10.74 -5.36 25.95 10.35 -6.43 24.20 167.73 145.95 43.64 168.62 147.66 44.50 1ec9_c07 source 1ec9 GLUCARATE DEHYDRATASE : 6 hits 1ec9_c07 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 177 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 203 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 8.74 45.76 47.19 9.33 46.93 45.56 184.39 157.95 13.11 185.86 157.96 14.60 coo 11.68 42.31 52.96 12.05 43.92 51.65 178.57 156.37 9.84 177.44 156.14 8.05 coo 18.07 52.81 49.62 14.17 49.99 48.07 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS A 187 HIS~? 25.73 N9 ADE A 500 A 177 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 203 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 8.74 45.76 47.19 9.33 46.93 45.56 179.01 171.47 26.59 179.51 173.49 26.31 coo 11.68 42.31 52.96 12.05 43.92 51.65 184.84 171.88 24.93 186.38 173.28 25.14 coo 18.07 52.81 49.62 14.17 49.99 48.07 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 177 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 203 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 8.74 45.76 47.19 9.33 46.93 45.56 171.08 125.47 9.27 172.48 124.18 10.15 coo 11.68 42.31 52.96 12.05 43.92 51.65 169.82 131.15 6.22 168.64 132.89 5.97 coo 18.07 52.81 49.62 14.17 49.99 48.07 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 177 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 203 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 8.74 45.76 47.19 9.33 46.93 45.56 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 11.68 42.31 52.96 12.05 43.92 51.65 174.65 109.33 0.17 174.41 107.27 0.58 coo 18.07 52.81 49.62 14.17 49.99 48.07 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 5 3 # 5 A 99 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 177 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 203 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 8.74 45.76 47.19 9.33 46.93 45.56 157.21 117.94 38.21 157.48 118.99 40.00 coo 11.68 42.31 52.96 12.05 43.92 51.65 157.90 117.18 31.56 156.68 116.62 29.91 coo 18.07 52.81 49.62 14.17 49.99 48.07 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 6 3 # 6 A 99 HIS C 187 HIS~? 27.79 O3 GOL C1901 A 177 ASP C 183 ASP~? 25.06 O3 GOL C1901 A 203 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 8.74 45.76 47.19 9.33 46.93 45.56 174.78 109.74 44.68 175.79 108.53 43.31 coo 11.68 42.31 52.96 12.05 43.92 51.65 169.34 110.13 50.56 169.06 109.63 52.58 coo 18.07 52.81 49.62 14.17 49.99 48.07 177.05 121.15 50.66 176.96 126.15 48.94 1ecx_c02 source 1ecx AMINOTRANSFERASE : 6 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 177 ASP A 175 ASP.? 10.98 C4 ADE A 500 B 203 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 14.87 88.04 21.51 13.64 87.90 19.81 184.39 157.95 13.11 185.86 157.96 14.60 coo 15.87 92.46 27.37 14.46 91.76 25.94 178.57 156.37 9.84 177.44 156.14 8.05 coo 3.60 91.42 23.52 8.20 89.55 22.63 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS A 187 HIS~? 25.73 N9 ADE A 500 B 177 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 203 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 14.87 88.04 21.51 13.64 87.90 19.81 179.01 171.47 26.59 179.51 173.49 26.31 coo 15.87 92.46 27.37 14.46 91.76 25.94 184.84 171.88 24.93 186.38 173.28 25.14 coo 3.60 91.42 23.52 8.20 89.55 22.63 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 177 ASP B 175 ASP.? 4.91 O1 CIT A1102 B 203 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 14.87 88.04 21.51 13.64 87.90 19.81 171.08 125.47 9.27 172.48 124.18 10.15 coo 15.87 92.46 27.37 14.46 91.76 25.94 169.82 131.15 6.22 168.64 132.89 5.97 coo 3.60 91.42 23.52 8.20 89.55 22.63 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 177 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 203 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 14.87 88.04 21.51 13.64 87.90 19.81 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 15.87 92.46 27.37 14.46 91.76 25.94 174.65 109.33 0.17 174.41 107.27 0.58 coo 3.60 91.42 23.52 8.20 89.55 22.63 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 5 3 # 5 B 99 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 177 ASP C 175 ASP.? 10.66 O1 GOL C1901 B 203 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 14.87 88.04 21.51 13.64 87.90 19.81 157.21 117.94 38.21 157.48 118.99 40.00 coo 15.87 92.46 27.37 14.46 91.76 25.94 157.90 117.18 31.56 156.68 116.62 29.91 coo 3.60 91.42 23.52 8.20 89.55 22.63 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 6 3 # 6 B 99 HIS C 187 HIS~? 27.79 O3 GOL C1901 B 177 ASP C 183 ASP~? 25.06 O3 GOL C1901 B 203 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 14.87 88.04 21.51 13.64 87.90 19.81 174.78 109.74 44.68 175.79 108.53 43.31 coo 15.87 92.46 27.37 14.46 91.76 25.94 169.34 110.13 50.56 169.06 109.63 52.58 coo 3.60 91.42 23.52 8.20 89.55 22.63 177.05 121.15 50.66 176.96 126.15 48.94 1ecx_c03 source 1ecx AMINOTRANSFERASE : 6 hits 1ecx_c03 naa= 3 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 A 66 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 110 GLY A 45 GLY.? 10.73 N9 ADE A 500 A 140 TYR A 47 TYR^? 13.72 N3 ADE A 500 coo 24.53 0.12 1.91 23.47 1.90 2.27 191.47 153.75 14.17 189.52 154.05 13.44 coo 22.96 1.26 5.85 23.32 1.32 6.60 194.65 155.46 18.65 194.04 154.92 18.22 coo 21.28 7.32 1.28 21.07 5.14 3.02 198.66 149.45 16.16 201.00 150.74 16.95 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 A 66 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 110 GLY A 45 GLY.? 10.73 N9 ADE A 500 A 140 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo 24.53 0.12 1.91 23.47 1.90 2.27 191.47 153.75 14.17 189.52 154.05 13.44 coo 22.96 1.26 5.85 23.32 1.32 6.60 194.65 155.46 18.65 194.04 154.92 18.22 coo 21.28 7.32 1.28 21.07 5.14 3.02 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 A 66 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 110 GLY B 45 GLY.? 23.68 O4 CIT A1102 A 140 TYR B 47 TYR^? 27.62 O4 CIT A1102 coo 24.53 0.12 1.91 23.47 1.90 2.27 174.27 123.90 17.18 173.55 124.80 15.43 coo 22.96 1.26 5.85 23.32 1.32 6.60 177.24 119.43 17.85 177.04 120.22 17.68 coo 21.28 7.32 1.28 21.07 5.14 3.02 177.82 122.79 24.63 178.10 120.27 25.77 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 A 66 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 110 GLY B 45 GLY.? 23.68 O4 CIT A1102 A 140 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 24.53 0.12 1.91 23.47 1.90 2.27 174.27 123.90 17.18 173.55 124.80 15.43 coo 22.96 1.26 5.85 23.32 1.32 6.60 177.24 119.43 17.85 177.04 120.22 17.68 coo 21.28 7.32 1.28 21.07 5.14 3.02 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 5 3 # 5 A 66 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 110 GLY B 46 GLY.? 23.93 O4 CIT A1102 A 140 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 24.53 0.12 1.91 23.47 1.90 2.27 174.27 123.90 17.18 173.55 124.80 15.43 coo 22.96 1.26 5.85 23.32 1.32 6.60 179.08 121.64 20.30 178.23 121.42 20.36 coo 21.28 7.32 1.28 21.07 5.14 3.02 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 6 3 # 6 A 66 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 110 GLY C 45 GLY.? 11.06 O3 GOL C1901 A 140 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo 24.53 0.12 1.91 23.47 1.90 2.27 153.36 123.09 43.85 154.03 121.98 42.20 coo 22.96 1.26 5.85 23.32 1.32 6.60 155.66 124.22 48.62 155.39 124.25 47.85 coo 21.28 7.32 1.28 21.07 5.14 3.02 149.80 129.36 48.45 149.55 129.08 51.21 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 7 3 # 7 A 66 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 110 GLY C 45 GLY.? 11.06 O3 GOL C1901 A 140 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 24.53 0.12 1.91 23.47 1.90 2.27 153.36 123.09 43.85 154.03 121.98 42.20 coo 22.96 1.26 5.85 23.32 1.32 6.60 155.66 124.22 48.62 155.39 124.25 47.85 coo 21.28 7.32 1.28 21.07 5.14 3.02 155.65 129.37 42.44 156.62 127.68 44.43 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 8 3 # 8 A 66 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 110 GLY C 46 GLY.? 11.75 O3 GOL C1901 A 140 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 24.53 0.12 1.91 23.47 1.90 2.27 153.36 123.09 43.85 154.03 121.98 42.20 coo 22.96 1.26 5.85 23.32 1.32 6.60 154.15 127.64 48.04 153.68 126.93 48.08 coo 21.28 7.32 1.28 21.07 5.14 3.02 155.65 129.37 42.44 156.62 127.68 44.43 1ef8_c00 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 8 hits 1ef8_c00 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 110 GLY A 45 GLY.? 10.73 N9 ADE A 500 B 140 TYR A 47 TYR^? 13.72 N3 ADE A 500 coo 15.25 42.02 9.50 15.08 40.17 8.54 191.47 153.75 14.17 189.52 154.05 13.44 coo 16.54 37.86 10.86 17.07 37.78 11.48 194.65 155.46 18.65 194.04 154.92 18.22 coo 8.70 35.97 10.91 11.44 36.02 10.35 198.66 149.45 16.16 201.00 150.74 16.95 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 B 66 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 110 GLY B 45 GLY.? 23.68 O4 CIT A1102 B 140 TYR B 47 TYR^? 27.62 O4 CIT A1102 coo 15.25 42.02 9.50 15.08 40.17 8.54 174.27 123.90 17.18 173.55 124.80 15.43 coo 16.54 37.86 10.86 17.07 37.78 11.48 177.24 119.43 17.85 177.04 120.22 17.68 coo 8.70 35.97 10.91 11.44 36.02 10.35 177.82 122.79 24.63 178.10 120.27 25.77 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 B 66 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 110 GLY C 45 GLY.? 11.06 O3 GOL C1901 B 140 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo 15.25 42.02 9.50 15.08 40.17 8.54 153.36 123.09 43.85 154.03 121.98 42.20 coo 16.54 37.86 10.86 17.07 37.78 11.48 155.66 124.22 48.62 155.39 124.25 47.85 coo 8.70 35.97 10.91 11.44 36.02 10.35 149.80 129.36 48.45 149.55 129.08 51.21 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 42 HIS.? -4.20 N3 ADE A 500s C 110 GLY A 45 GLY.? 10.73 N9 ADE A 500 C 140 TYR A 47 TYR^? 13.72 N3 ADE A 500 coo -9.82 10.01 28.41 -9.17 11.02 26.71 191.47 153.75 14.17 189.52 154.05 13.44 coo -5.73 12.49 27.77 -5.15 12.61 28.37 194.65 155.46 18.65 194.04 154.92 18.22 coo -4.68 8.05 21.05 -4.91 10.19 22.84 198.66 149.45 16.16 201.00 150.74 16.95 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 C 66 HIS B 42 HIS.? 18.79 O1 CIT A1102 C 110 GLY B 45 GLY.? 23.68 O4 CIT A1102 C 140 TYR B 47 TYR^? 27.62 O4 CIT A1102 coo -9.82 10.01 28.41 -9.17 11.02 26.71 174.27 123.90 17.18 173.55 124.80 15.43 coo -5.73 12.49 27.77 -5.15 12.61 28.37 177.24 119.43 17.85 177.04 120.22 17.68 coo -4.68 8.05 21.05 -4.91 10.19 22.84 177.82 122.79 24.63 178.10 120.27 25.77 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 C 66 HIS C 42 HIS.? 5.32 O3 GOL C1901 C 110 GLY C 45 GLY.? 11.06 O3 GOL C1901 C 140 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo -9.82 10.01 28.41 -9.17 11.02 26.71 153.36 123.09 43.85 154.03 121.98 42.20 coo -5.73 12.49 27.77 -5.15 12.61 28.37 155.66 124.22 48.62 155.39 124.25 47.85 coo -4.68 8.05 21.05 -4.91 10.19 22.84 149.80 129.36 48.45 149.55 129.08 51.21 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 3 hits 1ef8_c02 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 246 ASP A 119 ASP.? 23.37 C8 ADE A 500 B 275 HIS A 187 HIS~? 25.73 N9 ADE A 500 coo 34.84 56.77 81.62 34.95 54.74 82.03 184.84 171.88 24.93 186.38 173.28 25.14 coo 43.18 49.30 68.39 44.75 49.87 69.78 170.58 160.79 28.87 171.46 159.09 29.69 coo 38.73 55.10 77.62 36.80 55.01 78.46 179.01 171.47 26.59 179.51 173.49 26.31 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 1 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 183 ASP~? 24.76 N9 ADE A 500 C 246 ASP A 119 ASP.? 23.37 C8 ADE A 500 C 275 HIS A 187 HIS~? 25.73 N9 ADE A 500 coo 1.90 35.26 72.76 3.20 35.74 71.18 184.84 171.88 24.93 186.38 173.28 25.14 coo 12.03 20.33 71.56 10.48 19.25 70.56 170.58 160.79 28.87 171.46 159.09 29.69 coo 3.92 29.96 71.75 4.22 31.96 72.31 179.01 171.47 26.59 179.51 173.49 26.31 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP B 183 ASP~? 28.98 C2 CIT A1102 C 246 ASP B 119 ASP.? 20.62 O7 CIT A1102 C 275 HIS B 187 HIS~? 26.45 C2 CIT A1102 coo 1.90 35.26 72.76 3.20 35.74 71.18 174.65 109.33 0.17 174.41 107.27 0.58 coo 12.03 20.33 71.56 10.48 19.25 70.56 184.41 123.54 -7.24 185.10 123.40 -9.24 coo 3.92 29.96 71.75 4.22 31.96 72.31 176.75 112.07 -5.75 176.32 110.31 -6.80 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 2 hits 1ehy_c02 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 197 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 223 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 184.39 157.95 13.11 185.86 157.96 14.60 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 178.57 156.37 9.84 177.44 156.14 8.05 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS A 187 HIS~? 25.73 N9 ADE A 500 A 197 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 223 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 179.01 171.47 26.59 179.51 173.49 26.31 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 184.84 171.88 24.93 186.38 173.28 25.14 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 197 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 223 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 171.08 125.47 9.27 172.48 124.18 10.15 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 169.82 131.15 6.22 168.64 132.89 5.97 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 197 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 223 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 176.75 112.07 -5.75 176.32 110.31 -6.80 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 174.65 109.33 0.17 174.41 107.27 0.58 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 A 114 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 197 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 223 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 157.21 117.94 38.21 157.48 118.99 40.00 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 157.90 117.18 31.56 156.68 116.62 29.91 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 6 3 # 6 A 114 HIS C 187 HIS~? 27.79 O3 GOL C1901 A 197 ASP C 183 ASP~? 25.06 O3 GOL C1901 A 223 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 174.78 109.74 44.68 175.79 108.53 43.31 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 169.34 110.13 50.56 169.06 109.63 52.58 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 177.05 121.15 50.66 176.96 126.15 48.94 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 6 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 187 HIS~? 25.73 N9 ADE A 500 B 197 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 223 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 179.01 171.47 26.59 179.51 173.49 26.31 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 184.84 171.88 24.93 186.38 173.28 25.14 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 197 ASP B 175 ASP.? 4.91 O1 CIT A1102 B 223 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 171.08 125.47 9.27 172.48 124.18 10.15 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 169.82 131.15 6.22 168.64 132.89 5.97 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 197 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 223 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 176.75 112.07 -5.75 176.32 110.31 -6.80 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 174.65 109.33 0.17 174.41 107.27 0.58 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 197 ASP C 175 ASP.? 10.66 O1 GOL C1901 B 223 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 157.21 117.94 38.21 157.48 118.99 40.00 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 157.90 117.18 31.56 156.68 116.62 29.91 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 5 3 # 5 B 114 HIS C 187 HIS~? 27.79 O3 GOL C1901 B 197 ASP C 183 ASP~? 25.06 O3 GOL C1901 B 223 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 174.78 109.74 44.68 175.79 108.53 43.31 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 169.34 110.13 50.56 169.06 109.63 52.58 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 177.05 121.15 50.66 176.96 126.15 48.94 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 5 hits 1elq_c03 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 194 ALA~? 24.12 N9 ADE A 500 A 257 ALA A 198 ALA~? 22.51 N9 ADE A 500 A 328 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 39.84 24.12 8.44 38.50 24.23 9.11 184.86 165.44 32.34 184.45 166.79 31.77 coo 43.22 26.73 5.37 41.81 27.09 5.79 189.84 163.90 29.97 190.40 165.13 30.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 195 ALA~? 27.08 N9 ADE A 500 A 257 ALA A 194 ALA~? 24.12 N9 ADE A 500 A 328 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 39.84 24.12 8.44 38.50 24.23 9.11 188.15 166.18 34.05 188.29 166.96 35.33 coo 43.22 26.73 5.37 41.81 27.09 5.79 184.86 165.44 32.34 184.45 166.79 31.77 coo 38.17 34.10 6.67 37.72 32.06 6.84 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 195 ALA~? 27.08 N9 ADE A 500 A 257 ALA A 198 ALA~? 22.51 N9 ADE A 500 A 328 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 39.84 24.12 8.44 38.50 24.23 9.11 188.15 166.18 34.05 188.29 166.96 35.33 coo 43.22 26.73 5.37 41.81 27.09 5.79 189.84 163.90 29.97 190.40 165.13 30.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 198 ALA~? 22.51 N9 ADE A 500 A 257 ALA A 194 ALA~? 24.12 N9 ADE A 500 A 328 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 39.84 24.12 8.44 38.50 24.23 9.11 189.84 163.90 29.97 190.40 165.13 30.64 coo 43.22 26.73 5.37 41.81 27.09 5.79 184.86 165.44 32.34 184.45 166.79 31.77 coo 38.17 34.10 6.67 37.72 32.06 6.84 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 198 ALA~? 22.51 N9 ADE A 500 A 257 ALA A 201 ALA~? 17.12 N9 ADE A 500 A 328 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 39.84 24.12 8.44 38.50 24.23 9.11 189.84 163.90 29.97 190.40 165.13 30.64 coo 43.22 26.73 5.37 41.81 27.09 5.79 189.52 162.53 24.76 188.43 163.45 25.31 coo 38.17 34.10 6.67 37.72 32.06 6.84 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 201 ALA~? 17.12 N9 ADE A 500 A 257 ALA A 198 ALA~? 22.51 N9 ADE A 500 A 328 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 39.84 24.12 8.44 38.50 24.23 9.11 189.52 162.53 24.76 188.43 163.45 25.31 coo 43.22 26.73 5.37 41.81 27.09 5.79 189.84 163.90 29.97 190.40 165.13 30.64 coo 38.17 34.10 6.67 37.72 32.06 6.84 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA B 195 ALA~? 32.61 O4 CIT A1102 A 257 ALA B 194 ALA~? 27.91 C2 CIT A1102 A 328 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 39.84 24.12 8.44 38.50 24.23 9.11 185.78 108.35 3.71 186.55 107.14 3.21 coo 43.22 26.73 5.37 41.81 27.09 5.79 184.96 111.42 1.60 183.70 111.01 0.84 coo 38.17 34.10 6.67 37.72 32.06 6.84 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA B 198 ALA.? 29.73 O4 CIT A1102 A 257 ALA B 194 ALA~? 27.91 C2 CIT A1102 A 328 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 39.84 24.12 8.44 38.50 24.23 9.11 183.32 111.00 7.40 183.44 109.49 7.28 coo 43.22 26.73 5.37 41.81 27.09 5.79 184.96 111.42 1.60 183.70 111.01 0.84 coo 38.17 34.10 6.67 37.72 32.06 6.84 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA B 198 ALA.? 29.73 O4 CIT A1102 A 257 ALA B 201 ALA.? 25.06 C2 CIT A1102 A 328 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 39.84 24.12 8.44 38.50 24.23 9.11 183.32 111.00 7.40 183.44 109.49 7.28 coo 43.22 26.73 5.37 41.81 27.09 5.79 179.08 113.99 8.58 179.23 113.12 7.33 coo 38.17 34.10 6.67 37.72 32.06 6.84 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA C 194 ALA~? 26.52 O3 GOL C1901 A 257 ALA C 198 ALA~? 24.12 O3 GOL C1901 A 328 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 39.84 24.12 8.44 38.50 24.23 9.11 174.02 118.87 51.06 174.07 117.35 50.94 coo 43.22 26.73 5.37 41.81 27.09 5.79 168.86 120.30 53.31 169.26 119.70 54.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 169.34 110.13 50.56 169.06 109.63 52.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA C 195 ALA~? 29.46 O3 GOL C1901 A 257 ALA C 194 ALA~? 26.52 O3 GOL C1901 A 328 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 39.84 24.12 8.44 38.50 24.23 9.11 173.84 119.71 54.74 175.00 119.64 55.71 coo 43.22 26.73 5.37 41.81 27.09 5.79 174.02 118.87 51.06 174.07 117.35 50.94 coo 38.17 34.10 6.67 37.72 32.06 6.84 169.34 110.13 50.56 169.06 109.63 52.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA C 195 ALA~? 29.46 O3 GOL C1901 A 257 ALA C 198 ALA~? 24.12 O3 GOL C1901 A 328 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 39.84 24.12 8.44 38.50 24.23 9.11 173.84 119.71 54.74 175.00 119.64 55.71 coo 43.22 26.73 5.37 41.81 27.09 5.79 168.86 120.30 53.31 169.26 119.70 54.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 169.34 110.13 50.56 169.06 109.63 52.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA C 198 ALA~? 24.12 O3 GOL C1901 A 257 ALA C 194 ALA~? 26.52 O3 GOL C1901 A 328 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 39.84 24.12 8.44 38.50 24.23 9.11 168.86 120.30 53.31 169.26 119.70 54.63 coo 43.22 26.73 5.37 41.81 27.09 5.79 174.02 118.87 51.06 174.07 117.35 50.94 coo 38.17 34.10 6.67 37.72 32.06 6.84 169.34 110.13 50.56 169.06 109.63 52.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA C 198 ALA~? 24.12 O3 GOL C1901 A 257 ALA C 201 ALA~? 18.41 O3 GOL C1901 A 328 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 39.84 24.12 8.44 38.50 24.23 9.11 168.86 120.30 53.31 169.26 119.70 54.63 coo 43.22 26.73 5.37 41.81 27.09 5.79 164.63 119.64 49.73 165.82 118.76 49.44 coo 38.17 34.10 6.67 37.72 32.06 6.84 169.34 110.13 50.56 169.06 109.63 52.58 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA C 201 ALA~? 18.41 O3 GOL C1901 A 257 ALA C 198 ALA~? 24.12 O3 GOL C1901 A 328 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 39.84 24.12 8.44 38.50 24.23 9.11 164.63 119.64 49.73 165.82 118.76 49.44 coo 43.22 26.73 5.37 41.81 27.09 5.79 168.86 120.30 53.31 169.26 119.70 54.63 coo 38.17 34.10 6.67 37.72 32.06 6.84 169.34 110.13 50.56 169.06 109.63 52.58 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 15 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 124 SER^? 19.87 C8 ADE A 500 A 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 34.67 35.79 48.83 33.57 37.88 49.47 182.61 151.80 32.41 184.93 152.05 33.02 coo 29.60 38.99 53.89 30.10 37.88 51.36 185.14 149.36 25.84 186.22 148.61 23.38 coo 32.73 32.94 54.42 29.29 32.83 50.35 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER B 124 SER^? 23.63 O4 CIT A1102 A 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 34.67 35.79 48.83 33.57 37.88 49.47 191.23 122.78 5.73 191.55 121.05 7.41 coo 29.60 38.99 53.89 30.10 37.88 51.36 186.72 125.72 10.79 185.00 126.80 12.71 coo 32.73 32.94 54.42 29.29 32.83 50.35 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 A 116 SER C 124 SER^? 23.11 O1 GOL C1901 A 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 34.67 35.79 48.83 33.57 37.88 49.47 172.32 130.73 43.72 171.22 130.88 45.88 coo 29.60 38.99 53.89 30.10 37.88 51.36 165.10 130.81 41.92 162.37 130.83 41.35 coo 32.73 32.94 54.42 29.29 32.83 50.35 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 124 SER^? 19.87 C8 ADE A 500 B 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 B 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 30.90 35.65 89.60 29.85 37.72 88.83 182.61 151.80 32.41 184.93 152.05 33.02 coo 24.43 38.83 86.53 27.07 38.03 86.12 185.14 149.36 25.84 186.22 148.61 23.38 coo 25.13 32.62 89.49 27.74 32.61 84.91 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER B 124 SER^? 23.63 O4 CIT A1102 B 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 B 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 30.90 35.65 89.60 29.85 37.72 88.83 191.23 122.78 5.73 191.55 121.05 7.41 coo 24.43 38.83 86.53 27.07 38.03 86.12 186.72 125.72 10.79 185.00 126.80 12.71 coo 25.13 32.62 89.49 27.74 32.61 84.91 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 B 116 SER C 124 SER^? 23.11 O1 GOL C1901 B 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 B 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 30.90 35.65 89.60 29.85 37.72 88.83 172.32 130.73 43.72 171.22 130.88 45.88 coo 24.43 38.83 86.53 27.07 38.03 86.12 165.10 130.81 41.92 162.37 130.83 41.35 coo 25.13 32.62 89.49 27.74 32.61 84.91 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 124 SER^? 19.87 C8 ADE A 500 C 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 C 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -8.96 33.70 98.81 -8.96 35.77 97.56 182.61 151.80 32.41 184.93 152.05 33.02 coo -8.28 37.01 91.79 -6.99 36.16 94.13 185.14 149.36 25.84 186.22 148.61 23.38 coo -10.48 30.66 93.19 -5.27 31.07 94.32 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER B 124 SER^? 23.63 O4 CIT A1102 C 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 C 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -8.96 33.70 98.81 -8.96 35.77 97.56 191.23 122.78 5.73 191.55 121.05 7.41 coo -8.28 37.01 91.79 -6.99 36.16 94.13 186.72 125.72 10.79 185.00 126.80 12.71 coo -10.48 30.66 93.19 -5.27 31.07 94.32 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 C 116 SER C 124 SER^? 23.11 O1 GOL C1901 C 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 C 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -8.96 33.70 98.81 -8.96 35.77 97.56 172.32 130.73 43.72 171.22 130.88 45.88 coo -8.28 37.01 91.79 -6.99 36.16 94.13 165.10 130.81 41.92 162.37 130.83 41.35 coo -10.48 30.66 93.19 -5.27 31.07 94.32 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 124 SER^? 19.87 C8 ADE A 500 D 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 D 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -29.80 31.30 63.54 -28.79 33.52 63.37 182.61 151.80 32.41 184.93 152.05 33.02 coo -23.30 35.33 62.20 -25.10 34.24 64.06 185.14 149.36 25.84 186.22 148.61 23.38 coo -24.76 28.82 60.31 -24.27 29.01 65.58 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER B 124 SER^? 23.63 O4 CIT A1102 D 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 D 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -29.80 31.30 63.54 -28.79 33.52 63.37 191.23 122.78 5.73 191.55 121.05 7.41 coo -23.30 35.33 62.20 -25.10 34.24 64.06 186.72 125.72 10.79 185.00 126.80 12.71 coo -24.76 28.82 60.31 -24.27 29.01 65.58 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 D 116 SER C 124 SER^? 23.11 O1 GOL C1901 D 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 D 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -29.80 31.30 63.54 -28.79 33.52 63.37 172.32 130.73 43.72 171.22 130.88 45.88 coo -23.30 35.33 62.20 -25.10 34.24 64.06 165.10 130.81 41.92 162.37 130.83 41.35 coo -24.76 28.82 60.31 -24.27 29.01 65.58 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 124 SER^? 19.87 C8 ADE A 500 E 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 E 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -3.01 32.72 32.71 -2.80 34.91 33.79 182.61 151.80 32.41 184.93 152.05 33.02 coo 0.04 36.70 38.68 -2.21 35.46 37.50 185.14 149.36 25.84 186.22 148.61 23.38 coo 1.93 30.52 36.31 -2.84 30.18 38.54 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER B 124 SER^? 23.63 O4 CIT A1102 E 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 E 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -3.01 32.72 32.71 -2.80 34.91 33.79 191.23 122.78 5.73 191.55 121.05 7.41 coo 0.04 36.70 38.68 -2.21 35.46 37.50 186.72 125.72 10.79 185.00 126.80 12.71 coo 1.93 30.52 36.31 -2.84 30.18 38.54 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 E 116 SER C 124 SER^? 23.11 O1 GOL C1901 E 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 E 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -3.01 32.72 32.71 -2.80 34.91 33.79 172.32 130.73 43.72 171.22 130.88 45.88 coo 0.04 36.70 38.68 -2.21 35.46 37.50 165.10 130.81 41.92 162.37 130.83 41.35 coo 1.93 30.52 36.31 -2.84 30.18 38.54 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 124 SER^? 19.87 C8 ADE A 500 F 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 F 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 55.30 92.46 56.72 55.15 90.39 55.38 182.61 151.80 32.41 184.93 152.05 33.02 coo 54.49 89.31 49.65 53.35 90.16 52.06 185.14 149.36 25.84 186.22 148.61 23.38 coo 56.78 95.62 51.15 51.59 95.31 52.37 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER B 124 SER^? 23.63 O4 CIT A1102 F 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 F 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 55.30 92.46 56.72 55.15 90.39 55.38 191.23 122.78 5.73 191.55 121.05 7.41 coo 54.49 89.31 49.65 53.35 90.16 52.06 186.72 125.72 10.79 185.00 126.80 12.71 coo 56.78 95.62 51.15 51.59 95.31 52.37 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 F 116 SER C 124 SER^? 23.11 O1 GOL C1901 F 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 F 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 55.30 92.46 56.72 55.15 90.39 55.38 172.32 130.73 43.72 171.22 130.88 45.88 coo 54.49 89.31 49.65 53.35 90.16 52.06 165.10 130.81 41.92 162.37 130.83 41.35 coo 56.78 95.62 51.15 51.59 95.31 52.37 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 124 SER^? 19.87 C8 ADE A 500 G 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 G 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 76.25 95.63 21.56 75.29 93.40 21.36 182.61 151.80 32.41 184.93 152.05 33.02 coo 69.78 91.62 20.06 71.51 92.68 22.02 185.14 149.36 25.84 186.22 148.61 23.38 coo 71.19 98.21 18.32 70.69 97.75 23.67 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER B 124 SER^? 23.63 O4 CIT A1102 G 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 G 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 76.25 95.63 21.56 75.29 93.40 21.36 191.23 122.78 5.73 191.55 121.05 7.41 coo 69.78 91.62 20.06 71.51 92.68 22.02 186.72 125.72 10.79 185.00 126.80 12.71 coo 71.19 98.21 18.32 70.69 97.75 23.67 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 G 116 SER C 124 SER^? 23.11 O1 GOL C1901 G 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 G 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 76.25 95.63 21.56 75.29 93.40 21.36 172.32 130.73 43.72 171.22 130.88 45.88 coo 69.78 91.62 20.06 71.51 92.68 22.02 165.10 130.81 41.92 162.37 130.83 41.35 coo 71.19 98.21 18.32 70.69 97.75 23.67 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 124 SER^? 19.87 C8 ADE A 500 H 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 H 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 15.45 90.62 47.70 16.55 88.57 46.97 182.61 151.80 32.41 184.93 152.05 33.02 coo 21.92 87.58 44.67 19.30 88.41 44.23 185.14 149.36 25.84 186.22 148.61 23.38 coo 21.26 93.70 47.67 18.47 93.68 43.08 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER B 124 SER^? 23.63 O4 CIT A1102 H 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 H 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 15.45 90.62 47.70 16.55 88.57 46.97 191.23 122.78 5.73 191.55 121.05 7.41 coo 21.92 87.58 44.67 19.30 88.41 44.23 186.72 125.72 10.79 185.00 126.80 12.71 coo 21.26 93.70 47.67 18.47 93.68 43.08 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 H 116 SER C 124 SER^? 23.11 O1 GOL C1901 H 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 H 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 15.45 90.62 47.70 16.55 88.57 46.97 172.32 130.73 43.72 171.22 130.88 45.88 coo 21.92 87.58 44.67 19.30 88.41 44.23 165.10 130.81 41.92 162.37 130.83 41.35 coo 21.26 93.70 47.67 18.47 93.68 43.08 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 124 SER^? 19.87 C8 ADE A 500 I 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 I 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 11.78 90.82 7.18 12.84 88.72 7.93 182.61 151.80 32.41 184.93 152.05 33.02 coo 16.78 87.76 12.19 16.39 88.69 9.59 185.14 149.36 25.84 186.22 148.61 23.38 coo 13.67 93.83 12.65 17.08 93.94 8.58 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER B 124 SER^? 23.63 O4 CIT A1102 I 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 I 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 11.78 90.82 7.18 12.84 88.72 7.93 191.23 122.78 5.73 191.55 121.05 7.41 coo 16.78 87.76 12.19 16.39 88.69 9.59 186.72 125.72 10.79 185.00 126.80 12.71 coo 13.67 93.83 12.65 17.08 93.94 8.58 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 I 116 SER C 124 SER^? 23.11 O1 GOL C1901 I 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 I 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 11.78 90.82 7.18 12.84 88.72 7.93 172.32 130.73 43.72 171.22 130.88 45.88 coo 16.78 87.76 12.19 16.39 88.69 9.59 165.10 130.81 41.92 162.37 130.83 41.35 coo 13.67 93.83 12.65 17.08 93.94 8.58 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 124 SER^? 19.87 C8 ADE A 500 J 140 TYR A 113 TYR^? 11.47 C8 ADE A 500 J 144 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 182.61 151.80 32.41 184.93 152.05 33.02 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 185.14 149.36 25.84 186.22 148.61 23.38 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER B 124 SER^? 23.63 O4 CIT A1102 J 140 TYR B 113 TYR^? 17.81 O4 CIT A1102 J 144 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 191.23 122.78 5.73 191.55 121.05 7.41 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 186.72 125.72 10.79 185.00 126.80 12.71 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 J 116 SER C 124 SER^? 23.11 O1 GOL C1901 J 140 TYR C 113 TYR^? 15.28 O1 GOL C1901 J 144 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 172.32 130.73 43.72 171.22 130.88 45.88 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 165.10 130.81 41.92 162.37 130.83 41.35 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 168.56 136.65 44.17 170.62 139.01 49.65 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 3 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 62 LYS^? 14.90 N3 ADE A 500 A 193 GLU A 59 GLU^? 13.22 O6 CIT A1102 A 217 VAL A 60 VAL^? 13.59 O5 CIT A1102 coo 2.10 10.68 61.44 -2.14 13.16 60.61 170.54 158.67 6.99 175.63 160.94 7.57 coo -5.33 11.71 69.72 -4.62 11.92 67.73 169.62 150.86 -1.29 170.91 152.08 -2.44 coo 0.07 12.29 66.53 -0.24 11.95 64.38 170.06 152.94 4.41 171.33 152.24 6.01 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 62 LYS^? 14.90 N3 ADE A 500 A 193 GLU A 59 GLU^? 13.22 O6 CIT A1102 A 217 VAL A 74 VAL^? 16.61 N6 ADE A 500 coo 2.10 10.68 61.44 -2.14 13.16 60.61 170.54 158.67 6.99 175.63 160.94 7.57 coo -5.33 11.71 69.72 -4.62 11.92 67.73 169.62 150.86 -1.29 170.91 152.08 -2.44 coo 0.07 12.29 66.53 -0.24 11.95 64.38 173.01 156.27 1.25 173.56 157.28 3.08 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS B 62 LYS^? 8.83 O2 CIT A1102 A 193 GLU B 59 GLU^? 11.03 O1 CIT A1102 A 217 VAL B 60 VAL^? -4.57 O5 CIT A1102s coo 2.10 10.68 61.44 -2.14 13.16 60.61 165.33 135.53 -1.27 161.40 132.35 2.38 coo -5.33 11.71 69.72 -4.62 11.92 67.73 162.57 145.21 3.58 161.45 143.81 4.68 coo 0.07 12.29 66.53 -0.24 11.95 64.38 166.43 141.05 1.66 168.22 140.12 2.45 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 159 LYS B 62 LYS^? 8.83 O2 CIT A1102 A 193 GLU B 59 GLU^? 11.03 O1 CIT A1102 A 217 VAL B 74 VAL^? 7.48 O1 CIT A1102 coo 2.10 10.68 61.44 -2.14 13.16 60.61 165.33 135.53 -1.27 161.40 132.35 2.38 coo -5.33 11.71 69.72 -4.62 11.92 67.73 162.57 145.21 3.58 161.45 143.81 4.68 coo 0.07 12.29 66.53 -0.24 11.95 64.38 161.92 138.99 3.33 162.30 136.86 3.71 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 159 LYS C 62 LYS^? 15.99 O2 GOL C1901 A 193 GLU C 59 GLU^? 20.19 O2 GOL C1901 A 217 VAL C 60 VAL^? 17.16 O1 GOL C1901 coo 2.10 10.68 61.44 -2.14 13.16 60.61 160.07 111.06 24.23 156.23 109.52 28.21 coo -5.33 11.71 69.72 -4.62 11.92 67.73 152.75 116.35 16.84 151.33 114.88 17.42 coo 0.07 12.29 66.53 -0.24 11.95 64.38 157.24 116.01 20.95 157.48 117.21 22.73 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 159 LYS C 62 LYS^? 15.99 O2 GOL C1901 A 193 GLU C 59 GLU^? 20.19 O2 GOL C1901 A 217 VAL C 74 VAL^? 16.81 O2 GOL C1901 coo 2.10 10.68 61.44 -2.14 13.16 60.61 160.07 111.06 24.23 156.23 109.52 28.21 coo -5.33 11.71 69.72 -4.62 11.92 67.73 152.75 116.35 16.84 151.33 114.88 17.42 coo 0.07 12.29 66.53 -0.24 11.95 64.38 153.58 112.61 22.27 154.78 112.02 23.98 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 6 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 87 THR.? 16.32 N9 ADE A 500 A 159 LYS A 41 LYS^? 15.86 N3 ADE A 500 A 193 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo -2.58 16.31 54.79 -4.02 14.93 55.64 199.26 148.57 23.25 200.05 148.42 21.27 coo 2.10 10.68 61.44 -2.14 13.16 60.61 197.56 153.42 13.51 201.64 156.08 17.41 coo -5.33 11.71 69.72 -4.62 11.92 67.73 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 87 THR.? 16.32 N9 ADE A 500 A 159 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 193 GLU A 155 GLU.? 30.36 C8 ADE A 500 coo -2.58 16.31 54.79 -4.02 14.93 55.64 199.26 148.57 23.25 200.05 148.42 21.27 coo 2.10 10.68 61.44 -2.14 13.16 60.61 192.52 142.86 28.75 192.00 138.78 32.31 coo -5.33 11.71 69.72 -4.62 11.92 67.73 202.13 137.32 32.16 203.15 136.76 33.90 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR A 177 THR^? 11.99 N9 ADE A 500 A 159 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 193 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo -2.58 16.31 54.79 -4.02 14.93 55.64 182.36 161.43 14.75 180.27 161.91 14.59 coo 2.10 10.68 61.44 -2.14 13.16 60.61 189.82 158.18 22.25 194.56 162.25 23.07 coo -5.33 11.71 69.72 -4.62 11.92 67.73 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR A 177 THR^? 11.99 N9 ADE A 500 A 159 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 193 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo -2.58 16.31 54.79 -4.02 14.93 55.64 182.36 161.43 14.75 180.27 161.91 14.59 coo 2.10 10.68 61.44 -2.14 13.16 60.61 182.91 155.29 23.54 184.46 151.31 19.55 coo -5.33 11.71 69.72 -4.62 11.92 67.73 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR A 177 THR^? 11.99 N9 ADE A 500 A 159 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 193 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo -2.58 16.31 54.79 -4.02 14.93 55.64 182.36 161.43 14.75 180.27 161.91 14.59 coo 2.10 10.68 61.44 -2.14 13.16 60.61 185.07 167.50 20.34 181.31 169.96 15.85 coo -5.33 11.71 69.72 -4.62 11.92 67.73 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 6 3 # 6 A 38 THR B 87 THR.? 28.94 O4 CIT A1102 A 159 LYS B 41 LYS^? 27.96 O1 GOL C1901 A 193 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo -2.58 16.31 54.79 -4.02 14.93 55.64 184.52 120.26 23.93 182.79 120.64 25.15 coo 2.10 10.68 61.44 -2.14 13.16 60.61 174.17 121.55 22.91 175.90 116.24 24.75 coo -5.33 11.71 69.72 -4.62 11.92 67.73 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 7 3 # 7 A 38 THR B 87 THR.? 28.94 O4 CIT A1102 A 159 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 193 GLU B 155 GLU.? 33.13 C8 ADE A 500 coo -2.58 16.31 54.79 -4.02 14.93 55.64 184.52 120.26 23.93 182.79 120.64 25.15 coo 2.10 10.68 61.44 -2.14 13.16 60.61 192.36 125.68 19.31 197.51 127.46 19.90 coo -5.33 11.71 69.72 -4.62 11.92 67.73 197.70 123.91 29.28 199.42 125.11 29.52 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 8 3 # 8 A 38 THR B 177 THR^? 12.64 C2 CIT A1102 A 159 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 193 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo -2.58 16.31 54.79 -4.02 14.93 55.64 170.76 123.10 5.75 170.51 123.79 3.70 coo 2.10 10.68 61.44 -2.14 13.16 60.61 179.28 118.69 11.71 177.59 112.91 13.79 coo -5.33 11.71 69.72 -4.62 11.92 67.73 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 9 3 # 9 A 38 THR B 177 THR^? 12.64 C2 CIT A1102 A 159 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 193 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo -2.58 16.31 54.79 -4.02 14.93 55.64 170.76 123.10 5.75 170.51 123.79 3.70 coo 2.10 10.68 61.44 -2.14 13.16 60.61 179.28 118.69 11.71 177.59 112.91 13.79 coo -5.33 11.71 69.72 -4.62 11.92 67.73 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 10 3 # 10 A 38 THR B 177 THR^? 12.64 C2 CIT A1102 A 159 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 193 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo -2.58 16.31 54.79 -4.02 14.93 55.64 170.76 123.10 5.75 170.51 123.79 3.70 coo 2.10 10.68 61.44 -2.14 13.16 60.61 181.66 123.79 6.82 179.82 128.66 10.46 coo -5.33 11.71 69.72 -4.62 11.92 67.73 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 11 3 # 11 A 38 THR C 87 THR.? 16.92 O3 GOL C1901 A 159 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 193 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo -2.58 16.31 54.79 -4.02 14.93 55.64 154.44 133.19 51.68 152.52 132.26 51.51 coo 2.10 10.68 61.44 -2.14 13.16 60.61 149.18 124.89 48.07 150.57 125.16 54.16 coo -5.33 11.71 69.72 -4.62 11.92 67.73 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 12 3 # 12 A 38 THR C 87 THR.? 16.92 O3 GOL C1901 A 159 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 193 GLU C 155 GLU~? 32.67 O1 GOL C1901 coo -2.58 16.31 54.79 -4.02 14.93 55.64 154.44 133.19 51.68 152.52 132.26 51.51 coo 2.10 10.68 61.44 -2.14 13.16 60.61 161.71 139.26 46.53 163.20 144.39 46.83 coo -5.33 11.71 69.72 -4.62 11.92 67.73 159.66 146.89 54.14 160.20 148.86 54.76 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 13 3 # 13 A 38 THR C 177 THR^? 13.25 C1 GOL C1901 A 159 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 193 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo -2.58 16.31 54.79 -4.02 14.93 55.64 160.22 114.99 39.13 161.63 113.91 37.82 coo 2.10 10.68 61.44 -2.14 13.16 60.61 161.58 122.48 47.40 160.49 120.58 53.33 coo -5.33 11.71 69.72 -4.62 11.92 67.73 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 14 3 # 14 A 38 THR C 177 THR^? 13.25 C1 GOL C1901 A 159 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 193 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -2.58 16.31 54.79 -4.02 14.93 55.64 160.22 114.99 39.13 161.63 113.91 37.82 coo 2.10 10.68 61.44 -2.14 13.16 60.61 161.58 122.48 47.40 160.49 120.58 53.33 coo -5.33 11.71 69.72 -4.62 11.92 67.73 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 15 3 # 15 A 38 THR C 177 THR^? 13.25 C1 GOL C1901 A 159 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 193 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo -2.58 16.31 54.79 -4.02 14.93 55.64 160.22 114.99 39.13 161.63 113.91 37.82 coo 2.10 10.68 61.44 -2.14 13.16 60.61 165.62 124.17 41.44 160.89 126.43 37.84 coo -5.33 11.71 69.72 -4.62 11.92 67.73 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 16 3 # 16 A 38 THR C 177 THR^? 13.25 C1 GOL C1901 A 159 LYS C 180 LYS.? 20.00 O3 GOL C1901 A 193 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -2.58 16.31 54.79 -4.02 14.93 55.64 160.22 114.99 39.13 161.63 113.91 37.82 coo 2.10 10.68 61.44 -2.14 13.16 60.61 163.89 112.64 46.86 163.54 106.47 45.76 coo -5.33 11.71 69.72 -4.62 11.92 67.73 170.51 115.98 53.19 171.23 115.96 55.18 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 16 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 52 ASP^? 9.33 O4 CIT A1102 260 GLU A 165 GLU^? 4.52 C8 ADE A 500 370 TYR A 83 TYR^? 11.70 N6 ADE A 500 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 185.72 140.93 6.30 184.35 140.00 4.99 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 185.43 146.45 17.17 186.00 148.48 17.29 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 192.51 141.71 13.59 192.79 138.96 13.21 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 52 ASP^? 16.07 C8 ADE A 500 260 GLU B 165 GLU^? 13.88 O4 CIT A1102 370 TYR B 83 TYR^? 20.46 C8 ADE A 500 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 173.93 140.35 20.11 173.24 142.10 19.12 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 180.17 131.30 14.36 179.09 129.62 13.64 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 179.54 132.93 23.44 180.82 135.06 24.75 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP C 52 ASP^? 12.06 O1 GOL C1901 260 GLU C 165 GLU^? 7.74 O1 GOL C1901 370 TYR C 83 TYR^? 12.44 O1 GOL C1901 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 147.21 130.59 30.19 147.01 130.37 28.08 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 157.34 129.59 37.15 157.60 127.69 38.11 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 149.52 133.95 39.18 148.57 136.34 38.09 1euu_c00 source 1euu SIALIDASE : 3 hits 1euu_c00 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 155 GLU.? 30.36 C8 ADE A 500 A 260 ARG B 108 ARG^? 25.54 C8 ADE A 500 A 270 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 50.99 29.43 12.86 52.11 29.45 14.65 202.13 137.32 32.16 203.15 136.76 33.90 coo 39.80 27.50 22.98 42.20 26.56 21.34 188.64 131.77 26.61 189.85 131.11 29.36 coo 48.83 21.70 19.50 47.44 24.99 15.25 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 260 ARG A 43 ARG.? 7.62 C2 ADE A 500 A 270 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 50.99 29.43 12.86 52.11 29.45 14.65 185.43 146.45 17.17 186.00 148.48 17.29 coo 39.80 27.50 22.98 42.20 26.56 21.34 190.33 158.90 11.08 189.17 159.63 8.34 coo 48.83 21.70 19.50 47.44 24.99 15.25 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 260 ARG A 53 ARG^? 5.21 N6 ADE A 500 A 270 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 50.99 29.43 12.86 52.11 29.45 14.65 185.43 146.45 17.17 186.00 148.48 17.29 coo 39.80 27.50 22.98 42.20 26.56 21.34 184.38 147.77 2.51 183.90 149.96 4.60 coo 48.83 21.70 19.50 47.44 24.99 15.25 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 155 GLU.? 33.13 C8 ADE A 500 A 260 ARG A 108 ARG^? 21.78 N7 ADE A 500 A 270 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 50.99 29.43 12.86 52.11 29.45 14.65 197.70 123.91 29.28 199.42 125.11 29.52 coo 39.80 27.50 22.98 42.20 26.56 21.34 195.17 135.76 22.50 193.88 133.29 23.81 coo 48.83 21.70 19.50 47.44 24.99 15.25 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 5 3 # 5 A 34 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 260 ARG B 43 ARG.? 18.57 O1 CIT A1102 A 270 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 50.99 29.43 12.86 52.11 29.45 14.65 180.17 131.30 14.36 179.09 129.62 13.64 coo 39.80 27.50 22.98 42.20 26.56 21.34 169.37 120.65 13.94 167.07 120.51 11.92 coo 48.83 21.70 19.50 47.44 24.99 15.25 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 6 3 # 6 A 34 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 260 ARG B 53 ARG^? 12.50 O1 CIT A1102 A 270 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 50.99 29.43 12.86 52.11 29.45 14.65 180.17 131.30 14.36 179.09 129.62 13.64 coo 39.80 27.50 22.98 42.20 26.56 21.34 166.97 137.64 16.68 167.60 135.18 14.95 coo 48.83 21.70 19.50 47.44 24.99 15.25 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 7 3 # 7 A 34 GLU B 184 GLU~? 19.18 C2 CIT A1102 A 260 ARG B 43 ARG.? 18.57 O1 CIT A1102 A 270 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 50.99 29.43 12.86 52.11 29.45 14.65 174.79 115.83 -0.09 173.37 117.02 0.92 coo 39.80 27.50 22.98 42.20 26.56 21.34 169.37 120.65 13.94 167.07 120.51 11.92 coo 48.83 21.70 19.50 47.44 24.99 15.25 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 8 3 # 8 A 34 GLU C 155 GLU~? 32.67 O1 GOL C1901 A 260 ARG C 108 ARG^? 22.96 O1 GOL C1901 A 270 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 50.99 29.43 12.86 52.11 29.45 14.65 159.66 146.89 54.14 160.20 148.86 54.76 coo 39.80 27.50 22.98 42.20 26.56 21.34 152.54 142.82 43.26 151.11 144.25 45.58 coo 48.83 21.70 19.50 47.44 24.99 15.25 161.71 139.26 46.53 163.20 144.39 46.83 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 9 3 # 9 A 34 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 260 ARG C 43 ARG.? 5.25 O3 GOL C1901 A 270 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 50.99 29.43 12.86 52.11 29.45 14.65 157.34 129.59 37.15 157.60 127.69 38.11 coo 39.80 27.50 22.98 42.20 26.56 21.34 154.24 116.29 44.96 152.24 116.07 42.61 coo 48.83 21.70 19.50 47.44 24.99 15.25 163.30 119.33 38.22 166.56 114.68 36.90 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 10 3 # 10 A 34 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 260 ARG C 53 ARG^? 4.89 O2 GOL C1901 A 270 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 50.99 29.43 12.86 52.11 29.45 14.65 157.34 129.59 37.15 157.60 127.69 38.11 coo 39.80 27.50 22.98 42.20 26.56 21.34 146.33 122.48 29.52 148.17 121.33 31.67 coo 48.83 21.70 19.50 47.44 24.99 15.25 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 11 3 # 11 A 34 GLU C 184 GLU~? 18.70 O3 GOL C1901 A 260 ARG C 43 ARG.? 5.25 O3 GOL C1901 A 270 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 50.99 29.43 12.86 52.11 29.45 14.65 168.68 112.73 44.51 166.86 112.61 43.45 coo 39.80 27.50 22.98 42.20 26.56 21.34 154.24 116.29 44.96 152.24 116.07 42.61 coo 48.83 21.70 19.50 47.44 24.99 15.25 163.30 119.33 38.22 166.56 114.68 36.90 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 11 hits 1euy_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 130 ASP~? 27.60 C8 ADE A 500 C 117 GLU A 156 GLU.? 23.41 C8 ADE A 500 C 131 GLU A 135 GLU.? 23.34 C8 ADE A 500 coo 68.01 56.37 72.57 68.42 56.10 70.51 188.71 136.74 34.61 188.50 136.01 36.57 coo 66.59 62.50 67.44 67.57 60.64 67.12 196.65 137.08 28.97 194.78 136.94 30.01 coo 69.24 52.27 71.96 69.91 50.26 71.89 187.40 140.84 33.48 189.24 139.81 33.69 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 1 hits 1f6d_c02 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 187 HIS~? 25.73 N9 ADE A 500 C 62 LYS A 193 LYS~? 24.54 N9 ADE A 500 F 35 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 15.40 22.79 16.66 13.93 24.10 15.98 179.01 171.47 26.59 179.51 173.49 26.31 coo 19.95 18.98 4.81 18.82 20.94 10.49 183.60 164.07 35.65 183.22 158.61 36.42 coo 16.32 15.30 17.19 17.71 14.73 18.69 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS B 187 HIS~? 26.45 C2 CIT A1102 C 62 LYS B 193 LYS~? 27.56 O4 CIT A1102 F 35 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 15.40 22.79 16.66 13.93 24.10 15.98 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 19.95 18.98 4.81 18.82 20.94 10.49 188.45 111.50 0.09 191.63 115.50 2.10 coo 16.32 15.30 17.19 17.71 14.73 18.69 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS C 187 HIS~? 27.79 O3 GOL C1901 C 62 LYS C 193 LYS~? 28.43 O1 GOL C1901 F 35 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 15.40 22.79 16.66 13.93 24.10 15.98 174.78 109.74 44.68 175.79 108.53 43.31 coo 19.95 18.98 4.81 18.82 20.94 10.49 177.05 121.15 50.66 176.96 126.15 48.94 coo 16.32 15.30 17.19 17.71 14.73 18.69 169.34 110.13 50.56 169.06 109.63 52.58 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 3 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 49 LYS^? 10.58 N6 ADE A 500 C 105 HIS A 176 HIS^? 6.39 N3 ADE A 500 D 35 ASP A 172 ASP~? 9.43 N1 ADE A 500 coo 38.76 28.25 7.87 36.33 26.41 13.58 193.06 146.52 10.07 195.03 144.09 6.09 coo 34.93 19.72 17.37 34.72 18.17 15.98 184.39 157.95 13.11 185.86 157.96 14.60 coo 41.01 23.02 20.83 40.65 24.26 22.55 180.59 154.59 5.93 180.83 155.75 4.19 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 193 LYS~? 24.54 N9 ADE A 500 C 105 HIS A 187 HIS~? 25.73 N9 ADE A 500 D 35 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 38.76 28.25 7.87 36.33 26.41 13.58 183.60 164.07 35.65 183.22 158.61 36.42 coo 34.93 19.72 17.37 34.72 18.17 15.98 179.01 171.47 26.59 179.51 173.49 26.31 coo 41.01 23.02 20.83 40.65 24.26 22.55 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS B 49 LYS^? 24.07 O1 GOL C1901 C 105 HIS B 176 HIS^? 13.79 O1 CIT A1102 D 35 ASP B 172 ASP~? 8.81 O1 CIT A1102 coo 38.76 28.25 7.87 36.33 26.41 13.58 174.03 130.60 22.66 171.30 132.48 26.53 coo 34.93 19.72 17.37 34.72 18.17 15.98 171.08 125.47 9.27 172.48 124.18 10.15 coo 41.01 23.02 20.83 40.65 24.26 22.55 166.30 133.15 8.87 164.29 132.56 8.69 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS B 193 LYS~? 27.56 O4 CIT A1102 C 105 HIS B 187 HIS~? 26.45 C2 CIT A1102 D 35 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 38.76 28.25 7.87 36.33 26.41 13.58 188.45 111.50 0.09 191.63 115.50 2.10 coo 34.93 19.72 17.37 34.72 18.17 15.98 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 41.01 23.02 20.83 40.65 24.26 22.55 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 5 3 # 5 B 62 LYS C 49 LYS^? 10.29 O2 GOL C1901 C 105 HIS C 176 HIS^? 7.29 C1 GOL C1901 D 35 ASP C 172 ASP~? 9.22 O2 GOL C1901 coo 38.76 28.25 7.87 36.33 26.41 13.58 147.41 128.03 39.92 142.61 128.90 38.51 coo 34.93 19.72 17.37 34.72 18.17 15.98 157.21 117.94 38.21 157.48 118.99 40.00 coo 41.01 23.02 20.83 40.65 24.26 22.55 153.21 116.81 30.64 152.37 114.88 30.62 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 6 3 # 6 B 62 LYS C 193 LYS~? 28.43 O1 GOL C1901 C 105 HIS C 187 HIS~? 27.79 O3 GOL C1901 D 35 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 38.76 28.25 7.87 36.33 26.41 13.58 177.05 121.15 50.66 176.96 126.15 48.94 coo 34.93 19.72 17.37 34.72 18.17 15.98 174.78 109.74 44.68 175.79 108.53 43.31 coo 41.01 23.02 20.83 40.65 24.26 22.55 169.34 110.13 50.56 169.06 109.63 52.58 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 6 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 193 LYS~? 24.54 N9 ADE A 500 B 105 HIS A 187 HIS~? 25.73 N9 ADE A 500 E 35 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 20.51 39.76 8.83 21.23 37.38 14.18 183.60 164.07 35.65 183.22 158.61 36.42 coo 27.18 37.56 20.68 29.07 38.28 20.13 179.01 171.47 26.59 179.51 173.49 26.31 coo 19.97 40.39 22.03 18.53 39.30 23.18 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS B 193 LYS~? 27.56 O4 CIT A1102 B 105 HIS B 187 HIS~? 26.45 C2 CIT A1102 E 35 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 20.51 39.76 8.83 21.23 37.38 14.18 188.45 111.50 0.09 191.63 115.50 2.10 coo 27.18 37.56 20.68 29.07 38.28 20.13 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 19.97 40.39 22.03 18.53 39.30 23.18 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS C 193 LYS~? 28.43 O1 GOL C1901 B 105 HIS C 187 HIS~? 27.79 O3 GOL C1901 E 35 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 20.51 39.76 8.83 21.23 37.38 14.18 177.05 121.15 50.66 176.96 126.15 48.94 coo 27.18 37.56 20.68 29.07 38.28 20.13 174.78 109.74 44.68 175.79 108.53 43.31 coo 19.97 40.39 22.03 18.53 39.30 23.18 169.34 110.13 50.56 169.06 109.63 52.58 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 3 hits 1f80_c05 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 18 PHE~? 23.25 N9 ADE A 500 A 210 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 244 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 9.23 46.77 25.11 11.48 48.39 24.76 201.55 150.80 30.31 200.89 148.25 31.29 coo 10.51 37.86 19.71 9.07 39.38 20.04 203.27 140.75 25.55 204.24 138.86 25.61 coo -1.20 42.34 17.67 3.19 45.13 19.06 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 95 PHE^? 15.24 N9 ADE A 500 A 210 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 244 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 9.23 46.77 25.11 11.48 48.39 24.76 185.36 159.68 24.99 184.83 158.72 27.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 184.84 171.88 24.93 186.38 173.28 25.14 coo -1.20 42.34 17.67 3.19 45.13 19.06 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 146 PHE^? 14.35 N9 ADE A 500 A 210 ASP A 119 ASP.? 23.37 C8 ADE A 500 A 244 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo 9.23 46.77 25.11 11.48 48.39 24.76 180.53 160.39 22.57 180.33 162.62 20.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 170.58 160.79 28.87 171.46 159.09 29.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 179.30 153.63 32.06 174.52 149.85 32.01 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 146 PHE^? 14.35 N9 ADE A 500 A 210 ASP A 119 ASP.? 23.37 C8 ADE A 500 A 244 LYS A 186 LYS~? 28.00 N9 ADE A 500 coo 9.23 46.77 25.11 11.48 48.39 24.76 180.53 160.39 22.57 180.33 162.62 20.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 170.58 160.79 28.87 171.46 159.09 29.69 coo -1.20 42.34 17.67 3.19 45.13 19.06 182.07 169.10 30.10 186.87 173.28 30.86 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 146 PHE^? 14.35 N9 ADE A 500 A 210 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 244 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 9.23 46.77 25.11 11.48 48.39 24.76 180.53 160.39 22.57 180.33 162.62 20.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 184.84 171.88 24.93 186.38 173.28 25.14 coo -1.20 42.34 17.67 3.19 45.13 19.06 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE B 18 PHE~? 34.51 O4 CIT A1102 A 210 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 244 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 9.23 46.77 25.11 11.48 48.39 24.76 189.87 114.75 23.00 191.73 115.42 25.00 coo 10.51 37.86 19.71 9.07 39.38 20.04 190.60 123.10 30.08 190.26 121.25 31.09 coo -1.20 42.34 17.67 3.19 45.13 19.06 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE B 129 PHE.? 19.08 N7 ADE A 500 A 210 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 244 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 9.23 46.77 25.11 11.48 48.39 24.76 195.26 133.73 19.36 192.72 134.81 19.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 203.27 140.75 25.55 204.24 138.86 25.61 coo -1.20 42.34 17.67 3.19 45.13 19.06 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 146 PHE^? 15.86 C2 CIT A1102 A 210 ASP B 119 ASP.? 20.62 O7 CIT A1102 A 244 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo 9.23 46.77 25.11 11.48 48.39 24.76 178.16 121.58 2.78 175.54 120.91 2.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 184.41 123.54 -7.24 185.10 123.40 -9.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 190.30 123.24 2.08 193.85 127.78 -0.15 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE B 146 PHE^? 15.86 C2 CIT A1102 A 210 ASP B 119 ASP.? 20.62 O7 CIT A1102 A 244 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 9.23 46.77 25.11 11.48 48.39 24.76 178.16 121.58 2.78 175.54 120.91 2.10 coo 10.51 37.86 19.71 9.07 39.38 20.04 184.41 123.54 -7.24 185.10 123.40 -9.24 coo -1.20 42.34 17.67 3.19 45.13 19.06 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE C 18 PHE~? 24.42 O3 GOL C1901 A 210 ASP C 158 ASP~? 26.27 O1 GOL C1901 A 244 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 9.23 46.77 25.11 11.48 48.39 24.76 159.76 134.50 57.07 160.74 136.25 55.14 coo 10.51 37.86 19.71 9.07 39.38 20.04 152.92 141.67 53.35 151.80 143.42 53.28 coo -1.20 42.34 17.67 3.19 45.13 19.06 161.71 139.26 46.53 163.20 144.39 46.83 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE C 95 PHE^? 18.35 C1 GOL C1901 A 210 ASP C 183 ASP~? 25.06 O3 GOL C1901 A 244 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 9.23 46.77 25.11 11.48 48.39 24.76 166.44 121.18 45.60 168.59 122.86 46.18 coo 10.51 37.86 19.71 9.07 39.38 20.04 169.34 110.13 50.56 169.06 109.63 52.58 coo -1.20 42.34 17.67 3.19 45.13 19.06 177.05 121.15 50.66 176.96 126.15 48.94 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE C 146 PHE^? 16.71 C1 GOL C1901 A 210 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 244 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo 9.23 46.77 25.11 11.48 48.39 24.76 167.22 118.61 41.10 166.40 115.95 40.88 coo 10.51 37.86 19.71 9.07 39.38 20.04 178.03 118.40 36.14 177.70 120.46 36.31 coo -1.20 42.34 17.67 3.19 45.13 19.06 174.37 128.14 41.95 175.88 130.01 36.96 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 12 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 18 PHE~? 23.25 N9 ADE A 500 B 210 ASP A 158 ASP.? 25.18 C8 ADE A 500 B 244 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 8.76 47.85 34.91 11.08 46.36 35.41 201.55 150.80 30.31 200.89 148.25 31.29 coo 9.06 56.85 40.30 7.71 55.27 39.90 203.27 140.75 25.55 204.24 138.86 25.61 coo -2.38 51.82 41.62 2.07 49.19 40.42 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 95 PHE^? 15.24 N9 ADE A 500 B 210 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 244 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 8.76 47.85 34.91 11.08 46.36 35.41 185.36 159.68 24.99 184.83 158.72 27.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 184.84 171.88 24.93 186.38 173.28 25.14 coo -2.38 51.82 41.62 2.07 49.19 40.42 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 146 PHE^? 14.35 N9 ADE A 500 B 210 ASP A 119 ASP.? 23.37 C8 ADE A 500 B 244 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo 8.76 47.85 34.91 11.08 46.36 35.41 180.53 160.39 22.57 180.33 162.62 20.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 170.58 160.79 28.87 171.46 159.09 29.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 179.30 153.63 32.06 174.52 149.85 32.01 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 146 PHE^? 14.35 N9 ADE A 500 B 210 ASP A 119 ASP.? 23.37 C8 ADE A 500 B 244 LYS A 186 LYS~? 28.00 N9 ADE A 500 coo 8.76 47.85 34.91 11.08 46.36 35.41 180.53 160.39 22.57 180.33 162.62 20.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 170.58 160.79 28.87 171.46 159.09 29.69 coo -2.38 51.82 41.62 2.07 49.19 40.42 182.07 169.10 30.10 186.87 173.28 30.86 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 146 PHE^? 14.35 N9 ADE A 500 B 210 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 244 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 8.76 47.85 34.91 11.08 46.36 35.41 180.53 160.39 22.57 180.33 162.62 20.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 184.84 171.88 24.93 186.38 173.28 25.14 coo -2.38 51.82 41.62 2.07 49.19 40.42 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 18 PHE~? 34.51 O4 CIT A1102 B 210 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 244 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 8.76 47.85 34.91 11.08 46.36 35.41 189.87 114.75 23.00 191.73 115.42 25.00 coo 9.06 56.85 40.30 7.71 55.27 39.90 190.60 123.10 30.08 190.26 121.25 31.09 coo -2.38 51.82 41.62 2.07 49.19 40.42 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE B 129 PHE.? 19.08 N7 ADE A 500 B 210 ASP A 158 ASP.? 25.18 C8 ADE A 500 B 244 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 8.76 47.85 34.91 11.08 46.36 35.41 195.26 133.73 19.36 192.72 134.81 19.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 203.27 140.75 25.55 204.24 138.86 25.61 coo -2.38 51.82 41.62 2.07 49.19 40.42 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 146 PHE^? 15.86 C2 CIT A1102 B 210 ASP B 119 ASP.? 20.62 O7 CIT A1102 B 244 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo 8.76 47.85 34.91 11.08 46.36 35.41 178.16 121.58 2.78 175.54 120.91 2.10 coo 9.06 56.85 40.30 7.71 55.27 39.90 184.41 123.54 -7.24 185.10 123.40 -9.24 coo -2.38 51.82 41.62 2.07 49.19 40.42 190.30 123.24 2.08 193.85 127.78 -0.15 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE C 18 PHE~? 24.42 O3 GOL C1901 B 210 ASP C 158 ASP~? 26.27 O1 GOL C1901 B 244 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 8.76 47.85 34.91 11.08 46.36 35.41 159.76 134.50 57.07 160.74 136.25 55.14 coo 9.06 56.85 40.30 7.71 55.27 39.90 152.92 141.67 53.35 151.80 143.42 53.28 coo -2.38 51.82 41.62 2.07 49.19 40.42 161.71 139.26 46.53 163.20 144.39 46.83 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE C 95 PHE^? 18.35 C1 GOL C1901 B 210 ASP C 183 ASP~? 25.06 O3 GOL C1901 B 244 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 8.76 47.85 34.91 11.08 46.36 35.41 166.44 121.18 45.60 168.59 122.86 46.18 coo 9.06 56.85 40.30 7.71 55.27 39.90 169.34 110.13 50.56 169.06 109.63 52.58 coo -2.38 51.82 41.62 2.07 49.19 40.42 177.05 121.15 50.66 176.96 126.15 48.94 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 B 112 PHE C 146 PHE^? 16.71 C1 GOL C1901 B 210 ASP C 119 ASP.? 26.31 O1 GOL C1901 B 244 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo 8.76 47.85 34.91 11.08 46.36 35.41 167.22 118.61 41.10 166.40 115.95 40.88 coo 9.06 56.85 40.30 7.71 55.27 39.90 178.03 118.40 36.14 177.70 120.46 36.31 coo -2.38 51.82 41.62 2.07 49.19 40.42 174.37 128.14 41.95 175.88 130.01 36.96 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 11 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 210 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 244 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 11.28 44.53 18.60 9.91 46.00 19.20 184.39 157.95 13.11 185.86 157.96 14.60 coo 10.51 37.86 19.71 9.07 39.38 20.04 178.57 156.37 9.84 177.44 156.14 8.05 coo -1.20 42.34 17.67 3.19 45.13 19.06 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 187 HIS~? 25.73 N9 ADE A 500 A 210 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 244 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 11.28 44.53 18.60 9.91 46.00 19.20 179.01 171.47 26.59 179.51 173.49 26.31 coo 10.51 37.86 19.71 9.07 39.38 20.04 184.84 171.88 24.93 186.38 173.28 25.14 coo -1.20 42.34 17.67 3.19 45.13 19.06 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 210 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 244 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 11.28 44.53 18.60 9.91 46.00 19.20 171.08 125.47 9.27 172.48 124.18 10.15 coo 10.51 37.86 19.71 9.07 39.38 20.04 169.82 131.15 6.22 168.64 132.89 5.97 coo -1.20 42.34 17.67 3.19 45.13 19.06 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 210 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 244 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 11.28 44.53 18.60 9.91 46.00 19.20 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 10.51 37.86 19.71 9.07 39.38 20.04 174.65 109.33 0.17 174.41 107.27 0.58 coo -1.20 42.34 17.67 3.19 45.13 19.06 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 136 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 210 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 244 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 11.28 44.53 18.60 9.91 46.00 19.20 157.21 117.94 38.21 157.48 118.99 40.00 coo 10.51 37.86 19.71 9.07 39.38 20.04 157.90 117.18 31.56 156.68 116.62 29.91 coo -1.20 42.34 17.67 3.19 45.13 19.06 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 136 HIS C 187 HIS~? 27.79 O3 GOL C1901 A 210 ASP C 183 ASP~? 25.06 O3 GOL C1901 A 244 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 11.28 44.53 18.60 9.91 46.00 19.20 174.78 109.74 44.68 175.79 108.53 43.31 coo 10.51 37.86 19.71 9.07 39.38 20.04 169.34 110.13 50.56 169.06 109.63 52.58 coo -1.20 42.34 17.67 3.19 45.13 19.06 177.05 121.15 50.66 176.96 126.15 48.94 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 6 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 210 ASP A 175 ASP.? 10.98 C4 ADE A 500 B 244 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 10.08 50.18 41.78 8.91 48.61 41.04 184.39 157.95 13.11 185.86 157.96 14.60 coo 9.06 56.85 40.30 7.71 55.27 39.90 178.57 156.37 9.84 177.44 156.14 8.05 coo -2.38 51.82 41.62 2.07 49.19 40.42 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 187 HIS~? 25.73 N9 ADE A 500 B 210 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 244 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 10.08 50.18 41.78 8.91 48.61 41.04 179.01 171.47 26.59 179.51 173.49 26.31 coo 9.06 56.85 40.30 7.71 55.27 39.90 184.84 171.88 24.93 186.38 173.28 25.14 coo -2.38 51.82 41.62 2.07 49.19 40.42 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 210 ASP B 175 ASP.? 4.91 O1 CIT A1102 B 244 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 10.08 50.18 41.78 8.91 48.61 41.04 171.08 125.47 9.27 172.48 124.18 10.15 coo 9.06 56.85 40.30 7.71 55.27 39.90 169.82 131.15 6.22 168.64 132.89 5.97 coo -2.38 51.82 41.62 2.07 49.19 40.42 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 210 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 244 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 10.08 50.18 41.78 8.91 48.61 41.04 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 9.06 56.85 40.30 7.71 55.27 39.90 174.65 109.33 0.17 174.41 107.27 0.58 coo -2.38 51.82 41.62 2.07 49.19 40.42 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 136 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 210 ASP C 175 ASP.? 10.66 O1 GOL C1901 B 244 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 10.08 50.18 41.78 8.91 48.61 41.04 157.21 117.94 38.21 157.48 118.99 40.00 coo 9.06 56.85 40.30 7.71 55.27 39.90 157.90 117.18 31.56 156.68 116.62 29.91 coo -2.38 51.82 41.62 2.07 49.19 40.42 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 136 HIS C 187 HIS~? 27.79 O3 GOL C1901 B 210 ASP C 183 ASP~? 25.06 O3 GOL C1901 B 244 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 10.08 50.18 41.78 8.91 48.61 41.04 174.78 109.74 44.68 175.79 108.53 43.31 coo 9.06 56.85 40.30 7.71 55.27 39.90 169.34 110.13 50.56 169.06 109.63 52.58 coo -2.38 51.82 41.62 2.07 49.19 40.42 177.05 121.15 50.66 176.96 126.15 48.94 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 6 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 A 142 LEU A 30 LEU~? 19.54 N9 ADE A 500 A 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 198.66 149.45 16.16 201.00 150.74 16.95 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 202.74 144.10 20.76 201.41 143.57 22.39 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 A 142 LEU A 33 LEU~? 17.67 N7 ADE A 500 A 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 198.66 149.45 16.16 201.00 150.74 16.95 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 201.31 140.77 16.43 199.20 140.97 16.79 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 A 142 LEU A 86 LEU^? 12.71 N9 ADE A 500 A 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 198.66 149.45 16.16 201.00 150.74 16.95 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 194.71 148.92 23.13 193.24 150.49 22.94 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 A 142 LEU A 162 LEU^? 13.88 C8 ADE A 500 A 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 198.66 149.45 16.16 201.00 150.74 16.95 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 194.06 141.28 20.24 193.66 140.74 18.18 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 137 TYR A 83 TYR^? 11.70 N6 ADE A 500 A 142 LEU A 33 LEU~? 17.67 N7 ADE A 500 A 165 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 192.51 141.71 13.59 192.79 138.96 13.21 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 201.31 140.77 16.43 199.20 140.97 16.79 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 A 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 142 LEU A 86 LEU^? 12.71 N9 ADE A 500 A 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 185.14 149.36 25.84 186.22 148.61 23.38 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 194.71 148.92 23.13 193.24 150.49 22.94 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 A 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 142 LEU A 86 LEU^? 12.71 N9 ADE A 500 A 165 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 185.14 149.36 25.84 186.22 148.61 23.38 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 194.71 148.92 23.13 193.24 150.49 22.94 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 A 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 142 LEU A 115 LEU^? 14.78 C8 ADE A 500 A 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 185.14 149.36 25.84 186.22 148.61 23.38 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 179.69 153.76 27.15 180.08 151.90 26.13 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 A 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 142 LEU A 200 LEU~? 16.58 N9 ADE A 500 A 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 185.14 149.36 25.84 186.22 148.61 23.38 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 189.20 158.71 27.56 189.21 156.96 28.83 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 A 137 TYR A 117 TYR.? 18.31 C8 ADE A 500 A 142 LEU A 188 LEU~? 20.46 N9 ADE A 500 A 165 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 174.51 155.83 27.46 174.88 153.07 27.26 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 178.54 164.92 27.62 177.65 164.04 25.88 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 179.30 153.63 32.06 174.52 149.85 32.01 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 A 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 A 142 LEU B 30 LEU~? 31.26 O4 CIT A1102 A 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 177.82 122.79 24.63 178.10 120.27 25.77 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 184.70 122.72 29.40 186.23 123.32 28.00 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 A 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 A 142 LEU B 33 LEU~? 27.87 C8 ADE A 500 A 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 177.82 122.79 24.63 178.10 120.27 25.77 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 182.48 127.54 30.60 182.82 128.96 29.02 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 A 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 A 142 LEU B 162 LEU^? 22.55 N7 ADE A 500 A 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 177.82 122.79 24.63 178.10 120.27 25.77 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 185.36 129.41 23.16 183.75 130.83 23.34 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 A 137 TYR B 83 TYR^? 20.46 C8 ADE A 500 A 142 LEU B 33 LEU~? 27.87 C8 ADE A 500 A 165 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 179.54 132.93 23.44 180.82 135.06 24.75 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 182.48 127.54 30.60 182.82 128.96 29.02 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 A 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 142 LEU B 86 LEU^? 23.67 O4 CIT A1102 A 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 186.72 125.72 10.79 185.00 126.80 12.71 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 184.32 122.30 19.71 183.30 122.12 17.79 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 A 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 142 LEU B 86 LEU^? 23.67 O4 CIT A1102 A 165 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 186.72 125.72 10.79 185.00 126.80 12.71 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 184.32 122.30 19.71 183.30 122.12 17.79 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 A 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 142 LEU B 115 LEU^? 16.04 O4 CIT A1102 A 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 186.72 125.72 10.79 185.00 126.80 12.71 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 185.73 124.71 3.76 185.76 126.42 5.07 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 A 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 142 LEU B 151 LEU^? 28.13 O4 CIT A1102 A 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 186.72 125.72 10.79 185.00 126.80 12.71 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 187.74 119.73 19.81 189.08 120.38 21.37 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 A 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 142 LEU B 200 LEU.? 23.95 O4 CIT A1102 A 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 186.72 125.72 10.79 185.00 126.80 12.71 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 183.15 116.29 9.52 185.15 116.82 10.13 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 A 137 TYR B 117 TYR.? 15.40 O4 CIT A1102 A 142 LEU B 188 LEU.? 20.30 C2 CIT A1102 A 165 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 184.92 125.90 -1.64 186.19 127.72 0.06 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 180.24 116.94 -2.21 178.78 118.54 -2.13 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 190.30 123.24 2.08 193.85 127.78 -0.15 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 A 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 A 142 LEU C 30 LEU~? 20.29 O1 GOL C1901 A 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 149.80 129.36 48.45 149.55 129.08 51.21 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 149.67 136.76 51.63 151.47 137.62 50.77 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 A 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 A 142 LEU C 33 LEU~? 17.92 O1 GOL C1901 A 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 149.80 129.36 48.45 149.55 129.08 51.21 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 146.64 137.29 47.35 147.68 137.63 45.49 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 A 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 A 142 LEU C 86 LEU^? 15.36 O1 GOL C1901 A 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 149.80 129.36 48.45 149.55 129.08 51.21 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 157.40 132.07 48.36 158.48 130.43 47.55 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 A 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 A 142 LEU C 162 LEU^? 15.28 O1 GOL C1901 A 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 149.80 129.36 48.45 149.55 129.08 51.21 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 153.66 137.34 43.51 152.39 136.80 41.85 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 A 137 TYR C 83 TYR^? 12.44 O1 GOL C1901 A 142 LEU C 33 LEU~? 17.92 O1 GOL C1901 A 165 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 149.52 133.95 39.18 148.57 136.34 38.09 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 146.64 137.29 47.35 147.68 137.63 45.49 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 26 3 # 26 A 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 142 LEU C 86 LEU^? 15.36 O1 GOL C1901 A 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 165.10 130.81 41.92 162.37 130.83 41.35 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 157.40 132.07 48.36 158.48 130.43 47.55 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 27 3 # 27 A 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 142 LEU C 86 LEU^? 15.36 O1 GOL C1901 A 165 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 165.10 130.81 41.92 162.37 130.83 41.35 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 157.40 132.07 48.36 158.48 130.43 47.55 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 28 3 # 28 A 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 142 LEU C 151 LEU^? 20.26 O1 GOL C1901 A 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 165.10 130.81 41.92 162.37 130.83 41.35 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 159.74 133.84 50.79 159.17 135.82 51.44 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 29 3 # 29 A 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 142 LEU C 151 LEU^? 20.26 O1 GOL C1901 A 165 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 165.10 130.81 41.92 162.37 130.83 41.35 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 159.74 133.84 50.79 159.17 135.82 51.44 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 30 3 # 30 A 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 142 LEU C 200 LEU~? 19.60 O3 GOL C1901 A 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 165.10 130.81 41.92 162.37 130.83 41.35 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 166.37 124.06 49.56 166.53 126.19 49.48 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 31 3 # 31 A 137 TYR C 117 TYR.? 21.72 O1 GOL C1901 A 142 LEU C 188 LEU~? 23.70 C1 GOL C1901 A 165 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 173.67 123.08 36.58 172.76 125.64 35.98 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 174.22 115.06 42.61 172.47 116.15 43.19 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 174.37 128.14 41.95 175.88 130.01 36.96 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 31 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 B 142 LEU A 30 LEU~? 19.54 N9 ADE A 500 B 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 198.66 149.45 16.16 201.00 150.74 16.95 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 202.74 144.10 20.76 201.41 143.57 22.39 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 B 142 LEU A 33 LEU~? 17.67 N7 ADE A 500 B 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 198.66 149.45 16.16 201.00 150.74 16.95 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 201.31 140.77 16.43 199.20 140.97 16.79 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 B 142 LEU A 162 LEU^? 13.88 C8 ADE A 500 B 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 198.66 149.45 16.16 201.00 150.74 16.95 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 194.06 141.28 20.24 193.66 140.74 18.18 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR A 83 TYR^? 11.70 N6 ADE A 500 B 142 LEU A 33 LEU~? 17.67 N7 ADE A 500 B 165 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 192.51 141.71 13.59 192.79 138.96 13.21 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 201.31 140.77 16.43 199.20 140.97 16.79 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 B 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 B 142 LEU A 86 LEU^? 12.71 N9 ADE A 500 B 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 185.14 149.36 25.84 186.22 148.61 23.38 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 194.71 148.92 23.13 193.24 150.49 22.94 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 B 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 B 142 LEU A 86 LEU^? 12.71 N9 ADE A 500 B 165 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 185.14 149.36 25.84 186.22 148.61 23.38 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 194.71 148.92 23.13 193.24 150.49 22.94 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 B 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 B 142 LEU A 115 LEU^? 14.78 C8 ADE A 500 B 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 185.14 149.36 25.84 186.22 148.61 23.38 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 179.69 153.76 27.15 180.08 151.90 26.13 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 B 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 B 142 LEU A 200 LEU~? 16.58 N9 ADE A 500 B 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 185.14 149.36 25.84 186.22 148.61 23.38 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 189.20 158.71 27.56 189.21 156.96 28.83 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 B 137 TYR A 117 TYR.? 18.31 C8 ADE A 500 B 142 LEU A 188 LEU~? 20.46 N9 ADE A 500 B 165 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 174.51 155.83 27.46 174.88 153.07 27.26 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 178.54 164.92 27.62 177.65 164.04 25.88 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 179.30 153.63 32.06 174.52 149.85 32.01 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 B 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 B 142 LEU B 30 LEU~? 31.26 O4 CIT A1102 B 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 177.82 122.79 24.63 178.10 120.27 25.77 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 184.70 122.72 29.40 186.23 123.32 28.00 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 B 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 B 142 LEU B 33 LEU~? 27.87 C8 ADE A 500 B 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 177.82 122.79 24.63 178.10 120.27 25.77 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 182.48 127.54 30.60 182.82 128.96 29.02 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 B 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 B 142 LEU B 162 LEU^? 22.55 N7 ADE A 500 B 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 177.82 122.79 24.63 178.10 120.27 25.77 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 185.36 129.41 23.16 183.75 130.83 23.34 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 B 137 TYR B 83 TYR^? 20.46 C8 ADE A 500 B 142 LEU B 33 LEU~? 27.87 C8 ADE A 500 B 165 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 179.54 132.93 23.44 180.82 135.06 24.75 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 182.48 127.54 30.60 182.82 128.96 29.02 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 B 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 B 142 LEU B 86 LEU^? 23.67 O4 CIT A1102 B 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 186.72 125.72 10.79 185.00 126.80 12.71 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 184.32 122.30 19.71 183.30 122.12 17.79 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 B 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 B 142 LEU B 86 LEU^? 23.67 O4 CIT A1102 B 165 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 186.72 125.72 10.79 185.00 126.80 12.71 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 184.32 122.30 19.71 183.30 122.12 17.79 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 B 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 B 142 LEU B 115 LEU^? 16.04 O4 CIT A1102 B 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 186.72 125.72 10.79 185.00 126.80 12.71 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 185.73 124.71 3.76 185.76 126.42 5.07 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 B 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 B 142 LEU B 151 LEU^? 28.13 O4 CIT A1102 B 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 186.72 125.72 10.79 185.00 126.80 12.71 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 187.74 119.73 19.81 189.08 120.38 21.37 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 B 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 B 142 LEU B 151 LEU^? 28.13 O4 CIT A1102 B 165 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 186.72 125.72 10.79 185.00 126.80 12.71 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 187.74 119.73 19.81 189.08 120.38 21.37 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 B 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 B 142 LEU B 200 LEU.? 23.95 O4 CIT A1102 B 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 186.72 125.72 10.79 185.00 126.80 12.71 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 183.15 116.29 9.52 185.15 116.82 10.13 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 B 137 TYR B 117 TYR.? 15.40 O4 CIT A1102 B 142 LEU B 188 LEU.? 20.30 C2 CIT A1102 B 165 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 184.92 125.90 -1.64 186.19 127.72 0.06 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 180.24 116.94 -2.21 178.78 118.54 -2.13 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 190.30 123.24 2.08 193.85 127.78 -0.15 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 B 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 B 142 LEU C 30 LEU~? 20.29 O1 GOL C1901 B 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 149.80 129.36 48.45 149.55 129.08 51.21 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 149.67 136.76 51.63 151.47 137.62 50.77 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 B 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 B 142 LEU C 33 LEU~? 17.92 O1 GOL C1901 B 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 149.80 129.36 48.45 149.55 129.08 51.21 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 146.64 137.29 47.35 147.68 137.63 45.49 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 B 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 B 142 LEU C 162 LEU^? 15.28 O1 GOL C1901 B 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 149.80 129.36 48.45 149.55 129.08 51.21 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 153.66 137.34 43.51 152.39 136.80 41.85 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 B 137 TYR C 83 TYR^? 12.44 O1 GOL C1901 B 142 LEU C 33 LEU~? 17.92 O1 GOL C1901 B 165 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 149.52 133.95 39.18 148.57 136.34 38.09 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 146.64 137.29 47.35 147.68 137.63 45.49 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 B 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 B 142 LEU C 86 LEU^? 15.36 O1 GOL C1901 B 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 165.10 130.81 41.92 162.37 130.83 41.35 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 157.40 132.07 48.36 158.48 130.43 47.55 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 26 3 # 26 B 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 B 142 LEU C 86 LEU^? 15.36 O1 GOL C1901 B 165 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 165.10 130.81 41.92 162.37 130.83 41.35 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 157.40 132.07 48.36 158.48 130.43 47.55 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 27 3 # 27 B 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 B 142 LEU C 151 LEU^? 20.26 O1 GOL C1901 B 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 165.10 130.81 41.92 162.37 130.83 41.35 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 159.74 133.84 50.79 159.17 135.82 51.44 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 28 3 # 28 B 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 B 142 LEU C 151 LEU^? 20.26 O1 GOL C1901 B 165 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 165.10 130.81 41.92 162.37 130.83 41.35 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 159.74 133.84 50.79 159.17 135.82 51.44 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 29 3 # 29 B 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 B 142 LEU C 200 LEU~? 19.60 O3 GOL C1901 B 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 165.10 130.81 41.92 162.37 130.83 41.35 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 166.37 124.06 49.56 166.53 126.19 49.48 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 30 3 # 30 B 137 TYR C 117 TYR.? 21.72 O1 GOL C1901 B 142 LEU C 188 LEU~? 23.70 C1 GOL C1901 B 165 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 173.67 123.08 36.58 172.76 125.64 35.98 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 174.22 115.06 42.61 172.47 116.15 43.19 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 174.37 128.14 41.95 175.88 130.01 36.96 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 30 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 C 142 LEU A 30 LEU~? 19.54 N9 ADE A 500 C 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 198.66 149.45 16.16 201.00 150.74 16.95 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 202.74 144.10 20.76 201.41 143.57 22.39 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 C 142 LEU A 33 LEU~? 17.67 N7 ADE A 500 C 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 198.66 149.45 16.16 201.00 150.74 16.95 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 201.31 140.77 16.43 199.20 140.97 16.79 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 C 142 LEU A 162 LEU^? 13.88 C8 ADE A 500 C 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 198.66 149.45 16.16 201.00 150.74 16.95 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 194.06 141.28 20.24 193.66 140.74 18.18 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR A 83 TYR^? 11.70 N6 ADE A 500 C 142 LEU A 33 LEU~? 17.67 N7 ADE A 500 C 165 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 192.51 141.71 13.59 192.79 138.96 13.21 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 201.31 140.77 16.43 199.20 140.97 16.79 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 137 TYR A 83 TYR^? 11.70 N6 ADE A 500 C 142 LEU A 162 LEU^? 13.88 C8 ADE A 500 C 165 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 192.51 141.71 13.59 192.79 138.96 13.21 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 194.06 141.28 20.24 193.66 140.74 18.18 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 C 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 C 142 LEU A 86 LEU^? 12.71 N9 ADE A 500 C 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 185.14 149.36 25.84 186.22 148.61 23.38 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 194.71 148.92 23.13 193.24 150.49 22.94 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 C 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 C 142 LEU A 86 LEU^? 12.71 N9 ADE A 500 C 165 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 185.14 149.36 25.84 186.22 148.61 23.38 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 194.71 148.92 23.13 193.24 150.49 22.94 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 C 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 C 142 LEU A 115 LEU^? 14.78 C8 ADE A 500 C 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 185.14 149.36 25.84 186.22 148.61 23.38 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 179.69 153.76 27.15 180.08 151.90 26.13 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 C 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 C 142 LEU A 200 LEU~? 16.58 N9 ADE A 500 C 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 185.14 149.36 25.84 186.22 148.61 23.38 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 189.20 158.71 27.56 189.21 156.96 28.83 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 C 137 TYR A 117 TYR.? 18.31 C8 ADE A 500 C 142 LEU A 188 LEU~? 20.46 N9 ADE A 500 C 165 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 174.51 155.83 27.46 174.88 153.07 27.26 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 178.54 164.92 27.62 177.65 164.04 25.88 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 179.30 153.63 32.06 174.52 149.85 32.01 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 C 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 C 142 LEU B 30 LEU~? 31.26 O4 CIT A1102 C 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 177.82 122.79 24.63 178.10 120.27 25.77 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 184.70 122.72 29.40 186.23 123.32 28.00 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 C 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 C 142 LEU B 33 LEU~? 27.87 C8 ADE A 500 C 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 177.82 122.79 24.63 178.10 120.27 25.77 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 182.48 127.54 30.60 182.82 128.96 29.02 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 C 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 C 142 LEU B 162 LEU^? 22.55 N7 ADE A 500 C 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 177.82 122.79 24.63 178.10 120.27 25.77 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 185.36 129.41 23.16 183.75 130.83 23.34 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 C 137 TYR B 83 TYR^? 20.46 C8 ADE A 500 C 142 LEU B 33 LEU~? 27.87 C8 ADE A 500 C 165 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 179.54 132.93 23.44 180.82 135.06 24.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 182.48 127.54 30.60 182.82 128.96 29.02 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 C 137 TYR B 83 TYR^? 20.46 C8 ADE A 500 C 142 LEU B 162 LEU^? 22.55 N7 ADE A 500 C 165 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 179.54 132.93 23.44 180.82 135.06 24.75 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 185.36 129.41 23.16 183.75 130.83 23.34 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 C 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 C 142 LEU B 86 LEU^? 23.67 O4 CIT A1102 C 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 186.72 125.72 10.79 185.00 126.80 12.71 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 184.32 122.30 19.71 183.30 122.12 17.79 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 C 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 C 142 LEU B 86 LEU^? 23.67 O4 CIT A1102 C 165 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 186.72 125.72 10.79 185.00 126.80 12.71 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 184.32 122.30 19.71 183.30 122.12 17.79 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 C 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 C 142 LEU B 115 LEU^? 16.04 O4 CIT A1102 C 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 186.72 125.72 10.79 185.00 126.80 12.71 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 185.73 124.71 3.76 185.76 126.42 5.07 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 C 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 C 142 LEU B 200 LEU.? 23.95 O4 CIT A1102 C 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 186.72 125.72 10.79 185.00 126.80 12.71 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 183.15 116.29 9.52 185.15 116.82 10.13 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 C 137 TYR B 117 TYR.? 15.40 O4 CIT A1102 C 142 LEU B 188 LEU.? 20.30 C2 CIT A1102 C 165 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 184.92 125.90 -1.64 186.19 127.72 0.06 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 180.24 116.94 -2.21 178.78 118.54 -2.13 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 190.30 123.24 2.08 193.85 127.78 -0.15 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 C 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 C 142 LEU C 30 LEU~? 20.29 O1 GOL C1901 C 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 149.80 129.36 48.45 149.55 129.08 51.21 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 149.67 136.76 51.63 151.47 137.62 50.77 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 C 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 C 142 LEU C 33 LEU~? 17.92 O1 GOL C1901 C 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 149.80 129.36 48.45 149.55 129.08 51.21 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 146.64 137.29 47.35 147.68 137.63 45.49 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 C 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 C 142 LEU C 162 LEU^? 15.28 O1 GOL C1901 C 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 149.80 129.36 48.45 149.55 129.08 51.21 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 153.66 137.34 43.51 152.39 136.80 41.85 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 C 137 TYR C 83 TYR^? 12.44 O1 GOL C1901 C 142 LEU C 33 LEU~? 17.92 O1 GOL C1901 C 165 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 149.52 133.95 39.18 148.57 136.34 38.09 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 146.64 137.29 47.35 147.68 137.63 45.49 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 C 137 TYR C 83 TYR^? 12.44 O1 GOL C1901 C 142 LEU C 162 LEU^? 15.28 O1 GOL C1901 C 165 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 149.52 133.95 39.18 148.57 136.34 38.09 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 153.66 137.34 43.51 152.39 136.80 41.85 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 26 3 # 26 C 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 C 142 LEU C 86 LEU^? 15.36 O1 GOL C1901 C 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 165.10 130.81 41.92 162.37 130.83 41.35 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 157.40 132.07 48.36 158.48 130.43 47.55 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 27 3 # 27 C 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 C 142 LEU C 86 LEU^? 15.36 O1 GOL C1901 C 165 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 165.10 130.81 41.92 162.37 130.83 41.35 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 157.40 132.07 48.36 158.48 130.43 47.55 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 28 3 # 28 C 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 C 142 LEU C 151 LEU^? 20.26 O1 GOL C1901 C 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 165.10 130.81 41.92 162.37 130.83 41.35 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 159.74 133.84 50.79 159.17 135.82 51.44 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 29 3 # 29 C 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 C 142 LEU C 151 LEU^? 20.26 O1 GOL C1901 C 165 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 165.10 130.81 41.92 162.37 130.83 41.35 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 159.74 133.84 50.79 159.17 135.82 51.44 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 30 3 # 30 C 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 C 142 LEU C 200 LEU~? 19.60 O3 GOL C1901 C 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 165.10 130.81 41.92 162.37 130.83 41.35 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 166.37 124.06 49.56 166.53 126.19 49.48 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 31 3 # 31 C 137 TYR C 117 TYR.? 21.72 O1 GOL C1901 C 142 LEU C 188 LEU~? 23.70 C1 GOL C1901 C 165 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 173.67 123.08 36.58 172.76 125.64 35.98 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 174.22 115.06 42.61 172.47 116.15 43.19 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 174.37 128.14 41.95 175.88 130.01 36.96 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 31 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 D 142 LEU A 30 LEU~? 19.54 N9 ADE A 500 D 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 198.66 149.45 16.16 201.00 150.74 16.95 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 202.74 144.10 20.76 201.41 143.57 22.39 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 D 142 LEU A 33 LEU~? 17.67 N7 ADE A 500 D 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 198.66 149.45 16.16 201.00 150.74 16.95 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 201.31 140.77 16.43 199.20 140.97 16.79 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR A 47 TYR^? 13.72 N3 ADE A 500 D 142 LEU A 162 LEU^? 13.88 C8 ADE A 500 D 165 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 198.66 149.45 16.16 201.00 150.74 16.95 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 194.06 141.28 20.24 193.66 140.74 18.18 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR A 83 TYR^? 11.70 N6 ADE A 500 D 142 LEU A 33 LEU~? 17.67 N7 ADE A 500 D 165 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 192.51 141.71 13.59 192.79 138.96 13.21 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 201.31 140.77 16.43 199.20 140.97 16.79 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 D 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 D 142 LEU A 86 LEU^? 12.71 N9 ADE A 500 D 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 185.14 149.36 25.84 186.22 148.61 23.38 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 194.71 148.92 23.13 193.24 150.49 22.94 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 6 3 # 6 D 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 D 142 LEU A 86 LEU^? 12.71 N9 ADE A 500 D 165 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 185.14 149.36 25.84 186.22 148.61 23.38 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 194.71 148.92 23.13 193.24 150.49 22.94 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 7 3 # 7 D 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 D 142 LEU A 115 LEU^? 14.78 C8 ADE A 500 D 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 185.14 149.36 25.84 186.22 148.61 23.38 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 179.69 153.76 27.15 180.08 151.90 26.13 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 8 3 # 8 D 137 TYR A 113 TYR^? 11.47 C8 ADE A 500 D 142 LEU A 200 LEU~? 16.58 N9 ADE A 500 D 165 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 185.14 149.36 25.84 186.22 148.61 23.38 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 189.20 158.71 27.56 189.21 156.96 28.83 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 9 3 # 9 D 137 TYR A 117 TYR.? 18.31 C8 ADE A 500 D 142 LEU A 188 LEU~? 20.46 N9 ADE A 500 D 165 LYS A 123 LYS^? 21.83 C8 ADE A 500 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 174.51 155.83 27.46 174.88 153.07 27.26 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 178.54 164.92 27.62 177.65 164.04 25.88 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 179.30 153.63 32.06 174.52 149.85 32.01 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 10 3 # 10 D 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 D 142 LEU B 30 LEU~? 31.26 O4 CIT A1102 D 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 177.82 122.79 24.63 178.10 120.27 25.77 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 184.70 122.72 29.40 186.23 123.32 28.00 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 11 3 # 11 D 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 D 142 LEU B 33 LEU~? 27.87 C8 ADE A 500 D 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 177.82 122.79 24.63 178.10 120.27 25.77 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 182.48 127.54 30.60 182.82 128.96 29.02 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 12 3 # 12 D 137 TYR B 47 TYR^? 27.62 O4 CIT A1102 D 142 LEU B 162 LEU^? 22.55 N7 ADE A 500 D 165 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 177.82 122.79 24.63 178.10 120.27 25.77 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 185.36 129.41 23.16 183.75 130.83 23.34 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 13 3 # 13 D 137 TYR B 83 TYR^? 20.46 C8 ADE A 500 D 142 LEU B 33 LEU~? 27.87 C8 ADE A 500 D 165 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 179.54 132.93 23.44 180.82 135.06 24.75 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 182.48 127.54 30.60 182.82 128.96 29.02 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 14 3 # 14 D 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 D 142 LEU B 86 LEU^? 23.67 O4 CIT A1102 D 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 186.72 125.72 10.79 185.00 126.80 12.71 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 184.32 122.30 19.71 183.30 122.12 17.79 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 15 3 # 15 D 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 D 142 LEU B 86 LEU^? 23.67 O4 CIT A1102 D 165 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 186.72 125.72 10.79 185.00 126.80 12.71 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 184.32 122.30 19.71 183.30 122.12 17.79 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 16 3 # 16 D 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 D 142 LEU B 115 LEU^? 16.04 O4 CIT A1102 D 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 186.72 125.72 10.79 185.00 126.80 12.71 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 185.73 124.71 3.76 185.76 126.42 5.07 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 17 3 # 17 D 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 D 142 LEU B 151 LEU^? 28.13 O4 CIT A1102 D 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 186.72 125.72 10.79 185.00 126.80 12.71 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 187.74 119.73 19.81 189.08 120.38 21.37 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 18 3 # 18 D 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 D 142 LEU B 151 LEU^? 28.13 O4 CIT A1102 D 165 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 186.72 125.72 10.79 185.00 126.80 12.71 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 187.74 119.73 19.81 189.08 120.38 21.37 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 19 3 # 19 D 137 TYR B 113 TYR^? 17.81 O4 CIT A1102 D 142 LEU B 200 LEU.? 23.95 O4 CIT A1102 D 165 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 186.72 125.72 10.79 185.00 126.80 12.71 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 183.15 116.29 9.52 185.15 116.82 10.13 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 20 3 # 20 D 137 TYR B 117 TYR.? 15.40 O4 CIT A1102 D 142 LEU B 188 LEU.? 20.30 C2 CIT A1102 D 165 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 184.92 125.90 -1.64 186.19 127.72 0.06 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 180.24 116.94 -2.21 178.78 118.54 -2.13 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 190.30 123.24 2.08 193.85 127.78 -0.15 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 21 3 # 21 D 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 D 142 LEU C 30 LEU~? 20.29 O1 GOL C1901 D 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 149.80 129.36 48.45 149.55 129.08 51.21 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 149.67 136.76 51.63 151.47 137.62 50.77 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 22 3 # 22 D 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 D 142 LEU C 33 LEU~? 17.92 O1 GOL C1901 D 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 149.80 129.36 48.45 149.55 129.08 51.21 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 146.64 137.29 47.35 147.68 137.63 45.49 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 23 3 # 23 D 137 TYR C 47 TYR^? 13.41 O3 GOL C1901 D 142 LEU C 162 LEU^? 15.28 O1 GOL C1901 D 165 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 149.80 129.36 48.45 149.55 129.08 51.21 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 153.66 137.34 43.51 152.39 136.80 41.85 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 24 3 # 24 D 137 TYR C 83 TYR^? 12.44 O1 GOL C1901 D 142 LEU C 33 LEU~? 17.92 O1 GOL C1901 D 165 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 149.52 133.95 39.18 148.57 136.34 38.09 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 146.64 137.29 47.35 147.68 137.63 45.49 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 25 3 # 25 D 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 D 142 LEU C 86 LEU^? 15.36 O1 GOL C1901 D 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 165.10 130.81 41.92 162.37 130.83 41.35 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 157.40 132.07 48.36 158.48 130.43 47.55 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 26 3 # 26 D 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 D 142 LEU C 86 LEU^? 15.36 O1 GOL C1901 D 165 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 165.10 130.81 41.92 162.37 130.83 41.35 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 157.40 132.07 48.36 158.48 130.43 47.55 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 27 3 # 27 D 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 D 142 LEU C 151 LEU^? 20.26 O1 GOL C1901 D 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 165.10 130.81 41.92 162.37 130.83 41.35 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 159.74 133.84 50.79 159.17 135.82 51.44 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 28 3 # 28 D 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 D 142 LEU C 151 LEU^? 20.26 O1 GOL C1901 D 165 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 165.10 130.81 41.92 162.37 130.83 41.35 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 159.74 133.84 50.79 159.17 135.82 51.44 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 29 3 # 29 D 137 TYR C 113 TYR^? 15.28 O1 GOL C1901 D 142 LEU C 200 LEU~? 19.60 O3 GOL C1901 D 165 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 165.10 130.81 41.92 162.37 130.83 41.35 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 166.37 124.06 49.56 166.53 126.19 49.48 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 30 3 # 30 D 137 TYR C 117 TYR.? 21.72 O1 GOL C1901 D 142 LEU C 188 LEU~? 23.70 C1 GOL C1901 D 165 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 173.67 123.08 36.58 172.76 125.64 35.98 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 174.22 115.06 42.61 172.47 116.15 43.19 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 174.37 128.14 41.95 175.88 130.01 36.96 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 30 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 90 SER.? 14.48 N3 ADE A 500 A 48 THR A 87 THR.? 16.32 N9 ADE A 500 A 165 LYS A 20 LYS~? 27.72 N9 ADE A 500 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 199.47 153.71 22.16 199.01 152.90 19.92 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 199.26 148.57 23.25 200.05 148.42 21.27 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 198.50 157.87 31.43 197.45 157.77 37.73 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER A 90 SER.? 14.48 N3 ADE A 500 A 48 THR A 87 THR.? 16.32 N9 ADE A 500 A 165 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 199.47 153.71 22.16 199.01 152.90 19.92 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 199.26 148.57 23.25 200.05 148.42 21.27 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 47 SER B 90 SER.? 26.90 O4 CIT A1102 A 48 THR B 87 THR.? 28.94 O4 CIT A1102 A 165 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 181.23 117.12 21.89 179.24 118.41 21.27 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 184.52 120.26 23.93 182.79 120.64 25.15 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 186.73 109.97 17.12 190.68 107.86 12.58 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 47 SER B 90 SER.? 26.90 O4 CIT A1102 A 48 THR B 87 THR.? 28.94 O4 CIT A1102 A 165 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 181.23 117.12 21.89 179.24 118.41 21.27 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 184.52 120.26 23.93 182.79 120.64 25.15 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 A 47 SER C 90 SER.? 14.02 O3 GOL C1901 A 48 THR C 87 THR.? 16.92 O3 GOL C1901 A 165 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 155.07 128.53 53.12 154.12 126.92 51.57 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 154.44 133.19 51.68 152.52 132.26 51.51 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 161.58 122.48 47.40 160.49 120.58 53.33 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 90 SER.? 14.48 N3 ADE A 500 B 48 THR A 87 THR.? 16.32 N9 ADE A 500 B 165 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 199.47 153.71 22.16 199.01 152.90 19.92 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 199.26 148.57 23.25 200.05 148.42 21.27 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 90 SER.? 26.90 O4 CIT A1102 B 48 THR B 87 THR.? 28.94 O4 CIT A1102 B 165 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 181.23 117.12 21.89 179.24 118.41 21.27 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 184.52 120.26 23.93 182.79 120.64 25.15 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 47 SER C 90 SER.? 14.02 O3 GOL C1901 B 48 THR C 87 THR.? 16.92 O3 GOL C1901 B 165 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 155.07 128.53 53.12 154.12 126.92 51.57 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 154.44 133.19 51.68 152.52 132.26 51.51 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 161.58 122.48 47.40 160.49 120.58 53.33 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 3 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 90 SER.? 14.48 N3 ADE A 500 C 48 THR A 87 THR.? 16.32 N9 ADE A 500 C 165 LYS A 20 LYS~? 27.72 N9 ADE A 500 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 199.47 153.71 22.16 199.01 152.90 19.92 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 199.26 148.57 23.25 200.05 148.42 21.27 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 198.50 157.87 31.43 197.45 157.77 37.73 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER A 90 SER.? 14.48 N3 ADE A 500 C 48 THR A 87 THR.? 16.32 N9 ADE A 500 C 165 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 199.47 153.71 22.16 199.01 152.90 19.92 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 199.26 148.57 23.25 200.05 148.42 21.27 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 47 SER B 90 SER.? 26.90 O4 CIT A1102 C 48 THR B 87 THR.? 28.94 O4 CIT A1102 C 165 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 181.23 117.12 21.89 179.24 118.41 21.27 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 184.52 120.26 23.93 182.79 120.64 25.15 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 186.73 109.97 17.12 190.68 107.86 12.58 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 47 SER B 90 SER.? 26.90 O4 CIT A1102 C 48 THR B 87 THR.? 28.94 O4 CIT A1102 C 165 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 181.23 117.12 21.89 179.24 118.41 21.27 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 184.52 120.26 23.93 182.79 120.64 25.15 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 5 3 # 5 C 47 SER C 90 SER.? 14.02 O3 GOL C1901 C 48 THR C 87 THR.? 16.92 O3 GOL C1901 C 165 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 155.07 128.53 53.12 154.12 126.92 51.57 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 154.44 133.19 51.68 152.52 132.26 51.51 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 161.58 122.48 47.40 160.49 120.58 53.33 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 5 hits 1fdy_c06 naa= 3 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 47 SER A 90 SER.? 14.48 N3 ADE A 500 D 48 THR A 87 THR.? 16.32 N9 ADE A 500 D 165 LYS A 94 LYS^? 16.74 N9 ADE A 500 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 199.47 153.71 22.16 199.01 152.90 19.92 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 199.26 148.57 23.25 200.05 148.42 21.27 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 189.82 158.18 22.25 194.56 162.25 23.07 ULMN 3 1fdy_c07 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 47 SER C 90 SER.? 14.02 O3 GOL C1901 D 48 THR C 87 THR.? 16.92 O3 GOL C1901 D 165 LYS C 94 LYS^? 16.92 O3 GOL C1901 coo -21.69 -90.39 -8.89 -21.07 -88.29 -10.03 155.07 128.53 53.12 154.12 126.92 51.57 coo -19.38 -93.32 -7.98 -17.24 -93.31 -7.67 154.44 133.19 51.68 152.52 132.26 51.51 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 161.58 122.48 47.40 160.49 120.58 53.33 1fdy_c07 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c07 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 50 GLU^? -3.91 N6 ADE A 500s B 319 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 359 ARG B 101 ARG.? -6.88 O4 CIT A1102s coo 10.77 13.13 40.94 11.03 14.73 39.51 187.90 146.65 6.60 187.00 148.18 5.47 coo 3.77 12.64 38.21 3.35 14.53 37.39 185.72 140.93 6.30 184.35 140.00 4.99 coo -1.16 15.32 35.60 -3.32 13.56 36.98 179.40 137.94 3.82 182.23 139.06 3.56 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU B 50 GLU^? 15.33 O1 CIT A1102 B 319 ASP B 52 ASP^? 16.07 C8 ADE A 500 B 359 ARG A 101 ARG.? 15.15 C8 ADE A 500 coo 10.77 13.13 40.94 11.03 14.73 39.51 171.15 134.64 18.99 169.39 134.49 17.85 coo 3.77 12.64 38.21 3.35 14.53 37.39 173.93 140.35 20.11 173.24 142.10 19.12 coo -1.16 15.32 35.60 -3.32 13.56 36.98 173.48 146.74 16.27 172.57 144.92 18.53 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 2 hits 1fr8_c01 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 49 LYS^? 10.58 N6 ADE A 500 A 331 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 188 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 130.22 155.23 83.49 125.21 153.71 84.04 193.06 146.52 10.07 195.03 144.09 6.09 coo 120.90 152.23 75.28 120.94 153.09 77.19 188.90 156.57 17.91 187.92 156.12 16.11 coo 122.04 152.80 81.06 120.71 154.37 81.46 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 331 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 188 HIS A 104 HIS^? 8.41 C8 ADE A 500 coo 130.22 155.23 83.49 125.21 153.71 84.04 182.91 155.29 23.54 184.46 151.31 19.55 coo 120.90 152.23 75.28 120.94 153.09 77.19 185.43 146.45 17.17 186.00 148.48 17.29 coo 122.04 152.80 81.06 120.71 154.37 81.46 183.15 146.13 20.69 182.60 148.09 20.18 ULMN 3 1fuq_c00 FUMARASE C user 3 3 # 3 A 324 LYS B 49 LYS^? 24.07 O1 GOL C1901 A 331 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 188 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 130.22 155.23 83.49 125.21 153.71 84.04 174.03 130.60 22.66 171.30 132.48 26.53 coo 120.90 152.23 75.28 120.94 153.09 77.19 174.85 121.76 12.80 173.53 120.38 11.97 coo 122.04 152.80 81.06 120.71 154.37 81.46 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1fuq_c00 FUMARASE C user 4 3 # 4 A 324 LYS C 49 LYS^? 10.29 O2 GOL C1901 A 331 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 188 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 130.22 155.23 83.49 125.21 153.71 84.04 147.41 128.03 39.92 142.61 128.90 38.51 coo 120.90 152.23 75.28 120.94 153.09 77.19 157.18 120.22 44.20 157.97 118.54 45.19 coo 122.04 152.80 81.06 120.71 154.37 81.46 153.36 123.09 43.85 154.03 121.98 42.20 1fuq_c00 source 1fuq FUMARASE C : 4 hits 1fuq_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP B 139 TRP^? 16.21 O4 CIT A1102 A 317 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 365 ARG B 101 ARG.? -6.88 O4 CIT A1102s coo 79.91 26.87 38.77 78.95 23.18 37.81 186.72 130.16 9.65 187.54 130.72 13.46 coo 85.55 26.30 41.25 85.59 24.97 39.65 180.17 131.30 14.36 179.09 129.62 13.64 coo 83.47 25.30 27.10 83.44 27.82 25.29 179.40 137.94 3.82 182.23 139.06 3.56 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP C 139 TRP^? 15.96 O1 GOL C1901 A 317 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 365 ARG C 101 ARG.? 18.11 O1 GOL C1901 coo 79.91 26.87 38.77 78.95 23.18 37.81 164.72 132.19 37.65 162.24 134.97 38.90 coo 85.55 26.30 41.25 85.59 24.97 39.65 157.34 129.59 37.15 157.60 127.69 38.11 coo 83.47 25.30 27.10 83.44 27.82 25.29 163.77 126.78 27.00 165.49 129.29 26.85 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 2 hits 1g8o_c01 naa= 3 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 1 3 # 1 A 130 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 153 ASN A 35 ASN~? 19.82 C2 ADE A 500 A 189 GLN A 32 GLN~? 25.17 N1 ADE A 500 coo 27.45 53.97 73.24 26.29 54.34 71.54 203.35 139.46 11.01 205.31 139.04 11.69 coo 29.93 52.22 70.56 29.34 51.93 68.54 205.66 144.31 11.38 206.37 146.04 12.39 coo 26.19 47.96 71.25 25.92 49.81 70.24 207.67 139.81 16.25 208.68 138.93 14.58 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 2 3 # 2 A 130 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 153 ASN A 35 ASN~? 19.82 C2 ADE A 500 A 189 GLN A 38 GLN~? 16.18 N1 ADE A 500 coo 27.45 53.97 73.24 26.29 54.34 71.54 203.35 139.46 11.01 205.31 139.04 11.69 coo 29.93 52.22 70.56 29.34 51.93 68.54 205.66 144.31 11.38 206.37 146.04 12.39 coo 26.19 47.96 71.25 25.92 49.81 70.24 201.31 144.17 6.55 201.09 144.12 4.42 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 3 3 # 3 A 130 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 153 ASN B 35 ASN~? 25.18 O1 GOL C1901 A 189 GLN B 32 GLN~? 31.87 O1 GOL C1901 coo 27.45 53.97 73.24 26.29 54.34 71.54 178.67 130.13 34.24 179.32 129.31 36.04 coo 29.93 52.22 70.56 29.34 51.93 68.54 176.57 125.33 34.40 176.61 123.22 34.34 coo 26.19 47.96 71.25 25.92 49.81 70.24 181.82 126.23 36.63 183.21 126.21 38.24 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 4 3 # 4 A 130 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 153 ASN B 35 ASN~? 25.18 O1 GOL C1901 A 189 GLN C 121 GLN.? 26.97 O1 GOL C1901 coo 27.45 53.97 73.24 26.29 54.34 71.54 178.67 130.13 34.24 179.32 129.31 36.04 coo 29.93 52.22 70.56 29.34 51.93 68.54 176.57 125.33 34.40 176.61 123.22 34.34 coo 26.19 47.96 71.25 25.92 49.81 70.24 178.02 124.63 39.26 178.36 125.72 37.48 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 5 3 # 5 A 130 ASP C 36 ASP~? 21.70 O1 GOL C1901 A 153 ASN C 35 ASN~? 19.36 O3 GOL C1901 A 189 GLN C 32 GLN~? 25.53 O1 GOL C1901 coo 27.45 53.97 73.24 26.29 54.34 71.54 140.93 137.00 45.78 140.14 138.07 47.46 coo 29.93 52.22 70.56 29.34 51.93 68.54 140.68 133.60 49.75 141.25 132.82 51.65 coo 26.19 47.96 71.25 25.92 49.81 70.24 142.17 139.35 51.79 141.77 141.42 51.49 ULMN 3 1ga8_c00 GALACTOSYL TRANSFERASE LGTC user 6 3 # 6 A 130 ASP C 36 ASP~? 21.70 O1 GOL C1901 A 153 ASN C 35 ASN~? 19.36 O3 GOL C1901 A 189 GLN C 38 GLN~? 14.38 C3 GOL C1901 coo 27.45 53.97 73.24 26.29 54.34 71.54 140.93 137.00 45.78 140.14 138.07 47.46 coo 29.93 52.22 70.56 29.34 51.93 68.54 140.68 133.60 49.75 141.25 132.82 51.65 coo 26.19 47.96 71.25 25.92 49.81 70.24 140.00 128.89 43.97 138.34 128.25 42.75 1ga8_c00 source 1ga8 GALACTOSYL TRANSFERASE LGTC : 6 hits 1ga8_c00 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 98 ASN^? 5.64 N9 ADE A 500 A 108 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 144 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo 51.28 61.14 17.85 51.16 61.61 19.96 179.72 154.52 15.51 181.63 154.42 14.60 coo 52.62 57.63 23.12 50.77 57.51 22.26 184.39 157.95 13.11 185.86 157.96 14.60 coo 46.65 56.95 20.09 48.42 58.17 20.01 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN B 98 ASN^? 8.56 C4 CIT A1102 A 108 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 144 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 51.28 61.14 17.85 51.16 61.61 19.96 174.94 129.17 6.18 173.60 130.41 7.30 coo 52.62 57.63 23.12 50.77 57.51 22.26 171.08 125.47 9.27 172.48 124.18 10.15 coo 46.65 56.95 20.09 48.42 58.17 20.01 169.82 131.15 6.22 168.64 132.89 5.97 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 3 3 # 3 A 106 ASN C 98 ASN^? 8.51 O1 GOL C1901 A 108 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 144 ASP C 175 ASP.? 10.66 O1 GOL C1901 coo 51.28 61.14 17.85 51.16 61.61 19.96 160.68 120.91 34.68 159.00 120.62 33.38 coo 52.62 57.63 23.12 50.77 57.51 22.26 157.21 117.94 38.21 157.48 118.99 40.00 coo 46.65 56.95 20.09 48.42 58.17 20.01 157.90 117.18 31.56 156.68 116.62 29.91 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 3 hits 1grc_c02 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 129 PHE.? 20.13 C8 ADE A 500 A 298 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 329 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 188.97 135.38 27.69 188.93 135.61 24.90 coo 2.59 0.29 25.55 4.65 0.18 25.07 188.71 136.74 34.61 188.50 136.01 36.57 coo 12.42 6.10 23.27 9.95 1.57 20.16 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE B 18 PHE~? 34.51 O4 CIT A1102 A 298 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 329 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 189.87 114.75 23.00 191.73 115.42 25.00 coo 2.59 0.29 25.55 4.65 0.18 25.07 190.60 123.10 30.08 190.26 121.25 31.09 coo 12.42 6.10 23.27 9.95 1.57 20.16 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE C 18 PHE~? 24.42 O3 GOL C1901 A 298 ASP C 158 ASP~? 26.27 O1 GOL C1901 A 329 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 159.76 134.50 57.07 160.74 136.25 55.14 coo 2.59 0.29 25.55 4.65 0.18 25.07 152.92 141.67 53.35 151.80 143.42 53.28 coo 12.42 6.10 23.27 9.95 1.57 20.16 161.71 139.26 46.53 163.20 144.39 46.83 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 129 PHE.? 20.13 C8 ADE A 500 B 298 ASP A 130 ASP~? 27.60 C8 ADE A 500 B 329 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 188.97 135.38 27.69 188.93 135.61 24.90 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 188.71 136.74 34.61 188.50 136.01 36.57 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE B 18 PHE~? 34.51 O4 CIT A1102 B 298 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 329 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 189.87 114.75 23.00 191.73 115.42 25.00 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 190.60 123.10 30.08 190.26 121.25 31.09 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE C 18 PHE~? 24.42 O3 GOL C1901 B 298 ASP C 158 ASP~? 26.27 O1 GOL C1901 B 329 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 159.76 134.50 57.07 160.74 136.25 55.14 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 152.92 141.67 53.35 151.80 143.42 53.28 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 161.71 139.26 46.53 163.20 144.39 46.83 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 129 PHE.? 20.13 C8 ADE A 500 C 298 ASP A 130 ASP~? 27.60 C8 ADE A 500 C 329 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 17.41 60.57 64.39 18.40 58.12 65.34 188.97 135.38 27.69 188.93 135.61 24.90 coo 24.10 66.43 63.33 24.18 64.30 63.40 188.71 136.74 34.61 188.50 136.01 36.57 coo 27.64 56.61 58.17 22.18 57.92 60.36 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE B 18 PHE~? 34.51 O4 CIT A1102 C 298 ASP B 158 ASP.? 34.51 N7 ADE A 500 C 329 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 17.41 60.57 64.39 18.40 58.12 65.34 189.87 114.75 23.00 191.73 115.42 25.00 coo 24.10 66.43 63.33 24.18 64.30 63.40 190.60 123.10 30.08 190.26 121.25 31.09 coo 27.64 56.61 58.17 22.18 57.92 60.36 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE C 18 PHE~? 24.42 O3 GOL C1901 C 298 ASP C 158 ASP~? 26.27 O1 GOL C1901 C 329 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 17.41 60.57 64.39 18.40 58.12 65.34 159.76 134.50 57.07 160.74 136.25 55.14 coo 24.10 66.43 63.33 24.18 64.30 63.40 152.92 141.67 53.35 151.80 143.42 53.28 coo 27.64 56.61 58.17 22.18 57.92 60.36 161.71 139.26 46.53 163.20 144.39 46.83 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 129 PHE.? 20.13 C8 ADE A 500 D 298 ASP A 130 ASP~? 27.60 C8 ADE A 500 D 329 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 35.44 53.35 83.81 35.65 54.53 81.28 188.97 135.38 27.69 188.93 135.61 24.90 coo 29.72 46.46 83.60 30.79 47.36 81.99 188.71 136.74 34.61 188.50 136.01 36.57 coo 36.89 44.91 74.55 37.33 48.94 79.01 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE B 18 PHE~? 34.51 O4 CIT A1102 D 298 ASP B 158 ASP.? 34.51 N7 ADE A 500 D 329 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 35.44 53.35 83.81 35.65 54.53 81.28 189.87 114.75 23.00 191.73 115.42 25.00 coo 29.72 46.46 83.60 30.79 47.36 81.99 190.60 123.10 30.08 190.26 121.25 31.09 coo 36.89 44.91 74.55 37.33 48.94 79.01 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE C 18 PHE~? 24.42 O3 GOL C1901 D 298 ASP C 158 ASP~? 26.27 O1 GOL C1901 D 329 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 35.44 53.35 83.81 35.65 54.53 81.28 159.76 134.50 57.07 160.74 136.25 55.14 coo 29.72 46.46 83.60 30.79 47.36 81.99 152.92 141.67 53.35 151.80 143.42 53.28 coo 36.89 44.91 74.55 37.33 48.94 79.01 161.71 139.26 46.53 163.20 144.39 46.83 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 3 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 124 SER^? 19.87 C8 ADE A 500 A 164 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 168 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 32.37 52.40 49.35 31.32 53.88 47.74 182.61 151.80 32.41 184.93 152.05 33.02 coo 29.69 55.04 42.83 31.98 53.56 43.49 185.14 149.36 25.84 186.22 148.61 23.38 coo 26.96 50.99 47.03 31.03 48.83 44.33 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER B 124 SER^? 23.63 O4 CIT A1102 A 164 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 168 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 32.37 52.40 49.35 31.32 53.88 47.74 191.23 122.78 5.73 191.55 121.05 7.41 coo 29.69 55.04 42.83 31.98 53.56 43.49 186.72 125.72 10.79 185.00 126.80 12.71 coo 26.96 50.99 47.03 31.03 48.83 44.33 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 A 151 SER C 124 SER^? 23.11 O1 GOL C1901 A 164 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 168 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 32.37 52.40 49.35 31.32 53.88 47.74 172.32 130.73 43.72 171.22 130.88 45.88 coo 29.69 55.04 42.83 31.98 53.56 43.49 165.10 130.81 41.92 162.37 130.83 41.35 coo 26.96 50.99 47.03 31.03 48.83 44.33 168.56 136.65 44.17 170.62 139.01 49.65 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 124 SER^? 19.87 C8 ADE A 500 B 164 TYR A 113 TYR^? 11.47 C8 ADE A 500 B 168 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 13.08 50.93 56.67 13.12 48.99 55.27 182.61 151.80 32.41 184.93 152.05 33.02 coo 11.52 46.03 51.32 10.06 47.90 52.76 185.14 149.36 25.84 186.22 148.61 23.38 coo 15.72 50.86 51.22 10.77 52.35 51.39 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER B 124 SER^? 23.63 O4 CIT A1102 B 164 TYR B 113 TYR^? 17.81 O4 CIT A1102 B 168 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 13.08 50.93 56.67 13.12 48.99 55.27 191.23 122.78 5.73 191.55 121.05 7.41 coo 11.52 46.03 51.32 10.06 47.90 52.76 186.72 125.72 10.79 185.00 126.80 12.71 coo 15.72 50.86 51.22 10.77 52.35 51.39 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 B 151 SER C 124 SER^? 23.11 O1 GOL C1901 B 164 TYR C 113 TYR^? 15.28 O1 GOL C1901 B 168 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 13.08 50.93 56.67 13.12 48.99 55.27 172.32 130.73 43.72 171.22 130.88 45.88 coo 11.52 46.03 51.32 10.06 47.90 52.76 165.10 130.81 41.92 162.37 130.83 41.35 coo 15.72 50.86 51.22 10.77 52.35 51.39 168.56 136.65 44.17 170.62 139.01 49.65 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 124 SER^? 19.87 C8 ADE A 500 C 164 TYR A 113 TYR^? 11.47 C8 ADE A 500 C 168 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 11.22 34.38 82.32 11.07 36.29 83.78 182.61 151.80 32.41 184.93 152.05 33.02 coo 8.83 39.27 87.38 7.60 37.43 85.69 185.14 149.36 25.84 186.22 148.61 23.38 coo 12.98 34.46 88.14 8.11 32.96 87.14 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER B 124 SER^? 23.63 O4 CIT A1102 C 164 TYR B 113 TYR^? 17.81 O4 CIT A1102 C 168 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 11.22 34.38 82.32 11.07 36.29 83.78 191.23 122.78 5.73 191.55 121.05 7.41 coo 8.83 39.27 87.38 7.60 37.43 85.69 186.72 125.72 10.79 185.00 126.80 12.71 coo 12.98 34.46 88.14 8.11 32.96 87.14 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 C 151 SER C 124 SER^? 23.11 O1 GOL C1901 C 164 TYR C 113 TYR^? 15.28 O1 GOL C1901 C 168 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 11.22 34.38 82.32 11.07 36.29 83.78 172.32 130.73 43.72 171.22 130.88 45.88 coo 8.83 39.27 87.38 7.60 37.43 85.69 165.10 130.81 41.92 162.37 130.83 41.35 coo 12.98 34.46 88.14 8.11 32.96 87.14 168.56 136.65 44.17 170.62 139.01 49.65 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 124 SER^? 19.87 C8 ADE A 500 D 164 TYR A 113 TYR^? 11.47 C8 ADE A 500 D 168 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 29.15 32.90 92.57 27.86 31.44 94.02 182.61 151.80 32.41 184.93 152.05 33.02 coo 25.49 30.28 98.59 27.88 31.73 98.26 185.14 149.36 25.84 186.22 148.61 23.38 coo 23.46 34.31 94.02 27.08 36.46 97.29 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER B 124 SER^? 23.63 O4 CIT A1102 D 164 TYR B 113 TYR^? 17.81 O4 CIT A1102 D 168 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 29.15 32.90 92.57 27.86 31.44 94.02 191.23 122.78 5.73 191.55 121.05 7.41 coo 25.49 30.28 98.59 27.88 31.73 98.26 186.72 125.72 10.79 185.00 126.80 12.71 coo 23.46 34.31 94.02 27.08 36.46 97.29 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 D 151 SER C 124 SER^? 23.11 O1 GOL C1901 D 164 TYR C 113 TYR^? 15.28 O1 GOL C1901 D 168 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 29.15 32.90 92.57 27.86 31.44 94.02 172.32 130.73 43.72 171.22 130.88 45.88 coo 25.49 30.28 98.59 27.88 31.73 98.26 165.10 130.81 41.92 162.37 130.83 41.35 coo 23.46 34.31 94.02 27.08 36.46 97.29 168.56 136.65 44.17 170.62 139.01 49.65 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 3 hits 1gz6_c03 naa= 3 ULMN 3 1hrk_c00 FERROCHELATASE user 1 3 # 1 A 263 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 341 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 343 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 191.47 153.75 14.17 189.52 154.05 13.44 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 185.28 156.61 18.37 185.56 154.55 18.68 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1hrk_c00 FERROCHELATASE user 2 3 # 2 A 263 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 341 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 343 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 191.47 153.75 14.17 189.52 154.05 13.44 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 184.39 157.95 13.11 185.86 157.96 14.60 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1hrk_c00 FERROCHELATASE user 3 3 # 3 A 263 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 341 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 343 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 185.28 156.61 18.37 185.56 154.55 18.68 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 191.47 153.75 14.17 189.52 154.05 13.44 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1hrk_c00 FERROCHELATASE user 4 3 # 4 A 263 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 341 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 343 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 184.39 157.95 13.11 185.86 157.96 14.60 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 191.47 153.75 14.17 189.52 154.05 13.44 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1hrk_c00 FERROCHELATASE user 5 3 # 5 A 263 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 341 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 343 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 174.27 123.90 17.18 173.55 124.80 15.43 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 176.50 123.51 9.48 177.50 124.87 10.72 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1hrk_c00 FERROCHELATASE user 6 3 # 6 A 263 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 341 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 343 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 174.27 123.90 17.18 173.55 124.80 15.43 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 171.08 125.47 9.27 172.48 124.18 10.15 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1hrk_c00 FERROCHELATASE user 7 3 # 7 A 263 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 341 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 343 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 176.50 123.51 9.48 177.50 124.87 10.72 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 174.27 123.90 17.18 173.55 124.80 15.43 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1hrk_c00 FERROCHELATASE user 8 3 # 8 A 263 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 341 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 343 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 171.08 125.47 9.27 172.48 124.18 10.15 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 174.27 123.90 17.18 173.55 124.80 15.43 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1hrk_c00 FERROCHELATASE user 9 3 # 9 A 263 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 341 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 153.36 123.09 43.85 154.03 121.98 42.20 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 160.37 121.38 41.43 159.84 123.37 41.06 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c00 FERROCHELATASE user 10 3 # 10 A 263 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 341 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 153.36 123.09 43.85 154.03 121.98 42.20 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 157.21 117.94 38.21 157.48 118.99 40.00 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c00 FERROCHELATASE user 11 3 # 11 A 263 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 341 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 160.37 121.38 41.43 159.84 123.37 41.06 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 153.36 123.09 43.85 154.03 121.98 42.20 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c00 FERROCHELATASE user 12 3 # 12 A 263 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 341 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 157.21 117.94 38.21 157.48 118.99 40.00 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 153.36 123.09 43.85 154.03 121.98 42.20 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c00 FERROCHELATASE user 13 3 # 13 A 263 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 341 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 160.20 116.89 49.36 158.52 117.92 48.65 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 153.36 123.09 43.85 154.03 121.98 42.20 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c00 FERROCHELATASE user 14 3 # 14 A 263 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 341 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 160.20 116.89 49.36 158.52 117.92 48.65 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 160.37 121.38 41.43 159.84 123.37 41.06 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 157.18 120.22 44.20 157.97 118.54 45.19 1hrk_c00 source 1hrk FERROCHELATASE : 14 hits 1hrk_c00 naa= 3 ULMN 3 1hrk_c01 FERROCHELATASE user 1 3 # 1 B 263 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 341 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 343 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 191.47 153.75 14.17 189.52 154.05 13.44 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 185.28 156.61 18.37 185.56 154.55 18.68 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1hrk_c01 FERROCHELATASE user 2 3 # 2 B 263 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 341 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 343 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 191.47 153.75 14.17 189.52 154.05 13.44 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 184.39 157.95 13.11 185.86 157.96 14.60 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1hrk_c01 FERROCHELATASE user 3 3 # 3 B 263 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 341 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 343 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 185.28 156.61 18.37 185.56 154.55 18.68 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 191.47 153.75 14.17 189.52 154.05 13.44 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1hrk_c01 FERROCHELATASE user 4 3 # 4 B 263 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 341 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 343 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 184.39 157.95 13.11 185.86 157.96 14.60 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 191.47 153.75 14.17 189.52 154.05 13.44 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1hrk_c01 FERROCHELATASE user 5 3 # 5 B 263 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 341 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 343 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 174.27 123.90 17.18 173.55 124.80 15.43 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 176.50 123.51 9.48 177.50 124.87 10.72 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1hrk_c01 FERROCHELATASE user 6 3 # 6 B 263 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 341 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 343 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 174.27 123.90 17.18 173.55 124.80 15.43 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 171.08 125.47 9.27 172.48 124.18 10.15 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1hrk_c01 FERROCHELATASE user 7 3 # 7 B 263 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 341 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 343 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 176.50 123.51 9.48 177.50 124.87 10.72 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 174.27 123.90 17.18 173.55 124.80 15.43 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1hrk_c01 FERROCHELATASE user 8 3 # 8 B 263 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 341 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 343 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 171.08 125.47 9.27 172.48 124.18 10.15 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 174.27 123.90 17.18 173.55 124.80 15.43 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1hrk_c01 FERROCHELATASE user 9 3 # 9 B 263 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 341 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 153.36 123.09 43.85 154.03 121.98 42.20 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 160.37 121.38 41.43 159.84 123.37 41.06 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c01 FERROCHELATASE user 10 3 # 10 B 263 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 341 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 153.36 123.09 43.85 154.03 121.98 42.20 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 157.21 117.94 38.21 157.48 118.99 40.00 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c01 FERROCHELATASE user 11 3 # 11 B 263 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 341 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 153.36 123.09 43.85 154.03 121.98 42.20 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 160.20 116.89 49.36 158.52 117.92 48.65 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c01 FERROCHELATASE user 12 3 # 12 B 263 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 341 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 160.37 121.38 41.43 159.84 123.37 41.06 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 153.36 123.09 43.85 154.03 121.98 42.20 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c01 FERROCHELATASE user 13 3 # 13 B 263 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 341 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 160.37 121.38 41.43 159.84 123.37 41.06 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 160.20 116.89 49.36 158.52 117.92 48.65 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c01 FERROCHELATASE user 14 3 # 14 B 263 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 341 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 157.21 117.94 38.21 157.48 118.99 40.00 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 153.36 123.09 43.85 154.03 121.98 42.20 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c01 FERROCHELATASE user 15 3 # 15 B 263 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 341 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 160.20 116.89 49.36 158.52 117.92 48.65 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 153.36 123.09 43.85 154.03 121.98 42.20 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1hrk_c01 FERROCHELATASE user 16 3 # 16 B 263 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 341 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 343 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 160.20 116.89 49.36 158.52 117.92 48.65 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 160.37 121.38 41.43 159.84 123.37 41.06 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 157.18 120.22 44.20 157.97 118.54 45.19 1hrk_c01 source 1hrk FERROCHELATASE : 16 hits 1hrk_c01 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 327 GLU C 50 GLU^? -3.82 O2 GOL C1901s A 339 ARG C 53 ARG^? 4.89 O2 GOL C1901 coo 85.81 57.99 116.01 86.03 55.86 115.89 185.72 140.93 6.30 184.35 140.00 4.99 coo 75.11 41.01 160.30 76.65 40.06 161.41 147.72 125.56 34.28 147.67 123.54 33.74 coo 82.23 40.35 159.87 85.09 40.67 161.01 146.33 122.48 29.52 148.17 121.33 31.67 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 327 GLU C 156 GLU~? 24.55 O1 GOL C1901 A 339 ARG C 108 ARG^? 22.96 O1 GOL C1901 coo 85.81 57.99 116.01 86.03 55.86 115.89 180.59 154.59 5.93 180.83 155.75 4.19 coo 75.11 41.01 160.30 76.65 40.06 161.41 157.99 144.71 47.12 158.90 144.92 45.19 coo 82.23 40.35 159.87 85.09 40.67 161.01 152.54 142.82 43.26 151.11 144.25 45.58 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP C 36 ASP~? 21.70 O1 GOL C1901 A 327 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 339 ARG B 43 ARG.? 18.57 O1 CIT A1102 coo 85.81 57.99 116.01 86.03 55.86 115.89 140.93 137.00 45.78 140.14 138.07 47.46 coo 75.11 41.01 160.30 76.65 40.06 161.41 174.85 121.76 12.80 173.53 120.38 11.97 coo 82.23 40.35 159.87 85.09 40.67 161.01 169.37 120.65 13.94 167.07 120.51 11.92 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP C 52 ASP^? 12.06 O1 GOL C1901 A 327 GLU A 156 GLU.? 23.41 C8 ADE A 500 A 339 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 85.81 57.99 116.01 86.03 55.86 115.89 147.21 130.59 30.19 147.01 130.37 28.08 coo 75.11 41.01 160.30 76.65 40.06 161.41 196.65 137.08 28.97 194.78 136.94 30.01 coo 82.23 40.35 159.87 85.09 40.67 161.01 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP C 52 ASP^? 12.06 O1 GOL C1901 A 327 GLU B 156 GLU.? 24.53 N7 ADE A 500 A 339 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 85.81 57.99 116.01 86.03 55.86 115.89 147.21 130.59 30.19 147.01 130.37 28.08 coo 75.11 41.01 160.30 76.65 40.06 161.41 194.44 129.17 25.88 194.48 130.18 24.03 coo 82.23 40.35 159.87 85.09 40.67 161.01 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP C 89 ASP.? 17.67 O3 GOL C1901 A 327 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 339 ARG B 43 ARG.? 18.57 O1 CIT A1102 coo 85.81 57.99 116.01 86.03 55.86 115.89 152.15 130.32 56.35 151.16 130.16 54.50 coo 75.11 41.01 160.30 76.65 40.06 161.41 174.85 121.76 12.80 173.53 120.38 11.97 coo 82.23 40.35 159.87 85.09 40.67 161.01 169.37 120.65 13.94 167.07 120.51 11.92 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP C 158 ASP~? 26.27 O1 GOL C1901 A 327 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 339 ARG B 43 ARG.? 18.57 O1 CIT A1102 coo 85.81 57.99 116.01 86.03 55.86 115.89 152.92 141.67 53.35 151.80 143.42 53.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 174.85 121.76 12.80 173.53 120.38 11.97 coo 82.23 40.35 159.87 85.09 40.67 161.01 169.37 120.65 13.94 167.07 120.51 11.92 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP C 158 ASP~? 26.27 O1 GOL C1901 A 327 GLU B 174 GLU~? 9.44 O1 CIT A1102 A 339 ARG B 76 ARG^? 5.63 O1 CIT A1102 coo 85.81 57.99 116.01 86.03 55.86 115.89 152.92 141.67 53.35 151.80 143.42 53.28 coo 75.11 41.01 160.30 76.65 40.06 161.41 163.25 129.94 5.84 161.93 130.97 4.55 coo 82.23 40.35 159.87 85.09 40.67 161.01 166.15 136.82 7.45 164.99 134.62 5.65 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP C 172 ASP~? 9.22 O2 GOL C1901 A 327 GLU A 156 GLU.? 23.41 C8 ADE A 500 A 339 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 85.81 57.99 116.01 86.03 55.86 115.89 153.21 116.81 30.64 152.37 114.88 30.62 coo 75.11 41.01 160.30 76.65 40.06 161.41 196.65 137.08 28.97 194.78 136.94 30.01 coo 82.23 40.35 159.87 85.09 40.67 161.01 195.17 135.76 22.50 193.88 133.29 23.81 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 9 hits 1hto_c00 naa= 3 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 A 47 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 107 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 137 SER A 149 SER^? 11.10 N9 ADE A 500 coo 5.11 -0.55 31.43 1.36 1.90 33.24 189.82 158.18 22.25 194.56 162.25 23.07 coo 6.14 -0.73 24.01 6.05 0.83 25.40 191.47 153.75 14.17 189.52 154.05 13.44 coo 1.06 -1.40 35.67 2.72 0.28 35.10 188.74 152.31 25.78 189.32 151.10 23.76 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 A 47 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 107 HIS A 202 HIS.? 13.56 N3 ADE A 500 A 137 SER A 149 SER^? 11.10 N9 ADE A 500 coo 5.11 -0.55 31.43 1.36 1.90 33.24 189.82 158.18 22.25 194.56 162.25 23.07 coo 6.14 -0.73 24.01 6.05 0.83 25.40 190.73 163.86 19.83 191.04 162.27 18.50 coo 1.06 -1.40 35.67 2.72 0.28 35.10 188.74 152.31 25.78 189.32 151.10 23.76 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 3 3 # 3 A 47 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 107 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 137 SER B 149 SER^? 19.92 O4 CIT A1102 coo 5.11 -0.55 31.43 1.36 1.90 33.24 179.28 118.69 11.71 177.59 112.91 13.79 coo 6.14 -0.73 24.01 6.05 0.83 25.40 174.27 123.90 17.18 173.55 124.80 15.43 coo 1.06 -1.40 35.67 2.72 0.28 35.10 184.89 121.99 12.52 183.61 123.38 14.10 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 4 3 # 4 A 47 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 107 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 137 SER C 149 SER^? 14.30 O1 GOL C1901 coo 5.11 -0.55 31.43 1.36 1.90 33.24 161.58 122.48 47.40 160.49 120.58 53.33 coo 6.14 -0.73 24.01 6.05 0.83 25.40 153.36 123.09 43.85 154.03 121.98 42.20 coo 1.06 -1.40 35.67 2.72 0.28 35.10 163.58 128.93 46.04 161.38 129.11 45.07 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 5 3 # 5 A 47 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 107 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 137 SER C 149 SER^? 14.30 O1 GOL C1901 coo 5.11 -0.55 31.43 1.36 1.90 33.24 161.58 122.48 47.40 160.49 120.58 53.33 coo 6.14 -0.73 24.01 6.05 0.83 25.40 160.20 116.89 49.36 158.52 117.92 48.65 coo 1.06 -1.40 35.67 2.72 0.28 35.10 163.58 128.93 46.04 161.38 129.11 45.07 1hy3_c00 source 1hy3 ESTROGEN SULFOTRANSFERASE : 5 hits 1hy3_c00 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 107 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 137 SER A 149 SER^? 11.10 N9 ADE A 500 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 189.82 158.18 22.25 194.56 162.25 23.07 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 191.47 153.75 14.17 189.52 154.05 13.44 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 188.74 152.31 25.78 189.32 151.10 23.76 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 B 47 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 107 HIS A 202 HIS.? 13.56 N3 ADE A 500 B 137 SER A 149 SER^? 11.10 N9 ADE A 500 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 189.82 158.18 22.25 194.56 162.25 23.07 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 190.73 163.86 19.83 191.04 162.27 18.50 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 188.74 152.31 25.78 189.32 151.10 23.76 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 3 3 # 3 B 47 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 107 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 137 SER B 149 SER^? 19.92 O4 CIT A1102 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 179.28 118.69 11.71 177.59 112.91 13.79 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 174.27 123.90 17.18 173.55 124.80 15.43 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 184.89 121.99 12.52 183.61 123.38 14.10 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 4 3 # 4 B 47 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 107 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 137 SER C 149 SER^? 14.30 O1 GOL C1901 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 161.58 122.48 47.40 160.49 120.58 53.33 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 153.36 123.09 43.85 154.03 121.98 42.20 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 163.58 128.93 46.04 161.38 129.11 45.07 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 5 3 # 5 B 47 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 107 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 137 SER C 149 SER^? 14.30 O1 GOL C1901 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 161.58 122.48 47.40 160.49 120.58 53.33 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 160.20 116.89 49.36 158.52 117.92 48.65 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 163.58 128.93 46.04 161.38 129.11 45.07 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 5 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 200 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 226 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 23.24 46.58 4.39 24.43 46.59 2.66 184.39 157.95 13.11 185.86 157.96 14.60 coo 24.51 43.28 11.18 25.17 44.50 9.58 178.57 156.37 9.84 177.44 156.14 8.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 187 HIS~? 25.73 N9 ADE A 500 A 200 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 226 LYS A 193 LYS~? 24.54 N9 ADE A 500 coo 23.24 46.58 4.39 24.43 46.59 2.66 179.01 171.47 26.59 179.51 173.49 26.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 184.84 171.88 24.93 186.38 173.28 25.14 coo 34.47 51.09 7.19 28.58 51.18 7.53 183.60 164.07 35.65 183.22 158.61 36.42 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 200 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 226 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 23.24 46.58 4.39 24.43 46.59 2.66 171.08 125.47 9.27 172.48 124.18 10.15 coo 24.51 43.28 11.18 25.17 44.50 9.58 169.82 131.15 6.22 168.64 132.89 5.97 coo 34.47 51.09 7.19 28.58 51.18 7.53 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 200 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 226 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 23.24 46.58 4.39 24.43 46.59 2.66 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 24.51 43.28 11.18 25.17 44.50 9.58 174.65 109.33 0.17 174.41 107.27 0.58 coo 34.47 51.09 7.19 28.58 51.18 7.53 188.45 111.50 0.09 191.63 115.50 2.10 ULMN 3 1i29_c01 CSDB user 5 3 # 5 A 123 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 200 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 226 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 23.24 46.58 4.39 24.43 46.59 2.66 157.21 117.94 38.21 157.48 118.99 40.00 coo 24.51 43.28 11.18 25.17 44.50 9.58 157.90 117.18 31.56 156.68 116.62 29.91 coo 34.47 51.09 7.19 28.58 51.18 7.53 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1i29_c01 CSDB user 6 3 # 6 A 123 HIS C 187 HIS~? 27.79 O3 GOL C1901 A 200 ASP C 183 ASP~? 25.06 O3 GOL C1901 A 226 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 23.24 46.58 4.39 24.43 46.59 2.66 174.78 109.74 44.68 175.79 108.53 43.31 coo 24.51 43.28 11.18 25.17 44.50 9.58 169.34 110.13 50.56 169.06 109.63 52.58 coo 34.47 51.09 7.19 28.58 51.18 7.53 177.05 121.15 50.66 176.96 126.15 48.94 1i29_c01 source 1i29 CSDB : 6 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 64 VAL.? 21.22 N3 ADE A 500 A 200 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 226 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 19.13 38.05 1.41 19.72 38.80 -0.53 171.32 165.04 6.63 171.31 165.37 4.49 coo 24.51 43.28 11.18 25.17 44.50 9.58 178.57 156.37 9.84 177.44 156.14 8.05 coo 34.47 51.09 7.19 28.58 51.18 7.53 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 136 VAL.? 18.66 C8 ADE A 500 A 200 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 226 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 183.08 140.76 29.51 181.38 141.90 28.79 coo 24.51 43.28 11.18 25.17 44.50 9.58 178.67 130.13 34.24 179.32 129.31 36.04 coo 34.47 51.09 7.19 28.58 51.18 7.53 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL C 114 VAL^? 20.50 O1 GOL C1901 A 200 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 226 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 169.18 127.76 44.39 169.90 127.19 46.35 coo 24.51 43.28 11.18 25.17 44.50 9.58 178.67 130.13 34.24 179.32 129.31 36.04 coo 34.47 51.09 7.19 28.58 51.18 7.53 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL C 116 VAL^? 21.24 O1 GOL C1901 A 200 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 226 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 171.81 122.27 41.21 172.19 121.04 42.96 coo 24.51 43.28 11.18 25.17 44.50 9.58 178.67 130.13 34.24 179.32 129.31 36.04 coo 34.47 51.09 7.19 28.58 51.18 7.53 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL C 122 VAL^? 24.59 O1 GOL C1901 A 200 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 226 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 175.34 124.54 42.59 174.82 123.84 44.59 coo 24.51 43.28 11.18 25.17 44.50 9.58 178.67 130.13 34.24 179.32 129.31 36.04 coo 34.47 51.09 7.19 28.58 51.18 7.53 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL C 122 VAL^? 24.59 O1 GOL C1901 A 200 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 226 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 19.13 38.05 1.41 19.72 38.80 -0.53 175.34 124.54 42.59 174.82 123.84 44.59 coo 24.51 43.28 11.18 25.17 44.50 9.58 178.67 130.13 34.24 179.32 129.31 36.04 coo 34.47 51.09 7.19 28.58 51.18 7.53 174.03 130.60 22.66 171.30 132.48 26.53 1i29_c03 source 1i29 CSDB : 6 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 165 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 189.82 158.18 22.25 194.56 162.25 23.07 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 182.91 155.29 23.54 184.46 151.31 19.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 189.82 158.18 22.25 194.56 162.25 23.07 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 182.91 155.29 23.54 184.46 151.31 19.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 180.69 158.10 18.36 176.95 162.62 18.15 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 182.91 155.29 23.54 184.46 151.31 19.55 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 74 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 192.52 142.86 28.75 192.00 138.78 32.31 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 186.22 145.69 31.90 189.62 146.93 37.05 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 74 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 186.22 145.69 31.90 189.62 146.93 37.05 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 192.52 142.86 28.75 192.00 138.78 32.31 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 74 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 182.91 155.29 23.54 184.46 151.31 19.55 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 189.82 158.18 22.25 194.56 162.25 23.07 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 74 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 182.91 155.29 23.54 184.46 151.31 19.55 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 180.69 158.10 18.36 176.95 162.62 18.15 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 A 14 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 179.28 118.69 11.71 177.59 112.91 13.79 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 181.66 123.79 6.82 179.82 128.66 10.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 A 14 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 175.75 125.08 4.60 173.18 124.12 -0.61 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 181.66 123.79 6.82 179.82 128.66 10.46 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 A 14 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 74 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 192.36 125.68 19.31 197.51 127.46 19.90 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 193.73 125.48 11.85 197.51 120.83 13.59 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 A 14 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 74 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 193.73 125.48 11.85 197.51 120.83 13.59 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 192.36 125.68 19.31 197.51 127.46 19.90 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 A 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 181.66 123.79 6.82 179.82 128.66 10.46 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 179.28 118.69 11.71 177.59 112.91 13.79 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 A 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 181.66 123.79 6.82 179.82 128.66 10.46 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 179.28 118.69 11.71 177.59 112.91 13.79 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 A 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 74 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 181.66 123.79 6.82 179.82 128.66 10.46 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 175.75 125.08 4.60 173.18 124.12 -0.61 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 A 14 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 161.58 122.48 47.40 160.49 120.58 53.33 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 165.62 124.17 41.44 160.89 126.43 37.84 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 A 14 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 165 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 163.30 119.33 38.22 166.56 114.68 36.90 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 165.62 124.17 41.44 160.89 126.43 37.84 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 A 14 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 74 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 161.71 139.26 46.53 163.20 144.39 46.83 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 168.56 136.65 44.17 170.62 139.01 49.65 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 A 14 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 74 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 168.56 136.65 44.17 170.62 139.01 49.65 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 161.71 139.26 46.53 163.20 144.39 46.83 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 19 3 # 19 A 14 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 74 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 165.62 124.17 41.44 160.89 126.43 37.84 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 161.58 122.48 47.40 160.49 120.58 53.33 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 174.54 125.67 53.14 175.81 126.60 51.73 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 19 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 189.82 158.18 22.25 194.56 162.25 23.07 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 182.91 155.29 23.54 184.46 151.31 19.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 180.69 158.10 18.36 176.95 162.62 18.15 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 182.91 155.29 23.54 184.46 151.31 19.55 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 74 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 192.52 142.86 28.75 192.00 138.78 32.31 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 186.22 145.69 31.90 189.62 146.93 37.05 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 74 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 186.22 145.69 31.90 189.62 146.93 37.05 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 192.52 142.86 28.75 192.00 138.78 32.31 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 74 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 182.91 155.29 23.54 184.46 151.31 19.55 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 189.82 158.18 22.25 194.56 162.25 23.07 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 74 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 182.91 155.29 23.54 184.46 151.31 19.55 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 180.69 158.10 18.36 176.95 162.62 18.15 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 179.28 118.69 11.71 177.59 112.91 13.79 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 181.66 123.79 6.82 179.82 128.66 10.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 175.75 125.08 4.60 173.18 124.12 -0.61 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 181.66 123.79 6.82 179.82 128.66 10.46 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 9 3 # 9 B 14 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 74 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 192.36 125.68 19.31 197.51 127.46 19.90 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 193.73 125.48 11.85 197.51 120.83 13.59 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 10 3 # 10 B 14 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 74 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 193.73 125.48 11.85 197.51 120.83 13.59 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 192.36 125.68 19.31 197.51 127.46 19.90 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 11 3 # 11 B 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 181.66 123.79 6.82 179.82 128.66 10.46 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 179.28 118.69 11.71 177.59 112.91 13.79 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 12 3 # 12 B 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 74 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 181.66 123.79 6.82 179.82 128.66 10.46 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 175.75 125.08 4.60 173.18 124.12 -0.61 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 13 3 # 13 B 14 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 161.58 122.48 47.40 160.49 120.58 53.33 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 165.62 124.17 41.44 160.89 126.43 37.84 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 14 3 # 14 B 14 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 165 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 163.30 119.33 38.22 166.56 114.68 36.90 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 165.62 124.17 41.44 160.89 126.43 37.84 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 15 3 # 15 B 14 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 74 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 161.71 139.26 46.53 163.20 144.39 46.83 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 168.56 136.65 44.17 170.62 139.01 49.65 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 16 3 # 16 B 14 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 74 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 168.56 136.65 44.17 170.62 139.01 49.65 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 161.71 139.26 46.53 163.20 144.39 46.83 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 17 3 # 17 B 14 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 74 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 165.62 124.17 41.44 160.89 126.43 37.84 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 161.58 122.48 47.40 160.49 120.58 53.33 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 18 3 # 18 B 14 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 74 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 165 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 165.62 124.17 41.44 160.89 126.43 37.84 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 163.30 119.33 38.22 166.56 114.68 36.90 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 170.51 115.98 53.19 171.23 115.96 55.18 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 18 hits 1idt_c01 naa= 3 ULMN 3 1ig8_c00 HEXOKINASE PII user 1 3 # 1 A 158 SER A 79 SER.? 7.17 O4 CIT A1102 A 173 ARG A 101 ARG.? 15.15 C8 ADE A 500 A 211 ASP A 52 ASP^? 9.33 O4 CIT A1102 coo 22.72 76.24 0.23 24.60 76.86 -1.25 179.20 144.60 7.13 179.51 142.21 7.02 coo 18.77 77.82 11.69 20.55 80.22 10.73 173.48 146.74 16.27 172.57 144.92 18.53 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 185.72 140.93 6.30 184.35 140.00 4.99 ULMN 3 1ig8_c00 HEXOKINASE PII user 2 3 # 2 A 158 SER B 79 SER.? 11.49 O4 CIT A1102 A 173 ARG B 101 ARG.? -6.88 O4 CIT A1102s A 211 ASP B 52 ASP^? 16.07 C8 ADE A 500 coo 22.72 76.24 0.23 24.60 76.86 -1.25 172.67 140.46 12.34 174.10 141.88 13.69 coo 18.77 77.82 11.69 20.55 80.22 10.73 179.40 137.94 3.82 182.23 139.06 3.56 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 173.93 140.35 20.11 173.24 142.10 19.12 ULMN 3 1ig8_c00 HEXOKINASE PII user 3 3 # 3 A 158 SER C 79 SER.? 11.88 O1 GOL C1901 A 173 ARG C 101 ARG.? 18.11 O1 GOL C1901 A 211 ASP C 52 ASP^? 12.06 O1 GOL C1901 coo 22.72 76.24 0.23 24.60 76.86 -1.25 152.54 126.39 26.52 151.63 128.65 26.08 coo 18.77 77.82 11.69 20.55 80.22 10.73 163.77 126.78 27.00 165.49 129.29 26.85 coo 26.87 77.59 -3.91 27.39 79.28 -2.83 147.21 130.59 30.19 147.01 130.37 28.08 1ig8_c00 source 1ig8 HEXOKINASE PII : 3 hits 1ig8_c00 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP B 158 ASP.? 34.51 N7 ADE A 500 158 THR B 87 THR.? 28.94 O4 CIT A1102 317 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo -2.63 8.40 35.07 -3.66 9.81 36.17 190.60 123.10 30.08 190.26 121.25 31.09 coo -5.30 12.75 41.86 -4.34 13.05 39.99 184.52 120.26 23.93 182.79 120.64 25.15 coo -12.63 17.64 33.66 -10.65 17.90 34.40 178.03 118.40 36.14 177.70 120.46 36.31 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 1 hits 1inp_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 204 GLU B 25 GLU.? 28.27 O1 GOL C1901 A 279 TYR B 47 TYR^? 27.62 O4 CIT A1102 coo 5.85 5.60 30.32 5.00 7.49 29.88 178.03 118.40 36.14 177.70 120.46 36.31 coo 7.79 1.83 27.81 9.08 3.25 26.92 179.49 113.39 31.74 177.60 113.83 30.87 coo 8.22 7.77 18.64 7.58 8.47 21.28 177.82 122.79 24.63 178.10 120.27 25.77 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 1 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 61 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 162 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 174.85 121.76 12.80 173.53 120.38 11.97 coo -4.89 20.85 5.22 -3.95 21.69 6.91 180.17 131.30 14.36 179.09 129.62 13.64 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 61 GLU C 50 GLU^? -3.82 O2 GOL C1901s A 162 HIS C 176 HIS^? 7.29 C1 GOL C1901 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 157.18 120.22 44.20 157.97 118.54 45.19 coo -4.89 20.85 5.22 -3.95 21.69 6.91 147.72 125.56 34.28 147.67 123.54 33.74 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 157.21 117.94 38.21 157.48 118.99 40.00 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 61 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 162 HIS C 176 HIS^? 7.29 C1 GOL C1901 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 157.18 120.22 44.20 157.97 118.54 45.19 coo -4.89 20.85 5.22 -3.95 21.69 6.91 157.34 129.59 37.15 157.60 127.69 38.11 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 157.21 117.94 38.21 157.48 118.99 40.00 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 61 GLU C 184 GLU~? 18.70 O3 GOL C1901 A 162 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 157.18 120.22 44.20 157.97 118.54 45.19 coo -4.89 20.85 5.22 -3.95 21.69 6.91 168.68 112.73 44.51 166.86 112.61 43.45 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 160.20 116.89 49.36 158.52 117.92 48.65 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 4 hits 1j53_c00 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 76 ARG^? 12.51 N1 ADE A 500 C 201 HIS A 96 HIS^? 6.77 N9 ADE A 500 C 204 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 30.92 14.23 15.70 28.82 13.90 13.48 176.90 153.44 4.90 177.24 156.32 3.96 coo 20.16 5.55 18.86 20.00 7.59 19.34 185.28 156.61 18.37 185.56 154.55 18.68 coo 24.92 3.29 16.90 24.41 4.92 15.69 184.39 157.95 13.11 185.86 157.96 14.60 1j70_c02 source 1j70 ATP SULPHURYLASE : 1 hits 1j70_c02 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU B 156 GLU.? 24.53 N7 ADE A 500 A 163 ARG B 108 ARG^? 25.54 C8 ADE A 500 A 222 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 51.27 81.34 48.31 51.67 80.79 50.28 194.44 129.17 25.88 194.48 130.18 24.03 coo 48.06 78.22 50.94 48.51 78.27 53.98 188.64 131.77 26.61 189.85 131.11 29.36 coo 54.85 84.16 52.60 54.26 81.23 53.34 195.17 135.76 22.50 193.88 133.29 23.81 1kim_c00 source 1kim THYMIDINE KINASE : 1 hits 1kim_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 24.97 5.82 58.78 26.79 1.97 55.46 189.82 158.18 22.25 194.56 162.25 23.07 coo 19.46 3.44 61.93 23.95 1.12 60.13 182.91 155.29 23.54 184.46 151.31 19.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 24.97 5.82 58.78 26.79 1.97 55.46 180.69 158.10 18.36 176.95 162.62 18.15 coo 19.46 3.44 61.93 23.95 1.12 60.13 182.91 155.29 23.54 184.46 151.31 19.55 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 74 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 24.97 5.82 58.78 26.79 1.97 55.46 192.52 142.86 28.75 192.00 138.78 32.31 coo 19.46 3.44 61.93 23.95 1.12 60.13 186.22 145.69 31.90 189.62 146.93 37.05 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 74 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 24.97 5.82 58.78 26.79 1.97 55.46 186.22 145.69 31.90 189.62 146.93 37.05 coo 19.46 3.44 61.93 23.95 1.12 60.13 192.52 142.86 28.75 192.00 138.78 32.31 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 74 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 24.97 5.82 58.78 26.79 1.97 55.46 182.91 155.29 23.54 184.46 151.31 19.55 coo 19.46 3.44 61.93 23.95 1.12 60.13 189.82 158.18 22.25 194.56 162.25 23.07 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 74 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 24.97 5.82 58.78 26.79 1.97 55.46 182.91 155.29 23.54 184.46 151.31 19.55 coo 19.46 3.44 61.93 23.95 1.12 60.13 180.69 158.10 18.36 176.95 162.62 18.15 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 24.97 5.82 58.78 26.79 1.97 55.46 179.28 118.69 11.71 177.59 112.91 13.79 coo 19.46 3.44 61.93 23.95 1.12 60.13 181.66 123.79 6.82 179.82 128.66 10.46 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 24.97 5.82 58.78 26.79 1.97 55.46 175.75 125.08 4.60 173.18 124.12 -0.61 coo 19.46 3.44 61.93 23.95 1.12 60.13 181.66 123.79 6.82 179.82 128.66 10.46 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 74 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 24.97 5.82 58.78 26.79 1.97 55.46 192.36 125.68 19.31 197.51 127.46 19.90 coo 19.46 3.44 61.93 23.95 1.12 60.13 193.73 125.48 11.85 197.51 120.83 13.59 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 74 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 24.97 5.82 58.78 26.79 1.97 55.46 193.73 125.48 11.85 197.51 120.83 13.59 coo 19.46 3.44 61.93 23.95 1.12 60.13 192.36 125.68 19.31 197.51 127.46 19.90 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 24.97 5.82 58.78 26.79 1.97 55.46 181.66 123.79 6.82 179.82 128.66 10.46 coo 19.46 3.44 61.93 23.95 1.12 60.13 179.28 118.69 11.71 177.59 112.91 13.79 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 24.97 5.82 58.78 26.79 1.97 55.46 181.66 123.79 6.82 179.82 128.66 10.46 coo 19.46 3.44 61.93 23.95 1.12 60.13 179.28 118.69 11.71 177.59 112.91 13.79 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 74 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 24.97 5.82 58.78 26.79 1.97 55.46 181.66 123.79 6.82 179.82 128.66 10.46 coo 19.46 3.44 61.93 23.95 1.12 60.13 175.75 125.08 4.60 173.18 124.12 -0.61 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 24.97 5.82 58.78 26.79 1.97 55.46 161.58 122.48 47.40 160.49 120.58 53.33 coo 19.46 3.44 61.93 23.95 1.12 60.13 165.62 124.17 41.44 160.89 126.43 37.84 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 165 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 24.97 5.82 58.78 26.79 1.97 55.46 163.30 119.33 38.22 166.56 114.68 36.90 coo 19.46 3.44 61.93 23.95 1.12 60.13 165.62 124.17 41.44 160.89 126.43 37.84 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 74 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 24.97 5.82 58.78 26.79 1.97 55.46 161.71 139.26 46.53 163.20 144.39 46.83 coo 19.46 3.44 61.93 23.95 1.12 60.13 168.56 136.65 44.17 170.62 139.01 49.65 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 74 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 24.97 5.82 58.78 26.79 1.97 55.46 168.56 136.65 44.17 170.62 139.01 49.65 coo 19.46 3.44 61.93 23.95 1.12 60.13 161.71 139.26 46.53 163.20 144.39 46.83 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 74 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 24.97 5.82 58.78 26.79 1.97 55.46 165.62 124.17 41.44 160.89 126.43 37.84 coo 19.46 3.44 61.93 23.95 1.12 60.13 161.58 122.48 47.40 160.49 120.58 53.33 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 174.54 125.67 53.14 175.81 126.60 51.73 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 18 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 4.84 5.09 23.75 3.30 1.39 27.48 189.82 158.18 22.25 194.56 162.25 23.07 coo 10.43 2.88 20.75 5.72 0.41 23.95 182.91 155.29 23.54 184.46 151.31 19.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 4.84 5.09 23.75 3.30 1.39 27.48 180.69 158.10 18.36 176.95 162.62 18.15 coo 10.43 2.88 20.75 5.72 0.41 23.95 182.91 155.29 23.54 184.46 151.31 19.55 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 74 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 4.84 5.09 23.75 3.30 1.39 27.48 192.52 142.86 28.75 192.00 138.78 32.31 coo 10.43 2.88 20.75 5.72 0.41 23.95 186.22 145.69 31.90 189.62 146.93 37.05 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 74 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 4.84 5.09 23.75 3.30 1.39 27.48 186.22 145.69 31.90 189.62 146.93 37.05 coo 10.43 2.88 20.75 5.72 0.41 23.95 192.52 142.86 28.75 192.00 138.78 32.31 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 74 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 4.84 5.09 23.75 3.30 1.39 27.48 182.91 155.29 23.54 184.46 151.31 19.55 coo 10.43 2.88 20.75 5.72 0.41 23.95 189.82 158.18 22.25 194.56 162.25 23.07 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 74 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 4.84 5.09 23.75 3.30 1.39 27.48 182.91 155.29 23.54 184.46 151.31 19.55 coo 10.43 2.88 20.75 5.72 0.41 23.95 180.69 158.10 18.36 176.95 162.62 18.15 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 4.84 5.09 23.75 3.30 1.39 27.48 179.28 118.69 11.71 177.59 112.91 13.79 coo 10.43 2.88 20.75 5.72 0.41 23.95 181.66 123.79 6.82 179.82 128.66 10.46 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 4.84 5.09 23.75 3.30 1.39 27.48 175.75 125.08 4.60 173.18 124.12 -0.61 coo 10.43 2.88 20.75 5.72 0.41 23.95 181.66 123.79 6.82 179.82 128.66 10.46 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 74 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 4.84 5.09 23.75 3.30 1.39 27.48 192.36 125.68 19.31 197.51 127.46 19.90 coo 10.43 2.88 20.75 5.72 0.41 23.95 193.73 125.48 11.85 197.51 120.83 13.59 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 74 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 4.84 5.09 23.75 3.30 1.39 27.48 193.73 125.48 11.85 197.51 120.83 13.59 coo 10.43 2.88 20.75 5.72 0.41 23.95 192.36 125.68 19.31 197.51 127.46 19.90 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 4.84 5.09 23.75 3.30 1.39 27.48 181.66 123.79 6.82 179.82 128.66 10.46 coo 10.43 2.88 20.75 5.72 0.41 23.95 179.28 118.69 11.71 177.59 112.91 13.79 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 4.84 5.09 23.75 3.30 1.39 27.48 181.66 123.79 6.82 179.82 128.66 10.46 coo 10.43 2.88 20.75 5.72 0.41 23.95 179.28 118.69 11.71 177.59 112.91 13.79 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 74 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 4.84 5.09 23.75 3.30 1.39 27.48 181.66 123.79 6.82 179.82 128.66 10.46 coo 10.43 2.88 20.75 5.72 0.41 23.95 175.75 125.08 4.60 173.18 124.12 -0.61 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 4.84 5.09 23.75 3.30 1.39 27.48 161.58 122.48 47.40 160.49 120.58 53.33 coo 10.43 2.88 20.75 5.72 0.41 23.95 165.62 124.17 41.44 160.89 126.43 37.84 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 165 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 4.84 5.09 23.75 3.30 1.39 27.48 163.30 119.33 38.22 166.56 114.68 36.90 coo 10.43 2.88 20.75 5.72 0.41 23.95 165.62 124.17 41.44 160.89 126.43 37.84 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 74 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 4.84 5.09 23.75 3.30 1.39 27.48 161.71 139.26 46.53 163.20 144.39 46.83 coo 10.43 2.88 20.75 5.72 0.41 23.95 168.56 136.65 44.17 170.62 139.01 49.65 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 74 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 4.84 5.09 23.75 3.30 1.39 27.48 168.56 136.65 44.17 170.62 139.01 49.65 coo 10.43 2.88 20.75 5.72 0.41 23.95 161.71 139.26 46.53 163.20 144.39 46.83 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 74 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 4.84 5.09 23.75 3.30 1.39 27.48 165.62 124.17 41.44 160.89 126.43 37.84 coo 10.43 2.88 20.75 5.72 0.41 23.95 161.58 122.48 47.40 160.49 120.58 53.33 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 174.54 125.67 53.14 175.81 126.60 51.73 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 18 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 C 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 C 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 17.59 37.25 25.80 19.64 34.15 21.60 189.82 158.18 22.25 194.56 162.25 23.07 coo 12.29 34.52 28.11 16.84 32.47 25.43 182.91 155.29 23.54 184.46 151.31 19.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS A 97 LYS^? 15.28 N9 ADE A 500 C 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 C 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 17.59 37.25 25.80 19.64 34.15 21.60 180.69 158.10 18.36 176.95 162.62 18.15 coo 12.29 34.52 28.11 16.84 32.47 25.43 182.91 155.29 23.54 184.46 151.31 19.55 coo 12.06 27.10 15.56 13.23 27.02 13.80 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS A 110 LYS.? 23.26 C8 ADE A 500 C 74 LYS A 126 LYS^? 24.40 C8 ADE A 500 C 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 17.59 37.25 25.80 19.64 34.15 21.60 192.52 142.86 28.75 192.00 138.78 32.31 coo 12.29 34.52 28.11 16.84 32.47 25.43 186.22 145.69 31.90 189.62 146.93 37.05 coo 12.06 27.10 15.56 13.23 27.02 13.80 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 C 14 LYS A 126 LYS^? 24.40 C8 ADE A 500 C 74 LYS A 110 LYS.? 23.26 C8 ADE A 500 C 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 17.59 37.25 25.80 19.64 34.15 21.60 186.22 145.69 31.90 189.62 146.93 37.05 coo 12.29 34.52 28.11 16.84 32.47 25.43 192.52 142.86 28.75 192.00 138.78 32.31 coo 12.06 27.10 15.56 13.23 27.02 13.80 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 C 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 C 74 LYS A 94 LYS^? 16.74 N9 ADE A 500 C 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 17.59 37.25 25.80 19.64 34.15 21.60 182.91 155.29 23.54 184.46 151.31 19.55 coo 12.29 34.52 28.11 16.84 32.47 25.43 189.82 158.18 22.25 194.56 162.25 23.07 coo 12.06 27.10 15.56 13.23 27.02 13.80 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 C 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 C 74 LYS A 97 LYS^? 15.28 N9 ADE A 500 C 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 17.59 37.25 25.80 19.64 34.15 21.60 182.91 155.29 23.54 184.46 151.31 19.55 coo 12.29 34.52 28.11 16.84 32.47 25.43 180.69 158.10 18.36 176.95 162.62 18.15 coo 12.06 27.10 15.56 13.23 27.02 13.80 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 C 14 LYS B 94 LYS^? 27.17 C2 CIT A1102 C 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 C 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 17.59 37.25 25.80 19.64 34.15 21.60 179.28 118.69 11.71 177.59 112.91 13.79 coo 12.29 34.52 28.11 16.84 32.47 25.43 181.66 123.79 6.82 179.82 128.66 10.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 C 14 LYS B 97 LYS^? 12.22 C2 CIT A1102 C 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 C 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 17.59 37.25 25.80 19.64 34.15 21.60 175.75 125.08 4.60 173.18 124.12 -0.61 coo 12.29 34.52 28.11 16.84 32.47 25.43 181.66 123.79 6.82 179.82 128.66 10.46 coo 12.06 27.10 15.56 13.23 27.02 13.80 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 C 14 LYS B 110 LYS.? 26.40 N7 ADE A 500 C 74 LYS B 126 LYS^? 29.75 O4 CIT A1102 C 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 17.59 37.25 25.80 19.64 34.15 21.60 192.36 125.68 19.31 197.51 127.46 19.90 coo 12.29 34.52 28.11 16.84 32.47 25.43 193.73 125.48 11.85 197.51 120.83 13.59 coo 12.06 27.10 15.56 13.23 27.02 13.80 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 C 14 LYS B 126 LYS^? 29.75 O4 CIT A1102 C 74 LYS B 110 LYS.? 26.40 N7 ADE A 500 C 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 17.59 37.25 25.80 19.64 34.15 21.60 193.73 125.48 11.85 197.51 120.83 13.59 coo 12.29 34.52 28.11 16.84 32.47 25.43 192.36 125.68 19.31 197.51 127.46 19.90 coo 12.06 27.10 15.56 13.23 27.02 13.80 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 C 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 C 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 C 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 17.59 37.25 25.80 19.64 34.15 21.60 181.66 123.79 6.82 179.82 128.66 10.46 coo 12.29 34.52 28.11 16.84 32.47 25.43 179.28 118.69 11.71 177.59 112.91 13.79 coo 12.06 27.10 15.56 13.23 27.02 13.80 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 C 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 C 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 C 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 17.59 37.25 25.80 19.64 34.15 21.60 181.66 123.79 6.82 179.82 128.66 10.46 coo 12.29 34.52 28.11 16.84 32.47 25.43 179.28 118.69 11.71 177.59 112.91 13.79 coo 12.06 27.10 15.56 13.23 27.02 13.80 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 C 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 C 74 LYS B 97 LYS^? 12.22 C2 CIT A1102 C 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 17.59 37.25 25.80 19.64 34.15 21.60 181.66 123.79 6.82 179.82 128.66 10.46 coo 12.29 34.52 28.11 16.84 32.47 25.43 175.75 125.08 4.60 173.18 124.12 -0.61 coo 12.06 27.10 15.56 13.23 27.02 13.80 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 C 14 LYS C 94 LYS^? 16.92 O3 GOL C1901 C 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 C 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 17.59 37.25 25.80 19.64 34.15 21.60 161.58 122.48 47.40 160.49 120.58 53.33 coo 12.29 34.52 28.11 16.84 32.47 25.43 165.62 124.17 41.44 160.89 126.43 37.84 coo 12.06 27.10 15.56 13.23 27.02 13.80 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 C 14 LYS C 97 LYS^? 17.09 C1 GOL C1901 C 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 C 165 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 17.59 37.25 25.80 19.64 34.15 21.60 163.30 119.33 38.22 166.56 114.68 36.90 coo 12.29 34.52 28.11 16.84 32.47 25.43 165.62 124.17 41.44 160.89 126.43 37.84 coo 12.06 27.10 15.56 13.23 27.02 13.80 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 C 14 LYS C 110 LYS.? 26.32 O1 GOL C1901 C 74 LYS C 126 LYS^? 28.06 O1 GOL C1901 C 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 17.59 37.25 25.80 19.64 34.15 21.60 161.71 139.26 46.53 163.20 144.39 46.83 coo 12.29 34.52 28.11 16.84 32.47 25.43 168.56 136.65 44.17 170.62 139.01 49.65 coo 12.06 27.10 15.56 13.23 27.02 13.80 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 C 14 LYS C 126 LYS^? 28.06 O1 GOL C1901 C 74 LYS C 110 LYS.? 26.32 O1 GOL C1901 C 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 17.59 37.25 25.80 19.64 34.15 21.60 168.56 136.65 44.17 170.62 139.01 49.65 coo 12.29 34.52 28.11 16.84 32.47 25.43 161.71 139.26 46.53 163.20 144.39 46.83 coo 12.06 27.10 15.56 13.23 27.02 13.80 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 C 14 LYS C 147 LYS^? 10.01 O1 GOL C1901 C 74 LYS C 94 LYS^? 16.92 O3 GOL C1901 C 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 17.59 37.25 25.80 19.64 34.15 21.60 165.62 124.17 41.44 160.89 126.43 37.84 coo 12.29 34.52 28.11 16.84 32.47 25.43 161.58 122.48 47.40 160.49 120.58 53.33 coo 12.06 27.10 15.56 13.23 27.02 13.80 174.54 125.67 53.14 175.81 126.60 51.73 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 18 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 D 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 D 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 189.82 158.18 22.25 194.56 162.25 23.07 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 182.91 155.29 23.54 184.46 151.31 19.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 97 LYS^? 15.28 N9 ADE A 500 D 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 D 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 180.69 158.10 18.36 176.95 162.62 18.15 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 182.91 155.29 23.54 184.46 151.31 19.55 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 110 LYS.? 23.26 C8 ADE A 500 D 74 LYS A 126 LYS^? 24.40 C8 ADE A 500 D 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 192.52 142.86 28.75 192.00 138.78 32.31 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 186.22 145.69 31.90 189.62 146.93 37.05 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS A 126 LYS^? 24.40 C8 ADE A 500 D 74 LYS A 110 LYS.? 23.26 C8 ADE A 500 D 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 186.22 145.69 31.90 189.62 146.93 37.05 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 192.52 142.86 28.75 192.00 138.78 32.31 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 D 74 LYS A 94 LYS^? 16.74 N9 ADE A 500 D 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 182.91 155.29 23.54 184.46 151.31 19.55 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 189.82 158.18 22.25 194.56 162.25 23.07 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 D 74 LYS A 97 LYS^? 15.28 N9 ADE A 500 D 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 182.91 155.29 23.54 184.46 151.31 19.55 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 180.69 158.10 18.36 176.95 162.62 18.15 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS B 94 LYS^? 27.17 C2 CIT A1102 D 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 D 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 179.28 118.69 11.71 177.59 112.91 13.79 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 181.66 123.79 6.82 179.82 128.66 10.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS B 97 LYS^? 12.22 C2 CIT A1102 D 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 D 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 175.75 125.08 4.60 173.18 124.12 -0.61 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 181.66 123.79 6.82 179.82 128.66 10.46 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 D 14 LYS B 110 LYS.? 26.40 N7 ADE A 500 D 74 LYS B 126 LYS^? 29.75 O4 CIT A1102 D 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 192.36 125.68 19.31 197.51 127.46 19.90 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 193.73 125.48 11.85 197.51 120.83 13.59 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 D 14 LYS B 126 LYS^? 29.75 O4 CIT A1102 D 74 LYS B 110 LYS.? 26.40 N7 ADE A 500 D 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 193.73 125.48 11.85 197.51 120.83 13.59 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 192.36 125.68 19.31 197.51 127.46 19.90 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 D 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 D 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 D 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 181.66 123.79 6.82 179.82 128.66 10.46 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 179.28 118.69 11.71 177.59 112.91 13.79 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 D 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 D 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 D 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 181.66 123.79 6.82 179.82 128.66 10.46 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 179.28 118.69 11.71 177.59 112.91 13.79 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 D 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 D 74 LYS B 97 LYS^? 12.22 C2 CIT A1102 D 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 181.66 123.79 6.82 179.82 128.66 10.46 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 175.75 125.08 4.60 173.18 124.12 -0.61 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 D 14 LYS C 94 LYS^? 16.92 O3 GOL C1901 D 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 D 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 161.58 122.48 47.40 160.49 120.58 53.33 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 165.62 124.17 41.44 160.89 126.43 37.84 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 D 14 LYS C 97 LYS^? 17.09 C1 GOL C1901 D 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 D 165 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 163.30 119.33 38.22 166.56 114.68 36.90 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 165.62 124.17 41.44 160.89 126.43 37.84 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 D 14 LYS C 110 LYS.? 26.32 O1 GOL C1901 D 74 LYS C 126 LYS^? 28.06 O1 GOL C1901 D 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 161.71 139.26 46.53 163.20 144.39 46.83 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 168.56 136.65 44.17 170.62 139.01 49.65 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 D 14 LYS C 126 LYS^? 28.06 O1 GOL C1901 D 74 LYS C 110 LYS.? 26.32 O1 GOL C1901 D 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 168.56 136.65 44.17 170.62 139.01 49.65 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 161.71 139.26 46.53 163.20 144.39 46.83 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 D 14 LYS C 147 LYS^? 10.01 O1 GOL C1901 D 74 LYS C 94 LYS^? 16.92 O3 GOL C1901 D 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 165.62 124.17 41.44 160.89 126.43 37.84 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 161.58 122.48 47.40 160.49 120.58 53.33 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 174.54 125.67 53.14 175.81 126.60 51.73 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 18 hits 1kqc_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 130 ASP~? 27.60 C8 ADE A 500 262 LYS A 126 LYS^? 24.40 C8 ADE A 500 336 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 61.88 50.78 12.96 63.84 50.60 13.71 188.71 136.74 34.61 188.50 136.01 36.57 coo 63.59 44.40 18.32 63.20 49.74 17.95 186.22 145.69 31.90 189.62 146.93 37.05 coo 72.60 57.42 15.86 71.61 56.68 18.70 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 2 3 # 2 255 ASP A 175 ASP.? 10.98 C4 ADE A 500 262 LYS A 62 LYS^? 14.90 N3 ADE A 500 336 ARG A 101 ARG.? 15.15 C8 ADE A 500 coo 61.88 50.78 12.96 63.84 50.60 13.71 178.57 156.37 9.84 177.44 156.14 8.05 coo 63.59 44.40 18.32 63.20 49.74 17.95 170.54 158.67 6.99 175.63 160.94 7.57 coo 72.60 57.42 15.86 71.61 56.68 18.70 173.48 146.74 16.27 172.57 144.92 18.53 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 3 3 # 3 255 ASP B 172 ASP~? 8.81 O1 CIT A1102 262 LYS B 62 LYS^? 8.83 O2 CIT A1102 336 ARG B 101 ARG.? -6.88 O4 CIT A1102s coo 61.88 50.78 12.96 63.84 50.60 13.71 166.30 133.15 8.87 164.29 132.56 8.69 coo 63.59 44.40 18.32 63.20 49.74 17.95 165.33 135.53 -1.27 161.40 132.35 2.38 coo 72.60 57.42 15.86 71.61 56.68 18.70 179.40 137.94 3.82 182.23 139.06 3.56 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 4 3 # 4 255 ASP B 175 ASP.? 4.91 O1 CIT A1102 262 LYS B 62 LYS^? 8.83 O2 CIT A1102 336 ARG B 101 ARG.? -6.88 O4 CIT A1102s coo 61.88 50.78 12.96 63.84 50.60 13.71 169.82 131.15 6.22 168.64 132.89 5.97 coo 63.59 44.40 18.32 63.20 49.74 17.95 165.33 135.53 -1.27 161.40 132.35 2.38 coo 72.60 57.42 15.86 71.61 56.68 18.70 179.40 137.94 3.82 182.23 139.06 3.56 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 5 3 # 5 255 ASP C 175 ASP.? 10.66 O1 GOL C1901 262 LYS C 62 LYS^? 15.99 O2 GOL C1901 336 ARG C 101 ARG.? 18.11 O1 GOL C1901 coo 61.88 50.78 12.96 63.84 50.60 13.71 157.90 117.18 31.56 156.68 116.62 29.91 coo 63.59 44.40 18.32 63.20 49.74 17.95 160.07 111.06 24.23 156.23 109.52 28.21 coo 72.60 57.42 15.86 71.61 56.68 18.70 163.77 126.78 27.00 165.49 129.29 26.85 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 5 hits 1lam_c00 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 45 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 261 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo 49.89 1.93 30.83 50.54 1.43 32.81 185.28 156.61 18.37 185.56 154.55 18.68 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 191.47 153.75 14.17 189.52 154.05 13.44 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 45 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 261 PHE A 48 PHE^? 4.82 C2 ADE A 500 coo 49.89 1.93 30.83 50.54 1.43 32.81 185.28 156.61 18.37 185.56 154.55 18.68 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 184.39 157.95 13.11 185.86 157.96 14.60 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 192.28 150.01 12.11 192.07 151.51 9.74 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 45 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 261 PHE A 48 PHE^? 4.82 C2 ADE A 500 coo 49.89 1.93 30.83 50.54 1.43 32.81 184.39 157.95 13.11 185.86 157.96 14.60 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 185.28 156.61 18.37 185.56 154.55 18.68 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 192.28 150.01 12.11 192.07 151.51 9.74 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 45 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 261 PHE B 161 PHE^? 22.57 O4 CIT A1102 coo 49.89 1.93 30.83 50.54 1.43 32.81 176.50 123.51 9.48 177.50 124.87 10.72 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 174.27 123.90 17.18 173.55 124.80 15.43 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 187.70 125.47 18.98 188.18 126.81 16.59 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 45 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 261 PHE B 173 PHE~? 14.11 O1 CIT A1102 coo 49.89 1.93 30.83 50.54 1.43 32.81 176.50 123.51 9.48 177.50 124.87 10.72 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 174.27 123.90 17.18 173.55 124.80 15.43 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 165.53 127.89 11.96 166.03 128.02 14.71 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 45 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 261 PHE B 48 PHE^? 19.83 O1 CIT A1102 coo 49.89 1.93 30.83 50.54 1.43 32.81 176.50 123.51 9.48 177.50 124.87 10.72 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 171.08 125.47 9.27 172.48 124.18 10.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 174.23 127.42 20.06 171.47 127.09 19.71 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 7 3 # 7 A 44 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 45 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 261 PHE B 48 PHE^? 19.83 O1 CIT A1102 coo 49.89 1.93 30.83 50.54 1.43 32.81 171.08 125.47 9.27 172.48 124.18 10.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 176.50 123.51 9.48 177.50 124.87 10.72 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 174.23 127.42 20.06 171.47 127.09 19.71 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 8 3 # 8 A 44 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 45 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 261 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo 49.89 1.93 30.83 50.54 1.43 32.81 160.37 121.38 41.43 159.84 123.37 41.06 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 153.36 123.09 43.85 154.03 121.98 42.20 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 9 3 # 9 A 44 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 45 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 261 PHE C 173 PHE~? 4.81 C3 GOL C1901 coo 49.89 1.93 30.83 50.54 1.43 32.81 160.37 121.38 41.43 159.84 123.37 41.06 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 153.36 123.09 43.85 154.03 121.98 42.20 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 151.21 115.28 36.33 149.30 116.99 37.50 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 9 hits 1luc_c00 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP B 89 ASP.? 31.34 O4 CIT A1102 A 295 GLU B 25 GLU.? 28.27 O1 GOL C1901 A 369 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 11.74 38.14 80.19 10.63 36.40 80.65 181.93 115.70 26.33 180.57 117.33 26.20 coo 16.11 33.72 80.99 14.10 33.54 81.63 179.49 113.39 31.74 177.60 113.83 30.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 295 GLU B 25 GLU.? 28.27 O1 GOL C1901 A 369 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 11.74 38.14 80.19 10.63 36.40 80.65 178.03 118.40 36.14 177.70 120.46 36.31 coo 16.11 33.72 80.99 14.10 33.54 81.63 179.49 113.39 31.74 177.60 113.83 30.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 181.93 115.70 26.33 180.57 117.33 26.20 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 2 hits 1m53_c03 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 279 GLU B 155 GLU.? 33.13 C8 ADE A 500 A 369 ASP A 89 ASP.? 18.10 N3 ADE A 500 coo 11.74 38.14 80.19 10.63 36.40 80.65 203.27 140.75 25.55 204.24 138.86 25.61 coo 16.54 46.37 63.94 14.77 45.79 62.95 197.70 123.91 29.28 199.42 125.11 29.52 coo 12.19 31.08 87.29 11.13 32.66 86.38 203.02 151.24 21.31 203.43 152.46 19.71 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 279 GLU A 156 GLU.? 23.41 C8 ADE A 500 A 369 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 11.74 38.14 80.19 10.63 36.40 80.65 178.67 130.13 34.24 179.32 129.31 36.04 coo 16.54 46.37 63.94 14.77 45.79 62.95 196.65 137.08 28.97 194.78 136.94 30.01 coo 12.19 31.08 87.29 11.13 32.66 86.38 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 279 GLU C 135 GLU.? 26.33 O1 GOL C1901 A 369 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 11.74 38.14 80.19 10.63 36.40 80.65 178.67 130.13 34.24 179.32 129.31 36.04 coo 16.54 46.37 63.94 14.77 45.79 62.95 168.08 142.51 43.72 166.57 142.98 45.14 coo 12.19 31.08 87.29 11.13 32.66 86.38 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 279 GLU A 135 GLU.? 23.34 C8 ADE A 500 A 369 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 11.74 38.14 80.19 10.63 36.40 80.65 190.60 123.10 30.08 190.26 121.25 31.09 coo 16.54 46.37 63.94 14.77 45.79 62.95 187.40 140.84 33.48 189.24 139.81 33.69 coo 12.19 31.08 87.29 11.13 32.66 86.38 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 279 GLU A 155 GLU.? 30.36 C8 ADE A 500 A 369 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 11.74 38.14 80.19 10.63 36.40 80.65 190.60 123.10 30.08 190.26 121.25 31.09 coo 16.54 46.37 63.94 14.77 45.79 62.95 202.13 137.32 32.16 203.15 136.76 33.90 coo 12.19 31.08 87.29 11.13 32.66 86.38 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 279 GLU C 182 GLU~? 26.37 O3 GOL C1901 A 369 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 11.74 38.14 80.19 10.63 36.40 80.65 178.03 118.40 36.14 177.70 120.46 36.31 coo 16.54 46.37 63.94 14.77 45.79 62.95 170.51 115.98 53.19 171.23 115.96 55.18 coo 12.19 31.08 87.29 11.13 32.66 86.38 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 279 GLU C 192 GLU~? 35.32 O3 GOL C1901 A 369 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 11.74 38.14 80.19 10.63 36.40 80.65 178.03 118.40 36.14 177.70 120.46 36.31 coo 16.54 46.37 63.94 14.77 45.79 62.95 180.77 119.87 52.99 182.51 120.63 53.94 coo 12.19 31.08 87.29 11.13 32.66 86.38 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 279 GLU C 196 GLU~? 28.79 C1 GOL C1901 A 369 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 11.74 38.14 80.19 10.63 36.40 80.65 178.03 118.40 36.14 177.70 120.46 36.31 coo 16.54 46.37 63.94 14.77 45.79 62.95 174.54 125.67 53.14 175.81 126.60 51.73 coo 12.19 31.08 87.29 11.13 32.66 86.38 181.93 115.70 26.33 180.57 117.33 26.20 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 8 hits 1m53_c06 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 97 LYS^? 15.28 N9 ADE A 500 166 LYS A 147 LYS^? 6.48 C8 ADE A 500 324 SER A 54 SER.? 4.61 O3 CIT A1102 coo 25.93 8.11 25.51 26.40 7.80 19.66 180.69 158.10 18.36 176.95 162.62 18.15 coo 27.27 1.43 25.09 29.18 5.25 22.89 182.91 155.29 23.54 184.46 151.31 19.55 coo 46.32 14.55 19.93 45.95 12.72 21.27 180.68 142.57 2.59 178.38 141.86 2.59 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 110 LYS.? 23.26 C8 ADE A 500 166 LYS A 126 LYS^? 24.40 C8 ADE A 500 324 SER B 29 SER~? 33.20 C8 ADE A 500 coo 25.93 8.11 25.51 26.40 7.80 19.66 192.52 142.86 28.75 192.00 138.78 32.31 coo 27.27 1.43 25.09 29.18 5.25 22.89 186.22 145.69 31.90 189.62 146.93 37.05 coo 46.32 14.55 19.93 45.95 12.72 21.27 186.12 123.79 33.89 187.98 123.41 32.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 147 LYS^? 6.48 C8 ADE A 500 166 LYS A 97 LYS^? 15.28 N9 ADE A 500 324 SER B 164 SER^? 16.78 N7 ADE A 500 coo 25.93 8.11 25.51 26.40 7.80 19.66 182.91 155.29 23.54 184.46 151.31 19.55 coo 27.27 1.43 25.09 29.18 5.25 22.89 180.69 158.10 18.36 176.95 162.62 18.15 coo 46.32 14.55 19.93 45.95 12.72 21.27 181.99 133.83 18.01 182.11 135.27 19.93 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 193 LYS~? 24.54 N9 ADE A 500 166 LYS A 186 LYS~? 28.00 N9 ADE A 500 324 SER A 17 SER~? 27.08 N9 ADE A 500 coo 25.93 8.11 25.51 26.40 7.80 19.66 183.60 164.07 35.65 183.22 158.61 36.42 coo 27.27 1.43 25.09 29.18 5.25 22.89 182.07 169.10 30.10 186.87 173.28 30.86 coo 46.32 14.55 19.93 45.95 12.72 21.27 201.16 153.98 34.19 202.99 152.33 34.41 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS A 193 LYS~? 24.54 N9 ADE A 500 166 LYS A 186 LYS~? 28.00 N9 ADE A 500 324 SER A 90 SER.? 14.48 N3 ADE A 500 coo 25.93 8.11 25.51 26.40 7.80 19.66 183.60 164.07 35.65 183.22 158.61 36.42 coo 27.27 1.43 25.09 29.18 5.25 22.89 182.07 169.10 30.10 186.87 173.28 30.86 coo 46.32 14.55 19.93 45.95 12.72 21.27 199.47 153.71 22.16 199.01 152.90 19.92 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS B 97 LYS^? 12.22 C2 CIT A1102 166 LYS B 147 LYS^? 12.56 O4 CIT A1102 324 SER B 54 SER.? 13.70 O5 CIT A1102 coo 25.93 8.11 25.51 26.40 7.80 19.66 175.75 125.08 4.60 173.18 124.12 -0.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 181.66 123.79 6.82 179.82 128.66 10.46 coo 46.32 14.55 19.93 45.95 12.72 21.27 170.01 143.15 16.19 170.47 144.95 14.66 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS B 110 LYS.? 26.40 N7 ADE A 500 166 LYS B 126 LYS^? 29.75 O4 CIT A1102 324 SER A 28 SER~? 27.19 N9 ADE A 500 coo 25.93 8.11 25.51 26.40 7.80 19.66 192.36 125.68 19.31 197.51 127.46 19.90 coo 27.27 1.43 25.09 29.18 5.25 22.89 193.73 125.48 11.85 197.51 120.83 13.59 coo 46.32 14.55 19.93 45.95 12.72 21.27 208.59 143.21 20.48 210.21 141.62 21.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS B 147 LYS^? 12.56 O4 CIT A1102 166 LYS B 94 LYS^? 27.17 C2 CIT A1102 324 SER A 164 SER^? 10.66 N7 ADE A 500 coo 25.93 8.11 25.51 26.40 7.80 19.66 181.66 123.79 6.82 179.82 128.66 10.46 coo 27.27 1.43 25.09 29.18 5.25 22.89 179.28 118.69 11.71 177.59 112.91 13.79 coo 46.32 14.55 19.93 45.95 12.72 21.27 187.50 142.03 16.61 188.23 139.96 15.55 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 9 3 # 9 164 LYS B 147 LYS^? 12.56 O4 CIT A1102 166 LYS B 97 LYS^? 12.22 C2 CIT A1102 324 SER A 164 SER^? 10.66 N7 ADE A 500 coo 25.93 8.11 25.51 26.40 7.80 19.66 181.66 123.79 6.82 179.82 128.66 10.46 coo 27.27 1.43 25.09 29.18 5.25 22.89 175.75 125.08 4.60 173.18 124.12 -0.61 coo 46.32 14.55 19.93 45.95 12.72 21.27 187.50 142.03 16.61 188.23 139.96 15.55 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 10 3 # 10 164 LYS B 193 LYS~? 27.56 O4 CIT A1102 166 LYS B 186 LYS~? 32.32 C2 CIT A1102 324 SER B 17 SER~? 37.01 O4 CIT A1102 coo 25.93 8.11 25.51 26.40 7.80 19.66 188.45 111.50 0.09 191.63 115.50 2.10 coo 27.27 1.43 25.09 29.18 5.25 22.89 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 46.32 14.55 19.93 45.95 12.72 21.27 191.23 110.45 20.70 191.91 111.25 22.90 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 11 3 # 11 164 LYS B 193 LYS~? 27.56 O4 CIT A1102 166 LYS B 186 LYS~? 32.32 C2 CIT A1102 324 SER B 90 SER.? 26.90 O4 CIT A1102 coo 25.93 8.11 25.51 26.40 7.80 19.66 188.45 111.50 0.09 191.63 115.50 2.10 coo 27.27 1.43 25.09 29.18 5.25 22.89 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 46.32 14.55 19.93 45.95 12.72 21.27 181.23 117.12 21.89 179.24 118.41 21.27 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 12 3 # 12 164 LYS C 97 LYS^? 17.09 C1 GOL C1901 166 LYS C 147 LYS^? 10.01 O1 GOL C1901 324 SER B 29 SER~? 33.20 C8 ADE A 500 coo 25.93 8.11 25.51 26.40 7.80 19.66 163.30 119.33 38.22 166.56 114.68 36.90 coo 27.27 1.43 25.09 29.18 5.25 22.89 165.62 124.17 41.44 160.89 126.43 37.84 coo 46.32 14.55 19.93 45.95 12.72 21.27 186.12 123.79 33.89 187.98 123.41 32.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 13 3 # 13 164 LYS C 97 LYS^? 17.09 C1 GOL C1901 166 LYS C 147 LYS^? 10.01 O1 GOL C1901 324 SER C 54 SER.? 14.46 O1 GOL C1901 coo 25.93 8.11 25.51 26.40 7.80 19.66 163.30 119.33 38.22 166.56 114.68 36.90 coo 27.27 1.43 25.09 29.18 5.25 22.89 165.62 124.17 41.44 160.89 126.43 37.84 coo 46.32 14.55 19.93 45.95 12.72 21.27 147.47 126.83 25.21 148.44 127.11 23.04 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 14 3 # 14 164 LYS C 147 LYS^? 10.01 O1 GOL C1901 166 LYS C 97 LYS^? 17.09 C1 GOL C1901 324 SER B 28 SER~? 35.46 O1 GOL C1901 coo 25.93 8.11 25.51 26.40 7.80 19.66 165.62 124.17 41.44 160.89 126.43 37.84 coo 27.27 1.43 25.09 29.18 5.25 22.89 163.30 119.33 38.22 166.56 114.68 36.90 coo 46.32 14.55 19.93 45.95 12.72 21.27 184.73 120.38 34.92 186.87 120.34 36.01 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 15 3 # 15 164 LYS C 147 LYS^? 10.01 O1 GOL C1901 166 LYS C 97 LYS^? 17.09 C1 GOL C1901 324 SER B 29 SER~? 33.20 C8 ADE A 500 coo 25.93 8.11 25.51 26.40 7.80 19.66 165.62 124.17 41.44 160.89 126.43 37.84 coo 27.27 1.43 25.09 29.18 5.25 22.89 163.30 119.33 38.22 166.56 114.68 36.90 coo 46.32 14.55 19.93 45.95 12.72 21.27 186.12 123.79 33.89 187.98 123.41 32.34 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 16 3 # 16 164 LYS C 193 LYS~? 28.43 O1 GOL C1901 166 LYS C 186 LYS~? 29.69 O3 GOL C1901 324 SER C 17 SER~? 28.78 O3 GOL C1901 coo 25.93 8.11 25.51 26.40 7.80 19.66 177.05 121.15 50.66 176.96 126.15 48.94 coo 27.27 1.43 25.09 29.18 5.25 22.89 174.37 114.14 48.91 174.42 112.17 55.03 coo 46.32 14.55 19.93 45.95 12.72 21.27 163.51 133.37 60.38 162.40 135.36 61.06 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 17 3 # 17 164 LYS C 193 LYS~? 28.43 O1 GOL C1901 166 LYS C 186 LYS~? 29.69 O3 GOL C1901 324 SER C 90 SER.? 14.02 O3 GOL C1901 coo 25.93 8.11 25.51 26.40 7.80 19.66 177.05 121.15 50.66 176.96 126.15 48.94 coo 27.27 1.43 25.09 29.18 5.25 22.89 174.37 114.14 48.91 174.42 112.17 55.03 coo 46.32 14.55 19.93 45.95 12.72 21.27 155.07 128.53 53.12 154.12 126.92 51.57 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 17 hits 1mdr_c01 naa= 3 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 A 199 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 246 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 255 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 184.39 157.95 13.11 185.86 157.96 14.60 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 191.47 153.75 14.17 189.52 154.05 13.44 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 A 199 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 246 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 255 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 171.08 125.47 9.27 172.48 124.18 10.15 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 174.27 123.90 17.18 173.55 124.80 15.43 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 A 199 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 255 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 160.37 121.38 41.43 159.84 123.37 41.06 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 153.36 123.09 43.85 154.03 121.98 42.20 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 149.80 129.36 48.45 149.55 129.08 51.21 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 A 199 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 157.21 117.94 38.21 157.48 118.99 40.00 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 153.36 123.09 43.85 154.03 121.98 42.20 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 155.65 129.37 42.44 156.62 127.68 44.43 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 A 199 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 160.20 116.89 49.36 158.52 117.92 48.65 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 153.36 123.09 43.85 154.03 121.98 42.20 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 155.65 129.37 42.44 156.62 127.68 44.43 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 A 199 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 246 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 160.20 116.89 49.36 158.52 117.92 48.65 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 160.37 121.38 41.43 159.84 123.37 41.06 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 155.65 129.37 42.44 156.62 127.68 44.43 1mpy_c00 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c00 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 246 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 255 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 184.39 157.95 13.11 185.86 157.96 14.60 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 191.47 153.75 14.17 189.52 154.05 13.44 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 B 199 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 246 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 255 TYR B 47 TYR^? 27.62 O4 CIT A1102 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 176.50 123.51 9.48 177.50 124.87 10.72 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 174.27 123.90 17.18 173.55 124.80 15.43 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 177.82 122.79 24.63 178.10 120.27 25.77 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 B 199 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 246 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 255 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 171.08 125.47 9.27 172.48 124.18 10.15 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 174.27 123.90 17.18 173.55 124.80 15.43 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 B 199 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 255 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 160.37 121.38 41.43 159.84 123.37 41.06 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 153.36 123.09 43.85 154.03 121.98 42.20 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 149.80 129.36 48.45 149.55 129.08 51.21 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 B 199 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 157.21 117.94 38.21 157.48 118.99 40.00 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 153.36 123.09 43.85 154.03 121.98 42.20 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 155.65 129.37 42.44 156.62 127.68 44.43 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 B 199 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 160.20 116.89 49.36 158.52 117.92 48.65 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 153.36 123.09 43.85 154.03 121.98 42.20 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 155.65 129.37 42.44 156.62 127.68 44.43 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 7 3 # 7 B 199 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 246 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 160.20 116.89 49.36 158.52 117.92 48.65 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 160.37 121.38 41.43 159.84 123.37 41.06 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 155.65 129.37 42.44 156.62 127.68 44.43 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 7 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS A 176 HIS^? 6.39 N3 ADE A 500 C 246 HIS A 42 HIS.? -4.20 N3 ADE A 500s C 255 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 184.39 157.95 13.11 185.86 157.96 14.60 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 191.47 153.75 14.17 189.52 154.05 13.44 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 C 199 HIS B 176 HIS^? 13.79 O1 CIT A1102 C 246 HIS B 42 HIS.? 18.79 O1 CIT A1102 C 255 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 171.08 125.47 9.27 172.48 124.18 10.15 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 174.27 123.90 17.18 173.55 124.80 15.43 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 C 199 HIS C 96 HIS^? 9.69 C1 GOL C1901 C 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 C 255 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 160.37 121.38 41.43 159.84 123.37 41.06 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 153.36 123.09 43.85 154.03 121.98 42.20 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 149.80 129.36 48.45 149.55 129.08 51.21 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 C 199 HIS C 176 HIS^? 7.29 C1 GOL C1901 C 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 C 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 157.21 117.94 38.21 157.48 118.99 40.00 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 153.36 123.09 43.85 154.03 121.98 42.20 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 155.65 129.37 42.44 156.62 127.68 44.43 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 C 199 HIS C 202 HIS.? 13.21 O3 GOL C1901 C 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 C 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 160.20 116.89 49.36 158.52 117.92 48.65 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 153.36 123.09 43.85 154.03 121.98 42.20 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 155.65 129.37 42.44 156.62 127.68 44.43 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 C 199 HIS C 202 HIS.? 13.21 O3 GOL C1901 C 246 HIS C 96 HIS^? 9.69 C1 GOL C1901 C 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 160.20 116.89 49.36 158.52 117.92 48.65 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 160.37 121.38 41.43 159.84 123.37 41.06 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 155.65 129.37 42.44 156.62 127.68 44.43 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS A 176 HIS^? 6.39 N3 ADE A 500 D 246 HIS A 42 HIS.? -4.20 N3 ADE A 500s D 255 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 184.39 157.95 13.11 185.86 157.96 14.60 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 191.47 153.75 14.17 189.52 154.05 13.44 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 D 199 HIS B 96 HIS^? 15.42 O4 CIT A1102 D 246 HIS B 42 HIS.? 18.79 O1 CIT A1102 D 255 TYR B 47 TYR^? 27.62 O4 CIT A1102 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 176.50 123.51 9.48 177.50 124.87 10.72 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 174.27 123.90 17.18 173.55 124.80 15.43 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 177.82 122.79 24.63 178.10 120.27 25.77 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 D 199 HIS B 176 HIS^? 13.79 O1 CIT A1102 D 246 HIS B 42 HIS.? 18.79 O1 CIT A1102 D 255 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 171.08 125.47 9.27 172.48 124.18 10.15 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 174.27 123.90 17.18 173.55 124.80 15.43 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 D 199 HIS C 96 HIS^? 9.69 C1 GOL C1901 D 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 D 255 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 160.37 121.38 41.43 159.84 123.37 41.06 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 153.36 123.09 43.85 154.03 121.98 42.20 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 149.80 129.36 48.45 149.55 129.08 51.21 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 D 199 HIS C 176 HIS^? 7.29 C1 GOL C1901 D 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 D 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 157.21 117.94 38.21 157.48 118.99 40.00 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 153.36 123.09 43.85 154.03 121.98 42.20 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 155.65 129.37 42.44 156.62 127.68 44.43 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 D 199 HIS C 202 HIS.? 13.21 O3 GOL C1901 D 246 HIS C 42 HIS.? 5.32 O3 GOL C1901 D 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 160.20 116.89 49.36 158.52 117.92 48.65 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 153.36 123.09 43.85 154.03 121.98 42.20 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 155.65 129.37 42.44 156.62 127.68 44.43 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 7 3 # 7 D 199 HIS C 202 HIS.? 13.21 O3 GOL C1901 D 246 HIS C 96 HIS^? 9.69 C1 GOL C1901 D 255 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 160.20 116.89 49.36 158.52 117.92 48.65 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 160.37 121.38 41.43 159.84 123.37 41.06 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 155.65 129.37 42.44 156.62 127.68 44.43 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 7 hits 1mpy_c03 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 46 GLY.? 10.99 N9 ADE A 500 A 501 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 367 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 195.68 151.83 18.82 195.79 152.36 18.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 184.84 171.88 24.93 186.38 173.28 25.14 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 46 GLY.? 10.99 N9 ADE A 500 A 501 ASP B 130 ASP~? 26.83 N6 ADE A 500 B 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 195.68 151.83 18.82 195.79 152.36 18.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 200.55 129.62 17.17 202.64 129.41 16.98 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 93 GLY^? 10.42 N9 ADE A 500 A 501 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 367 TYR C 131 TYR.? 29.32 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 191.16 154.66 21.80 191.10 155.17 22.59 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 185.72 140.93 6.30 184.35 140.00 4.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.57 146.54 37.64 168.87 149.06 36.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 109 GLY^? 18.96 C8 ADE A 500 A 501 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 367 TYR C 117 TYR.? 21.72 O1 GOL C1901 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 194.47 140.38 26.65 193.77 140.12 26.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 185.72 140.93 6.30 184.35 140.00 4.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 173.67 123.08 36.58 172.76 125.64 35.98 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 109 GLY^? 18.96 C8 ADE A 500 A 501 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 367 TYR C 131 TYR.? 29.32 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 194.47 140.38 26.65 193.77 140.12 26.60 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 185.72 140.93 6.30 184.35 140.00 4.99 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.57 146.54 37.64 168.87 149.06 36.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY A 111 GLY^? 16.58 C8 ADE A 500 A 501 ASP A 36 ASP~? 21.71 N6 ADE A 500 B 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 191.04 146.32 28.35 190.54 145.86 28.86 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 203.35 139.46 11.01 205.31 139.04 11.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY A 111 GLY^? 16.58 C8 ADE A 500 A 501 ASP B 130 ASP~? 26.83 N6 ADE A 500 B 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 191.04 146.32 28.35 190.54 145.86 28.86 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 200.55 129.62 17.17 202.64 129.41 16.98 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY A 111 GLY^? 16.58 C8 ADE A 500 A 501 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 191.04 146.32 28.35 190.54 145.86 28.86 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 190.60 123.10 30.08 190.26 121.25 31.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY A 128 GLY.? 19.63 C8 ADE A 500 A 501 ASP A 36 ASP~? 21.71 N6 ADE A 500 B 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 188.72 140.03 29.58 187.87 139.89 29.50 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 203.35 139.46 11.01 205.31 139.04 11.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 10 3 # 10 A 465 GLY A 134 GLY~? 24.98 C8 ADE A 500 A 501 ASP A 158 ASP.? 25.18 C8 ADE A 500 B 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 182.81 140.38 35.92 183.52 140.16 35.69 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 203.27 140.75 25.55 204.24 138.86 25.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 11 3 # 11 A 465 GLY A 134 GLY~? 24.98 C8 ADE A 500 A 501 ASP C 119 ASP.? 26.31 O1 GOL C1901 B 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 182.81 140.38 35.92 183.52 140.16 35.69 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 178.03 118.40 36.14 177.70 120.46 36.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 12 3 # 12 A 465 GLY A 134 GLY~? 24.98 C8 ADE A 500 A 501 ASP C 119 ASP.? 26.31 O1 GOL C1901 B 367 TYR B 131 TYR~? 20.61 N6 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 182.81 140.38 35.92 183.52 140.16 35.69 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 178.03 118.40 36.14 177.70 120.46 36.31 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 200.50 135.01 13.30 202.41 136.93 13.95 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 13 3 # 13 A 465 GLY A 143 GLY.? 12.19 C8 ADE A 500 A 501 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 367 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 174.93 153.96 17.89 174.52 154.02 18.66 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 184.84 171.88 24.93 186.38 173.28 25.14 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 14 3 # 14 A 465 GLY A 160 GLY.? 18.25 C8 ADE A 500 A 501 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 367 TYR A 117 TYR.? 18.31 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 198.27 144.01 24.73 197.89 143.68 25.40 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 190.60 123.10 30.08 190.26 121.25 31.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 174.51 155.83 27.46 174.88 153.07 27.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 15 3 # 15 A 465 GLY A 181 GLY~? 18.98 N9 ADE A 500 A 501 ASP A 89 ASP.? 18.10 N3 ADE A 500 B 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 187.72 167.74 23.06 186.98 167.48 23.15 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 203.02 151.24 21.31 203.43 152.46 19.71 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 16 3 # 16 A 465 GLY B 45 GLY.? 23.68 O4 CIT A1102 A 501 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 367 TYR B 131 TYR~? 20.61 N6 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 177.24 119.43 17.85 177.04 120.22 17.68 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 174.65 109.33 0.17 174.41 107.27 0.58 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 200.50 135.01 13.30 202.41 136.93 13.95 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 17 3 # 17 A 465 GLY B 46 GLY.? 23.93 O4 CIT A1102 A 501 ASP A 130 ASP~? 27.60 C8 ADE A 500 B 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 179.08 121.64 20.30 178.23 121.42 20.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 188.71 136.74 34.61 188.50 136.01 36.57 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 18 3 # 18 A 465 GLY B 46 GLY.? 23.93 O4 CIT A1102 A 501 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 367 TYR B 131 TYR~? 20.61 N6 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 179.08 121.64 20.30 178.23 121.42 20.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 174.65 109.33 0.17 174.41 107.27 0.58 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 200.50 135.01 13.30 202.41 136.93 13.95 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 19 3 # 19 A 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 A 501 ASP A 130 ASP~? 27.60 C8 ADE A 500 B 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 190.52 123.97 16.51 191.16 124.37 16.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 188.71 136.74 34.61 188.50 136.01 36.57 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 20 3 # 20 A 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 A 501 ASP A 158 ASP.? 25.18 C8 ADE A 500 B 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 190.52 123.97 16.51 191.16 124.37 16.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 203.27 140.75 25.55 204.24 138.86 25.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 21 3 # 21 A 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 A 501 ASP A 158 ASP.? 25.18 C8 ADE A 500 B 367 TYR C 117 TYR.? 21.72 O1 GOL C1901 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 190.52 123.97 16.51 191.16 124.37 16.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 203.27 140.75 25.55 204.24 138.86 25.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 173.67 123.08 36.58 172.76 125.64 35.98 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 22 3 # 22 A 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 A 501 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 190.52 123.97 16.51 191.16 124.37 16.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 178.67 130.13 34.24 179.32 129.31 36.04 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 23 3 # 23 A 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 A 501 ASP B 175 ASP.? 4.91 O1 CIT A1102 B 367 TYR A 47 TYR^? 13.72 N3 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 190.52 123.97 16.51 191.16 124.37 16.16 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 169.82 131.15 6.22 168.64 132.89 5.97 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 198.66 149.45 16.16 201.00 150.74 16.95 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 24 3 # 24 A 465 GLY B 128 GLY.? 22.81 N7 ADE A 500 A 501 ASP A 89 ASP.? 18.10 N3 ADE A 500 B 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 194.68 129.33 16.90 194.61 129.94 16.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 203.02 151.24 21.31 203.43 152.46 19.71 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 25 3 # 25 A 465 GLY B 128 GLY.? 22.81 N7 ADE A 500 A 501 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 194.68 129.33 16.90 194.61 129.94 16.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 178.67 130.13 34.24 179.32 129.31 36.04 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 26 3 # 26 A 465 GLY B 128 GLY.? 22.81 N7 ADE A 500 A 501 ASP B 89 ASP.? 31.34 O4 CIT A1102 B 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 194.68 129.33 16.90 194.61 129.94 16.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 181.93 115.70 26.33 180.57 117.33 26.20 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 27 3 # 27 A 465 GLY B 134 GLY~? 24.07 N6 ADE A 500 A 501 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 4.40 25.46 -23.33 5.00 25.87 -23.68 199.49 129.07 9.64 199.41 129.13 10.41 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 190.60 123.10 30.08 190.26 121.25 31.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 28 3 # 28 A 465 GLY B 143 GLY.? 6.99 O4 CIT A1102 A 501 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 367 TYR B 131 TYR~? 20.61 N6 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 177.58 131.25 1.88 178.27 131.09 1.31 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 174.65 109.33 0.17 174.41 107.27 0.58 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 200.50 135.01 13.30 202.41 136.93 13.95 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 29 3 # 29 A 465 GLY B 160 GLY.? 28.72 O4 CIT A1102 A 501 ASP A 158 ASP.? 25.18 C8 ADE A 500 B 367 TYR B 117 TYR.? 15.40 O4 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 188.00 123.61 24.63 188.78 123.73 24.22 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 203.27 140.75 25.55 204.24 138.86 25.61 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 184.92 125.90 -1.64 186.19 127.72 0.06 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 30 3 # 30 A 465 GLY C 46 GLY.? 11.75 O3 GOL C1901 A 501 ASP C 183 ASP~? 25.06 O3 GOL C1901 B 367 TYR C 131 TYR.? 29.32 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 154.15 127.64 48.04 153.68 126.93 48.08 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 169.34 110.13 50.56 169.06 109.63 52.58 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.57 146.54 37.64 168.87 149.06 36.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 31 3 # 31 A 465 GLY C 93 GLY^? 13.18 O3 GOL C1901 A 501 ASP C 52 ASP^? 12.06 O1 GOL C1901 B 367 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 159.81 125.78 46.83 160.54 125.64 47.42 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 147.21 130.59 30.19 147.01 130.37 28.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 32 3 # 32 A 465 GLY C 109 GLY^? 21.15 O1 GOL C1901 A 501 ASP C 52 ASP^? 12.06 O1 GOL C1901 B 367 TYR A 117 TYR.? 18.31 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 158.25 140.78 46.12 158.62 140.96 45.46 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 147.21 130.59 30.19 147.01 130.37 28.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 174.51 155.83 27.46 174.88 153.07 27.26 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 33 3 # 33 A 465 GLY C 109 GLY^? 21.15 O1 GOL C1901 A 501 ASP C 52 ASP^? 12.06 O1 GOL C1901 B 367 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 158.25 140.78 46.12 158.62 140.96 45.46 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 147.21 130.59 30.19 147.01 130.37 28.08 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 34 3 # 34 A 465 GLY C 134 GLY.? 28.65 O1 GOL C1901 A 501 ASP A 119 ASP.? 23.37 C8 ADE A 500 B 367 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 172.28 142.32 41.27 171.63 142.59 41.52 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 170.58 160.79 28.87 171.46 159.09 29.69 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 35 3 # 35 A 465 GLY C 134 GLY.? 28.65 O1 GOL C1901 A 501 ASP B 52 ASP^? 16.07 C8 ADE A 500 B 367 TYR C 47 TYR^? 13.41 O3 GOL C1901 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 172.28 142.32 41.27 171.63 142.59 41.52 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 173.93 140.35 20.11 173.24 142.10 19.12 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 149.80 129.36 48.45 149.55 129.08 51.21 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 36 3 # 36 A 465 GLY C 143 GLY.? 14.90 O1 GOL C1901 A 501 ASP C 183 ASP~? 25.06 O3 GOL C1901 B 367 TYR C 131 TYR.? 29.32 C8 ADE A 500 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 165.52 121.63 31.71 166.35 121.80 31.83 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 169.34 110.13 50.56 169.06 109.63 52.58 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 168.57 146.54 37.64 168.87 149.06 36.42 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 37 3 # 37 A 465 GLY C 190 GLY~? 29.91 O3 GOL C1901 A 501 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 367 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 178.54 116.34 48.35 177.72 116.48 48.49 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 190.60 123.10 30.08 190.26 121.25 31.09 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 155.65 129.37 42.44 156.62 127.68 44.43 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 37 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 46 GLY.? 10.99 N9 ADE A 500 D 501 ASP A 183 ASP~? 24.76 N9 ADE A 500 E 367 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 195.68 151.83 18.82 195.79 152.36 18.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 184.84 171.88 24.93 186.38 173.28 25.14 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 46 GLY.? 10.99 N9 ADE A 500 D 501 ASP B 130 ASP~? 26.83 N6 ADE A 500 E 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 195.68 151.83 18.82 195.79 152.36 18.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 200.55 129.62 17.17 202.64 129.41 16.98 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 93 GLY^? 10.42 N9 ADE A 500 D 501 ASP A 52 ASP^? 9.33 O4 CIT A1102 E 367 TYR C 131 TYR.? 29.32 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 191.16 154.66 21.80 191.10 155.17 22.59 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 185.72 140.93 6.30 184.35 140.00 4.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.57 146.54 37.64 168.87 149.06 36.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 109 GLY^? 18.96 C8 ADE A 500 D 501 ASP A 52 ASP^? 9.33 O4 CIT A1102 E 367 TYR C 117 TYR.? 21.72 O1 GOL C1901 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 194.47 140.38 26.65 193.77 140.12 26.60 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 185.72 140.93 6.30 184.35 140.00 4.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 173.67 123.08 36.58 172.76 125.64 35.98 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 109 GLY^? 18.96 C8 ADE A 500 D 501 ASP A 52 ASP^? 9.33 O4 CIT A1102 E 367 TYR C 131 TYR.? 29.32 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 194.47 140.38 26.65 193.77 140.12 26.60 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 185.72 140.93 6.30 184.35 140.00 4.99 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.57 146.54 37.64 168.87 149.06 36.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY A 111 GLY^? 16.58 C8 ADE A 500 D 501 ASP A 36 ASP~? 21.71 N6 ADE A 500 E 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 191.04 146.32 28.35 190.54 145.86 28.86 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 203.35 139.46 11.01 205.31 139.04 11.69 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY A 111 GLY^? 16.58 C8 ADE A 500 D 501 ASP B 130 ASP~? 26.83 N6 ADE A 500 E 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 191.04 146.32 28.35 190.54 145.86 28.86 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 200.55 129.62 17.17 202.64 129.41 16.98 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY A 111 GLY^? 16.58 C8 ADE A 500 D 501 ASP B 158 ASP.? 34.51 N7 ADE A 500 E 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 191.04 146.32 28.35 190.54 145.86 28.86 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 190.60 123.10 30.08 190.26 121.25 31.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY A 128 GLY.? 19.63 C8 ADE A 500 D 501 ASP A 36 ASP~? 21.71 N6 ADE A 500 E 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 188.72 140.03 29.58 187.87 139.89 29.50 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 203.35 139.46 11.01 205.31 139.04 11.69 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY A 134 GLY~? 24.98 C8 ADE A 500 D 501 ASP A 158 ASP.? 25.18 C8 ADE A 500 E 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 182.81 140.38 35.92 183.52 140.16 35.69 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 203.27 140.75 25.55 204.24 138.86 25.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 11 3 # 11 D 465 GLY A 134 GLY~? 24.98 C8 ADE A 500 D 501 ASP C 119 ASP.? 26.31 O1 GOL C1901 E 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 182.81 140.38 35.92 183.52 140.16 35.69 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 178.03 118.40 36.14 177.70 120.46 36.31 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 12 3 # 12 D 465 GLY A 143 GLY.? 12.19 C8 ADE A 500 D 501 ASP A 183 ASP~? 24.76 N9 ADE A 500 E 367 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 174.93 153.96 17.89 174.52 154.02 18.66 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 184.84 171.88 24.93 186.38 173.28 25.14 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 13 3 # 13 D 465 GLY A 160 GLY.? 18.25 C8 ADE A 500 D 501 ASP B 158 ASP.? 34.51 N7 ADE A 500 E 367 TYR A 117 TYR.? 18.31 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 198.27 144.01 24.73 197.89 143.68 25.40 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 190.60 123.10 30.08 190.26 121.25 31.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 174.51 155.83 27.46 174.88 153.07 27.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 14 3 # 14 D 465 GLY A 181 GLY~? 18.98 N9 ADE A 500 D 501 ASP A 89 ASP.? 18.10 N3 ADE A 500 E 367 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 187.72 167.74 23.06 186.98 167.48 23.15 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 203.02 151.24 21.31 203.43 152.46 19.71 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 15 3 # 15 D 465 GLY B 45 GLY.? 23.68 O4 CIT A1102 D 501 ASP B 183 ASP~? 28.98 C2 CIT A1102 E 367 TYR B 131 TYR~? 20.61 N6 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 177.24 119.43 17.85 177.04 120.22 17.68 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 174.65 109.33 0.17 174.41 107.27 0.58 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 200.50 135.01 13.30 202.41 136.93 13.95 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 16 3 # 16 D 465 GLY B 46 GLY.? 23.93 O4 CIT A1102 D 501 ASP A 130 ASP~? 27.60 C8 ADE A 500 E 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 179.08 121.64 20.30 178.23 121.42 20.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 188.71 136.74 34.61 188.50 136.01 36.57 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 17 3 # 17 D 465 GLY B 46 GLY.? 23.93 O4 CIT A1102 D 501 ASP B 183 ASP~? 28.98 C2 CIT A1102 E 367 TYR B 131 TYR~? 20.61 N6 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 179.08 121.64 20.30 178.23 121.42 20.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 174.65 109.33 0.17 174.41 107.27 0.58 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 200.50 135.01 13.30 202.41 136.93 13.95 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 18 3 # 18 D 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 D 501 ASP A 130 ASP~? 27.60 C8 ADE A 500 E 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 190.52 123.97 16.51 191.16 124.37 16.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 188.71 136.74 34.61 188.50 136.01 36.57 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 19 3 # 19 D 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 D 501 ASP A 158 ASP.? 25.18 C8 ADE A 500 E 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 190.52 123.97 16.51 191.16 124.37 16.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 203.27 140.75 25.55 204.24 138.86 25.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 20 3 # 20 D 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 D 501 ASP A 158 ASP.? 25.18 C8 ADE A 500 E 367 TYR C 117 TYR.? 21.72 O1 GOL C1901 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 190.52 123.97 16.51 191.16 124.37 16.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 203.27 140.75 25.55 204.24 138.86 25.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 173.67 123.08 36.58 172.76 125.64 35.98 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 21 3 # 21 D 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 D 501 ASP B 36 ASP~? 28.48 O1 GOL C1901 E 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 190.52 123.97 16.51 191.16 124.37 16.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 178.67 130.13 34.24 179.32 129.31 36.04 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 22 3 # 22 D 465 GLY B 111 GLY^? 24.48 O4 CIT A1102 D 501 ASP B 175 ASP.? 4.91 O1 CIT A1102 E 367 TYR A 47 TYR^? 13.72 N3 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 190.52 123.97 16.51 191.16 124.37 16.16 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 169.82 131.15 6.22 168.64 132.89 5.97 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 198.66 149.45 16.16 201.00 150.74 16.95 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 23 3 # 23 D 465 GLY B 128 GLY.? 22.81 N7 ADE A 500 D 501 ASP A 89 ASP.? 18.10 N3 ADE A 500 E 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 194.68 129.33 16.90 194.61 129.94 16.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 203.02 151.24 21.31 203.43 152.46 19.71 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 24 3 # 24 D 465 GLY B 128 GLY.? 22.81 N7 ADE A 500 D 501 ASP B 36 ASP~? 28.48 O1 GOL C1901 E 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 194.68 129.33 16.90 194.61 129.94 16.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 178.67 130.13 34.24 179.32 129.31 36.04 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 25 3 # 25 D 465 GLY B 128 GLY.? 22.81 N7 ADE A 500 D 501 ASP B 89 ASP.? 31.34 O4 CIT A1102 E 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 194.68 129.33 16.90 194.61 129.94 16.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 181.93 115.70 26.33 180.57 117.33 26.20 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 26 3 # 26 D 465 GLY B 134 GLY~? 24.07 N6 ADE A 500 D 501 ASP B 158 ASP.? 34.51 N7 ADE A 500 E 367 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 21.60 60.44 -42.77 21.61 59.72 -42.40 199.49 129.07 9.64 199.41 129.13 10.41 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 190.60 123.10 30.08 190.26 121.25 31.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 27 3 # 27 D 465 GLY B 143 GLY.? 6.99 O4 CIT A1102 D 501 ASP B 183 ASP~? 28.98 C2 CIT A1102 E 367 TYR B 131 TYR~? 20.61 N6 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 177.58 131.25 1.88 178.27 131.09 1.31 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 174.65 109.33 0.17 174.41 107.27 0.58 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 200.50 135.01 13.30 202.41 136.93 13.95 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 28 3 # 28 D 465 GLY B 160 GLY.? 28.72 O4 CIT A1102 D 501 ASP A 158 ASP.? 25.18 C8 ADE A 500 E 367 TYR B 117 TYR.? 15.40 O4 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 188.00 123.61 24.63 188.78 123.73 24.22 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 203.27 140.75 25.55 204.24 138.86 25.61 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 184.92 125.90 -1.64 186.19 127.72 0.06 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 29 3 # 29 D 465 GLY C 46 GLY.? 11.75 O3 GOL C1901 D 501 ASP C 183 ASP~? 25.06 O3 GOL C1901 E 367 TYR C 131 TYR.? 29.32 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 154.15 127.64 48.04 153.68 126.93 48.08 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 169.34 110.13 50.56 169.06 109.63 52.58 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.57 146.54 37.64 168.87 149.06 36.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 30 3 # 30 D 465 GLY C 93 GLY^? 13.18 O3 GOL C1901 D 501 ASP C 52 ASP^? 12.06 O1 GOL C1901 E 367 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 159.81 125.78 46.83 160.54 125.64 47.42 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 147.21 130.59 30.19 147.01 130.37 28.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 31 3 # 31 D 465 GLY C 109 GLY^? 21.15 O1 GOL C1901 D 501 ASP C 52 ASP^? 12.06 O1 GOL C1901 E 367 TYR A 117 TYR.? 18.31 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 158.25 140.78 46.12 158.62 140.96 45.46 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 147.21 130.59 30.19 147.01 130.37 28.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 174.51 155.83 27.46 174.88 153.07 27.26 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 32 3 # 32 D 465 GLY C 109 GLY^? 21.15 O1 GOL C1901 D 501 ASP C 52 ASP^? 12.06 O1 GOL C1901 E 367 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 158.25 140.78 46.12 158.62 140.96 45.46 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 147.21 130.59 30.19 147.01 130.37 28.08 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 33 3 # 33 D 465 GLY C 134 GLY.? 28.65 O1 GOL C1901 D 501 ASP A 119 ASP.? 23.37 C8 ADE A 500 E 367 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 172.28 142.32 41.27 171.63 142.59 41.52 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 170.58 160.79 28.87 171.46 159.09 29.69 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 34 3 # 34 D 465 GLY C 143 GLY.? 14.90 O1 GOL C1901 D 501 ASP C 183 ASP~? 25.06 O3 GOL C1901 E 367 TYR C 131 TYR.? 29.32 C8 ADE A 500 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 165.52 121.63 31.71 166.35 121.80 31.83 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 169.34 110.13 50.56 169.06 109.63 52.58 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 168.57 146.54 37.64 168.87 149.06 36.42 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 35 3 # 35 D 465 GLY C 190 GLY~? 29.91 O3 GOL C1901 D 501 ASP B 158 ASP.? 34.51 N7 ADE A 500 E 367 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 178.54 116.34 48.35 177.72 116.48 48.49 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 190.60 123.10 30.08 190.26 121.25 31.09 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 155.65 129.37 42.44 156.62 127.68 44.43 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 35 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 55 TYR C 117 TYR.? 21.72 O1 GOL C1901 A 84 LYS C 123 LYS^? 25.30 O1 GOL C1901 coo 11.09 42.89 24.44 11.32 42.06 22.49 178.67 130.13 34.24 179.32 129.31 36.04 coo 4.60 40.33 20.42 7.25 39.50 20.05 173.67 123.08 36.58 172.76 125.64 35.98 coo 9.71 44.83 15.47 10.13 41.43 19.93 174.37 128.14 41.95 175.88 130.01 36.96 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP B 119 ASP.? 20.62 O7 CIT A1102 A 55 TYR B 117 TYR.? 15.40 O4 CIT A1102 A 84 LYS B 123 LYS.? 21.18 O4 CIT A1102 coo 11.09 42.89 24.44 11.32 42.06 22.49 184.41 123.54 -7.24 185.10 123.40 -9.24 coo 4.60 40.33 20.42 7.25 39.50 20.05 184.92 125.90 -1.64 186.19 127.72 0.06 coo 9.71 44.83 15.47 10.13 41.43 19.93 190.30 123.24 2.08 193.85 127.78 -0.15 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 2 hits 1mrq_c02 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 169 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 327 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 20.73 15.53 25.54 22.09 15.64 19.40 182.07 169.10 30.10 186.87 173.28 30.86 coo 24.31 10.25 23.71 29.02 12.05 20.75 183.60 164.07 35.65 183.22 158.61 36.42 coo 21.86 20.40 18.59 22.12 18.33 18.33 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 169 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 327 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 20.73 15.53 25.54 22.09 15.64 19.40 175.75 125.08 4.60 173.18 124.12 -0.61 coo 24.31 10.25 23.71 29.02 12.05 20.75 181.66 123.79 6.82 179.82 128.66 10.46 coo 21.86 20.40 18.59 22.12 18.33 18.33 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 169 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 327 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 20.73 15.53 25.54 22.09 15.64 19.40 163.30 119.33 38.22 166.56 114.68 36.90 coo 24.31 10.25 23.71 29.02 12.05 20.75 165.62 124.17 41.44 160.89 126.43 37.84 coo 21.86 20.40 18.59 22.12 18.33 18.33 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 169 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 327 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo 20.73 15.53 25.54 22.09 15.64 19.40 163.30 119.33 38.22 166.56 114.68 36.90 coo 24.31 10.25 23.71 29.02 12.05 20.75 165.62 124.17 41.44 160.89 126.43 37.84 coo 21.86 20.40 18.59 22.12 18.33 18.33 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 5 3 # 5 A 167 LYS C 186 LYS~? 29.69 O3 GOL C1901 A 169 LYS C 193 LYS~? 28.43 O1 GOL C1901 A 327 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo 20.73 15.53 25.54 22.09 15.64 19.40 174.37 114.14 48.91 174.42 112.17 55.03 coo 24.31 10.25 23.71 29.02 12.05 20.75 177.05 121.15 50.66 176.96 126.15 48.94 coo 21.86 20.40 18.59 22.12 18.33 18.33 168.68 112.73 44.51 166.86 112.61 43.45 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 5 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 169 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 327 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 180.69 158.10 18.36 176.95 162.62 18.15 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 182.91 155.29 23.54 184.46 151.31 19.55 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 169 LYS A 193 LYS~? 24.54 N9 ADE A 500 B 327 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 182.07 169.10 30.10 186.87 173.28 30.86 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 183.60 164.07 35.65 183.22 158.61 36.42 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 169 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 327 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 175.75 125.08 4.60 173.18 124.12 -0.61 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 181.66 123.79 6.82 179.82 128.66 10.46 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 169 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 327 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 181.66 123.79 6.82 179.82 128.66 10.46 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 179.28 118.69 11.71 177.59 112.91 13.79 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 5 3 # 5 B 167 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 169 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 327 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 181.66 123.79 6.82 179.82 128.66 10.46 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 175.75 125.08 4.60 173.18 124.12 -0.61 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 6 3 # 6 B 167 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 169 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 327 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 163.30 119.33 38.22 166.56 114.68 36.90 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 165.62 124.17 41.44 160.89 126.43 37.84 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 7 3 # 7 B 167 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 169 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 327 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 163.30 119.33 38.22 166.56 114.68 36.90 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 165.62 124.17 41.44 160.89 126.43 37.84 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 8 3 # 8 B 167 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 169 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 327 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 165.62 124.17 41.44 160.89 126.43 37.84 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 161.58 122.48 47.40 160.49 120.58 53.33 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 9 3 # 9 B 167 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 169 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 327 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 165.62 124.17 41.44 160.89 126.43 37.84 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 163.30 119.33 38.22 166.56 114.68 36.90 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 10 3 # 10 B 167 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 169 LYS C 193 LYS~? 28.43 O1 GOL C1901 B 327 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 174.37 114.14 48.91 174.42 112.17 55.03 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 177.05 121.15 50.66 176.96 126.15 48.94 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 168.68 112.73 44.51 166.86 112.61 43.45 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 10 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 197 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 223 ALA B 195 ALA~? 32.61 O4 CIT A1102 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 176.75 112.07 -5.75 176.32 110.31 -6.80 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 174.65 109.33 0.17 174.41 107.27 0.58 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 185.78 108.35 3.71 186.55 107.14 3.21 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 197 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 223 ALA B 198 ALA.? 29.73 O4 CIT A1102 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 176.75 112.07 -5.75 176.32 110.31 -6.80 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 174.65 109.33 0.17 174.41 107.27 0.58 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 183.32 111.00 7.40 183.44 109.49 7.28 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 2 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 197 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 223 ALA B 195 ALA~? 32.61 O4 CIT A1102 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 176.75 112.07 -5.75 176.32 110.31 -6.80 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 174.65 109.33 0.17 174.41 107.27 0.58 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 185.78 108.35 3.71 186.55 107.14 3.21 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 197 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 223 ALA B 198 ALA.? 29.73 O4 CIT A1102 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 176.75 112.07 -5.75 176.32 110.31 -6.80 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 174.65 109.33 0.17 174.41 107.27 0.58 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 183.32 111.00 7.40 183.44 109.49 7.28 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 2 hits 1n2t_c03 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 290 LYS A 49 LYS^? 10.58 N6 ADE A 500 A 405 ARG A 53 ARG^? 5.21 N6 ADE A 500 coo 41.33 25.99 28.05 41.95 26.95 29.80 191.47 153.75 14.17 189.52 154.05 13.44 coo 37.11 33.75 31.82 38.72 27.95 29.90 193.06 146.52 10.07 195.03 144.09 6.09 coo 42.28 27.98 41.30 43.16 28.14 38.35 184.38 147.77 2.51 183.90 149.96 4.60 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 290 LYS B 49 LYS^? 24.07 O1 GOL C1901 A 405 ARG C 101 ARG.? 18.11 O1 GOL C1901 coo 41.33 25.99 28.05 41.95 26.95 29.80 174.27 123.90 17.18 173.55 124.80 15.43 coo 37.11 33.75 31.82 38.72 27.95 29.90 174.03 130.60 22.66 171.30 132.48 26.53 coo 42.28 27.98 41.30 43.16 28.14 38.35 163.77 126.78 27.00 165.49 129.29 26.85 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 3 3 # 3 A 264 HIS B 202 HIS.? 28.80 C2 CIT A1102 A 290 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 405 ARG B 43 ARG.? 18.57 O1 CIT A1102 coo 41.33 25.99 28.05 41.95 26.95 29.80 175.03 109.49 9.82 173.45 108.46 10.74 coo 37.11 33.75 31.82 38.72 27.95 29.90 179.28 118.69 11.71 177.59 112.91 13.79 coo 42.28 27.98 41.30 43.16 28.14 38.35 169.37 120.65 13.94 167.07 120.51 11.92 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 3 hits 1nhx_c00 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 50 GLU^? -3.91 N6 ADE A 500s B 128 HIS A 42 HIS.? -4.20 N3 ADE A 500s C 263 HIS A 104 HIS^? 8.41 C8 ADE A 500 coo 6.12 5.94 82.00 7.16 6.32 83.81 187.90 146.65 6.60 187.00 148.18 5.47 coo 12.51 16.35 80.99 13.16 14.90 82.37 191.47 153.75 14.17 189.52 154.05 13.44 coo 11.58 14.94 93.26 12.25 14.03 91.50 183.15 146.13 20.69 182.60 148.09 20.18 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 50 GLU^? -3.91 N6 ADE A 500s B 128 HIS A 176 HIS^? 6.39 N3 ADE A 500 C 263 HIS A 104 HIS^? 8.41 C8 ADE A 500 coo 6.12 5.94 82.00 7.16 6.32 83.81 187.90 146.65 6.60 187.00 148.18 5.47 coo 12.51 16.35 80.99 13.16 14.90 82.37 184.39 157.95 13.11 185.86 157.96 14.60 coo 11.58 14.94 93.26 12.25 14.03 91.50 183.15 146.13 20.69 182.60 148.09 20.18 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU A 184 GLU~? 18.03 N9 ADE A 500 B 128 HIS A 202 HIS.? 13.56 N3 ADE A 500 C 263 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 6.12 5.94 82.00 7.16 6.32 83.81 180.48 167.65 23.03 180.45 166.67 21.17 coo 12.51 16.35 80.99 13.16 14.90 82.37 190.73 163.86 19.83 191.04 162.27 18.50 coo 11.58 14.94 93.26 12.25 14.03 91.50 184.39 157.95 13.11 185.86 157.96 14.60 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU B 50 GLU^? 15.33 O1 CIT A1102 B 128 HIS B 42 HIS.? 18.79 O1 CIT A1102 C 263 HIS B 104 HIS^? 12.85 O4 CIT A1102 coo 6.12 5.94 82.00 7.16 6.32 83.81 171.15 134.64 18.99 169.39 134.49 17.85 coo 12.51 16.35 80.99 13.16 14.90 82.37 174.27 123.90 17.18 173.55 124.80 15.43 coo 11.58 14.94 93.26 12.25 14.03 91.50 183.49 131.36 11.56 181.98 130.36 10.51 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU B 50 GLU^? 15.33 O1 CIT A1102 B 128 HIS B 176 HIS^? 13.79 O1 CIT A1102 C 263 HIS B 104 HIS^? 12.85 O4 CIT A1102 coo 6.12 5.94 82.00 7.16 6.32 83.81 171.15 134.64 18.99 169.39 134.49 17.85 coo 12.51 16.35 80.99 13.16 14.90 82.37 171.08 125.47 9.27 172.48 124.18 10.15 coo 11.58 14.94 93.26 12.25 14.03 91.50 183.49 131.36 11.56 181.98 130.36 10.51 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 B 59 GLU C 50 GLU^? -3.82 O2 GOL C1901s B 128 HIS C 42 HIS.? 5.32 O3 GOL C1901 C 263 HIS C 104 HIS^? 12.14 O1 GOL C1901 coo 6.12 5.94 82.00 7.16 6.32 83.81 147.72 125.56 34.28 147.67 123.54 33.74 coo 12.51 16.35 80.99 13.16 14.90 82.37 153.36 123.09 43.85 154.03 121.98 42.20 coo 11.58 14.94 93.26 12.25 14.03 91.50 161.39 131.07 36.65 161.63 129.00 36.89 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 B 59 GLU C 50 GLU^? -3.82 O2 GOL C1901s B 128 HIS C 176 HIS^? 7.29 C1 GOL C1901 C 263 HIS C 104 HIS^? 12.14 O1 GOL C1901 coo 6.12 5.94 82.00 7.16 6.32 83.81 147.72 125.56 34.28 147.67 123.54 33.74 coo 12.51 16.35 80.99 13.16 14.90 82.37 157.21 117.94 38.21 157.48 118.99 40.00 coo 11.58 14.94 93.26 12.25 14.03 91.50 161.39 131.07 36.65 161.63 129.00 36.89 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 B 59 GLU C 184 GLU~? 18.70 O3 GOL C1901 B 128 HIS C 202 HIS.? 13.21 O3 GOL C1901 C 263 HIS C 176 HIS^? 7.29 C1 GOL C1901 coo 6.12 5.94 82.00 7.16 6.32 83.81 168.68 112.73 44.51 166.86 112.61 43.45 coo 12.51 16.35 80.99 13.16 14.90 82.37 160.20 116.89 49.36 158.52 117.92 48.65 coo 11.58 14.94 93.26 12.25 14.03 91.50 157.21 117.94 38.21 157.48 118.99 40.00 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 8 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 104 HIS^? 8.41 C8 ADE A 500 D 59 GLU A 50 GLU^? -3.91 N6 ADE A 500s D 128 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 183.15 146.13 20.69 182.60 148.09 20.18 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 187.90 146.65 6.60 187.00 148.18 5.47 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 104 HIS^? 8.41 C8 ADE A 500 D 59 GLU A 50 GLU^? -3.91 N6 ADE A 500s D 128 HIS A 176 HIS^? 6.39 N3 ADE A 500 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 183.15 146.13 20.69 182.60 148.09 20.18 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 187.90 146.65 6.60 187.00 148.18 5.47 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 184.39 157.95 13.11 185.86 157.96 14.60 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS A 176 HIS^? 6.39 N3 ADE A 500 D 59 GLU A 184 GLU~? 18.03 N9 ADE A 500 D 128 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 184.39 157.95 13.11 185.86 157.96 14.60 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 180.48 167.65 23.03 180.45 166.67 21.17 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS B 104 HIS^? 12.85 O4 CIT A1102 D 59 GLU B 50 GLU^? 15.33 O1 CIT A1102 D 128 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 183.49 131.36 11.56 181.98 130.36 10.51 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 171.15 134.64 18.99 169.39 134.49 17.85 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 A 263 HIS B 104 HIS^? 12.85 O4 CIT A1102 D 59 GLU B 50 GLU^? 15.33 O1 CIT A1102 D 128 HIS B 176 HIS^? 13.79 O1 CIT A1102 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 183.49 131.36 11.56 181.98 130.36 10.51 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 171.15 134.64 18.99 169.39 134.49 17.85 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 171.08 125.47 9.27 172.48 124.18 10.15 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 A 263 HIS C 104 HIS^? 12.14 O1 GOL C1901 D 59 GLU C 50 GLU^? -3.82 O2 GOL C1901s D 128 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 161.39 131.07 36.65 161.63 129.00 36.89 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 147.72 125.56 34.28 147.67 123.54 33.74 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 A 263 HIS C 104 HIS^? 12.14 O1 GOL C1901 D 59 GLU C 50 GLU^? -3.82 O2 GOL C1901s D 128 HIS C 176 HIS^? 7.29 C1 GOL C1901 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 161.39 131.07 36.65 161.63 129.00 36.89 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 147.72 125.56 34.28 147.67 123.54 33.74 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 157.21 117.94 38.21 157.48 118.99 40.00 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 A 263 HIS C 176 HIS^? 7.29 C1 GOL C1901 D 59 GLU C 184 GLU~? 18.70 O3 GOL C1901 D 128 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 157.21 117.94 38.21 157.48 118.99 40.00 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 168.68 112.73 44.51 166.86 112.61 43.45 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 160.20 116.89 49.36 158.52 117.92 48.65 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 8 hits 1ni4_c01 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 123 LYS^? 21.83 C8 ADE A 500 631 LYS C 126 LYS^? 28.06 O1 GOL C1901 708 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 8.61 33.06 11.15 10.12 29.19 8.82 179.30 153.63 32.06 174.52 149.85 32.01 coo -11.99 27.40 17.14 -13.60 24.52 11.71 168.56 136.65 44.17 170.62 139.01 49.65 coo 18.16 32.86 9.85 16.06 28.20 13.56 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 2 3 # 2 549 LYS B 180 LYS.? 22.96 O1 CIT A1102 631 LYS B 49 LYS^? 24.07 O1 GOL C1901 708 LYS B 186 LYS~? 32.32 C2 CIT A1102 coo 8.61 33.06 11.15 10.12 29.19 8.82 173.15 113.94 5.34 166.89 113.91 6.31 coo -11.99 27.40 17.14 -13.60 24.52 11.71 174.03 130.60 22.66 171.30 132.48 26.53 coo 18.16 32.86 9.85 16.06 28.20 13.56 180.39 111.43 -2.06 180.17 105.09 -1.71 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 3 3 # 3 549 LYS B 180 LYS.? 22.96 O1 CIT A1102 631 LYS C 62 LYS^? 15.99 O2 GOL C1901 708 LYS B 186 LYS~? 32.32 C2 CIT A1102 coo 8.61 33.06 11.15 10.12 29.19 8.82 173.15 113.94 5.34 166.89 113.91 6.31 coo -11.99 27.40 17.14 -13.60 24.52 11.71 160.07 111.06 24.23 156.23 109.52 28.21 coo 18.16 32.86 9.85 16.06 28.20 13.56 180.39 111.43 -2.06 180.17 105.09 -1.71 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 4 3 # 4 549 LYS C 97 LYS^? 17.09 C1 GOL C1901 631 LYS B 49 LYS^? 24.07 O1 GOL C1901 708 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo 8.61 33.06 11.15 10.12 29.19 8.82 163.30 119.33 38.22 166.56 114.68 36.90 coo -11.99 27.40 17.14 -13.60 24.52 11.71 174.03 130.60 22.66 171.30 132.48 26.53 coo 18.16 32.86 9.85 16.06 28.20 13.56 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 5 3 # 5 549 LYS C 123 LYS^? 25.30 O1 GOL C1901 631 LYS A 126 LYS^? 24.40 C8 ADE A 500 708 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 8.61 33.06 11.15 10.12 29.19 8.82 174.37 128.14 41.95 175.88 130.01 36.96 coo -11.99 27.40 17.14 -13.60 24.52 11.71 186.22 145.69 31.90 189.62 146.93 37.05 coo 18.16 32.86 9.85 16.06 28.20 13.56 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 6 3 # 6 549 LYS C 123 LYS^? 25.30 O1 GOL C1901 631 LYS A 126 LYS^? 24.40 C8 ADE A 500 708 LYS C 193 LYS~? 28.43 O1 GOL C1901 coo 8.61 33.06 11.15 10.12 29.19 8.82 174.37 128.14 41.95 175.88 130.01 36.96 coo -11.99 27.40 17.14 -13.60 24.52 11.71 186.22 145.69 31.90 189.62 146.93 37.05 coo 18.16 32.86 9.85 16.06 28.20 13.56 177.05 121.15 50.66 176.96 126.15 48.94 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 7 3 # 7 549 LYS C 180 LYS.? 20.00 O3 GOL C1901 631 LYS C 49 LYS^? 10.29 O2 GOL C1901 708 LYS C 186 LYS~? 29.69 O3 GOL C1901 coo 8.61 33.06 11.15 10.12 29.19 8.82 163.89 112.64 46.86 163.54 106.47 45.76 coo -11.99 27.40 17.14 -13.60 24.52 11.71 147.41 128.03 39.92 142.61 128.90 38.51 coo 18.16 32.86 9.85 16.06 28.20 13.56 174.37 114.14 48.91 174.42 112.17 55.03 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 7 hits 1nsf_c00 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 54 SER.? 4.61 O3 CIT A1102 A 154 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 261 ARG A 53 ARG^? 5.21 N6 ADE A 500 coo 16.10 74.10 3.11 17.18 73.52 5.20 180.68 142.57 2.59 178.38 141.86 2.59 coo 16.07 84.71 8.14 15.20 82.81 8.14 180.59 154.59 5.93 180.83 155.75 4.19 coo 10.59 77.85 4.81 13.09 76.36 5.76 184.38 147.77 2.51 183.90 149.96 4.60 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 79 SER.? 7.17 O4 CIT A1102 A 154 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 261 ARG A 53 ARG^? 5.21 N6 ADE A 500 coo 16.10 74.10 3.11 17.18 73.52 5.20 179.20 144.60 7.13 179.51 142.21 7.02 coo 16.07 84.71 8.14 15.20 82.81 8.14 180.59 154.59 5.93 180.83 155.75 4.19 coo 10.59 77.85 4.81 13.09 76.36 5.76 184.38 147.77 2.51 183.90 149.96 4.60 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER B 54 SER.? 13.70 O5 CIT A1102 A 154 ASP B 172 ASP~? 8.81 O1 CIT A1102 A 261 ARG B 53 ARG^? 12.50 O1 CIT A1102 coo 16.10 74.10 3.11 17.18 73.52 5.20 170.01 143.15 16.19 170.47 144.95 14.66 coo 16.07 84.71 8.14 15.20 82.81 8.14 166.30 133.15 8.87 164.29 132.56 8.69 coo 10.59 77.85 4.81 13.09 76.36 5.76 166.97 137.64 16.68 167.60 135.18 14.95 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER B 79 SER.? 11.49 O4 CIT A1102 A 154 ASP B 172 ASP~? 8.81 O1 CIT A1102 A 261 ARG B 53 ARG^? 12.50 O1 CIT A1102 coo 16.10 74.10 3.11 17.18 73.52 5.20 172.67 140.46 12.34 174.10 141.88 13.69 coo 16.07 84.71 8.14 15.20 82.81 8.14 166.30 133.15 8.87 164.29 132.56 8.69 coo 10.59 77.85 4.81 13.09 76.36 5.76 166.97 137.64 16.68 167.60 135.18 14.95 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER C 54 SER.? 14.46 O1 GOL C1901 A 154 ASP C 172 ASP~? 9.22 O2 GOL C1901 A 261 ARG C 53 ARG^? 4.89 O2 GOL C1901 coo 16.10 74.10 3.11 17.18 73.52 5.20 147.47 126.83 25.21 148.44 127.11 23.04 coo 16.07 84.71 8.14 15.20 82.81 8.14 153.21 116.81 30.64 152.37 114.88 30.62 coo 10.59 77.85 4.81 13.09 76.36 5.76 146.33 122.48 29.52 148.17 121.33 31.67 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 6 3 # 6 A 62 SER C 79 SER.? 11.88 O1 GOL C1901 A 154 ASP C 172 ASP~? 9.22 O2 GOL C1901 A 261 ARG C 53 ARG^? 4.89 O2 GOL C1901 coo 16.10 74.10 3.11 17.18 73.52 5.20 152.54 126.39 26.52 151.63 128.65 26.08 coo 16.07 84.71 8.14 15.20 82.81 8.14 153.21 116.81 30.64 152.37 114.88 30.62 coo 10.59 77.85 4.81 13.09 76.36 5.76 146.33 122.48 29.52 148.17 121.33 31.67 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 6 hits 1o98_c00 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 20 LYS~? 27.72 N9 ADE A 500 A 208 GLN A 112 GLN^? 20.81 C8 ADE A 500 A 209 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 198.50 157.87 31.43 197.45 157.77 37.73 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 187.82 149.99 31.85 188.55 150.31 33.84 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 A 175 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 208 GLN A 112 GLN^? 20.81 C8 ADE A 500 A 209 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 189.82 158.18 22.25 194.56 162.25 23.07 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 187.82 149.99 31.85 188.55 150.31 33.84 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 A 175 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 208 GLN B 112 GLN^? 26.54 O4 CIT A1102 A 209 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 179.28 118.69 11.71 177.59 112.91 13.79 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 191.75 121.43 11.28 193.26 119.92 11.27 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 A 175 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 208 GLN C 112 GLN^? 24.26 O1 GOL C1901 A 209 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 98.39 14.31 -19.34 101.13 12.36 -14.91 161.58 122.48 47.40 160.49 120.58 53.33 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 168.50 133.03 46.93 169.91 133.74 48.35 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 168.56 136.65 44.17 170.62 139.01 49.65 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 4 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 208 GLN A 112 GLN^? 20.81 C8 ADE A 500 B 209 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 105.03 46.01 19.55 106.59 42.35 15.55 189.82 158.18 22.25 194.56 162.25 23.07 coo 113.93 46.99 13.56 113.37 48.52 14.95 187.82 149.99 31.85 188.55 150.31 33.84 coo 115.66 49.12 8.60 111.19 49.52 4.73 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 208 GLN B 112 GLN^? 26.54 O4 CIT A1102 B 209 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 105.03 46.01 19.55 106.59 42.35 15.55 179.28 118.69 11.71 177.59 112.91 13.79 coo 113.93 46.99 13.56 113.37 48.52 14.95 191.75 121.43 11.28 193.26 119.92 11.27 coo 115.66 49.12 8.60 111.19 49.52 4.73 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 208 GLN C 112 GLN^? 24.26 O1 GOL C1901 B 209 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 105.03 46.01 19.55 106.59 42.35 15.55 161.58 122.48 47.40 160.49 120.58 53.33 coo 113.93 46.99 13.56 113.37 48.52 14.95 168.50 133.03 46.93 169.91 133.74 48.35 coo 115.66 49.12 8.60 111.19 49.52 4.73 168.56 136.65 44.17 170.62 139.01 49.65 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 3 hits 1ohh_c07 naa= 3 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 C 175 LYS A 20 LYS~? 27.72 N9 ADE A 500 C 208 GLN A 112 GLN^? 20.81 C8 ADE A 500 C 209 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 100.54 -2.78 25.52 103.29 2.02 24.05 198.50 157.87 31.43 197.45 157.77 37.73 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 187.82 149.99 31.85 188.55 150.31 33.84 coo 113.62 1.19 33.65 109.52 3.92 36.47 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 C 175 LYS A 94 LYS^? 16.74 N9 ADE A 500 C 208 GLN A 112 GLN^? 20.81 C8 ADE A 500 C 209 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 100.54 -2.78 25.52 103.29 2.02 24.05 189.82 158.18 22.25 194.56 162.25 23.07 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 187.82 149.99 31.85 188.55 150.31 33.84 coo 113.62 1.19 33.65 109.52 3.92 36.47 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 C 175 LYS B 20 LYS~? 34.92 O4 CIT A1102 C 208 GLN B 112 GLN^? 26.54 O4 CIT A1102 C 209 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 100.54 -2.78 25.52 103.29 2.02 24.05 186.73 109.97 17.12 190.68 107.86 12.58 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 191.75 121.43 11.28 193.26 119.92 11.27 coo 113.62 1.19 33.65 109.52 3.92 36.47 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 C 175 LYS B 94 LYS^? 27.17 C2 CIT A1102 C 208 GLN B 112 GLN^? 26.54 O4 CIT A1102 C 209 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 100.54 -2.78 25.52 103.29 2.02 24.05 179.28 118.69 11.71 177.59 112.91 13.79 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 191.75 121.43 11.28 193.26 119.92 11.27 coo 113.62 1.19 33.65 109.52 3.92 36.47 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 5 3 # 5 C 175 LYS C 20 LYS~? 29.81 O3 GOL C1901 C 208 GLN C 112 GLN^? 24.26 O1 GOL C1901 C 209 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 100.54 -2.78 25.52 103.29 2.02 24.05 163.54 128.31 58.75 169.18 130.90 60.17 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 168.50 133.03 46.93 169.91 133.74 48.35 coo 113.62 1.19 33.65 109.52 3.92 36.47 168.56 136.65 44.17 170.62 139.01 49.65 ULMN 3 1ohh_c08 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 6 3 # 6 C 175 LYS C 94 LYS^? 16.92 O3 GOL C1901 C 208 GLN C 112 GLN^? 24.26 O1 GOL C1901 C 209 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 100.54 -2.78 25.52 103.29 2.02 24.05 161.58 122.48 47.40 160.49 120.58 53.33 coo 111.02 -1.31 30.92 109.87 -2.78 29.89 168.50 133.03 46.93 169.91 133.74 48.35 coo 113.62 1.19 33.65 109.52 3.92 36.47 168.56 136.65 44.17 170.62 139.01 49.65 1ohh_c08 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 6 hits 1ohh_c08 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 A 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -3.50 124.89 25.05 -2.25 124.77 23.26 203.35 139.46 11.01 205.31 139.04 11.69 coo 1.87 119.38 16.45 1.41 122.11 16.84 198.66 149.45 16.16 201.00 150.74 16.95 coo -2.59 124.07 12.67 -0.91 126.17 18.42 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 A 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -3.50 124.89 25.05 -2.25 124.77 23.26 203.35 139.46 11.01 205.31 139.04 11.69 coo 1.87 119.38 16.45 1.41 122.11 16.84 192.51 141.71 13.59 192.79 138.96 13.21 coo -2.59 124.07 12.67 -0.91 126.17 18.42 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 A 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -3.50 124.89 25.05 -2.25 124.77 23.26 178.67 130.13 34.24 179.32 129.31 36.04 coo 1.87 119.38 16.45 1.41 122.11 16.84 177.82 122.79 24.63 178.10 120.27 25.77 coo -2.59 124.07 12.67 -0.91 126.17 18.42 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 A 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -3.50 124.89 25.05 -2.25 124.77 23.26 178.67 130.13 34.24 179.32 129.31 36.04 coo 1.87 119.38 16.45 1.41 122.11 16.84 179.54 132.93 23.44 180.82 135.06 24.75 coo -2.59 124.07 12.67 -0.91 126.17 18.42 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 A 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 A 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 A 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -3.50 124.89 25.05 -2.25 124.77 23.26 140.93 137.00 45.78 140.14 138.07 47.46 coo 1.87 119.38 16.45 1.41 122.11 16.84 149.80 129.36 48.45 149.55 129.08 51.21 coo -2.59 124.07 12.67 -0.91 126.17 18.42 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 A 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 A 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 A 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -3.50 124.89 25.05 -2.25 124.77 23.26 140.93 137.00 45.78 140.14 138.07 47.46 coo 1.87 119.38 16.45 1.41 122.11 16.84 149.52 133.95 39.18 148.57 136.34 38.09 coo -2.59 124.07 12.67 -0.91 126.17 18.42 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 B 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 B 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -7.43 109.06 51.23 -5.84 110.54 50.86 203.35 139.46 11.01 205.31 139.04 11.69 coo 0.22 114.56 44.62 -0.76 115.18 47.18 198.66 149.45 16.16 201.00 150.74 16.95 coo -4.18 120.17 46.85 -4.02 115.31 51.00 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 B 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 B 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -7.43 109.06 51.23 -5.84 110.54 50.86 203.35 139.46 11.01 205.31 139.04 11.69 coo 0.22 114.56 44.62 -0.76 115.18 47.18 192.51 141.71 13.59 192.79 138.96 13.21 coo -4.18 120.17 46.85 -4.02 115.31 51.00 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 B 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -7.43 109.06 51.23 -5.84 110.54 50.86 178.67 130.13 34.24 179.32 129.31 36.04 coo 0.22 114.56 44.62 -0.76 115.18 47.18 177.82 122.79 24.63 178.10 120.27 25.77 coo -4.18 120.17 46.85 -4.02 115.31 51.00 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 B 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -7.43 109.06 51.23 -5.84 110.54 50.86 178.67 130.13 34.24 179.32 129.31 36.04 coo 0.22 114.56 44.62 -0.76 115.18 47.18 179.54 132.93 23.44 180.82 135.06 24.75 coo -4.18 120.17 46.85 -4.02 115.31 51.00 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 B 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 B 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 B 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -7.43 109.06 51.23 -5.84 110.54 50.86 140.93 137.00 45.78 140.14 138.07 47.46 coo 0.22 114.56 44.62 -0.76 115.18 47.18 149.80 129.36 48.45 149.55 129.08 51.21 coo -4.18 120.17 46.85 -4.02 115.31 51.00 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 B 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 B 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 B 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -7.43 109.06 51.23 -5.84 110.54 50.86 140.93 137.00 45.78 140.14 138.07 47.46 coo 0.22 114.56 44.62 -0.76 115.18 47.18 149.52 133.95 39.18 148.57 136.34 38.09 coo -4.18 120.17 46.85 -4.02 115.31 51.00 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 C 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 C 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -13.49 79.65 43.90 -12.13 80.29 45.45 203.35 139.46 11.01 205.31 139.04 11.69 coo -5.65 86.78 48.49 -7.16 84.72 49.65 198.66 149.45 16.16 201.00 150.74 16.95 coo -11.22 87.18 53.49 -10.94 81.64 50.31 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 C 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 C 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -13.49 79.65 43.90 -12.13 80.29 45.45 203.35 139.46 11.01 205.31 139.04 11.69 coo -5.65 86.78 48.49 -7.16 84.72 49.65 192.51 141.71 13.59 192.79 138.96 13.21 coo -11.22 87.18 53.49 -10.94 81.64 50.31 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 C 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 C 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -13.49 79.65 43.90 -12.13 80.29 45.45 178.67 130.13 34.24 179.32 129.31 36.04 coo -5.65 86.78 48.49 -7.16 84.72 49.65 177.82 122.79 24.63 178.10 120.27 25.77 coo -11.22 87.18 53.49 -10.94 81.64 50.31 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 C 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 C 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -13.49 79.65 43.90 -12.13 80.29 45.45 178.67 130.13 34.24 179.32 129.31 36.04 coo -5.65 86.78 48.49 -7.16 84.72 49.65 179.54 132.93 23.44 180.82 135.06 24.75 coo -11.22 87.18 53.49 -10.94 81.64 50.31 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 C 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 C 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 C 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -13.49 79.65 43.90 -12.13 80.29 45.45 140.93 137.00 45.78 140.14 138.07 47.46 coo -5.65 86.78 48.49 -7.16 84.72 49.65 149.80 129.36 48.45 149.55 129.08 51.21 coo -11.22 87.18 53.49 -10.94 81.64 50.31 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 C 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 C 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 C 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -13.49 79.65 43.90 -12.13 80.29 45.45 140.93 137.00 45.78 140.14 138.07 47.46 coo -5.65 86.78 48.49 -7.16 84.72 49.65 149.52 133.95 39.18 148.57 136.34 38.09 coo -11.22 87.18 53.49 -10.94 81.64 50.31 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 D 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 D 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -13.44 77.36 13.12 -12.53 75.97 14.48 203.35 139.46 11.01 205.31 139.04 11.69 coo -7.85 74.44 22.75 -9.22 72.86 20.89 198.66 149.45 16.16 201.00 150.74 16.95 coo -14.24 70.61 23.48 -12.55 71.73 17.42 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 D 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 D 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -13.44 77.36 13.12 -12.53 75.97 14.48 203.35 139.46 11.01 205.31 139.04 11.69 coo -7.85 74.44 22.75 -9.22 72.86 20.89 192.51 141.71 13.59 192.79 138.96 13.21 coo -14.24 70.61 23.48 -12.55 71.73 17.42 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 D 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 D 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -13.44 77.36 13.12 -12.53 75.97 14.48 178.67 130.13 34.24 179.32 129.31 36.04 coo -7.85 74.44 22.75 -9.22 72.86 20.89 177.82 122.79 24.63 178.10 120.27 25.77 coo -14.24 70.61 23.48 -12.55 71.73 17.42 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 D 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 D 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -13.44 77.36 13.12 -12.53 75.97 14.48 178.67 130.13 34.24 179.32 129.31 36.04 coo -7.85 74.44 22.75 -9.22 72.86 20.89 179.54 132.93 23.44 180.82 135.06 24.75 coo -14.24 70.61 23.48 -12.55 71.73 17.42 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 D 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 D 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 D 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -13.44 77.36 13.12 -12.53 75.97 14.48 140.93 137.00 45.78 140.14 138.07 47.46 coo -7.85 74.44 22.75 -9.22 72.86 20.89 149.80 129.36 48.45 149.55 129.08 51.21 coo -14.24 70.61 23.48 -12.55 71.73 17.42 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 D 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 D 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 D 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -13.44 77.36 13.12 -12.53 75.97 14.48 140.93 137.00 45.78 140.14 138.07 47.46 coo -7.85 74.44 22.75 -9.22 72.86 20.89 149.52 133.95 39.18 148.57 136.34 38.09 coo -14.24 70.61 23.48 -12.55 71.73 17.42 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 E 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 E 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -7.12 105.25 1.43 -6.30 103.34 0.77 203.35 139.46 11.01 205.31 139.04 11.69 coo -3.11 94.55 3.01 -3.83 95.92 0.66 198.66 149.45 16.16 201.00 150.74 16.95 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 E 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 E 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -7.12 105.25 1.43 -6.30 103.34 0.77 203.35 139.46 11.01 205.31 139.04 11.69 coo -3.11 94.55 3.01 -3.83 95.92 0.66 192.51 141.71 13.59 192.79 138.96 13.21 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 E 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 E 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -7.12 105.25 1.43 -6.30 103.34 0.77 178.67 130.13 34.24 179.32 129.31 36.04 coo -3.11 94.55 3.01 -3.83 95.92 0.66 177.82 122.79 24.63 178.10 120.27 25.77 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 E 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 E 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -7.12 105.25 1.43 -6.30 103.34 0.77 178.67 130.13 34.24 179.32 129.31 36.04 coo -3.11 94.55 3.01 -3.83 95.92 0.66 179.54 132.93 23.44 180.82 135.06 24.75 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 E 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 E 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 E 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -7.12 105.25 1.43 -6.30 103.34 0.77 140.93 137.00 45.78 140.14 138.07 47.46 coo -3.11 94.55 3.01 -3.83 95.92 0.66 149.80 129.36 48.45 149.55 129.08 51.21 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 E 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 E 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 E 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -7.12 105.25 1.43 -6.30 103.34 0.77 140.93 137.00 45.78 140.14 138.07 47.46 coo -3.11 94.55 3.01 -3.83 95.92 0.66 149.52 133.95 39.18 148.57 136.34 38.09 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 F 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 F 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -44.75 128.15 10.28 -45.68 129.67 11.55 203.35 139.46 11.01 205.31 139.04 11.69 coo -50.43 131.90 19.60 -49.04 133.31 17.60 198.66 149.45 16.16 201.00 150.74 16.95 coo -44.10 135.86 19.99 -45.67 134.21 14.07 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 F 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 F 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -44.75 128.15 10.28 -45.68 129.67 11.55 203.35 139.46 11.01 205.31 139.04 11.69 coo -50.43 131.90 19.60 -49.04 133.31 17.60 192.51 141.71 13.59 192.79 138.96 13.21 coo -44.10 135.86 19.99 -45.67 134.21 14.07 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 F 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 F 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -44.75 128.15 10.28 -45.68 129.67 11.55 178.67 130.13 34.24 179.32 129.31 36.04 coo -50.43 131.90 19.60 -49.04 133.31 17.60 177.82 122.79 24.63 178.10 120.27 25.77 coo -44.10 135.86 19.99 -45.67 134.21 14.07 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 F 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 F 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -44.75 128.15 10.28 -45.68 129.67 11.55 178.67 130.13 34.24 179.32 129.31 36.04 coo -50.43 131.90 19.60 -49.04 133.31 17.60 179.54 132.93 23.44 180.82 135.06 24.75 coo -44.10 135.86 19.99 -45.67 134.21 14.07 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 F 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 F 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 F 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -44.75 128.15 10.28 -45.68 129.67 11.55 140.93 137.00 45.78 140.14 138.07 47.46 coo -50.43 131.90 19.60 -49.04 133.31 17.60 149.80 129.36 48.45 149.55 129.08 51.21 coo -44.10 135.86 19.99 -45.67 134.21 14.07 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 F 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 F 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 F 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -44.75 128.15 10.28 -45.68 129.67 11.55 140.93 137.00 45.78 140.14 138.07 47.46 coo -50.43 131.90 19.60 -49.04 133.31 17.60 149.52 133.95 39.18 148.57 136.34 38.09 coo -44.10 135.86 19.99 -45.67 134.21 14.07 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 G 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 G 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -44.97 128.78 41.20 -46.32 128.26 42.83 203.35 139.46 11.01 205.31 139.04 11.69 coo -52.83 122.13 46.42 -51.31 124.30 47.39 198.66 149.45 16.16 201.00 150.74 16.95 coo -47.30 122.24 51.49 -47.46 127.44 47.81 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 G 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 G 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -44.97 128.78 41.20 -46.32 128.26 42.83 203.35 139.46 11.01 205.31 139.04 11.69 coo -52.83 122.13 46.42 -51.31 124.30 47.39 192.51 141.71 13.59 192.79 138.96 13.21 coo -47.30 122.24 51.49 -47.46 127.44 47.81 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 G 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 G 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -44.97 128.78 41.20 -46.32 128.26 42.83 178.67 130.13 34.24 179.32 129.31 36.04 coo -52.83 122.13 46.42 -51.31 124.30 47.39 177.82 122.79 24.63 178.10 120.27 25.77 coo -47.30 122.24 51.49 -47.46 127.44 47.81 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 G 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 G 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -44.97 128.78 41.20 -46.32 128.26 42.83 178.67 130.13 34.24 179.32 129.31 36.04 coo -52.83 122.13 46.42 -51.31 124.30 47.39 179.54 132.93 23.44 180.82 135.06 24.75 coo -47.30 122.24 51.49 -47.46 127.44 47.81 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 G 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 G 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 G 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -44.97 128.78 41.20 -46.32 128.26 42.83 140.93 137.00 45.78 140.14 138.07 47.46 coo -52.83 122.13 46.42 -51.31 124.30 47.39 149.80 129.36 48.45 149.55 129.08 51.21 coo -47.30 122.24 51.49 -47.46 127.44 47.81 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 G 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 G 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 G 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -44.97 128.78 41.20 -46.32 128.26 42.83 140.93 137.00 45.78 140.14 138.07 47.46 coo -52.83 122.13 46.42 -51.31 124.30 47.39 149.52 133.95 39.18 148.57 136.34 38.09 coo -47.30 122.24 51.49 -47.46 127.44 47.81 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 H 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 H 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -51.11 100.30 51.41 -52.67 98.82 51.12 203.35 139.46 11.01 205.31 139.04 11.69 coo -58.70 94.17 45.32 -57.76 93.82 47.92 198.66 149.45 16.16 201.00 150.74 16.95 coo -54.32 88.79 48.13 -54.61 94.04 51.74 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 H 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 H 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -51.11 100.30 51.41 -52.67 98.82 51.12 203.35 139.46 11.01 205.31 139.04 11.69 coo -58.70 94.17 45.32 -57.76 93.82 47.92 192.51 141.71 13.59 192.79 138.96 13.21 coo -54.32 88.79 48.13 -54.61 94.04 51.74 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 H 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 H 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -51.11 100.30 51.41 -52.67 98.82 51.12 178.67 130.13 34.24 179.32 129.31 36.04 coo -58.70 94.17 45.32 -57.76 93.82 47.92 177.82 122.79 24.63 178.10 120.27 25.77 coo -54.32 88.79 48.13 -54.61 94.04 51.74 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 H 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 H 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -51.11 100.30 51.41 -52.67 98.82 51.12 178.67 130.13 34.24 179.32 129.31 36.04 coo -58.70 94.17 45.32 -57.76 93.82 47.92 179.54 132.93 23.44 180.82 135.06 24.75 coo -54.32 88.79 48.13 -54.61 94.04 51.74 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 H 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 H 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 H 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -51.11 100.30 51.41 -52.67 98.82 51.12 140.93 137.00 45.78 140.14 138.07 47.46 coo -58.70 94.17 45.32 -57.76 93.82 47.92 149.80 129.36 48.45 149.55 129.08 51.21 coo -54.32 88.79 48.13 -54.61 94.04 51.74 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 H 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 H 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 H 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -51.11 100.30 51.41 -52.67 98.82 51.12 140.93 137.00 45.78 140.14 138.07 47.46 coo -58.70 94.17 45.32 -57.76 93.82 47.92 149.52 133.95 39.18 148.57 136.34 38.09 coo -54.32 88.79 48.13 -54.61 94.04 51.74 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 I 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 I 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -54.65 81.97 26.87 -55.88 81.89 25.07 203.35 139.46 11.01 205.31 139.04 11.69 coo -59.92 86.62 17.74 -59.42 83.94 18.40 198.66 149.45 16.16 201.00 150.74 16.95 coo -55.38 81.61 14.50 -57.11 80.05 20.41 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 I 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 I 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -54.65 81.97 26.87 -55.88 81.89 25.07 203.35 139.46 11.01 205.31 139.04 11.69 coo -59.92 86.62 17.74 -59.42 83.94 18.40 192.51 141.71 13.59 192.79 138.96 13.21 coo -55.38 81.61 14.50 -57.11 80.05 20.41 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 I 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 I 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -54.65 81.97 26.87 -55.88 81.89 25.07 178.67 130.13 34.24 179.32 129.31 36.04 coo -59.92 86.62 17.74 -59.42 83.94 18.40 177.82 122.79 24.63 178.10 120.27 25.77 coo -55.38 81.61 14.50 -57.11 80.05 20.41 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 I 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 I 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -54.65 81.97 26.87 -55.88 81.89 25.07 178.67 130.13 34.24 179.32 129.31 36.04 coo -59.92 86.62 17.74 -59.42 83.94 18.40 179.54 132.93 23.44 180.82 135.06 24.75 coo -55.38 81.61 14.50 -57.11 80.05 20.41 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 I 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 I 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 I 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -54.65 81.97 26.87 -55.88 81.89 25.07 140.93 137.00 45.78 140.14 138.07 47.46 coo -59.92 86.62 17.74 -59.42 83.94 18.40 149.80 129.36 48.45 149.55 129.08 51.21 coo -55.38 81.61 14.50 -57.11 80.05 20.41 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 I 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 I 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 I 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -54.65 81.97 26.87 -55.88 81.89 25.07 140.93 137.00 45.78 140.14 138.07 47.46 coo -59.92 86.62 17.74 -59.42 83.94 18.40 149.52 133.95 39.18 148.57 136.34 38.09 coo -55.38 81.61 14.50 -57.11 80.05 20.41 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 J 146 TYR A 47 TYR^? 13.72 N3 ADE A 500 J 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -50.64 99.08 1.52 -51.52 100.83 0.67 203.35 139.46 11.01 205.31 139.04 11.69 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 198.66 149.45 16.16 201.00 150.74 16.95 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 36 ASP~? 21.71 N6 ADE A 500 J 146 TYR A 83 TYR^? 11.70 N6 ADE A 500 J 177 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -50.64 99.08 1.52 -51.52 100.83 0.67 203.35 139.46 11.01 205.31 139.04 11.69 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 192.51 141.71 13.59 192.79 138.96 13.21 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 J 146 TYR B 47 TYR^? 27.62 O4 CIT A1102 J 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -50.64 99.08 1.52 -51.52 100.83 0.67 178.67 130.13 34.24 179.32 129.31 36.04 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 177.82 122.79 24.63 178.10 120.27 25.77 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP B 36 ASP~? 28.48 O1 GOL C1901 J 146 TYR B 83 TYR^? 20.46 C8 ADE A 500 J 177 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -50.64 99.08 1.52 -51.52 100.83 0.67 178.67 130.13 34.24 179.32 129.31 36.04 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 179.54 132.93 23.44 180.82 135.06 24.75 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 5 3 # 5 J 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 J 146 TYR C 47 TYR^? 13.41 O3 GOL C1901 J 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -50.64 99.08 1.52 -51.52 100.83 0.67 140.93 137.00 45.78 140.14 138.07 47.46 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 149.80 129.36 48.45 149.55 129.08 51.21 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 6 3 # 6 J 24 ASP C 36 ASP~? 21.70 O1 GOL C1901 J 146 TYR C 83 TYR^? 12.44 O1 GOL C1901 J 177 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -50.64 99.08 1.52 -51.52 100.83 0.67 140.93 137.00 45.78 140.14 138.07 47.46 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 149.52 133.95 39.18 148.57 136.34 38.09 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 147.41 128.03 39.92 142.61 128.90 38.51 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 6 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 96 GLU B 192 GLU~? 33.56 O4 CIT A1102 A 132 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 31.23 12.29 16.44 30.82 11.56 18.39 174.65 109.33 0.17 174.41 107.27 0.58 coo 26.82 3.20 24.36 27.99 4.86 24.98 188.59 108.97 -3.25 189.65 108.47 -5.00 coo 29.99 0.62 22.18 30.38 6.69 20.81 188.45 111.50 0.09 191.63 115.50 2.10 1onr_c00 source 1onr TRANSALDOLASE B : 1 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 96 GLU B 192 GLU~? 33.56 O4 CIT A1102 B 132 LYS B 193 LYS~? 27.56 O4 CIT A1102 coo 31.16 57.31 -0.94 30.73 56.64 1.01 174.65 109.33 0.17 174.41 107.27 0.58 coo 26.69 48.45 7.18 27.85 50.13 7.74 188.59 108.97 -3.25 189.65 108.47 -5.00 coo 29.82 45.80 5.07 30.26 51.81 3.56 188.45 111.50 0.09 191.63 115.50 2.10 1onr_c01 source 1onr TRANSALDOLASE B : 1 hits 1onr_c01 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 38 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 46 TRP B 139 TRP^? 16.21 O4 CIT A1102 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 186.72 125.72 10.79 185.00 126.80 12.71 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 180.17 131.30 14.36 179.09 129.62 13.64 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 186.72 130.16 9.65 187.54 130.72 13.46 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 1 hits 1p7m_c00 naa= 3 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 3 # 1 A 160 GLU C 155 GLU~? 32.67 O1 GOL C1901 A 297 ASN C 154 ASN~? 23.43 O1 GOL C1901 A 375 GLU C 156 GLU~? 24.55 O1 GOL C1901 coo 63.94 10.02 33.47 64.31 8.24 32.38 159.66 146.89 54.14 160.20 148.86 54.76 coo 59.99 9.39 31.17 60.97 11.14 30.52 160.52 142.23 50.24 158.78 141.09 49.77 coo 61.89 10.05 27.30 63.60 9.39 28.40 157.99 144.71 47.12 158.90 144.92 45.19 ULMN 3 1pbg_c00 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 3 # 2 A 160 GLU C 156 GLU~? 24.55 O1 GOL C1901 A 297 ASN C 154 ASN~? 23.43 O1 GOL C1901 A 375 GLU C 155 GLU~? 32.67 O1 GOL C1901 coo 63.94 10.02 33.47 64.31 8.24 32.38 157.99 144.71 47.12 158.90 144.92 45.19 coo 59.99 9.39 31.17 60.97 11.14 30.52 160.52 142.23 50.24 158.78 141.09 49.77 coo 61.89 10.05 27.30 63.60 9.39 28.40 159.66 146.89 54.14 160.20 148.86 54.76 1pbg_c00 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 2 hits 1pbg_c00 naa= 3 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 3 # 1 B 160 GLU C 155 GLU~? 32.67 O1 GOL C1901 B 297 ASN C 154 ASN~? 23.43 O1 GOL C1901 B 375 GLU C 156 GLU~? 24.55 O1 GOL C1901 coo 23.66 16.69 85.20 24.17 18.76 84.94 159.66 146.89 54.14 160.20 148.86 54.76 coo 19.74 18.67 86.53 20.70 17.86 88.21 160.52 142.23 50.24 158.78 141.09 49.77 coo 21.67 20.74 89.92 23.35 20.55 88.67 157.99 144.71 47.12 158.90 144.92 45.19 ULMN 3 1pbg_c01 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 3 # 2 B 160 GLU C 156 GLU~? 24.55 O1 GOL C1901 B 297 ASN C 154 ASN~? 23.43 O1 GOL C1901 B 375 GLU C 155 GLU~? 32.67 O1 GOL C1901 coo 23.66 16.69 85.20 24.17 18.76 84.94 157.99 144.71 47.12 158.90 144.92 45.19 coo 19.74 18.67 86.53 20.70 17.86 88.21 160.52 142.23 50.24 158.78 141.09 49.77 coo 21.67 20.74 89.92 23.35 20.55 88.67 159.66 146.89 54.14 160.20 148.86 54.76 1pbg_c01 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 2 hits 1pbg_c01 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 259 TYR A 47 TYR^? 13.72 N3 ADE A 500 A 552 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 11.34 95.90 25.54 12.13 96.42 23.67 191.47 153.75 14.17 189.52 154.05 13.44 coo 14.91 97.39 18.63 13.39 95.60 20.20 198.66 149.45 16.16 201.00 150.74 16.95 coo 46.37 82.54 38.83 45.97 84.66 38.77 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 259 TYR A 47 TYR^? 13.72 N3 ADE A 500 A 552 ASP C 130 ASP.? 30.92 O1 GOL C1901 coo 11.34 95.90 25.54 12.13 96.42 23.67 191.47 153.75 14.17 189.52 154.05 13.44 coo 14.91 97.39 18.63 13.39 95.60 20.20 198.66 149.45 16.16 201.00 150.74 16.95 coo 46.37 82.54 38.83 45.97 84.66 38.77 167.73 145.95 43.64 168.62 147.66 44.50 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 259 TYR B 47 TYR^? 27.62 O4 CIT A1102 A 552 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 11.34 95.90 25.54 12.13 96.42 23.67 174.27 123.90 17.18 173.55 124.80 15.43 coo 14.91 97.39 18.63 13.39 95.60 20.20 177.82 122.79 24.63 178.10 120.27 25.77 coo 46.37 82.54 38.83 45.97 84.66 38.77 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 259 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 552 ASP C 172 ASP~? 9.22 O2 GOL C1901 coo 11.34 95.90 25.54 12.13 96.42 23.67 183.49 131.36 11.56 181.98 130.36 10.51 coo 14.91 97.39 18.63 13.39 95.60 20.20 186.72 125.72 10.79 185.00 126.80 12.71 coo 46.37 82.54 38.83 45.97 84.66 38.77 153.21 116.81 30.64 152.37 114.88 30.62 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 259 TYR C 47 TYR^? 13.41 O3 GOL C1901 A 552 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo 11.34 95.90 25.54 12.13 96.42 23.67 153.36 123.09 43.85 154.03 121.98 42.20 coo 14.91 97.39 18.63 13.39 95.60 20.20 149.80 129.36 48.45 149.55 129.08 51.21 coo 46.37 82.54 38.83 45.97 84.66 38.77 188.71 136.74 34.61 188.50 136.01 36.57 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 5 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 194 ALA~? 24.12 N9 ADE A 500 A 126 LEU A 185 LEU~? 20.19 N9 ADE A 500 A 158 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo -2.29 37.66 144.73 -1.46 37.12 145.87 184.86 165.44 32.34 184.45 166.79 31.77 coo -4.62 32.83 147.14 -5.50 32.85 149.12 184.18 165.92 27.88 184.62 163.92 28.49 coo -0.83 29.57 149.77 -0.39 31.47 148.95 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 201 ALA~? 17.12 N9 ADE A 500 A 126 LEU A 179 LEU.? 15.79 N9 ADE A 500 A 158 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo -2.29 37.66 144.73 -1.46 37.12 145.87 189.52 162.53 24.76 188.43 163.45 25.31 coo -4.62 32.83 147.14 -5.50 32.85 149.12 184.39 163.22 22.10 184.20 164.27 23.98 coo -0.83 29.57 149.77 -0.39 31.47 148.95 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 201 ALA~? 17.12 N9 ADE A 500 A 126 LEU A 185 LEU~? 20.19 N9 ADE A 500 A 158 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo -2.29 37.66 144.73 -1.46 37.12 145.87 189.52 162.53 24.76 188.43 163.45 25.31 coo -4.62 32.83 147.14 -5.50 32.85 149.12 184.18 165.92 27.88 184.62 163.92 28.49 coo -0.83 29.57 149.77 -0.39 31.47 148.95 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA B 194 ALA~? 27.91 C2 CIT A1102 A 126 LEU B 185 LEU~? 24.65 C2 CIT A1102 A 158 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo -2.29 37.66 144.73 -1.46 37.12 145.87 184.96 111.42 1.60 183.70 111.01 0.84 coo -4.62 32.83 147.14 -5.50 32.85 149.12 179.94 113.22 2.09 181.93 113.55 2.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA B 201 ALA.? 25.06 C2 CIT A1102 A 126 LEU B 179 LEU.? 19.82 C2 CIT A1102 A 158 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo -2.29 37.66 144.73 -1.46 37.12 145.87 179.08 113.99 8.58 179.23 113.12 7.33 coo -4.62 32.83 147.14 -5.50 32.85 149.12 175.42 117.47 3.45 176.95 116.74 4.78 coo -0.83 29.57 149.77 -0.39 31.47 148.95 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 201 ALA.? 25.06 C2 CIT A1102 A 126 LEU B 185 LEU~? 24.65 C2 CIT A1102 A 158 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo -2.29 37.66 144.73 -1.46 37.12 145.87 179.08 113.99 8.58 179.23 113.12 7.33 coo -4.62 32.83 147.14 -5.50 32.85 149.12 179.94 113.22 2.09 181.93 113.55 2.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA C 194 ALA~? 26.52 O3 GOL C1901 A 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 A 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo -2.29 37.66 144.73 -1.46 37.12 145.87 174.02 118.87 51.06 174.07 117.35 50.94 coo -4.62 32.83 147.14 -5.50 32.85 149.12 170.83 116.75 48.61 170.51 118.87 48.39 coo -0.83 29.57 149.77 -0.39 31.47 148.95 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA C 198 ALA~? 24.12 O3 GOL C1901 A 126 LEU C 197 LEU~? 23.74 C1 GOL C1901 A 158 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo -2.29 37.66 144.73 -1.46 37.12 145.87 168.86 120.30 53.31 169.26 119.70 54.63 coo -4.62 32.83 147.14 -5.50 32.85 149.12 171.31 122.49 49.83 172.36 123.89 48.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 A 126 LEU C 179 LEU.? 17.41 O3 GOL C1901 A 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo -2.29 37.66 144.73 -1.46 37.12 145.87 164.63 119.64 49.73 165.82 118.76 49.44 coo -4.62 32.83 147.14 -5.50 32.85 149.12 165.23 116.77 45.20 167.34 116.76 45.58 coo -0.83 29.57 149.77 -0.39 31.47 148.95 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 A 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 A 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 A 158 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -2.29 37.66 144.73 -1.46 37.12 145.87 164.63 119.64 49.73 165.82 118.76 49.44 coo -4.62 32.83 147.14 -5.50 32.85 149.12 170.83 116.75 48.61 170.51 118.87 48.39 coo -0.83 29.57 149.77 -0.39 31.47 148.95 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 A 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 A 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 A 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo -2.29 37.66 144.73 -1.46 37.12 145.87 164.63 119.64 49.73 165.82 118.76 49.44 coo -4.62 32.83 147.14 -5.50 32.85 149.12 170.83 116.75 48.61 170.51 118.87 48.39 coo -0.83 29.57 149.77 -0.39 31.47 148.95 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 A 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 A 126 LEU C 197 LEU~? 23.74 C1 GOL C1901 A 158 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -2.29 37.66 144.73 -1.46 37.12 145.87 164.63 119.64 49.73 165.82 118.76 49.44 coo -4.62 32.83 147.14 -5.50 32.85 149.12 171.31 122.49 49.83 172.36 123.89 48.55 coo -0.83 29.57 149.77 -0.39 31.47 148.95 170.51 115.98 53.19 171.23 115.96 55.18 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 12 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 194 ALA~? 24.12 N9 ADE A 500 B 126 LEU A 185 LEU~? 20.19 N9 ADE A 500 B 158 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo -39.79 4.61 147.27 -39.61 5.56 148.47 184.86 165.44 32.34 184.45 166.79 31.77 coo -34.22 5.06 149.25 -33.65 4.24 151.15 184.18 165.92 27.88 184.62 163.92 28.49 coo -33.03 9.93 151.71 -34.98 9.38 151.11 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 201 ALA~? 17.12 N9 ADE A 500 B 126 LEU A 179 LEU.? 15.79 N9 ADE A 500 B 158 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo -39.79 4.61 147.27 -39.61 5.56 148.47 189.52 162.53 24.76 188.43 163.45 25.31 coo -34.22 5.06 149.25 -33.65 4.24 151.15 184.39 163.22 22.10 184.20 164.27 23.98 coo -33.03 9.93 151.71 -34.98 9.38 151.11 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 201 ALA~? 17.12 N9 ADE A 500 B 126 LEU A 185 LEU~? 20.19 N9 ADE A 500 B 158 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo -39.79 4.61 147.27 -39.61 5.56 148.47 189.52 162.53 24.76 188.43 163.45 25.31 coo -34.22 5.06 149.25 -33.65 4.24 151.15 184.18 165.92 27.88 184.62 163.92 28.49 coo -33.03 9.93 151.71 -34.98 9.38 151.11 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA B 194 ALA~? 27.91 C2 CIT A1102 B 126 LEU B 185 LEU~? 24.65 C2 CIT A1102 B 158 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo -39.79 4.61 147.27 -39.61 5.56 148.47 184.96 111.42 1.60 183.70 111.01 0.84 coo -34.22 5.06 149.25 -33.65 4.24 151.15 179.94 113.22 2.09 181.93 113.55 2.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA B 201 ALA.? 25.06 C2 CIT A1102 B 126 LEU B 179 LEU.? 19.82 C2 CIT A1102 B 158 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo -39.79 4.61 147.27 -39.61 5.56 148.47 179.08 113.99 8.58 179.23 113.12 7.33 coo -34.22 5.06 149.25 -33.65 4.24 151.15 175.42 117.47 3.45 176.95 116.74 4.78 coo -33.03 9.93 151.71 -34.98 9.38 151.11 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA B 201 ALA.? 25.06 C2 CIT A1102 B 126 LEU B 185 LEU~? 24.65 C2 CIT A1102 B 158 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo -39.79 4.61 147.27 -39.61 5.56 148.47 179.08 113.99 8.58 179.23 113.12 7.33 coo -34.22 5.06 149.25 -33.65 4.24 151.15 179.94 113.22 2.09 181.93 113.55 2.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA C 194 ALA~? 26.52 O3 GOL C1901 B 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 B 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo -39.79 4.61 147.27 -39.61 5.56 148.47 174.02 118.87 51.06 174.07 117.35 50.94 coo -34.22 5.06 149.25 -33.65 4.24 151.15 170.83 116.75 48.61 170.51 118.87 48.39 coo -33.03 9.93 151.71 -34.98 9.38 151.11 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA C 198 ALA~? 24.12 O3 GOL C1901 B 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 B 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo -39.79 4.61 147.27 -39.61 5.56 148.47 168.86 120.30 53.31 169.26 119.70 54.63 coo -34.22 5.06 149.25 -33.65 4.24 151.15 170.83 116.75 48.61 170.51 118.87 48.39 coo -33.03 9.93 151.71 -34.98 9.38 151.11 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA C 198 ALA~? 24.12 O3 GOL C1901 B 126 LEU C 197 LEU~? 23.74 C1 GOL C1901 B 158 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo -39.79 4.61 147.27 -39.61 5.56 148.47 168.86 120.30 53.31 169.26 119.70 54.63 coo -34.22 5.06 149.25 -33.65 4.24 151.15 171.31 122.49 49.83 172.36 123.89 48.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 B 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 B 126 LEU C 179 LEU.? 17.41 O3 GOL C1901 B 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo -39.79 4.61 147.27 -39.61 5.56 148.47 164.63 119.64 49.73 165.82 118.76 49.44 coo -34.22 5.06 149.25 -33.65 4.24 151.15 165.23 116.77 45.20 167.34 116.76 45.58 coo -33.03 9.93 151.71 -34.98 9.38 151.11 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 B 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 B 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 B 158 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -39.79 4.61 147.27 -39.61 5.56 148.47 164.63 119.64 49.73 165.82 118.76 49.44 coo -34.22 5.06 149.25 -33.65 4.24 151.15 170.83 116.75 48.61 170.51 118.87 48.39 coo -33.03 9.93 151.71 -34.98 9.38 151.11 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 B 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 B 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 B 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo -39.79 4.61 147.27 -39.61 5.56 148.47 164.63 119.64 49.73 165.82 118.76 49.44 coo -34.22 5.06 149.25 -33.65 4.24 151.15 170.83 116.75 48.61 170.51 118.87 48.39 coo -33.03 9.93 151.71 -34.98 9.38 151.11 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 13 3 # 13 B 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 B 126 LEU C 197 LEU~? 23.74 C1 GOL C1901 B 158 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo -39.79 4.61 147.27 -39.61 5.56 148.47 164.63 119.64 49.73 165.82 118.76 49.44 coo -34.22 5.06 149.25 -33.65 4.24 151.15 171.31 122.49 49.83 172.36 123.89 48.55 coo -33.03 9.93 151.71 -34.98 9.38 151.11 170.51 115.98 53.19 171.23 115.96 55.18 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 13 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 194 ALA~? 24.12 N9 ADE A 500 C 126 LEU A 185 LEU~? 20.19 N9 ADE A 500 C 158 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 184.86 165.44 32.34 184.45 166.79 31.77 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 184.18 165.92 27.88 184.62 163.92 28.49 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 201 ALA~? 17.12 N9 ADE A 500 C 126 LEU A 179 LEU.? 15.79 N9 ADE A 500 C 158 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 189.52 162.53 24.76 188.43 163.45 25.31 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 184.39 163.22 22.10 184.20 164.27 23.98 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 201 ALA~? 17.12 N9 ADE A 500 C 126 LEU A 185 LEU~? 20.19 N9 ADE A 500 C 158 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 189.52 162.53 24.76 188.43 163.45 25.31 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 184.18 165.92 27.88 184.62 163.92 28.49 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA B 194 ALA~? 27.91 C2 CIT A1102 C 126 LEU B 185 LEU~? 24.65 C2 CIT A1102 C 158 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 184.96 111.42 1.60 183.70 111.01 0.84 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 179.94 113.22 2.09 181.93 113.55 2.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA B 201 ALA.? 25.06 C2 CIT A1102 C 126 LEU B 179 LEU.? 19.82 C2 CIT A1102 C 158 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 179.08 113.99 8.58 179.23 113.12 7.33 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 175.42 117.47 3.45 176.95 116.74 4.78 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 201 ALA.? 25.06 C2 CIT A1102 C 126 LEU B 185 LEU~? 24.65 C2 CIT A1102 C 158 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 179.08 113.99 8.58 179.23 113.12 7.33 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 179.94 113.22 2.09 181.93 113.55 2.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA C 194 ALA~? 26.52 O3 GOL C1901 C 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 C 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 174.02 118.87 51.06 174.07 117.35 50.94 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 170.83 116.75 48.61 170.51 118.87 48.39 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA C 198 ALA~? 24.12 O3 GOL C1901 C 126 LEU C 197 LEU~? 23.74 C1 GOL C1901 C 158 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 168.86 120.30 53.31 169.26 119.70 54.63 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 171.31 122.49 49.83 172.36 123.89 48.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 C 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 C 126 LEU C 179 LEU.? 17.41 O3 GOL C1901 C 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 164.63 119.64 49.73 165.82 118.76 49.44 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 165.23 116.77 45.20 167.34 116.76 45.58 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 10 3 # 10 C 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 C 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 C 158 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 164.63 119.64 49.73 165.82 118.76 49.44 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 170.83 116.75 48.61 170.51 118.87 48.39 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 11 3 # 11 C 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 C 126 LEU C 185 LEU~? 22.40 O3 GOL C1901 C 158 GLU C 184 GLU~? 18.70 O3 GOL C1901 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 164.63 119.64 49.73 165.82 118.76 49.44 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 170.83 116.75 48.61 170.51 118.87 48.39 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 168.68 112.73 44.51 166.86 112.61 43.45 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 12 3 # 12 C 70 ALA C 201 ALA~? 18.41 O3 GOL C1901 C 126 LEU C 197 LEU~? 23.74 C1 GOL C1901 C 158 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 164.63 119.64 49.73 165.82 118.76 49.44 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 171.31 122.49 49.83 172.36 123.89 48.55 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 170.51 115.98 53.19 171.23 115.96 55.18 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 12 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c03 SIROHEME SYNTHASE user 1 3 # 1 B 248 ASP C 175 ASP.? 10.66 O1 GOL C1901 B 270 LYS C 62 LYS^? 15.99 O2 GOL C1901 B 382 MET C 58 MET?? 15.27 O1 GOL C1901 coo -11.82 154.51 43.38 -12.86 152.74 43.79 157.90 117.18 31.56 156.68 116.62 29.91 coo -5.09 158.39 43.41 -0.74 158.80 47.15 160.07 111.06 24.23 156.23 109.52 28.21 coo -2.79 145.52 50.38 -5.75 148.14 51.66 152.62 120.30 19.40 155.36 122.65 21.82 1pjq_c03 source 1pjq SIROHEME SYNTHASE : 1 hits 1pjq_c03 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 78 GLN.? -2.82 O3 CIT A1102s 294 GLU A 59 GLU^? 13.22 O6 CIT A1102 304 ARG B 101 ARG.? -6.88 O4 CIT A1102s coo 15.89 18.45 46.53 15.82 16.91 48.02 174.92 143.73 3.06 173.78 141.94 2.87 coo 22.84 13.44 52.91 20.84 13.18 52.38 169.62 150.86 -1.29 170.91 152.08 -2.44 coo 8.71 17.11 46.51 7.23 17.64 49.20 179.40 137.94 3.82 182.23 139.06 3.56 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 107 GLN^? 13.61 N7 ADE A 500 294 GLU A 165 GLU^? 4.52 C8 ADE A 500 304 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 15.89 18.45 46.53 15.82 16.91 48.02 189.72 137.73 19.03 190.31 137.91 17.01 coo 22.84 13.44 52.91 20.84 13.18 52.38 185.43 146.45 17.17 186.00 148.48 17.29 coo 8.71 17.11 46.51 7.23 17.64 49.20 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN A 107 GLN^? 13.61 N7 ADE A 500 294 GLU B 165 GLU^? 13.88 O4 CIT A1102 304 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 15.89 18.45 46.53 15.82 16.91 48.02 189.72 137.73 19.03 190.31 137.91 17.01 coo 22.84 13.44 52.91 20.84 13.18 52.38 180.17 131.30 14.36 179.09 129.62 13.64 coo 8.71 17.11 46.51 7.23 17.64 49.20 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 4 3 # 4 111 GLN B 78 GLN.? 11.42 O5 CIT A1102 294 GLU A 61 GLU^? 16.24 O5 CIT A1102 304 ARG A 101 ARG.? 15.15 C8 ADE A 500 coo 15.89 18.45 46.53 15.82 16.91 48.02 169.82 145.33 10.20 170.62 147.30 10.35 coo 22.84 13.44 52.91 20.84 13.18 52.38 165.65 155.89 5.11 164.98 153.86 5.06 coo 8.71 17.11 46.51 7.23 17.64 49.20 173.48 146.74 16.27 172.57 144.92 18.53 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 5 3 # 5 111 GLN B 78 GLN.? 11.42 O5 CIT A1102 294 GLU B 59 GLU^? 11.03 O1 CIT A1102 304 ARG A 101 ARG.? 15.15 C8 ADE A 500 coo 15.89 18.45 46.53 15.82 16.91 48.02 169.82 145.33 10.20 170.62 147.30 10.35 coo 22.84 13.44 52.91 20.84 13.18 52.38 162.57 145.21 3.58 161.45 143.81 4.68 coo 8.71 17.11 46.51 7.23 17.64 49.20 173.48 146.74 16.27 172.57 144.92 18.53 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 6 3 # 6 111 GLN B 107 GLN^? 17.47 N7 ADE A 500 294 GLU A 165 GLU^? 4.52 C8 ADE A 500 304 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 15.89 18.45 46.53 15.82 16.91 48.02 186.39 134.92 21.23 184.61 135.48 22.22 coo 22.84 13.44 52.91 20.84 13.18 52.38 185.43 146.45 17.17 186.00 148.48 17.29 coo 8.71 17.11 46.51 7.23 17.64 49.20 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 7 3 # 7 111 GLN B 107 GLN^? 17.47 N7 ADE A 500 294 GLU A 165 GLU^? 4.52 C8 ADE A 500 304 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 15.89 18.45 46.53 15.82 16.91 48.02 186.39 134.92 21.23 184.61 135.48 22.22 coo 22.84 13.44 52.91 20.84 13.18 52.38 185.43 146.45 17.17 186.00 148.48 17.29 coo 8.71 17.11 46.51 7.23 17.64 49.20 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 8 3 # 8 111 GLN B 107 GLN^? 17.47 N7 ADE A 500 294 GLU B 165 GLU^? 13.88 O4 CIT A1102 304 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 15.89 18.45 46.53 15.82 16.91 48.02 186.39 134.92 21.23 184.61 135.48 22.22 coo 22.84 13.44 52.91 20.84 13.18 52.38 180.17 131.30 14.36 179.09 129.62 13.64 coo 8.71 17.11 46.51 7.23 17.64 49.20 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 9 3 # 9 111 GLN B 107 GLN^? 17.47 N7 ADE A 500 294 GLU B 165 GLU^? 13.88 O4 CIT A1102 304 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 15.89 18.45 46.53 15.82 16.91 48.02 186.39 134.92 21.23 184.61 135.48 22.22 coo 22.84 13.44 52.91 20.84 13.18 52.38 180.17 131.30 14.36 179.09 129.62 13.64 coo 8.71 17.11 46.51 7.23 17.64 49.20 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 10 3 # 10 111 GLN C 107 GLN^? 15.17 O1 GOL C1901 294 GLU C 165 GLU^? 7.74 O1 GOL C1901 304 ARG C 108 ARG^? 22.96 O1 GOL C1901 coo 15.89 18.45 46.53 15.82 16.91 48.02 154.42 138.86 37.89 152.43 138.24 37.46 coo 22.84 13.44 52.91 20.84 13.18 52.38 157.34 129.59 37.15 157.60 127.69 38.11 coo 8.71 17.11 46.51 7.23 17.64 49.20 152.54 142.82 43.26 151.11 144.25 45.58 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 10 hits 1pmi_c00 naa= 3 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 1 3 # 1 B 1 SER A 124 SER^? 19.87 C8 ADE A 500 B 69 ALA A 9 ALA.? 25.40 C8 ADE A 500 B 241 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 13.24 41.94 33.13 13.08 39.54 33.17 182.61 151.80 32.41 184.93 152.05 33.02 coo 9.15 37.89 36.69 10.55 37.76 37.22 180.07 153.14 36.34 179.43 153.62 37.66 coo 10.91 43.03 38.47 11.81 41.82 36.93 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 2 3 # 2 B 1 SER A 124 SER^? 19.87 C8 ADE A 500 B 69 ALA A 11 ALA.? 21.95 C8 ADE A 500 B 241 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 13.24 41.94 33.13 13.08 39.54 33.17 182.61 151.80 32.41 184.93 152.05 33.02 coo 9.15 37.89 36.69 10.55 37.76 37.22 184.58 149.32 36.59 184.98 149.21 35.13 coo 10.91 43.03 38.47 11.81 41.82 36.93 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 3 3 # 3 B 1 SER A 124 SER^? 19.87 C8 ADE A 500 B 69 ALA A 12 ALA.? 26.35 C8 ADE A 500 B 241 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 13.24 41.94 33.13 13.08 39.54 33.17 182.61 151.80 32.41 184.93 152.05 33.02 coo 9.15 37.89 36.69 10.55 37.76 37.22 186.45 152.13 38.28 186.94 151.40 39.53 coo 10.91 43.03 38.47 11.81 41.82 36.93 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 4 3 # 4 B 1 SER B 124 SER^? 23.63 O4 CIT A1102 B 69 ALA B 8 ALA.? 19.99 O4 CIT A1102 B 241 ASN B 10 ASN.? 24.71 O4 CIT A1102 coo 13.24 41.94 33.13 13.08 39.54 33.17 191.23 122.78 5.73 191.55 121.05 7.41 coo 9.15 37.89 36.69 10.55 37.76 37.22 194.65 130.01 5.34 193.39 129.45 6.01 coo 10.91 43.03 38.47 11.81 41.82 36.93 196.51 123.48 2.85 194.80 122.44 2.12 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 5 3 # 5 B 1 SER B 124 SER^? 23.63 O4 CIT A1102 B 69 ALA B 9 ALA.? 25.11 N6 ADE A 500 B 241 ASN B 10 ASN.? 24.71 O4 CIT A1102 coo 13.24 41.94 33.13 13.08 39.54 33.17 191.23 122.78 5.73 191.55 121.05 7.41 coo 9.15 37.89 36.69 10.55 37.76 37.22 197.54 127.53 5.34 198.69 127.54 6.34 coo 10.91 43.03 38.47 11.81 41.82 36.93 196.51 123.48 2.85 194.80 122.44 2.12 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 6 3 # 6 B 1 SER B 124 SER^? 23.63 O4 CIT A1102 B 69 ALA B 11 ALA.? 26.08 O4 CIT A1102 B 241 ASN B 10 ASN.? 24.71 O4 CIT A1102 coo 13.24 41.94 33.13 13.08 39.54 33.17 191.23 122.78 5.73 191.55 121.05 7.41 coo 9.15 37.89 36.69 10.55 37.76 37.22 196.30 121.74 7.22 195.68 122.25 8.51 coo 10.91 43.03 38.47 11.81 41.82 36.93 196.51 123.48 2.85 194.80 122.44 2.12 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 7 3 # 7 B 1 SER B 124 SER^? 23.63 O4 CIT A1102 B 69 ALA B 12 ALA.? 30.70 O4 CIT A1102 B 241 ASN B 10 ASN.? 24.71 O4 CIT A1102 coo 13.24 41.94 33.13 13.08 39.54 33.17 191.23 122.78 5.73 191.55 121.05 7.41 coo 9.15 37.89 36.69 10.55 37.76 37.22 196.42 117.97 7.74 197.73 117.26 8.08 coo 10.91 43.03 38.47 11.81 41.82 36.93 196.51 123.48 2.85 194.80 122.44 2.12 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 8 3 # 8 B 1 SER C 124 SER^? 23.11 O1 GOL C1901 B 69 ALA C 9 ALA.? 27.31 O1 GOL C1901 B 241 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 13.24 41.94 33.13 13.08 39.54 33.17 172.32 130.73 43.72 171.22 130.88 45.88 coo 9.15 37.89 36.69 10.55 37.76 37.22 177.77 129.63 43.13 177.69 129.10 41.68 coo 10.91 43.03 38.47 11.81 41.82 36.93 177.62 134.05 42.85 179.55 133.98 41.92 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 9 3 # 9 B 1 SER C 124 SER^? 23.11 O1 GOL C1901 B 69 ALA C 11 ALA.? 26.39 O1 GOL C1901 B 241 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 13.24 41.94 33.13 13.08 39.54 33.17 172.32 130.73 43.72 171.22 130.88 45.88 coo 9.15 37.89 36.69 10.55 37.76 37.22 174.78 134.78 46.35 173.59 134.60 45.42 coo 10.91 43.03 38.47 11.81 41.82 36.93 177.62 134.05 42.85 179.55 133.98 41.92 ULMN 3 1pnl_c00 PENICILLIN AMIDOHYDROLASE user 10 3 # 10 B 1 SER C 124 SER^? 23.11 O1 GOL C1901 B 69 ALA C 12 ALA.? 30.31 O1 GOL C1901 B 241 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 13.24 41.94 33.13 13.08 39.54 33.17 172.32 130.73 43.72 171.22 130.88 45.88 coo 9.15 37.89 36.69 10.55 37.76 37.22 175.10 133.55 49.92 175.68 134.37 51.04 coo 10.91 43.03 38.47 11.81 41.82 36.93 177.62 134.05 42.85 179.55 133.98 41.92 1pnl_c00 source 1pnl PENICILLIN AMIDOHYDROLASE : 10 hits 1pnl_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 43 ARG.? 7.62 C2 ADE A 500 A 479 PHE A 178 PHE^? 9.61 N3 ADE A 500 A 483 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo 17.33 52.29 2.24 18.71 54.03 0.18 190.33 158.90 11.08 189.17 159.63 8.34 coo 20.06 57.44 1.28 18.39 56.19 3.12 187.30 161.92 16.41 189.15 160.05 15.37 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG A 108 ARG^? 21.78 N7 ADE A 500 A 479 PHE A 157 PHE.? 18.76 C8 ADE A 500 A 483 GLU A 156 GLU.? 23.41 C8 ADE A 500 coo 17.33 52.29 2.24 18.71 54.03 0.18 195.17 135.76 22.50 193.88 133.29 23.81 coo 20.06 57.44 1.28 18.39 56.19 3.12 197.65 139.50 24.25 197.70 140.07 21.50 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 196.65 137.08 28.97 194.78 136.94 30.01 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 A 264 ARG B 43 ARG.? 18.57 O1 CIT A1102 A 479 PHE B 178 PHE.? 18.93 O1 CIT A1102 A 483 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo 17.33 52.29 2.24 18.71 54.03 0.18 169.37 120.65 13.94 167.07 120.51 11.92 coo 20.06 57.44 1.28 18.39 56.19 3.12 171.75 119.32 8.74 169.38 118.09 9.61 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 A 264 ARG B 108 ARG^? 25.54 C8 ADE A 500 A 479 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 483 GLU B 156 GLU.? 24.53 N7 ADE A 500 coo 17.33 52.29 2.24 18.71 54.03 0.18 188.64 131.77 26.61 189.85 131.11 29.36 coo 20.06 57.44 1.28 18.39 56.19 3.12 189.45 127.38 26.40 186.79 128.09 26.89 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 194.44 129.17 25.88 194.48 130.18 24.03 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 A 264 ARG C 43 ARG.? 5.25 O3 GOL C1901 A 479 PHE C 178 PHE^? 10.90 O3 GOL C1901 A 483 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 17.33 52.29 2.24 18.71 54.03 0.18 154.24 116.29 44.96 152.24 116.07 42.61 coo 20.06 57.44 1.28 18.39 56.19 3.12 159.27 115.44 43.88 157.53 113.30 44.32 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 A 264 ARG C 108 ARG^? 22.96 O1 GOL C1901 A 479 PHE C 157 PHE~? 20.21 O1 GOL C1901 A 483 GLU C 156 GLU~? 24.55 O1 GOL C1901 coo 17.33 52.29 2.24 18.71 54.03 0.18 152.54 142.82 43.26 151.11 144.25 45.58 coo 20.06 57.44 1.28 18.39 56.19 3.12 154.00 141.12 47.59 151.92 139.65 46.43 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 157.99 144.71 47.12 158.90 144.92 45.19 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 6 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 43 ARG.? 7.62 C2 ADE A 500 B 479 PHE A 178 PHE^? 9.61 N3 ADE A 500 B 483 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo -26.72 93.28 20.13 -28.02 93.55 17.39 190.33 158.90 11.08 189.17 159.63 8.34 coo -29.34 90.48 15.69 -27.62 89.95 17.80 187.30 161.92 16.41 189.15 160.05 15.37 coo -26.63 95.49 14.65 -25.77 93.77 13.77 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG A 108 ARG^? 21.78 N7 ADE A 500 B 479 PHE A 157 PHE.? 18.76 C8 ADE A 500 B 483 GLU A 156 GLU.? 23.41 C8 ADE A 500 coo -26.72 93.28 20.13 -28.02 93.55 17.39 195.17 135.76 22.50 193.88 133.29 23.81 coo -29.34 90.48 15.69 -27.62 89.95 17.80 197.65 139.50 24.25 197.70 140.07 21.50 coo -26.63 95.49 14.65 -25.77 93.77 13.77 196.65 137.08 28.97 194.78 136.94 30.01 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 3 # 3 B 264 ARG B 43 ARG.? 18.57 O1 CIT A1102 B 479 PHE B 178 PHE.? 18.93 O1 CIT A1102 B 483 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo -26.72 93.28 20.13 -28.02 93.55 17.39 169.37 120.65 13.94 167.07 120.51 11.92 coo -29.34 90.48 15.69 -27.62 89.95 17.80 171.75 119.32 8.74 169.38 118.09 9.61 coo -26.63 95.49 14.65 -25.77 93.77 13.77 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 3 # 4 B 264 ARG B 108 ARG^? 25.54 C8 ADE A 500 B 479 PHE B 157 PHE.? 26.46 N7 ADE A 500 B 483 GLU B 156 GLU.? 24.53 N7 ADE A 500 coo -26.72 93.28 20.13 -28.02 93.55 17.39 188.64 131.77 26.61 189.85 131.11 29.36 coo -29.34 90.48 15.69 -27.62 89.95 17.80 189.45 127.38 26.40 186.79 128.09 26.89 coo -26.63 95.49 14.65 -25.77 93.77 13.77 194.44 129.17 25.88 194.48 130.18 24.03 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 3 # 5 B 264 ARG C 43 ARG.? 5.25 O3 GOL C1901 B 479 PHE C 178 PHE^? 10.90 O3 GOL C1901 B 483 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo -26.72 93.28 20.13 -28.02 93.55 17.39 154.24 116.29 44.96 152.24 116.07 42.61 coo -29.34 90.48 15.69 -27.62 89.95 17.80 159.27 115.44 43.88 157.53 113.30 44.32 coo -26.63 95.49 14.65 -25.77 93.77 13.77 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 3 # 6 B 264 ARG C 108 ARG^? 22.96 O1 GOL C1901 B 479 PHE C 157 PHE~? 20.21 O1 GOL C1901 B 483 GLU C 156 GLU~? 24.55 O1 GOL C1901 coo -26.72 93.28 20.13 -28.02 93.55 17.39 152.54 142.82 43.26 151.11 144.25 45.58 coo -29.34 90.48 15.69 -27.62 89.95 17.80 154.00 141.12 47.59 151.92 139.65 46.43 coo -26.63 95.49 14.65 -25.77 93.77 13.77 157.99 144.71 47.12 158.90 144.92 45.19 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 6 hits 1pow_c03 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 67 ARG A 43 ARG.? 7.62 C2 ADE A 500 B 86 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 33.14 -5.53 11.32 32.45 -5.14 9.39 188.90 156.57 17.91 187.92 156.12 16.11 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 190.33 158.90 11.08 189.17 159.63 8.34 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 190.73 163.86 19.83 191.04 162.27 18.50 1pyl_c01 source 1pyl RIBONUCLEASE : 1 hits 1pyl_c01 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 33 LEU~? 17.67 N7 ADE A 500 A 58 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 120 LYS B 132 LYS~? 23.82 N6 ADE A 500 coo 34.02 69.29 75.26 34.82 67.82 76.74 201.31 140.77 16.43 199.20 140.97 16.79 coo 34.46 72.45 78.57 32.82 72.75 77.28 203.35 139.46 11.01 205.31 139.04 11.69 coo 28.96 77.64 81.19 29.05 74.53 77.51 203.58 131.98 12.65 206.21 136.25 10.92 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU B 33 LEU~? 27.87 C8 ADE A 500 A 58 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 120 LYS A 132 LYS~? 32.58 C8 ADE A 500 coo 34.02 69.29 75.26 34.82 67.82 76.74 182.48 127.54 30.60 182.82 128.96 29.02 coo 34.46 72.45 78.57 32.82 72.75 77.28 178.67 130.13 34.24 179.32 129.31 36.04 coo 28.96 77.64 81.19 29.05 74.53 77.51 183.55 135.22 37.19 185.46 129.22 37.94 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 33 LEU~? 17.67 N7 ADE A 500 B 58 ASP A 36 ASP~? 21.71 N6 ADE A 500 B 120 LYS B 132 LYS~? 23.82 N6 ADE A 500 coo 54.50 104.32 58.69 55.83 105.69 59.81 201.31 140.77 16.43 199.20 140.97 16.79 coo 57.63 101.19 59.83 56.60 100.89 57.99 203.35 139.46 11.01 205.31 139.04 11.69 coo 61.58 95.88 55.22 58.18 99.30 54.71 203.58 131.98 12.65 206.21 136.25 10.92 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU B 33 LEU~? 27.87 C8 ADE A 500 B 58 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 120 LYS A 132 LYS~? 32.58 C8 ADE A 500 coo 54.50 104.32 58.69 55.83 105.69 59.81 182.48 127.54 30.60 182.82 128.96 29.02 coo 57.63 101.19 59.83 56.60 100.89 57.99 178.67 130.13 34.24 179.32 129.31 36.04 coo 61.58 95.88 55.22 58.18 99.30 54.71 183.55 135.22 37.19 185.46 129.22 37.94 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c01 naa= 3 ULMN 3 1qaz_c00 ALGINATE LYASE A1-III user 1 3 # 1 A 191 ASN A 77 ASN^? 9.65 N6 ADE A 500 A 239 ARG B 101 ARG.? -6.88 O4 CIT A1102s A 246 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 2.50 7.27 18.06 0.76 7.28 16.81 179.83 147.18 2.66 181.08 147.98 1.14 coo -1.16 0.95 13.41 -2.50 3.71 13.61 179.40 137.94 3.82 182.23 139.06 3.56 coo 1.59 5.18 12.30 -0.74 6.52 11.61 175.94 140.65 -0.34 176.08 138.10 -1.42 1qaz_c00 source 1qaz ALGINATE LYASE A1-III : 1 hits 1qaz_c00 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 143 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 170 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo -2.40 27.37 52.92 -1.22 29.09 52.71 188.90 156.57 17.91 187.92 156.12 16.11 coo 1.36 26.79 49.43 3.17 26.89 50.50 191.47 153.75 14.17 189.52 154.05 13.44 coo 7.24 31.80 48.14 6.27 25.92 49.70 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 A 86 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 143 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 170 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo -2.40 27.37 52.92 -1.22 29.09 52.71 188.90 156.57 17.91 187.92 156.12 16.11 coo 1.36 26.79 49.43 3.17 26.89 50.50 191.47 153.75 14.17 189.52 154.05 13.44 coo 7.24 31.80 48.14 6.27 25.92 49.70 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 A 86 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 143 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 170 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo -2.40 27.37 52.92 -1.22 29.09 52.71 185.43 146.45 17.17 186.00 148.48 17.29 coo 1.36 26.79 49.43 3.17 26.89 50.50 183.15 146.13 20.69 182.60 148.09 20.18 coo 7.24 31.80 48.14 6.27 25.92 49.70 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 4 3 # 4 A 86 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 143 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 170 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo -2.40 27.37 52.92 -1.22 29.09 52.71 174.85 121.76 12.80 173.53 120.38 11.97 coo 1.36 26.79 49.43 3.17 26.89 50.50 174.27 123.90 17.18 173.55 124.80 15.43 coo 7.24 31.80 48.14 6.27 25.92 49.70 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 5 3 # 5 A 86 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 143 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 170 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo -2.40 27.37 52.92 -1.22 29.09 52.71 174.85 121.76 12.80 173.53 120.38 11.97 coo 1.36 26.79 49.43 3.17 26.89 50.50 174.27 123.90 17.18 173.55 124.80 15.43 coo 7.24 31.80 48.14 6.27 25.92 49.70 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 6 3 # 6 A 86 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 143 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 170 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo -2.40 27.37 52.92 -1.22 29.09 52.71 180.17 131.30 14.36 179.09 129.62 13.64 coo 1.36 26.79 49.43 3.17 26.89 50.50 183.49 131.36 11.56 181.98 130.36 10.51 coo 7.24 31.80 48.14 6.27 25.92 49.70 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 7 3 # 7 A 86 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 143 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 170 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo -2.40 27.37 52.92 -1.22 29.09 52.71 157.18 120.22 44.20 157.97 118.54 45.19 coo 1.36 26.79 49.43 3.17 26.89 50.50 153.36 123.09 43.85 154.03 121.98 42.20 coo 7.24 31.80 48.14 6.27 25.92 49.70 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 8 3 # 8 A 86 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 143 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 170 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo -2.40 27.37 52.92 -1.22 29.09 52.71 157.18 120.22 44.20 157.97 118.54 45.19 coo 1.36 26.79 49.43 3.17 26.89 50.50 153.36 123.09 43.85 154.03 121.98 42.20 coo 7.24 31.80 48.14 6.27 25.92 49.70 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 9 3 # 9 A 86 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 143 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 170 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -2.40 27.37 52.92 -1.22 29.09 52.71 157.18 120.22 44.20 157.97 118.54 45.19 coo 1.36 26.79 49.43 3.17 26.89 50.50 160.37 121.38 41.43 159.84 123.37 41.06 coo 7.24 31.80 48.14 6.27 25.92 49.70 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 10 3 # 10 A 86 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 143 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 170 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo -2.40 27.37 52.92 -1.22 29.09 52.71 157.18 120.22 44.20 157.97 118.54 45.19 coo 1.36 26.79 49.43 3.17 26.89 50.50 160.20 116.89 49.36 158.52 117.92 48.65 coo 7.24 31.80 48.14 6.27 25.92 49.70 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 11 3 # 11 A 86 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 143 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 170 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo -2.40 27.37 52.92 -1.22 29.09 52.71 157.34 129.59 37.15 157.60 127.69 38.11 coo 1.36 26.79 49.43 3.17 26.89 50.50 161.39 131.07 36.65 161.63 129.00 36.89 coo 7.24 31.80 48.14 6.27 25.92 49.70 165.62 124.17 41.44 160.89 126.43 37.84 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 11 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 143 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 170 LYS A 41 LYS^? 15.86 N3 ADE A 500 coo 13.90 37.16 5.96 12.00 36.26 6.12 188.90 156.57 17.91 187.92 156.12 16.11 coo 13.52 33.69 9.79 13.20 31.83 8.88 191.47 153.75 14.17 189.52 154.05 13.44 coo 7.52 28.83 11.02 13.59 28.74 9.95 197.56 153.42 13.51 201.64 156.08 17.41 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 B 86 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 143 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 170 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 13.90 37.16 5.96 12.00 36.26 6.12 188.90 156.57 17.91 187.92 156.12 16.11 coo 13.52 33.69 9.79 13.20 31.83 8.88 191.47 153.75 14.17 189.52 154.05 13.44 coo 7.52 28.83 11.02 13.59 28.74 9.95 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 B 86 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 143 HIS A 104 HIS^? 8.41 C8 ADE A 500 B 170 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 13.90 37.16 5.96 12.00 36.26 6.12 185.43 146.45 17.17 186.00 148.48 17.29 coo 13.52 33.69 9.79 13.20 31.83 8.88 183.15 146.13 20.69 182.60 148.09 20.18 coo 7.52 28.83 11.02 13.59 28.74 9.95 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 4 3 # 4 B 86 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 143 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 170 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 13.90 37.16 5.96 12.00 36.26 6.12 174.85 121.76 12.80 173.53 120.38 11.97 coo 13.52 33.69 9.79 13.20 31.83 8.88 174.27 123.90 17.18 173.55 124.80 15.43 coo 7.52 28.83 11.02 13.59 28.74 9.95 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 5 3 # 5 B 86 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 143 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 170 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 13.90 37.16 5.96 12.00 36.26 6.12 174.85 121.76 12.80 173.53 120.38 11.97 coo 13.52 33.69 9.79 13.20 31.83 8.88 174.27 123.90 17.18 173.55 124.80 15.43 coo 7.52 28.83 11.02 13.59 28.74 9.95 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 6 3 # 6 B 86 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 143 HIS B 104 HIS^? 12.85 O4 CIT A1102 B 170 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 13.90 37.16 5.96 12.00 36.26 6.12 180.17 131.30 14.36 179.09 129.62 13.64 coo 13.52 33.69 9.79 13.20 31.83 8.88 183.49 131.36 11.56 181.98 130.36 10.51 coo 7.52 28.83 11.02 13.59 28.74 9.95 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 7 3 # 7 B 86 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 143 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 170 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo 13.90 37.16 5.96 12.00 36.26 6.12 157.18 120.22 44.20 157.97 118.54 45.19 coo 13.52 33.69 9.79 13.20 31.83 8.88 153.36 123.09 43.85 154.03 121.98 42.20 coo 7.52 28.83 11.02 13.59 28.74 9.95 149.18 124.89 48.07 150.57 125.16 54.16 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 8 3 # 8 B 86 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 143 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 170 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 13.90 37.16 5.96 12.00 36.26 6.12 157.18 120.22 44.20 157.97 118.54 45.19 coo 13.52 33.69 9.79 13.20 31.83 8.88 153.36 123.09 43.85 154.03 121.98 42.20 coo 7.52 28.83 11.02 13.59 28.74 9.95 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 9 3 # 9 B 86 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 143 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 170 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 13.90 37.16 5.96 12.00 36.26 6.12 157.18 120.22 44.20 157.97 118.54 45.19 coo 13.52 33.69 9.79 13.20 31.83 8.88 160.37 121.38 41.43 159.84 123.37 41.06 coo 7.52 28.83 11.02 13.59 28.74 9.95 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 10 3 # 10 B 86 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 143 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 170 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo 13.90 37.16 5.96 12.00 36.26 6.12 157.18 120.22 44.20 157.97 118.54 45.19 coo 13.52 33.69 9.79 13.20 31.83 8.88 160.20 116.89 49.36 158.52 117.92 48.65 coo 7.52 28.83 11.02 13.59 28.74 9.95 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 11 3 # 11 B 86 GLU C 165 GLU^? 7.74 O1 GOL C1901 B 143 HIS C 104 HIS^? 12.14 O1 GOL C1901 B 170 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 13.90 37.16 5.96 12.00 36.26 6.12 157.34 129.59 37.15 157.60 127.69 38.11 coo 13.52 33.69 9.79 13.20 31.83 8.88 161.39 131.07 36.65 161.63 129.00 36.89 coo 7.52 28.83 11.02 13.59 28.74 9.95 165.62 124.17 41.44 160.89 126.43 37.84 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 11 hits 1qfe_c01 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS C 187 HIS~? 27.79 O3 GOL C1901 A 236 ASP B 89 ASP.? 31.34 O4 CIT A1102 A 261 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo 55.45 46.76 42.08 57.34 46.16 42.75 174.78 109.74 44.68 175.79 108.53 43.31 coo 48.87 29.19 44.63 49.10 27.34 43.63 181.93 115.70 26.33 180.57 117.33 26.20 coo 47.58 17.35 41.83 51.40 20.85 40.83 186.73 109.97 17.12 190.68 107.86 12.58 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS C 187 HIS~? 27.79 O3 GOL C1901 B 236 ASP B 89 ASP.? 31.34 O4 CIT A1102 B 261 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 174.78 109.74 44.68 175.79 108.53 43.31 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 181.93 115.70 26.33 180.57 117.33 26.20 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 186.73 109.97 17.12 190.68 107.86 12.58 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS C 187 HIS~? 27.79 O3 GOL C1901 C 236 ASP B 89 ASP.? 31.34 O4 CIT A1102 C 261 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo 55.11 47.10 12.61 53.44 47.85 11.58 174.78 109.74 44.68 175.79 108.53 43.31 coo 45.78 31.11 9.51 44.25 30.06 10.53 181.93 115.70 26.33 180.57 117.33 26.20 coo 37.54 22.37 12.10 37.83 27.55 13.24 186.73 109.97 17.12 190.68 107.86 12.58 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS C 187 HIS~? 27.79 O3 GOL C1901 D 236 ASP B 89 ASP.? 31.34 O4 CIT A1102 D 261 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 174.78 109.74 44.68 175.79 108.53 43.31 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 181.93 115.70 26.33 180.57 117.33 26.20 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 186.73 109.97 17.12 190.68 107.86 12.58 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS C 187 HIS~? 27.79 O3 GOL C1901 E 236 ASP B 89 ASP.? 31.34 O4 CIT A1102 E 261 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 174.78 109.74 44.68 175.79 108.53 43.31 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 181.93 115.70 26.33 180.57 117.33 26.20 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 186.73 109.97 17.12 190.68 107.86 12.58 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS C 187 HIS~? 27.79 O3 GOL C1901 F 236 ASP B 89 ASP.? 31.34 O4 CIT A1102 F 261 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 174.78 109.74 44.68 175.79 108.53 43.31 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 181.93 115.70 26.33 180.57 117.33 26.20 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 186.73 109.97 17.12 190.68 107.86 12.58 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS C 187 HIS~? 27.79 O3 GOL C1901 G 236 ASP B 89 ASP.? 31.34 O4 CIT A1102 G 261 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 174.78 109.74 44.68 175.79 108.53 43.31 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 181.93 115.70 26.33 180.57 117.33 26.20 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 186.73 109.97 17.12 190.68 107.86 12.58 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS C 187 HIS~? 27.79 O3 GOL C1901 H 236 ASP B 89 ASP.? 31.34 O4 CIT A1102 H 261 LYS B 20 LYS~? 34.92 O4 CIT A1102 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 174.78 109.74 44.68 175.79 108.53 43.31 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 181.93 115.70 26.33 180.57 117.33 26.20 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 186.73 109.97 17.12 190.68 107.86 12.58 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR C 117 TYR.? 21.72 O1 GOL C1901 A 236 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 261 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 55.48 26.51 40.65 55.39 23.99 39.43 173.67 123.08 36.58 172.76 125.64 35.98 coo 48.87 29.19 44.63 49.10 27.34 43.63 178.03 118.40 36.14 177.70 120.46 36.31 coo 47.58 17.35 41.83 51.40 20.85 40.83 174.17 121.55 22.91 175.90 116.24 24.75 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR C 117 TYR.? 21.72 O1 GOL C1901 B 236 ASP C 119 ASP.? 26.31 O1 GOL C1901 B 261 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 173.67 123.08 36.58 172.76 125.64 35.98 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 178.03 118.40 36.14 177.70 120.46 36.31 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 174.17 121.55 22.91 175.90 116.24 24.75 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR C 117 TYR.? 21.72 O1 GOL C1901 C 236 ASP C 119 ASP.? 26.31 O1 GOL C1901 C 261 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 39.51 34.34 13.63 37.63 32.61 14.79 173.67 123.08 36.58 172.76 125.64 35.98 coo 45.78 31.11 9.51 44.25 30.06 10.53 178.03 118.40 36.14 177.70 120.46 36.31 coo 37.54 22.37 12.10 37.83 27.55 13.24 174.17 121.55 22.91 175.90 116.24 24.75 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR C 117 TYR.? 21.72 O1 GOL C1901 D 236 ASP C 119 ASP.? 26.31 O1 GOL C1901 D 261 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 173.67 123.08 36.58 172.76 125.64 35.98 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 178.03 118.40 36.14 177.70 120.46 36.31 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 174.17 121.55 22.91 175.90 116.24 24.75 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR C 117 TYR.? 21.72 O1 GOL C1901 E 236 ASP C 119 ASP.? 26.31 O1 GOL C1901 E 261 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 173.67 123.08 36.58 172.76 125.64 35.98 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 178.03 118.40 36.14 177.70 120.46 36.31 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 174.17 121.55 22.91 175.90 116.24 24.75 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR C 117 TYR.? 21.72 O1 GOL C1901 F 236 ASP C 119 ASP.? 26.31 O1 GOL C1901 F 261 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 173.67 123.08 36.58 172.76 125.64 35.98 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 178.03 118.40 36.14 177.70 120.46 36.31 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 174.17 121.55 22.91 175.90 116.24 24.75 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR C 117 TYR.? 21.72 O1 GOL C1901 G 236 ASP C 119 ASP.? 26.31 O1 GOL C1901 G 261 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 173.67 123.08 36.58 172.76 125.64 35.98 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 178.03 118.40 36.14 177.70 120.46 36.31 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 174.17 121.55 22.91 175.90 116.24 24.75 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR C 117 TYR.? 21.72 O1 GOL C1901 H 236 ASP C 119 ASP.? 26.31 O1 GOL C1901 H 261 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 173.67 123.08 36.58 172.76 125.64 35.98 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 178.03 118.40 36.14 177.70 120.46 36.31 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 174.17 121.55 22.91 175.90 116.24 24.75 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c15 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 147 THR A 80 THR^? 4.30 N6 ADE A 500 A 294 ASP A 172 ASP~? 9.43 N1 ADE A 500 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 185.72 140.93 6.30 184.35 140.00 4.99 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 182.84 145.31 7.97 182.66 147.39 7.73 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 180.59 154.59 5.93 180.83 155.75 4.19 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 147 THR B 80 THR^? 11.53 O1 CIT A1102 A 294 ASP B 172 ASP~? 8.81 O1 CIT A1102 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 173.93 140.35 20.11 173.24 142.10 19.12 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 173.05 137.67 14.86 171.74 136.22 13.94 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 166.30 133.15 8.87 164.29 132.56 8.69 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP C 52 ASP^? 12.06 O1 GOL C1901 A 147 THR C 80 THR^? 5.30 O1 GOL C1901 A 294 ASP C 172 ASP~? 9.22 O2 GOL C1901 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 147.21 130.59 30.19 147.01 130.37 28.08 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 151.58 126.43 30.18 151.60 124.76 31.56 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 153.21 116.81 30.64 152.37 114.88 30.62 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 3 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP B 89 ASP.? 31.34 O4 CIT A1102 A 256 GLU B 25 GLU.? 28.27 O1 GOL C1901 A 329 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 28.46 69.88 26.74 30.40 70.70 26.53 181.93 115.70 26.33 180.57 117.33 26.20 coo 30.54 71.65 32.58 31.73 72.26 30.92 179.49 113.39 31.74 177.60 113.83 30.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 256 GLU B 25 GLU.? 28.27 O1 GOL C1901 A 329 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 28.46 69.88 26.74 30.40 70.70 26.53 178.03 118.40 36.14 177.70 120.46 36.31 coo 30.54 71.65 32.58 31.73 72.26 30.92 179.49 113.39 31.74 177.60 113.83 30.87 coo 37.87 70.12 31.80 36.61 69.74 30.15 181.93 115.70 26.33 180.57 117.33 26.20 1qho_c04 source 1qho ALPHA-AMYLASE : 2 hits 1qho_c04 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 260 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 329 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo 28.46 69.88 26.74 30.40 70.70 26.53 203.35 139.46 11.01 205.31 139.04 11.69 coo 30.73 81.29 37.61 31.23 82.07 35.69 203.27 140.75 25.55 204.24 138.86 25.61 coo 37.87 70.12 31.80 36.61 69.74 30.15 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 89 ASP.? 18.10 N3 ADE A 500 A 260 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 329 ASP A 158 ASP.? 25.18 C8 ADE A 500 coo 28.46 69.88 26.74 30.40 70.70 26.53 203.02 151.24 21.31 203.43 152.46 19.71 coo 30.73 81.29 37.61 31.23 82.07 35.69 203.35 139.46 11.01 205.31 139.04 11.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 203.27 140.75 25.55 204.24 138.86 25.61 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 260 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 329 ASP B 36 ASP~? 28.48 O1 GOL C1901 coo 28.46 69.88 26.74 30.40 70.70 26.53 188.71 136.74 34.61 188.50 136.01 36.57 coo 30.73 81.29 37.61 31.23 82.07 35.69 190.60 123.10 30.08 190.26 121.25 31.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 178.67 130.13 34.24 179.32 129.31 36.04 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 260 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 329 ASP A 89 ASP.? 18.10 N3 ADE A 500 coo 28.46 69.88 26.74 30.40 70.70 26.53 203.27 140.75 25.55 204.24 138.86 25.61 coo 30.73 81.29 37.61 31.23 82.07 35.69 203.35 139.46 11.01 205.31 139.04 11.69 coo 37.87 70.12 31.80 36.61 69.74 30.15 203.02 151.24 21.31 203.43 152.46 19.71 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 260 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 329 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo 28.46 69.88 26.74 30.40 70.70 26.53 178.67 130.13 34.24 179.32 129.31 36.04 coo 30.73 81.29 37.61 31.23 82.07 35.69 190.60 123.10 30.08 190.26 121.25 31.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 260 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 329 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 28.46 69.88 26.74 30.40 70.70 26.53 178.67 130.13 34.24 179.32 129.31 36.04 coo 30.73 81.29 37.61 31.23 82.07 35.69 190.60 123.10 30.08 190.26 121.25 31.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 89 ASP.? 31.34 O4 CIT A1102 A 260 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 329 ASP B 158 ASP.? 34.51 N7 ADE A 500 coo 28.46 69.88 26.74 30.40 70.70 26.53 181.93 115.70 26.33 180.57 117.33 26.20 coo 30.73 81.29 37.61 31.23 82.07 35.69 178.67 130.13 34.24 179.32 129.31 36.04 coo 37.87 70.12 31.80 36.61 69.74 30.15 190.60 123.10 30.08 190.26 121.25 31.09 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 130 ASP~? 26.83 N6 ADE A 500 A 260 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 329 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 28.46 69.88 26.74 30.40 70.70 26.53 200.55 129.62 17.17 202.64 129.41 16.98 coo 30.73 81.29 37.61 31.23 82.07 35.69 203.27 140.75 25.55 204.24 138.86 25.61 coo 37.87 70.12 31.80 36.61 69.74 30.15 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP C 89 ASP.? 17.67 O3 GOL C1901 A 260 ASP C 36 ASP~? 21.70 O1 GOL C1901 A 329 ASP C 158 ASP~? 26.27 O1 GOL C1901 coo 28.46 69.88 26.74 30.40 70.70 26.53 152.15 130.32 56.35 151.16 130.16 54.50 coo 30.73 81.29 37.61 31.23 82.07 35.69 140.93 137.00 45.78 140.14 138.07 47.46 coo 37.87 70.12 31.80 36.61 69.74 30.15 152.92 141.67 53.35 151.80 143.42 53.28 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 260 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 329 ASP B 36 ASP~? 28.48 O1 GOL C1901 coo 28.46 69.88 26.74 30.40 70.70 26.53 178.03 118.40 36.14 177.70 120.46 36.31 coo 30.73 81.29 37.61 31.23 82.07 35.69 190.60 123.10 30.08 190.26 121.25 31.09 coo 37.87 70.12 31.80 36.61 69.74 30.15 178.67 130.13 34.24 179.32 129.31 36.04 1qho_c07 source 1qho ALPHA-AMYLASE : 10 hits 1qho_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 51 THR^? 8.68 N6 ADE A 500 A 182 TYR A 83 TYR^? 11.70 N6 ADE A 500 A 186 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 69.38 87.38 24.64 71.11 88.47 25.40 189.89 142.39 7.18 190.42 141.55 9.05 coo 73.61 90.42 31.12 71.36 89.66 29.64 192.51 141.71 13.59 192.79 138.96 13.21 coo 73.54 84.00 28.64 69.01 86.68 29.71 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 51 THR^? 19.74 C8 ADE A 500 A 182 TYR B 83 TYR^? 20.46 C8 ADE A 500 A 186 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 69.38 87.38 24.64 71.11 88.47 25.40 174.04 136.47 22.40 175.88 136.63 23.40 coo 73.61 90.42 31.12 71.36 89.66 29.64 179.54 132.93 23.44 180.82 135.06 24.75 coo 73.54 84.00 28.64 69.01 86.68 29.71 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 3 # 3 A 145 THR C 51 THR^? 10.18 O1 GOL C1901 A 182 TYR C 83 TYR^? 12.44 O1 GOL C1901 A 186 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 69.38 87.38 24.64 71.11 88.47 25.40 146.36 130.30 34.58 146.96 132.15 35.42 coo 73.61 90.42 31.12 71.36 89.66 29.64 149.52 133.95 39.18 148.57 136.34 38.09 coo 73.54 84.00 28.64 69.01 86.68 29.71 147.41 128.03 39.92 142.61 128.90 38.51 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 3 hits 1qrr_c01 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 646 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 739 GLY A 128 GLY.? 19.63 C8 ADE A 500 coo -20.72 2.99 34.37 -21.94 1.82 35.61 183.15 146.13 20.69 182.60 148.09 20.18 coo -18.83 7.68 26.86 -20.89 7.78 26.56 173.93 140.35 20.11 173.24 142.10 19.12 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 188.72 140.03 29.58 187.87 139.89 29.50 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 646 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 739 GLY A 144 GLY.? 14.07 C8 ADE A 500 coo -20.72 2.99 34.37 -21.94 1.82 35.61 183.15 146.13 20.69 182.60 148.09 20.18 coo -18.83 7.68 26.86 -20.89 7.78 26.56 173.93 140.35 20.11 173.24 142.10 19.12 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 175.00 157.54 19.11 175.48 156.96 19.45 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 646 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 739 GLY A 170 GLY.? 7.13 N6 ADE A 500 coo -20.72 2.99 34.37 -21.94 1.82 35.61 183.15 146.13 20.69 182.60 148.09 20.18 coo -18.83 7.68 26.86 -20.89 7.78 26.56 173.93 140.35 20.11 173.24 142.10 19.12 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 179.43 148.38 7.40 178.96 149.01 7.51 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 646 ASP B 172 ASP~? 8.81 O1 CIT A1102 A 739 GLY B 144 GLY.? 9.82 C2 CIT A1102 coo -20.72 2.99 34.37 -21.94 1.82 35.61 171.08 125.47 9.27 172.48 124.18 10.15 coo -18.83 7.68 26.86 -20.89 7.78 26.56 166.30 133.15 8.87 164.29 132.56 8.69 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 177.04 128.09 -0.12 177.50 128.05 0.54 1qrz_c20 source 1qrz PLASMINOGEN : 4 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 646 ASP C 175 ASP.? 10.66 O1 GOL C1901 B 739 GLY C 93 GLY^? 13.18 O3 GOL C1901 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 157.21 117.94 38.21 157.48 118.99 40.00 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 157.90 117.18 31.56 156.68 116.62 29.91 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 159.81 125.78 46.83 160.54 125.64 47.42 1qrz_c21 source 1qrz PLASMINOGEN : 1 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 176 HIS^? 6.39 N3 ADE A 500 C 646 ASP A 175 ASP.? 10.98 C4 ADE A 500 C 739 GLY A 93 GLY^? 10.42 N9 ADE A 500 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 184.39 157.95 13.11 185.86 157.96 14.60 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 178.57 156.37 9.84 177.44 156.14 8.05 coo 7.82 1.25 3.03 7.30 1.31 3.65 191.16 154.66 21.80 191.10 155.17 22.59 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS B 176 HIS^? 13.79 O1 CIT A1102 C 646 ASP B 172 ASP~? 8.81 O1 CIT A1102 C 739 GLY B 144 GLY.? 9.82 C2 CIT A1102 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 171.08 125.47 9.27 172.48 124.18 10.15 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 166.30 133.15 8.87 164.29 132.56 8.69 coo 7.82 1.25 3.03 7.30 1.31 3.65 177.04 128.09 -0.12 177.50 128.05 0.54 1qrz_c22 source 1qrz PLASMINOGEN : 2 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 104 HIS^? 8.41 C8 ADE A 500 D 646 ASP B 52 ASP^? 16.07 C8 ADE A 500 D 739 GLY A 128 GLY.? 19.63 C8 ADE A 500 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 183.15 146.13 20.69 182.60 148.09 20.18 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 173.93 140.35 20.11 173.24 142.10 19.12 coo -45.82 1.31 41.67 -46.38 1.39 42.31 188.72 140.03 29.58 187.87 139.89 29.50 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 104 HIS^? 8.41 C8 ADE A 500 D 646 ASP B 52 ASP^? 16.07 C8 ADE A 500 D 739 GLY A 144 GLY.? 14.07 C8 ADE A 500 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 183.15 146.13 20.69 182.60 148.09 20.18 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 173.93 140.35 20.11 173.24 142.10 19.12 coo -45.82 1.31 41.67 -46.38 1.39 42.31 175.00 157.54 19.11 175.48 156.96 19.45 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS A 104 HIS^? 8.41 C8 ADE A 500 D 646 ASP B 52 ASP^? 16.07 C8 ADE A 500 D 739 GLY A 170 GLY.? 7.13 N6 ADE A 500 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 183.15 146.13 20.69 182.60 148.09 20.18 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 173.93 140.35 20.11 173.24 142.10 19.12 coo -45.82 1.31 41.67 -46.38 1.39 42.31 179.43 148.38 7.40 178.96 149.01 7.51 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS B 176 HIS^? 13.79 O1 CIT A1102 D 646 ASP B 172 ASP~? 8.81 O1 CIT A1102 D 739 GLY B 144 GLY.? 9.82 C2 CIT A1102 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 171.08 125.47 9.27 172.48 124.18 10.15 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 166.30 133.15 8.87 164.29 132.56 8.69 coo -45.82 1.31 41.67 -46.38 1.39 42.31 177.04 128.09 -0.12 177.50 128.05 0.54 1qrz_c23 source 1qrz PLASMINOGEN : 4 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 171 PHE.? -3.51 C4 ADE A 500s A 201 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 227 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 23.39 49.81 32.16 21.33 51.68 32.26 183.57 152.25 9.92 184.62 154.69 10.81 coo 25.52 45.12 37.98 23.98 46.65 37.85 178.57 156.37 9.84 177.44 156.14 8.05 coo 12.68 46.83 36.69 18.26 48.67 34.51 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 173 PHE~? 4.60 C2 ADE A 500 A 201 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 227 LYS A 97 LYS^? 15.28 N9 ADE A 500 coo 23.39 49.81 32.16 21.33 51.68 32.26 186.20 157.44 8.21 188.39 156.08 9.40 coo 25.52 45.12 37.98 23.98 46.65 37.85 180.59 154.59 5.93 180.83 155.75 4.19 coo 12.68 46.83 36.69 18.26 48.67 34.51 180.69 158.10 18.36 176.95 162.62 18.15 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE B 173 PHE~? 14.11 O1 CIT A1102 A 201 ASP B 172 ASP~? 8.81 O1 CIT A1102 A 227 LYS B 97 LYS^? 12.22 C2 CIT A1102 coo 23.39 49.81 32.16 21.33 51.68 32.26 165.53 127.89 11.96 166.03 128.02 14.71 coo 25.52 45.12 37.98 23.98 46.65 37.85 166.30 133.15 8.87 164.29 132.56 8.69 coo 12.68 46.83 36.69 18.26 48.67 34.51 175.75 125.08 4.60 173.18 124.12 -0.61 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE C 173 PHE~? 4.81 C3 GOL C1901 A 201 ASP C 172 ASP~? 9.22 O2 GOL C1901 A 227 LYS C 97 LYS^? 17.09 C1 GOL C1901 coo 23.39 49.81 32.16 21.33 51.68 32.26 151.21 115.28 36.33 149.30 116.99 37.50 coo 25.52 45.12 37.98 23.98 46.65 37.85 153.21 116.81 30.64 152.37 114.88 30.62 coo 12.68 46.83 36.69 18.26 48.67 34.51 163.30 119.33 38.22 166.56 114.68 36.90 1qz9_c02 source 1qz9 KYNURENINASE : 4 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 89 ASP.? 18.10 N3 ADE A 500 A 186 ASN A 159 ASN.? 24.44 N9 ADE A 500 A 260 ALA A 16 ALA~? 23.89 N9 ADE A 500 coo 11.81 33.10 11.71 13.07 31.45 11.40 203.02 151.24 21.31 203.43 152.46 19.71 coo 11.43 26.53 7.41 13.01 27.56 8.43 201.43 144.98 28.36 202.11 144.65 30.37 coo 21.53 26.33 6.96 20.26 25.69 7.52 197.90 152.07 34.51 198.25 150.79 33.76 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP B 89 ASP.? 31.34 O4 CIT A1102 A 186 ASN B 159 ASN.? 34.53 O4 CIT A1102 A 260 ALA B 16 ALA~? 33.45 O4 CIT A1102 coo 11.81 33.10 11.71 13.07 31.45 11.40 181.93 115.70 26.33 180.57 117.33 26.20 coo 11.43 26.53 7.41 13.01 27.56 8.43 190.73 119.78 25.86 192.60 118.87 26.28 coo 21.53 26.33 6.96 20.26 25.69 7.52 192.54 113.02 18.25 192.80 114.18 19.18 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 186 ASN B 35 ASN~? 25.18 O1 GOL C1901 A 260 ALA C 9 ALA.? 27.31 O1 GOL C1901 coo 11.81 33.10 11.71 13.07 31.45 11.40 178.03 118.40 36.14 177.70 120.46 36.31 coo 11.43 26.53 7.41 13.01 27.56 8.43 176.57 125.33 34.40 176.61 123.22 34.34 coo 21.53 26.33 6.96 20.26 25.69 7.52 177.77 129.63 43.13 177.69 129.10 41.68 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP C 158 ASP~? 26.27 O1 GOL C1901 A 186 ASN C 154 ASN~? 23.43 O1 GOL C1901 A 260 ALA C 16 ALA~? 26.79 O3 GOL C1901 coo 11.81 33.10 11.71 13.07 31.45 11.40 152.92 141.67 53.35 151.80 143.42 53.28 coo 11.43 26.53 7.41 13.01 27.56 8.43 160.52 142.23 50.24 158.78 141.09 49.77 coo 21.53 26.33 6.96 20.26 25.69 7.52 165.24 134.62 57.23 164.18 135.57 56.71 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 4 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 41 LYS A 41 LYS^? 15.86 N3 ADE A 500 A 119 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 185.28 156.61 18.37 185.56 154.55 18.68 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 197.56 153.42 13.51 201.64 156.08 17.41 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 41 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 119 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 185.28 156.61 18.37 185.56 154.55 18.68 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 185.07 167.50 20.34 181.31 169.96 15.85 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 3 3 # 3 A 12 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 41 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 119 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 184.39 157.95 13.11 185.86 157.96 14.60 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 185.07 167.50 20.34 181.31 169.96 15.85 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 4 3 # 4 A 12 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 41 LYS B 180 LYS.? 22.96 O1 CIT A1102 A 119 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 176.50 123.51 9.48 177.50 124.87 10.72 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 173.15 113.94 5.34 166.89 113.91 6.31 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 5 3 # 5 A 12 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 41 LYS B 180 LYS.? 22.96 O1 CIT A1102 A 119 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 171.08 125.47 9.27 172.48 124.18 10.15 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 173.15 113.94 5.34 166.89 113.91 6.31 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 6 3 # 6 A 12 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 41 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 119 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 160.37 121.38 41.43 159.84 123.37 41.06 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 149.18 124.89 48.07 150.57 125.16 54.16 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 160.20 116.89 49.36 158.52 117.92 48.65 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 7 3 # 7 A 12 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 41 LYS C 180 LYS.? 20.00 O3 GOL C1901 A 119 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 160.37 121.38 41.43 159.84 123.37 41.06 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 163.89 112.64 46.86 163.54 106.47 45.76 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 8 3 # 8 A 12 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 41 LYS C 180 LYS.? 20.00 O3 GOL C1901 A 119 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 157.21 117.94 38.21 157.48 118.99 40.00 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 163.89 112.64 46.86 163.54 106.47 45.76 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 9 3 # 9 A 12 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 41 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 119 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 160.20 116.89 49.36 158.52 117.92 48.65 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 149.18 124.89 48.07 150.57 125.16 54.16 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 160.37 121.38 41.43 159.84 123.37 41.06 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 9 hits 1rbn_c01 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 187 HIS~? 25.73 N9 ADE A 500 B 84 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 140 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 179.01 171.47 26.59 179.51 173.49 26.31 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 184.84 171.88 24.93 186.38 173.28 25.14 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 84 ASP B 175 ASP.? 4.91 O1 CIT A1102 B 140 GLY B 93 GLY^? 21.08 O4 CIT A1102 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 171.08 125.47 9.27 172.48 124.18 10.15 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 169.82 131.15 6.22 168.64 132.89 5.97 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 180.85 120.89 14.39 181.25 120.12 13.99 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 84 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 140 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 174.65 109.33 0.17 174.41 107.27 0.58 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 184.36 119.52 -4.81 184.70 120.30 -4.67 1rgq_c01 source 1rgq NS4A PEPTIDE : 3 hits 1rgq_c01 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG A 43 ARG.? 7.62 C2 ADE A 500 D 156 TYR A 47 TYR^? 13.72 N3 ADE A 500 D 188 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 190.33 158.90 11.08 189.17 159.63 8.34 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 198.66 149.45 16.16 201.00 150.74 16.95 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 3 # 2 D 129 ARG A 43 ARG.? 7.62 C2 ADE A 500 D 156 TYR A 84 TYR^? 7.34 N9 ADE A 500 D 188 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 190.33 158.90 11.08 189.17 159.63 8.34 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 190.70 148.50 17.91 191.29 151.03 18.92 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 3 3 # 3 D 129 ARG B 43 ARG.? 18.57 O1 CIT A1102 D 156 TYR B 47 TYR^? 27.62 O4 CIT A1102 D 188 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 169.37 120.65 13.94 167.07 120.51 11.92 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 177.82 122.79 24.63 178.10 120.27 25.77 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 4 3 # 4 D 129 ARG B 43 ARG.? 18.57 O1 CIT A1102 D 156 TYR B 84 TYR^? 19.29 O4 CIT A1102 D 188 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 169.37 120.65 13.94 167.07 120.51 11.92 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 180.02 126.93 17.73 179.63 124.28 16.92 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 5 3 # 5 D 129 ARG C 43 ARG.? 5.25 O3 GOL C1901 D 156 TYR C 47 TYR^? 13.41 O3 GOL C1901 D 188 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 154.24 116.29 44.96 152.24 116.07 42.61 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 149.80 129.36 48.45 149.55 129.08 51.21 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 6 3 # 6 D 129 ARG C 43 ARG.? 5.25 O3 GOL C1901 D 156 TYR C 84 TYR^? 9.85 O1 GOL C1901 D 188 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 154.24 116.29 44.96 152.24 116.07 42.61 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 155.65 129.37 42.44 156.62 127.68 44.43 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 153.36 123.09 43.85 154.03 121.98 42.20 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 6 hits 1ro7_c03 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 59 GLU^? 13.22 O6 CIT A1102 A 288 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 329 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 29.27 18.78 14.99 27.16 18.62 14.76 169.62 150.86 -1.29 170.91 152.08 -2.44 coo 49.52 10.06 10.36 50.99 9.65 8.92 184.39 157.95 13.11 185.86 157.96 14.60 coo 57.80 12.92 13.83 53.77 8.42 12.15 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 61 GLU^? 16.24 O5 CIT A1102 A 288 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 329 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 29.27 18.78 14.99 27.16 18.62 14.76 165.65 155.89 5.11 164.98 153.86 5.06 coo 49.52 10.06 10.36 50.99 9.65 8.92 185.28 156.61 18.37 185.56 154.55 18.68 coo 57.80 12.92 13.83 53.77 8.42 12.15 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 135 GLU.? 23.34 C8 ADE A 500 A 288 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 329 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 29.27 18.78 14.99 27.16 18.62 14.76 187.40 140.84 33.48 189.24 139.81 33.69 coo 49.52 10.06 10.36 50.99 9.65 8.92 185.28 156.61 18.37 185.56 154.55 18.68 coo 57.80 12.92 13.83 53.77 8.42 12.15 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU A 155 GLU.? 30.36 C8 ADE A 500 A 288 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 329 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 29.27 18.78 14.99 27.16 18.62 14.76 202.13 137.32 32.16 203.15 136.76 33.90 coo 49.52 10.06 10.36 50.99 9.65 8.92 183.15 146.13 20.69 182.60 148.09 20.18 coo 57.80 12.92 13.83 53.77 8.42 12.15 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU A 156 GLU.? 23.41 C8 ADE A 500 A 288 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 329 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 196.65 137.08 28.97 194.78 136.94 30.01 coo 49.52 10.06 10.36 50.99 9.65 8.92 183.49 131.36 11.56 181.98 130.36 10.51 coo 57.80 12.92 13.83 53.77 8.42 12.15 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU A 182 GLU~? 24.67 N9 ADE A 500 A 288 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 329 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 29.27 18.78 14.99 27.16 18.62 14.76 187.83 168.13 29.26 189.30 168.72 30.65 coo 49.52 10.06 10.36 50.99 9.65 8.92 191.47 153.75 14.17 189.52 154.05 13.44 coo 57.80 12.92 13.83 53.77 8.42 12.15 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU A 196 GLU~? 25.56 N9 ADE A 500 A 288 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 329 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 29.27 18.78 14.99 27.16 18.62 14.76 187.60 160.31 36.10 186.31 159.33 37.47 coo 49.52 10.06 10.36 50.99 9.65 8.92 191.47 153.75 14.17 189.52 154.05 13.44 coo 57.80 12.92 13.83 53.77 8.42 12.15 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU B 7 GLU.? 17.06 N6 ADE A 500 A 288 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 329 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 195.60 134.63 1.65 195.26 136.71 1.75 coo 49.52 10.06 10.36 50.99 9.65 8.92 176.50 123.51 9.48 177.50 124.87 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 173.15 113.94 5.34 166.89 113.91 6.31 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU B 59 GLU^? 11.03 O1 CIT A1102 A 288 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 329 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 162.57 145.21 3.58 161.45 143.81 4.68 coo 49.52 10.06 10.36 50.99 9.65 8.92 171.08 125.47 9.27 172.48 124.18 10.15 coo 57.80 12.92 13.83 53.77 8.42 12.15 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 A 137 GLU B 61 GLU^? -7.61 O6 CIT A1102s A 288 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 329 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 165.46 139.15 -4.12 166.35 139.75 -5.94 coo 49.52 10.06 10.36 50.99 9.65 8.92 176.50 123.51 9.48 177.50 124.87 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 173.15 113.94 5.34 166.89 113.91 6.31 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 A 137 GLU B 135 GLU.? 25.67 N6 ADE A 500 A 288 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 329 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 197.88 127.79 14.29 197.78 127.39 16.36 coo 49.52 10.06 10.36 50.99 9.65 8.92 176.50 123.51 9.48 177.50 124.87 10.72 coo 57.80 12.92 13.83 53.77 8.42 12.15 173.15 113.94 5.34 166.89 113.91 6.31 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 A 137 GLU B 155 GLU.? 33.13 C8 ADE A 500 A 288 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 329 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 197.70 123.91 29.28 199.42 125.11 29.52 coo 49.52 10.06 10.36 50.99 9.65 8.92 183.49 131.36 11.56 181.98 130.36 10.51 coo 57.80 12.92 13.83 53.77 8.42 12.15 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 A 137 GLU B 156 GLU.? 24.53 N7 ADE A 500 A 288 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 329 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 29.27 18.78 14.99 27.16 18.62 14.76 194.44 129.17 25.88 194.48 130.18 24.03 coo 49.52 10.06 10.36 50.99 9.65 8.92 183.15 146.13 20.69 182.60 148.09 20.18 coo 57.80 12.92 13.83 53.77 8.42 12.15 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 A 137 GLU B 182 GLU~? 29.98 C2 CIT A1102 A 288 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 329 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 29.27 18.78 14.99 27.16 18.62 14.76 180.61 109.47 2.81 182.18 108.21 3.48 coo 49.52 10.06 10.36 50.99 9.65 8.92 174.27 123.90 17.18 173.55 124.80 15.43 coo 57.80 12.92 13.83 53.77 8.42 12.15 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 15 3 # 15 A 137 GLU B 196 GLU~? 29.77 O4 CIT A1102 A 288 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 329 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 29.27 18.78 14.99 27.16 18.62 14.76 190.49 111.97 5.68 191.95 113.07 4.61 coo 49.52 10.06 10.36 50.99 9.65 8.92 174.27 123.90 17.18 173.55 124.80 15.43 coo 57.80 12.92 13.83 53.77 8.42 12.15 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 16 3 # 16 A 137 GLU C 25 GLU.? 20.39 O3 GOL C1901 A 288 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 329 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo 29.27 18.78 14.99 27.16 18.62 14.76 147.09 130.00 59.71 146.72 128.39 58.35 coo 49.52 10.06 10.36 50.99 9.65 8.92 160.37 121.38 41.43 159.84 123.37 41.06 coo 57.80 12.92 13.83 53.77 8.42 12.15 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 17 3 # 17 A 137 GLU C 59 GLU^? 20.19 O2 GOL C1901 A 288 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 329 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 152.75 116.35 16.84 151.33 114.88 17.42 coo 49.52 10.06 10.36 50.99 9.65 8.92 174.27 123.90 17.18 173.55 124.80 15.43 coo 57.80 12.92 13.83 53.77 8.42 12.15 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 18 3 # 18 A 137 GLU C 59 GLU^? 20.19 O2 GOL C1901 A 288 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 329 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 152.75 116.35 16.84 151.33 114.88 17.42 coo 49.52 10.06 10.36 50.99 9.65 8.92 171.08 125.47 9.27 172.48 124.18 10.15 coo 57.80 12.92 13.83 53.77 8.42 12.15 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 19 3 # 19 A 137 GLU C 59 GLU^? 20.19 O2 GOL C1901 A 288 HIS B 202 HIS.? 28.80 C2 CIT A1102 A 329 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 152.75 116.35 16.84 151.33 114.88 17.42 coo 49.52 10.06 10.36 50.99 9.65 8.92 175.03 109.49 9.82 173.45 108.46 10.74 coo 57.80 12.92 13.83 53.77 8.42 12.15 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 20 3 # 20 A 137 GLU C 59 GLU^? 20.19 O2 GOL C1901 A 288 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 329 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 29.27 18.78 14.99 27.16 18.62 14.76 152.75 116.35 16.84 151.33 114.88 17.42 coo 49.52 10.06 10.36 50.99 9.65 8.92 157.21 117.94 38.21 157.48 118.99 40.00 coo 57.80 12.92 13.83 53.77 8.42 12.15 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 21 3 # 21 A 137 GLU C 61 GLU^? 23.56 O1 GOL C1901 A 288 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 329 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo 29.27 18.78 14.99 27.16 18.62 14.76 160.74 113.36 18.70 162.31 114.29 17.61 coo 49.52 10.06 10.36 50.99 9.65 8.92 160.37 121.38 41.43 159.84 123.37 41.06 coo 57.80 12.92 13.83 53.77 8.42 12.15 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 22 3 # 22 A 137 GLU C 72 GLU^? 21.88 O2 GOL C1901 A 288 HIS B 202 HIS.? 28.80 C2 CIT A1102 A 329 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 29.27 18.78 14.99 27.16 18.62 14.76 157.04 105.81 21.84 155.70 105.06 23.29 coo 49.52 10.06 10.36 50.99 9.65 8.92 175.03 109.49 9.82 173.45 108.46 10.74 coo 57.80 12.92 13.83 53.77 8.42 12.15 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 23 3 # 23 A 137 GLU C 135 GLU.? 26.33 O1 GOL C1901 A 288 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 329 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo 29.27 18.78 14.99 27.16 18.62 14.76 168.08 142.51 43.72 166.57 142.98 45.14 coo 49.52 10.06 10.36 50.99 9.65 8.92 160.37 121.38 41.43 159.84 123.37 41.06 coo 57.80 12.92 13.83 53.77 8.42 12.15 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 24 3 # 24 A 137 GLU C 182 GLU~? 26.37 O3 GOL C1901 A 288 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 329 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 29.27 18.78 14.99 27.16 18.62 14.76 170.51 115.98 53.19 171.23 115.96 55.18 coo 49.52 10.06 10.36 50.99 9.65 8.92 153.36 123.09 43.85 154.03 121.98 42.20 coo 57.80 12.92 13.83 53.77 8.42 12.15 147.41 128.03 39.92 142.61 128.90 38.51 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 25 3 # 25 A 137 GLU C 196 GLU~? 28.79 C1 GOL C1901 A 288 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 329 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 29.27 18.78 14.99 27.16 18.62 14.76 174.54 125.67 53.14 175.81 126.60 51.73 coo 49.52 10.06 10.36 50.99 9.65 8.92 153.36 123.09 43.85 154.03 121.98 42.20 coo 57.80 12.92 13.83 53.77 8.42 12.15 147.41 128.03 39.92 142.61 128.90 38.51 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 25 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 59 GLU^? 13.22 O6 CIT A1102 B 288 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 329 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 169.62 150.86 -1.29 170.91 152.08 -2.44 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 184.39 157.95 13.11 185.86 157.96 14.60 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 135 GLU.? 23.34 C8 ADE A 500 B 288 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 329 LYS A 180 LYS~? 18.96 N3 ADE A 500 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 187.40 140.84 33.48 189.24 139.81 33.69 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 185.28 156.61 18.37 185.56 154.55 18.68 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 185.07 167.50 20.34 181.31 169.96 15.85 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU A 155 GLU.? 30.36 C8 ADE A 500 B 288 HIS A 104 HIS^? 8.41 C8 ADE A 500 B 329 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 202.13 137.32 32.16 203.15 136.76 33.90 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 183.15 146.13 20.69 182.60 148.09 20.18 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU A 156 GLU.? 23.41 C8 ADE A 500 B 288 HIS B 104 HIS^? 12.85 O4 CIT A1102 B 329 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 196.65 137.08 28.97 194.78 136.94 30.01 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 183.49 131.36 11.56 181.98 130.36 10.51 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU A 182 GLU~? 24.67 N9 ADE A 500 B 288 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 329 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 187.83 168.13 29.26 189.30 168.72 30.65 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 191.47 153.75 14.17 189.52 154.05 13.44 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU A 196 GLU~? 25.56 N9 ADE A 500 B 288 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 329 LYS A 49 LYS^? 10.58 N6 ADE A 500 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 187.60 160.31 36.10 186.31 159.33 37.47 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 191.47 153.75 14.17 189.52 154.05 13.44 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 193.06 146.52 10.07 195.03 144.09 6.09 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU B 7 GLU.? 17.06 N6 ADE A 500 B 288 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 329 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 195.60 134.63 1.65 195.26 136.71 1.75 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 176.50 123.51 9.48 177.50 124.87 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 173.15 113.94 5.34 166.89 113.91 6.31 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU B 59 GLU^? 11.03 O1 CIT A1102 B 288 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 329 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 162.57 145.21 3.58 161.45 143.81 4.68 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 171.08 125.47 9.27 172.48 124.18 10.15 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 B 137 GLU B 61 GLU^? -7.61 O6 CIT A1102s B 288 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 329 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 165.46 139.15 -4.12 166.35 139.75 -5.94 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 176.50 123.51 9.48 177.50 124.87 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 173.15 113.94 5.34 166.89 113.91 6.31 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 B 137 GLU B 135 GLU.? 25.67 N6 ADE A 500 B 288 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 329 LYS B 180 LYS.? 22.96 O1 CIT A1102 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 197.88 127.79 14.29 197.78 127.39 16.36 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 176.50 123.51 9.48 177.50 124.87 10.72 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 173.15 113.94 5.34 166.89 113.91 6.31 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 B 137 GLU B 155 GLU.? 33.13 C8 ADE A 500 B 288 HIS B 104 HIS^? 12.85 O4 CIT A1102 B 329 LYS B 147 LYS^? 12.56 O4 CIT A1102 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 197.70 123.91 29.28 199.42 125.11 29.52 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 183.49 131.36 11.56 181.98 130.36 10.51 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 181.66 123.79 6.82 179.82 128.66 10.46 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 B 137 GLU B 156 GLU.? 24.53 N7 ADE A 500 B 288 HIS A 104 HIS^? 8.41 C8 ADE A 500 B 329 LYS A 147 LYS^? 6.48 C8 ADE A 500 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 194.44 129.17 25.88 194.48 130.18 24.03 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 183.15 146.13 20.69 182.60 148.09 20.18 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 182.91 155.29 23.54 184.46 151.31 19.55 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 B 137 GLU B 182 GLU~? 29.98 C2 CIT A1102 B 288 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 329 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 180.61 109.47 2.81 182.18 108.21 3.48 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 174.27 123.90 17.18 173.55 124.80 15.43 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 B 137 GLU B 196 GLU~? 29.77 O4 CIT A1102 B 288 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 329 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 190.49 111.97 5.68 191.95 113.07 4.61 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 174.27 123.90 17.18 173.55 124.80 15.43 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 15 3 # 15 B 137 GLU C 59 GLU^? 20.19 O2 GOL C1901 B 288 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 329 LYS C 147 LYS^? 10.01 O1 GOL C1901 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 152.75 116.35 16.84 151.33 114.88 17.42 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 157.21 117.94 38.21 157.48 118.99 40.00 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 165.62 124.17 41.44 160.89 126.43 37.84 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 16 3 # 16 B 137 GLU C 61 GLU^? 23.56 O1 GOL C1901 B 288 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 329 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 160.74 113.36 18.70 162.31 114.29 17.61 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 160.37 121.38 41.43 159.84 123.37 41.06 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 17 3 # 17 B 137 GLU C 72 GLU^? 21.88 O2 GOL C1901 B 288 HIS B 202 HIS.? 28.80 C2 CIT A1102 B 329 LYS B 94 LYS^? 27.17 C2 CIT A1102 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 157.04 105.81 21.84 155.70 105.06 23.29 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 175.03 109.49 9.82 173.45 108.46 10.74 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 179.28 118.69 11.71 177.59 112.91 13.79 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 18 3 # 18 B 137 GLU C 135 GLU.? 26.33 O1 GOL C1901 B 288 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 329 LYS C 180 LYS.? 20.00 O3 GOL C1901 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 168.08 142.51 43.72 166.57 142.98 45.14 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 160.37 121.38 41.43 159.84 123.37 41.06 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 163.89 112.64 46.86 163.54 106.47 45.76 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 19 3 # 19 B 137 GLU C 196 GLU~? 28.79 C1 GOL C1901 B 288 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 329 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 174.54 125.67 53.14 175.81 126.60 51.73 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 153.36 123.09 43.85 154.03 121.98 42.20 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 147.41 128.03 39.92 142.61 128.90 38.51 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 19 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 187 HIS~? 25.73 N9 ADE A 500 B 102 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 193 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo -4.60 27.52 42.88 -4.63 27.41 40.76 179.01 171.47 26.59 179.51 173.49 26.31 coo -0.27 31.24 43.51 -1.49 29.62 42.98 184.84 171.88 24.93 186.38 173.28 25.14 coo -6.81 22.81 34.74 -6.42 23.54 34.62 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 193 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo -4.60 27.52 42.88 -4.63 27.41 40.76 176.75 112.07 -5.75 176.32 110.31 -6.80 coo -0.27 31.24 43.51 -1.49 29.62 42.98 174.65 109.33 0.17 174.41 107.27 0.58 coo -6.81 22.81 34.74 -6.42 23.54 34.62 184.36 119.52 -4.81 184.70 120.30 -4.67 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 B 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 B 193 GLY B 190 GLY~? 28.95 C2 CIT A1102 coo -4.60 27.52 42.88 -4.63 27.41 40.76 176.75 112.07 -5.75 176.32 110.31 -6.80 coo -0.27 31.24 43.51 -1.49 29.62 42.98 174.65 109.33 0.17 174.41 107.27 0.58 coo -6.81 22.81 34.74 -6.42 23.54 34.62 185.59 111.38 -4.25 185.26 111.65 -3.51 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 3 hits 1rtf_c06 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS A 104 HIS^? 8.41 C8 ADE A 500 62 GLU A 165 GLU^? 4.52 C8 ADE A 500 101 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 13.91 26.31 13.70 14.98 27.08 12.06 183.15 146.13 20.69 182.60 148.09 20.18 coo 9.15 26.32 13.85 8.75 28.20 13.02 185.43 146.45 17.17 186.00 148.48 17.29 coo 7.90 34.31 7.89 9.24 33.73 9.42 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 2 3 # 2 41 HIS A 104 HIS^? 8.41 C8 ADE A 500 62 GLU A 165 GLU^? 4.52 C8 ADE A 500 101 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 13.91 26.31 13.70 14.98 27.08 12.06 183.15 146.13 20.69 182.60 148.09 20.18 coo 9.15 26.32 13.85 8.75 28.20 13.02 185.43 146.45 17.17 186.00 148.48 17.29 coo 7.90 34.31 7.89 9.24 33.73 9.42 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 3 3 # 3 41 HIS B 104 HIS^? 12.85 O4 CIT A1102 62 GLU B 165 GLU^? 13.88 O4 CIT A1102 101 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 13.91 26.31 13.70 14.98 27.08 12.06 183.49 131.36 11.56 181.98 130.36 10.51 coo 9.15 26.32 13.85 8.75 28.20 13.02 180.17 131.30 14.36 179.09 129.62 13.64 coo 7.90 34.31 7.89 9.24 33.73 9.42 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 4 3 # 4 41 HIS B 104 HIS^? 12.85 O4 CIT A1102 62 GLU B 165 GLU^? 13.88 O4 CIT A1102 101 HIS B 96 HIS^? 15.42 O4 CIT A1102 coo 13.91 26.31 13.70 14.98 27.08 12.06 183.49 131.36 11.56 181.98 130.36 10.51 coo 9.15 26.32 13.85 8.75 28.20 13.02 180.17 131.30 14.36 179.09 129.62 13.64 coo 7.90 34.31 7.89 9.24 33.73 9.42 176.50 123.51 9.48 177.50 124.87 10.72 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 5 3 # 5 41 HIS C 104 HIS^? 12.14 O1 GOL C1901 62 GLU C 165 GLU^? 7.74 O1 GOL C1901 101 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 13.91 26.31 13.70 14.98 27.08 12.06 161.39 131.07 36.65 161.63 129.00 36.89 coo 9.15 26.32 13.85 8.75 28.20 13.02 157.34 129.59 37.15 157.60 127.69 38.11 coo 7.90 34.31 7.89 9.24 33.73 9.42 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 6 3 # 6 41 HIS C 104 HIS^? 12.14 O1 GOL C1901 62 GLU C 165 GLU^? 7.74 O1 GOL C1901 101 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 13.91 26.31 13.70 14.98 27.08 12.06 161.39 131.07 36.65 161.63 129.00 36.89 coo 9.15 26.32 13.85 8.75 28.20 13.02 157.34 129.59 37.15 157.60 127.69 38.11 coo 7.90 34.31 7.89 9.24 33.73 9.42 160.37 121.38 41.43 159.84 123.37 41.06 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 6 hits 1rtu_c00 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP C 52 ASP^? 12.06 O1 GOL C1901 595 GLU C 165 GLU^? 7.74 O1 GOL C1901 713 TYR C 83 TYR^? 12.44 O1 GOL C1901 coo 5.64 2.82 38.49 4.59 4.19 37.25 147.21 130.59 30.19 147.01 130.37 28.08 coo 4.35 13.73 37.63 3.39 12.18 36.55 157.34 129.59 37.15 157.60 127.69 38.11 coo 3.76 10.25 31.38 3.16 9.87 34.10 149.52 133.95 39.18 148.57 136.34 38.09 1sll_c00 source 1sll SIALIDASE L : 1 hits 1sll_c00 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 101 ARG.? 15.15 C8 ADE A 500 A 89 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 119 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 28.44 23.52 73.95 30.13 24.84 76.11 173.48 146.74 16.27 172.57 144.92 18.53 coo 21.34 20.13 69.47 22.14 19.11 71.12 183.15 146.13 20.69 182.60 148.09 20.18 coo 19.69 29.00 71.61 19.80 26.98 72.20 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG B 101 ARG.? -6.88 O4 CIT A1102s A 89 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 119 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo 28.44 23.52 73.95 30.13 24.84 76.11 179.40 137.94 3.82 182.23 139.06 3.56 coo 21.34 20.13 69.47 22.14 19.11 71.12 183.49 131.36 11.56 181.98 130.36 10.51 coo 19.69 29.00 71.61 19.80 26.98 72.20 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 A 87 ARG C 101 ARG.? 18.11 O1 GOL C1901 A 89 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 119 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 28.44 23.52 73.95 30.13 24.84 76.11 163.77 126.78 27.00 165.49 129.29 26.85 coo 21.34 20.13 69.47 22.14 19.11 71.12 161.39 131.07 36.65 161.63 129.00 36.89 coo 19.69 29.00 71.61 19.80 26.98 72.20 160.68 120.91 34.68 159.00 120.62 33.38 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 3 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 101 ARG.? 15.15 C8 ADE A 500 B 89 HIS A 104 HIS^? 8.41 C8 ADE A 500 B 119 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo -30.08 23.20 29.48 -31.80 24.60 27.35 173.48 146.74 16.27 172.57 144.92 18.53 coo -22.85 19.92 33.92 -23.63 18.94 32.24 183.15 146.13 20.69 182.60 148.09 20.18 coo -21.28 28.91 31.84 -21.35 26.90 31.17 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG B 101 ARG.? -6.88 O4 CIT A1102s B 89 HIS B 104 HIS^? 12.85 O4 CIT A1102 B 119 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo -30.08 23.20 29.48 -31.80 24.60 27.35 179.40 137.94 3.82 182.23 139.06 3.56 coo -22.85 19.92 33.92 -23.63 18.94 32.24 183.49 131.36 11.56 181.98 130.36 10.51 coo -21.28 28.91 31.84 -21.35 26.90 31.17 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 3 3 # 3 B 87 ARG C 101 ARG.? 18.11 O1 GOL C1901 B 89 HIS C 104 HIS^? 12.14 O1 GOL C1901 B 119 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo -30.08 23.20 29.48 -31.80 24.60 27.35 163.77 126.78 27.00 165.49 129.29 26.85 coo -22.85 19.92 33.92 -23.63 18.94 32.24 161.39 131.07 36.65 161.63 129.00 36.89 coo -21.28 28.91 31.84 -21.35 26.90 31.17 160.68 120.91 34.68 159.00 120.62 33.38 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 3 hits 1smn_c01 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 187 HIS~? 25.73 N9 ADE A 500 A 102 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 193 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo 15.02 29.17 19.44 15.63 29.96 17.60 179.01 171.47 26.59 179.51 173.49 26.31 coo 19.67 30.58 22.61 18.30 29.87 21.17 184.84 171.88 24.93 186.38 173.28 25.14 coo 14.52 29.10 10.01 15.08 29.66 10.19 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 193 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo 15.02 29.17 19.44 15.63 29.96 17.60 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 19.67 30.58 22.61 18.30 29.87 21.17 174.65 109.33 0.17 174.41 107.27 0.58 coo 14.52 29.10 10.01 15.08 29.66 10.19 184.36 119.52 -4.81 184.70 120.30 -4.67 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 193 GLY B 190 GLY~? 28.95 C2 CIT A1102 coo 15.02 29.17 19.44 15.63 29.96 17.60 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 19.67 30.58 22.61 18.30 29.87 21.17 174.65 109.33 0.17 174.41 107.27 0.58 coo 14.52 29.10 10.01 15.08 29.66 10.19 185.59 111.38 -4.25 185.26 111.65 -3.51 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 3 hits 1ssx_c02 naa= 3 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 1 3 # 1 E 166 ASP A 130 ASP~? 27.60 C8 ADE A 500 E 168 LYS A 132 LYS~? 32.58 C8 ADE A 500 E 171 ASN A 133 ASN~? 29.64 C8 ADE A 500 coo 5.36 16.20 22.10 3.88 17.00 23.31 188.71 136.74 34.61 188.50 136.01 36.57 coo 5.06 22.32 18.11 1.02 22.08 22.74 183.55 135.22 37.19 185.46 129.22 37.94 coo 6.68 21.78 22.39 5.28 20.74 23.60 186.76 138.66 38.21 187.61 137.64 39.89 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 2 3 # 2 E 166 ASP A 175 ASP.? 10.98 C4 ADE A 500 E 168 LYS A 97 LYS^? 15.28 N9 ADE A 500 E 171 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 5.36 16.20 22.10 3.88 17.00 23.31 178.57 156.37 9.84 177.44 156.14 8.05 coo 5.06 22.32 18.11 1.02 22.08 22.74 180.69 158.10 18.36 176.95 162.62 18.15 coo 6.68 21.78 22.39 5.28 20.74 23.60 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 3 3 # 3 E 166 ASP B 130 ASP~? 26.83 N6 ADE A 500 E 168 LYS B 132 LYS~? 23.82 N6 ADE A 500 E 171 ASN B 133 ASN~? 28.81 N6 ADE A 500 coo 5.36 16.20 22.10 3.88 17.00 23.31 200.55 129.62 17.17 202.64 129.41 16.98 coo 5.06 22.32 18.11 1.02 22.08 22.74 203.58 131.98 12.65 206.21 136.25 10.92 coo 6.68 21.78 22.39 5.28 20.74 23.60 202.41 127.52 13.21 204.35 127.28 14.04 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 4 3 # 4 E 166 ASP B 175 ASP.? 4.91 O1 CIT A1102 E 168 LYS B 97 LYS^? 12.22 C2 CIT A1102 E 171 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo 5.36 16.20 22.10 3.88 17.00 23.31 169.82 131.15 6.22 168.64 132.89 5.97 coo 5.06 22.32 18.11 1.02 22.08 22.74 175.75 125.08 4.60 173.18 124.12 -0.61 coo 6.68 21.78 22.39 5.28 20.74 23.60 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 5 3 # 5 E 166 ASP C 130 ASP.? 30.92 O1 GOL C1901 E 168 LYS C 132 LYS.? 31.57 C8 ADE A 500 E 171 ASN C 133 ASN.? 33.10 O1 GOL C1901 coo 5.36 16.20 22.10 3.88 17.00 23.31 167.73 145.95 43.64 168.62 147.66 44.50 coo 5.06 22.32 18.11 1.02 22.08 22.74 171.68 147.74 40.36 169.69 153.78 40.28 coo 6.68 21.78 22.39 5.28 20.74 23.60 171.58 145.70 44.65 171.99 147.56 45.54 ULMN 3 1stc_c03 CAMP-DEPENDENT PROTEIN KINASE user 6 3 # 6 E 166 ASP C 175 ASP.? 10.66 O1 GOL C1901 E 168 LYS C 97 LYS^? 17.09 C1 GOL C1901 E 171 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 5.36 16.20 22.10 3.88 17.00 23.31 157.90 117.18 31.56 156.68 116.62 29.91 coo 5.06 22.32 18.11 1.02 22.08 22.74 163.30 119.33 38.22 166.56 114.68 36.90 coo 6.68 21.78 22.39 5.28 20.74 23.60 160.68 120.91 34.68 159.00 120.62 33.38 1stc_c03 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 6 hits 1stc_c03 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 80 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 223 ARG B 76 ARG^? 5.63 O1 CIT A1102 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 191.47 153.75 14.17 189.52 154.05 13.44 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 188.90 156.57 17.91 187.92 156.12 16.11 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 166.15 136.82 7.45 164.99 134.62 5.65 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 80 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 223 ARG A 76 ARG^? 12.51 N1 ADE A 500 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 174.27 123.90 17.18 173.55 124.80 15.43 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 174.85 121.76 12.80 173.53 120.38 11.97 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 176.90 153.44 4.90 177.24 156.32 3.96 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 80 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 223 ARG C 53 ARG^? 4.89 O2 GOL C1901 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 174.27 123.90 17.18 173.55 124.80 15.43 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 174.85 121.76 12.80 173.53 120.38 11.97 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 146.33 122.48 29.52 148.17 121.33 31.67 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 80 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 223 ARG A 76 ARG^? 12.51 N1 ADE A 500 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 176.50 123.51 9.48 177.50 124.87 10.72 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 174.85 121.76 12.80 173.53 120.38 11.97 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 176.90 153.44 4.90 177.24 156.32 3.96 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 80 GLU B 44 GLU.? 19.02 O1 CIT A1102 B 223 ARG C 53 ARG^? 4.89 O2 GOL C1901 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 171.08 125.47 9.27 172.48 124.18 10.15 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 174.85 121.76 12.80 173.53 120.38 11.97 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 146.33 122.48 29.52 148.17 121.33 31.67 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 80 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 223 ARG B 53 ARG^? 12.50 O1 CIT A1102 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 153.36 123.09 43.85 154.03 121.98 42.20 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 157.18 120.22 44.20 157.97 118.54 45.19 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 166.97 137.64 16.68 167.60 135.18 14.95 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 7 3 # 7 B 8 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 80 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 223 ARG B 53 ARG^? 12.50 O1 CIT A1102 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 160.37 121.38 41.43 159.84 123.37 41.06 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 157.18 120.22 44.20 157.97 118.54 45.19 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 166.97 137.64 16.68 167.60 135.18 14.95 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 8 3 # 8 B 8 HIS C 104 HIS^? 12.14 O1 GOL C1901 B 80 GLU C 165 GLU^? 7.74 O1 GOL C1901 B 223 ARG B 76 ARG^? 5.63 O1 CIT A1102 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 161.39 131.07 36.65 161.63 129.00 36.89 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 157.34 129.59 37.15 157.60 127.69 38.11 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 166.15 136.82 7.45 164.99 134.62 5.65 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 9 3 # 9 B 8 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 80 GLU C 44 GLU.? 9.57 O3 GOL C1901 B 223 ARG B 53 ARG^? 12.50 O1 CIT A1102 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 157.21 117.94 38.21 157.48 118.99 40.00 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 157.18 120.22 44.20 157.97 118.54 45.19 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 166.97 137.64 16.68 167.60 135.18 14.95 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 10 3 # 10 B 8 HIS C 187 HIS~? 27.79 O3 GOL C1901 B 80 GLU C 184 GLU~? 18.70 O3 GOL C1901 B 223 ARG B 43 ARG.? 18.57 O1 CIT A1102 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 174.78 109.74 44.68 175.79 108.53 43.31 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 168.68 112.73 44.51 166.86 112.61 43.45 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 169.37 120.65 13.94 167.07 120.51 11.92 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 11 3 # 11 B 8 HIS C 187 HIS~? 27.79 O3 GOL C1901 B 80 GLU C 184 GLU~? 18.70 O3 GOL C1901 B 223 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 174.78 109.74 44.68 175.79 108.53 43.31 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 168.68 112.73 44.51 166.86 112.61 43.45 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 188.64 131.77 26.61 189.85 131.11 29.36 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 11 hits 1t0u_c01 naa= 3 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 1 3 # 1 A 261 GLY A 128 GLY.? 19.63 C8 ADE A 500 B 17 GLN A 112 GLN^? 20.81 C8 ADE A 500 B 140 GLU A 135 GLU.? 23.34 C8 ADE A 500 coo 61.49 19.86 5.96 61.52 19.46 5.16 188.72 140.03 29.58 187.87 139.89 29.50 coo 63.76 11.90 7.93 65.18 13.07 6.77 187.82 149.99 31.85 188.55 150.31 33.84 coo 66.44 19.00 7.38 67.69 17.67 8.37 187.40 140.84 33.48 189.24 139.81 33.69 ULMN 3 1t4c_c02 FORMYL-COENZYME A TRANSFERASE user 2 3 # 2 A 261 GLY B 128 GLY.? 22.81 N7 ADE A 500 B 17 GLN B 112 GLN^? 26.54 O4 CIT A1102 B 140 GLU B 135 GLU.? 25.67 N6 ADE A 500 coo 61.49 19.86 5.96 61.52 19.46 5.16 194.68 129.33 16.90 194.61 129.94 16.26 coo 63.76 11.90 7.93 65.18 13.07 6.77 191.75 121.43 11.28 193.26 119.92 11.27 coo 66.44 19.00 7.38 67.69 17.67 8.37 197.88 127.79 14.29 197.78 127.39 16.36 1t4c_c02 source 1t4c FORMYL-COENZYME A TRANSFERASE : 2 hits 1t4c_c02 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 174 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 404 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 185.28 156.61 18.37 185.56 154.55 18.68 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 178.57 156.37 9.84 177.44 156.14 8.05 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 174 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 404 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 176.50 123.51 9.48 177.50 124.87 10.72 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 169.82 131.15 6.22 168.64 132.89 5.97 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 174 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 404 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 160.37 121.38 41.43 159.84 123.37 41.06 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 157.90 117.18 31.56 156.68 116.62 29.91 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 155.65 129.37 42.44 156.62 127.68 44.43 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 3 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 96 HIS^? 6.77 N9 ADE A 500 C 174 ASP A 175 ASP.? 10.98 C4 ADE A 500 C 404 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 185.28 156.61 18.37 185.56 154.55 18.68 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 178.57 156.37 9.84 177.44 156.14 8.05 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS B 96 HIS^? 15.42 O4 CIT A1102 C 174 ASP B 175 ASP.? 4.91 O1 CIT A1102 C 404 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 176.50 123.51 9.48 177.50 124.87 10.72 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 169.82 131.15 6.22 168.64 132.89 5.97 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS C 96 HIS^? 9.69 C1 GOL C1901 C 174 ASP C 175 ASP.? 10.66 O1 GOL C1901 C 404 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 160.37 121.38 41.43 159.84 123.37 41.06 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 157.90 117.18 31.56 156.68 116.62 29.91 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 155.65 129.37 42.44 156.62 127.68 44.43 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 3 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 96 HIS^? 6.77 N9 ADE A 500 E 174 ASP A 175 ASP.? 10.98 C4 ADE A 500 E 404 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo -7.53-107.59 75.19 -8.14-106.04 76.47 185.28 156.61 18.37 185.56 154.55 18.68 coo -3.55-105.39 83.13 -5.21-106.24 82.09 178.57 156.37 9.84 177.44 156.14 8.05 coo -16.31-108.78 75.35 -14.20-107.14 76.16 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS B 96 HIS^? 15.42 O4 CIT A1102 E 174 ASP B 175 ASP.? 4.91 O1 CIT A1102 E 404 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo -7.53-107.59 75.19 -8.14-106.04 76.47 176.50 123.51 9.48 177.50 124.87 10.72 coo -3.55-105.39 83.13 -5.21-106.24 82.09 169.82 131.15 6.22 168.64 132.89 5.97 coo -16.31-108.78 75.35 -14.20-107.14 76.16 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS C 96 HIS^? 9.69 C1 GOL C1901 E 174 ASP C 175 ASP.? 10.66 O1 GOL C1901 E 404 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo -7.53-107.59 75.19 -8.14-106.04 76.47 160.37 121.38 41.43 159.84 123.37 41.06 coo -3.55-105.39 83.13 -5.21-106.24 82.09 157.90 117.18 31.56 156.68 116.62 29.91 coo -16.31-108.78 75.35 -14.20-107.14 76.16 155.65 129.37 42.44 156.62 127.68 44.43 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 3 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 96 HIS^? 6.77 N9 ADE A 500 G 174 ASP A 175 ASP.? 10.98 C4 ADE A 500 G 404 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo 60.48-101.16 45.95 60.56-101.20 43.85 185.28 156.61 18.37 185.56 154.55 18.68 coo 58.10-108.15 40.62 59.57-106.86 41.51 178.57 156.37 9.84 177.44 156.14 8.05 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS B 96 HIS^? 15.42 O4 CIT A1102 G 174 ASP B 175 ASP.? 4.91 O1 CIT A1102 G 404 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 60.48-101.16 45.95 60.56-101.20 43.85 176.50 123.51 9.48 177.50 124.87 10.72 coo 58.10-108.15 40.62 59.57-106.86 41.51 169.82 131.15 6.22 168.64 132.89 5.97 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS C 96 HIS^? 9.69 C1 GOL C1901 G 174 ASP C 175 ASP.? 10.66 O1 GOL C1901 G 404 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 60.48-101.16 45.95 60.56-101.20 43.85 160.37 121.38 41.43 159.84 123.37 41.06 coo 58.10-108.15 40.62 59.57-106.86 41.51 157.90 117.18 31.56 156.68 116.62 29.91 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 155.65 129.37 42.44 156.62 127.68 44.43 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 3 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 96 HIS^? 6.77 N9 ADE A 500 I 174 ASP A 175 ASP.? 10.98 C4 ADE A 500 I 404 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 185.28 156.61 18.37 185.56 154.55 18.68 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 178.57 156.37 9.84 177.44 156.14 8.05 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS B 96 HIS^? 15.42 O4 CIT A1102 I 174 ASP B 175 ASP.? 4.91 O1 CIT A1102 I 404 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 176.50 123.51 9.48 177.50 124.87 10.72 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 169.82 131.15 6.22 168.64 132.89 5.97 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS C 96 HIS^? 9.69 C1 GOL C1901 I 174 ASP C 175 ASP.? 10.66 O1 GOL C1901 I 404 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 160.37 121.38 41.43 159.84 123.37 41.06 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 157.90 117.18 31.56 156.68 116.62 29.91 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 155.65 129.37 42.44 156.62 127.68 44.43 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 3 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 96 HIS^? 6.77 N9 ADE A 500 K 174 ASP A 175 ASP.? 10.98 C4 ADE A 500 K 404 TYR A 84 TYR^? 7.34 N9 ADE A 500 coo 100.18 26.45 -1.32 99.24 26.12 0.53 185.28 156.61 18.37 185.56 154.55 18.68 coo 102.36 30.86 6.31 102.45 29.08 5.12 178.57 156.37 9.84 177.44 156.14 8.05 coo 99.93 17.48 -0.85 99.14 19.86 0.39 190.70 148.50 17.91 191.29 151.03 18.92 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS B 96 HIS^? 15.42 O4 CIT A1102 K 174 ASP B 175 ASP.? 4.91 O1 CIT A1102 K 404 TYR B 84 TYR^? 19.29 O4 CIT A1102 coo 100.18 26.45 -1.32 99.24 26.12 0.53 176.50 123.51 9.48 177.50 124.87 10.72 coo 102.36 30.86 6.31 102.45 29.08 5.12 169.82 131.15 6.22 168.64 132.89 5.97 coo 99.93 17.48 -0.85 99.14 19.86 0.39 180.02 126.93 17.73 179.63 124.28 16.92 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS C 96 HIS^? 9.69 C1 GOL C1901 K 174 ASP C 175 ASP.? 10.66 O1 GOL C1901 K 404 TYR C 84 TYR^? 9.85 O1 GOL C1901 coo 100.18 26.45 -1.32 99.24 26.12 0.53 160.37 121.38 41.43 159.84 123.37 41.06 coo 102.36 30.86 6.31 102.45 29.08 5.12 157.90 117.18 31.56 156.68 116.62 29.91 coo 99.93 17.48 -0.85 99.14 19.86 0.39 155.65 129.37 42.44 156.62 127.68 44.43 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 3 hits 1ti6_c11 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 97 LYS^? 15.28 N9 ADE A 500 138 ASN A 100 ASN.? 10.86 N7 ADE A 500 183 HIS A 104 HIS^? 8.41 C8 ADE A 500 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 180.69 158.10 18.36 176.95 162.62 18.15 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 175.81 151.36 12.66 175.13 152.21 10.81 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 183.15 146.13 20.69 182.60 148.09 20.18 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS A 147 LYS^? 6.48 C8 ADE A 500 138 ASN A 98 ASN^? 5.64 N9 ADE A 500 183 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 182.91 155.29 23.54 184.46 151.31 19.55 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 179.72 154.52 15.51 181.63 154.42 14.60 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 3 3 # 3 115 LYS B 97 LYS^? 12.22 C2 CIT A1102 138 ASN B 100 ASN.? -3.42 C4 CIT A1102s 183 HIS B 104 HIS^? 12.85 O4 CIT A1102 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 175.75 125.08 4.60 173.18 124.12 -0.61 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 174.18 134.78 4.77 172.12 135.04 4.40 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 183.49 131.36 11.56 181.98 130.36 10.51 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 4 3 # 4 115 LYS B 147 LYS^? 12.56 O4 CIT A1102 138 ASN B 98 ASN^? 8.56 C4 CIT A1102 183 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 181.66 123.79 6.82 179.82 128.66 10.46 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 174.94 129.17 6.18 173.60 130.41 7.30 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 5 3 # 5 115 LYS C 97 LYS^? 17.09 C1 GOL C1901 138 ASN C 100 ASN.? 12.22 O1 GOL C1901 183 HIS C 104 HIS^? 12.14 O1 GOL C1901 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 163.30 119.33 38.22 166.56 114.68 36.90 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 160.54 121.61 29.05 159.70 119.87 28.12 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 161.39 131.07 36.65 161.63 129.00 36.89 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 6 3 # 6 115 LYS C 147 LYS^? 10.01 O1 GOL C1901 138 ASN C 98 ASN^? 8.51 O1 GOL C1901 183 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 36.44 -9.55 24.75 39.00 -9.24 20.52 165.62 124.17 41.44 160.89 126.43 37.84 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 160.68 120.91 34.68 159.00 120.62 33.38 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 153.36 123.09 43.85 154.03 121.98 42.20 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 6 hits 1uag_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 126 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 171 ALA A 148 ALA^? 13.14 N9 ADE A 500 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 188.90 156.57 17.91 187.92 156.12 16.11 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 180.69 158.10 18.36 176.95 162.62 18.15 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 186.54 155.13 24.52 186.93 156.34 25.35 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 182 GLU~? 24.67 N9 ADE A 500 A 126 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 171 ALA A 201 ALA~? 17.12 N9 ADE A 500 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 187.83 168.13 29.26 189.30 168.72 30.65 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 185.07 167.50 20.34 181.31 169.96 15.85 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 189.52 162.53 24.76 188.43 163.45 25.31 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU A 182 GLU~? 24.67 N9 ADE A 500 A 126 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 171 ALA A 198 ALA~? 22.51 N9 ADE A 500 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 187.83 168.13 29.26 189.30 168.72 30.65 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 183.60 164.07 35.65 183.22 158.61 36.42 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 189.84 163.90 29.97 190.40 165.13 30.64 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU B 182 GLU~? 29.98 C2 CIT A1102 A 126 LYS B 180 LYS.? 22.96 O1 CIT A1102 A 171 ALA B 201 ALA.? 25.06 C2 CIT A1102 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 180.61 109.47 2.81 182.18 108.21 3.48 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 173.15 113.94 5.34 166.89 113.91 6.31 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 179.08 113.99 8.58 179.23 113.12 7.33 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 A 46 GLU B 182 GLU~? 29.98 C2 CIT A1102 A 126 LYS B 193 LYS~? 27.56 O4 CIT A1102 A 171 ALA B 198 ALA.? 29.73 O4 CIT A1102 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 180.61 109.47 2.81 182.18 108.21 3.48 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 188.45 111.50 0.09 191.63 115.50 2.10 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 183.32 111.00 7.40 183.44 109.49 7.28 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 A 46 GLU B 192 GLU~? 33.56 O4 CIT A1102 A 126 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 171 ALA B 195 ALA~? 32.61 O4 CIT A1102 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 188.59 108.97 -3.25 189.65 108.47 -5.00 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 185.78 108.35 3.71 186.55 107.14 3.21 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 A 46 GLU C 182 GLU~? 26.37 O3 GOL C1901 A 126 LYS C 193 LYS~? 28.43 O1 GOL C1901 A 171 ALA C 198 ALA~? 24.12 O3 GOL C1901 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 170.51 115.98 53.19 171.23 115.96 55.18 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 177.05 121.15 50.66 176.96 126.15 48.94 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 168.86 120.30 53.31 169.26 119.70 54.63 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 A 46 GLU C 192 GLU~? 35.32 O3 GOL C1901 A 126 LYS C 186 LYS~? 29.69 O3 GOL C1901 A 171 ALA C 195 ALA~? 29.46 O3 GOL C1901 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 180.77 119.87 52.99 182.51 120.63 53.94 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 174.37 114.14 48.91 174.42 112.17 55.03 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 173.84 119.71 54.74 175.00 119.64 55.71 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 8 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 126 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 171 ALA A 148 ALA^? 13.14 N9 ADE A 500 coo 20.47 87.42 16.54 20.16 87.17 14.45 188.90 156.57 17.91 187.92 156.12 16.11 coo 24.73 94.37 14.59 21.08 89.84 11.98 180.69 158.10 18.36 176.95 162.62 18.15 coo 24.38 86.32 12.71 22.88 86.54 12.71 186.54 155.13 24.52 186.93 156.34 25.35 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 182 GLU~? 24.67 N9 ADE A 500 B 126 LYS A 180 LYS~? 18.96 N3 ADE A 500 B 171 ALA A 201 ALA~? 17.12 N9 ADE A 500 coo 20.47 87.42 16.54 20.16 87.17 14.45 187.83 168.13 29.26 189.30 168.72 30.65 coo 24.73 94.37 14.59 21.08 89.84 11.98 185.07 167.50 20.34 181.31 169.96 15.85 coo 24.38 86.32 12.71 22.88 86.54 12.71 189.52 162.53 24.76 188.43 163.45 25.31 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU A 182 GLU~? 24.67 N9 ADE A 500 B 126 LYS A 193 LYS~? 24.54 N9 ADE A 500 B 171 ALA A 198 ALA~? 22.51 N9 ADE A 500 coo 20.47 87.42 16.54 20.16 87.17 14.45 187.83 168.13 29.26 189.30 168.72 30.65 coo 24.73 94.37 14.59 21.08 89.84 11.98 183.60 164.07 35.65 183.22 158.61 36.42 coo 24.38 86.32 12.71 22.88 86.54 12.71 189.84 163.90 29.97 190.40 165.13 30.64 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU A 192 GLU~? 30.91 N9 ADE A 500 B 126 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 171 ALA A 195 ALA~? 27.08 N9 ADE A 500 coo 20.47 87.42 16.54 20.16 87.17 14.45 184.22 167.29 40.11 184.97 165.39 40.74 coo 24.73 94.37 14.59 21.08 89.84 11.98 182.07 169.10 30.10 186.87 173.28 30.86 coo 24.38 86.32 12.71 22.88 86.54 12.71 188.15 166.18 34.05 188.29 166.96 35.33 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 5 3 # 5 B 46 GLU B 182 GLU~? 29.98 C2 CIT A1102 B 126 LYS B 180 LYS.? 22.96 O1 CIT A1102 B 171 ALA B 201 ALA.? 25.06 C2 CIT A1102 coo 20.47 87.42 16.54 20.16 87.17 14.45 180.61 109.47 2.81 182.18 108.21 3.48 coo 24.73 94.37 14.59 21.08 89.84 11.98 173.15 113.94 5.34 166.89 113.91 6.31 coo 24.38 86.32 12.71 22.88 86.54 12.71 179.08 113.99 8.58 179.23 113.12 7.33 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 6 3 # 6 B 46 GLU B 182 GLU~? 29.98 C2 CIT A1102 B 126 LYS B 193 LYS~? 27.56 O4 CIT A1102 B 171 ALA B 198 ALA.? 29.73 O4 CIT A1102 coo 20.47 87.42 16.54 20.16 87.17 14.45 180.61 109.47 2.81 182.18 108.21 3.48 coo 24.73 94.37 14.59 21.08 89.84 11.98 188.45 111.50 0.09 191.63 115.50 2.10 coo 24.38 86.32 12.71 22.88 86.54 12.71 183.32 111.00 7.40 183.44 109.49 7.28 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 7 3 # 7 B 46 GLU B 192 GLU~? 33.56 O4 CIT A1102 B 126 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 171 ALA B 195 ALA~? 32.61 O4 CIT A1102 coo 20.47 87.42 16.54 20.16 87.17 14.45 188.59 108.97 -3.25 189.65 108.47 -5.00 coo 24.73 94.37 14.59 21.08 89.84 11.98 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 24.38 86.32 12.71 22.88 86.54 12.71 185.78 108.35 3.71 186.55 107.14 3.21 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 8 3 # 8 B 46 GLU C 182 GLU~? 26.37 O3 GOL C1901 B 126 LYS C 193 LYS~? 28.43 O1 GOL C1901 B 171 ALA C 198 ALA~? 24.12 O3 GOL C1901 coo 20.47 87.42 16.54 20.16 87.17 14.45 170.51 115.98 53.19 171.23 115.96 55.18 coo 24.73 94.37 14.59 21.08 89.84 11.98 177.05 121.15 50.66 176.96 126.15 48.94 coo 24.38 86.32 12.71 22.88 86.54 12.71 168.86 120.30 53.31 169.26 119.70 54.63 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 9 3 # 9 B 46 GLU C 192 GLU~? 35.32 O3 GOL C1901 B 126 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 171 ALA C 195 ALA~? 29.46 O3 GOL C1901 coo 20.47 87.42 16.54 20.16 87.17 14.45 180.77 119.87 52.99 182.51 120.63 53.94 coo 24.73 94.37 14.59 21.08 89.84 11.98 174.37 114.14 48.91 174.42 112.17 55.03 coo 24.38 86.32 12.71 22.88 86.54 12.71 173.84 119.71 54.74 175.00 119.64 55.71 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 9 hits 1uf7_c01 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 42 HIS.? -4.20 N3 ADE A 500s 89 GLU A 44 GLU.? 5.64 N9 ADE A 500 243 ASN A 77 ASN^? 9.65 N6 ADE A 500 coo 5.83 15.74 17.38 6.41 17.70 17.86 191.47 153.75 14.17 189.52 154.05 13.44 coo 3.11 16.19 13.44 4.96 17.09 13.42 188.90 156.57 17.91 187.92 156.12 16.11 coo 0.53 21.81 31.33 1.05 20.47 29.70 179.83 147.18 2.66 181.08 147.98 1.14 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS A 104 HIS^? 8.41 C8 ADE A 500 89 GLU A 165 GLU^? 4.52 C8 ADE A 500 243 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 5.83 15.74 17.38 6.41 17.70 17.86 183.15 146.13 20.69 182.60 148.09 20.18 coo 3.11 16.19 13.44 4.96 17.09 13.42 185.43 146.45 17.17 186.00 148.48 17.29 coo 0.53 21.81 31.33 1.05 20.47 29.70 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS A 104 HIS^? 8.41 C8 ADE A 500 89 GLU A 165 GLU^? 4.52 C8 ADE A 500 243 ASN A 154 ASN.? 21.16 C8 ADE A 500 coo 5.83 15.74 17.38 6.41 17.70 17.86 183.15 146.13 20.69 182.60 148.09 20.18 coo 3.11 16.19 13.44 4.96 17.09 13.42 185.43 146.45 17.17 186.00 148.48 17.29 coo 0.53 21.81 31.33 1.05 20.47 29.70 196.82 141.64 30.94 196.98 141.72 28.81 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS A 176 HIS^? 6.39 N3 ADE A 500 89 GLU A 44 GLU.? 5.64 N9 ADE A 500 243 ASN A 77 ASN^? 9.65 N6 ADE A 500 coo 5.83 15.74 17.38 6.41 17.70 17.86 184.39 157.95 13.11 185.86 157.96 14.60 coo 3.11 16.19 13.44 4.96 17.09 13.42 188.90 156.57 17.91 187.92 156.12 16.11 coo 0.53 21.81 31.33 1.05 20.47 29.70 179.83 147.18 2.66 181.08 147.98 1.14 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 5 3 # 5 86 HIS B 104 HIS^? 12.85 O4 CIT A1102 89 GLU B 165 GLU^? 13.88 O4 CIT A1102 243 ASN B 154 ASN.? 28.91 N7 ADE A 500 coo 5.83 15.74 17.38 6.41 17.70 17.86 183.49 131.36 11.56 181.98 130.36 10.51 coo 3.11 16.19 13.44 4.96 17.09 13.42 180.17 131.30 14.36 179.09 129.62 13.64 coo 0.53 21.81 31.33 1.05 20.47 29.70 194.71 123.63 23.05 192.89 124.34 23.91 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 6 3 # 6 86 HIS B 176 HIS^? 13.79 O1 CIT A1102 89 GLU B 44 GLU.? 19.02 O1 CIT A1102 243 ASN B 77 ASN^? 12.53 O1 CIT A1102 coo 5.83 15.74 17.38 6.41 17.70 17.86 171.08 125.47 9.27 172.48 124.18 10.15 coo 3.11 16.19 13.44 4.96 17.09 13.42 174.85 121.76 12.80 173.53 120.38 11.97 coo 0.53 21.81 31.33 1.05 20.47 29.70 167.65 140.29 13.08 165.89 139.84 14.18 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 7 3 # 7 86 HIS C 104 HIS^? 12.14 O1 GOL C1901 89 GLU C 165 GLU^? 7.74 O1 GOL C1901 243 ASN B 35 ASN~? 25.18 O1 GOL C1901 coo 5.83 15.74 17.38 6.41 17.70 17.86 161.39 131.07 36.65 161.63 129.00 36.89 coo 3.11 16.19 13.44 4.96 17.09 13.42 157.34 129.59 37.15 157.60 127.69 38.11 coo 0.53 21.81 31.33 1.05 20.47 29.70 176.57 125.33 34.40 176.61 123.22 34.34 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 8 3 # 8 86 HIS C 104 HIS^? 12.14 O1 GOL C1901 89 GLU C 165 GLU^? 7.74 O1 GOL C1901 243 ASN C 154 ASN~? 23.43 O1 GOL C1901 coo 5.83 15.74 17.38 6.41 17.70 17.86 161.39 131.07 36.65 161.63 129.00 36.89 coo 3.11 16.19 13.44 4.96 17.09 13.42 157.34 129.59 37.15 157.60 127.69 38.11 coo 0.53 21.81 31.33 1.05 20.47 29.70 160.52 142.23 50.24 158.78 141.09 49.77 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 9 3 # 9 86 HIS C 176 HIS^? 7.29 C1 GOL C1901 89 GLU C 44 GLU.? 9.57 O3 GOL C1901 243 ASN C 77 ASN^? 9.92 O2 GOL C1901 coo 5.83 15.74 17.38 6.41 17.70 17.86 157.21 117.94 38.21 157.48 118.99 40.00 coo 3.11 16.19 13.44 4.96 17.09 13.42 157.18 120.22 44.20 157.97 118.54 45.19 coo 0.53 21.81 31.33 1.05 20.47 29.70 149.21 122.45 26.13 147.53 121.25 26.66 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 9 hits 1ula_c00 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU A 182 GLU~? 24.67 N9 ADE A 500 A 87 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 89 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 187.83 168.13 29.26 189.30 168.72 30.65 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 184.84 171.88 24.93 186.38 173.28 25.14 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 A 85 GLU A 184 GLU~? 18.03 N9 ADE A 500 A 87 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 89 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 180.48 167.65 23.03 180.45 166.67 21.17 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 184.84 171.88 24.93 186.38 173.28 25.14 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 A 85 GLU B 182 GLU~? 29.98 C2 CIT A1102 A 87 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 89 GLU B 184 GLU~? 19.18 C2 CIT A1102 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 180.61 109.47 2.81 182.18 108.21 3.48 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 174.65 109.33 0.17 174.41 107.27 0.58 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 174.79 115.83 -0.09 173.37 117.02 0.92 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 A 85 GLU B 184 GLU~? 19.18 C2 CIT A1102 A 87 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 89 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 174.79 115.83 -0.09 173.37 117.02 0.92 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 174.65 109.33 0.17 174.41 107.27 0.58 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 A 85 GLU C 184 GLU~? 18.70 O3 GOL C1901 A 87 ASP C 183 ASP~? 25.06 O3 GOL C1901 A 89 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 168.68 112.73 44.51 166.86 112.61 43.45 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 169.34 110.13 50.56 169.06 109.63 52.58 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 170.51 115.98 53.19 171.23 115.96 55.18 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 5 hits 1un1_c00 naa= 3 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 B 85 GLU A 182 GLU~? 24.67 N9 ADE A 500 B 87 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 89 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 19.32 178.30 3.72 20.56 176.87 2.77 187.83 168.13 29.26 189.30 168.72 30.65 coo 22.91 179.81 6.56 22.10 178.65 5.00 184.84 171.88 24.93 186.38 173.28 25.14 coo 26.74 177.55 7.48 27.16 177.47 5.41 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 B 85 GLU A 184 GLU~? 18.03 N9 ADE A 500 B 87 ASP A 183 ASP~? 24.76 N9 ADE A 500 B 89 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 19.32 178.30 3.72 20.56 176.87 2.77 180.48 167.65 23.03 180.45 166.67 21.17 coo 22.91 179.81 6.56 22.10 178.65 5.00 184.84 171.88 24.93 186.38 173.28 25.14 coo 26.74 177.55 7.48 27.16 177.47 5.41 187.83 168.13 29.26 189.30 168.72 30.65 1un1_c01 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 2 hits 1un1_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 89 ASP.? 31.34 O4 CIT A1102 255 GLU B 25 GLU.? 28.27 O1 GOL C1901 329 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 49.16 35.16 15.19 51.08 34.43 15.65 181.93 115.70 26.33 180.57 117.33 26.20 coo 52.57 37.12 10.17 53.37 35.95 11.75 179.49 113.39 31.74 177.60 113.83 30.87 coo 59.16 37.82 13.95 57.63 37.03 15.12 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP C 119 ASP.? 26.31 O1 GOL C1901 255 GLU B 25 GLU.? 28.27 O1 GOL C1901 329 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 49.16 35.16 15.19 51.08 34.43 15.65 178.03 118.40 36.14 177.70 120.46 36.31 coo 52.57 37.12 10.17 53.37 35.95 11.75 179.49 113.39 31.74 177.60 113.83 30.87 coo 59.16 37.82 13.95 57.63 37.03 15.12 181.93 115.70 26.33 180.57 117.33 26.20 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 36 ASP~? 21.71 N6 ADE A 500 218 GLU B 44 GLU.? 19.02 O1 CIT A1102 329 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo 49.16 35.16 15.19 51.08 34.43 15.65 203.35 139.46 11.01 205.31 139.04 11.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 174.85 121.76 12.80 173.53 120.38 11.97 coo 59.16 37.82 13.95 57.63 37.03 15.12 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 36 ASP~? 21.71 N6 ADE A 500 218 GLU B 50 GLU^? 15.33 O1 CIT A1102 329 ASP B 130 ASP~? 26.83 N6 ADE A 500 coo 49.16 35.16 15.19 51.08 34.43 15.65 203.35 139.46 11.01 205.31 139.04 11.69 coo 70.09 11.71 8.46 70.56 12.89 6.77 171.15 134.64 18.99 169.39 134.49 17.85 coo 59.16 37.82 13.95 57.63 37.03 15.12 200.55 129.62 17.17 202.64 129.41 16.98 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 89 ASP.? 18.10 N3 ADE A 500 218 GLU B 165 GLU^? 13.88 O4 CIT A1102 329 ASP A 158 ASP.? 25.18 C8 ADE A 500 coo 49.16 35.16 15.19 51.08 34.43 15.65 203.02 151.24 21.31 203.43 152.46 19.71 coo 70.09 11.71 8.46 70.56 12.89 6.77 180.17 131.30 14.36 179.09 129.62 13.64 coo 59.16 37.82 13.95 57.63 37.03 15.12 203.27 140.75 25.55 204.24 138.86 25.61 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 36 ASP~? 28.48 O1 GOL C1901 218 GLU A 50 GLU^? -3.91 N6 ADE A 500s 329 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo 49.16 35.16 15.19 51.08 34.43 15.65 178.67 130.13 34.24 179.32 129.31 36.04 coo 70.09 11.71 8.46 70.56 12.89 6.77 187.90 146.65 6.60 187.00 148.18 5.47 coo 59.16 37.82 13.95 57.63 37.03 15.12 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 89 ASP.? 31.34 O4 CIT A1102 218 GLU A 165 GLU^? 4.52 C8 ADE A 500 329 ASP B 158 ASP.? 34.51 N7 ADE A 500 coo 49.16 35.16 15.19 51.08 34.43 15.65 181.93 115.70 26.33 180.57 117.33 26.20 coo 70.09 11.71 8.46 70.56 12.89 6.77 185.43 146.45 17.17 186.00 148.48 17.29 coo 59.16 37.82 13.95 57.63 37.03 15.12 190.60 123.10 30.08 190.26 121.25 31.09 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 158 ASP.? 34.51 N7 ADE A 500 218 GLU C 182 GLU~? 26.37 O3 GOL C1901 329 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 49.16 35.16 15.19 51.08 34.43 15.65 190.60 123.10 30.08 190.26 121.25 31.09 coo 70.09 11.71 8.46 70.56 12.89 6.77 170.51 115.98 53.19 171.23 115.96 55.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP C 119 ASP.? 26.31 O1 GOL C1901 218 GLU A 155 GLU.? 30.36 C8 ADE A 500 329 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 49.16 35.16 15.19 51.08 34.43 15.65 178.03 118.40 36.14 177.70 120.46 36.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 202.13 137.32 32.16 203.15 136.76 33.90 coo 59.16 37.82 13.95 57.63 37.03 15.12 181.93 115.70 26.33 180.57 117.33 26.20 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP C 119 ASP.? 26.31 O1 GOL C1901 218 GLU B 135 GLU.? 25.67 N6 ADE A 500 329 ASP B 36 ASP~? 28.48 O1 GOL C1901 coo 49.16 35.16 15.19 51.08 34.43 15.65 178.03 118.40 36.14 177.70 120.46 36.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 197.88 127.79 14.29 197.78 127.39 16.36 coo 59.16 37.82 13.95 57.63 37.03 15.12 178.67 130.13 34.24 179.32 129.31 36.04 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP C 119 ASP.? 26.31 O1 GOL C1901 218 GLU C 59 GLU^? 20.19 O2 GOL C1901 329 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 49.16 35.16 15.19 51.08 34.43 15.65 178.03 118.40 36.14 177.70 120.46 36.31 coo 70.09 11.71 8.46 70.56 12.89 6.77 152.75 116.35 16.84 151.33 114.88 17.42 coo 59.16 37.82 13.95 57.63 37.03 15.12 181.93 115.70 26.33 180.57 117.33 26.20 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 9 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP B 36 ASP~? 28.48 O1 GOL C1901 242 GLU C 165 GLU^? 7.74 O1 GOL C1901 329 ASP A 130 ASP~? 27.60 C8 ADE A 500 coo 49.16 35.16 15.19 51.08 34.43 15.65 178.67 130.13 34.24 179.32 129.31 36.04 coo 30.42 34.74 5.00 29.09 35.09 3.38 157.34 129.59 37.15 157.60 127.69 38.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 188.71 136.74 34.61 188.50 136.01 36.57 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 89 ASP.? 31.34 O4 CIT A1102 242 GLU B 14 GLU.? 33.67 O4 CIT A1102 329 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 49.16 35.16 15.19 51.08 34.43 15.65 181.93 115.70 26.33 180.57 117.33 26.20 coo 30.42 34.74 5.00 29.09 35.09 3.38 196.57 114.78 10.83 198.67 114.78 11.14 coo 59.16 37.82 13.95 57.63 37.03 15.12 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP C 119 ASP.? 26.31 O1 GOL C1901 242 GLU C 44 GLU.? 9.57 O3 GOL C1901 329 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 49.16 35.16 15.19 51.08 34.43 15.65 178.03 118.40 36.14 177.70 120.46 36.31 coo 30.42 34.74 5.00 29.09 35.09 3.38 157.18 120.22 44.20 157.97 118.54 45.19 coo 59.16 37.82 13.95 57.63 37.03 15.12 181.93 115.70 26.33 180.57 117.33 26.20 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 3 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 156 GLU.? 23.41 C8 ADE A 500 A 596 ARG A 108 ARG^? 21.78 N7 ADE A 500 A 647 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 69.13 32.20 28.58 68.39 32.96 30.44 196.65 137.08 28.97 194.78 136.94 30.01 coo 70.89 37.31 29.70 69.54 36.29 32.39 195.17 135.76 22.50 193.88 133.29 23.81 coo 66.09 40.54 34.70 66.92 37.69 35.49 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU B 50 GLU^? 15.33 O1 CIT A1102 A 596 ARG B 53 ARG^? 12.50 O1 CIT A1102 A 647 ARG B 76 ARG^? 5.63 O1 CIT A1102 coo 69.13 32.20 28.58 68.39 32.96 30.44 171.15 134.64 18.99 169.39 134.49 17.85 coo 70.89 37.31 29.70 69.54 36.29 32.39 166.97 137.64 16.68 167.60 135.18 14.95 coo 66.09 40.54 34.70 66.92 37.69 35.49 166.15 136.82 7.45 164.99 134.62 5.65 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU C 50 GLU^? -3.82 O2 GOL C1901s A 596 ARG C 53 ARG^? 4.89 O2 GOL C1901 A 647 ARG C 76 ARG^? 12.29 O2 GOL C1901 coo 69.13 32.20 28.58 68.39 32.96 30.44 147.72 125.56 34.28 147.67 123.54 33.74 coo 70.89 37.31 29.70 69.54 36.29 32.39 146.33 122.48 29.52 148.17 121.33 31.67 coo 66.09 40.54 34.70 66.92 37.69 35.49 153.02 116.91 26.58 154.63 114.54 27.70 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 156 GLU.? 23.41 C8 ADE A 500 B 596 ARG A 108 ARG^? 21.78 N7 ADE A 500 B 647 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 38.22 57.83 70.36 36.82 56.74 69.18 196.65 137.08 28.97 194.78 136.94 30.01 coo 34.24 60.89 68.08 33.31 57.93 67.63 195.17 135.76 22.50 193.88 133.29 23.81 coo 31.43 57.38 61.97 31.90 55.58 64.41 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU B 50 GLU^? 15.33 O1 CIT A1102 B 596 ARG B 53 ARG^? 12.50 O1 CIT A1102 B 647 ARG B 76 ARG^? 5.63 O1 CIT A1102 coo 38.22 57.83 70.36 36.82 56.74 69.18 171.15 134.64 18.99 169.39 134.49 17.85 coo 34.24 60.89 68.08 33.31 57.93 67.63 166.97 137.64 16.68 167.60 135.18 14.95 coo 31.43 57.38 61.97 31.90 55.58 64.41 166.15 136.82 7.45 164.99 134.62 5.65 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU C 50 GLU^? -3.82 O2 GOL C1901s B 596 ARG C 53 ARG^? 4.89 O2 GOL C1901 B 647 ARG C 76 ARG^? 12.29 O2 GOL C1901 coo 38.22 57.83 70.36 36.82 56.74 69.18 147.72 125.56 34.28 147.67 123.54 33.74 coo 34.24 60.89 68.08 33.31 57.93 67.63 146.33 122.48 29.52 148.17 121.33 31.67 coo 31.43 57.38 61.97 31.90 55.58 64.41 153.02 116.91 26.58 154.63 114.54 27.70 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 156 GLU.? 23.41 C8 ADE A 500 C 596 ARG A 108 ARG^? 21.78 N7 ADE A 500 C 647 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 11.31 31.26 27.00 13.31 30.71 26.58 196.65 137.08 28.97 194.78 136.94 30.01 coo 13.44 32.78 22.07 15.56 30.91 23.37 195.17 135.76 22.50 193.88 133.29 23.81 coo 21.00 33.35 22.82 19.83 30.82 24.09 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU B 50 GLU^? 15.33 O1 CIT A1102 C 596 ARG B 53 ARG^? 12.50 O1 CIT A1102 C 647 ARG B 76 ARG^? 5.63 O1 CIT A1102 coo 11.31 31.26 27.00 13.31 30.71 26.58 171.15 134.64 18.99 169.39 134.49 17.85 coo 13.44 32.78 22.07 15.56 30.91 23.37 166.97 137.64 16.68 167.60 135.18 14.95 coo 21.00 33.35 22.82 19.83 30.82 24.09 166.15 136.82 7.45 164.99 134.62 5.65 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU C 50 GLU^? -3.82 O2 GOL C1901s C 596 ARG C 53 ARG^? 4.89 O2 GOL C1901 C 647 ARG C 76 ARG^? 12.29 O2 GOL C1901 coo 11.31 31.26 27.00 13.31 30.71 26.58 147.72 125.56 34.28 147.67 123.54 33.74 coo 13.44 32.78 22.07 15.56 30.91 23.37 146.33 122.48 29.52 148.17 121.33 31.67 coo 21.00 33.35 22.82 19.83 30.82 24.09 153.02 116.91 26.58 154.63 114.54 27.70 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 156 GLU.? 23.41 C8 ADE A 500 D 596 ARG A 108 ARG^? 21.78 N7 ADE A 500 D 647 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 196.65 137.08 28.97 194.78 136.94 30.01 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 195.17 135.76 22.50 193.88 133.29 23.81 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU B 50 GLU^? 15.33 O1 CIT A1102 D 596 ARG B 53 ARG^? 12.50 O1 CIT A1102 D 647 ARG B 76 ARG^? 5.63 O1 CIT A1102 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 171.15 134.64 18.99 169.39 134.49 17.85 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 166.97 137.64 16.68 167.60 135.18 14.95 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 166.15 136.82 7.45 164.99 134.62 5.65 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU C 50 GLU^? -3.82 O2 GOL C1901s D 596 ARG C 53 ARG^? 4.89 O2 GOL C1901 D 647 ARG C 76 ARG^? 12.29 O2 GOL C1901 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 147.72 125.56 34.28 147.67 123.54 33.74 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 146.33 122.48 29.52 148.17 121.33 31.67 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 153.02 116.91 26.58 154.63 114.54 27.70 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 3 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 156 GLU.? 23.41 C8 ADE A 500 E 596 ARG A 108 ARG^? 21.78 N7 ADE A 500 E 647 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 196.65 137.08 28.97 194.78 136.94 30.01 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 195.17 135.76 22.50 193.88 133.29 23.81 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 188.64 131.77 26.61 189.85 131.11 29.36 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 156 GLU.? 23.41 C8 ADE A 500 F 596 ARG A 108 ARG^? 21.78 N7 ADE A 500 F 647 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 196.65 137.08 28.97 194.78 136.94 30.01 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 195.17 135.76 22.50 193.88 133.29 23.81 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 188.64 131.77 26.61 189.85 131.11 29.36 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 10 ASN.? 24.13 C8 ADE A 500 457 GLY A 134 GLY~? 24.98 C8 ADE A 500 459 GLU A 135 GLU.? 23.34 C8 ADE A 500 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 180.16 148.75 36.49 180.73 146.67 36.56 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 182.81 140.38 35.92 183.52 140.16 35.69 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 187.40 140.84 33.48 189.24 139.81 33.69 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 159 ASN.? 24.44 N9 ADE A 500 457 GLY A 109 GLY^? 18.96 C8 ADE A 500 459 GLU A 156 GLU.? 23.41 C8 ADE A 500 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 201.43 144.98 28.36 202.11 144.65 30.37 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 194.47 140.38 26.65 193.77 140.12 26.60 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 196.65 137.08 28.97 194.78 136.94 30.01 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 154 ASN.? 28.91 N7 ADE A 500 457 GLY B 128 GLY.? 22.81 N7 ADE A 500 459 GLU B 135 GLU.? 25.67 N6 ADE A 500 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 194.71 123.63 23.05 192.89 124.34 23.91 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 194.68 129.33 16.90 194.61 129.94 16.26 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 197.88 127.79 14.29 197.78 127.39 16.36 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN B 159 ASN.? 34.53 O4 CIT A1102 457 GLY B 109 GLY^? 25.56 N7 ADE A 500 459 GLU B 156 GLU.? 24.53 N7 ADE A 500 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 190.73 119.78 25.86 192.60 118.87 26.28 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 191.39 127.14 22.65 191.56 127.78 22.18 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 194.44 129.17 25.88 194.48 130.18 24.03 1vom_c00 source 1vom MYOSIN : 4 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 18 PHE~? 23.25 N9 ADE A 500 A 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 A 198 PRO A 27 PRO~? 23.31 N9 ADE A 500 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 201.55 150.80 30.31 200.89 148.25 31.29 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 201.43 144.98 28.36 202.11 144.65 30.37 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 204.95 144.38 24.49 206.61 145.48 23.48 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE A 157 PHE.? 18.76 C8 ADE A 500 A 197 ASN A 154 ASN.? 21.16 C8 ADE A 500 A 198 PRO A 153 PRO.? 23.56 C8 ADE A 500 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 197.65 139.50 24.25 197.70 140.07 21.50 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 196.82 141.64 30.94 196.98 141.72 28.81 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 197.72 146.76 34.19 197.45 146.12 32.09 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 A 100 PHE A 157 PHE.? 18.76 C8 ADE A 500 A 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 A 198 PRO A 88 PRO.? 20.18 N9 ADE A 500 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 197.65 139.50 24.25 197.70 140.07 21.50 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 201.43 144.98 28.36 202.11 144.65 30.37 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 202.87 148.33 25.57 201.23 149.80 25.32 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 A 100 PHE A 157 PHE.? 18.76 C8 ADE A 500 A 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 A 198 PRO A 153 PRO.? 23.56 C8 ADE A 500 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 197.65 139.50 24.25 197.70 140.07 21.50 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 201.43 144.98 28.36 202.11 144.65 30.37 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 197.72 146.76 34.19 197.45 146.12 32.09 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 A 100 PHE A 161 PHE^? 14.06 C8 ADE A 500 A 197 ASN A 154 ASN.? 21.16 C8 ADE A 500 A 198 PRO A 153 PRO.? 23.56 C8 ADE A 500 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 192.43 145.24 24.85 189.68 145.10 25.32 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 196.82 141.64 30.94 196.98 141.72 28.81 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 197.72 146.76 34.19 197.45 146.12 32.09 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 A 100 PHE A 161 PHE^? 14.06 C8 ADE A 500 A 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 A 198 PRO A 27 PRO~? 23.31 N9 ADE A 500 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 192.43 145.24 24.85 189.68 145.10 25.32 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 201.43 144.98 28.36 202.11 144.65 30.37 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 204.95 144.38 24.49 206.61 145.48 23.48 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 7 3 # 7 A 100 PHE A 161 PHE^? 14.06 C8 ADE A 500 A 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 A 198 PRO A 88 PRO.? 20.18 N9 ADE A 500 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 192.43 145.24 24.85 189.68 145.10 25.32 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 201.43 144.98 28.36 202.11 144.65 30.37 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 202.87 148.33 25.57 201.23 149.80 25.32 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 8 3 # 8 A 100 PHE A 161 PHE^? 14.06 C8 ADE A 500 A 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 A 198 PRO A 153 PRO.? 23.56 C8 ADE A 500 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 192.43 145.24 24.85 189.68 145.10 25.32 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 201.43 144.98 28.36 202.11 144.65 30.37 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 197.72 146.76 34.19 197.45 146.12 32.09 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 9 3 # 9 A 100 PHE A 171 PHE.? -3.51 C4 ADE A 500s A 197 ASN A 100 ASN.? 10.86 N7 ADE A 500 A 198 PRO A 169 PRO.? 11.58 O3 CIT A1102 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 183.57 152.25 9.92 184.62 154.69 10.81 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 175.81 151.36 12.66 175.13 152.21 10.81 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 173.66 149.49 8.03 175.40 148.44 8.93 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 10 3 # 10 A 100 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 197 ASN B 154 ASN.? 28.91 N7 ADE A 500 A 198 PRO B 153 PRO.? 32.36 O4 CIT A1102 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 189.45 127.38 26.40 186.79 128.09 26.89 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 194.71 123.63 23.05 192.89 124.34 23.91 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 194.89 117.71 20.70 193.52 119.33 21.38 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 11 3 # 11 A 100 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 A 198 PRO B 27 PRO~? 35.03 O4 CIT A1102 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 189.45 127.38 26.40 186.79 128.09 26.89 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 190.73 119.78 25.86 192.60 118.87 26.28 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 186.84 119.32 29.83 185.35 118.38 31.18 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 12 3 # 12 A 100 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 A 198 PRO B 88 PRO.? 32.08 O4 CIT A1102 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 189.45 127.38 26.40 186.79 128.09 26.89 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 190.73 119.78 25.86 192.60 118.87 26.28 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 187.04 117.57 26.28 185.95 117.50 24.34 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 13 3 # 13 A 100 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 A 198 PRO B 153 PRO.? 32.36 O4 CIT A1102 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 189.45 127.38 26.40 186.79 128.09 26.89 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 190.73 119.78 25.86 192.60 118.87 26.28 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 194.89 117.71 20.70 193.52 119.33 21.38 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 14 3 # 14 A 100 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 197 ASN B 154 ASN.? 28.91 N7 ADE A 500 A 198 PRO B 153 PRO.? 32.36 O4 CIT A1102 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 187.70 125.47 18.98 188.18 126.81 16.59 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 194.71 123.63 23.05 192.89 124.34 23.91 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 194.89 117.71 20.70 193.52 119.33 21.38 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 15 3 # 15 A 100 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 A 198 PRO B 27 PRO~? 35.03 O4 CIT A1102 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 187.70 125.47 18.98 188.18 126.81 16.59 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 190.73 119.78 25.86 192.60 118.87 26.28 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 186.84 119.32 29.83 185.35 118.38 31.18 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 16 3 # 16 A 100 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 A 198 PRO B 88 PRO.? 32.08 O4 CIT A1102 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 187.70 125.47 18.98 188.18 126.81 16.59 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 190.73 119.78 25.86 192.60 118.87 26.28 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 187.04 117.57 26.28 185.95 117.50 24.34 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 17 3 # 17 A 100 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 A 198 PRO B 153 PRO.? 32.36 O4 CIT A1102 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 187.70 125.47 18.98 188.18 126.81 16.59 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 190.73 119.78 25.86 192.60 118.87 26.28 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 194.89 117.71 20.70 193.52 119.33 21.38 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 18 3 # 18 A 100 PHE B 171 PHE.? 11.13 O1 CIT A1102 A 197 ASN B 100 ASN.? -3.42 C4 CIT A1102s A 198 PRO B 169 PRO.? -3.96 O5 CIT A1102s coo 5.24 -2.19 28.74 3.83 -0.30 30.29 170.58 131.61 12.01 169.84 128.92 11.74 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 174.18 134.78 4.77 172.12 135.04 4.40 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 170.88 139.44 5.26 172.14 139.13 7.05 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 19 3 # 19 A 100 PHE C 18 PHE~? 24.42 O3 GOL C1901 A 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 A 198 PRO C 27 PRO~? 23.31 O3 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 159.76 134.50 57.07 160.74 136.25 55.14 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 157.28 138.82 54.17 158.01 140.31 55.50 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 151.33 137.59 55.42 149.64 136.60 56.48 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 20 3 # 20 A 100 PHE C 157 PHE~? 20.21 O1 GOL C1901 A 197 ASN C 154 ASN~? 23.43 O1 GOL C1901 A 198 PRO C 153 PRO.? 26.38 O1 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 154.00 141.12 47.59 151.92 139.65 46.43 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 160.52 142.23 50.24 158.78 141.09 49.77 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 163.98 139.52 54.60 162.30 139.04 53.24 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 21 3 # 21 A 100 PHE C 157 PHE~? 20.21 O1 GOL C1901 A 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 A 198 PRO C 27 PRO~? 23.31 O3 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 154.00 141.12 47.59 151.92 139.65 46.43 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 157.28 138.82 54.17 158.01 140.31 55.50 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 151.33 137.59 55.42 149.64 136.60 56.48 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 22 3 # 22 A 100 PHE C 157 PHE~? 20.21 O1 GOL C1901 A 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 A 198 PRO C 88 PRO.? 21.30 O3 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 154.00 141.12 47.59 151.92 139.65 46.43 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 157.28 138.82 54.17 158.01 140.31 55.50 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 154.56 135.29 55.49 155.42 133.46 54.57 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 23 3 # 23 A 100 PHE C 157 PHE~? 20.21 O1 GOL C1901 A 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 A 198 PRO C 153 PRO.? 26.38 O1 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 154.00 141.12 47.59 151.92 139.65 46.43 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 157.28 138.82 54.17 158.01 140.31 55.50 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 163.98 139.52 54.60 162.30 139.04 53.24 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 24 3 # 24 A 100 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 197 ASN C 154 ASN~? 23.43 O1 GOL C1901 A 198 PRO C 153 PRO.? 26.38 O1 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 159.14 135.31 45.76 161.07 134.95 43.76 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 160.52 142.23 50.24 158.78 141.09 49.77 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 163.98 139.52 54.60 162.30 139.04 53.24 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 25 3 # 25 A 100 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 A 198 PRO C 27 PRO~? 23.31 O3 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 159.14 135.31 45.76 161.07 134.95 43.76 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 157.28 138.82 54.17 158.01 140.31 55.50 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 151.33 137.59 55.42 149.64 136.60 56.48 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 26 3 # 26 A 100 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 A 198 PRO C 88 PRO.? 21.30 O3 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 159.14 135.31 45.76 161.07 134.95 43.76 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 157.28 138.82 54.17 158.01 140.31 55.50 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 154.56 135.29 55.49 155.42 133.46 54.57 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 27 3 # 27 A 100 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 A 198 PRO C 153 PRO.? 26.38 O1 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 159.14 135.31 45.76 161.07 134.95 43.76 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 157.28 138.82 54.17 158.01 140.31 55.50 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 163.98 139.52 54.60 162.30 139.04 53.24 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 28 3 # 28 A 100 PHE C 171 PHE.? -4.01 O1 GOL C1901s A 197 ASN C 100 ASN.? 12.22 O1 GOL C1901 A 198 PRO C 169 PRO.? 12.81 O1 GOL C1901 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 153.30 120.94 34.06 153.74 119.07 36.11 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 160.54 121.61 29.05 159.70 119.87 28.12 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 157.51 121.07 24.54 156.80 122.79 25.76 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 28 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 18 PHE~? 23.25 N9 ADE A 500 B 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 B 198 PRO A 27 PRO~? 23.31 N9 ADE A 500 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 201.55 150.80 30.31 200.89 148.25 31.29 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 201.43 144.98 28.36 202.11 144.65 30.37 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 204.95 144.38 24.49 206.61 145.48 23.48 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE A 157 PHE.? 18.76 C8 ADE A 500 B 197 ASN A 154 ASN.? 21.16 C8 ADE A 500 B 198 PRO A 153 PRO.? 23.56 C8 ADE A 500 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 197.65 139.50 24.25 197.70 140.07 21.50 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 196.82 141.64 30.94 196.98 141.72 28.81 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 197.72 146.76 34.19 197.45 146.12 32.09 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 3 # 3 B 100 PHE A 157 PHE.? 18.76 C8 ADE A 500 B 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 B 198 PRO A 27 PRO~? 23.31 N9 ADE A 500 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 197.65 139.50 24.25 197.70 140.07 21.50 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 201.43 144.98 28.36 202.11 144.65 30.37 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 204.95 144.38 24.49 206.61 145.48 23.48 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 3 # 4 B 100 PHE A 157 PHE.? 18.76 C8 ADE A 500 B 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 B 198 PRO A 88 PRO.? 20.18 N9 ADE A 500 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 197.65 139.50 24.25 197.70 140.07 21.50 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 201.43 144.98 28.36 202.11 144.65 30.37 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 202.87 148.33 25.57 201.23 149.80 25.32 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 5 3 # 5 B 100 PHE A 157 PHE.? 18.76 C8 ADE A 500 B 197 ASN A 159 ASN.? 24.44 N9 ADE A 500 B 198 PRO A 153 PRO.? 23.56 C8 ADE A 500 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 197.65 139.50 24.25 197.70 140.07 21.50 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 201.43 144.98 28.36 202.11 144.65 30.37 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 197.72 146.76 34.19 197.45 146.12 32.09 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 6 3 # 6 B 100 PHE A 161 PHE^? 14.06 C8 ADE A 500 B 197 ASN A 154 ASN.? 21.16 C8 ADE A 500 B 198 PRO A 153 PRO.? 23.56 C8 ADE A 500 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 192.43 145.24 24.85 189.68 145.10 25.32 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 196.82 141.64 30.94 196.98 141.72 28.81 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 197.72 146.76 34.19 197.45 146.12 32.09 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 7 3 # 7 B 100 PHE A 171 PHE.? -3.51 C4 ADE A 500s B 197 ASN A 100 ASN.? 10.86 N7 ADE A 500 B 198 PRO A 169 PRO.? 11.58 O3 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 183.57 152.25 9.92 184.62 154.69 10.81 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 175.81 151.36 12.66 175.13 152.21 10.81 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 173.66 149.49 8.03 175.40 148.44 8.93 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 8 3 # 8 B 100 PHE B 18 PHE~? 34.51 O4 CIT A1102 B 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 B 198 PRO B 27 PRO~? 35.03 O4 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 189.87 114.75 23.00 191.73 115.42 25.00 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 190.73 119.78 25.86 192.60 118.87 26.28 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 186.84 119.32 29.83 185.35 118.38 31.18 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 9 3 # 9 B 100 PHE B 157 PHE.? 26.46 N7 ADE A 500 B 197 ASN B 154 ASN.? 28.91 N7 ADE A 500 B 198 PRO B 153 PRO.? 32.36 O4 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 189.45 127.38 26.40 186.79 128.09 26.89 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 194.71 123.63 23.05 192.89 124.34 23.91 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 194.89 117.71 20.70 193.52 119.33 21.38 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 10 3 # 10 B 100 PHE B 157 PHE.? 26.46 N7 ADE A 500 B 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 B 198 PRO B 27 PRO~? 35.03 O4 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 189.45 127.38 26.40 186.79 128.09 26.89 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 190.73 119.78 25.86 192.60 118.87 26.28 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 186.84 119.32 29.83 185.35 118.38 31.18 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 11 3 # 11 B 100 PHE B 157 PHE.? 26.46 N7 ADE A 500 B 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 B 198 PRO B 88 PRO.? 32.08 O4 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 189.45 127.38 26.40 186.79 128.09 26.89 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 190.73 119.78 25.86 192.60 118.87 26.28 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 187.04 117.57 26.28 185.95 117.50 24.34 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 12 3 # 12 B 100 PHE B 157 PHE.? 26.46 N7 ADE A 500 B 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 B 198 PRO B 153 PRO.? 32.36 O4 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 189.45 127.38 26.40 186.79 128.09 26.89 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 190.73 119.78 25.86 192.60 118.87 26.28 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 194.89 117.71 20.70 193.52 119.33 21.38 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 13 3 # 13 B 100 PHE B 161 PHE^? 22.57 O4 CIT A1102 B 197 ASN B 154 ASN.? 28.91 N7 ADE A 500 B 198 PRO B 153 PRO.? 32.36 O4 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 187.70 125.47 18.98 188.18 126.81 16.59 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 194.71 123.63 23.05 192.89 124.34 23.91 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 194.89 117.71 20.70 193.52 119.33 21.38 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 14 3 # 14 B 100 PHE B 161 PHE^? 22.57 O4 CIT A1102 B 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 B 198 PRO B 27 PRO~? 35.03 O4 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 187.70 125.47 18.98 188.18 126.81 16.59 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 190.73 119.78 25.86 192.60 118.87 26.28 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 186.84 119.32 29.83 185.35 118.38 31.18 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 15 3 # 15 B 100 PHE B 161 PHE^? 22.57 O4 CIT A1102 B 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 B 198 PRO B 88 PRO.? 32.08 O4 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 187.70 125.47 18.98 188.18 126.81 16.59 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 190.73 119.78 25.86 192.60 118.87 26.28 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 187.04 117.57 26.28 185.95 117.50 24.34 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 16 3 # 16 B 100 PHE B 161 PHE^? 22.57 O4 CIT A1102 B 197 ASN B 159 ASN.? 34.53 O4 CIT A1102 B 198 PRO B 153 PRO.? 32.36 O4 CIT A1102 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 187.70 125.47 18.98 188.18 126.81 16.59 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 190.73 119.78 25.86 192.60 118.87 26.28 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 194.89 117.71 20.70 193.52 119.33 21.38 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 17 3 # 17 B 100 PHE B 171 PHE.? 11.13 O1 CIT A1102 B 197 ASN B 100 ASN.? -3.42 C4 CIT A1102s B 198 PRO B 169 PRO.? -3.96 O5 CIT A1102s coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 170.58 131.61 12.01 169.84 128.92 11.74 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 174.18 134.78 4.77 172.12 135.04 4.40 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 170.88 139.44 5.26 172.14 139.13 7.05 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 18 3 # 18 B 100 PHE C 18 PHE~? 24.42 O3 GOL C1901 B 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 B 198 PRO C 27 PRO~? 23.31 O3 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 159.76 134.50 57.07 160.74 136.25 55.14 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 157.28 138.82 54.17 158.01 140.31 55.50 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 151.33 137.59 55.42 149.64 136.60 56.48 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 19 3 # 19 B 100 PHE C 157 PHE~? 20.21 O1 GOL C1901 B 197 ASN C 154 ASN~? 23.43 O1 GOL C1901 B 198 PRO C 153 PRO.? 26.38 O1 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 154.00 141.12 47.59 151.92 139.65 46.43 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 160.52 142.23 50.24 158.78 141.09 49.77 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 163.98 139.52 54.60 162.30 139.04 53.24 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 20 3 # 20 B 100 PHE C 157 PHE~? 20.21 O1 GOL C1901 B 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 B 198 PRO C 27 PRO~? 23.31 O3 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 154.00 141.12 47.59 151.92 139.65 46.43 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 157.28 138.82 54.17 158.01 140.31 55.50 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 151.33 137.59 55.42 149.64 136.60 56.48 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 21 3 # 21 B 100 PHE C 157 PHE~? 20.21 O1 GOL C1901 B 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 B 198 PRO C 88 PRO.? 21.30 O3 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 154.00 141.12 47.59 151.92 139.65 46.43 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 157.28 138.82 54.17 158.01 140.31 55.50 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 154.56 135.29 55.49 155.42 133.46 54.57 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 22 3 # 22 B 100 PHE C 157 PHE~? 20.21 O1 GOL C1901 B 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 B 198 PRO C 153 PRO.? 26.38 O1 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 154.00 141.12 47.59 151.92 139.65 46.43 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 157.28 138.82 54.17 158.01 140.31 55.50 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 163.98 139.52 54.60 162.30 139.04 53.24 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 23 3 # 23 B 100 PHE C 161 PHE^? 16.85 O1 GOL C1901 B 197 ASN C 154 ASN~? 23.43 O1 GOL C1901 B 198 PRO C 153 PRO.? 26.38 O1 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 159.14 135.31 45.76 161.07 134.95 43.76 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 160.52 142.23 50.24 158.78 141.09 49.77 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 163.98 139.52 54.60 162.30 139.04 53.24 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 24 3 # 24 B 100 PHE C 161 PHE^? 16.85 O1 GOL C1901 B 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 B 198 PRO C 27 PRO~? 23.31 O3 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 159.14 135.31 45.76 161.07 134.95 43.76 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 157.28 138.82 54.17 158.01 140.31 55.50 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 151.33 137.59 55.42 149.64 136.60 56.48 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 25 3 # 25 B 100 PHE C 161 PHE^? 16.85 O1 GOL C1901 B 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 B 198 PRO C 88 PRO.? 21.30 O3 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 159.14 135.31 45.76 161.07 134.95 43.76 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 157.28 138.82 54.17 158.01 140.31 55.50 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 154.56 135.29 55.49 155.42 133.46 54.57 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 26 3 # 26 B 100 PHE C 161 PHE^? 16.85 O1 GOL C1901 B 197 ASN C 159 ASN.? 26.35 O1 GOL C1901 B 198 PRO C 153 PRO.? 26.38 O1 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 159.14 135.31 45.76 161.07 134.95 43.76 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 157.28 138.82 54.17 158.01 140.31 55.50 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 163.98 139.52 54.60 162.30 139.04 53.24 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 27 3 # 27 B 100 PHE C 171 PHE.? -4.01 O1 GOL C1901s B 197 ASN C 100 ASN.? 12.22 O1 GOL C1901 B 198 PRO C 169 PRO.? 12.81 O1 GOL C1901 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 153.30 120.94 34.06 153.74 119.07 36.11 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 160.54 121.61 29.05 159.70 119.87 28.12 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 157.51 121.07 24.54 156.80 122.79 25.76 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 27 hits 1vq1_c01 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 317 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 365 ARG A 43 ARG.? 7.62 C2 ADE A 500 coo 1.77 6.56 57.05 3.05 7.44 59.37 190.70 148.50 17.91 191.29 151.03 18.92 coo 3.06 2.85 52.79 4.83 3.89 53.24 185.43 146.45 17.17 186.00 148.48 17.29 coo 3.82 17.09 49.56 4.09 14.32 50.84 190.33 158.90 11.08 189.17 159.63 8.34 ULMN 3 1vzx_c02 2.04.01.0087 user 2 3 # 2 A 314 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 317 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 365 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 1.77 6.56 57.05 3.05 7.44 59.37 190.70 148.50 17.91 191.29 151.03 18.92 coo 3.06 2.85 52.79 4.83 3.89 53.24 185.43 146.45 17.17 186.00 148.48 17.29 coo 3.82 17.09 49.56 4.09 14.32 50.84 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1vzx_c02 2.04.01.0087 user 3 3 # 3 A 314 TYR B 84 TYR^? 19.29 O4 CIT A1102 A 317 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 365 ARG B 43 ARG.? 18.57 O1 CIT A1102 coo 1.77 6.56 57.05 3.05 7.44 59.37 180.02 126.93 17.73 179.63 124.28 16.92 coo 3.06 2.85 52.79 4.83 3.89 53.24 180.17 131.30 14.36 179.09 129.62 13.64 coo 3.82 17.09 49.56 4.09 14.32 50.84 169.37 120.65 13.94 167.07 120.51 11.92 ULMN 3 1vzx_c02 2.04.01.0087 user 4 3 # 4 A 314 TYR B 84 TYR^? 19.29 O4 CIT A1102 A 317 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 365 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 1.77 6.56 57.05 3.05 7.44 59.37 180.02 126.93 17.73 179.63 124.28 16.92 coo 3.06 2.85 52.79 4.83 3.89 53.24 180.17 131.30 14.36 179.09 129.62 13.64 coo 3.82 17.09 49.56 4.09 14.32 50.84 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1vzx_c02 2.04.01.0087 user 5 3 # 5 A 314 TYR C 84 TYR^? 9.85 O1 GOL C1901 A 317 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 365 ARG C 43 ARG.? 5.25 O3 GOL C1901 coo 1.77 6.56 57.05 3.05 7.44 59.37 155.65 129.37 42.44 156.62 127.68 44.43 coo 3.06 2.85 52.79 4.83 3.89 53.24 157.34 129.59 37.15 157.60 127.69 38.11 coo 3.82 17.09 49.56 4.09 14.32 50.84 154.24 116.29 44.96 152.24 116.07 42.61 ULMN 3 1vzx_c02 2.04.01.0087 user 6 3 # 6 A 314 TYR C 84 TYR^? 9.85 O1 GOL C1901 A 317 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 365 ARG C 108 ARG^? 22.96 O1 GOL C1901 coo 1.77 6.56 57.05 3.05 7.44 59.37 155.65 129.37 42.44 156.62 127.68 44.43 coo 3.06 2.85 52.79 4.83 3.89 53.24 157.34 129.59 37.15 157.60 127.69 38.11 coo 3.82 17.09 49.56 4.09 14.32 50.84 152.54 142.82 43.26 151.11 144.25 45.58 1vzx_c02 source 1vzx 2.04.01.0087 : 6 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 84 TYR^? 7.34 N9 ADE A 500 B1317 GLU A 165 GLU^? 4.52 C8 ADE A 500 B1365 ARG A 43 ARG.? 7.62 C2 ADE A 500 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 190.70 148.50 17.91 191.29 151.03 18.92 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 185.43 146.45 17.17 186.00 148.48 17.29 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 190.33 158.90 11.08 189.17 159.63 8.34 ULMN 3 1vzx_c03 2.04.01.0087 user 2 3 # 2 B1314 TYR A 84 TYR^? 7.34 N9 ADE A 500 B1317 GLU A 165 GLU^? 4.52 C8 ADE A 500 B1365 ARG A 108 ARG^? 21.78 N7 ADE A 500 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 190.70 148.50 17.91 191.29 151.03 18.92 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 185.43 146.45 17.17 186.00 148.48 17.29 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 195.17 135.76 22.50 193.88 133.29 23.81 ULMN 3 1vzx_c03 2.04.01.0087 user 3 3 # 3 B1314 TYR B 84 TYR^? 19.29 O4 CIT A1102 B1317 GLU B 165 GLU^? 13.88 O4 CIT A1102 B1365 ARG B 43 ARG.? 18.57 O1 CIT A1102 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 180.02 126.93 17.73 179.63 124.28 16.92 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 180.17 131.30 14.36 179.09 129.62 13.64 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 169.37 120.65 13.94 167.07 120.51 11.92 ULMN 3 1vzx_c03 2.04.01.0087 user 4 3 # 4 B1314 TYR B 84 TYR^? 19.29 O4 CIT A1102 B1317 GLU B 165 GLU^? 13.88 O4 CIT A1102 B1365 ARG B 108 ARG^? 25.54 C8 ADE A 500 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 180.02 126.93 17.73 179.63 124.28 16.92 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 180.17 131.30 14.36 179.09 129.62 13.64 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 188.64 131.77 26.61 189.85 131.11 29.36 ULMN 3 1vzx_c03 2.04.01.0087 user 5 3 # 5 B1314 TYR C 84 TYR^? 9.85 O1 GOL C1901 B1317 GLU C 165 GLU^? 7.74 O1 GOL C1901 B1365 ARG C 43 ARG.? 5.25 O3 GOL C1901 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 155.65 129.37 42.44 156.62 127.68 44.43 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 157.34 129.59 37.15 157.60 127.69 38.11 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 154.24 116.29 44.96 152.24 116.07 42.61 ULMN 3 1vzx_c03 2.04.01.0087 user 6 3 # 6 B1314 TYR C 84 TYR^? 9.85 O1 GOL C1901 B1317 GLU C 165 GLU^? 7.74 O1 GOL C1901 B1365 ARG C 108 ARG^? 22.96 O1 GOL C1901 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 155.65 129.37 42.44 156.62 127.68 44.43 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 157.34 129.59 37.15 157.60 127.69 38.11 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 152.54 142.82 43.26 151.11 144.25 45.58 1vzx_c03 source 1vzx 2.04.01.0087 : 6 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 83 TYR^? 11.70 N6 ADE A 500 A 40 ASP A 36 ASP~? 21.71 N6 ADE A 500 A 103 LEU A 39 LEU.? 12.17 N1 ADE A 500 coo 12.09 16.13 10.57 11.28 18.80 10.73 192.51 141.71 13.59 192.79 138.96 13.21 coo 7.55 25.51 14.34 9.65 25.73 14.24 203.35 139.46 11.01 205.31 139.04 11.69 coo 11.83 18.73 16.99 10.99 19.71 15.26 197.86 146.42 12.68 196.98 144.60 13.43 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 40 ASP A 89 ASP.? 18.10 N3 ADE A 500 A 103 LEU A 85 LEU^? 13.47 C8 ADE A 500 coo 12.09 16.13 10.57 11.28 18.80 10.73 190.70 148.50 17.91 191.29 151.03 18.92 coo 7.55 25.51 14.34 9.65 25.73 14.24 203.02 151.24 21.31 203.43 152.46 19.71 coo 11.83 18.73 16.99 10.99 19.71 15.26 195.93 145.82 18.39 197.54 144.79 19.36 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR A 84 TYR^? 7.34 N9 ADE A 500 A 40 ASP A 89 ASP.? 18.10 N3 ADE A 500 A 103 LEU A 86 LEU^? 12.71 N9 ADE A 500 coo 12.09 16.13 10.57 11.28 18.80 10.73 190.70 148.50 17.91 191.29 151.03 18.92 coo 7.55 25.51 14.34 9.65 25.73 14.24 203.02 151.24 21.31 203.43 152.46 19.71 coo 11.83 18.73 16.99 10.99 19.71 15.26 194.71 148.92 23.13 193.24 150.49 22.94 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 47 TYR^? 27.62 O4 CIT A1102 A 40 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 103 LEU B 30 LEU~? 31.26 O4 CIT A1102 coo 12.09 16.13 10.57 11.28 18.80 10.73 177.82 122.79 24.63 178.10 120.27 25.77 coo 7.55 25.51 14.34 9.65 25.73 14.24 178.03 118.40 36.14 177.70 120.46 36.31 coo 11.83 18.73 16.99 10.99 19.71 15.26 184.70 122.72 29.40 186.23 123.32 28.00 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 83 TYR^? 20.46 C8 ADE A 500 A 40 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 103 LEU B 39 LEU.? 25.35 O4 CIT A1102 coo 12.09 16.13 10.57 11.28 18.80 10.73 179.54 132.93 23.44 180.82 135.06 24.75 coo 7.55 25.51 14.34 9.65 25.73 14.24 178.67 130.13 34.24 179.32 129.31 36.04 coo 11.83 18.73 16.99 10.99 19.71 15.26 176.61 126.91 26.39 178.05 128.48 26.01 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 6 3 # 6 A 16 TYR C 83 TYR^? 12.44 O1 GOL C1901 A 40 ASP C 36 ASP~? 21.70 O1 GOL C1901 A 103 LEU C 39 LEU.? 12.09 O1 GOL C1901 coo 12.09 16.13 10.57 11.28 18.80 10.73 149.52 133.95 39.18 148.57 136.34 38.09 coo 7.55 25.51 14.34 9.65 25.73 14.24 140.93 137.00 45.78 140.14 138.07 47.46 coo 11.83 18.73 16.99 10.99 19.71 15.26 146.73 130.48 44.97 147.41 132.07 43.70 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 6 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 83 TYR^? 11.70 N6 ADE A 500 B 40 ASP A 36 ASP~? 21.71 N6 ADE A 500 B 103 LEU A 39 LEU.? 12.17 N1 ADE A 500 coo 14.25 20.09 37.35 13.48 17.40 37.38 192.51 141.71 13.59 192.79 138.96 13.21 coo 9.39 10.77 34.53 11.50 10.63 34.41 203.35 139.46 11.01 205.31 139.04 11.69 coo 12.89 17.60 31.13 12.34 16.51 32.90 197.86 146.42 12.68 196.98 144.60 13.43 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 83 TYR^? 20.46 C8 ADE A 500 B 40 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 103 LEU B 39 LEU.? 25.35 O4 CIT A1102 coo 14.25 20.09 37.35 13.48 17.40 37.38 179.54 132.93 23.44 180.82 135.06 24.75 coo 9.39 10.77 34.53 11.50 10.63 34.41 178.67 130.13 34.24 179.32 129.31 36.04 coo 12.89 17.60 31.13 12.34 16.51 32.90 176.61 126.91 26.39 178.05 128.48 26.01 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR C 83 TYR^? 12.44 O1 GOL C1901 B 40 ASP C 36 ASP~? 21.70 O1 GOL C1901 B 103 LEU C 39 LEU.? 12.09 O1 GOL C1901 coo 14.25 20.09 37.35 13.48 17.40 37.38 149.52 133.95 39.18 148.57 136.34 38.09 coo 9.39 10.77 34.53 11.50 10.63 34.41 140.93 137.00 45.78 140.14 138.07 47.46 coo 12.89 17.60 31.13 12.34 16.51 32.90 146.73 130.48 44.97 147.41 132.07 43.70 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 3 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 169 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 288 GLU B 50 GLU^? 15.33 O1 CIT A1102 coo 67.72 35.99 30.87 69.77 36.13 31.33 183.15 146.13 20.69 182.60 148.09 20.18 coo 73.17 30.66 22.56 72.87 30.30 20.46 173.93 140.35 20.11 173.24 142.10 19.12 coo 74.06 28.51 15.92 73.77 29.56 17.73 171.15 134.64 18.99 169.39 134.49 17.85 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 169 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 288 GLU A 50 GLU^? -3.91 N6 ADE A 500s coo 67.72 35.99 30.87 69.77 36.13 31.33 183.49 131.36 11.56 181.98 130.36 10.51 coo 73.17 30.66 22.56 72.87 30.30 20.46 185.72 140.93 6.30 184.35 140.00 4.99 coo 74.06 28.51 15.92 73.77 29.56 17.73 187.90 146.65 6.60 187.00 148.18 5.47 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 2 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 201 ALA~? 17.12 N9 ADE A 500 B 182 GLY A 45 GLY.? 10.73 N9 ADE A 500 B 183 GLY A 93 GLY^? 10.42 N9 ADE A 500 coo 38.36-101.47-135.52 39.62-101.29-136.35 189.52 162.53 24.76 188.43 163.45 25.31 coo 41.93-102.35-126.87 41.52-101.89-126.30 194.65 155.46 18.65 194.04 154.92 18.22 coo 38.37-101.99-128.11 38.63-102.24-127.37 191.16 154.66 21.80 191.10 155.17 22.59 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA B 201 ALA.? 25.06 C2 CIT A1102 B 182 GLY B 45 GLY.? 23.68 O4 CIT A1102 B 183 GLY B 93 GLY^? 21.08 O4 CIT A1102 coo 38.36-101.47-135.52 39.62-101.29-136.35 179.08 113.99 8.58 179.23 113.12 7.33 coo 41.93-102.35-126.87 41.52-101.89-126.30 177.24 119.43 17.85 177.04 120.22 17.68 coo 38.37-101.99-128.11 38.63-102.24-127.37 180.85 120.89 14.39 181.25 120.12 13.99 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA C 201 ALA~? 18.41 O3 GOL C1901 B 182 GLY C 45 GLY.? 11.06 O3 GOL C1901 B 183 GLY C 93 GLY^? 13.18 O3 GOL C1901 coo 38.36-101.47-135.52 39.62-101.29-136.35 164.63 119.64 49.73 165.82 118.76 49.44 coo 41.93-102.35-126.87 41.52-101.89-126.30 155.66 124.22 48.62 155.39 124.25 47.85 coo 38.37-101.99-128.11 38.63-102.24-127.37 159.81 125.78 46.83 160.54 125.64 47.42 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 3 hits 1xny_c01 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 128 GLY.? 19.63 C8 ADE A 500 B 175 ARG B 108 ARG^? 25.54 C8 ADE A 500 B 242 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 99.45 58.28 3.33 99.57 58.61 4.10 188.72 140.03 29.58 187.87 139.89 29.50 coo 106.37 63.53 0.89 108.02 63.40 -1.62 188.64 131.77 26.61 189.85 131.11 29.36 coo 100.93 69.04 4.38 99.52 68.48 2.09 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY B 160 GLY.? 28.72 O4 CIT A1102 B 175 ARG B 108 ARG^? 25.54 C8 ADE A 500 B 242 TYR B 83 TYR^? 20.46 C8 ADE A 500 coo 99.45 58.28 3.33 99.57 58.61 4.10 188.00 123.61 24.63 188.78 123.73 24.22 coo 106.37 63.53 0.89 108.02 63.40 -1.62 188.64 131.77 26.61 189.85 131.11 29.36 coo 100.93 69.04 4.38 99.52 68.48 2.09 179.54 132.93 23.44 180.82 135.06 24.75 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY C 160 GLY.? 20.08 O1 GOL C1901 B 175 ARG C 108 ARG^? 22.96 O1 GOL C1901 B 242 TYR C 83 TYR^? 12.44 O1 GOL C1901 coo 99.45 58.28 3.33 99.57 58.61 4.10 155.40 137.81 49.75 156.15 138.23 49.61 coo 106.37 63.53 0.89 108.02 63.40 -1.62 152.54 142.82 43.26 151.11 144.25 45.58 coo 100.93 69.04 4.38 99.52 68.48 2.09 149.52 133.95 39.18 148.57 136.34 38.09 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 3 hits 1xva_c03 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER A 124 SER^? 19.87 C8 ADE A 500 A 178 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 182 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 81.46 10.53 21.66 82.20 10.82 19.39 182.61 151.80 32.41 184.93 152.05 33.02 coo 87.67 8.69 17.10 86.62 10.83 18.52 185.14 149.36 25.84 186.22 148.61 23.38 coo 85.30 6.17 22.83 87.26 11.02 23.50 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER B 124 SER^? 23.63 O4 CIT A1102 A 178 TYR B 113 TYR^? 17.81 O4 CIT A1102 A 182 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 81.46 10.53 21.66 82.20 10.82 19.39 191.23 122.78 5.73 191.55 121.05 7.41 coo 87.67 8.69 17.10 86.62 10.83 18.52 186.72 125.72 10.79 185.00 126.80 12.71 coo 85.30 6.17 22.83 87.26 11.02 23.50 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 A 164 SER C 124 SER^? 23.11 O1 GOL C1901 A 178 TYR C 113 TYR^? 15.28 O1 GOL C1901 A 182 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 81.46 10.53 21.66 82.20 10.82 19.39 172.32 130.73 43.72 171.22 130.88 45.88 coo 87.67 8.69 17.10 86.62 10.83 18.52 165.10 130.81 41.92 162.37 130.83 41.35 coo 85.30 6.17 22.83 87.26 11.02 23.50 168.56 136.65 44.17 170.62 139.01 49.65 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 3 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER A 124 SER^? 19.87 C8 ADE A 500 B 178 TYR A 113 TYR^? 11.47 C8 ADE A 500 B 182 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 61.22 3.61 34.51 60.46 1.86 35.98 182.61 151.80 32.41 184.93 152.05 33.02 coo 54.99 -1.20 35.40 56.04 1.15 36.44 185.14 149.36 25.84 186.22 148.61 23.38 coo 57.40 2.23 30.19 55.43 5.44 33.87 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER B 124 SER^? 23.63 O4 CIT A1102 B 178 TYR B 113 TYR^? 17.81 O4 CIT A1102 B 182 LYS B 126 LYS^? 29.75 O4 CIT A1102 coo 61.22 3.61 34.51 60.46 1.86 35.98 191.23 122.78 5.73 191.55 121.05 7.41 coo 54.99 -1.20 35.40 56.04 1.15 36.44 186.72 125.72 10.79 185.00 126.80 12.71 coo 57.40 2.23 30.19 55.43 5.44 33.87 193.73 125.48 11.85 197.51 120.83 13.59 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 3 # 3 B 164 SER C 124 SER^? 23.11 O1 GOL C1901 B 178 TYR C 113 TYR^? 15.28 O1 GOL C1901 B 182 LYS C 126 LYS^? 28.06 O1 GOL C1901 coo 61.22 3.61 34.51 60.46 1.86 35.98 172.32 130.73 43.72 171.22 130.88 45.88 coo 54.99 -1.20 35.40 56.04 1.15 36.44 165.10 130.81 41.92 162.37 130.83 41.35 coo 57.40 2.23 30.19 55.43 5.44 33.87 168.56 136.65 44.17 170.62 139.01 49.65 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 3 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 18.28 7.83 36.39 22.82 8.75 39.52 189.82 158.18 22.25 194.56 162.25 23.07 coo 14.16 13.09 37.03 20.00 12.44 37.49 182.91 155.29 23.54 184.46 151.31 19.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 18.28 7.83 36.39 22.82 8.75 39.52 180.69 158.10 18.36 176.95 162.62 18.15 coo 14.16 13.09 37.03 20.00 12.44 37.49 182.91 155.29 23.54 184.46 151.31 19.55 coo 22.22 16.06 48.76 23.94 15.33 49.78 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 74 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 18.28 7.83 36.39 22.82 8.75 39.52 192.52 142.86 28.75 192.00 138.78 32.31 coo 14.16 13.09 37.03 20.00 12.44 37.49 186.22 145.69 31.90 189.62 146.93 37.05 coo 22.22 16.06 48.76 23.94 15.33 49.78 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 126 LYS^? 24.40 C8 ADE A 500 A 74 LYS A 110 LYS.? 23.26 C8 ADE A 500 A 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 18.28 7.83 36.39 22.82 8.75 39.52 186.22 145.69 31.90 189.62 146.93 37.05 coo 14.16 13.09 37.03 20.00 12.44 37.49 192.52 142.86 28.75 192.00 138.78 32.31 coo 22.22 16.06 48.76 23.94 15.33 49.78 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 74 LYS A 94 LYS^? 16.74 N9 ADE A 500 A 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 18.28 7.83 36.39 22.82 8.75 39.52 182.91 155.29 23.54 184.46 151.31 19.55 coo 14.16 13.09 37.03 20.00 12.44 37.49 189.82 158.18 22.25 194.56 162.25 23.07 coo 22.22 16.06 48.76 23.94 15.33 49.78 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 74 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 18.28 7.83 36.39 22.82 8.75 39.52 182.91 155.29 23.54 184.46 151.31 19.55 coo 14.16 13.09 37.03 20.00 12.44 37.49 180.69 158.10 18.36 176.95 162.62 18.15 coo 22.22 16.06 48.76 23.94 15.33 49.78 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 18.28 7.83 36.39 22.82 8.75 39.52 179.28 118.69 11.71 177.59 112.91 13.79 coo 14.16 13.09 37.03 20.00 12.44 37.49 181.66 123.79 6.82 179.82 128.66 10.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 18.28 7.83 36.39 22.82 8.75 39.52 175.75 125.08 4.60 173.18 124.12 -0.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 181.66 123.79 6.82 179.82 128.66 10.46 coo 22.22 16.06 48.76 23.94 15.33 49.78 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 A 14 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 74 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 18.28 7.83 36.39 22.82 8.75 39.52 192.36 125.68 19.31 197.51 127.46 19.90 coo 14.16 13.09 37.03 20.00 12.44 37.49 193.73 125.48 11.85 197.51 120.83 13.59 coo 22.22 16.06 48.76 23.94 15.33 49.78 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 A 14 LYS B 126 LYS^? 29.75 O4 CIT A1102 A 74 LYS B 110 LYS.? 26.40 N7 ADE A 500 A 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 18.28 7.83 36.39 22.82 8.75 39.52 193.73 125.48 11.85 197.51 120.83 13.59 coo 14.16 13.09 37.03 20.00 12.44 37.49 192.36 125.68 19.31 197.51 127.46 19.90 coo 22.22 16.06 48.76 23.94 15.33 49.78 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 A 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 18.28 7.83 36.39 22.82 8.75 39.52 181.66 123.79 6.82 179.82 128.66 10.46 coo 14.16 13.09 37.03 20.00 12.44 37.49 179.28 118.69 11.71 177.59 112.91 13.79 coo 22.22 16.06 48.76 23.94 15.33 49.78 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 A 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 A 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 18.28 7.83 36.39 22.82 8.75 39.52 181.66 123.79 6.82 179.82 128.66 10.46 coo 14.16 13.09 37.03 20.00 12.44 37.49 179.28 118.69 11.71 177.59 112.91 13.79 coo 22.22 16.06 48.76 23.94 15.33 49.78 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 A 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 74 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 18.28 7.83 36.39 22.82 8.75 39.52 181.66 123.79 6.82 179.82 128.66 10.46 coo 14.16 13.09 37.03 20.00 12.44 37.49 175.75 125.08 4.60 173.18 124.12 -0.61 coo 22.22 16.06 48.76 23.94 15.33 49.78 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 A 14 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 18.28 7.83 36.39 22.82 8.75 39.52 161.58 122.48 47.40 160.49 120.58 53.33 coo 14.16 13.09 37.03 20.00 12.44 37.49 165.62 124.17 41.44 160.89 126.43 37.84 coo 22.22 16.06 48.76 23.94 15.33 49.78 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 A 14 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 165 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 18.28 7.83 36.39 22.82 8.75 39.52 163.30 119.33 38.22 166.56 114.68 36.90 coo 14.16 13.09 37.03 20.00 12.44 37.49 165.62 124.17 41.44 160.89 126.43 37.84 coo 22.22 16.06 48.76 23.94 15.33 49.78 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 A 14 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 74 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 18.28 7.83 36.39 22.82 8.75 39.52 161.71 139.26 46.53 163.20 144.39 46.83 coo 14.16 13.09 37.03 20.00 12.44 37.49 168.56 136.65 44.17 170.62 139.01 49.65 coo 22.22 16.06 48.76 23.94 15.33 49.78 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 A 14 LYS C 126 LYS^? 28.06 O1 GOL C1901 A 74 LYS C 110 LYS.? 26.32 O1 GOL C1901 A 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 18.28 7.83 36.39 22.82 8.75 39.52 168.56 136.65 44.17 170.62 139.01 49.65 coo 14.16 13.09 37.03 20.00 12.44 37.49 161.71 139.26 46.53 163.20 144.39 46.83 coo 22.22 16.06 48.76 23.94 15.33 49.78 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 A 14 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 74 LYS C 94 LYS^? 16.92 O3 GOL C1901 A 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 18.28 7.83 36.39 22.82 8.75 39.52 165.62 124.17 41.44 160.89 126.43 37.84 coo 14.16 13.09 37.03 20.00 12.44 37.49 161.58 122.48 47.40 160.49 120.58 53.33 coo 22.22 16.06 48.76 23.94 15.33 49.78 174.54 125.67 53.14 175.81 126.60 51.73 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 18 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 165 GLU A 184 GLU~? 18.03 N9 ADE A 500 coo 13.51 0.92 76.10 12.98 6.13 74.68 189.82 158.18 22.25 194.56 162.25 23.07 coo 19.89 -0.55 76.51 17.10 4.32 77.43 182.91 155.29 23.54 184.46 151.31 19.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 180.48 167.65 23.03 180.45 166.67 21.17 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 13.51 0.92 76.10 12.98 6.13 74.68 189.82 158.18 22.25 194.56 162.25 23.07 coo 19.89 -0.55 76.51 17.10 4.32 77.43 182.91 155.29 23.54 184.46 151.31 19.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 74 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 13.51 0.92 76.10 12.98 6.13 74.68 180.69 158.10 18.36 176.95 162.62 18.15 coo 19.89 -0.55 76.51 17.10 4.32 77.43 182.91 155.29 23.54 184.46 151.31 19.55 coo 21.39 11.56 68.52 20.24 13.13 67.73 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 74 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 13.51 0.92 76.10 12.98 6.13 74.68 192.52 142.86 28.75 192.00 138.78 32.31 coo 19.89 -0.55 76.51 17.10 4.32 77.43 186.22 145.69 31.90 189.62 146.93 37.05 coo 21.39 11.56 68.52 20.24 13.13 67.73 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 B 14 LYS A 126 LYS^? 24.40 C8 ADE A 500 B 74 LYS A 110 LYS.? 23.26 C8 ADE A 500 B 165 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 13.51 0.92 76.10 12.98 6.13 74.68 186.22 145.69 31.90 189.62 146.93 37.05 coo 19.89 -0.55 76.51 17.10 4.32 77.43 192.52 142.86 28.75 192.00 138.78 32.31 coo 21.39 11.56 68.52 20.24 13.13 67.73 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 B 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 74 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 165 GLU A 196 GLU~? 25.56 N9 ADE A 500 coo 13.51 0.92 76.10 12.98 6.13 74.68 182.91 155.29 23.54 184.46 151.31 19.55 coo 19.89 -0.55 76.51 17.10 4.32 77.43 189.82 158.18 22.25 194.56 162.25 23.07 coo 21.39 11.56 68.52 20.24 13.13 67.73 187.60 160.31 36.10 186.31 159.33 37.47 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 B 14 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 74 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 165 GLU A 182 GLU~? 24.67 N9 ADE A 500 coo 13.51 0.92 76.10 12.98 6.13 74.68 182.91 155.29 23.54 184.46 151.31 19.55 coo 19.89 -0.55 76.51 17.10 4.32 77.43 180.69 158.10 18.36 176.95 162.62 18.15 coo 21.39 11.56 68.52 20.24 13.13 67.73 187.83 168.13 29.26 189.30 168.72 30.65 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 B 14 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 13.51 0.92 76.10 12.98 6.13 74.68 179.28 118.69 11.71 177.59 112.91 13.79 coo 19.89 -0.55 76.51 17.10 4.32 77.43 181.66 123.79 6.82 179.82 128.66 10.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 9 3 # 9 B 14 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 74 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 13.51 0.92 76.10 12.98 6.13 74.68 175.75 125.08 4.60 173.18 124.12 -0.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 181.66 123.79 6.82 179.82 128.66 10.46 coo 21.39 11.56 68.52 20.24 13.13 67.73 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 10 3 # 10 B 14 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 74 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 13.51 0.92 76.10 12.98 6.13 74.68 192.36 125.68 19.31 197.51 127.46 19.90 coo 19.89 -0.55 76.51 17.10 4.32 77.43 193.73 125.48 11.85 197.51 120.83 13.59 coo 21.39 11.56 68.52 20.24 13.13 67.73 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 11 3 # 11 B 14 LYS B 126 LYS^? 29.75 O4 CIT A1102 B 74 LYS B 110 LYS.? 26.40 N7 ADE A 500 B 165 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 13.51 0.92 76.10 12.98 6.13 74.68 193.73 125.48 11.85 197.51 120.83 13.59 coo 19.89 -0.55 76.51 17.10 4.32 77.43 192.36 125.68 19.31 197.51 127.46 19.90 coo 21.39 11.56 68.52 20.24 13.13 67.73 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 12 3 # 12 B 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 13.51 0.92 76.10 12.98 6.13 74.68 181.66 123.79 6.82 179.82 128.66 10.46 coo 19.89 -0.55 76.51 17.10 4.32 77.43 179.28 118.69 11.71 177.59 112.91 13.79 coo 21.39 11.56 68.52 20.24 13.13 67.73 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 13 3 # 13 B 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 74 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 165 GLU B 196 GLU~? 29.77 O4 CIT A1102 coo 13.51 0.92 76.10 12.98 6.13 74.68 181.66 123.79 6.82 179.82 128.66 10.46 coo 19.89 -0.55 76.51 17.10 4.32 77.43 179.28 118.69 11.71 177.59 112.91 13.79 coo 21.39 11.56 68.52 20.24 13.13 67.73 190.49 111.97 5.68 191.95 113.07 4.61 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 14 3 # 14 B 14 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 74 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 165 GLU B 182 GLU~? 29.98 C2 CIT A1102 coo 13.51 0.92 76.10 12.98 6.13 74.68 181.66 123.79 6.82 179.82 128.66 10.46 coo 19.89 -0.55 76.51 17.10 4.32 77.43 175.75 125.08 4.60 173.18 124.12 -0.61 coo 21.39 11.56 68.52 20.24 13.13 67.73 180.61 109.47 2.81 182.18 108.21 3.48 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 15 3 # 15 B 14 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 13.51 0.92 76.10 12.98 6.13 74.68 161.58 122.48 47.40 160.49 120.58 53.33 coo 19.89 -0.55 76.51 17.10 4.32 77.43 165.62 124.17 41.44 160.89 126.43 37.84 coo 21.39 11.56 68.52 20.24 13.13 67.73 174.54 125.67 53.14 175.81 126.60 51.73 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 16 3 # 16 B 14 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 74 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 165 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 13.51 0.92 76.10 12.98 6.13 74.68 163.30 119.33 38.22 166.56 114.68 36.90 coo 19.89 -0.55 76.51 17.10 4.32 77.43 165.62 124.17 41.44 160.89 126.43 37.84 coo 21.39 11.56 68.52 20.24 13.13 67.73 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 17 3 # 17 B 14 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 74 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 13.51 0.92 76.10 12.98 6.13 74.68 161.71 139.26 46.53 163.20 144.39 46.83 coo 19.89 -0.55 76.51 17.10 4.32 77.43 168.56 136.65 44.17 170.62 139.01 49.65 coo 21.39 11.56 68.52 20.24 13.13 67.73 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 18 3 # 18 B 14 LYS C 126 LYS^? 28.06 O1 GOL C1901 B 74 LYS C 110 LYS.? 26.32 O1 GOL C1901 B 165 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 13.51 0.92 76.10 12.98 6.13 74.68 168.56 136.65 44.17 170.62 139.01 49.65 coo 19.89 -0.55 76.51 17.10 4.32 77.43 161.71 139.26 46.53 163.20 144.39 46.83 coo 21.39 11.56 68.52 20.24 13.13 67.73 157.34 129.59 37.15 157.60 127.69 38.11 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 19 3 # 19 B 14 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 74 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 165 GLU C 196 GLU~? 28.79 C1 GOL C1901 coo 13.51 0.92 76.10 12.98 6.13 74.68 165.62 124.17 41.44 160.89 126.43 37.84 coo 19.89 -0.55 76.51 17.10 4.32 77.43 161.58 122.48 47.40 160.49 120.58 53.33 coo 21.39 11.56 68.52 20.24 13.13 67.73 174.54 125.67 53.14 175.81 126.60 51.73 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 19 hits 1ylu_c01 naa= 3 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 1 3 # 1 A 369 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 371 LYS A 132 LYS~? 32.58 C8 ADE A 500 A 374 ASN A 133 ASN~? 29.64 C8 ADE A 500 coo -5.17 31.09 15.73 -7.07 31.12 16.73 188.71 136.74 34.61 188.50 136.01 36.57 coo -4.43 30.92 22.89 -6.61 31.91 19.71 183.55 135.22 37.19 185.46 129.22 37.94 coo -4.84 27.04 20.49 -6.40 27.76 19.26 186.76 138.66 38.21 187.61 137.64 39.89 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 2 3 # 2 A 369 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 371 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 374 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo -5.17 31.09 15.73 -7.07 31.12 16.73 178.57 156.37 9.84 177.44 156.14 8.05 coo -4.43 30.92 22.89 -6.61 31.91 19.71 180.69 158.10 18.36 176.95 162.62 18.15 coo -4.84 27.04 20.49 -6.40 27.76 19.26 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 3 3 # 3 A 369 ASP B 130 ASP~? 26.83 N6 ADE A 500 A 371 LYS B 132 LYS~? 23.82 N6 ADE A 500 A 374 ASN B 133 ASN~? 28.81 N6 ADE A 500 coo -5.17 31.09 15.73 -7.07 31.12 16.73 200.55 129.62 17.17 202.64 129.41 16.98 coo -4.43 30.92 22.89 -6.61 31.91 19.71 203.58 131.98 12.65 206.21 136.25 10.92 coo -4.84 27.04 20.49 -6.40 27.76 19.26 202.41 127.52 13.21 204.35 127.28 14.04 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 4 3 # 4 A 369 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 371 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 374 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo -5.17 31.09 15.73 -7.07 31.12 16.73 169.82 131.15 6.22 168.64 132.89 5.97 coo -4.43 30.92 22.89 -6.61 31.91 19.71 175.75 125.08 4.60 173.18 124.12 -0.61 coo -4.84 27.04 20.49 -6.40 27.76 19.26 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 3 1zrz_c03 PROTEIN KINASE C, IOTA user 5 3 # 5 A 369 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 371 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 374 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo -5.17 31.09 15.73 -7.07 31.12 16.73 157.90 117.18 31.56 156.68 116.62 29.91 coo -4.43 30.92 22.89 -6.61 31.91 19.71 163.30 119.33 38.22 166.56 114.68 36.90 coo -4.84 27.04 20.49 -6.40 27.76 19.26 160.68 120.91 34.68 159.00 120.62 33.38 1zrz_c03 source 1zrz PROTEIN KINASE C, IOTA : 5 hits 1zrz_c03 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 37 TRP~? 16.06 N6 ADE A 500 223 ASP B 130 ASP~? 26.83 N6 ADE A 500 258 ALA B 8 ALA.? 19.99 O4 CIT A1102 coo 128.40 33.01 26.67 128.12 36.28 28.81 199.31 139.07 11.62 196.71 138.80 14.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 200.55 129.62 17.17 202.64 129.41 16.98 coo 141.00 37.49 25.74 139.80 37.53 24.78 194.65 130.01 5.34 193.39 129.45 6.01 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP A 37 TRP~? 16.06 N6 ADE A 500 223 ASP B 130 ASP~? 26.83 N6 ADE A 500 258 ALA B 9 ALA.? 25.11 N6 ADE A 500 coo 128.40 33.01 26.67 128.12 36.28 28.81 199.31 139.07 11.62 196.71 138.80 14.55 coo 127.91 41.73 23.55 129.18 40.35 24.44 200.55 129.62 17.17 202.64 129.41 16.98 coo 141.00 37.49 25.74 139.80 37.53 24.78 197.54 127.53 5.34 198.69 127.54 6.34 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 3 3 # 3 142 TRP B 37 TRP~? 24.65 C8 ADE A 500 223 ASP A 130 ASP~? 27.60 C8 ADE A 500 258 ALA C 9 ALA.? 27.31 O1 GOL C1901 coo 128.40 33.01 26.67 128.12 36.28 28.81 179.47 132.20 30.73 182.06 132.56 27.80 coo 127.91 41.73 23.55 129.18 40.35 24.44 188.71 136.74 34.61 188.50 136.01 36.57 coo 141.00 37.49 25.74 139.80 37.53 24.78 177.77 129.63 43.13 177.69 129.10 41.68 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 3 hits 2aat_c01 naa= 3 ULMN 3 2adm_c00 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 A 105 ASN B 100 ASN.? -3.42 C4 CIT A1102s A 106 PRO B 169 PRO.? -3.96 O5 CIT A1102s A 108 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 34.91 38.94 20.48 33.53 38.20 19.00 174.18 134.78 4.77 172.12 135.04 4.40 coo 36.18 33.51 20.99 37.11 35.33 20.14 170.88 139.44 5.26 172.14 139.13 7.05 coo 33.01 33.46 15.68 31.96 34.97 17.80 175.94 140.65 -0.34 176.08 138.10 -1.42 2adm_c00 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c00 naa= 3 ULMN 3 2adm_c01 ADENINE-N6-DNA-METHYLTRANSFERASE TAQuser 1 3 # 1 B 105 ASN B 100 ASN.? -3.42 C4 CIT A1102s B 106 PRO B 169 PRO.? -3.96 O5 CIT A1102s B 108 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 5.98 38.14 46.94 7.30 38.92 45.46 174.18 134.78 4.77 172.12 135.04 4.40 coo 4.66 43.53 47.47 3.74 41.73 46.59 170.88 139.44 5.26 172.14 139.13 7.05 coo 7.86 43.80 42.15 8.87 42.26 44.27 175.94 140.65 -0.34 176.08 138.10 -1.42 2adm_c01 source 2adm ADENINE-N6-DNA-METHYLTRANSFERASE TAQI : 1 hits 2adm_c01 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP B 89 ASP.? 31.34 O4 CIT A1102 219 GLU B 25 GLU.? 28.27 O1 GOL C1901 294 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 27.89 102.52 14.98 29.35 101.92 13.57 181.93 115.70 26.33 180.57 117.33 26.20 coo 25.84 105.87 9.06 27.86 105.55 8.74 179.49 113.39 31.74 177.60 113.83 30.87 coo 33.16 106.80 7.72 33.34 104.87 6.92 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP C 119 ASP.? 26.31 O1 GOL C1901 219 GLU B 25 GLU.? 28.27 O1 GOL C1901 294 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 27.89 102.52 14.98 29.35 101.92 13.57 178.03 118.40 36.14 177.70 120.46 36.31 coo 25.84 105.87 9.06 27.86 105.55 8.74 179.49 113.39 31.74 177.60 113.83 30.87 coo 33.16 106.80 7.72 33.34 104.87 6.92 181.93 115.70 26.33 180.57 117.33 26.20 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 2 hits 2amg_c02 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP C 119 ASP.? 26.31 O1 GOL C1901 231 ASP A 130 ASP~? 27.60 C8 ADE A 500 294 ASP B 89 ASP.? 31.34 O4 CIT A1102 coo 27.89 102.52 14.98 29.35 101.92 13.57 178.03 118.40 36.14 177.70 120.46 36.31 coo 14.74 93.05 -1.00 14.30 94.22 0.73 188.71 136.74 34.61 188.50 136.01 36.57 coo 33.16 106.80 7.72 33.34 104.87 6.92 181.93 115.70 26.33 180.57 117.33 26.20 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 1 hits 2amg_c06 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 163 ALA B 148 ALA^? 20.27 O4 CIT A1102 B 182 SER B 149 SER^? 19.92 O4 CIT A1102 coo 30.42 1.98 4.36 29.07 0.41 4.68 176.50 123.51 9.48 177.50 124.87 10.72 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 182.64 121.34 9.52 182.83 119.91 9.05 coo 24.00 -0.17 2.07 24.51 1.00 0.04 184.89 121.99 12.52 183.61 123.38 14.10 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 1 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 108 ARG^? 21.78 N7 ADE A 500 A 161 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 174 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 195.17 135.76 22.50 193.88 133.29 23.81 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 188.71 136.74 34.61 188.50 136.01 36.57 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG C 101 ARG.? 18.11 O1 GOL C1901 A 161 ASP B 36 ASP~? 28.48 O1 GOL C1901 A 174 TYR C 117 TYR.? 21.72 O1 GOL C1901 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 163.77 126.78 27.00 165.49 129.29 26.85 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 178.67 130.13 34.24 179.32 129.31 36.04 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 173.67 123.08 36.58 172.76 125.64 35.98 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 108 ARG^? 21.78 N7 ADE A 500 B 161 ASP A 130 ASP~? 27.60 C8 ADE A 500 B 174 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 195.17 135.76 22.50 193.88 133.29 23.81 coo -14.86 10.19 8.14 -14.82 12.31 8.42 188.71 136.74 34.61 188.50 136.01 36.57 coo -21.46 12.70 8.53 -19.04 12.30 7.24 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG C 101 ARG.? 18.11 O1 GOL C1901 B 161 ASP B 36 ASP~? 28.48 O1 GOL C1901 B 174 TYR C 117 TYR.? 21.72 O1 GOL C1901 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 163.77 126.78 27.00 165.49 129.29 26.85 coo -14.86 10.19 8.14 -14.82 12.31 8.42 178.67 130.13 34.24 179.32 129.31 36.04 coo -21.46 12.70 8.53 -19.04 12.30 7.24 173.67 123.08 36.58 172.76 125.64 35.98 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 108 ARG^? 21.78 N7 ADE A 500 C 161 ASP A 130 ASP~? 27.60 C8 ADE A 500 C 174 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo 2.84 19.43 40.34 1.59 20.35 37.65 195.17 135.76 22.50 193.88 133.29 23.81 coo -0.62 11.10 28.05 -0.65 13.15 27.46 188.71 136.74 34.61 188.50 136.01 36.57 coo 5.94 13.28 27.17 3.53 13.05 28.58 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG C 101 ARG.? 18.11 O1 GOL C1901 C 161 ASP B 36 ASP~? 28.48 O1 GOL C1901 C 174 TYR C 117 TYR.? 21.72 O1 GOL C1901 coo 2.84 19.43 40.34 1.59 20.35 37.65 163.77 126.78 27.00 165.49 129.29 26.85 coo -0.62 11.10 28.05 -0.65 13.15 27.46 178.67 130.13 34.24 179.32 129.31 36.04 coo 5.94 13.28 27.17 3.53 13.05 28.58 173.67 123.08 36.58 172.76 125.64 35.98 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 108 ARG^? 21.78 N7 ADE A 500 D 161 ASP A 130 ASP~? 27.60 C8 ADE A 500 D 174 TYR A 131 TYR~? 27.02 C8 ADE A 500 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 195.17 135.76 22.50 193.88 133.29 23.81 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 188.71 136.74 34.61 188.50 136.01 36.57 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 182.79 134.12 33.10 182.43 131.46 33.83 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG C 101 ARG.? 18.11 O1 GOL C1901 D 161 ASP B 36 ASP~? 28.48 O1 GOL C1901 D 174 TYR C 117 TYR.? 21.72 O1 GOL C1901 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 163.77 126.78 27.00 165.49 129.29 26.85 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 178.67 130.13 34.24 179.32 129.31 36.04 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 173.67 123.08 36.58 172.76 125.64 35.98 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 233 GLU A 50 GLU^? -3.91 N6 ADE A 500s A 300 ASN A 77 ASN^? 9.65 N6 ADE A 500 coo 12.51 17.07 49.46 12.44 16.89 47.35 185.72 140.93 6.30 184.35 140.00 4.99 coo 6.52 19.14 48.16 7.77 18.42 46.61 187.90 146.65 6.60 187.00 148.18 5.47 coo 9.30 22.40 41.76 10.10 20.96 40.36 179.83 147.18 2.66 181.08 147.98 1.14 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 233 GLU A 155 GLU.? 30.36 C8 ADE A 500 A 300 ASN A 154 ASN.? 21.16 C8 ADE A 500 coo 12.51 17.07 49.46 12.44 16.89 47.35 203.27 140.75 25.55 204.24 138.86 25.61 coo 6.52 19.14 48.16 7.77 18.42 46.61 202.13 137.32 32.16 203.15 136.76 33.90 coo 9.30 22.40 41.76 10.10 20.96 40.36 196.82 141.64 30.94 196.98 141.72 28.81 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 3 3 # 3 A 197 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 233 GLU B 50 GLU^? 15.33 O1 CIT A1102 A 300 ASN B 77 ASN^? 12.53 O1 CIT A1102 coo 12.51 17.07 49.46 12.44 16.89 47.35 173.93 140.35 20.11 173.24 142.10 19.12 coo 6.52 19.14 48.16 7.77 18.42 46.61 171.15 134.64 18.99 169.39 134.49 17.85 coo 9.30 22.40 41.76 10.10 20.96 40.36 167.65 140.29 13.08 165.89 139.84 14.18 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 4 3 # 4 A 197 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 233 GLU B 155 GLU.? 33.13 C8 ADE A 500 A 300 ASN B 154 ASN.? 28.91 N7 ADE A 500 coo 12.51 17.07 49.46 12.44 16.89 47.35 190.60 123.10 30.08 190.26 121.25 31.09 coo 6.52 19.14 48.16 7.77 18.42 46.61 197.70 123.91 29.28 199.42 125.11 29.52 coo 9.30 22.40 41.76 10.10 20.96 40.36 194.71 123.63 23.05 192.89 124.34 23.91 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 5 3 # 5 A 197 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 233 GLU B 156 GLU.? 24.53 N7 ADE A 500 A 300 ASN B 154 ASN.? 28.91 N7 ADE A 500 coo 12.51 17.07 49.46 12.44 16.89 47.35 190.60 123.10 30.08 190.26 121.25 31.09 coo 6.52 19.14 48.16 7.77 18.42 46.61 194.44 129.17 25.88 194.48 130.18 24.03 coo 9.30 22.40 41.76 10.10 20.96 40.36 194.71 123.63 23.05 192.89 124.34 23.91 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 6 3 # 6 A 197 ASP C 52 ASP^? 12.06 O1 GOL C1901 A 233 GLU C 50 GLU^? -3.82 O2 GOL C1901s A 300 ASN C 77 ASN^? 9.92 O2 GOL C1901 coo 12.51 17.07 49.46 12.44 16.89 47.35 147.21 130.59 30.19 147.01 130.37 28.08 coo 6.52 19.14 48.16 7.77 18.42 46.61 147.72 125.56 34.28 147.67 123.54 33.74 coo 9.30 22.40 41.76 10.10 20.96 40.36 149.21 122.45 26.13 147.53 121.25 26.66 2cpu_c01 source 2cpu ALPHA-AMYLASE : 6 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 14 GLU.? 28.29 N9 ADE A 500 A 156 GLU A 196 GLU~? 25.56 N9 ADE A 500 A 194 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 74.14 15.91 8.55 72.08 15.36 8.63 191.26 153.03 39.37 191.20 151.63 40.96 coo 67.47 20.07 1.34 65.99 20.06 2.88 187.60 160.31 36.10 186.31 159.33 37.47 coo 67.44 25.26 13.91 67.54 23.65 15.28 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 50 GLU^? -3.91 N6 ADE A 500s A 156 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 74.14 15.91 8.55 72.08 15.36 8.63 187.90 146.65 6.60 187.00 148.18 5.47 coo 67.47 20.07 1.34 65.99 20.06 2.88 185.43 146.45 17.17 186.00 148.48 17.29 coo 67.44 25.26 13.91 67.54 23.65 15.28 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 61 GLU^? 16.24 O5 CIT A1102 A 156 GLU A 59 GLU^? 13.22 O6 CIT A1102 A 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 74.14 15.91 8.55 72.08 15.36 8.63 165.65 155.89 5.11 164.98 153.86 5.06 coo 67.47 20.07 1.34 65.99 20.06 2.88 169.62 150.86 -1.29 170.91 152.08 -2.44 coo 67.44 25.26 13.91 67.54 23.65 15.28 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 156 GLU A 44 GLU.? 5.64 N9 ADE A 500 A 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 74.14 15.91 8.55 72.08 15.36 8.63 185.43 146.45 17.17 186.00 148.48 17.29 coo 67.47 20.07 1.34 65.99 20.06 2.88 188.90 156.57 17.91 187.92 156.12 16.11 coo 67.44 25.26 13.91 67.54 23.65 15.28 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 156 GLU A 50 GLU^? -3.91 N6 ADE A 500s A 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 74.14 15.91 8.55 72.08 15.36 8.63 185.43 146.45 17.17 186.00 148.48 17.29 coo 67.47 20.07 1.34 65.99 20.06 2.88 187.90 146.65 6.60 187.00 148.18 5.47 coo 67.44 25.26 13.91 67.54 23.65 15.28 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU A 196 GLU~? 25.56 N9 ADE A 500 A 156 GLU A 14 GLU.? 28.29 N9 ADE A 500 A 194 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 74.14 15.91 8.55 72.08 15.36 8.63 187.60 160.31 36.10 186.31 159.33 37.47 coo 67.47 20.07 1.34 65.99 20.06 2.88 191.26 153.03 39.37 191.20 151.63 40.96 coo 67.44 25.26 13.91 67.54 23.65 15.28 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU B 50 GLU^? 15.33 O1 CIT A1102 A 156 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 194 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 74.14 15.91 8.55 72.08 15.36 8.63 171.15 134.64 18.99 169.39 134.49 17.85 coo 67.47 20.07 1.34 65.99 20.06 2.88 180.17 131.30 14.36 179.09 129.62 13.64 coo 67.44 25.26 13.91 67.54 23.65 15.28 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 156 GLU B 44 GLU.? 19.02 O1 CIT A1102 A 194 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 74.14 15.91 8.55 72.08 15.36 8.63 180.17 131.30 14.36 179.09 129.62 13.64 coo 67.47 20.07 1.34 65.99 20.06 2.88 174.85 121.76 12.80 173.53 120.38 11.97 coo 67.44 25.26 13.91 67.54 23.65 15.28 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 156 GLU B 50 GLU^? 15.33 O1 CIT A1102 A 194 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 74.14 15.91 8.55 72.08 15.36 8.63 180.17 131.30 14.36 179.09 129.62 13.64 coo 67.47 20.07 1.34 65.99 20.06 2.88 171.15 134.64 18.99 169.39 134.49 17.85 coo 67.44 25.26 13.91 67.54 23.65 15.28 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU C 14 GLU.? 32.06 O1 GOL C1901 A 156 GLU C 196 GLU~? 28.79 C1 GOL C1901 A 194 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 74.14 15.91 8.55 72.08 15.36 8.63 173.34 134.38 54.29 174.51 136.04 54.85 coo 67.47 20.07 1.34 65.99 20.06 2.88 174.54 125.67 53.14 175.81 126.60 51.73 coo 67.44 25.26 13.91 67.54 23.65 15.28 177.62 134.05 42.85 179.55 133.98 41.92 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU C 50 GLU^? -3.82 O2 GOL C1901s A 156 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 74.14 15.91 8.55 72.08 15.36 8.63 147.72 125.56 34.28 147.67 123.54 33.74 coo 67.47 20.07 1.34 65.99 20.06 2.88 157.34 129.59 37.15 157.60 127.69 38.11 coo 67.44 25.26 13.91 67.54 23.65 15.28 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c00 CHITINASE C user 12 3 # 12 A 147 GLU C 61 GLU^? 23.56 O1 GOL C1901 A 156 GLU C 59 GLU^? 20.19 O2 GOL C1901 A 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 74.14 15.91 8.55 72.08 15.36 8.63 160.74 113.36 18.70 162.31 114.29 17.61 coo 67.47 20.07 1.34 65.99 20.06 2.88 152.75 116.35 16.84 151.33 114.88 17.42 coo 67.44 25.26 13.91 67.54 23.65 15.28 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c00 CHITINASE C user 13 3 # 13 A 147 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 156 GLU C 44 GLU.? 9.57 O3 GOL C1901 A 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 74.14 15.91 8.55 72.08 15.36 8.63 157.34 129.59 37.15 157.60 127.69 38.11 coo 67.47 20.07 1.34 65.99 20.06 2.88 157.18 120.22 44.20 157.97 118.54 45.19 coo 67.44 25.26 13.91 67.54 23.65 15.28 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c00 CHITINASE C user 14 3 # 14 A 147 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 156 GLU C 50 GLU^? -3.82 O2 GOL C1901s A 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 74.14 15.91 8.55 72.08 15.36 8.63 157.34 129.59 37.15 157.60 127.69 38.11 coo 67.47 20.07 1.34 65.99 20.06 2.88 147.72 125.56 34.28 147.67 123.54 33.74 coo 67.44 25.26 13.91 67.54 23.65 15.28 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c00 CHITINASE C user 15 3 # 15 A 147 GLU C 196 GLU~? 28.79 C1 GOL C1901 A 156 GLU C 14 GLU.? 32.06 O1 GOL C1901 A 194 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 74.14 15.91 8.55 72.08 15.36 8.63 174.54 125.67 53.14 175.81 126.60 51.73 coo 67.47 20.07 1.34 65.99 20.06 2.88 173.34 134.38 54.29 174.51 136.04 54.85 coo 67.44 25.26 13.91 67.54 23.65 15.28 177.62 134.05 42.85 179.55 133.98 41.92 2dbt_c00 source 2dbt CHITINASE C : 15 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 14 GLU.? 28.29 N9 ADE A 500 B 156 GLU A 196 GLU~? 25.56 N9 ADE A 500 B 194 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 45.64 63.11 17.20 47.48 62.43 16.45 191.26 153.03 39.37 191.20 151.63 40.96 coo 54.43 67.89 19.82 55.62 67.90 18.07 187.60 160.31 36.10 186.31 159.33 37.47 coo 49.79 70.75 7.78 50.10 68.90 6.86 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 50 GLU^? -3.91 N6 ADE A 500s B 156 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 45.64 63.11 17.20 47.48 62.43 16.45 187.90 146.65 6.60 187.00 148.18 5.47 coo 54.43 67.89 19.82 55.62 67.90 18.07 185.43 146.45 17.17 186.00 148.48 17.29 coo 49.79 70.75 7.78 50.10 68.90 6.86 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 156 GLU A 44 GLU.? 5.64 N9 ADE A 500 B 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 45.64 63.11 17.20 47.48 62.43 16.45 185.43 146.45 17.17 186.00 148.48 17.29 coo 54.43 67.89 19.82 55.62 67.90 18.07 188.90 156.57 17.91 187.92 156.12 16.11 coo 49.79 70.75 7.78 50.10 68.90 6.86 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 156 GLU A 50 GLU^? -3.91 N6 ADE A 500s B 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 45.64 63.11 17.20 47.48 62.43 16.45 185.43 146.45 17.17 186.00 148.48 17.29 coo 54.43 67.89 19.82 55.62 67.90 18.07 187.90 146.65 6.60 187.00 148.18 5.47 coo 49.79 70.75 7.78 50.10 68.90 6.86 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU A 196 GLU~? 25.56 N9 ADE A 500 B 156 GLU A 14 GLU.? 28.29 N9 ADE A 500 B 194 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 45.64 63.11 17.20 47.48 62.43 16.45 187.60 160.31 36.10 186.31 159.33 37.47 coo 54.43 67.89 19.82 55.62 67.90 18.07 191.26 153.03 39.37 191.20 151.63 40.96 coo 49.79 70.75 7.78 50.10 68.90 6.86 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU B 14 GLU.? 33.67 O4 CIT A1102 B 156 GLU B 196 GLU~? 29.77 O4 CIT A1102 B 194 ASN B 10 ASN.? 24.71 O4 CIT A1102 coo 45.64 63.11 17.20 47.48 62.43 16.45 196.57 114.78 10.83 198.67 114.78 11.14 coo 54.43 67.89 19.82 55.62 67.90 18.07 190.49 111.97 5.68 191.95 113.07 4.61 coo 49.79 70.75 7.78 50.10 68.90 6.86 196.51 123.48 2.85 194.80 122.44 2.12 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU B 50 GLU^? 15.33 O1 CIT A1102 B 156 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 194 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 45.64 63.11 17.20 47.48 62.43 16.45 171.15 134.64 18.99 169.39 134.49 17.85 coo 54.43 67.89 19.82 55.62 67.90 18.07 180.17 131.30 14.36 179.09 129.62 13.64 coo 49.79 70.75 7.78 50.10 68.90 6.86 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 156 GLU B 50 GLU^? 15.33 O1 CIT A1102 B 194 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 45.64 63.11 17.20 47.48 62.43 16.45 180.17 131.30 14.36 179.09 129.62 13.64 coo 54.43 67.89 19.82 55.62 67.90 18.07 171.15 134.64 18.99 169.39 134.49 17.85 coo 49.79 70.75 7.78 50.10 68.90 6.86 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU B 196 GLU~? 29.77 O4 CIT A1102 B 156 GLU B 14 GLU.? 33.67 O4 CIT A1102 B 194 ASN B 10 ASN.? 24.71 O4 CIT A1102 coo 45.64 63.11 17.20 47.48 62.43 16.45 190.49 111.97 5.68 191.95 113.07 4.61 coo 54.43 67.89 19.82 55.62 67.90 18.07 196.57 114.78 10.83 198.67 114.78 11.14 coo 49.79 70.75 7.78 50.10 68.90 6.86 196.51 123.48 2.85 194.80 122.44 2.12 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU C 14 GLU.? 32.06 O1 GOL C1901 B 156 GLU C 196 GLU~? 28.79 C1 GOL C1901 B 194 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 45.64 63.11 17.20 47.48 62.43 16.45 173.34 134.38 54.29 174.51 136.04 54.85 coo 54.43 67.89 19.82 55.62 67.90 18.07 174.54 125.67 53.14 175.81 126.60 51.73 coo 49.79 70.75 7.78 50.10 68.90 6.86 177.62 134.05 42.85 179.55 133.98 41.92 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU C 50 GLU^? -3.82 O2 GOL C1901s B 156 GLU C 165 GLU^? 7.74 O1 GOL C1901 B 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 45.64 63.11 17.20 47.48 62.43 16.45 147.72 125.56 34.28 147.67 123.54 33.74 coo 54.43 67.89 19.82 55.62 67.90 18.07 157.34 129.59 37.15 157.60 127.69 38.11 coo 49.79 70.75 7.78 50.10 68.90 6.86 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU C 165 GLU^? 7.74 O1 GOL C1901 B 156 GLU C 50 GLU^? -3.82 O2 GOL C1901s B 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 45.64 63.11 17.20 47.48 62.43 16.45 157.34 129.59 37.15 157.60 127.69 38.11 coo 54.43 67.89 19.82 55.62 67.90 18.07 147.72 125.56 34.28 147.67 123.54 33.74 coo 49.79 70.75 7.78 50.10 68.90 6.86 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c01 CHITINASE C user 13 3 # 13 B 147 GLU C 196 GLU~? 28.79 C1 GOL C1901 B 156 GLU C 14 GLU.? 32.06 O1 GOL C1901 B 194 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 45.64 63.11 17.20 47.48 62.43 16.45 174.54 125.67 53.14 175.81 126.60 51.73 coo 54.43 67.89 19.82 55.62 67.90 18.07 173.34 134.38 54.29 174.51 136.04 54.85 coo 49.79 70.75 7.78 50.10 68.90 6.86 177.62 134.05 42.85 179.55 133.98 41.92 2dbt_c01 source 2dbt CHITINASE C : 13 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 14 GLU.? 28.29 N9 ADE A 500 C 156 GLU A 196 GLU~? 25.56 N9 ADE A 500 C 194 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 41.23 29.31 13.28 43.03 29.85 12.29 191.26 153.03 39.37 191.20 151.63 40.96 coo 44.75 23.09 5.51 46.77 22.91 6.12 187.60 160.31 36.10 186.31 159.33 37.47 coo 49.75 21.00 18.12 50.45 23.02 18.26 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 50 GLU^? -3.91 N6 ADE A 500s C 156 GLU A 165 GLU^? 4.52 C8 ADE A 500 C 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 41.23 29.31 13.28 43.03 29.85 12.29 187.90 146.65 6.60 187.00 148.18 5.47 coo 44.75 23.09 5.51 46.77 22.91 6.12 185.43 146.45 17.17 186.00 148.48 17.29 coo 49.75 21.00 18.12 50.45 23.02 18.26 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 61 GLU^? 16.24 O5 CIT A1102 C 156 GLU A 59 GLU^? 13.22 O6 CIT A1102 C 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 41.23 29.31 13.28 43.03 29.85 12.29 165.65 155.89 5.11 164.98 153.86 5.06 coo 44.75 23.09 5.51 46.77 22.91 6.12 169.62 150.86 -1.29 170.91 152.08 -2.44 coo 49.75 21.00 18.12 50.45 23.02 18.26 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 165 GLU^? 4.52 C8 ADE A 500 C 156 GLU A 44 GLU.? 5.64 N9 ADE A 500 C 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 41.23 29.31 13.28 43.03 29.85 12.29 185.43 146.45 17.17 186.00 148.48 17.29 coo 44.75 23.09 5.51 46.77 22.91 6.12 188.90 156.57 17.91 187.92 156.12 16.11 coo 49.75 21.00 18.12 50.45 23.02 18.26 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 165 GLU^? 4.52 C8 ADE A 500 C 156 GLU A 50 GLU^? -3.91 N6 ADE A 500s C 194 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 41.23 29.31 13.28 43.03 29.85 12.29 185.43 146.45 17.17 186.00 148.48 17.29 coo 44.75 23.09 5.51 46.77 22.91 6.12 187.90 146.65 6.60 187.00 148.18 5.47 coo 49.75 21.00 18.12 50.45 23.02 18.26 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU A 196 GLU~? 25.56 N9 ADE A 500 C 156 GLU A 14 GLU.? 28.29 N9 ADE A 500 C 194 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 41.23 29.31 13.28 43.03 29.85 12.29 187.60 160.31 36.10 186.31 159.33 37.47 coo 44.75 23.09 5.51 46.77 22.91 6.12 191.26 153.03 39.37 191.20 151.63 40.96 coo 49.75 21.00 18.12 50.45 23.02 18.26 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU B 50 GLU^? 15.33 O1 CIT A1102 C 156 GLU B 165 GLU^? 13.88 O4 CIT A1102 C 194 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 41.23 29.31 13.28 43.03 29.85 12.29 171.15 134.64 18.99 169.39 134.49 17.85 coo 44.75 23.09 5.51 46.77 22.91 6.12 180.17 131.30 14.36 179.09 129.62 13.64 coo 49.75 21.00 18.12 50.45 23.02 18.26 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU B 61 GLU^? -7.61 O6 CIT A1102s C 156 GLU B 59 GLU^? 11.03 O1 CIT A1102 C 194 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 41.23 29.31 13.28 43.03 29.85 12.29 165.46 139.15 -4.12 166.35 139.75 -5.94 coo 44.75 23.09 5.51 46.77 22.91 6.12 162.57 145.21 3.58 161.45 143.81 4.68 coo 49.75 21.00 18.12 50.45 23.02 18.26 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU B 165 GLU^? 13.88 O4 CIT A1102 C 156 GLU B 44 GLU.? 19.02 O1 CIT A1102 C 194 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 41.23 29.31 13.28 43.03 29.85 12.29 180.17 131.30 14.36 179.09 129.62 13.64 coo 44.75 23.09 5.51 46.77 22.91 6.12 174.85 121.76 12.80 173.53 120.38 11.97 coo 49.75 21.00 18.12 50.45 23.02 18.26 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU B 165 GLU^? 13.88 O4 CIT A1102 C 156 GLU B 50 GLU^? 15.33 O1 CIT A1102 C 194 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 41.23 29.31 13.28 43.03 29.85 12.29 180.17 131.30 14.36 179.09 129.62 13.64 coo 44.75 23.09 5.51 46.77 22.91 6.12 171.15 134.64 18.99 169.39 134.49 17.85 coo 49.75 21.00 18.12 50.45 23.02 18.26 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2dbt_c02 CHITINASE C user 11 3 # 11 C 147 GLU C 14 GLU.? 32.06 O1 GOL C1901 C 156 GLU C 196 GLU~? 28.79 C1 GOL C1901 C 194 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 41.23 29.31 13.28 43.03 29.85 12.29 173.34 134.38 54.29 174.51 136.04 54.85 coo 44.75 23.09 5.51 46.77 22.91 6.12 174.54 125.67 53.14 175.81 126.60 51.73 coo 49.75 21.00 18.12 50.45 23.02 18.26 177.62 134.05 42.85 179.55 133.98 41.92 ULMN 3 2dbt_c02 CHITINASE C user 12 3 # 12 C 147 GLU C 50 GLU^? -3.82 O2 GOL C1901s C 156 GLU C 165 GLU^? 7.74 O1 GOL C1901 C 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 41.23 29.31 13.28 43.03 29.85 12.29 147.72 125.56 34.28 147.67 123.54 33.74 coo 44.75 23.09 5.51 46.77 22.91 6.12 157.34 129.59 37.15 157.60 127.69 38.11 coo 49.75 21.00 18.12 50.45 23.02 18.26 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c02 CHITINASE C user 13 3 # 13 C 147 GLU C 61 GLU^? 23.56 O1 GOL C1901 C 156 GLU C 59 GLU^? 20.19 O2 GOL C1901 C 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 41.23 29.31 13.28 43.03 29.85 12.29 160.74 113.36 18.70 162.31 114.29 17.61 coo 44.75 23.09 5.51 46.77 22.91 6.12 152.75 116.35 16.84 151.33 114.88 17.42 coo 49.75 21.00 18.12 50.45 23.02 18.26 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c02 CHITINASE C user 14 3 # 14 C 147 GLU C 165 GLU^? 7.74 O1 GOL C1901 C 156 GLU C 44 GLU.? 9.57 O3 GOL C1901 C 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 41.23 29.31 13.28 43.03 29.85 12.29 157.34 129.59 37.15 157.60 127.69 38.11 coo 44.75 23.09 5.51 46.77 22.91 6.12 157.18 120.22 44.20 157.97 118.54 45.19 coo 49.75 21.00 18.12 50.45 23.02 18.26 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c02 CHITINASE C user 15 3 # 15 C 147 GLU C 165 GLU^? 7.74 O1 GOL C1901 C 156 GLU C 50 GLU^? -3.82 O2 GOL C1901s C 194 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 41.23 29.31 13.28 43.03 29.85 12.29 157.34 129.59 37.15 157.60 127.69 38.11 coo 44.75 23.09 5.51 46.77 22.91 6.12 147.72 125.56 34.28 147.67 123.54 33.74 coo 49.75 21.00 18.12 50.45 23.02 18.26 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2dbt_c02 CHITINASE C user 16 3 # 16 C 147 GLU C 196 GLU~? 28.79 C1 GOL C1901 C 156 GLU C 14 GLU.? 32.06 O1 GOL C1901 C 194 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 41.23 29.31 13.28 43.03 29.85 12.29 174.54 125.67 53.14 175.81 126.60 51.73 coo 44.75 23.09 5.51 46.77 22.91 6.12 173.34 134.38 54.29 174.51 136.04 54.85 coo 49.75 21.00 18.12 50.45 23.02 18.26 177.62 134.05 42.85 179.55 133.98 41.92 2dbt_c02 source 2dbt CHITINASE C : 16 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 A 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 A 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 5.98 42.76 7.73 10.19 38.62 9.02 193.06 146.52 10.07 195.03 144.09 6.09 coo 2.77 37.17 4.99 6.33 34.76 8.06 197.56 153.42 13.51 201.64 156.08 17.41 coo 0.07 40.30 18.65 -0.21 42.34 18.18 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 A 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 5.98 42.76 7.73 10.19 38.62 9.02 182.91 155.29 23.54 184.46 151.31 19.55 coo 2.77 37.17 4.99 6.33 34.76 8.06 180.69 158.10 18.36 176.95 162.62 18.15 coo 0.07 40.30 18.65 -0.21 42.34 18.18 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 3 3 # 3 A 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 A 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 A 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 5.98 42.76 7.73 10.19 38.62 9.02 182.07 169.10 30.10 186.87 173.28 30.86 coo 2.77 37.17 4.99 6.33 34.76 8.06 183.60 164.07 35.65 183.22 158.61 36.42 coo 0.07 40.30 18.65 -0.21 42.34 18.18 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 4 3 # 4 A 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 A 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 5.98 42.76 7.73 10.19 38.62 9.02 181.66 123.79 6.82 179.82 128.66 10.46 coo 2.77 37.17 4.99 6.33 34.76 8.06 175.75 125.08 4.60 173.18 124.12 -0.61 coo 0.07 40.30 18.65 -0.21 42.34 18.18 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 5 3 # 5 A 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 A 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 5.98 42.76 7.73 10.19 38.62 9.02 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 2.77 37.17 4.99 6.33 34.76 8.06 188.45 111.50 0.09 191.63 115.50 2.10 coo 0.07 40.30 18.65 -0.21 42.34 18.18 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 6 3 # 6 A 182 LYS B 193 LYS~? 27.56 O4 CIT A1102 A 184 LYS B 186 LYS~? 32.32 C2 CIT A1102 A 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 5.98 42.76 7.73 10.19 38.62 9.02 188.45 111.50 0.09 191.63 115.50 2.10 coo 2.77 37.17 4.99 6.33 34.76 8.06 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 0.07 40.30 18.65 -0.21 42.34 18.18 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 7 3 # 7 A 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 A 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 5.98 42.76 7.73 10.19 38.62 9.02 147.41 128.03 39.92 142.61 128.90 38.51 coo 2.77 37.17 4.99 6.33 34.76 8.06 149.18 124.89 48.07 150.57 125.16 54.16 coo 0.07 40.30 18.65 -0.21 42.34 18.18 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 8 3 # 8 A 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 A 184 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 5.98 42.76 7.73 10.19 38.62 9.02 165.62 124.17 41.44 160.89 126.43 37.84 coo 2.77 37.17 4.99 6.33 34.76 8.06 163.30 119.33 38.22 166.56 114.68 36.90 coo 0.07 40.30 18.65 -0.21 42.34 18.18 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 9 3 # 9 A 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 A 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 A 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 5.98 42.76 7.73 10.19 38.62 9.02 174.37 114.14 48.91 174.42 112.17 55.03 coo 2.77 37.17 4.99 6.33 34.76 8.06 177.05 121.15 50.66 176.96 126.15 48.94 coo 0.07 40.30 18.65 -0.21 42.34 18.18 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 B 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 B 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 38.76 2.27 4.00 34.00 5.99 4.37 193.06 146.52 10.07 195.03 144.09 6.09 coo 40.63 7.13 9.06 35.85 7.36 8.95 197.56 153.42 13.51 201.64 156.08 17.41 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 345 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 38.76 2.27 4.00 34.00 5.99 4.37 189.82 158.18 22.25 194.56 162.25 23.07 coo 40.63 7.13 9.06 35.85 7.36 8.95 182.91 155.29 23.54 184.46 151.31 19.55 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 38.76 2.27 4.00 34.00 5.99 4.37 180.69 158.10 18.36 176.95 162.62 18.15 coo 40.63 7.13 9.06 35.85 7.36 8.95 182.91 155.29 23.54 184.46 151.31 19.55 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 184 LYS A 94 LYS^? 16.74 N9 ADE A 500 B 345 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo 38.76 2.27 4.00 34.00 5.99 4.37 182.91 155.29 23.54 184.46 151.31 19.55 coo 40.63 7.13 9.06 35.85 7.36 8.95 189.82 158.18 22.25 194.56 162.25 23.07 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 5 3 # 5 B 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 B 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 B 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 38.76 2.27 4.00 34.00 5.99 4.37 182.91 155.29 23.54 184.46 151.31 19.55 coo 40.63 7.13 9.06 35.85 7.36 8.95 180.69 158.10 18.36 176.95 162.62 18.15 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 6 3 # 6 B 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 B 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 38.76 2.27 4.00 34.00 5.99 4.37 182.07 169.10 30.10 186.87 173.28 30.86 coo 40.63 7.13 9.06 35.85 7.36 8.95 183.60 164.07 35.65 183.22 158.61 36.42 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 7 3 # 7 B 182 LYS A 193 LYS~? 24.54 N9 ADE A 500 B 184 LYS A 186 LYS~? 28.00 N9 ADE A 500 B 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 38.76 2.27 4.00 34.00 5.99 4.37 183.60 164.07 35.65 183.22 158.61 36.42 coo 40.63 7.13 9.06 35.85 7.36 8.95 182.07 169.10 30.10 186.87 173.28 30.86 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 8 3 # 8 B 182 LYS B 49 LYS^? 24.07 O1 GOL C1901 B 184 LYS B 41 LYS^? 27.96 O1 GOL C1901 B 345 ASP B 36 ASP~? 28.48 O1 GOL C1901 coo 38.76 2.27 4.00 34.00 5.99 4.37 174.03 130.60 22.66 171.30 132.48 26.53 coo 40.63 7.13 9.06 35.85 7.36 8.95 174.17 121.55 22.91 175.90 116.24 24.75 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 178.67 130.13 34.24 179.32 129.31 36.04 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 9 3 # 9 B 182 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 184 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 345 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 38.76 2.27 4.00 34.00 5.99 4.37 179.28 118.69 11.71 177.59 112.91 13.79 coo 40.63 7.13 9.06 35.85 7.36 8.95 181.66 123.79 6.82 179.82 128.66 10.46 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 10 3 # 10 B 182 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 184 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 38.76 2.27 4.00 34.00 5.99 4.37 175.75 125.08 4.60 173.18 124.12 -0.61 coo 40.63 7.13 9.06 35.85 7.36 8.95 181.66 123.79 6.82 179.82 128.66 10.46 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 11 3 # 11 B 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 184 LYS B 94 LYS^? 27.17 C2 CIT A1102 B 345 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 38.76 2.27 4.00 34.00 5.99 4.37 181.66 123.79 6.82 179.82 128.66 10.46 coo 40.63 7.13 9.06 35.85 7.36 8.95 179.28 118.69 11.71 177.59 112.91 13.79 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 169.82 131.15 6.22 168.64 132.89 5.97 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 12 3 # 12 B 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 B 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 B 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 38.76 2.27 4.00 34.00 5.99 4.37 181.66 123.79 6.82 179.82 128.66 10.46 coo 40.63 7.13 9.06 35.85 7.36 8.95 175.75 125.08 4.60 173.18 124.12 -0.61 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 13 3 # 13 B 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 B 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 38.76 2.27 4.00 34.00 5.99 4.37 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 40.63 7.13 9.06 35.85 7.36 8.95 188.45 111.50 0.09 191.63 115.50 2.10 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 14 3 # 14 B 182 LYS B 193 LYS~? 27.56 O4 CIT A1102 B 184 LYS B 186 LYS~? 32.32 C2 CIT A1102 B 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 38.76 2.27 4.00 34.00 5.99 4.37 188.45 111.50 0.09 191.63 115.50 2.10 coo 40.63 7.13 9.06 35.85 7.36 8.95 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 15 3 # 15 B 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 B 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 B 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 38.76 2.27 4.00 34.00 5.99 4.37 147.41 128.03 39.92 142.61 128.90 38.51 coo 40.63 7.13 9.06 35.85 7.36 8.95 149.18 124.89 48.07 150.57 125.16 54.16 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 16 3 # 16 B 182 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 184 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 345 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 38.76 2.27 4.00 34.00 5.99 4.37 161.58 122.48 47.40 160.49 120.58 53.33 coo 40.63 7.13 9.06 35.85 7.36 8.95 165.62 124.17 41.44 160.89 126.43 37.84 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 169.34 110.13 50.56 169.06 109.63 52.58 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 17 3 # 17 B 182 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 184 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 38.76 2.27 4.00 34.00 5.99 4.37 163.30 119.33 38.22 166.56 114.68 36.90 coo 40.63 7.13 9.06 35.85 7.36 8.95 165.62 124.17 41.44 160.89 126.43 37.84 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 18 3 # 18 B 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 184 LYS C 94 LYS^? 16.92 O3 GOL C1901 B 345 ASP C 175 ASP.? 10.66 O1 GOL C1901 coo 38.76 2.27 4.00 34.00 5.99 4.37 165.62 124.17 41.44 160.89 126.43 37.84 coo 40.63 7.13 9.06 35.85 7.36 8.95 161.58 122.48 47.40 160.49 120.58 53.33 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 157.90 117.18 31.56 156.68 116.62 29.91 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 19 3 # 19 B 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 B 184 LYS C 97 LYS^? 17.09 C1 GOL C1901 B 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 38.76 2.27 4.00 34.00 5.99 4.37 165.62 124.17 41.44 160.89 126.43 37.84 coo 40.63 7.13 9.06 35.85 7.36 8.95 163.30 119.33 38.22 166.56 114.68 36.90 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 20 3 # 20 B 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 B 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 38.76 2.27 4.00 34.00 5.99 4.37 174.37 114.14 48.91 174.42 112.17 55.03 coo 40.63 7.13 9.06 35.85 7.36 8.95 177.05 121.15 50.66 176.96 126.15 48.94 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 21 3 # 21 B 182 LYS C 193 LYS~? 28.43 O1 GOL C1901 B 184 LYS C 186 LYS~? 29.69 O3 GOL C1901 B 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 38.76 2.27 4.00 34.00 5.99 4.37 177.05 121.15 50.66 176.96 126.15 48.94 coo 40.63 7.13 9.06 35.85 7.36 8.95 174.37 114.14 48.91 174.42 112.17 55.03 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 21 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 C 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 C 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo -5.66 12.40 71.13 -2.66 9.98 66.50 193.06 146.52 10.07 195.03 144.09 6.09 coo 0.95 12.72 73.51 1.58 12.72 68.31 197.56 153.42 13.51 201.64 156.08 17.41 coo -4.59 24.28 66.67 -6.26 24.34 67.99 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 C 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 C 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo -5.66 12.40 71.13 -2.66 9.98 66.50 182.91 155.29 23.54 184.46 151.31 19.55 coo 0.95 12.72 73.51 1.58 12.72 68.31 180.69 158.10 18.36 176.95 162.62 18.15 coo -4.59 24.28 66.67 -6.26 24.34 67.99 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 3 3 # 3 C 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 C 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 C 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo -5.66 12.40 71.13 -2.66 9.98 66.50 182.07 169.10 30.10 186.87 173.28 30.86 coo 0.95 12.72 73.51 1.58 12.72 68.31 183.60 164.07 35.65 183.22 158.61 36.42 coo -4.59 24.28 66.67 -6.26 24.34 67.99 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 4 3 # 4 C 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 C 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 C 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo -5.66 12.40 71.13 -2.66 9.98 66.50 181.66 123.79 6.82 179.82 128.66 10.46 coo 0.95 12.72 73.51 1.58 12.72 68.31 175.75 125.08 4.60 173.18 124.12 -0.61 coo -4.59 24.28 66.67 -6.26 24.34 67.99 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 5 3 # 5 C 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 C 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 C 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo -5.66 12.40 71.13 -2.66 9.98 66.50 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 0.95 12.72 73.51 1.58 12.72 68.31 188.45 111.50 0.09 191.63 115.50 2.10 coo -4.59 24.28 66.67 -6.26 24.34 67.99 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 6 3 # 6 C 182 LYS B 193 LYS~? 27.56 O4 CIT A1102 C 184 LYS B 186 LYS~? 32.32 C2 CIT A1102 C 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo -5.66 12.40 71.13 -2.66 9.98 66.50 188.45 111.50 0.09 191.63 115.50 2.10 coo 0.95 12.72 73.51 1.58 12.72 68.31 180.39 111.43 -2.06 180.17 105.09 -1.71 coo -4.59 24.28 66.67 -6.26 24.34 67.99 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 7 3 # 7 C 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 C 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 C 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo -5.66 12.40 71.13 -2.66 9.98 66.50 147.41 128.03 39.92 142.61 128.90 38.51 coo 0.95 12.72 73.51 1.58 12.72 68.31 149.18 124.89 48.07 150.57 125.16 54.16 coo -4.59 24.28 66.67 -6.26 24.34 67.99 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 8 3 # 8 C 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 C 184 LYS C 97 LYS^? 17.09 C1 GOL C1901 C 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo -5.66 12.40 71.13 -2.66 9.98 66.50 165.62 124.17 41.44 160.89 126.43 37.84 coo 0.95 12.72 73.51 1.58 12.72 68.31 163.30 119.33 38.22 166.56 114.68 36.90 coo -4.59 24.28 66.67 -6.26 24.34 67.99 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 9 3 # 9 C 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 C 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 C 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo -5.66 12.40 71.13 -2.66 9.98 66.50 174.37 114.14 48.91 174.42 112.17 55.03 coo 0.95 12.72 73.51 1.58 12.72 68.31 177.05 121.15 50.66 176.96 126.15 48.94 coo -4.59 24.28 66.67 -6.26 24.34 67.99 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 9 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 D 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 D 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 193.06 146.52 10.07 195.03 144.09 6.09 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 197.56 153.42 13.51 201.64 156.08 17.41 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 D 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 D 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 182.07 169.10 30.10 186.87 173.28 30.86 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 183.60 164.07 35.65 183.22 158.61 36.42 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 3 3 # 3 D 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 D 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 D 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 181.66 123.79 6.82 179.82 128.66 10.46 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 175.75 125.08 4.60 173.18 124.12 -0.61 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 4 3 # 4 D 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 D 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 D 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 188.45 111.50 0.09 191.63 115.50 2.10 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 5 3 # 5 D 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 D 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 D 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 147.41 128.03 39.92 142.61 128.90 38.51 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 149.18 124.89 48.07 150.57 125.16 54.16 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 6 3 # 6 D 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 D 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 D 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 174.37 114.14 48.91 174.42 112.17 55.03 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 177.05 121.15 50.66 176.96 126.15 48.94 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 E 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 E 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo -21.16 62.58 121.86 -16.35 60.33 119.23 193.06 146.52 10.07 195.03 144.09 6.09 coo -23.22 55.98 120.74 -18.11 55.31 120.43 197.56 153.42 13.51 201.64 156.08 17.41 coo -17.15 59.71 133.33 -17.96 61.54 134.01 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 E 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 E 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo -21.16 62.58 121.86 -16.35 60.33 119.23 182.07 169.10 30.10 186.87 173.28 30.86 coo -23.22 55.98 120.74 -18.11 55.31 120.43 183.60 164.07 35.65 183.22 158.61 36.42 coo -17.15 59.71 133.33 -17.96 61.54 134.01 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 3 3 # 3 E 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 E 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 E 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo -21.16 62.58 121.86 -16.35 60.33 119.23 181.66 123.79 6.82 179.82 128.66 10.46 coo -23.22 55.98 120.74 -18.11 55.31 120.43 175.75 125.08 4.60 173.18 124.12 -0.61 coo -17.15 59.71 133.33 -17.96 61.54 134.01 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 4 3 # 4 E 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 E 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 E 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo -21.16 62.58 121.86 -16.35 60.33 119.23 180.39 111.43 -2.06 180.17 105.09 -1.71 coo -23.22 55.98 120.74 -18.11 55.31 120.43 188.45 111.50 0.09 191.63 115.50 2.10 coo -17.15 59.71 133.33 -17.96 61.54 134.01 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 5 3 # 5 E 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 E 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 E 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo -21.16 62.58 121.86 -16.35 60.33 119.23 147.41 128.03 39.92 142.61 128.90 38.51 coo -23.22 55.98 120.74 -18.11 55.31 120.43 149.18 124.89 48.07 150.57 125.16 54.16 coo -17.15 59.71 133.33 -17.96 61.54 134.01 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 6 3 # 6 E 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 E 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 E 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo -21.16 62.58 121.86 -16.35 60.33 119.23 174.37 114.14 48.91 174.42 112.17 55.03 coo -23.22 55.98 120.74 -18.11 55.31 120.43 177.05 121.15 50.66 176.96 126.15 48.94 coo -17.15 59.71 133.33 -17.96 61.54 134.01 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 F 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 F 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 10.64 34.02 91.30 6.30 35.60 95.11 193.06 146.52 10.07 195.03 144.09 6.09 coo 13.75 39.76 94.12 11.42 37.23 97.89 197.56 153.42 13.51 201.64 156.08 17.41 coo 16.35 26.90 99.56 16.81 25.90 97.75 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 F 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 F 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 10.64 34.02 91.30 6.30 35.60 95.11 182.07 169.10 30.10 186.87 173.28 30.86 coo 13.75 39.76 94.12 11.42 37.23 97.89 183.60 164.07 35.65 183.22 158.61 36.42 coo 16.35 26.90 99.56 16.81 25.90 97.75 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS B 49 LYS^? 24.07 O1 GOL C1901 F 184 LYS B 41 LYS^? 27.96 O1 GOL C1901 F 345 ASP B 36 ASP~? 28.48 O1 GOL C1901 coo 10.64 34.02 91.30 6.30 35.60 95.11 174.03 130.60 22.66 171.30 132.48 26.53 coo 13.75 39.76 94.12 11.42 37.23 97.89 174.17 121.55 22.91 175.90 116.24 24.75 coo 16.35 26.90 99.56 16.81 25.90 97.75 178.67 130.13 34.24 179.32 129.31 36.04 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 F 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 F 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 10.64 34.02 91.30 6.30 35.60 95.11 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 13.75 39.76 94.12 11.42 37.23 97.89 188.45 111.50 0.09 191.63 115.50 2.10 coo 16.35 26.90 99.56 16.81 25.90 97.75 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 5 3 # 5 F 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 F 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 F 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 10.64 34.02 91.30 6.30 35.60 95.11 147.41 128.03 39.92 142.61 128.90 38.51 coo 13.75 39.76 94.12 11.42 37.23 97.89 149.18 124.89 48.07 150.57 125.16 54.16 coo 16.35 26.90 99.56 16.81 25.90 97.75 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 6 3 # 6 F 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 F 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 F 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 10.64 34.02 91.30 6.30 35.60 95.11 174.37 114.14 48.91 174.42 112.17 55.03 coo 13.75 39.76 94.12 11.42 37.23 97.89 177.05 121.15 50.66 176.96 126.15 48.94 coo 16.35 26.90 99.56 16.81 25.90 97.75 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 G 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 G 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 39.68 42.04 76.11 43.42 46.43 74.96 193.06 146.52 10.07 195.03 144.09 6.09 coo 36.69 47.69 78.93 39.38 50.40 75.35 197.56 153.42 13.51 201.64 156.08 17.41 coo 33.43 44.37 65.47 33.10 42.30 65.37 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 G 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 G 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 39.68 42.04 76.11 43.42 46.43 74.96 182.91 155.29 23.54 184.46 151.31 19.55 coo 36.69 47.69 78.93 39.38 50.40 75.35 180.69 158.10 18.36 176.95 162.62 18.15 coo 33.43 44.37 65.47 33.10 42.30 65.37 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 3 3 # 3 G 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 G 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 G 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 39.68 42.04 76.11 43.42 46.43 74.96 182.07 169.10 30.10 186.87 173.28 30.86 coo 36.69 47.69 78.93 39.38 50.40 75.35 183.60 164.07 35.65 183.22 158.61 36.42 coo 33.43 44.37 65.47 33.10 42.30 65.37 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 4 3 # 4 G 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 G 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 G 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 39.68 42.04 76.11 43.42 46.43 74.96 181.66 123.79 6.82 179.82 128.66 10.46 coo 36.69 47.69 78.93 39.38 50.40 75.35 175.75 125.08 4.60 173.18 124.12 -0.61 coo 33.43 44.37 65.47 33.10 42.30 65.37 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 5 3 # 5 G 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 G 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 G 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 39.68 42.04 76.11 43.42 46.43 74.96 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 36.69 47.69 78.93 39.38 50.40 75.35 188.45 111.50 0.09 191.63 115.50 2.10 coo 33.43 44.37 65.47 33.10 42.30 65.37 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 6 3 # 6 G 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 G 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 G 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 39.68 42.04 76.11 43.42 46.43 74.96 147.41 128.03 39.92 142.61 128.90 38.51 coo 36.69 47.69 78.93 39.38 50.40 75.35 149.18 124.89 48.07 150.57 125.16 54.16 coo 33.43 44.37 65.47 33.10 42.30 65.37 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 7 3 # 7 G 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 G 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 G 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 39.68 42.04 76.11 43.42 46.43 74.96 174.37 114.14 48.91 174.42 112.17 55.03 coo 36.69 47.69 78.93 39.38 50.40 75.35 177.05 121.15 50.66 176.96 126.15 48.94 coo 33.43 44.37 65.47 33.10 42.30 65.37 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 7 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 H 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 H 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 71.58 83.18 80.51 66.88 79.77 79.84 193.06 146.52 10.07 195.03 144.09 6.09 coo 73.65 78.64 75.66 68.14 79.07 75.04 197.56 153.42 13.51 201.64 156.08 17.41 coo 67.43 90.73 71.39 68.27 92.30 72.52 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 H 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 H 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 71.58 83.18 80.51 66.88 79.77 79.84 182.07 169.10 30.10 186.87 173.28 30.86 coo 73.65 78.64 75.66 68.14 79.07 75.04 183.60 164.07 35.65 183.22 158.61 36.42 coo 67.43 90.73 71.39 68.27 92.30 72.52 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 3 3 # 3 H 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 H 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 H 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 71.58 83.18 80.51 66.88 79.77 79.84 181.66 123.79 6.82 179.82 128.66 10.46 coo 73.65 78.64 75.66 68.14 79.07 75.04 175.75 125.08 4.60 173.18 124.12 -0.61 coo 67.43 90.73 71.39 68.27 92.30 72.52 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 4 3 # 4 H 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 H 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 H 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 71.58 83.18 80.51 66.88 79.77 79.84 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 73.65 78.64 75.66 68.14 79.07 75.04 188.45 111.50 0.09 191.63 115.50 2.10 coo 67.43 90.73 71.39 68.27 92.30 72.52 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 5 3 # 5 H 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 H 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 H 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 71.58 83.18 80.51 66.88 79.77 79.84 147.41 128.03 39.92 142.61 128.90 38.51 coo 73.65 78.64 75.66 68.14 79.07 75.04 149.18 124.89 48.07 150.57 125.16 54.16 coo 67.43 90.73 71.39 68.27 92.30 72.52 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 6 3 # 6 H 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 H 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 H 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 71.58 83.18 80.51 66.88 79.77 79.84 174.37 114.14 48.91 174.42 112.17 55.03 coo 73.65 78.64 75.66 68.14 79.07 75.04 177.05 121.15 50.66 176.96 126.15 48.94 coo 67.43 90.73 71.39 68.27 92.30 72.52 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 I 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 I 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 60.20 96.92 42.53 57.60 93.13 38.67 193.06 146.52 10.07 195.03 144.09 6.09 coo 54.31 95.46 46.01 55.34 91.59 42.65 197.56 153.42 13.51 201.64 156.08 17.41 coo 66.35 87.81 48.53 68.10 89.01 48.77 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 I 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 I 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 60.20 96.92 42.53 57.60 93.13 38.67 182.07 169.10 30.10 186.87 173.28 30.86 coo 54.31 95.46 46.01 55.34 91.59 42.65 183.60 164.07 35.65 183.22 158.61 36.42 coo 66.35 87.81 48.53 68.10 89.01 48.77 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 3 3 # 3 I 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 I 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 I 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 60.20 96.92 42.53 57.60 93.13 38.67 181.66 123.79 6.82 179.82 128.66 10.46 coo 54.31 95.46 46.01 55.34 91.59 42.65 175.75 125.08 4.60 173.18 124.12 -0.61 coo 66.35 87.81 48.53 68.10 89.01 48.77 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 4 3 # 4 I 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 I 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 I 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 60.20 96.92 42.53 57.60 93.13 38.67 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 54.31 95.46 46.01 55.34 91.59 42.65 188.45 111.50 0.09 191.63 115.50 2.10 coo 66.35 87.81 48.53 68.10 89.01 48.77 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 5 3 # 5 I 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 I 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 I 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 60.20 96.92 42.53 57.60 93.13 38.67 147.41 128.03 39.92 142.61 128.90 38.51 coo 54.31 95.46 46.01 55.34 91.59 42.65 149.18 124.89 48.07 150.57 125.16 54.16 coo 66.35 87.81 48.53 68.10 89.01 48.77 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 6 3 # 6 I 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 I 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 I 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 60.20 96.92 42.53 57.60 93.13 38.67 174.37 114.14 48.91 174.42 112.17 55.03 coo 54.31 95.46 46.01 55.34 91.59 42.65 177.05 121.15 50.66 176.96 126.15 48.94 coo 66.35 87.81 48.53 68.10 89.01 48.77 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 6 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 J 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 J 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 25.22 70.55 14.03 27.64 73.07 18.65 193.06 146.52 10.07 195.03 144.09 6.09 coo 31.73 69.87 11.50 32.73 70.19 16.40 197.56 153.42 13.51 201.64 156.08 17.41 coo 25.87 58.42 18.79 23.95 58.54 17.90 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 94 LYS^? 16.74 N9 ADE A 500 J 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 J 345 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 25.22 70.55 14.03 27.64 73.07 18.65 189.82 158.18 22.25 194.56 162.25 23.07 coo 31.73 69.87 11.50 32.73 70.19 16.40 182.91 155.29 23.54 184.46 151.31 19.55 coo 25.87 58.42 18.79 23.95 58.54 17.90 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS A 97 LYS^? 15.28 N9 ADE A 500 J 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 J 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 25.22 70.55 14.03 27.64 73.07 18.65 180.69 158.10 18.36 176.95 162.62 18.15 coo 31.73 69.87 11.50 32.73 70.19 16.40 182.91 155.29 23.54 184.46 151.31 19.55 coo 25.87 58.42 18.79 23.95 58.54 17.90 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 4 3 # 4 J 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 J 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 J 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 25.22 70.55 14.03 27.64 73.07 18.65 182.91 155.29 23.54 184.46 151.31 19.55 coo 31.73 69.87 11.50 32.73 70.19 16.40 180.69 158.10 18.36 176.95 162.62 18.15 coo 25.87 58.42 18.79 23.95 58.54 17.90 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 5 3 # 5 J 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 J 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 J 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 25.22 70.55 14.03 27.64 73.07 18.65 182.07 169.10 30.10 186.87 173.28 30.86 coo 31.73 69.87 11.50 32.73 70.19 16.40 183.60 164.07 35.65 183.22 158.61 36.42 coo 25.87 58.42 18.79 23.95 58.54 17.90 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 6 3 # 6 J 182 LYS B 97 LYS^? 12.22 C2 CIT A1102 J 184 LYS B 147 LYS^? 12.56 O4 CIT A1102 J 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 25.22 70.55 14.03 27.64 73.07 18.65 175.75 125.08 4.60 173.18 124.12 -0.61 coo 31.73 69.87 11.50 32.73 70.19 16.40 181.66 123.79 6.82 179.82 128.66 10.46 coo 25.87 58.42 18.79 23.95 58.54 17.90 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 7 3 # 7 J 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 J 184 LYS B 94 LYS^? 27.17 C2 CIT A1102 J 345 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 25.22 70.55 14.03 27.64 73.07 18.65 181.66 123.79 6.82 179.82 128.66 10.46 coo 31.73 69.87 11.50 32.73 70.19 16.40 179.28 118.69 11.71 177.59 112.91 13.79 coo 25.87 58.42 18.79 23.95 58.54 17.90 169.82 131.15 6.22 168.64 132.89 5.97 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 8 3 # 8 J 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 J 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 J 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 25.22 70.55 14.03 27.64 73.07 18.65 181.66 123.79 6.82 179.82 128.66 10.46 coo 31.73 69.87 11.50 32.73 70.19 16.40 175.75 125.08 4.60 173.18 124.12 -0.61 coo 25.87 58.42 18.79 23.95 58.54 17.90 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 9 3 # 9 J 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 J 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 J 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 25.22 70.55 14.03 27.64 73.07 18.65 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 31.73 69.87 11.50 32.73 70.19 16.40 188.45 111.50 0.09 191.63 115.50 2.10 coo 25.87 58.42 18.79 23.95 58.54 17.90 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 10 3 # 10 J 182 LYS B 193 LYS~? 27.56 O4 CIT A1102 J 184 LYS B 186 LYS~? 32.32 C2 CIT A1102 J 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 25.22 70.55 14.03 27.64 73.07 18.65 188.45 111.50 0.09 191.63 115.50 2.10 coo 31.73 69.87 11.50 32.73 70.19 16.40 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 25.87 58.42 18.79 23.95 58.54 17.90 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 11 3 # 11 J 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 J 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 J 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 25.22 70.55 14.03 27.64 73.07 18.65 147.41 128.03 39.92 142.61 128.90 38.51 coo 31.73 69.87 11.50 32.73 70.19 16.40 149.18 124.89 48.07 150.57 125.16 54.16 coo 25.87 58.42 18.79 23.95 58.54 17.90 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 12 3 # 12 J 182 LYS C 97 LYS^? 17.09 C1 GOL C1901 J 184 LYS C 147 LYS^? 10.01 O1 GOL C1901 J 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 25.22 70.55 14.03 27.64 73.07 18.65 163.30 119.33 38.22 166.56 114.68 36.90 coo 31.73 69.87 11.50 32.73 70.19 16.40 165.62 124.17 41.44 160.89 126.43 37.84 coo 25.87 58.42 18.79 23.95 58.54 17.90 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 13 3 # 13 J 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 J 184 LYS C 97 LYS^? 17.09 C1 GOL C1901 J 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 25.22 70.55 14.03 27.64 73.07 18.65 165.62 124.17 41.44 160.89 126.43 37.84 coo 31.73 69.87 11.50 32.73 70.19 16.40 163.30 119.33 38.22 166.56 114.68 36.90 coo 25.87 58.42 18.79 23.95 58.54 17.90 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 14 3 # 14 J 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 J 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 J 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 25.22 70.55 14.03 27.64 73.07 18.65 174.37 114.14 48.91 174.42 112.17 55.03 coo 31.73 69.87 11.50 32.73 70.19 16.40 177.05 121.15 50.66 176.96 126.15 48.94 coo 25.87 58.42 18.79 23.95 58.54 17.90 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 15 3 # 15 J 182 LYS C 193 LYS~? 28.43 O1 GOL C1901 J 184 LYS C 186 LYS~? 29.69 O3 GOL C1901 J 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 25.22 70.55 14.03 27.64 73.07 18.65 177.05 121.15 50.66 176.96 126.15 48.94 coo 31.73 69.87 11.50 32.73 70.19 16.40 174.37 114.14 48.91 174.42 112.17 55.03 coo 25.87 58.42 18.79 23.95 58.54 17.90 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 15 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 K 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 K 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 193.06 146.52 10.07 195.03 144.09 6.09 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 197.56 153.42 13.51 201.64 156.08 17.41 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 K 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 K 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 182.91 155.29 23.54 184.46 151.31 19.55 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 180.69 158.10 18.36 176.95 162.62 18.15 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 3 3 # 3 K 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 K 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 K 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 182.07 169.10 30.10 186.87 173.28 30.86 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 183.60 164.07 35.65 183.22 158.61 36.42 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 4 3 # 4 K 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 K 184 LYS B 94 LYS^? 27.17 C2 CIT A1102 K 345 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 181.66 123.79 6.82 179.82 128.66 10.46 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 179.28 118.69 11.71 177.59 112.91 13.79 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 169.82 131.15 6.22 168.64 132.89 5.97 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 5 3 # 5 K 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 K 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 K 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 181.66 123.79 6.82 179.82 128.66 10.46 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 175.75 125.08 4.60 173.18 124.12 -0.61 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 6 3 # 6 K 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 K 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 K 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 188.45 111.50 0.09 191.63 115.50 2.10 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 7 3 # 7 K 182 LYS B 193 LYS~? 27.56 O4 CIT A1102 K 184 LYS B 186 LYS~? 32.32 C2 CIT A1102 K 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 188.45 111.50 0.09 191.63 115.50 2.10 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 8 3 # 8 K 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 K 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 K 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 147.41 128.03 39.92 142.61 128.90 38.51 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 149.18 124.89 48.07 150.57 125.16 54.16 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 9 3 # 9 K 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 K 184 LYS C 97 LYS^? 17.09 C1 GOL C1901 K 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 165.62 124.17 41.44 160.89 126.43 37.84 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 163.30 119.33 38.22 166.56 114.68 36.90 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 10 3 # 10 K 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 K 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 K 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 174.37 114.14 48.91 174.42 112.17 55.03 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 177.05 121.15 50.66 176.96 126.15 48.94 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 10 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 L 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 L 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 193.06 146.52 10.07 195.03 144.09 6.09 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 197.56 153.42 13.51 201.64 156.08 17.41 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 94 LYS^? 16.74 N9 ADE A 500 L 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 L 345 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 189.82 158.18 22.25 194.56 162.25 23.07 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 182.91 155.29 23.54 184.46 151.31 19.55 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS A 97 LYS^? 15.28 N9 ADE A 500 L 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 L 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 180.69 158.10 18.36 176.95 162.62 18.15 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 182.91 155.29 23.54 184.46 151.31 19.55 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS A 97 LYS^? 15.28 N9 ADE A 500 L 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 L 345 ASP A 172 ASP~? 9.43 N1 ADE A 500 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 180.69 158.10 18.36 176.95 162.62 18.15 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 182.91 155.29 23.54 184.46 151.31 19.55 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 180.59 154.59 5.93 180.83 155.75 4.19 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 5 3 # 5 L 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 L 184 LYS A 94 LYS^? 16.74 N9 ADE A 500 L 345 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 182.91 155.29 23.54 184.46 151.31 19.55 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 189.82 158.18 22.25 194.56 162.25 23.07 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 6 3 # 6 L 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 L 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 L 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 182.91 155.29 23.54 184.46 151.31 19.55 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 180.69 158.10 18.36 176.95 162.62 18.15 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 7 3 # 7 L 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 L 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 L 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 182.07 169.10 30.10 186.87 173.28 30.86 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 183.60 164.07 35.65 183.22 158.61 36.42 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 8 3 # 8 L 182 LYS A 193 LYS~? 24.54 N9 ADE A 500 L 184 LYS A 186 LYS~? 28.00 N9 ADE A 500 L 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 183.60 164.07 35.65 183.22 158.61 36.42 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 182.07 169.10 30.10 186.87 173.28 30.86 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 9 3 # 9 L 182 LYS B 49 LYS^? 24.07 O1 GOL C1901 L 184 LYS B 41 LYS^? 27.96 O1 GOL C1901 L 345 ASP B 36 ASP~? 28.48 O1 GOL C1901 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 174.03 130.60 22.66 171.30 132.48 26.53 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 174.17 121.55 22.91 175.90 116.24 24.75 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 178.67 130.13 34.24 179.32 129.31 36.04 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 10 3 # 10 L 182 LYS B 94 LYS^? 27.17 C2 CIT A1102 L 184 LYS B 147 LYS^? 12.56 O4 CIT A1102 L 345 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 179.28 118.69 11.71 177.59 112.91 13.79 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 181.66 123.79 6.82 179.82 128.66 10.46 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 11 3 # 11 L 182 LYS B 97 LYS^? 12.22 C2 CIT A1102 L 184 LYS B 147 LYS^? 12.56 O4 CIT A1102 L 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 175.75 125.08 4.60 173.18 124.12 -0.61 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 181.66 123.79 6.82 179.82 128.66 10.46 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 12 3 # 12 L 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 L 184 LYS B 94 LYS^? 27.17 C2 CIT A1102 L 345 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 181.66 123.79 6.82 179.82 128.66 10.46 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 179.28 118.69 11.71 177.59 112.91 13.79 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 169.82 131.15 6.22 168.64 132.89 5.97 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 13 3 # 13 L 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 L 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 L 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 181.66 123.79 6.82 179.82 128.66 10.46 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 175.75 125.08 4.60 173.18 124.12 -0.61 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 14 3 # 14 L 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 L 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 L 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 188.45 111.50 0.09 191.63 115.50 2.10 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 15 3 # 15 L 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 L 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 L 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 147.41 128.03 39.92 142.61 128.90 38.51 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 149.18 124.89 48.07 150.57 125.16 54.16 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 16 3 # 16 L 182 LYS C 94 LYS^? 16.92 O3 GOL C1901 L 184 LYS C 147 LYS^? 10.01 O1 GOL C1901 L 345 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 161.58 122.48 47.40 160.49 120.58 53.33 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 165.62 124.17 41.44 160.89 126.43 37.84 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 169.34 110.13 50.56 169.06 109.63 52.58 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 17 3 # 17 L 182 LYS C 97 LYS^? 17.09 C1 GOL C1901 L 184 LYS C 147 LYS^? 10.01 O1 GOL C1901 L 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 163.30 119.33 38.22 166.56 114.68 36.90 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 165.62 124.17 41.44 160.89 126.43 37.84 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 18 3 # 18 L 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 L 184 LYS C 94 LYS^? 16.92 O3 GOL C1901 L 345 ASP C 175 ASP.? 10.66 O1 GOL C1901 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 165.62 124.17 41.44 160.89 126.43 37.84 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 161.58 122.48 47.40 160.49 120.58 53.33 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 157.90 117.18 31.56 156.68 116.62 29.91 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 19 3 # 19 L 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 L 184 LYS C 97 LYS^? 17.09 C1 GOL C1901 L 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 165.62 124.17 41.44 160.89 126.43 37.84 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 163.30 119.33 38.22 166.56 114.68 36.90 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 20 3 # 20 L 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 L 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 L 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 174.37 114.14 48.91 174.42 112.17 55.03 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 177.05 121.15 50.66 176.96 126.15 48.94 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 21 3 # 21 L 182 LYS C 193 LYS~? 28.43 O1 GOL C1901 L 184 LYS C 186 LYS~? 29.69 O3 GOL C1901 L 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 177.05 121.15 50.66 176.96 126.15 48.94 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 174.37 114.14 48.91 174.42 112.17 55.03 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 21 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 M 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 M 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 193.06 146.52 10.07 195.03 144.09 6.09 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 197.56 153.42 13.51 201.64 156.08 17.41 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 94 LYS^? 16.74 N9 ADE A 500 M 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 M 345 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 189.82 158.18 22.25 194.56 162.25 23.07 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 182.91 155.29 23.54 184.46 151.31 19.55 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS A 97 LYS^? 15.28 N9 ADE A 500 M 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 M 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 180.69 158.10 18.36 176.95 162.62 18.15 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 182.91 155.29 23.54 184.46 151.31 19.55 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS A 97 LYS^? 15.28 N9 ADE A 500 M 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 M 345 ASP A 172 ASP~? 9.43 N1 ADE A 500 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 180.69 158.10 18.36 176.95 162.62 18.15 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 182.91 155.29 23.54 184.46 151.31 19.55 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 180.59 154.59 5.93 180.83 155.75 4.19 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 5 3 # 5 M 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 M 184 LYS A 94 LYS^? 16.74 N9 ADE A 500 M 345 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 182.91 155.29 23.54 184.46 151.31 19.55 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 189.82 158.18 22.25 194.56 162.25 23.07 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 6 3 # 6 M 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 M 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 M 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 182.91 155.29 23.54 184.46 151.31 19.55 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 180.69 158.10 18.36 176.95 162.62 18.15 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 7 3 # 7 M 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 M 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 M 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 182.07 169.10 30.10 186.87 173.28 30.86 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 183.60 164.07 35.65 183.22 158.61 36.42 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 8 3 # 8 M 182 LYS A 193 LYS~? 24.54 N9 ADE A 500 M 184 LYS A 186 LYS~? 28.00 N9 ADE A 500 M 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 183.60 164.07 35.65 183.22 158.61 36.42 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 182.07 169.10 30.10 186.87 173.28 30.86 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 9 3 # 9 M 182 LYS B 94 LYS^? 27.17 C2 CIT A1102 M 184 LYS B 147 LYS^? 12.56 O4 CIT A1102 M 345 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 179.28 118.69 11.71 177.59 112.91 13.79 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 181.66 123.79 6.82 179.82 128.66 10.46 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 10 3 # 10 M 182 LYS B 97 LYS^? 12.22 C2 CIT A1102 M 184 LYS B 147 LYS^? 12.56 O4 CIT A1102 M 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 175.75 125.08 4.60 173.18 124.12 -0.61 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 181.66 123.79 6.82 179.82 128.66 10.46 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 11 3 # 11 M 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 M 184 LYS B 94 LYS^? 27.17 C2 CIT A1102 M 345 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 181.66 123.79 6.82 179.82 128.66 10.46 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 179.28 118.69 11.71 177.59 112.91 13.79 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 169.82 131.15 6.22 168.64 132.89 5.97 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 12 3 # 12 M 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 M 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 M 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 181.66 123.79 6.82 179.82 128.66 10.46 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 175.75 125.08 4.60 173.18 124.12 -0.61 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 13 3 # 13 M 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 M 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 M 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 180.39 111.43 -2.06 180.17 105.09 -1.71 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 188.45 111.50 0.09 191.63 115.50 2.10 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 14 3 # 14 M 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 M 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 M 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 147.41 128.03 39.92 142.61 128.90 38.51 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 149.18 124.89 48.07 150.57 125.16 54.16 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 15 3 # 15 M 182 LYS C 94 LYS^? 16.92 O3 GOL C1901 M 184 LYS C 147 LYS^? 10.01 O1 GOL C1901 M 345 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 161.58 122.48 47.40 160.49 120.58 53.33 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 165.62 124.17 41.44 160.89 126.43 37.84 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 169.34 110.13 50.56 169.06 109.63 52.58 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 16 3 # 16 M 182 LYS C 97 LYS^? 17.09 C1 GOL C1901 M 184 LYS C 147 LYS^? 10.01 O1 GOL C1901 M 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 163.30 119.33 38.22 166.56 114.68 36.90 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 165.62 124.17 41.44 160.89 126.43 37.84 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 17 3 # 17 M 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 M 184 LYS C 94 LYS^? 16.92 O3 GOL C1901 M 345 ASP C 175 ASP.? 10.66 O1 GOL C1901 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 165.62 124.17 41.44 160.89 126.43 37.84 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 161.58 122.48 47.40 160.49 120.58 53.33 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 157.90 117.18 31.56 156.68 116.62 29.91 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 18 3 # 18 M 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 M 184 LYS C 97 LYS^? 17.09 C1 GOL C1901 M 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 165.62 124.17 41.44 160.89 126.43 37.84 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 163.30 119.33 38.22 166.56 114.68 36.90 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 19 3 # 19 M 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 M 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 M 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 174.37 114.14 48.91 174.42 112.17 55.03 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 177.05 121.15 50.66 176.96 126.15 48.94 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 19 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 N 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 N 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 193.06 146.52 10.07 195.03 144.09 6.09 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 197.56 153.42 13.51 201.64 156.08 17.41 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 N 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 N 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 182.07 169.10 30.10 186.87 173.28 30.86 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 183.60 164.07 35.65 183.22 158.61 36.42 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 3 3 # 3 N 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 N 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 N 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 188.45 111.50 0.09 191.63 115.50 2.10 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 4 3 # 4 N 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 N 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 N 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 147.41 128.03 39.92 142.61 128.90 38.51 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 149.18 124.89 48.07 150.57 125.16 54.16 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 5 3 # 5 N 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 N 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 N 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 174.37 114.14 48.91 174.42 112.17 55.03 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 177.05 121.15 50.66 176.96 126.15 48.94 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 5 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 O 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 O 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 193.06 146.52 10.07 195.03 144.09 6.09 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 197.56 153.42 13.51 201.64 156.08 17.41 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 O 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 O 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 182.91 155.29 23.54 184.46 151.31 19.55 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 180.69 158.10 18.36 176.95 162.62 18.15 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 3 3 # 3 O 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 O 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 O 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 182.07 169.10 30.10 186.87 173.28 30.86 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 183.60 164.07 35.65 183.22 158.61 36.42 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 4 3 # 4 O 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 O 184 LYS B 94 LYS^? 27.17 C2 CIT A1102 O 345 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 181.66 123.79 6.82 179.82 128.66 10.46 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 179.28 118.69 11.71 177.59 112.91 13.79 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 169.82 131.15 6.22 168.64 132.89 5.97 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 5 3 # 5 O 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 O 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 O 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 181.66 123.79 6.82 179.82 128.66 10.46 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 175.75 125.08 4.60 173.18 124.12 -0.61 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 6 3 # 6 O 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 O 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 O 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 188.45 111.50 0.09 191.63 115.50 2.10 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 7 3 # 7 O 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 O 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 O 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 147.41 128.03 39.92 142.61 128.90 38.51 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 149.18 124.89 48.07 150.57 125.16 54.16 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 8 3 # 8 O 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 O 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 O 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 174.37 114.14 48.91 174.42 112.17 55.03 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 177.05 121.15 50.66 176.96 126.15 48.94 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 8 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 49 LYS^? 10.58 N6 ADE A 500 P 184 LYS A 41 LYS^? 15.86 N3 ADE A 500 P 345 ASP A 36 ASP~? 21.71 N6 ADE A 500 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 193.06 146.52 10.07 195.03 144.09 6.09 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 197.56 153.42 13.51 201.64 156.08 17.41 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 203.35 139.46 11.01 205.31 139.04 11.69 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 94 LYS^? 16.74 N9 ADE A 500 P 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 P 345 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 189.82 158.18 22.25 194.56 162.25 23.07 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 182.91 155.29 23.54 184.46 151.31 19.55 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS A 97 LYS^? 15.28 N9 ADE A 500 P 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 P 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 180.69 158.10 18.36 176.95 162.62 18.15 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 182.91 155.29 23.54 184.46 151.31 19.55 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS A 97 LYS^? 15.28 N9 ADE A 500 P 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 P 345 ASP A 172 ASP~? 9.43 N1 ADE A 500 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 180.69 158.10 18.36 176.95 162.62 18.15 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 182.91 155.29 23.54 184.46 151.31 19.55 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 180.59 154.59 5.93 180.83 155.75 4.19 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 5 3 # 5 P 182 LYS A 97 LYS^? 15.28 N9 ADE A 500 P 184 LYS A 147 LYS^? 6.48 C8 ADE A 500 P 345 ASP A 183 ASP~? 24.76 N9 ADE A 500 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 180.69 158.10 18.36 176.95 162.62 18.15 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 182.91 155.29 23.54 184.46 151.31 19.55 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 184.84 171.88 24.93 186.38 173.28 25.14 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 6 3 # 6 P 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 P 184 LYS A 94 LYS^? 16.74 N9 ADE A 500 P 345 ASP A 175 ASP.? 10.98 C4 ADE A 500 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 182.91 155.29 23.54 184.46 151.31 19.55 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 189.82 158.18 22.25 194.56 162.25 23.07 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 178.57 156.37 9.84 177.44 156.14 8.05 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 7 3 # 7 P 182 LYS A 147 LYS^? 6.48 C8 ADE A 500 P 184 LYS A 97 LYS^? 15.28 N9 ADE A 500 P 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 182.91 155.29 23.54 184.46 151.31 19.55 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 180.69 158.10 18.36 176.95 162.62 18.15 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 8 3 # 8 P 182 LYS A 186 LYS~? 28.00 N9 ADE A 500 P 184 LYS A 193 LYS~? 24.54 N9 ADE A 500 P 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 182.07 169.10 30.10 186.87 173.28 30.86 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 183.60 164.07 35.65 183.22 158.61 36.42 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 9 3 # 9 P 182 LYS A 193 LYS~? 24.54 N9 ADE A 500 P 184 LYS A 186 LYS~? 28.00 N9 ADE A 500 P 345 ASP A 119 ASP.? 23.37 C8 ADE A 500 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 183.60 164.07 35.65 183.22 158.61 36.42 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 182.07 169.10 30.10 186.87 173.28 30.86 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 170.58 160.79 28.87 171.46 159.09 29.69 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 10 3 # 10 P 182 LYS B 94 LYS^? 27.17 C2 CIT A1102 P 184 LYS B 147 LYS^? 12.56 O4 CIT A1102 P 345 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 179.28 118.69 11.71 177.59 112.91 13.79 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 181.66 123.79 6.82 179.82 128.66 10.46 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 174.65 109.33 0.17 174.41 107.27 0.58 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 11 3 # 11 P 182 LYS B 97 LYS^? 12.22 C2 CIT A1102 P 184 LYS B 147 LYS^? 12.56 O4 CIT A1102 P 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 175.75 125.08 4.60 173.18 124.12 -0.61 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 181.66 123.79 6.82 179.82 128.66 10.46 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 12 3 # 12 P 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 P 184 LYS B 94 LYS^? 27.17 C2 CIT A1102 P 345 ASP B 175 ASP.? 4.91 O1 CIT A1102 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 181.66 123.79 6.82 179.82 128.66 10.46 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 179.28 118.69 11.71 177.59 112.91 13.79 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 169.82 131.15 6.22 168.64 132.89 5.97 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 13 3 # 13 P 182 LYS B 147 LYS^? 12.56 O4 CIT A1102 P 184 LYS B 97 LYS^? 12.22 C2 CIT A1102 P 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 181.66 123.79 6.82 179.82 128.66 10.46 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 175.75 125.08 4.60 173.18 124.12 -0.61 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 14 3 # 14 P 182 LYS B 186 LYS~? 32.32 C2 CIT A1102 P 184 LYS B 193 LYS~? 27.56 O4 CIT A1102 P 345 ASP B 119 ASP.? 20.62 O7 CIT A1102 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 188.45 111.50 0.09 191.63 115.50 2.10 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 184.41 123.54 -7.24 185.10 123.40 -9.24 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 15 3 # 15 P 182 LYS C 49 LYS^? 10.29 O2 GOL C1901 P 184 LYS C 41 LYS^? 15.03 O3 GOL C1901 P 345 ASP C 36 ASP~? 21.70 O1 GOL C1901 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 147.41 128.03 39.92 142.61 128.90 38.51 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 149.18 124.89 48.07 150.57 125.16 54.16 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 140.93 137.00 45.78 140.14 138.07 47.46 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 16 3 # 16 P 182 LYS C 94 LYS^? 16.92 O3 GOL C1901 P 184 LYS C 147 LYS^? 10.01 O1 GOL C1901 P 345 ASP C 183 ASP~? 25.06 O3 GOL C1901 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 161.58 122.48 47.40 160.49 120.58 53.33 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 165.62 124.17 41.44 160.89 126.43 37.84 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 169.34 110.13 50.56 169.06 109.63 52.58 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 17 3 # 17 P 182 LYS C 97 LYS^? 17.09 C1 GOL C1901 P 184 LYS C 147 LYS^? 10.01 O1 GOL C1901 P 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 163.30 119.33 38.22 166.56 114.68 36.90 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 165.62 124.17 41.44 160.89 126.43 37.84 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 18 3 # 18 P 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 P 184 LYS C 94 LYS^? 16.92 O3 GOL C1901 P 345 ASP C 175 ASP.? 10.66 O1 GOL C1901 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 165.62 124.17 41.44 160.89 126.43 37.84 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 161.58 122.48 47.40 160.49 120.58 53.33 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 157.90 117.18 31.56 156.68 116.62 29.91 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 19 3 # 19 P 182 LYS C 147 LYS^? 10.01 O1 GOL C1901 P 184 LYS C 97 LYS^? 17.09 C1 GOL C1901 P 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 165.62 124.17 41.44 160.89 126.43 37.84 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 163.30 119.33 38.22 166.56 114.68 36.90 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 20 3 # 20 P 182 LYS C 186 LYS~? 29.69 O3 GOL C1901 P 184 LYS C 193 LYS~? 28.43 O1 GOL C1901 P 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 174.37 114.14 48.91 174.42 112.17 55.03 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 177.05 121.15 50.66 176.96 126.15 48.94 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 178.03 118.40 36.14 177.70 120.46 36.31 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 21 3 # 21 P 182 LYS C 193 LYS~? 28.43 O1 GOL C1901 P 184 LYS C 186 LYS~? 29.69 O3 GOL C1901 P 345 ASP C 119 ASP.? 26.31 O1 GOL C1901 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 177.05 121.15 50.66 176.96 126.15 48.94 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 174.37 114.14 48.91 174.42 112.17 55.03 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 178.03 118.40 36.14 177.70 120.46 36.31 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 21 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE B 18 PHE~? 34.51 O4 CIT A1102 A 245 ASP B 89 ASP.? 31.34 O4 CIT A1102 A 273 LYS B 41 LYS^? 27.96 O1 GOL C1901 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 189.87 114.75 23.00 191.73 115.42 25.00 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 181.93 115.70 26.33 180.57 117.33 26.20 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 174.17 121.55 22.91 175.90 116.24 24.75 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE C 18 PHE~? 24.42 O3 GOL C1901 A 245 ASP C 89 ASP.? 17.67 O3 GOL C1901 A 273 LYS C 41 LYS^? 15.03 O3 GOL C1901 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 159.76 134.50 57.07 160.74 136.25 55.14 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 152.15 130.32 56.35 151.16 130.16 54.50 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 149.18 124.89 48.07 150.57 125.16 54.16 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 2 hits 2gsa_c04 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 341 GLU B 165 GLU^? 13.88 O4 CIT A1102 A 356 HIS B 96 HIS^? 15.42 O4 CIT A1102 coo 121.00 36.37 19.26 121.57 38.37 19.56 183.49 131.36 11.56 181.98 130.36 10.51 coo 125.72 32.70 19.75 124.44 34.16 18.84 180.17 131.30 14.36 179.09 129.62 13.64 coo 124.34 41.73 25.55 123.79 42.60 23.72 176.50 123.51 9.48 177.50 124.87 10.72 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 341 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 356 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 121.00 36.37 19.26 121.57 38.37 19.56 161.39 131.07 36.65 161.63 129.00 36.89 coo 125.72 32.70 19.75 124.44 34.16 18.84 157.34 129.59 37.15 157.60 127.69 38.11 coo 124.34 41.73 25.55 123.79 42.60 23.72 160.37 121.38 41.43 159.84 123.37 41.06 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 2 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS B 104 HIS^? 12.85 O4 CIT A1102 B 341 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 356 HIS B 96 HIS^? 15.42 O4 CIT A1102 coo 77.20 37.63 -25.62 77.60 39.62 -25.06 183.49 131.36 11.56 181.98 130.36 10.51 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 180.17 131.30 14.36 179.09 129.62 13.64 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 176.50 123.51 9.48 177.50 124.87 10.72 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 1 hits 2isd_c01 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 187 HIS~? 25.73 N9 ADE A 500 A 102 ASP A 183 ASP~? 24.76 N9 ADE A 500 A 193 GLY A 120 GLY.? 22.88 N9 ADE A 500 coo 14.96 29.22 19.55 15.62 29.93 17.67 179.01 171.47 26.59 179.51 173.49 26.31 coo 19.64 30.69 22.61 18.18 29.94 21.25 184.84 171.88 24.93 186.38 173.28 25.14 coo 14.54 28.99 9.76 15.06 29.59 10.02 174.96 162.20 29.93 174.67 161.48 29.96 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 193 GLY B 120 GLY.? 21.76 O7 CIT A1102 coo 14.96 29.22 19.55 15.62 29.93 17.67 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 19.64 30.69 22.61 18.18 29.94 21.25 174.65 109.33 0.17 174.41 107.27 0.58 coo 14.54 28.99 9.76 15.06 29.59 10.02 184.36 119.52 -4.81 184.70 120.30 -4.67 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 3 3 # 3 A 57 HIS B 187 HIS~? 26.45 C2 CIT A1102 A 102 ASP B 183 ASP~? 28.98 C2 CIT A1102 A 193 GLY B 190 GLY~? 28.95 C2 CIT A1102 coo 14.96 29.22 19.55 15.62 29.93 17.67 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 19.64 30.69 22.61 18.18 29.94 21.25 174.65 109.33 0.17 174.41 107.27 0.58 coo 14.54 28.99 9.76 15.06 29.59 10.02 185.59 111.38 -4.25 185.26 111.65 -3.51 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 3 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 18 PHE~? 23.25 N9 ADE A 500 A 263 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 292 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 51.51 50.32 16.39 52.13 49.68 13.75 201.55 150.80 30.31 200.89 148.25 31.29 coo 54.43 44.82 23.74 55.21 45.06 21.80 203.27 140.75 25.55 204.24 138.86 25.61 coo 63.95 45.30 16.71 59.11 49.15 16.05 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE B 18 PHE~? 34.51 O4 CIT A1102 A 263 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 292 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 51.51 50.32 16.39 52.13 49.68 13.75 189.87 114.75 23.00 191.73 115.42 25.00 coo 54.43 44.82 23.74 55.21 45.06 21.80 190.60 123.10 30.08 190.26 121.25 31.09 coo 63.95 45.30 16.71 59.11 49.15 16.05 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE C 18 PHE~? 24.42 O3 GOL C1901 A 263 ASP C 158 ASP~? 26.27 O1 GOL C1901 A 292 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 51.51 50.32 16.39 52.13 49.68 13.75 159.76 134.50 57.07 160.74 136.25 55.14 coo 54.43 44.82 23.74 55.21 45.06 21.80 152.92 141.67 53.35 151.80 143.42 53.28 coo 63.95 45.30 16.71 59.11 49.15 16.05 161.71 139.26 46.53 163.20 144.39 46.83 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 18 PHE~? 23.25 N9 ADE A 500 B 263 ASP A 158 ASP.? 25.18 C8 ADE A 500 B 292 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 49.99 26.05 6.28 51.46 26.87 8.49 201.55 150.80 30.31 200.89 148.25 31.29 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 203.27 140.75 25.55 204.24 138.86 25.61 coo 60.53 31.67 0.97 57.79 27.51 3.63 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE B 18 PHE~? 34.51 O4 CIT A1102 B 263 ASP B 158 ASP.? 34.51 N7 ADE A 500 B 292 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 49.99 26.05 6.28 51.46 26.87 8.49 189.87 114.75 23.00 191.73 115.42 25.00 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 190.60 123.10 30.08 190.26 121.25 31.09 coo 60.53 31.67 0.97 57.79 27.51 3.63 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE C 18 PHE~? 24.42 O3 GOL C1901 B 263 ASP C 158 ASP~? 26.27 O1 GOL C1901 B 292 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 49.99 26.05 6.28 51.46 26.87 8.49 159.76 134.50 57.07 160.74 136.25 55.14 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 152.92 141.67 53.35 151.80 143.42 53.28 coo 60.53 31.67 0.97 57.79 27.51 3.63 161.71 139.26 46.53 163.20 144.39 46.83 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 18 PHE~? 23.25 N9 ADE A 500 C 263 ASP A 158 ASP.? 25.18 C8 ADE A 500 C 292 LYS A 110 LYS.? 23.26 C8 ADE A 500 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 201.55 150.80 30.31 200.89 148.25 31.29 coo 19.84 12.02 9.33 18.68 11.23 7.75 203.27 140.75 25.55 204.24 138.86 25.61 coo 12.82 3.49 4.98 17.80 5.59 1.90 192.52 142.86 28.75 192.00 138.78 32.31 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 18 PHE~? 34.51 O4 CIT A1102 C 263 ASP B 158 ASP.? 34.51 N7 ADE A 500 C 292 LYS B 110 LYS.? 26.40 N7 ADE A 500 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 189.87 114.75 23.00 191.73 115.42 25.00 coo 19.84 12.02 9.33 18.68 11.23 7.75 190.60 123.10 30.08 190.26 121.25 31.09 coo 12.82 3.49 4.98 17.80 5.59 1.90 192.36 125.68 19.31 197.51 127.46 19.90 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE C 18 PHE~? 24.42 O3 GOL C1901 C 263 ASP C 158 ASP~? 26.27 O1 GOL C1901 C 292 LYS C 110 LYS.? 26.32 O1 GOL C1901 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 159.76 134.50 57.07 160.74 136.25 55.14 coo 19.84 12.02 9.33 18.68 11.23 7.75 152.92 141.67 53.35 151.80 143.42 53.28 coo 12.82 3.49 4.98 17.80 5.59 1.90 161.71 139.26 46.53 163.20 144.39 46.83 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 3 hits 2oat_c05 naa= 3 ULMN 3 2phk_c03 MC-PEPTIDE user 1 3 # 1 A 149 ASP A 130 ASP~? 27.60 C8 ADE A 500 A 151 LYS A 132 LYS~? 32.58 C8 ADE A 500 A 154 ASN A 133 ASN~? 29.64 C8 ADE A 500 coo 41.42 17.90 44.98 43.39 18.36 45.61 188.71 136.74 34.61 188.50 136.01 36.57 coo 45.75 16.58 39.61 47.43 18.26 45.54 183.55 135.22 37.19 185.46 129.22 37.94 coo 44.77 13.10 43.25 45.01 14.21 45.03 186.76 138.66 38.21 187.61 137.64 39.89 ULMN 3 2phk_c03 MC-PEPTIDE user 2 3 # 2 A 149 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 151 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 154 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 41.42 17.90 44.98 43.39 18.36 45.61 178.57 156.37 9.84 177.44 156.14 8.05 coo 45.75 16.58 39.61 47.43 18.26 45.54 180.69 158.10 18.36 176.95 162.62 18.15 coo 44.77 13.10 43.25 45.01 14.21 45.03 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 2phk_c03 MC-PEPTIDE user 3 3 # 3 A 149 ASP B 130 ASP~? 26.83 N6 ADE A 500 A 151 LYS B 132 LYS~? 23.82 N6 ADE A 500 A 154 ASN B 133 ASN~? 28.81 N6 ADE A 500 coo 41.42 17.90 44.98 43.39 18.36 45.61 200.55 129.62 17.17 202.64 129.41 16.98 coo 45.75 16.58 39.61 47.43 18.26 45.54 203.58 131.98 12.65 206.21 136.25 10.92 coo 44.77 13.10 43.25 45.01 14.21 45.03 202.41 127.52 13.21 204.35 127.28 14.04 ULMN 3 2phk_c03 MC-PEPTIDE user 4 3 # 4 A 149 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 151 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 154 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo 41.42 17.90 44.98 43.39 18.36 45.61 169.82 131.15 6.22 168.64 132.89 5.97 coo 45.75 16.58 39.61 47.43 18.26 45.54 175.75 125.08 4.60 173.18 124.12 -0.61 coo 44.77 13.10 43.25 45.01 14.21 45.03 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 3 2phk_c03 MC-PEPTIDE user 5 3 # 5 A 149 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 151 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 154 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 41.42 17.90 44.98 43.39 18.36 45.61 157.90 117.18 31.56 156.68 116.62 29.91 coo 45.75 16.58 39.61 47.43 18.26 45.54 163.30 119.33 38.22 166.56 114.68 36.90 coo 44.77 13.10 43.25 45.01 14.21 45.03 160.68 120.91 34.68 159.00 120.62 33.38 2phk_c03 source 2phk MC-PEPTIDE : 5 hits 2phk_c03 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 40 LYS A 41 LYS^? 15.86 N3 ADE A 500 A 116 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 12.34 -0.45 10.80 13.53 1.19 11.34 185.28 156.61 18.37 185.56 154.55 18.68 coo 18.50 3.53 20.10 16.17 2.61 14.41 197.56 153.42 13.51 201.64 156.08 17.41 coo 14.70 6.01 5.61 14.27 7.69 6.78 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 40 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 116 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 12.34 -0.45 10.80 13.53 1.19 11.34 185.28 156.61 18.37 185.56 154.55 18.68 coo 18.50 3.53 20.10 16.17 2.61 14.41 185.07 167.50 20.34 181.31 169.96 15.85 coo 14.70 6.01 5.61 14.27 7.69 6.78 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 3 3 # 3 A 12 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 40 LYS A 180 LYS~? 18.96 N3 ADE A 500 A 116 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 12.34 -0.45 10.80 13.53 1.19 11.34 184.39 157.95 13.11 185.86 157.96 14.60 coo 18.50 3.53 20.10 16.17 2.61 14.41 185.07 167.50 20.34 181.31 169.96 15.85 coo 14.70 6.01 5.61 14.27 7.69 6.78 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 4 3 # 4 A 12 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 40 LYS B 180 LYS.? 22.96 O1 CIT A1102 A 116 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 12.34 -0.45 10.80 13.53 1.19 11.34 176.50 123.51 9.48 177.50 124.87 10.72 coo 18.50 3.53 20.10 16.17 2.61 14.41 173.15 113.94 5.34 166.89 113.91 6.31 coo 14.70 6.01 5.61 14.27 7.69 6.78 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 5 3 # 5 A 12 HIS B 176 HIS^? 13.79 O1 CIT A1102 A 40 LYS B 180 LYS.? 22.96 O1 CIT A1102 A 116 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 12.34 -0.45 10.80 13.53 1.19 11.34 171.08 125.47 9.27 172.48 124.18 10.15 coo 18.50 3.53 20.10 16.17 2.61 14.41 173.15 113.94 5.34 166.89 113.91 6.31 coo 14.70 6.01 5.61 14.27 7.69 6.78 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 6 3 # 6 A 12 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 40 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 116 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo 12.34 -0.45 10.80 13.53 1.19 11.34 160.37 121.38 41.43 159.84 123.37 41.06 coo 18.50 3.53 20.10 16.17 2.61 14.41 149.18 124.89 48.07 150.57 125.16 54.16 coo 14.70 6.01 5.61 14.27 7.69 6.78 160.20 116.89 49.36 158.52 117.92 48.65 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 7 3 # 7 A 12 HIS C 96 HIS^? 9.69 C1 GOL C1901 A 40 LYS C 180 LYS.? 20.00 O3 GOL C1901 A 116 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 12.34 -0.45 10.80 13.53 1.19 11.34 160.37 121.38 41.43 159.84 123.37 41.06 coo 18.50 3.53 20.10 16.17 2.61 14.41 163.89 112.64 46.86 163.54 106.47 45.76 coo 14.70 6.01 5.61 14.27 7.69 6.78 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 8 3 # 8 A 12 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 40 LYS C 180 LYS.? 20.00 O3 GOL C1901 A 116 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 12.34 -0.45 10.80 13.53 1.19 11.34 157.21 117.94 38.21 157.48 118.99 40.00 coo 18.50 3.53 20.10 16.17 2.61 14.41 163.89 112.64 46.86 163.54 106.47 45.76 coo 14.70 6.01 5.61 14.27 7.69 6.78 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 9 3 # 9 A 12 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 40 LYS C 41 LYS^? 15.03 O3 GOL C1901 A 116 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 12.34 -0.45 10.80 13.53 1.19 11.34 160.20 116.89 49.36 158.52 117.92 48.65 coo 18.50 3.53 20.10 16.17 2.61 14.41 149.18 124.89 48.07 150.57 125.16 54.16 coo 14.70 6.01 5.61 14.27 7.69 6.78 160.37 121.38 41.43 159.84 123.37 41.06 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 9 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 40 LYS A 41 LYS^? 15.86 N3 ADE A 500 B 116 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo -6.35 21.42 14.69 -6.06 23.46 15.04 185.28 156.61 18.37 185.56 154.55 18.68 coo -10.61 31.45 9.72 -8.75 26.69 13.45 197.56 153.42 13.51 201.64 156.08 17.41 coo -0.95 25.22 19.68 -0.68 26.73 18.24 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 40 LYS A 180 LYS~? 18.96 N3 ADE A 500 B 116 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo -6.35 21.42 14.69 -6.06 23.46 15.04 185.28 156.61 18.37 185.56 154.55 18.68 coo -10.61 31.45 9.72 -8.75 26.69 13.45 185.07 167.50 20.34 181.31 169.96 15.85 coo -0.95 25.22 19.68 -0.68 26.73 18.24 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 3 3 # 3 B 12 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 40 LYS A 180 LYS~? 18.96 N3 ADE A 500 B 116 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo -6.35 21.42 14.69 -6.06 23.46 15.04 184.39 157.95 13.11 185.86 157.96 14.60 coo -10.61 31.45 9.72 -8.75 26.69 13.45 185.07 167.50 20.34 181.31 169.96 15.85 coo -0.95 25.22 19.68 -0.68 26.73 18.24 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 4 3 # 4 B 12 HIS A 202 HIS.? 13.56 N3 ADE A 500 B 40 LYS A 41 LYS^? 15.86 N3 ADE A 500 B 116 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo -6.35 21.42 14.69 -6.06 23.46 15.04 190.73 163.86 19.83 191.04 162.27 18.50 coo -10.61 31.45 9.72 -8.75 26.69 13.45 197.56 153.42 13.51 201.64 156.08 17.41 coo -0.95 25.22 19.68 -0.68 26.73 18.24 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 5 3 # 5 B 12 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 40 LYS B 180 LYS.? 22.96 O1 CIT A1102 B 116 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo -6.35 21.42 14.69 -6.06 23.46 15.04 176.50 123.51 9.48 177.50 124.87 10.72 coo -10.61 31.45 9.72 -8.75 26.69 13.45 173.15 113.94 5.34 166.89 113.91 6.31 coo -0.95 25.22 19.68 -0.68 26.73 18.24 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 6 3 # 6 B 12 HIS B 176 HIS^? 13.79 O1 CIT A1102 B 40 LYS B 180 LYS.? 22.96 O1 CIT A1102 B 116 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo -6.35 21.42 14.69 -6.06 23.46 15.04 171.08 125.47 9.27 172.48 124.18 10.15 coo -10.61 31.45 9.72 -8.75 26.69 13.45 173.15 113.94 5.34 166.89 113.91 6.31 coo -0.95 25.22 19.68 -0.68 26.73 18.24 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 7 3 # 7 B 12 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 40 LYS C 41 LYS^? 15.03 O3 GOL C1901 B 116 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo -6.35 21.42 14.69 -6.06 23.46 15.04 160.37 121.38 41.43 159.84 123.37 41.06 coo -10.61 31.45 9.72 -8.75 26.69 13.45 149.18 124.89 48.07 150.57 125.16 54.16 coo -0.95 25.22 19.68 -0.68 26.73 18.24 160.20 116.89 49.36 158.52 117.92 48.65 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 8 3 # 8 B 12 HIS C 96 HIS^? 9.69 C1 GOL C1901 B 40 LYS C 180 LYS.? 20.00 O3 GOL C1901 B 116 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo -6.35 21.42 14.69 -6.06 23.46 15.04 160.37 121.38 41.43 159.84 123.37 41.06 coo -10.61 31.45 9.72 -8.75 26.69 13.45 163.89 112.64 46.86 163.54 106.47 45.76 coo -0.95 25.22 19.68 -0.68 26.73 18.24 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 9 3 # 9 B 12 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 40 LYS C 180 LYS.? 20.00 O3 GOL C1901 B 116 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo -6.35 21.42 14.69 -6.06 23.46 15.04 157.21 117.94 38.21 157.48 118.99 40.00 coo -10.61 31.45 9.72 -8.75 26.69 13.45 163.89 112.64 46.86 163.54 106.47 45.76 coo -0.95 25.22 19.68 -0.68 26.73 18.24 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 10 3 # 10 B 12 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 40 LYS C 41 LYS^? 15.03 O3 GOL C1901 B 116 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo -6.35 21.42 14.69 -6.06 23.46 15.04 160.20 116.89 49.36 158.52 117.92 48.65 coo -10.61 31.45 9.72 -8.75 26.69 13.45 149.18 124.89 48.07 150.57 125.16 54.16 coo -0.95 25.22 19.68 -0.68 26.73 18.24 160.37 121.38 41.43 159.84 123.37 41.06 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 10 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 36 ASP~? 21.71 N6 ADE A 500 166 GLY A 46 GLY.? 10.99 N9 ADE A 500 169 GLU A 44 GLU.? 5.64 N9 ADE A 500 coo 8.28 6.87 1.62 10.08 5.77 1.34 203.35 139.46 11.01 205.31 139.04 11.69 coo -8.58 13.22 3.21 -8.90 13.15 4.05 195.68 151.83 18.82 195.79 152.36 18.16 coo -16.67 7.89 2.78 -17.65 6.56 1.49 188.90 156.57 17.91 187.92 156.12 16.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 52 ASP^? 9.33 O4 CIT A1102 166 GLY B 128 GLY.? 22.81 N7 ADE A 500 169 GLU B 156 GLU.? 24.53 N7 ADE A 500 coo 8.28 6.87 1.62 10.08 5.77 1.34 185.72 140.93 6.30 184.35 140.00 4.99 coo -8.58 13.22 3.21 -8.90 13.15 4.05 194.68 129.33 16.90 194.61 129.94 16.26 coo -16.67 7.89 2.78 -17.65 6.56 1.49 194.44 129.17 25.88 194.48 130.18 24.03 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 158 ASP.? 25.18 C8 ADE A 500 166 GLY B 134 GLY~? 24.07 N6 ADE A 500 169 GLU B 7 GLU.? 17.06 N6 ADE A 500 coo 8.28 6.87 1.62 10.08 5.77 1.34 203.27 140.75 25.55 204.24 138.86 25.61 coo -8.58 13.22 3.21 -8.90 13.15 4.05 199.49 129.07 9.64 199.41 129.13 10.41 coo -16.67 7.89 2.78 -17.65 6.56 1.49 195.60 134.63 1.65 195.26 136.71 1.75 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 183 ASP~? 24.76 N9 ADE A 500 166 GLY A 93 GLY^? 10.42 N9 ADE A 500 169 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 8.28 6.87 1.62 10.08 5.77 1.34 184.84 171.88 24.93 186.38 173.28 25.14 coo -8.58 13.22 3.21 -8.90 13.15 4.05 191.16 154.66 21.80 191.10 155.17 22.59 coo -16.67 7.89 2.78 -17.65 6.56 1.49 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 36 ASP~? 28.48 O1 GOL C1901 166 GLY B 46 GLY.? 23.93 O4 CIT A1102 169 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo 8.28 6.87 1.62 10.08 5.77 1.34 178.67 130.13 34.24 179.32 129.31 36.04 coo -8.58 13.22 3.21 -8.90 13.15 4.05 179.08 121.64 20.30 178.23 121.42 20.36 coo -16.67 7.89 2.78 -17.65 6.56 1.49 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 36 ASP~? 28.48 O1 GOL C1901 166 GLY C 190 GLY~? 29.91 O3 GOL C1901 169 GLU C 182 GLU~? 26.37 O3 GOL C1901 coo 8.28 6.87 1.62 10.08 5.77 1.34 178.67 130.13 34.24 179.32 129.31 36.04 coo -8.58 13.22 3.21 -8.90 13.15 4.05 178.54 116.34 48.35 177.72 116.48 48.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 170.51 115.98 53.19 171.23 115.96 55.18 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 52 ASP^? 16.07 C8 ADE A 500 166 GLY A 111 GLY^? 16.58 C8 ADE A 500 169 GLU A 156 GLU.? 23.41 C8 ADE A 500 coo 8.28 6.87 1.62 10.08 5.77 1.34 173.93 140.35 20.11 173.24 142.10 19.12 coo -8.58 13.22 3.21 -8.90 13.15 4.05 191.04 146.32 28.35 190.54 145.86 28.86 coo -16.67 7.89 2.78 -17.65 6.56 1.49 196.65 137.08 28.97 194.78 136.94 30.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP B 52 ASP^? 16.07 C8 ADE A 500 166 GLY A 128 GLY.? 19.63 C8 ADE A 500 169 GLU A 156 GLU.? 23.41 C8 ADE A 500 coo 8.28 6.87 1.62 10.08 5.77 1.34 173.93 140.35 20.11 173.24 142.10 19.12 coo -8.58 13.22 3.21 -8.90 13.15 4.05 188.72 140.03 29.58 187.87 139.89 29.50 coo -16.67 7.89 2.78 -17.65 6.56 1.49 196.65 137.08 28.97 194.78 136.94 30.01 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 175 ASP.? 4.91 O1 CIT A1102 166 GLY A 170 GLY.? 7.13 N6 ADE A 500 169 GLU A 50 GLU^? -3.91 N6 ADE A 500s coo 8.28 6.87 1.62 10.08 5.77 1.34 169.82 131.15 6.22 168.64 132.89 5.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 179.43 148.38 7.40 178.96 149.01 7.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 187.90 146.65 6.60 187.00 148.18 5.47 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 175 ASP.? 4.91 O1 CIT A1102 166 GLY A 170 GLY.? 7.13 N6 ADE A 500 169 GLU A 165 GLU^? 4.52 C8 ADE A 500 coo 8.28 6.87 1.62 10.08 5.77 1.34 169.82 131.15 6.22 168.64 132.89 5.97 coo -8.58 13.22 3.21 -8.90 13.15 4.05 179.43 148.38 7.40 178.96 149.01 7.51 coo -16.67 7.89 2.78 -17.65 6.56 1.49 185.43 146.45 17.17 186.00 148.48 17.29 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP B 183 ASP~? 28.98 C2 CIT A1102 166 GLY B 93 GLY^? 21.08 O4 CIT A1102 169 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 8.28 6.87 1.62 10.08 5.77 1.34 174.65 109.33 0.17 174.41 107.27 0.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 180.85 120.89 14.39 181.25 120.12 13.99 coo -16.67 7.89 2.78 -17.65 6.56 1.49 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP C 36 ASP~? 21.70 O1 GOL C1901 166 GLY C 46 GLY.? 11.75 O3 GOL C1901 169 GLU C 44 GLU.? 9.57 O3 GOL C1901 coo 8.28 6.87 1.62 10.08 5.77 1.34 140.93 137.00 45.78 140.14 138.07 47.46 coo -8.58 13.22 3.21 -8.90 13.15 4.05 154.15 127.64 48.04 153.68 126.93 48.08 coo -16.67 7.89 2.78 -17.65 6.56 1.49 157.18 120.22 44.20 157.97 118.54 45.19 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP C 119 ASP.? 26.31 O1 GOL C1901 166 GLY B 46 GLY.? 23.93 O4 CIT A1102 169 GLU B 44 GLU.? 19.02 O1 CIT A1102 coo 8.28 6.87 1.62 10.08 5.77 1.34 178.03 118.40 36.14 177.70 120.46 36.31 coo -8.58 13.22 3.21 -8.90 13.15 4.05 179.08 121.64 20.30 178.23 121.42 20.36 coo -16.67 7.89 2.78 -17.65 6.56 1.49 174.85 121.76 12.80 173.53 120.38 11.97 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP C 119 ASP.? 26.31 O1 GOL C1901 166 GLY B 46 GLY.? 23.93 O4 CIT A1102 169 GLU B 165 GLU^? 13.88 O4 CIT A1102 coo 8.28 6.87 1.62 10.08 5.77 1.34 178.03 118.40 36.14 177.70 120.46 36.31 coo -8.58 13.22 3.21 -8.90 13.15 4.05 179.08 121.64 20.30 178.23 121.42 20.36 coo -16.67 7.89 2.78 -17.65 6.56 1.49 180.17 131.30 14.36 179.09 129.62 13.64 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP C 183 ASP~? 25.06 O3 GOL C1901 166 GLY C 93 GLY^? 13.18 O3 GOL C1901 169 GLU C 165 GLU^? 7.74 O1 GOL C1901 coo 8.28 6.87 1.62 10.08 5.77 1.34 169.34 110.13 50.56 169.06 109.63 52.58 coo -8.58 13.22 3.21 -8.90 13.15 4.05 159.81 125.78 46.83 160.54 125.64 47.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 157.34 129.59 37.15 157.60 127.69 38.11 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 15 hits 2tdt_c00 naa= 3 ULMN 3 2xis_c00 XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLuser 1 3 # 1 183 LYS B 186 LYS~? 32.32 C2 CIT A1102 220 HIS B 187 HIS~? 26.45 C2 CIT A1102 255 ASP B 183 ASP~? 28.98 C2 CIT A1102 coo 11.94 40.77 50.56 7.67 36.15 49.76 180.39 111.43 -2.06 180.17 105.09 -1.71 coo 10.50 40.09 46.76 10.54 37.99 46.56 176.75 112.07 -5.75 176.32 110.31 -6.80 coo 4.47 38.05 47.65 5.63 36.87 46.50 174.65 109.33 0.17 174.41 107.27 0.58 2xis_c00 source 2xis XYLOSE ISOMERASE (E.C.5.3.1.5) COMPLEX WITH XY: 1 hits 2xis_c00 naa= 3 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 1 3 # 1 A 202 HIS A 202 HIS.? 13.56 N3 ADE A 500 A 295 HIS A 176 HIS^? 6.39 N3 ADE A 500 A 296 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 65.34 65.04 50.22 63.95 63.70 51.06 190.73 163.86 19.83 191.04 162.27 18.50 coo 63.46 53.34 50.98 63.08 55.39 51.17 184.39 157.95 13.11 185.86 157.96 14.60 coo 64.71 54.80 47.28 63.92 56.57 48.06 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 2 3 # 2 A 202 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 295 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 296 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 65.34 65.04 50.22 63.95 63.70 51.06 161.39 131.07 36.65 161.63 129.00 36.89 coo 63.46 53.34 50.98 63.08 55.39 51.17 157.21 117.94 38.21 157.48 118.99 40.00 coo 64.71 54.80 47.28 63.92 56.57 48.06 160.37 121.38 41.43 159.84 123.37 41.06 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 3 3 # 3 A 202 HIS C 202 HIS.? 13.21 O3 GOL C1901 A 295 HIS C 176 HIS^? 7.29 C1 GOL C1901 A 296 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 65.34 65.04 50.22 63.95 63.70 51.06 160.20 116.89 49.36 158.52 117.92 48.65 coo 63.46 53.34 50.98 63.08 55.39 51.17 157.21 117.94 38.21 157.48 118.99 40.00 coo 64.71 54.80 47.28 63.92 56.57 48.06 160.37 121.38 41.43 159.84 123.37 41.06 4kbp_c00 source 4kbp PURPLE ACID PHOSPHATASE : 3 hits 4kbp_c00 naa= 3 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 1 3 # 1 B 202 HIS A 202 HIS.? 13.56 N3 ADE A 500 B 295 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 296 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 20.09 23.80 58.44 19.07 25.34 59.44 190.73 163.86 19.83 191.04 162.27 18.50 coo 19.00 35.58 58.05 18.83 33.61 58.74 184.39 157.95 13.11 185.86 157.96 14.60 coo 22.88 34.01 57.66 22.04 32.37 58.63 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 2 3 # 2 B 202 HIS C 202 HIS.? 13.21 O3 GOL C1901 B 295 HIS C 176 HIS^? 7.29 C1 GOL C1901 B 296 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 20.09 23.80 58.44 19.07 25.34 59.44 160.20 116.89 49.36 158.52 117.92 48.65 coo 19.00 35.58 58.05 18.83 33.61 58.74 157.21 117.94 38.21 157.48 118.99 40.00 coo 22.88 34.01 57.66 22.04 32.37 58.63 160.37 121.38 41.43 159.84 123.37 41.06 4kbp_c01 source 4kbp PURPLE ACID PHOSPHATASE : 2 hits 4kbp_c01 naa= 3 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 1 3 # 1 C 202 HIS A 202 HIS.? 13.56 N3 ADE A 500 C 295 HIS A 176 HIS^? 6.39 N3 ADE A 500 C 296 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 56.07 24.38 61.64 57.15 25.46 60.21 190.73 163.86 19.83 191.04 162.27 18.50 coo 57.19 35.56 57.82 57.34 33.47 57.88 184.39 157.95 13.11 185.86 157.96 14.60 coo 53.24 34.19 58.78 54.08 32.31 58.44 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 2 3 # 2 C 202 HIS C 104 HIS^? 12.14 O1 GOL C1901 C 295 HIS C 176 HIS^? 7.29 C1 GOL C1901 C 296 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 56.07 24.38 61.64 57.15 25.46 60.21 161.39 131.07 36.65 161.63 129.00 36.89 coo 57.19 35.56 57.82 57.34 33.47 57.88 157.21 117.94 38.21 157.48 118.99 40.00 coo 53.24 34.19 58.78 54.08 32.31 58.44 160.37 121.38 41.43 159.84 123.37 41.06 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 3 3 # 3 C 202 HIS C 202 HIS.? 13.21 O3 GOL C1901 C 295 HIS C 176 HIS^? 7.29 C1 GOL C1901 C 296 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 56.07 24.38 61.64 57.15 25.46 60.21 160.20 116.89 49.36 158.52 117.92 48.65 coo 57.19 35.56 57.82 57.34 33.47 57.88 157.21 117.94 38.21 157.48 118.99 40.00 coo 53.24 34.19 58.78 54.08 32.31 58.44 160.37 121.38 41.43 159.84 123.37 41.06 4kbp_c02 source 4kbp PURPLE ACID PHOSPHATASE : 3 hits 4kbp_c02 naa= 3 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 1 3 # 1 D 202 HIS A 202 HIS.? 13.56 N3 ADE A 500 D 295 HIS A 176 HIS^? 6.39 N3 ADE A 500 D 296 HIS A 96 HIS^? 6.77 N9 ADE A 500 coo 61.78 113.98 49.61 62.80 115.33 50.85 190.73 163.86 19.83 191.04 162.27 18.50 coo 63.27 125.61 50.94 63.59 123.54 51.16 184.39 157.95 13.11 185.86 157.96 14.60 coo 63.24 124.12 46.99 63.79 122.40 48.02 185.28 156.61 18.37 185.56 154.55 18.68 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 2 3 # 2 D 202 HIS C 202 HIS.? 13.21 O3 GOL C1901 D 295 HIS C 176 HIS^? 7.29 C1 GOL C1901 D 296 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 61.78 113.98 49.61 62.80 115.33 50.85 160.20 116.89 49.36 158.52 117.92 48.65 coo 63.27 125.61 50.94 63.59 123.54 51.16 157.21 117.94 38.21 157.48 118.99 40.00 coo 63.24 124.12 46.99 63.79 122.40 48.02 160.37 121.38 41.43 159.84 123.37 41.06 4kbp_c03 source 4kbp PURPLE ACID PHOSPHATASE : 2 hits 4kbp_c03 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 41 LYS A 41 LYS^? 15.86 N3 ADE A 500 119 HIS A 202 HIS.? 13.56 N3 ADE A 500 coo 28.18 18.67 11.43 28.83 17.39 9.89 185.28 156.61 18.37 185.56 154.55 18.68 coo 25.33 8.32 6.30 27.86 13.90 7.82 197.56 153.42 13.51 201.64 156.08 17.41 coo 33.68 19.99 5.35 34.98 18.36 5.19 190.73 163.86 19.83 191.04 162.27 18.50 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS A 96 HIS^? 6.77 N9 ADE A 500 41 LYS A 180 LYS~? 18.96 N3 ADE A 500 119 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 28.18 18.67 11.43 28.83 17.39 9.89 185.28 156.61 18.37 185.56 154.55 18.68 coo 25.33 8.32 6.30 27.86 13.90 7.82 185.07 167.50 20.34 181.31 169.96 15.85 coo 33.68 19.99 5.35 34.98 18.36 5.19 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 5rsa_c01 RIBONUCLEASE A user 3 3 # 3 12 HIS A 176 HIS^? 6.39 N3 ADE A 500 41 LYS A 147 LYS^? 6.48 C8 ADE A 500 119 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 28.18 18.67 11.43 28.83 17.39 9.89 184.39 157.95 13.11 185.86 157.96 14.60 coo 25.33 8.32 6.30 27.86 13.90 7.82 182.91 155.29 23.54 184.46 151.31 19.55 coo 33.68 19.99 5.35 34.98 18.36 5.19 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 5rsa_c01 RIBONUCLEASE A user 4 3 # 4 12 HIS A 176 HIS^? 6.39 N3 ADE A 500 41 LYS A 180 LYS~? 18.96 N3 ADE A 500 119 HIS A 42 HIS.? -4.20 N3 ADE A 500s coo 28.18 18.67 11.43 28.83 17.39 9.89 184.39 157.95 13.11 185.86 157.96 14.60 coo 25.33 8.32 6.30 27.86 13.90 7.82 185.07 167.50 20.34 181.31 169.96 15.85 coo 33.68 19.99 5.35 34.98 18.36 5.19 191.47 153.75 14.17 189.52 154.05 13.44 ULMN 3 5rsa_c01 RIBONUCLEASE A user 5 3 # 5 12 HIS B 96 HIS^? 15.42 O4 CIT A1102 41 LYS B 180 LYS.? 22.96 O1 CIT A1102 119 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 28.18 18.67 11.43 28.83 17.39 9.89 176.50 123.51 9.48 177.50 124.87 10.72 coo 25.33 8.32 6.30 27.86 13.90 7.82 173.15 113.94 5.34 166.89 113.91 6.31 coo 33.68 19.99 5.35 34.98 18.36 5.19 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 5rsa_c01 RIBONUCLEASE A user 6 3 # 6 12 HIS B 176 HIS^? 13.79 O1 CIT A1102 41 LYS B 147 LYS^? 12.56 O4 CIT A1102 119 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 28.18 18.67 11.43 28.83 17.39 9.89 171.08 125.47 9.27 172.48 124.18 10.15 coo 25.33 8.32 6.30 27.86 13.90 7.82 181.66 123.79 6.82 179.82 128.66 10.46 coo 33.68 19.99 5.35 34.98 18.36 5.19 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 5rsa_c01 RIBONUCLEASE A user 7 3 # 7 12 HIS B 176 HIS^? 13.79 O1 CIT A1102 41 LYS B 180 LYS.? 22.96 O1 CIT A1102 119 HIS B 42 HIS.? 18.79 O1 CIT A1102 coo 28.18 18.67 11.43 28.83 17.39 9.89 171.08 125.47 9.27 172.48 124.18 10.15 coo 25.33 8.32 6.30 27.86 13.90 7.82 173.15 113.94 5.34 166.89 113.91 6.31 coo 33.68 19.99 5.35 34.98 18.36 5.19 174.27 123.90 17.18 173.55 124.80 15.43 ULMN 3 5rsa_c01 RIBONUCLEASE A user 8 3 # 8 12 HIS C 96 HIS^? 9.69 C1 GOL C1901 41 LYS C 41 LYS^? 15.03 O3 GOL C1901 119 HIS C 202 HIS.? 13.21 O3 GOL C1901 coo 28.18 18.67 11.43 28.83 17.39 9.89 160.37 121.38 41.43 159.84 123.37 41.06 coo 25.33 8.32 6.30 27.86 13.90 7.82 149.18 124.89 48.07 150.57 125.16 54.16 coo 33.68 19.99 5.35 34.98 18.36 5.19 160.20 116.89 49.36 158.52 117.92 48.65 ULMN 3 5rsa_c01 RIBONUCLEASE A user 9 3 # 9 12 HIS C 96 HIS^? 9.69 C1 GOL C1901 41 LYS C 180 LYS.? 20.00 O3 GOL C1901 119 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 28.18 18.67 11.43 28.83 17.39 9.89 160.37 121.38 41.43 159.84 123.37 41.06 coo 25.33 8.32 6.30 27.86 13.90 7.82 163.89 112.64 46.86 163.54 106.47 45.76 coo 33.68 19.99 5.35 34.98 18.36 5.19 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 5rsa_c01 RIBONUCLEASE A user 10 3 # 10 12 HIS C 176 HIS^? 7.29 C1 GOL C1901 41 LYS C 147 LYS^? 10.01 O1 GOL C1901 119 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 28.18 18.67 11.43 28.83 17.39 9.89 157.21 117.94 38.21 157.48 118.99 40.00 coo 25.33 8.32 6.30 27.86 13.90 7.82 165.62 124.17 41.44 160.89 126.43 37.84 coo 33.68 19.99 5.35 34.98 18.36 5.19 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 5rsa_c01 RIBONUCLEASE A user 11 3 # 11 12 HIS C 176 HIS^? 7.29 C1 GOL C1901 41 LYS C 180 LYS.? 20.00 O3 GOL C1901 119 HIS C 42 HIS.? 5.32 O3 GOL C1901 coo 28.18 18.67 11.43 28.83 17.39 9.89 157.21 117.94 38.21 157.48 118.99 40.00 coo 25.33 8.32 6.30 27.86 13.90 7.82 163.89 112.64 46.86 163.54 106.47 45.76 coo 33.68 19.99 5.35 34.98 18.36 5.19 153.36 123.09 43.85 154.03 121.98 42.20 ULMN 3 5rsa_c01 RIBONUCLEASE A user 12 3 # 12 12 HIS C 202 HIS.? 13.21 O3 GOL C1901 41 LYS C 41 LYS^? 15.03 O3 GOL C1901 119 HIS C 96 HIS^? 9.69 C1 GOL C1901 coo 28.18 18.67 11.43 28.83 17.39 9.89 160.20 116.89 49.36 158.52 117.92 48.65 coo 25.33 8.32 6.30 27.86 13.90 7.82 149.18 124.89 48.07 150.57 125.16 54.16 coo 33.68 19.99 5.35 34.98 18.36 5.19 160.37 121.38 41.43 159.84 123.37 41.06 5rsa_c01 source 5rsa RIBONUCLEASE A : 12 hits 5rsa_c01 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 99 GLY A 160 GLY.? 18.25 C8 ADE A 500 A 125 ASN A 154 ASN.? 21.16 C8 ADE A 500 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 203.27 140.75 25.55 204.24 138.86 25.61 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 198.27 144.01 24.73 197.89 143.68 25.40 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 196.82 141.64 30.94 196.98 141.72 28.81 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP B 158 ASP.? 34.51 N7 ADE A 500 A 99 GLY B 160 GLY.? 28.72 O4 CIT A1102 A 125 ASN B 154 ASN.? 28.91 N7 ADE A 500 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 190.60 123.10 30.08 190.26 121.25 31.09 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 188.00 123.61 24.63 188.78 123.73 24.22 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 194.71 123.63 23.05 192.89 124.34 23.91 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 3 3 # 3 A 81 ASP C 158 ASP~? 26.27 O1 GOL C1901 A 99 GLY C 160 GLY.? 20.08 O1 GOL C1901 A 125 ASN C 154 ASN~? 23.43 O1 GOL C1901 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 152.92 141.67 53.35 151.80 143.42 53.28 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 155.40 137.81 49.75 156.15 138.23 49.61 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 160.52 142.23 50.24 158.78 141.09 49.77 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 3 hits 1hkd_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 10 ASN.? 24.13 C8 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 180.16 148.75 36.49 180.73 146.67 36.56 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 35 ASN~? 19.82 C2 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 205.66 144.31 11.38 206.37 146.04 12.39 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 70 ASN.? 27.03 O5 CIT A1102 coo 5.80 63.03 55.85 5.52 65.03 56.45 164.71 166.31 5.05 164.08 165.27 3.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 77 ASN^? 9.65 N6 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 179.83 147.18 2.66 181.08 147.98 1.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 133 ASN~? 29.64 C8 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 186.76 138.66 38.21 187.61 137.64 39.89 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN A 154 ASN.? 21.16 C8 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 196.82 141.64 30.94 196.98 141.72 28.81 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN A 159 ASN.? 24.44 N9 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 201.43 144.98 28.36 202.11 144.65 30.37 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 10 ASN.? 24.71 O4 CIT A1102 coo 5.80 63.03 55.85 5.52 65.03 56.45 196.51 123.48 2.85 194.80 122.44 2.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 35 ASN~? 25.18 O1 GOL C1901 coo 5.80 63.03 55.85 5.52 65.03 56.45 176.57 125.33 34.40 176.61 123.22 34.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 70 ASN.? 13.06 O2 CIT A1102 coo 5.80 63.03 55.85 5.52 65.03 56.45 160.75 132.93 -9.37 159.25 133.21 -7.90 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 77 ASN^? 12.53 O1 CIT A1102 coo 5.80 63.03 55.85 5.52 65.03 56.45 167.65 140.29 13.08 165.89 139.84 14.18 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo 5.80 63.03 55.85 5.52 65.03 56.45 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 15 1 # 15 A 461 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 5.80 63.03 55.85 5.52 65.03 56.45 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 16 1 # 16 A 461 ASN B 133 ASN~? 28.81 N6 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 202.41 127.52 13.21 204.35 127.28 14.04 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 17 1 # 17 A 461 ASN B 154 ASN.? 28.91 N7 ADE A 500 coo 5.80 63.03 55.85 5.52 65.03 56.45 194.71 123.63 23.05 192.89 124.34 23.91 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 18 1 # 18 A 461 ASN B 159 ASN.? 34.53 O4 CIT A1102 coo 5.80 63.03 55.85 5.52 65.03 56.45 190.73 119.78 25.86 192.60 118.87 26.28 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 19 1 # 19 A 461 ASN C 10 ASN.? 30.52 O1 GOL C1901 coo 5.80 63.03 55.85 5.52 65.03 56.45 177.62 134.05 42.85 179.55 133.98 41.92 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 20 1 # 20 A 461 ASN C 35 ASN~? 19.36 O3 GOL C1901 coo 5.80 63.03 55.85 5.52 65.03 56.45 140.68 133.60 49.75 141.25 132.82 51.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 21 1 # 21 A 461 ASN C 77 ASN^? 9.92 O2 GOL C1901 coo 5.80 63.03 55.85 5.52 65.03 56.45 149.21 122.45 26.13 147.53 121.25 26.66 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 22 1 # 22 A 461 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 5.80 63.03 55.85 5.52 65.03 56.45 160.68 120.91 34.68 159.00 120.62 33.38 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 23 1 # 23 A 461 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 5.80 63.03 55.85 5.52 65.03 56.45 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 24 1 # 24 A 461 ASN C 133 ASN.? 33.10 O1 GOL C1901 coo 5.80 63.03 55.85 5.52 65.03 56.45 171.58 145.70 44.65 171.99 147.56 45.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 25 1 # 25 A 461 ASN C 154 ASN~? 23.43 O1 GOL C1901 coo 5.80 63.03 55.85 5.52 65.03 56.45 160.52 142.23 50.24 158.78 141.09 49.77 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 26 1 # 26 A 461 ASN C 159 ASN.? 26.35 O1 GOL C1901 coo 5.80 63.03 55.85 5.52 65.03 56.45 157.28 138.82 54.17 158.01 140.31 55.50 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 26 hits 1kbk_p00 naa= 1 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 1 4 # 1 A 25 ILE A 99 ILE.? 12.36 C8 ADE A 500 A 52 ASN C 100 ASN.? 12.22 O1 GOL C1901 A 53 VAL C 167 VAL^? 8.15 O1 GOL C1901 A 78 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 175.57 156.34 12.34 174.66 157.43 12.43 coo 81.20 29.47 37.49 79.47 28.44 38.24 160.54 121.61 29.05 159.70 119.87 28.12 coo 82.17 24.86 36.27 81.03 23.67 37.80 156.80 126.29 30.31 157.16 124.69 31.72 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 2 4 # 2 A 25 ILE A 99 ILE.? 12.36 C8 ADE A 500 A 52 ASN C 100 ASN.? 12.22 O1 GOL C1901 A 53 VAL C 168 VAL.? 12.36 O1 GOL C1901 A 78 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 175.57 156.34 12.34 174.66 157.43 12.43 coo 81.20 29.47 37.49 79.47 28.44 38.24 160.54 121.61 29.05 159.70 119.87 28.12 coo 82.17 24.86 36.27 81.03 23.67 37.80 156.97 125.20 26.71 157.51 126.85 25.35 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 3 4 # 3 A 25 ILE C 99 ILE.? 13.68 O1 GOL C1901 A 52 ASN A 100 ASN.? 10.86 N7 ADE A 500 A 53 VAL A 167 VAL^? 5.66 N7 ADE A 500 A 78 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 161.43 116.98 30.81 162.32 116.55 29.80 coo 81.20 29.47 37.49 79.47 28.44 38.24 175.81 151.36 12.66 175.13 152.21 10.81 coo 82.17 24.86 36.27 81.03 23.67 37.80 179.77 147.01 12.10 180.70 148.96 12.24 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 160.68 120.91 34.68 159.00 120.62 33.38 ULMN 4 1qfw_p00 GONADOTROPIN ALPHA SUBUNIT user 4 4 # 4 A 25 ILE C 99 ILE.? 13.68 O1 GOL C1901 A 52 ASN A 100 ASN.? 10.86 N7 ADE A 500 A 53 VAL A 168 VAL.? 10.65 O3 CIT A1102 A 78 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 71.59 -7.22 17.04 71.86 -6.51 15.90 161.43 116.98 30.81 162.32 116.55 29.80 coo 81.20 29.47 37.49 79.47 28.44 38.24 175.81 151.36 12.66 175.13 152.21 10.81 coo 82.17 24.86 36.27 81.03 23.67 37.80 176.32 146.65 10.55 175.46 144.66 10.43 coo 75.27 -4.71 13.39 75.98 -6.45 14.35 160.68 120.91 34.68 159.00 120.62 33.38 1qfw_p00 source 1qfw GONADOTROPIN ALPHA SUBUNIT : 4 hits 1qfw_p00 naa= 4 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 56 TYR.? -3.24 O3 CIT A1102s A 108 ASN B 98 ASN^? 8.56 C4 CIT A1102 A 135 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 17.59 4.66 17.88 15.38 5.96 18.97 175.94 140.65 -0.34 176.08 138.10 -1.42 coo 12.36 16.24 15.27 12.06 14.29 16.05 174.94 129.17 6.18 173.60 130.41 7.30 coo 18.05 11.56 12.71 17.57 10.75 14.60 174.18 134.78 4.77 172.12 135.04 4.40 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 1 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 56 TYR.? -3.24 O3 CIT A1102s A 108 ASN B 98 ASN^? 8.56 C4 CIT A1102 A 135 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 17.50 4.57 17.85 15.28 5.88 18.97 175.94 140.65 -0.34 176.08 138.10 -1.42 coo 12.22 15.98 15.24 11.94 14.05 16.09 174.94 129.17 6.18 173.60 130.41 7.30 coo 17.94 11.43 12.65 17.42 10.61 14.53 174.18 134.78 4.77 172.12 135.04 4.40 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 1 hits 1uy4_p00 naa= 3 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 1 3 # 1 A 44 ASN A 100 ASN.? 10.86 N7 ADE A 500 A 213 PRO A 169 PRO.? 11.58 O3 CIT A1102 A 219 ASN B 77 ASN^? 12.53 O1 CIT A1102 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 175.81 151.36 12.66 175.13 152.21 10.81 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 173.66 149.49 8.03 175.40 148.44 8.93 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 167.65 140.29 13.08 165.89 139.84 14.18 ULMN 3 1wbf_p00 PROTEIN (AGGLUTININ) user 2 3 # 2 A 44 ASN B 100 ASN.? -3.42 C4 CIT A1102s A 213 PRO B 169 PRO.? -3.96 O5 CIT A1102s A 219 ASN A 77 ASN^? 9.65 N6 ADE A 500 coo -7.34 -5.74 33.55 -6.42 -4.32 34.85 174.18 134.78 4.77 172.12 135.04 4.40 coo -10.08 -3.19 35.19 -11.51 -3.72 33.58 170.88 139.44 5.26 172.14 139.13 7.05 coo -15.60 -12.66 27.15 -15.94 -14.47 28.23 179.83 147.18 2.66 181.08 147.98 1.14 1wbf_p00 source 1wbf PROTEIN (AGGLUTININ) : 2 hits 1wbf_p00 naa= 3 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 53 ARG^? 5.21 N6 ADE A 500 A 188 TYR A 56 TYR.? -3.24 O3 CIT A1102s A 190 SER A 54 SER.? 4.61 O3 CIT A1102 coo 37.69 7.64 13.51 38.82 8.84 16.11 184.38 147.77 2.51 183.90 149.96 4.60 coo 47.14 12.10 13.73 48.75 12.33 16.01 175.94 140.65 -0.34 176.08 138.10 -1.42 coo 43.77 6.93 15.46 45.49 7.21 17.11 180.68 142.57 2.59 178.38 141.86 2.59 ULMN 3 2p3i_p00 VP4 user 2 3 # 2 A 101 ARG B 53 ARG^? 12.50 O1 CIT A1102 A 188 TYR B 56 TYR.? 17.06 O5 CIT A1102 A 190 SER B 54 SER.? 13.70 O5 CIT A1102 coo 37.69 7.64 13.51 38.82 8.84 16.11 166.97 137.64 16.68 167.60 135.18 14.95 coo 47.14 12.10 13.73 48.75 12.33 16.01 168.51 148.73 14.38 168.50 150.54 16.52 coo 43.77 6.93 15.46 45.49 7.21 17.11 170.01 143.15 16.19 170.47 144.95 14.66 ULMN 3 2p3i_p00 VP4 user 3 3 # 3 A 101 ARG B 108 ARG^? 25.54 C8 ADE A 500 A 188 TYR B 83 TYR^? 20.46 C8 ADE A 500 A 190 SER A 137 SER.? 19.19 C8 ADE A 500 coo 37.69 7.64 13.51 38.82 8.84 16.11 188.64 131.77 26.61 189.85 131.11 29.36 coo 47.14 12.10 13.73 48.75 12.33 16.01 179.54 132.93 23.44 180.82 135.06 24.75 coo 43.77 6.93 15.46 45.49 7.21 17.11 184.43 139.00 26.42 183.74 136.66 26.44 ULMN 3 2p3i_p00 VP4 user 4 3 # 4 A 101 ARG C 53 ARG^? 4.89 O2 GOL C1901 A 188 TYR C 56 TYR.? 18.89 O2 GOL C1901 A 190 SER C 54 SER.? 14.46 O1 GOL C1901 coo 37.69 7.64 13.51 38.82 8.84 16.11 146.33 122.48 29.52 148.17 121.33 31.67 coo 47.14 12.10 13.73 48.75 12.33 16.01 147.08 126.92 19.41 145.08 128.68 18.52 coo 43.77 6.93 15.46 45.49 7.21 17.11 147.47 126.83 25.21 148.44 127.11 23.04 2p3i_p00 source 2p3i VP4 : 4 hits 2p3i_p00 naa= 3 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 98 ASN^? 5.64 N9 ADE A 500 A 460 GLY A 143 GLY.? 12.19 C8 ADE A 500 A 461 ASN A 100 ASN.? 10.86 N7 ADE A 500 coo 15.00 94.38 6.97 13.00 93.59 6.99 179.72 154.52 15.51 181.63 154.42 14.60 coo 19.48 94.04 5.03 19.26 94.00 5.78 174.93 153.96 17.89 174.52 154.02 18.66 coo 20.23 95.69 9.16 21.55 97.37 9.20 175.81 151.36 12.66 175.13 152.21 10.81 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 100 ASN.? 10.86 N7 ADE A 500 A 460 GLY A 143 GLY.? 12.19 C8 ADE A 500 A 461 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 15.00 94.38 6.97 13.00 93.59 6.99 175.81 151.36 12.66 175.13 152.21 10.81 coo 19.48 94.04 5.03 19.26 94.00 5.78 174.93 153.96 17.89 174.52 154.02 18.66 coo 20.23 95.69 9.16 21.55 97.37 9.20 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN A 154 ASN.? 21.16 C8 ADE A 500 A 460 GLY A 160 GLY.? 18.25 C8 ADE A 500 A 461 ASN A 159 ASN.? 24.44 N9 ADE A 500 coo 15.00 94.38 6.97 13.00 93.59 6.99 196.82 141.64 30.94 196.98 141.72 28.81 coo 19.48 94.04 5.03 19.26 94.00 5.78 198.27 144.01 24.73 197.89 143.68 25.40 coo 20.23 95.69 9.16 21.55 97.37 9.20 201.43 144.98 28.36 202.11 144.65 30.37 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN B 98 ASN^? 8.56 C4 CIT A1102 A 460 GLY B 143 GLY.? 6.99 O4 CIT A1102 A 461 ASN B 100 ASN.? -3.42 C4 CIT A1102s coo 15.00 94.38 6.97 13.00 93.59 6.99 174.94 129.17 6.18 173.60 130.41 7.30 coo 19.48 94.04 5.03 19.26 94.00 5.78 177.58 131.25 1.88 178.27 131.09 1.31 coo 20.23 95.69 9.16 21.55 97.37 9.20 174.18 134.78 4.77 172.12 135.04 4.40 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 5 3 # 5 A 459 ASN B 100 ASN.? -3.42 C4 CIT A1102s A 460 GLY B 143 GLY.? 6.99 O4 CIT A1102 A 461 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo 15.00 94.38 6.97 13.00 93.59 6.99 174.18 134.78 4.77 172.12 135.04 4.40 coo 19.48 94.04 5.03 19.26 94.00 5.78 177.58 131.25 1.88 178.27 131.09 1.31 coo 20.23 95.69 9.16 21.55 97.37 9.20 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 6 3 # 6 A 459 ASN B 154 ASN.? 28.91 N7 ADE A 500 A 460 GLY B 160 GLY.? 28.72 O4 CIT A1102 A 461 ASN B 159 ASN.? 34.53 O4 CIT A1102 coo 15.00 94.38 6.97 13.00 93.59 6.99 194.71 123.63 23.05 192.89 124.34 23.91 coo 19.48 94.04 5.03 19.26 94.00 5.78 188.00 123.61 24.63 188.78 123.73 24.22 coo 20.23 95.69 9.16 21.55 97.37 9.20 190.73 119.78 25.86 192.60 118.87 26.28 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 7 3 # 7 A 459 ASN C 98 ASN^? 8.51 O1 GOL C1901 A 460 GLY C 143 GLY.? 14.90 O1 GOL C1901 A 461 ASN C 100 ASN.? 12.22 O1 GOL C1901 coo 15.00 94.38 6.97 13.00 93.59 6.99 160.68 120.91 34.68 159.00 120.62 33.38 coo 19.48 94.04 5.03 19.26 94.00 5.78 165.52 121.63 31.71 166.35 121.80 31.83 coo 20.23 95.69 9.16 21.55 97.37 9.20 160.54 121.61 29.05 159.70 119.87 28.12 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 8 3 # 8 A 459 ASN C 100 ASN.? 12.22 O1 GOL C1901 A 460 GLY C 143 GLY.? 14.90 O1 GOL C1901 A 461 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 15.00 94.38 6.97 13.00 93.59 6.99 160.54 121.61 29.05 159.70 119.87 28.12 coo 19.48 94.04 5.03 19.26 94.00 5.78 165.52 121.63 31.71 166.35 121.80 31.83 coo 20.23 95.69 9.16 21.55 97.37 9.20 160.68 120.91 34.68 159.00 120.62 33.38 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 9 3 # 9 A 459 ASN C 154 ASN~? 23.43 O1 GOL C1901 A 460 GLY C 160 GLY.? 20.08 O1 GOL C1901 A 461 ASN C 159 ASN.? 26.35 O1 GOL C1901 coo 15.00 94.38 6.97 13.00 93.59 6.99 160.52 142.23 50.24 158.78 141.09 49.77 coo 19.48 94.04 5.03 19.26 94.00 5.78 155.40 137.81 49.75 156.15 138.23 49.61 coo 20.23 95.69 9.16 21.55 97.37 9.20 157.28 138.82 54.17 158.01 140.31 55.50 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 9 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 133 ASN~? 29.64 C8 ADE A 500 A 384 ASN B 154 ASN.? 28.91 N7 ADE A 500 A 385 GLU B 155 GLU.? 33.13 C8 ADE A 500 coo 22.28 63.17 110.61 22.47 65.06 111.53 186.76 138.66 38.21 187.61 137.64 39.89 coo 7.06 50.07 96.17 8.50 48.54 96.31 194.71 123.63 23.05 192.89 124.34 23.91 coo 11.59 49.83 99.41 10.92 47.97 100.16 197.70 123.91 29.28 199.42 125.11 29.52 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 154 ASN.? 21.16 C8 ADE A 500 A 384 ASN B 133 ASN~? 28.81 N6 ADE A 500 A 385 GLU B 135 GLU.? 25.67 N6 ADE A 500 coo 22.28 63.17 110.61 22.47 65.06 111.53 196.82 141.64 30.94 196.98 141.72 28.81 coo 7.06 50.07 96.17 8.50 48.54 96.31 202.41 127.52 13.21 204.35 127.28 14.04 coo 11.59 49.83 99.41 10.92 47.97 100.16 197.88 127.79 14.29 197.78 127.39 16.36 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN A 159 ASN.? 24.44 N9 ADE A 500 A 384 ASN B 154 ASN.? 28.91 N7 ADE A 500 A 385 GLU B 155 GLU.? 33.13 C8 ADE A 500 coo 22.28 63.17 110.61 22.47 65.06 111.53 201.43 144.98 28.36 202.11 144.65 30.37 coo 7.06 50.07 96.17 8.50 48.54 96.31 194.71 123.63 23.05 192.89 124.34 23.91 coo 11.59 49.83 99.41 10.92 47.97 100.16 197.70 123.91 29.28 199.42 125.11 29.52 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN B 35 ASN~? 25.18 O1 GOL C1901 A 384 ASN C 133 ASN.? 33.10 O1 GOL C1901 A 385 GLU C 135 GLU.? 26.33 O1 GOL C1901 coo 22.28 63.17 110.61 22.47 65.06 111.53 176.57 125.33 34.40 176.61 123.22 34.34 coo 7.06 50.07 96.17 8.50 48.54 96.31 171.58 145.70 44.65 171.99 147.56 45.54 coo 11.59 49.83 99.41 10.92 47.97 100.16 168.08 142.51 43.72 166.57 142.98 45.14 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN B 133 ASN~? 28.81 N6 ADE A 500 A 384 ASN A 154 ASN.? 21.16 C8 ADE A 500 A 385 GLU A 155 GLU.? 30.36 C8 ADE A 500 coo 22.28 63.17 110.61 22.47 65.06 111.53 202.41 127.52 13.21 204.35 127.28 14.04 coo 7.06 50.07 96.17 8.50 48.54 96.31 196.82 141.64 30.94 196.98 141.72 28.81 coo 11.59 49.83 99.41 10.92 47.97 100.16 202.13 137.32 32.16 203.15 136.76 33.90 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 133 ASN~? 28.81 N6 ADE A 500 A 384 ASN A 154 ASN.? 21.16 C8 ADE A 500 A 385 GLU A 156 GLU.? 23.41 C8 ADE A 500 coo 22.28 63.17 110.61 22.47 65.06 111.53 202.41 127.52 13.21 204.35 127.28 14.04 coo 7.06 50.07 96.17 8.50 48.54 96.31 196.82 141.64 30.94 196.98 141.72 28.81 coo 11.59 49.83 99.41 10.92 47.97 100.16 196.65 137.08 28.97 194.78 136.94 30.01 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 7 3 # 7 A 270 ASN B 154 ASN.? 28.91 N7 ADE A 500 A 384 ASN A 133 ASN~? 29.64 C8 ADE A 500 A 385 GLU A 135 GLU.? 23.34 C8 ADE A 500 coo 22.28 63.17 110.61 22.47 65.06 111.53 194.71 123.63 23.05 192.89 124.34 23.91 coo 7.06 50.07 96.17 8.50 48.54 96.31 186.76 138.66 38.21 187.61 137.64 39.89 coo 11.59 49.83 99.41 10.92 47.97 100.16 187.40 140.84 33.48 189.24 139.81 33.69 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 8 3 # 8 A 270 ASN B 159 ASN.? 34.53 O4 CIT A1102 A 384 ASN A 154 ASN.? 21.16 C8 ADE A 500 A 385 GLU A 155 GLU.? 30.36 C8 ADE A 500 coo 22.28 63.17 110.61 22.47 65.06 111.53 190.73 119.78 25.86 192.60 118.87 26.28 coo 7.06 50.07 96.17 8.50 48.54 96.31 196.82 141.64 30.94 196.98 141.72 28.81 coo 11.59 49.83 99.41 10.92 47.97 100.16 202.13 137.32 32.16 203.15 136.76 33.90 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 9 3 # 9 A 270 ASN B 159 ASN.? 34.53 O4 CIT A1102 A 384 ASN A 154 ASN.? 21.16 C8 ADE A 500 A 385 GLU A 156 GLU.? 23.41 C8 ADE A 500 coo 22.28 63.17 110.61 22.47 65.06 111.53 190.73 119.78 25.86 192.60 118.87 26.28 coo 7.06 50.07 96.17 8.50 48.54 96.31 196.82 141.64 30.94 196.98 141.72 28.81 coo 11.59 49.83 99.41 10.92 47.97 100.16 196.65 137.08 28.97 194.78 136.94 30.01 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 9 hits 2v3r_p00 naa= 3 ULMN 3 1b01_d00 GENE REGULATION/DNA user 1 3 # 1 B 4 ARG A 101 ARG.? 15.15 C8 ADE A 500 B 6 THR B 57 THR^? 12.97 O5 CIT A1102 B 8 THR B 75 THR^? 10.98 O1 CIT A1102 coo 40.52 16.08 100.90 37.97 16.41 102.60 173.48 146.74 16.27 172.57 144.92 18.53 coo 36.11 13.64 95.03 34.54 14.86 95.91 165.99 145.04 10.45 163.91 145.03 10.88 coo 32.72 8.05 92.39 31.25 9.11 91.35 162.70 140.84 6.57 161.52 142.36 7.49 1b01_d00 source 1b01 GENE REGULATION/DNA : 1 hits 1b01_d00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 113 TYR^? 11.47 C8 ADE A 500 I 306 VAL A 114 VAL^? 16.96 N9 ADE A 500 I 308 VAL A 116 VAL^? 17.89 N9 ADE A 500 coo 26.18 35.24 6.87 24.33 35.18 8.97 185.14 149.36 25.84 186.22 148.61 23.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 184.01 153.91 29.04 184.98 155.35 30.34 coo 16.43 30.18 9.35 15.05 30.67 11.01 179.03 158.24 27.58 179.91 160.14 28.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 113 TYR^? 11.47 C8 ADE A 500 I 306 VAL A 114 VAL^? 16.96 N9 ADE A 500 I 308 VAL A 122 VAL^? 21.23 N9 ADE A 500 coo 26.18 35.24 6.87 24.33 35.18 8.97 185.14 149.36 25.84 186.22 148.61 23.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 184.01 153.91 29.04 184.98 155.35 30.34 coo 16.43 30.18 9.35 15.05 30.67 11.01 178.67 157.33 32.12 180.52 158.43 32.37 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 113 TYR^? 11.47 C8 ADE A 500 I 306 VAL A 141 VAL^? 11.21 C8 ADE A 500 I 308 VAL A 145 VAL.? 14.45 C8 ADE A 500 coo 26.18 35.24 6.87 24.33 35.18 8.97 185.14 149.36 25.84 186.22 148.61 23.38 coo 23.55 29.53 9.81 23.15 27.39 10.24 177.62 149.60 22.03 179.34 150.89 21.68 coo 16.43 30.18 9.35 15.05 30.67 11.01 176.76 156.46 22.30 176.13 155.01 23.81 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 117 TYR.? 18.31 C8 ADE A 500 I 306 VAL A 116 VAL^? 17.89 N9 ADE A 500 I 308 VAL A 114 VAL^? 16.96 N9 ADE A 500 coo 26.18 35.24 6.87 24.33 35.18 8.97 174.51 155.83 27.46 174.88 153.07 27.26 coo 23.55 29.53 9.81 23.15 27.39 10.24 179.03 158.24 27.58 179.91 160.14 28.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 184.01 153.91 29.04 184.98 155.35 30.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 117 TYR.? 18.31 C8 ADE A 500 I 306 VAL A 116 VAL^? 17.89 N9 ADE A 500 I 308 VAL A 189 VAL~? 23.29 N9 ADE A 500 coo 26.18 35.24 6.87 24.33 35.18 8.97 174.51 155.83 27.46 174.88 153.07 27.26 coo 23.55 29.53 9.81 23.15 27.39 10.24 179.03 158.24 27.58 179.91 160.14 28.03 coo 16.43 30.18 9.35 15.05 30.67 11.01 179.16 164.93 32.00 180.56 163.43 31.28 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 117 TYR.? 18.31 C8 ADE A 500 I 306 VAL A 122 VAL^? 21.23 N9 ADE A 500 I 308 VAL A 114 VAL^? 16.96 N9 ADE A 500 coo 26.18 35.24 6.87 24.33 35.18 8.97 174.51 155.83 27.46 174.88 153.07 27.26 coo 23.55 29.53 9.81 23.15 27.39 10.24 178.67 157.33 32.12 180.52 158.43 32.37 coo 16.43 30.18 9.35 15.05 30.67 11.01 184.01 153.91 29.04 184.98 155.35 30.34 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR A 117 TYR.? 18.31 C8 ADE A 500 I 306 VAL A 122 VAL^? 21.23 N9 ADE A 500 I 308 VAL A 189 VAL~? 23.29 N9 ADE A 500 coo 26.18 35.24 6.87 24.33 35.18 8.97 174.51 155.83 27.46 174.88 153.07 27.26 coo 23.55 29.53 9.81 23.15 27.39 10.24 178.67 157.33 32.12 180.52 158.43 32.37 coo 16.43 30.18 9.35 15.05 30.67 11.01 179.16 164.93 32.00 180.56 163.43 31.28 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 113 TYR^? 17.81 O4 CIT A1102 I 306 VAL B 114 VAL^? 21.37 O4 CIT A1102 I 308 VAL B 116 VAL^? 19.12 O4 CIT A1102 coo 26.18 35.24 6.87 24.33 35.18 8.97 186.72 125.72 10.79 185.00 126.80 12.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 187.20 121.57 7.01 187.54 119.42 6.92 coo 16.43 30.18 9.35 15.05 30.67 11.01 183.91 121.70 1.00 183.40 119.59 1.01 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 113 TYR^? 17.81 O4 CIT A1102 I 306 VAL B 114 VAL^? 21.37 O4 CIT A1102 I 308 VAL B 122 VAL.? 21.87 O4 CIT A1102 coo 26.18 35.24 6.87 24.33 35.18 8.97 186.72 125.72 10.79 185.00 126.80 12.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 187.20 121.57 7.01 187.54 119.42 6.92 coo 16.43 30.18 9.35 15.05 30.67 11.01 188.20 120.86 -0.01 187.44 119.02 0.88 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 113 TYR^? 17.81 O4 CIT A1102 I 306 VAL B 141 VAL^? 11.04 O4 CIT A1102 I 308 VAL B 145 VAL.? 12.69 O4 CIT A1102 coo 26.18 35.24 6.87 24.33 35.18 8.97 186.72 125.72 10.79 185.00 126.80 12.71 coo 23.55 29.53 9.81 23.15 27.39 10.24 183.12 131.20 5.11 183.01 129.18 5.91 coo 16.43 30.18 9.35 15.05 30.67 11.01 180.11 126.34 1.26 182.18 126.88 1.13 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 117 TYR.? 15.40 O4 CIT A1102 I 306 VAL B 116 VAL^? 19.12 O4 CIT A1102 I 308 VAL B 114 VAL^? 21.37 O4 CIT A1102 coo 26.18 35.24 6.87 24.33 35.18 8.97 184.92 125.90 -1.64 186.19 127.72 0.06 coo 23.55 29.53 9.81 23.15 27.39 10.24 183.91 121.70 1.00 183.40 119.59 1.01 coo 16.43 30.18 9.35 15.05 30.67 11.01 187.20 121.57 7.01 187.54 119.42 6.92 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 117 TYR.? 15.40 O4 CIT A1102 I 306 VAL B 116 VAL^? 19.12 O4 CIT A1102 I 308 VAL B 189 VAL.? 25.00 C2 CIT A1102 coo 26.18 35.24 6.87 24.33 35.18 8.97 184.92 125.90 -1.64 186.19 127.72 0.06 coo 23.55 29.53 9.81 23.15 27.39 10.24 183.91 121.70 1.00 183.40 119.59 1.01 coo 16.43 30.18 9.35 15.05 30.67 11.01 184.10 114.66 -3.06 185.19 115.56 -1.41 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 13 3 # 13 I 303 TYR B 117 TYR.? 15.40 O4 CIT A1102 I 306 VAL B 122 VAL.? 21.87 O4 CIT A1102 I 308 VAL B 114 VAL^? 21.37 O4 CIT A1102 coo 26.18 35.24 6.87 24.33 35.18 8.97 184.92 125.90 -1.64 186.19 127.72 0.06 coo 23.55 29.53 9.81 23.15 27.39 10.24 188.20 120.86 -0.01 187.44 119.02 0.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 187.20 121.57 7.01 187.54 119.42 6.92 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 14 3 # 14 I 303 TYR B 117 TYR.? 15.40 O4 CIT A1102 I 306 VAL B 122 VAL.? 21.87 O4 CIT A1102 I 308 VAL B 189 VAL.? 25.00 C2 CIT A1102 coo 26.18 35.24 6.87 24.33 35.18 8.97 184.92 125.90 -1.64 186.19 127.72 0.06 coo 23.55 29.53 9.81 23.15 27.39 10.24 188.20 120.86 -0.01 187.44 119.02 0.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 184.10 114.66 -3.06 185.19 115.56 -1.41 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 15 3 # 15 I 303 TYR C 113 TYR^? 15.28 O1 GOL C1901 I 306 VAL C 114 VAL^? 20.50 O1 GOL C1901 I 308 VAL C 116 VAL^? 21.24 O1 GOL C1901 coo 26.18 35.24 6.87 24.33 35.18 8.97 165.10 130.81 41.92 162.37 130.83 41.35 coo 23.55 29.53 9.81 23.15 27.39 10.24 169.18 127.76 44.39 169.90 127.19 46.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 171.81 122.27 41.21 172.19 121.04 42.96 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 16 3 # 16 I 303 TYR C 113 TYR^? 15.28 O1 GOL C1901 I 306 VAL C 114 VAL^? 20.50 O1 GOL C1901 I 308 VAL C 122 VAL^? 24.59 O1 GOL C1901 coo 26.18 35.24 6.87 24.33 35.18 8.97 165.10 130.81 41.92 162.37 130.83 41.35 coo 23.55 29.53 9.81 23.15 27.39 10.24 169.18 127.76 44.39 169.90 127.19 46.35 coo 16.43 30.18 9.35 15.05 30.67 11.01 175.34 124.54 42.59 174.82 123.84 44.59 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 17 3 # 17 I 303 TYR C 113 TYR^? 15.28 O1 GOL C1901 I 306 VAL C 141 VAL^? 15.00 O1 GOL C1901 I 308 VAL C 145 VAL.? 17.37 O1 GOL C1901 coo 26.18 35.24 6.87 24.33 35.18 8.97 165.10 130.81 41.92 162.37 130.83 41.35 coo 23.55 29.53 9.81 23.15 27.39 10.24 166.44 127.56 34.33 165.34 126.87 36.10 coo 16.43 30.18 9.35 15.05 30.67 11.01 168.22 121.35 36.52 169.51 122.99 36.03 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 18 3 # 18 I 303 TYR C 117 TYR.? 21.72 O1 GOL C1901 I 306 VAL C 116 VAL^? 21.24 O1 GOL C1901 I 308 VAL C 114 VAL^? 20.50 O1 GOL C1901 coo 26.18 35.24 6.87 24.33 35.18 8.97 173.67 123.08 36.58 172.76 125.64 35.98 coo 23.55 29.53 9.81 23.15 27.39 10.24 171.81 122.27 41.21 172.19 121.04 42.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 169.18 127.76 44.39 169.90 127.19 46.35 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 19 3 # 19 I 303 TYR C 117 TYR.? 21.72 O1 GOL C1901 I 306 VAL C 116 VAL^? 21.24 O1 GOL C1901 I 308 VAL C 189 VAL~? 26.13 C1 GOL C1901 coo 26.18 35.24 6.87 24.33 35.18 8.97 173.67 123.08 36.58 172.76 125.64 35.98 coo 23.55 29.53 9.81 23.15 27.39 10.24 171.81 122.27 41.21 172.19 121.04 42.96 coo 16.43 30.18 9.35 15.05 30.67 11.01 176.43 117.89 45.62 175.06 119.54 45.95 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 20 3 # 20 I 303 TYR C 117 TYR.? 21.72 O1 GOL C1901 I 306 VAL C 122 VAL^? 24.59 O1 GOL C1901 I 308 VAL C 114 VAL^? 20.50 O1 GOL C1901 coo 26.18 35.24 6.87 24.33 35.18 8.97 173.67 123.08 36.58 172.76 125.64 35.98 coo 23.55 29.53 9.81 23.15 27.39 10.24 175.34 124.54 42.59 174.82 123.84 44.59 coo 16.43 30.18 9.35 15.05 30.67 11.01 169.18 127.76 44.39 169.90 127.19 46.35 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 21 3 # 21 I 303 TYR C 117 TYR.? 21.72 O1 GOL C1901 I 306 VAL C 122 VAL^? 24.59 O1 GOL C1901 I 308 VAL C 189 VAL~? 26.13 C1 GOL C1901 coo 26.18 35.24 6.87 24.33 35.18 8.97 173.67 123.08 36.58 172.76 125.64 35.98 coo 23.55 29.53 9.81 23.15 27.39 10.24 175.34 124.54 42.59 174.82 123.84 44.59 coo 16.43 30.18 9.35 15.05 30.67 11.01 176.43 117.89 45.62 175.06 119.54 45.95 1cqt_d00 source 1cqt GENE REGULATION/DNA : 21 hits 1cqt_d00 naa= 3 ULMN 4 1r8d_d00 TRANSCRIPTION/DNA user 1 4 # 1 B 17 ARG A 43 ARG.? 7.62 C2 ADE A 500 B 20 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 21 HIS A 176 HIS^? 6.39 N3 ADE A 500 B 38 TYR A 83 TYR^? 11.70 N6 ADE A 500 coo 53.31 58.22 4.99 55.65 57.76 6.91 190.33 158.90 11.08 189.17 159.63 8.34 coo 56.22 57.57 0.52 55.60 58.94 -0.95 191.47 153.75 14.17 189.52 154.05 13.44 coo 55.74 52.78 6.87 56.27 52.02 8.75 184.39 157.95 13.11 185.86 157.96 14.60 coo 59.03 61.07 -9.78 58.14 63.71 -10.03 192.51 141.71 13.59 192.79 138.96 13.21 1r8d_d00 source 1r8d TRANSCRIPTION/DNA : 1 hits 1r8d_d00 naa= 4 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 110 LYS.? 23.26 C8 ADE A 500 A1294 ASN A 154 ASN.? 21.16 C8 ADE A 500 A1297 GLU A 155 GLU.? 30.36 C8 ADE A 500 coo 39.24 18.84-161.99 36.62 21.47-165.99 192.52 142.86 28.75 192.00 138.78 32.31 coo 33.53 17.37-161.81 34.31 17.81-163.76 196.82 141.64 30.94 196.98 141.72 28.81 coo 29.78 23.31-161.30 31.23 23.66-162.84 202.13 137.32 32.16 203.15 136.76 33.90 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS B 110 LYS.? 26.40 N7 ADE A 500 A1294 ASN B 154 ASN.? 28.91 N7 ADE A 500 A1297 GLU B 155 GLU.? 33.13 C8 ADE A 500 coo 39.24 18.84-161.99 36.62 21.47-165.99 192.36 125.68 19.31 197.51 127.46 19.90 coo 33.53 17.37-161.81 34.31 17.81-163.76 194.71 123.63 23.05 192.89 124.34 23.91 coo 29.78 23.31-161.30 31.23 23.66-162.84 197.70 123.91 29.28 199.42 125.11 29.52 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS C 110 LYS.? 26.32 O1 GOL C1901 A1294 ASN C 154 ASN~? 23.43 O1 GOL C1901 A1297 GLU C 155 GLU~? 32.67 O1 GOL C1901 coo 39.24 18.84-161.99 36.62 21.47-165.99 161.71 139.26 46.53 163.20 144.39 46.83 coo 33.53 17.37-161.81 34.31 17.81-163.76 160.52 142.23 50.24 158.78 141.09 49.77 coo 29.78 23.31-161.30 31.23 23.66-162.84 159.66 146.89 54.14 160.20 148.86 54.76 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 3 hits 1xpx_d00 naa= 3 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 5 ARG A 76 ARG^? 12.51 N1 ADE A 500 A 50 LYS A 97 LYS^? 15.28 N9 ADE A 500 A 51 ASN A 98 ASN^? 5.64 N9 ADE A 500 coo 28.68 23.77 42.74 27.76 26.72 42.93 176.90 153.44 4.90 177.24 156.32 3.96 coo 14.40 30.33 40.28 14.25 28.31 45.36 180.69 158.10 18.36 176.95 162.62 18.15 coo 19.09 30.55 41.51 19.09 28.89 42.82 179.72 154.52 15.51 181.63 154.42 14.60 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 5 ARG B 76 ARG^? 5.63 O1 CIT A1102 A 50 LYS B 97 LYS^? 12.22 C2 CIT A1102 A 51 ASN B 98 ASN^? 8.56 C4 CIT A1102 coo 28.68 23.77 42.74 27.76 26.72 42.93 166.15 136.82 7.45 164.99 134.62 5.65 coo 14.40 30.33 40.28 14.25 28.31 45.36 175.75 125.08 4.60 173.18 124.12 -0.61 coo 19.09 30.55 41.51 19.09 28.89 42.82 174.94 129.17 6.18 173.60 130.41 7.30 ULMN 3 2hos_d00 TRANSCRIPTION/DNA user 3 3 # 3 A 5 ARG C 76 ARG^? 12.29 O2 GOL C1901 A 50 LYS C 97 LYS^? 17.09 C1 GOL C1901 A 51 ASN C 98 ASN^? 8.51 O1 GOL C1901 coo 28.68 23.77 42.74 27.76 26.72 42.93 153.02 116.91 26.58 154.63 114.54 27.70 coo 14.40 30.33 40.28 14.25 28.31 45.36 163.30 119.33 38.22 166.56 114.68 36.90 coo 19.09 30.55 41.51 19.09 28.89 42.82 160.68 120.91 34.68 159.00 120.62 33.38 2hos_d00 source 2hos TRANSCRIPTION/DNA : 3 hits 2hos_d00 naa= 3 ULMN 4 2jzw_d00 VIRAL PROTEIN/DNA user 1 4 # 1 A 13 VAL A 166 VAL^? 7.84 N7 ADE A 500 A 24 THR A 80 THR^? 4.30 N6 ADE A 500 A 26 ARG A 53 ARG^? 5.21 N6 ADE A 500 A 27 ASN A 77 ASN^? 9.65 N6 ADE A 500 coo -7.80 -8.09 -1.93 -7.75 -6.18 -3.08 181.86 144.06 13.30 181.30 142.06 12.65 coo -8.07 -1.12 -3.46 -7.60 -2.11 -5.34 182.84 145.31 7.97 182.66 147.39 7.73 coo -7.45 1.42 -8.63 -9.67 1.71 -10.78 184.38 147.77 2.51 183.90 149.96 4.60 coo -11.40 1.86 -5.16 -10.85 1.18 -7.11 179.83 147.18 2.66 181.08 147.98 1.14 ULMN 4 2jzw_d00 VIRAL PROTEIN/DNA user 2 4 # 2 A 13 VAL A 167 VAL^? 5.66 N7 ADE A 500 A 24 THR A 80 THR^? 4.30 N6 ADE A 500 A 26 ARG A 53 ARG^? 5.21 N6 ADE A 500 A 27 ASN A 77 ASN^? 9.65 N6 ADE A 500 coo -7.80 -8.09 -1.93 -7.75 -6.18 -3.08 179.77 147.01 12.10 180.70 148.96 12.24 coo -8.07 -1.12 -3.46 -7.60 -2.11 -5.34 182.84 145.31 7.97 182.66 147.39 7.73 coo -7.45 1.42 -8.63 -9.67 1.71 -10.78 184.38 147.77 2.51 183.90 149.96 4.60 coo -11.40 1.86 -5.16 -10.85 1.18 -7.11 179.83 147.18 2.66 181.08 147.98 1.14 ULMN 4 2jzw_d00 VIRAL PROTEIN/DNA user 3 4 # 3 A 13 VAL B 166 VAL^? 10.79 O4 CIT A1102 A 24 THR B 80 THR^? 11.53 O1 CIT A1102 A 26 ARG B 53 ARG^? 12.50 O1 CIT A1102 A 27 ASN B 77 ASN^? 12.53 O1 CIT A1102 coo -7.80 -8.09 -1.93 -7.75 -6.18 -3.08 178.33 136.80 13.13 178.76 138.88 13.62 coo -8.07 -1.12 -3.46 -7.60 -2.11 -5.34 173.05 137.67 14.86 171.74 136.22 13.94 coo -7.45 1.42 -8.63 -9.67 1.71 -10.78 166.97 137.64 16.68 167.60 135.18 14.95 coo -11.40 1.86 -5.16 -10.85 1.18 -7.11 167.65 140.29 13.08 165.89 139.84 14.18 ULMN 4 2jzw_d00 VIRAL PROTEIN/DNA user 4 4 # 4 A 13 VAL B 167 VAL^? 7.72 O4 CIT A1102 A 24 THR B 80 THR^? 11.53 O1 CIT A1102 A 26 ARG B 53 ARG^? 12.50 O1 CIT A1102 A 27 ASN B 77 ASN^? 12.53 O1 CIT A1102 coo -7.80 -8.09 -1.93 -7.75 -6.18 -3.08 175.73 136.30 10.41 174.85 134.33 10.25 coo -8.07 -1.12 -3.46 -7.60 -2.11 -5.34 173.05 137.67 14.86 171.74 136.22 13.94 coo -7.45 1.42 -8.63 -9.67 1.71 -10.78 166.97 137.64 16.68 167.60 135.18 14.95 coo -11.40 1.86 -5.16 -10.85 1.18 -7.11 167.65 140.29 13.08 165.89 139.84 14.18 ULMN 4 2jzw_d00 VIRAL PROTEIN/DNA user 5 4 # 5 A 13 VAL C 166 VAL^? 10.25 O1 GOL C1901 A 24 THR C 80 THR^? 5.30 O1 GOL C1901 A 26 ARG C 53 ARG^? 4.89 O2 GOL C1901 A 27 ASN C 77 ASN^? 9.92 O2 GOL C1901 coo -7.80 -8.09 -1.93 -7.75 -6.18 -3.08 155.88 129.75 31.46 155.29 131.11 29.87 coo -8.07 -1.12 -3.46 -7.60 -2.11 -5.34 151.58 126.43 30.18 151.60 124.76 31.56 coo -7.45 1.42 -8.63 -9.67 1.71 -10.78 146.33 122.48 29.52 148.17 121.33 31.67 coo -11.40 1.86 -5.16 -10.85 1.18 -7.11 149.21 122.45 26.13 147.53 121.25 26.66 ULMN 4 2jzw_d00 VIRAL PROTEIN/DNA user 6 4 # 6 A 13 VAL C 167 VAL^? 8.15 O1 GOL C1901 A 24 THR C 80 THR^? 5.30 O1 GOL C1901 A 26 ARG C 53 ARG^? 4.89 O2 GOL C1901 A 27 ASN C 77 ASN^? 9.92 O2 GOL C1901 coo -7.80 -8.09 -1.93 -7.75 -6.18 -3.08 156.80 126.29 30.31 157.16 124.69 31.72 coo -8.07 -1.12 -3.46 -7.60 -2.11 -5.34 151.58 126.43 30.18 151.60 124.76 31.56 coo -7.45 1.42 -8.63 -9.67 1.71 -10.78 146.33 122.48 29.52 148.17 121.33 31.67 coo -11.40 1.86 -5.16 -10.85 1.18 -7.11 149.21 122.45 26.13 147.53 121.25 26.66 2jzw_d00 source 2jzw VIRAL PROTEIN/DNA : 6 hits 2jzw_d00 naa= 4 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 54 SER.? 4.61 O3 CIT A1102 B 37 ASN A 77 ASN^? 9.65 N6 ADE A 500 B 45 THR B 57 THR^? 12.97 O5 CIT A1102 coo -19.49 41.97 71.08 -17.37 40.80 71.17 180.68 142.57 2.59 178.38 141.86 2.59 coo -23.05 39.62 69.74 -22.86 39.59 67.61 179.83 147.18 2.66 181.08 147.98 1.14 coo -30.87 34.84 80.57 -28.94 34.51 81.49 165.99 145.04 10.45 163.91 145.03 10.88 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 1 hits 2z3x_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 149 SER^? 11.10 N9 ADE A 500 A 20 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 22 LEU A 179 LEU.? 15.79 N9 ADE A 500 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 188.74 152.31 25.78 189.32 151.10 23.76 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 185.28 156.61 18.37 185.56 154.55 18.68 coo -14.55 2.62 13.63 -14.94 2.66 11.50 184.39 163.22 22.10 184.20 164.27 23.98 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER B 149 SER^? 19.92 O4 CIT A1102 A 20 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 22 LEU B 179 LEU.? 19.82 C2 CIT A1102 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 184.89 121.99 12.52 183.61 123.38 14.10 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 176.50 123.51 9.48 177.50 124.87 10.72 coo -14.55 2.62 13.63 -14.94 2.66 11.50 175.42 117.47 3.45 176.95 116.74 4.78 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 2 hits 3gxq_d00 naa= 3 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN A 31 GLN~? 20.10 N3 ADE A 500 A 41 TYR A 47 TYR^? 13.72 N3 ADE A 500 A 43 ASN A 35 ASN~? 19.82 C2 ADE A 500 coo 22.03 6.35 12.16 20.71 6.08 10.54 207.25 146.56 17.53 206.34 147.70 15.98 coo 18.67 0.21 9.03 16.70 -1.66 8.55 198.66 149.45 16.16 201.00 150.74 16.95 coo 14.90 7.30 8.78 14.25 8.14 6.97 205.66 144.31 11.38 206.37 146.04 12.39 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 1 hits 3ssc_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 208 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 296 SER B 164 SER^? 16.78 N7 ADE A 500 coo 12.72 17.48 24.71 12.80 19.37 23.81 191.47 153.75 14.17 189.52 154.05 13.44 coo 18.47 29.19 29.68 19.30 29.17 27.75 180.59 154.59 5.93 180.83 155.75 4.19 coo 6.89 17.22 46.63 5.08 16.21 47.91 181.99 133.83 18.01 182.11 135.27 19.93 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 42 HIS.? -4.20 N3 ADE A 500s A 208 ASP A 175 ASP.? 10.98 C4 ADE A 500 A 296 SER B 164 SER^? 16.78 N7 ADE A 500 coo 12.72 17.48 24.71 12.80 19.37 23.81 191.47 153.75 14.17 189.52 154.05 13.44 coo 18.47 29.19 29.68 19.30 29.17 27.75 178.57 156.37 9.84 177.44 156.14 8.05 coo 6.89 17.22 46.63 5.08 16.21 47.91 181.99 133.83 18.01 182.11 135.27 19.93 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 208 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 296 SER B 137 SER.? 16.00 N6 ADE A 500 coo 12.72 17.48 24.71 12.80 19.37 23.81 185.28 156.61 18.37 185.56 154.55 18.68 coo 18.47 29.19 29.68 19.30 29.17 27.75 180.59 154.59 5.93 180.83 155.75 4.19 coo 6.89 17.22 46.63 5.08 16.21 47.91 192.22 133.71 14.40 193.34 135.87 14.56 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS A 96 HIS^? 6.77 N9 ADE A 500 A 208 ASP A 172 ASP~? 9.43 N1 ADE A 500 A 296 SER B 164 SER^? 16.78 N7 ADE A 500 coo 12.72 17.48 24.71 12.80 19.37 23.81 185.28 156.61 18.37 185.56 154.55 18.68 coo 18.47 29.19 29.68 19.30 29.17 27.75 180.59 154.59 5.93 180.83 155.75 4.19 coo 6.89 17.22 46.63 5.08 16.21 47.91 181.99 133.83 18.01 182.11 135.27 19.93 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS A 104 HIS^? 8.41 C8 ADE A 500 A 208 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 296 SER A 29 SER~? 23.57 C8 ADE A 500 coo 12.72 17.48 24.71 12.80 19.37 23.81 183.15 146.13 20.69 182.60 148.09 20.18 coo 18.47 29.19 29.68 19.30 29.17 27.75 185.72 140.93 6.30 184.35 140.00 4.99 coo 6.89 17.22 46.63 5.08 16.21 47.91 205.95 140.49 20.33 204.83 140.40 22.50 ULMN 3 2odj_o00 PORIN D user 6 3 # 6 A 156 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 208 ASP B 172 ASP~? 8.81 O1 CIT A1102 A 296 SER A 164 SER^? 10.66 N7 ADE A 500 coo 12.72 17.48 24.71 12.80 19.37 23.81 174.27 123.90 17.18 173.55 124.80 15.43 coo 18.47 29.19 29.68 19.30 29.17 27.75 166.30 133.15 8.87 164.29 132.56 8.69 coo 6.89 17.22 46.63 5.08 16.21 47.91 187.50 142.03 16.61 188.23 139.96 15.55 ULMN 3 2odj_o00 PORIN D user 7 3 # 7 A 156 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 208 ASP B 172 ASP~? 8.81 O1 CIT A1102 A 296 SER C 79 SER.? 11.88 O1 GOL C1901 coo 12.72 17.48 24.71 12.80 19.37 23.81 174.27 123.90 17.18 173.55 124.80 15.43 coo 18.47 29.19 29.68 19.30 29.17 27.75 166.30 133.15 8.87 164.29 132.56 8.69 coo 6.89 17.22 46.63 5.08 16.21 47.91 152.54 126.39 26.52 151.63 128.65 26.08 ULMN 3 2odj_o00 PORIN D user 8 3 # 8 A 156 HIS B 42 HIS.? 18.79 O1 CIT A1102 A 208 ASP B 175 ASP.? 4.91 O1 CIT A1102 A 296 SER A 164 SER^? 10.66 N7 ADE A 500 coo 12.72 17.48 24.71 12.80 19.37 23.81 174.27 123.90 17.18 173.55 124.80 15.43 coo 18.47 29.19 29.68 19.30 29.17 27.75 169.82 131.15 6.22 168.64 132.89 5.97 coo 6.89 17.22 46.63 5.08 16.21 47.91 187.50 142.03 16.61 188.23 139.96 15.55 ULMN 3 2odj_o00 PORIN D user 9 3 # 9 A 156 HIS B 96 HIS^? 15.42 O4 CIT A1102 A 208 ASP B 172 ASP~? 8.81 O1 CIT A1102 A 296 SER A 164 SER^? 10.66 N7 ADE A 500 coo 12.72 17.48 24.71 12.80 19.37 23.81 176.50 123.51 9.48 177.50 124.87 10.72 coo 18.47 29.19 29.68 19.30 29.17 27.75 166.30 133.15 8.87 164.29 132.56 8.69 coo 6.89 17.22 46.63 5.08 16.21 47.91 187.50 142.03 16.61 188.23 139.96 15.55 ULMN 3 2odj_o00 PORIN D user 10 3 # 10 A 156 HIS B 104 HIS^? 12.85 O4 CIT A1102 A 208 ASP B 52 ASP^? 16.07 C8 ADE A 500 A 296 SER B 29 SER~? 33.20 C8 ADE A 500 coo 12.72 17.48 24.71 12.80 19.37 23.81 183.49 131.36 11.56 181.98 130.36 10.51 coo 18.47 29.19 29.68 19.30 29.17 27.75 173.93 140.35 20.11 173.24 142.10 19.12 coo 6.89 17.22 46.63 5.08 16.21 47.91 186.12 123.79 33.89 187.98 123.41 32.34 ULMN 3 2odj_o00 PORIN D user 11 3 # 11 A 156 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 208 ASP C 89 ASP.? 17.67 O3 GOL C1901 A 296 SER C 137 SER.? 22.99 O1 GOL C1901 coo 12.72 17.48 24.71 12.80 19.37 23.81 153.36 123.09 43.85 154.03 121.98 42.20 coo 18.47 29.19 29.68 19.30 29.17 27.75 152.15 130.32 56.35 151.16 130.16 54.50 coo 6.89 17.22 46.63 5.08 16.21 47.91 163.55 140.21 37.15 163.65 142.66 37.22 ULMN 3 2odj_o00 PORIN D user 12 3 # 12 A 156 HIS C 42 HIS.? 5.32 O3 GOL C1901 A 208 ASP C 175 ASP.? 10.66 O1 GOL C1901 A 296 SER C 137 SER.? 22.99 O1 GOL C1901 coo 12.72 17.48 24.71 12.80 19.37 23.81 153.36 123.09 43.85 154.03 121.98 42.20 coo 18.47 29.19 29.68 19.30 29.17 27.75 157.90 117.18 31.56 156.68 116.62 29.91 coo 6.89 17.22 46.63 5.08 16.21 47.91 163.55 140.21 37.15 163.65 142.66 37.22 ULMN 3 2odj_o00 PORIN D user 13 3 # 13 A 156 HIS C 104 HIS^? 12.14 O1 GOL C1901 A 208 ASP C 52 ASP^? 12.06 O1 GOL C1901 A 296 SER C 29 SER~? 23.88 O1 GOL C1901 coo 12.72 17.48 24.71 12.80 19.37 23.81 161.39 131.07 36.65 161.63 129.00 36.89 coo 18.47 29.19 29.68 19.30 29.17 27.75 147.21 130.59 30.19 147.01 130.37 28.08 coo 6.89 17.22 46.63 5.08 16.21 47.91 147.11 140.58 52.92 148.91 141.55 51.57 2odj_o00 source 2ODJ PORIN D : 13 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 208 ASP A 172 ASP~? 9.43 N1 ADE A 500 B 296 SER B 164 SER^? 16.78 N7 ADE A 500 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 191.47 153.75 14.17 189.52 154.05 13.44 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 180.59 154.59 5.93 180.83 155.75 4.19 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 181.99 133.83 18.01 182.11 135.27 19.93 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 42 HIS.? -4.20 N3 ADE A 500s B 208 ASP A 175 ASP.? 10.98 C4 ADE A 500 B 296 SER B 164 SER^? 16.78 N7 ADE A 500 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 191.47 153.75 14.17 189.52 154.05 13.44 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 178.57 156.37 9.84 177.44 156.14 8.05 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 181.99 133.83 18.01 182.11 135.27 19.93 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS A 96 HIS^? 6.77 N9 ADE A 500 B 208 ASP A 172 ASP~? 9.43 N1 ADE A 500 B 296 SER B 164 SER^? 16.78 N7 ADE A 500 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 185.28 156.61 18.37 185.56 154.55 18.68 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 180.59 154.59 5.93 180.83 155.75 4.19 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 181.99 133.83 18.01 182.11 135.27 19.93 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS A 104 HIS^? 8.41 C8 ADE A 500 B 208 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 296 SER A 29 SER~? 23.57 C8 ADE A 500 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 183.15 146.13 20.69 182.60 148.09 20.18 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 185.72 140.93 6.30 184.35 140.00 4.99 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 205.95 140.49 20.33 204.83 140.40 22.50 ULMN 3 2odj_o01 PORIN D user 5 3 # 5 B 156 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 208 ASP B 172 ASP~? 8.81 O1 CIT A1102 B 296 SER A 164 SER^? 10.66 N7 ADE A 500 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 174.27 123.90 17.18 173.55 124.80 15.43 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 166.30 133.15 8.87 164.29 132.56 8.69 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 187.50 142.03 16.61 188.23 139.96 15.55 ULMN 3 2odj_o01 PORIN D user 6 3 # 6 B 156 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 208 ASP B 172 ASP~? 8.81 O1 CIT A1102 B 296 SER C 79 SER.? 11.88 O1 GOL C1901 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 174.27 123.90 17.18 173.55 124.80 15.43 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 166.30 133.15 8.87 164.29 132.56 8.69 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 152.54 126.39 26.52 151.63 128.65 26.08 ULMN 3 2odj_o01 PORIN D user 7 3 # 7 B 156 HIS B 42 HIS.? 18.79 O1 CIT A1102 B 208 ASP B 175 ASP.? 4.91 O1 CIT A1102 B 296 SER A 164 SER^? 10.66 N7 ADE A 500 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 174.27 123.90 17.18 173.55 124.80 15.43 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 169.82 131.15 6.22 168.64 132.89 5.97 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 187.50 142.03 16.61 188.23 139.96 15.55 ULMN 3 2odj_o01 PORIN D user 8 3 # 8 B 156 HIS B 96 HIS^? 15.42 O4 CIT A1102 B 208 ASP B 172 ASP~? 8.81 O1 CIT A1102 B 296 SER A 164 SER^? 10.66 N7 ADE A 500 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 176.50 123.51 9.48 177.50 124.87 10.72 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 166.30 133.15 8.87 164.29 132.56 8.69 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 187.50 142.03 16.61 188.23 139.96 15.55 ULMN 3 2odj_o01 PORIN D user 9 3 # 9 B 156 HIS B 104 HIS^? 12.85 O4 CIT A1102 B 208 ASP B 52 ASP^? 16.07 C8 ADE A 500 B 296 SER B 29 SER~? 33.20 C8 ADE A 500 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 183.49 131.36 11.56 181.98 130.36 10.51 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 173.93 140.35 20.11 173.24 142.10 19.12 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 186.12 123.79 33.89 187.98 123.41 32.34 ULMN 3 2odj_o01 PORIN D user 10 3 # 10 B 156 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 208 ASP C 89 ASP.? 17.67 O3 GOL C1901 B 296 SER C 137 SER.? 22.99 O1 GOL C1901 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 153.36 123.09 43.85 154.03 121.98 42.20 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 152.15 130.32 56.35 151.16 130.16 54.50 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 163.55 140.21 37.15 163.65 142.66 37.22 ULMN 3 2odj_o01 PORIN D user 11 3 # 11 B 156 HIS C 42 HIS.? 5.32 O3 GOL C1901 B 208 ASP C 175 ASP.? 10.66 O1 GOL C1901 B 296 SER C 137 SER.? 22.99 O1 GOL C1901 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 153.36 123.09 43.85 154.03 121.98 42.20 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 157.90 117.18 31.56 156.68 116.62 29.91 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 163.55 140.21 37.15 163.65 142.66 37.22 ULMN 3 2odj_o01 PORIN D user 12 3 # 12 B 156 HIS C 104 HIS^? 12.14 O1 GOL C1901 B 208 ASP C 52 ASP^? 12.06 O1 GOL C1901 B 296 SER C 29 SER~? 23.88 O1 GOL C1901 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 161.39 131.07 36.65 161.63 129.00 36.89 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 147.21 130.59 30.19 147.01 130.37 28.08 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 147.11 140.58 52.92 148.91 141.55 51.57 2odj_o01 source 2ODJ PORIN D : 12 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 29 SER~? 23.57 C8 ADE A 500 A 166 PHE A 157 PHE.? 18.76 C8 ADE A 500 A 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 205.95 140.49 20.33 204.83 140.40 22.50 coo -36.62 39.62 84.60 -38.76 41.24 85.25 197.65 139.50 24.25 197.70 140.07 21.50 coo -36.55 45.66 79.22 -38.34 43.94 80.53 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 29 SER~? 23.57 C8 ADE A 500 A 166 PHE A 157 PHE.? 18.76 C8 ADE A 500 A 182 PHE B 129 PHE.? 19.08 N7 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 205.95 140.49 20.33 204.83 140.40 22.50 coo -36.62 39.62 84.60 -38.76 41.24 85.25 197.65 139.50 24.25 197.70 140.07 21.50 coo -36.55 45.66 79.22 -38.34 43.94 80.53 195.26 133.73 19.36 192.72 134.81 19.79 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 79 SER.? 7.17 O4 CIT A1102 A 166 PHE A 171 PHE.? -3.51 C4 ADE A 500s A 182 PHE A 48 PHE^? 4.82 C2 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 179.20 144.60 7.13 179.51 142.21 7.02 coo -36.62 39.62 84.60 -38.76 41.24 85.25 183.57 152.25 9.92 184.62 154.69 10.81 coo -36.55 45.66 79.22 -38.34 43.94 80.53 192.28 150.01 12.11 192.07 151.51 9.74 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 90 SER.? 14.48 N3 ADE A 500 A 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 A 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 199.47 153.71 22.16 199.01 152.90 19.92 coo -36.62 39.62 84.60 -38.76 41.24 85.25 191.79 152.73 29.72 190.51 152.36 32.17 coo -36.55 45.66 79.22 -38.34 43.94 80.53 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER A 90 SER.? 14.48 N3 ADE A 500 A 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 A 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 199.47 153.71 22.16 199.01 152.90 19.92 coo -36.62 39.62 84.60 -38.76 41.24 85.25 191.79 152.73 29.72 190.51 152.36 32.17 coo -36.55 45.66 79.22 -38.34 43.94 80.53 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER A 90 SER.? 14.48 N3 ADE A 500 A 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 A 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 199.47 153.71 22.16 199.01 152.90 19.92 coo -36.62 39.62 84.60 -38.76 41.24 85.25 192.43 145.24 24.85 189.68 145.10 25.32 coo -36.55 45.66 79.22 -38.34 43.94 80.53 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER A 124 SER^? 19.87 C8 ADE A 500 A 166 PHE A 95 PHE^? 15.24 N9 ADE A 500 A 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 182.61 151.80 32.41 184.93 152.05 33.02 coo -36.62 39.62 84.60 -38.76 41.24 85.25 185.36 159.68 24.99 184.83 158.72 27.56 coo -36.55 45.66 79.22 -38.34 43.94 80.53 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER A 124 SER^? 19.87 C8 ADE A 500 A 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 A 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 182.61 151.80 32.41 184.93 152.05 33.02 coo -36.62 39.62 84.60 -38.76 41.24 85.25 191.79 152.73 29.72 190.51 152.36 32.17 coo -36.55 45.66 79.22 -38.34 43.94 80.53 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER A 124 SER^? 19.87 C8 ADE A 500 A 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 A 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 182.61 151.80 32.41 184.93 152.05 33.02 coo -36.62 39.62 84.60 -38.76 41.24 85.25 191.79 152.73 29.72 190.51 152.36 32.17 coo -36.55 45.66 79.22 -38.34 43.94 80.53 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER A 137 SER.? 19.19 C8 ADE A 500 A 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 A 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 184.43 139.00 26.42 183.74 136.66 26.44 coo -36.62 39.62 84.60 -38.76 41.24 85.25 192.43 145.24 24.85 189.68 145.10 25.32 coo -36.55 45.66 79.22 -38.34 43.94 80.53 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 11 3 # 11 A 130 SER A 149 SER^? 11.10 N9 ADE A 500 A 166 PHE A 146 PHE^? 14.35 N9 ADE A 500 A 182 PHE A 178 PHE^? 9.61 N3 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 188.74 152.31 25.78 189.32 151.10 23.76 coo -36.62 39.62 84.60 -38.76 41.24 85.25 180.53 160.39 22.57 180.33 162.62 20.86 coo -36.55 45.66 79.22 -38.34 43.94 80.53 187.30 161.92 16.41 189.15 160.05 15.37 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 12 3 # 12 A 130 SER A 164 SER^? 10.66 N7 ADE A 500 A 166 PHE A 48 PHE^? 4.82 C2 ADE A 500 A 182 PHE A 171 PHE.? -3.51 C4 ADE A 500s coo -46.28 37.24 81.97 -44.96 39.32 82.40 187.50 142.03 16.61 188.23 139.96 15.55 coo -36.62 39.62 84.60 -38.76 41.24 85.25 192.28 150.01 12.11 192.07 151.51 9.74 coo -36.55 45.66 79.22 -38.34 43.94 80.53 183.57 152.25 9.92 184.62 154.69 10.81 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 13 3 # 13 A 130 SER A 164 SER^? 10.66 N7 ADE A 500 A 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 A 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 187.50 142.03 16.61 188.23 139.96 15.55 coo -36.62 39.62 84.60 -38.76 41.24 85.25 192.43 145.24 24.85 189.68 145.10 25.32 coo -36.55 45.66 79.22 -38.34 43.94 80.53 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 14 3 # 14 A 130 SER A 164 SER^? 10.66 N7 ADE A 500 A 166 PHE B 129 PHE.? 19.08 N7 ADE A 500 A 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 187.50 142.03 16.61 188.23 139.96 15.55 coo -36.62 39.62 84.60 -38.76 41.24 85.25 195.26 133.73 19.36 192.72 134.81 19.79 coo -36.55 45.66 79.22 -38.34 43.94 80.53 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 15 3 # 15 A 130 SER B 29 SER~? 33.20 C8 ADE A 500 A 166 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 182 PHE A 129 PHE.? 20.13 C8 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 186.12 123.79 33.89 187.98 123.41 32.34 coo -36.62 39.62 84.60 -38.76 41.24 85.25 189.45 127.38 26.40 186.79 128.09 26.89 coo -36.55 45.66 79.22 -38.34 43.94 80.53 188.97 135.38 27.69 188.93 135.61 24.90 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 16 3 # 16 A 130 SER B 29 SER~? 33.20 C8 ADE A 500 A 166 PHE B 157 PHE.? 26.46 N7 ADE A 500 A 182 PHE B 161 PHE^? 22.57 O4 CIT A1102 coo -46.28 37.24 81.97 -44.96 39.32 82.40 186.12 123.79 33.89 187.98 123.41 32.34 coo -36.62 39.62 84.60 -38.76 41.24 85.25 189.45 127.38 26.40 186.79 128.09 26.89 coo -36.55 45.66 79.22 -38.34 43.94 80.53 187.70 125.47 18.98 188.18 126.81 16.59 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 17 3 # 17 A 130 SER B 79 SER.? 11.49 O4 CIT A1102 A 166 PHE B 171 PHE.? 11.13 O1 CIT A1102 A 182 PHE B 173 PHE~? 14.11 O1 CIT A1102 coo -46.28 37.24 81.97 -44.96 39.32 82.40 172.67 140.46 12.34 174.10 141.88 13.69 coo -36.62 39.62 84.60 -38.76 41.24 85.25 170.58 131.61 12.01 169.84 128.92 11.74 coo -36.55 45.66 79.22 -38.34 43.94 80.53 165.53 127.89 11.96 166.03 128.02 14.71 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 18 3 # 18 A 130 SER B 90 SER.? 26.90 O4 CIT A1102 A 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 A 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -46.28 37.24 81.97 -44.96 39.32 82.40 181.23 117.12 21.89 179.24 118.41 21.27 coo -36.62 39.62 84.60 -38.76 41.24 85.25 188.19 118.44 13.90 190.60 118.29 12.52 coo -36.55 45.66 79.22 -38.34 43.94 80.53 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 19 3 # 19 A 130 SER B 90 SER.? 26.90 O4 CIT A1102 A 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 181.23 117.12 21.89 179.24 118.41 21.27 coo -36.62 39.62 84.60 -38.76 41.24 85.25 187.70 125.47 18.98 188.18 126.81 16.59 coo -36.55 45.66 79.22 -38.34 43.94 80.53 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 20 3 # 20 A 130 SER B 124 SER^? 23.63 O4 CIT A1102 A 166 PHE B 95 PHE^? 20.65 O4 CIT A1102 A 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -46.28 37.24 81.97 -44.96 39.32 82.40 191.23 122.78 5.73 191.55 121.05 7.41 coo -36.62 39.62 84.60 -38.76 41.24 85.25 180.74 118.63 6.48 183.40 118.33 5.64 coo -36.55 45.66 79.22 -38.34 43.94 80.53 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 21 3 # 21 A 130 SER B 124 SER^? 23.63 O4 CIT A1102 A 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 A 182 PHE B 161 PHE^? 22.57 O4 CIT A1102 coo -46.28 37.24 81.97 -44.96 39.32 82.40 191.23 122.78 5.73 191.55 121.05 7.41 coo -36.62 39.62 84.60 -38.76 41.24 85.25 188.19 118.44 13.90 190.60 118.29 12.52 coo -36.55 45.66 79.22 -38.34 43.94 80.53 187.70 125.47 18.98 188.18 126.81 16.59 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 22 3 # 22 A 130 SER B 124 SER^? 23.63 O4 CIT A1102 A 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 A 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -46.28 37.24 81.97 -44.96 39.32 82.40 191.23 122.78 5.73 191.55 121.05 7.41 coo -36.62 39.62 84.60 -38.76 41.24 85.25 188.19 118.44 13.90 190.60 118.29 12.52 coo -36.55 45.66 79.22 -38.34 43.94 80.53 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 23 3 # 23 A 130 SER B 137 SER.? 16.00 N6 ADE A 500 A 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 192.22 133.71 14.40 193.34 135.87 14.56 coo -36.62 39.62 84.60 -38.76 41.24 85.25 187.70 125.47 18.98 188.18 126.81 16.59 coo -36.55 45.66 79.22 -38.34 43.94 80.53 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 24 3 # 24 A 130 SER B 149 SER^? 19.92 O4 CIT A1102 A 166 PHE B 146 PHE^? 15.86 C2 CIT A1102 A 182 PHE B 178 PHE.? 18.93 O1 CIT A1102 coo -46.28 37.24 81.97 -44.96 39.32 82.40 184.89 121.99 12.52 183.61 123.38 14.10 coo -36.62 39.62 84.60 -38.76 41.24 85.25 178.16 121.58 2.78 175.54 120.91 2.10 coo -36.55 45.66 79.22 -38.34 43.94 80.53 171.75 119.32 8.74 169.38 118.09 9.61 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 25 3 # 25 A 130 SER B 164 SER^? 16.78 N7 ADE A 500 A 166 PHE A 129 PHE.? 20.13 C8 ADE A 500 A 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 181.99 133.83 18.01 182.11 135.27 19.93 coo -36.62 39.62 84.60 -38.76 41.24 85.25 188.97 135.38 27.69 188.93 135.61 24.90 coo -36.55 45.66 79.22 -38.34 43.94 80.53 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 26 3 # 26 A 130 SER B 164 SER^? 16.78 N7 ADE A 500 A 166 PHE B 48 PHE^? 19.83 O1 CIT A1102 A 182 PHE B 171 PHE.? 11.13 O1 CIT A1102 coo -46.28 37.24 81.97 -44.96 39.32 82.40 181.99 133.83 18.01 182.11 135.27 19.93 coo -36.62 39.62 84.60 -38.76 41.24 85.25 174.23 127.42 20.06 171.47 127.09 19.71 coo -36.55 45.66 79.22 -38.34 43.94 80.53 170.58 131.61 12.01 169.84 128.92 11.74 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 27 3 # 27 A 130 SER B 164 SER^? 16.78 N7 ADE A 500 A 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 A 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -46.28 37.24 81.97 -44.96 39.32 82.40 181.99 133.83 18.01 182.11 135.27 19.93 coo -36.62 39.62 84.60 -38.76 41.24 85.25 187.70 125.47 18.98 188.18 126.81 16.59 coo -36.55 45.66 79.22 -38.34 43.94 80.53 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 28 3 # 28 A 130 SER C 29 SER~? 23.88 O1 GOL C1901 A 166 PHE C 157 PHE~? 20.21 O1 GOL C1901 A 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 147.11 140.58 52.92 148.91 141.55 51.57 coo -36.62 39.62 84.60 -38.76 41.24 85.25 154.00 141.12 47.59 151.92 139.65 46.43 coo -36.55 45.66 79.22 -38.34 43.94 80.53 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 29 3 # 29 A 130 SER C 79 SER.? 11.88 O1 GOL C1901 A 166 PHE C 171 PHE.? -4.01 O1 GOL C1901s A 182 PHE C 173 PHE~? 4.81 C3 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 152.54 126.39 26.52 151.63 128.65 26.08 coo -36.62 39.62 84.60 -38.76 41.24 85.25 153.30 120.94 34.06 153.74 119.07 36.11 coo -36.55 45.66 79.22 -38.34 43.94 80.53 151.21 115.28 36.33 149.30 116.99 37.50 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 30 3 # 30 A 130 SER C 90 SER.? 14.02 O3 GOL C1901 A 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 A 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 155.07 128.53 53.12 154.12 126.92 51.57 coo -36.62 39.62 84.60 -38.76 41.24 85.25 165.27 130.81 50.33 167.94 131.66 50.23 coo -36.55 45.66 79.22 -38.34 43.94 80.53 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 31 3 # 31 A 130 SER C 90 SER.? 14.02 O3 GOL C1901 A 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 155.07 128.53 53.12 154.12 126.92 51.57 coo -36.62 39.62 84.60 -38.76 41.24 85.25 159.14 135.31 45.76 161.07 134.95 43.76 coo -36.55 45.66 79.22 -38.34 43.94 80.53 154.00 141.12 47.59 151.92 139.65 46.43 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 32 3 # 32 A 130 SER C 124 SER^? 23.11 O1 GOL C1901 A 166 PHE C 95 PHE^? 18.35 C1 GOL C1901 A 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 172.32 130.73 43.72 171.22 130.88 45.88 coo -36.62 39.62 84.60 -38.76 41.24 85.25 166.44 121.18 45.60 168.59 122.86 46.18 coo -36.55 45.66 79.22 -38.34 43.94 80.53 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 33 3 # 33 A 130 SER C 124 SER^? 23.11 O1 GOL C1901 A 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 A 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 172.32 130.73 43.72 171.22 130.88 45.88 coo -36.62 39.62 84.60 -38.76 41.24 85.25 165.27 130.81 50.33 167.94 131.66 50.23 coo -36.55 45.66 79.22 -38.34 43.94 80.53 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 34 3 # 34 A 130 SER C 124 SER^? 23.11 O1 GOL C1901 A 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 A 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 172.32 130.73 43.72 171.22 130.88 45.88 coo -36.62 39.62 84.60 -38.76 41.24 85.25 165.27 130.81 50.33 167.94 131.66 50.23 coo -36.55 45.66 79.22 -38.34 43.94 80.53 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 35 3 # 35 A 130 SER C 137 SER.? 22.99 O1 GOL C1901 A 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 163.55 140.21 37.15 163.65 142.66 37.22 coo -36.62 39.62 84.60 -38.76 41.24 85.25 159.14 135.31 45.76 161.07 134.95 43.76 coo -36.55 45.66 79.22 -38.34 43.94 80.53 154.00 141.12 47.59 151.92 139.65 46.43 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 36 3 # 36 A 130 SER C 149 SER^? 14.30 O1 GOL C1901 A 166 PHE C 146 PHE^? 16.71 C1 GOL C1901 A 182 PHE C 178 PHE^? 10.90 O3 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 163.58 128.93 46.04 161.38 129.11 45.07 coo -36.62 39.62 84.60 -38.76 41.24 85.25 167.22 118.61 41.10 166.40 115.95 40.88 coo -36.55 45.66 79.22 -38.34 43.94 80.53 159.27 115.44 43.88 157.53 113.30 44.32 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 37 3 # 37 A 130 SER C 164 SER^? 12.32 O1 GOL C1901 A 166 PHE C 48 PHE^? -4.71 O3 GOL C1901s A 182 PHE C 171 PHE.? -4.01 O1 GOL C1901s coo -46.28 37.24 81.97 -44.96 39.32 82.40 154.76 133.75 36.85 152.97 135.36 36.47 coo -36.62 39.62 84.60 -38.76 41.24 85.25 150.16 125.74 41.77 148.90 123.30 41.28 coo -36.55 45.66 79.22 -38.34 43.94 80.53 153.30 120.94 34.06 153.74 119.07 36.11 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 38 3 # 38 A 130 SER C 164 SER^? 12.32 O1 GOL C1901 A 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 A 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -46.28 37.24 81.97 -44.96 39.32 82.40 154.76 133.75 36.85 152.97 135.36 36.47 coo -36.62 39.62 84.60 -38.76 41.24 85.25 159.14 135.31 45.76 161.07 134.95 43.76 coo -36.55 45.66 79.22 -38.34 43.94 80.53 154.00 141.12 47.59 151.92 139.65 46.43 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 38 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 29 SER~? 23.57 C8 ADE A 500 B 166 PHE A 157 PHE.? 18.76 C8 ADE A 500 B 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 205.95 140.49 20.33 204.83 140.40 22.50 coo -29.59 43.40 95.66 -28.22 45.54 94.50 197.65 139.50 24.25 197.70 140.07 21.50 coo -32.72 50.15 98.46 -30.32 48.85 97.77 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 29 SER~? 23.57 C8 ADE A 500 B 166 PHE A 157 PHE.? 18.76 C8 ADE A 500 B 182 PHE B 129 PHE.? 19.08 N7 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 205.95 140.49 20.33 204.83 140.40 22.50 coo -29.59 43.40 95.66 -28.22 45.54 94.50 197.65 139.50 24.25 197.70 140.07 21.50 coo -32.72 50.15 98.46 -30.32 48.85 97.77 195.26 133.73 19.36 192.72 134.81 19.79 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 79 SER.? 7.17 O4 CIT A1102 B 166 PHE A 171 PHE.? -3.51 C4 ADE A 500s B 182 PHE A 48 PHE^? 4.82 C2 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 179.20 144.60 7.13 179.51 142.21 7.02 coo -29.59 43.40 95.66 -28.22 45.54 94.50 183.57 152.25 9.92 184.62 154.69 10.81 coo -32.72 50.15 98.46 -30.32 48.85 97.77 192.28 150.01 12.11 192.07 151.51 9.74 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 79 SER.? 7.17 O4 CIT A1102 B 166 PHE A 171 PHE.? -3.51 C4 ADE A 500s B 182 PHE A 173 PHE~? 4.60 C2 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 179.20 144.60 7.13 179.51 142.21 7.02 coo -29.59 43.40 95.66 -28.22 45.54 94.50 183.57 152.25 9.92 184.62 154.69 10.81 coo -32.72 50.15 98.46 -30.32 48.85 97.77 186.20 157.44 8.21 188.39 156.08 9.40 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER A 90 SER.? 14.48 N3 ADE A 500 B 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 B 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 199.47 153.71 22.16 199.01 152.90 19.92 coo -29.59 43.40 95.66 -28.22 45.54 94.50 191.79 152.73 29.72 190.51 152.36 32.17 coo -32.72 50.15 98.46 -30.32 48.85 97.77 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER A 90 SER.? 14.48 N3 ADE A 500 B 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 B 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 199.47 153.71 22.16 199.01 152.90 19.92 coo -29.59 43.40 95.66 -28.22 45.54 94.50 192.43 145.24 24.85 189.68 145.10 25.32 coo -32.72 50.15 98.46 -30.32 48.85 97.77 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER A 124 SER^? 19.87 C8 ADE A 500 B 166 PHE A 95 PHE^? 15.24 N9 ADE A 500 B 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 182.61 151.80 32.41 184.93 152.05 33.02 coo -29.59 43.40 95.66 -28.22 45.54 94.50 185.36 159.68 24.99 184.83 158.72 27.56 coo -32.72 50.15 98.46 -30.32 48.85 97.77 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER A 124 SER^? 19.87 C8 ADE A 500 B 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 B 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 182.61 151.80 32.41 184.93 152.05 33.02 coo -29.59 43.40 95.66 -28.22 45.54 94.50 191.79 152.73 29.72 190.51 152.36 32.17 coo -32.72 50.15 98.46 -30.32 48.85 97.77 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER A 124 SER^? 19.87 C8 ADE A 500 B 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 B 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 182.61 151.80 32.41 184.93 152.05 33.02 coo -29.59 43.40 95.66 -28.22 45.54 94.50 191.79 152.73 29.72 190.51 152.36 32.17 coo -32.72 50.15 98.46 -30.32 48.85 97.77 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER A 137 SER.? 19.19 C8 ADE A 500 B 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 B 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 184.43 139.00 26.42 183.74 136.66 26.44 coo -29.59 43.40 95.66 -28.22 45.54 94.50 192.43 145.24 24.85 189.68 145.10 25.32 coo -32.72 50.15 98.46 -30.32 48.85 97.77 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 11 3 # 11 B 130 SER A 149 SER^? 11.10 N9 ADE A 500 B 166 PHE A 146 PHE^? 14.35 N9 ADE A 500 B 182 PHE A 178 PHE^? 9.61 N3 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 188.74 152.31 25.78 189.32 151.10 23.76 coo -29.59 43.40 95.66 -28.22 45.54 94.50 180.53 160.39 22.57 180.33 162.62 20.86 coo -32.72 50.15 98.46 -30.32 48.85 97.77 187.30 161.92 16.41 189.15 160.05 15.37 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 12 3 # 12 B 130 SER A 164 SER^? 10.66 N7 ADE A 500 B 166 PHE A 48 PHE^? 4.82 C2 ADE A 500 B 182 PHE A 171 PHE.? -3.51 C4 ADE A 500s coo -19.94 46.29 97.83 -22.38 46.56 97.60 187.50 142.03 16.61 188.23 139.96 15.55 coo -29.59 43.40 95.66 -28.22 45.54 94.50 192.28 150.01 12.11 192.07 151.51 9.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 183.57 152.25 9.92 184.62 154.69 10.81 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 13 3 # 13 B 130 SER A 164 SER^? 10.66 N7 ADE A 500 B 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 B 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 187.50 142.03 16.61 188.23 139.96 15.55 coo -29.59 43.40 95.66 -28.22 45.54 94.50 192.43 145.24 24.85 189.68 145.10 25.32 coo -32.72 50.15 98.46 -30.32 48.85 97.77 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 14 3 # 14 B 130 SER A 164 SER^? 10.66 N7 ADE A 500 B 166 PHE B 129 PHE.? 19.08 N7 ADE A 500 B 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 187.50 142.03 16.61 188.23 139.96 15.55 coo -29.59 43.40 95.66 -28.22 45.54 94.50 195.26 133.73 19.36 192.72 134.81 19.79 coo -32.72 50.15 98.46 -30.32 48.85 97.77 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 15 3 # 15 B 130 SER B 29 SER~? 33.20 C8 ADE A 500 B 166 PHE B 157 PHE.? 26.46 N7 ADE A 500 B 182 PHE A 129 PHE.? 20.13 C8 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 186.12 123.79 33.89 187.98 123.41 32.34 coo -29.59 43.40 95.66 -28.22 45.54 94.50 189.45 127.38 26.40 186.79 128.09 26.89 coo -32.72 50.15 98.46 -30.32 48.85 97.77 188.97 135.38 27.69 188.93 135.61 24.90 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 16 3 # 16 B 130 SER B 29 SER~? 33.20 C8 ADE A 500 B 166 PHE B 157 PHE.? 26.46 N7 ADE A 500 B 182 PHE B 161 PHE^? 22.57 O4 CIT A1102 coo -19.94 46.29 97.83 -22.38 46.56 97.60 186.12 123.79 33.89 187.98 123.41 32.34 coo -29.59 43.40 95.66 -28.22 45.54 94.50 189.45 127.38 26.40 186.79 128.09 26.89 coo -32.72 50.15 98.46 -30.32 48.85 97.77 187.70 125.47 18.98 188.18 126.81 16.59 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 17 3 # 17 B 130 SER B 79 SER.? 11.49 O4 CIT A1102 B 166 PHE B 171 PHE.? 11.13 O1 CIT A1102 B 182 PHE B 48 PHE^? 19.83 O1 CIT A1102 coo -19.94 46.29 97.83 -22.38 46.56 97.60 172.67 140.46 12.34 174.10 141.88 13.69 coo -29.59 43.40 95.66 -28.22 45.54 94.50 170.58 131.61 12.01 169.84 128.92 11.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 174.23 127.42 20.06 171.47 127.09 19.71 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 18 3 # 18 B 130 SER B 79 SER.? 11.49 O4 CIT A1102 B 166 PHE B 171 PHE.? 11.13 O1 CIT A1102 B 182 PHE B 173 PHE~? 14.11 O1 CIT A1102 coo -19.94 46.29 97.83 -22.38 46.56 97.60 172.67 140.46 12.34 174.10 141.88 13.69 coo -29.59 43.40 95.66 -28.22 45.54 94.50 170.58 131.61 12.01 169.84 128.92 11.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 165.53 127.89 11.96 166.03 128.02 14.71 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 19 3 # 19 B 130 SER B 90 SER.? 26.90 O4 CIT A1102 B 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 B 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -19.94 46.29 97.83 -22.38 46.56 97.60 181.23 117.12 21.89 179.24 118.41 21.27 coo -29.59 43.40 95.66 -28.22 45.54 94.50 188.19 118.44 13.90 190.60 118.29 12.52 coo -32.72 50.15 98.46 -30.32 48.85 97.77 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 20 3 # 20 B 130 SER B 90 SER.? 26.90 O4 CIT A1102 B 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 B 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 181.23 117.12 21.89 179.24 118.41 21.27 coo -29.59 43.40 95.66 -28.22 45.54 94.50 187.70 125.47 18.98 188.18 126.81 16.59 coo -32.72 50.15 98.46 -30.32 48.85 97.77 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 21 3 # 21 B 130 SER B 124 SER^? 23.63 O4 CIT A1102 B 166 PHE B 95 PHE^? 20.65 O4 CIT A1102 B 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -19.94 46.29 97.83 -22.38 46.56 97.60 191.23 122.78 5.73 191.55 121.05 7.41 coo -29.59 43.40 95.66 -28.22 45.54 94.50 180.74 118.63 6.48 183.40 118.33 5.64 coo -32.72 50.15 98.46 -30.32 48.85 97.77 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 22 3 # 22 B 130 SER B 124 SER^? 23.63 O4 CIT A1102 B 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 B 182 PHE B 161 PHE^? 22.57 O4 CIT A1102 coo -19.94 46.29 97.83 -22.38 46.56 97.60 191.23 122.78 5.73 191.55 121.05 7.41 coo -29.59 43.40 95.66 -28.22 45.54 94.50 188.19 118.44 13.90 190.60 118.29 12.52 coo -32.72 50.15 98.46 -30.32 48.85 97.77 187.70 125.47 18.98 188.18 126.81 16.59 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 23 3 # 23 B 130 SER B 124 SER^? 23.63 O4 CIT A1102 B 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 B 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -19.94 46.29 97.83 -22.38 46.56 97.60 191.23 122.78 5.73 191.55 121.05 7.41 coo -29.59 43.40 95.66 -28.22 45.54 94.50 188.19 118.44 13.90 190.60 118.29 12.52 coo -32.72 50.15 98.46 -30.32 48.85 97.77 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 24 3 # 24 B 130 SER B 137 SER.? 16.00 N6 ADE A 500 B 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 B 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 192.22 133.71 14.40 193.34 135.87 14.56 coo -29.59 43.40 95.66 -28.22 45.54 94.50 187.70 125.47 18.98 188.18 126.81 16.59 coo -32.72 50.15 98.46 -30.32 48.85 97.77 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 25 3 # 25 B 130 SER B 149 SER^? 19.92 O4 CIT A1102 B 166 PHE B 146 PHE^? 15.86 C2 CIT A1102 B 182 PHE B 178 PHE.? 18.93 O1 CIT A1102 coo -19.94 46.29 97.83 -22.38 46.56 97.60 184.89 121.99 12.52 183.61 123.38 14.10 coo -29.59 43.40 95.66 -28.22 45.54 94.50 178.16 121.58 2.78 175.54 120.91 2.10 coo -32.72 50.15 98.46 -30.32 48.85 97.77 171.75 119.32 8.74 169.38 118.09 9.61 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 26 3 # 26 B 130 SER B 164 SER^? 16.78 N7 ADE A 500 B 166 PHE A 129 PHE.? 20.13 C8 ADE A 500 B 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 181.99 133.83 18.01 182.11 135.27 19.93 coo -29.59 43.40 95.66 -28.22 45.54 94.50 188.97 135.38 27.69 188.93 135.61 24.90 coo -32.72 50.15 98.46 -30.32 48.85 97.77 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 27 3 # 27 B 130 SER B 164 SER^? 16.78 N7 ADE A 500 B 166 PHE B 48 PHE^? 19.83 O1 CIT A1102 B 182 PHE B 171 PHE.? 11.13 O1 CIT A1102 coo -19.94 46.29 97.83 -22.38 46.56 97.60 181.99 133.83 18.01 182.11 135.27 19.93 coo -29.59 43.40 95.66 -28.22 45.54 94.50 174.23 127.42 20.06 171.47 127.09 19.71 coo -32.72 50.15 98.46 -30.32 48.85 97.77 170.58 131.61 12.01 169.84 128.92 11.74 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 28 3 # 28 B 130 SER B 164 SER^? 16.78 N7 ADE A 500 B 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 B 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -19.94 46.29 97.83 -22.38 46.56 97.60 181.99 133.83 18.01 182.11 135.27 19.93 coo -29.59 43.40 95.66 -28.22 45.54 94.50 187.70 125.47 18.98 188.18 126.81 16.59 coo -32.72 50.15 98.46 -30.32 48.85 97.77 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 29 3 # 29 B 130 SER C 17 SER~? 28.78 O3 GOL C1901 B 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 B 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 163.51 133.37 60.38 162.40 135.36 61.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 165.27 130.81 50.33 167.94 131.66 50.23 coo -32.72 50.15 98.46 -30.32 48.85 97.77 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 30 3 # 30 B 130 SER C 29 SER~? 23.88 O1 GOL C1901 B 166 PHE C 157 PHE~? 20.21 O1 GOL C1901 B 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 147.11 140.58 52.92 148.91 141.55 51.57 coo -29.59 43.40 95.66 -28.22 45.54 94.50 154.00 141.12 47.59 151.92 139.65 46.43 coo -32.72 50.15 98.46 -30.32 48.85 97.77 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 31 3 # 31 B 130 SER C 79 SER.? 11.88 O1 GOL C1901 B 166 PHE C 171 PHE.? -4.01 O1 GOL C1901s B 182 PHE C 173 PHE~? 4.81 C3 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 152.54 126.39 26.52 151.63 128.65 26.08 coo -29.59 43.40 95.66 -28.22 45.54 94.50 153.30 120.94 34.06 153.74 119.07 36.11 coo -32.72 50.15 98.46 -30.32 48.85 97.77 151.21 115.28 36.33 149.30 116.99 37.50 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 32 3 # 32 B 130 SER C 90 SER.? 14.02 O3 GOL C1901 B 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 B 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 155.07 128.53 53.12 154.12 126.92 51.57 coo -29.59 43.40 95.66 -28.22 45.54 94.50 165.27 130.81 50.33 167.94 131.66 50.23 coo -32.72 50.15 98.46 -30.32 48.85 97.77 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 33 3 # 33 B 130 SER C 90 SER.? 14.02 O3 GOL C1901 B 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 B 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 155.07 128.53 53.12 154.12 126.92 51.57 coo -29.59 43.40 95.66 -28.22 45.54 94.50 159.14 135.31 45.76 161.07 134.95 43.76 coo -32.72 50.15 98.46 -30.32 48.85 97.77 154.00 141.12 47.59 151.92 139.65 46.43 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 34 3 # 34 B 130 SER C 124 SER^? 23.11 O1 GOL C1901 B 166 PHE C 95 PHE^? 18.35 C1 GOL C1901 B 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 172.32 130.73 43.72 171.22 130.88 45.88 coo -29.59 43.40 95.66 -28.22 45.54 94.50 166.44 121.18 45.60 168.59 122.86 46.18 coo -32.72 50.15 98.46 -30.32 48.85 97.77 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 35 3 # 35 B 130 SER C 124 SER^? 23.11 O1 GOL C1901 B 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 B 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 172.32 130.73 43.72 171.22 130.88 45.88 coo -29.59 43.40 95.66 -28.22 45.54 94.50 165.27 130.81 50.33 167.94 131.66 50.23 coo -32.72 50.15 98.46 -30.32 48.85 97.77 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 36 3 # 36 B 130 SER C 124 SER^? 23.11 O1 GOL C1901 B 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 B 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 172.32 130.73 43.72 171.22 130.88 45.88 coo -29.59 43.40 95.66 -28.22 45.54 94.50 165.27 130.81 50.33 167.94 131.66 50.23 coo -32.72 50.15 98.46 -30.32 48.85 97.77 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 37 3 # 37 B 130 SER C 137 SER.? 22.99 O1 GOL C1901 B 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 B 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 163.55 140.21 37.15 163.65 142.66 37.22 coo -29.59 43.40 95.66 -28.22 45.54 94.50 159.14 135.31 45.76 161.07 134.95 43.76 coo -32.72 50.15 98.46 -30.32 48.85 97.77 154.00 141.12 47.59 151.92 139.65 46.43 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 38 3 # 38 B 130 SER C 149 SER^? 14.30 O1 GOL C1901 B 166 PHE C 146 PHE^? 16.71 C1 GOL C1901 B 182 PHE C 178 PHE^? 10.90 O3 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 163.58 128.93 46.04 161.38 129.11 45.07 coo -29.59 43.40 95.66 -28.22 45.54 94.50 167.22 118.61 41.10 166.40 115.95 40.88 coo -32.72 50.15 98.46 -30.32 48.85 97.77 159.27 115.44 43.88 157.53 113.30 44.32 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 39 3 # 39 B 130 SER C 164 SER^? 12.32 O1 GOL C1901 B 166 PHE C 48 PHE^? -4.71 O3 GOL C1901s B 182 PHE C 171 PHE.? -4.01 O1 GOL C1901s coo -19.94 46.29 97.83 -22.38 46.56 97.60 154.76 133.75 36.85 152.97 135.36 36.47 coo -29.59 43.40 95.66 -28.22 45.54 94.50 150.16 125.74 41.77 148.90 123.30 41.28 coo -32.72 50.15 98.46 -30.32 48.85 97.77 153.30 120.94 34.06 153.74 119.07 36.11 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 40 3 # 40 B 130 SER C 164 SER^? 12.32 O1 GOL C1901 B 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 B 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -19.94 46.29 97.83 -22.38 46.56 97.60 154.76 133.75 36.85 152.97 135.36 36.47 coo -29.59 43.40 95.66 -28.22 45.54 94.50 159.14 135.31 45.76 161.07 134.95 43.76 coo -32.72 50.15 98.46 -30.32 48.85 97.77 154.00 141.12 47.59 151.92 139.65 46.43 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 40 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 29 SER~? 23.57 C8 ADE A 500 C 166 PHE A 157 PHE.? 18.76 C8 ADE A 500 C 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 205.95 140.49 20.33 204.83 140.40 22.50 coo -11.14 61.91 46.89 -9.88 60.30 48.76 197.65 139.50 24.25 197.70 140.07 21.50 coo -7.71 55.92 42.70 -7.18 57.60 44.85 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 29 SER~? 23.57 C8 ADE A 500 C 166 PHE A 157 PHE.? 18.76 C8 ADE A 500 C 182 PHE B 129 PHE.? 19.08 N7 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 205.95 140.49 20.33 204.83 140.40 22.50 coo -11.14 61.91 46.89 -9.88 60.30 48.76 197.65 139.50 24.25 197.70 140.07 21.50 coo -7.71 55.92 42.70 -7.18 57.60 44.85 195.26 133.73 19.36 192.72 134.81 19.79 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 79 SER.? 7.17 O4 CIT A1102 C 166 PHE A 171 PHE.? -3.51 C4 ADE A 500s C 182 PHE A 48 PHE^? 4.82 C2 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 179.20 144.60 7.13 179.51 142.21 7.02 coo -11.14 61.91 46.89 -9.88 60.30 48.76 183.57 152.25 9.92 184.62 154.69 10.81 coo -7.71 55.92 42.70 -7.18 57.60 44.85 192.28 150.01 12.11 192.07 151.51 9.74 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 90 SER.? 14.48 N3 ADE A 500 C 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 C 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 199.47 153.71 22.16 199.01 152.90 19.92 coo -11.14 61.91 46.89 -9.88 60.30 48.76 191.79 152.73 29.72 190.51 152.36 32.17 coo -7.71 55.92 42.70 -7.18 57.60 44.85 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER A 90 SER.? 14.48 N3 ADE A 500 C 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 C 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 199.47 153.71 22.16 199.01 152.90 19.92 coo -11.14 61.91 46.89 -9.88 60.30 48.76 191.79 152.73 29.72 190.51 152.36 32.17 coo -7.71 55.92 42.70 -7.18 57.60 44.85 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER A 90 SER.? 14.48 N3 ADE A 500 C 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 C 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 199.47 153.71 22.16 199.01 152.90 19.92 coo -11.14 61.91 46.89 -9.88 60.30 48.76 192.43 145.24 24.85 189.68 145.10 25.32 coo -7.71 55.92 42.70 -7.18 57.60 44.85 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER A 124 SER^? 19.87 C8 ADE A 500 C 166 PHE A 95 PHE^? 15.24 N9 ADE A 500 C 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 182.61 151.80 32.41 184.93 152.05 33.02 coo -11.14 61.91 46.89 -9.88 60.30 48.76 185.36 159.68 24.99 184.83 158.72 27.56 coo -7.71 55.92 42.70 -7.18 57.60 44.85 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER A 124 SER^? 19.87 C8 ADE A 500 C 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 C 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 182.61 151.80 32.41 184.93 152.05 33.02 coo -11.14 61.91 46.89 -9.88 60.30 48.76 191.79 152.73 29.72 190.51 152.36 32.17 coo -7.71 55.92 42.70 -7.18 57.60 44.85 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 9 3 # 9 C 130 SER A 124 SER^? 19.87 C8 ADE A 500 C 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 C 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 182.61 151.80 32.41 184.93 152.05 33.02 coo -11.14 61.91 46.89 -9.88 60.30 48.76 191.79 152.73 29.72 190.51 152.36 32.17 coo -7.71 55.92 42.70 -7.18 57.60 44.85 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 10 3 # 10 C 130 SER A 137 SER.? 19.19 C8 ADE A 500 C 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 C 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 184.43 139.00 26.42 183.74 136.66 26.44 coo -11.14 61.91 46.89 -9.88 60.30 48.76 192.43 145.24 24.85 189.68 145.10 25.32 coo -7.71 55.92 42.70 -7.18 57.60 44.85 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 11 3 # 11 C 130 SER A 149 SER^? 11.10 N9 ADE A 500 C 166 PHE A 146 PHE^? 14.35 N9 ADE A 500 C 182 PHE A 178 PHE^? 9.61 N3 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 188.74 152.31 25.78 189.32 151.10 23.76 coo -11.14 61.91 46.89 -9.88 60.30 48.76 180.53 160.39 22.57 180.33 162.62 20.86 coo -7.71 55.92 42.70 -7.18 57.60 44.85 187.30 161.92 16.41 189.15 160.05 15.37 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 12 3 # 12 C 130 SER A 164 SER^? 10.66 N7 ADE A 500 C 166 PHE A 48 PHE^? 4.82 C2 ADE A 500 C 182 PHE A 171 PHE.? -3.51 C4 ADE A 500s coo -2.19 64.27 51.12 -3.34 62.10 50.60 187.50 142.03 16.61 188.23 139.96 15.55 coo -11.14 61.91 46.89 -9.88 60.30 48.76 192.28 150.01 12.11 192.07 151.51 9.74 coo -7.71 55.92 42.70 -7.18 57.60 44.85 183.57 152.25 9.92 184.62 154.69 10.81 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 13 3 # 13 C 130 SER A 164 SER^? 10.66 N7 ADE A 500 C 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 C 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 187.50 142.03 16.61 188.23 139.96 15.55 coo -11.14 61.91 46.89 -9.88 60.30 48.76 192.43 145.24 24.85 189.68 145.10 25.32 coo -7.71 55.92 42.70 -7.18 57.60 44.85 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 14 3 # 14 C 130 SER A 164 SER^? 10.66 N7 ADE A 500 C 166 PHE B 129 PHE.? 19.08 N7 ADE A 500 C 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 187.50 142.03 16.61 188.23 139.96 15.55 coo -11.14 61.91 46.89 -9.88 60.30 48.76 195.26 133.73 19.36 192.72 134.81 19.79 coo -7.71 55.92 42.70 -7.18 57.60 44.85 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 15 3 # 15 C 130 SER B 29 SER~? 33.20 C8 ADE A 500 C 166 PHE B 157 PHE.? 26.46 N7 ADE A 500 C 182 PHE A 129 PHE.? 20.13 C8 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 186.12 123.79 33.89 187.98 123.41 32.34 coo -11.14 61.91 46.89 -9.88 60.30 48.76 189.45 127.38 26.40 186.79 128.09 26.89 coo -7.71 55.92 42.70 -7.18 57.60 44.85 188.97 135.38 27.69 188.93 135.61 24.90 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 16 3 # 16 C 130 SER B 29 SER~? 33.20 C8 ADE A 500 C 166 PHE B 157 PHE.? 26.46 N7 ADE A 500 C 182 PHE B 161 PHE^? 22.57 O4 CIT A1102 coo -2.19 64.27 51.12 -3.34 62.10 50.60 186.12 123.79 33.89 187.98 123.41 32.34 coo -11.14 61.91 46.89 -9.88 60.30 48.76 189.45 127.38 26.40 186.79 128.09 26.89 coo -7.71 55.92 42.70 -7.18 57.60 44.85 187.70 125.47 18.98 188.18 126.81 16.59 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 17 3 # 17 C 130 SER B 79 SER.? 11.49 O4 CIT A1102 C 166 PHE B 171 PHE.? 11.13 O1 CIT A1102 C 182 PHE B 173 PHE~? 14.11 O1 CIT A1102 coo -2.19 64.27 51.12 -3.34 62.10 50.60 172.67 140.46 12.34 174.10 141.88 13.69 coo -11.14 61.91 46.89 -9.88 60.30 48.76 170.58 131.61 12.01 169.84 128.92 11.74 coo -7.71 55.92 42.70 -7.18 57.60 44.85 165.53 127.89 11.96 166.03 128.02 14.71 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 18 3 # 18 C 130 SER B 90 SER.? 26.90 O4 CIT A1102 C 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 C 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -2.19 64.27 51.12 -3.34 62.10 50.60 181.23 117.12 21.89 179.24 118.41 21.27 coo -11.14 61.91 46.89 -9.88 60.30 48.76 188.19 118.44 13.90 190.60 118.29 12.52 coo -7.71 55.92 42.70 -7.18 57.60 44.85 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 19 3 # 19 C 130 SER B 90 SER.? 26.90 O4 CIT A1102 C 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 C 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 181.23 117.12 21.89 179.24 118.41 21.27 coo -11.14 61.91 46.89 -9.88 60.30 48.76 187.70 125.47 18.98 188.18 126.81 16.59 coo -7.71 55.92 42.70 -7.18 57.60 44.85 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 20 3 # 20 C 130 SER B 124 SER^? 23.63 O4 CIT A1102 C 166 PHE B 95 PHE^? 20.65 O4 CIT A1102 C 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -2.19 64.27 51.12 -3.34 62.10 50.60 191.23 122.78 5.73 191.55 121.05 7.41 coo -11.14 61.91 46.89 -9.88 60.30 48.76 180.74 118.63 6.48 183.40 118.33 5.64 coo -7.71 55.92 42.70 -7.18 57.60 44.85 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 21 3 # 21 C 130 SER B 124 SER^? 23.63 O4 CIT A1102 C 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 C 182 PHE B 161 PHE^? 22.57 O4 CIT A1102 coo -2.19 64.27 51.12 -3.34 62.10 50.60 191.23 122.78 5.73 191.55 121.05 7.41 coo -11.14 61.91 46.89 -9.88 60.30 48.76 188.19 118.44 13.90 190.60 118.29 12.52 coo -7.71 55.92 42.70 -7.18 57.60 44.85 187.70 125.47 18.98 188.18 126.81 16.59 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 22 3 # 22 C 130 SER B 124 SER^? 23.63 O4 CIT A1102 C 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 C 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -2.19 64.27 51.12 -3.34 62.10 50.60 191.23 122.78 5.73 191.55 121.05 7.41 coo -11.14 61.91 46.89 -9.88 60.30 48.76 188.19 118.44 13.90 190.60 118.29 12.52 coo -7.71 55.92 42.70 -7.18 57.60 44.85 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 23 3 # 23 C 130 SER B 137 SER.? 16.00 N6 ADE A 500 C 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 C 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 192.22 133.71 14.40 193.34 135.87 14.56 coo -11.14 61.91 46.89 -9.88 60.30 48.76 187.70 125.47 18.98 188.18 126.81 16.59 coo -7.71 55.92 42.70 -7.18 57.60 44.85 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 24 3 # 24 C 130 SER B 149 SER^? 19.92 O4 CIT A1102 C 166 PHE B 146 PHE^? 15.86 C2 CIT A1102 C 182 PHE B 178 PHE.? 18.93 O1 CIT A1102 coo -2.19 64.27 51.12 -3.34 62.10 50.60 184.89 121.99 12.52 183.61 123.38 14.10 coo -11.14 61.91 46.89 -9.88 60.30 48.76 178.16 121.58 2.78 175.54 120.91 2.10 coo -7.71 55.92 42.70 -7.18 57.60 44.85 171.75 119.32 8.74 169.38 118.09 9.61 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 25 3 # 25 C 130 SER B 164 SER^? 16.78 N7 ADE A 500 C 166 PHE A 129 PHE.? 20.13 C8 ADE A 500 C 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 181.99 133.83 18.01 182.11 135.27 19.93 coo -11.14 61.91 46.89 -9.88 60.30 48.76 188.97 135.38 27.69 188.93 135.61 24.90 coo -7.71 55.92 42.70 -7.18 57.60 44.85 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 26 3 # 26 C 130 SER B 164 SER^? 16.78 N7 ADE A 500 C 166 PHE B 48 PHE^? 19.83 O1 CIT A1102 C 182 PHE B 171 PHE.? 11.13 O1 CIT A1102 coo -2.19 64.27 51.12 -3.34 62.10 50.60 181.99 133.83 18.01 182.11 135.27 19.93 coo -11.14 61.91 46.89 -9.88 60.30 48.76 174.23 127.42 20.06 171.47 127.09 19.71 coo -7.71 55.92 42.70 -7.18 57.60 44.85 170.58 131.61 12.01 169.84 128.92 11.74 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 27 3 # 27 C 130 SER B 164 SER^? 16.78 N7 ADE A 500 C 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 C 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -2.19 64.27 51.12 -3.34 62.10 50.60 181.99 133.83 18.01 182.11 135.27 19.93 coo -11.14 61.91 46.89 -9.88 60.30 48.76 187.70 125.47 18.98 188.18 126.81 16.59 coo -7.71 55.92 42.70 -7.18 57.60 44.85 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 28 3 # 28 C 130 SER C 29 SER~? 23.88 O1 GOL C1901 C 166 PHE C 157 PHE~? 20.21 O1 GOL C1901 C 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 147.11 140.58 52.92 148.91 141.55 51.57 coo -11.14 61.91 46.89 -9.88 60.30 48.76 154.00 141.12 47.59 151.92 139.65 46.43 coo -7.71 55.92 42.70 -7.18 57.60 44.85 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 29 3 # 29 C 130 SER C 79 SER.? 11.88 O1 GOL C1901 C 166 PHE C 171 PHE.? -4.01 O1 GOL C1901s C 182 PHE C 173 PHE~? 4.81 C3 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 152.54 126.39 26.52 151.63 128.65 26.08 coo -11.14 61.91 46.89 -9.88 60.30 48.76 153.30 120.94 34.06 153.74 119.07 36.11 coo -7.71 55.92 42.70 -7.18 57.60 44.85 151.21 115.28 36.33 149.30 116.99 37.50 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 30 3 # 30 C 130 SER C 90 SER.? 14.02 O3 GOL C1901 C 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 C 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 155.07 128.53 53.12 154.12 126.92 51.57 coo -11.14 61.91 46.89 -9.88 60.30 48.76 165.27 130.81 50.33 167.94 131.66 50.23 coo -7.71 55.92 42.70 -7.18 57.60 44.85 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 31 3 # 31 C 130 SER C 90 SER.? 14.02 O3 GOL C1901 C 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 C 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 155.07 128.53 53.12 154.12 126.92 51.57 coo -11.14 61.91 46.89 -9.88 60.30 48.76 159.14 135.31 45.76 161.07 134.95 43.76 coo -7.71 55.92 42.70 -7.18 57.60 44.85 154.00 141.12 47.59 151.92 139.65 46.43 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 32 3 # 32 C 130 SER C 124 SER^? 23.11 O1 GOL C1901 C 166 PHE C 95 PHE^? 18.35 C1 GOL C1901 C 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 172.32 130.73 43.72 171.22 130.88 45.88 coo -11.14 61.91 46.89 -9.88 60.30 48.76 166.44 121.18 45.60 168.59 122.86 46.18 coo -7.71 55.92 42.70 -7.18 57.60 44.85 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 33 3 # 33 C 130 SER C 124 SER^? 23.11 O1 GOL C1901 C 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 C 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 172.32 130.73 43.72 171.22 130.88 45.88 coo -11.14 61.91 46.89 -9.88 60.30 48.76 165.27 130.81 50.33 167.94 131.66 50.23 coo -7.71 55.92 42.70 -7.18 57.60 44.85 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 34 3 # 34 C 130 SER C 124 SER^? 23.11 O1 GOL C1901 C 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 C 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 172.32 130.73 43.72 171.22 130.88 45.88 coo -11.14 61.91 46.89 -9.88 60.30 48.76 165.27 130.81 50.33 167.94 131.66 50.23 coo -7.71 55.92 42.70 -7.18 57.60 44.85 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 35 3 # 35 C 130 SER C 137 SER.? 22.99 O1 GOL C1901 C 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 C 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 163.55 140.21 37.15 163.65 142.66 37.22 coo -11.14 61.91 46.89 -9.88 60.30 48.76 159.14 135.31 45.76 161.07 134.95 43.76 coo -7.71 55.92 42.70 -7.18 57.60 44.85 154.00 141.12 47.59 151.92 139.65 46.43 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 36 3 # 36 C 130 SER C 149 SER^? 14.30 O1 GOL C1901 C 166 PHE C 95 PHE^? 18.35 C1 GOL C1901 C 182 PHE C 178 PHE^? 10.90 O3 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 163.58 128.93 46.04 161.38 129.11 45.07 coo -11.14 61.91 46.89 -9.88 60.30 48.76 166.44 121.18 45.60 168.59 122.86 46.18 coo -7.71 55.92 42.70 -7.18 57.60 44.85 159.27 115.44 43.88 157.53 113.30 44.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 37 3 # 37 C 130 SER C 149 SER^? 14.30 O1 GOL C1901 C 166 PHE C 146 PHE^? 16.71 C1 GOL C1901 C 182 PHE C 178 PHE^? 10.90 O3 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 163.58 128.93 46.04 161.38 129.11 45.07 coo -11.14 61.91 46.89 -9.88 60.30 48.76 167.22 118.61 41.10 166.40 115.95 40.88 coo -7.71 55.92 42.70 -7.18 57.60 44.85 159.27 115.44 43.88 157.53 113.30 44.32 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 38 3 # 38 C 130 SER C 164 SER^? 12.32 O1 GOL C1901 C 166 PHE C 48 PHE^? -4.71 O3 GOL C1901s C 182 PHE C 171 PHE.? -4.01 O1 GOL C1901s coo -2.19 64.27 51.12 -3.34 62.10 50.60 154.76 133.75 36.85 152.97 135.36 36.47 coo -11.14 61.91 46.89 -9.88 60.30 48.76 150.16 125.74 41.77 148.90 123.30 41.28 coo -7.71 55.92 42.70 -7.18 57.60 44.85 153.30 120.94 34.06 153.74 119.07 36.11 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 39 3 # 39 C 130 SER C 164 SER^? 12.32 O1 GOL C1901 C 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 C 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -2.19 64.27 51.12 -3.34 62.10 50.60 154.76 133.75 36.85 152.97 135.36 36.47 coo -11.14 61.91 46.89 -9.88 60.30 48.76 159.14 135.31 45.76 161.07 134.95 43.76 coo -7.71 55.92 42.70 -7.18 57.60 44.85 154.00 141.12 47.59 151.92 139.65 46.43 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 39 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 29 SER~? 23.57 C8 ADE A 500 D 166 PHE A 157 PHE.? 18.76 C8 ADE A 500 D 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 205.95 140.49 20.33 204.83 140.40 22.50 coo -23.62 58.20 50.84 -23.76 56.14 48.96 197.65 139.50 24.25 197.70 140.07 21.50 coo -23.08 51.44 54.96 -24.43 52.71 52.88 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 29 SER~? 23.57 C8 ADE A 500 D 166 PHE A 157 PHE.? 18.76 C8 ADE A 500 D 182 PHE B 129 PHE.? 19.08 N7 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 205.95 140.49 20.33 204.83 140.40 22.50 coo -23.62 58.20 50.84 -23.76 56.14 48.96 197.65 139.50 24.25 197.70 140.07 21.50 coo -23.08 51.44 54.96 -24.43 52.71 52.88 195.26 133.73 19.36 192.72 134.81 19.79 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 79 SER.? 7.17 O4 CIT A1102 D 166 PHE A 171 PHE.? -3.51 C4 ADE A 500s D 182 PHE A 48 PHE^? 4.82 C2 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 179.20 144.60 7.13 179.51 142.21 7.02 coo -23.62 58.20 50.84 -23.76 56.14 48.96 183.57 152.25 9.92 184.62 154.69 10.81 coo -23.08 51.44 54.96 -24.43 52.71 52.88 192.28 150.01 12.11 192.07 151.51 9.74 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 79 SER.? 7.17 O4 CIT A1102 D 166 PHE A 171 PHE.? -3.51 C4 ADE A 500s D 182 PHE A 173 PHE~? 4.60 C2 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 179.20 144.60 7.13 179.51 142.21 7.02 coo -23.62 58.20 50.84 -23.76 56.14 48.96 183.57 152.25 9.92 184.62 154.69 10.81 coo -23.08 51.44 54.96 -24.43 52.71 52.88 186.20 157.44 8.21 188.39 156.08 9.40 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 90 SER.? 14.48 N3 ADE A 500 D 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 D 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 199.47 153.71 22.16 199.01 152.90 19.92 coo -23.62 58.20 50.84 -23.76 56.14 48.96 191.79 152.73 29.72 190.51 152.36 32.17 coo -23.08 51.44 54.96 -24.43 52.71 52.88 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 90 SER.? 14.48 N3 ADE A 500 D 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 D 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 199.47 153.71 22.16 199.01 152.90 19.92 coo -23.62 58.20 50.84 -23.76 56.14 48.96 192.43 145.24 24.85 189.68 145.10 25.32 coo -23.08 51.44 54.96 -24.43 52.71 52.88 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER A 124 SER^? 19.87 C8 ADE A 500 D 166 PHE A 95 PHE^? 15.24 N9 ADE A 500 D 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 182.61 151.80 32.41 184.93 152.05 33.02 coo -23.62 58.20 50.84 -23.76 56.14 48.96 185.36 159.68 24.99 184.83 158.72 27.56 coo -23.08 51.44 54.96 -24.43 52.71 52.88 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER A 124 SER^? 19.87 C8 ADE A 500 D 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 D 182 PHE A 161 PHE^? 14.06 C8 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 182.61 151.80 32.41 184.93 152.05 33.02 coo -23.62 58.20 50.84 -23.76 56.14 48.96 191.79 152.73 29.72 190.51 152.36 32.17 coo -23.08 51.44 54.96 -24.43 52.71 52.88 192.43 145.24 24.85 189.68 145.10 25.32 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER A 124 SER^? 19.87 C8 ADE A 500 D 166 PHE A 150 PHE^? 18.52 N9 ADE A 500 D 182 PHE A 199 PHE~? 19.95 N9 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 182.61 151.80 32.41 184.93 152.05 33.02 coo -23.62 58.20 50.84 -23.76 56.14 48.96 191.79 152.73 29.72 190.51 152.36 32.17 coo -23.08 51.44 54.96 -24.43 52.71 52.88 192.76 159.38 30.65 191.50 156.98 31.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER A 137 SER.? 19.19 C8 ADE A 500 D 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 D 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 184.43 139.00 26.42 183.74 136.66 26.44 coo -23.62 58.20 50.84 -23.76 56.14 48.96 192.43 145.24 24.85 189.68 145.10 25.32 coo -23.08 51.44 54.96 -24.43 52.71 52.88 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER A 149 SER^? 11.10 N9 ADE A 500 D 166 PHE A 146 PHE^? 14.35 N9 ADE A 500 D 182 PHE A 178 PHE^? 9.61 N3 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 188.74 152.31 25.78 189.32 151.10 23.76 coo -23.62 58.20 50.84 -23.76 56.14 48.96 180.53 160.39 22.57 180.33 162.62 20.86 coo -23.08 51.44 54.96 -24.43 52.71 52.88 187.30 161.92 16.41 189.15 160.05 15.37 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 12 3 # 12 D 130 SER A 164 SER^? 10.66 N7 ADE A 500 D 166 PHE A 48 PHE^? 4.82 C2 ADE A 500 D 182 PHE A 171 PHE.? -3.51 C4 ADE A 500s coo -32.42 55.27 46.18 -30.51 54.94 47.67 187.50 142.03 16.61 188.23 139.96 15.55 coo -23.62 58.20 50.84 -23.76 56.14 48.96 192.28 150.01 12.11 192.07 151.51 9.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 183.57 152.25 9.92 184.62 154.69 10.81 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 13 3 # 13 D 130 SER A 164 SER^? 10.66 N7 ADE A 500 D 166 PHE A 161 PHE^? 14.06 C8 ADE A 500 D 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 187.50 142.03 16.61 188.23 139.96 15.55 coo -23.62 58.20 50.84 -23.76 56.14 48.96 192.43 145.24 24.85 189.68 145.10 25.32 coo -23.08 51.44 54.96 -24.43 52.71 52.88 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 14 3 # 14 D 130 SER A 164 SER^? 10.66 N7 ADE A 500 D 166 PHE B 129 PHE.? 19.08 N7 ADE A 500 D 182 PHE A 157 PHE.? 18.76 C8 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 187.50 142.03 16.61 188.23 139.96 15.55 coo -23.62 58.20 50.84 -23.76 56.14 48.96 195.26 133.73 19.36 192.72 134.81 19.79 coo -23.08 51.44 54.96 -24.43 52.71 52.88 197.65 139.50 24.25 197.70 140.07 21.50 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 15 3 # 15 D 130 SER B 29 SER~? 33.20 C8 ADE A 500 D 166 PHE B 157 PHE.? 26.46 N7 ADE A 500 D 182 PHE A 129 PHE.? 20.13 C8 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 186.12 123.79 33.89 187.98 123.41 32.34 coo -23.62 58.20 50.84 -23.76 56.14 48.96 189.45 127.38 26.40 186.79 128.09 26.89 coo -23.08 51.44 54.96 -24.43 52.71 52.88 188.97 135.38 27.69 188.93 135.61 24.90 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 16 3 # 16 D 130 SER B 29 SER~? 33.20 C8 ADE A 500 D 166 PHE B 157 PHE.? 26.46 N7 ADE A 500 D 182 PHE B 161 PHE^? 22.57 O4 CIT A1102 coo -32.42 55.27 46.18 -30.51 54.94 47.67 186.12 123.79 33.89 187.98 123.41 32.34 coo -23.62 58.20 50.84 -23.76 56.14 48.96 189.45 127.38 26.40 186.79 128.09 26.89 coo -23.08 51.44 54.96 -24.43 52.71 52.88 187.70 125.47 18.98 188.18 126.81 16.59 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 17 3 # 17 D 130 SER B 79 SER.? 11.49 O4 CIT A1102 D 166 PHE B 171 PHE.? 11.13 O1 CIT A1102 D 182 PHE B 48 PHE^? 19.83 O1 CIT A1102 coo -32.42 55.27 46.18 -30.51 54.94 47.67 172.67 140.46 12.34 174.10 141.88 13.69 coo -23.62 58.20 50.84 -23.76 56.14 48.96 170.58 131.61 12.01 169.84 128.92 11.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 174.23 127.42 20.06 171.47 127.09 19.71 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 18 3 # 18 D 130 SER B 79 SER.? 11.49 O4 CIT A1102 D 166 PHE B 171 PHE.? 11.13 O1 CIT A1102 D 182 PHE B 173 PHE~? 14.11 O1 CIT A1102 coo -32.42 55.27 46.18 -30.51 54.94 47.67 172.67 140.46 12.34 174.10 141.88 13.69 coo -23.62 58.20 50.84 -23.76 56.14 48.96 170.58 131.61 12.01 169.84 128.92 11.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 165.53 127.89 11.96 166.03 128.02 14.71 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 19 3 # 19 D 130 SER B 90 SER.? 26.90 O4 CIT A1102 D 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 D 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -32.42 55.27 46.18 -30.51 54.94 47.67 181.23 117.12 21.89 179.24 118.41 21.27 coo -23.62 58.20 50.84 -23.76 56.14 48.96 188.19 118.44 13.90 190.60 118.29 12.52 coo -23.08 51.44 54.96 -24.43 52.71 52.88 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 20 3 # 20 D 130 SER B 90 SER.? 26.90 O4 CIT A1102 D 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 D 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 181.23 117.12 21.89 179.24 118.41 21.27 coo -23.62 58.20 50.84 -23.76 56.14 48.96 187.70 125.47 18.98 188.18 126.81 16.59 coo -23.08 51.44 54.96 -24.43 52.71 52.88 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 21 3 # 21 D 130 SER B 124 SER^? 23.63 O4 CIT A1102 D 166 PHE B 95 PHE^? 20.65 O4 CIT A1102 D 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -32.42 55.27 46.18 -30.51 54.94 47.67 191.23 122.78 5.73 191.55 121.05 7.41 coo -23.62 58.20 50.84 -23.76 56.14 48.96 180.74 118.63 6.48 183.40 118.33 5.64 coo -23.08 51.44 54.96 -24.43 52.71 52.88 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 22 3 # 22 D 130 SER B 124 SER^? 23.63 O4 CIT A1102 D 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 D 182 PHE B 161 PHE^? 22.57 O4 CIT A1102 coo -32.42 55.27 46.18 -30.51 54.94 47.67 191.23 122.78 5.73 191.55 121.05 7.41 coo -23.62 58.20 50.84 -23.76 56.14 48.96 188.19 118.44 13.90 190.60 118.29 12.52 coo -23.08 51.44 54.96 -24.43 52.71 52.88 187.70 125.47 18.98 188.18 126.81 16.59 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 23 3 # 23 D 130 SER B 124 SER^? 23.63 O4 CIT A1102 D 166 PHE B 150 PHE^? 25.99 O4 CIT A1102 D 182 PHE B 199 PHE.? 28.01 O4 CIT A1102 coo -32.42 55.27 46.18 -30.51 54.94 47.67 191.23 122.78 5.73 191.55 121.05 7.41 coo -23.62 58.20 50.84 -23.76 56.14 48.96 188.19 118.44 13.90 190.60 118.29 12.52 coo -23.08 51.44 54.96 -24.43 52.71 52.88 185.84 112.69 11.52 187.91 114.38 10.70 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 24 3 # 24 D 130 SER B 137 SER.? 16.00 N6 ADE A 500 D 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 D 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 192.22 133.71 14.40 193.34 135.87 14.56 coo -23.62 58.20 50.84 -23.76 56.14 48.96 187.70 125.47 18.98 188.18 126.81 16.59 coo -23.08 51.44 54.96 -24.43 52.71 52.88 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 25 3 # 25 D 130 SER B 149 SER^? 19.92 O4 CIT A1102 D 166 PHE B 146 PHE^? 15.86 C2 CIT A1102 D 182 PHE B 178 PHE.? 18.93 O1 CIT A1102 coo -32.42 55.27 46.18 -30.51 54.94 47.67 184.89 121.99 12.52 183.61 123.38 14.10 coo -23.62 58.20 50.84 -23.76 56.14 48.96 178.16 121.58 2.78 175.54 120.91 2.10 coo -23.08 51.44 54.96 -24.43 52.71 52.88 171.75 119.32 8.74 169.38 118.09 9.61 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 26 3 # 26 D 130 SER B 164 SER^? 16.78 N7 ADE A 500 D 166 PHE A 129 PHE.? 20.13 C8 ADE A 500 D 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 181.99 133.83 18.01 182.11 135.27 19.93 coo -23.62 58.20 50.84 -23.76 56.14 48.96 188.97 135.38 27.69 188.93 135.61 24.90 coo -23.08 51.44 54.96 -24.43 52.71 52.88 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 27 3 # 27 D 130 SER B 164 SER^? 16.78 N7 ADE A 500 D 166 PHE B 48 PHE^? 19.83 O1 CIT A1102 D 182 PHE B 171 PHE.? 11.13 O1 CIT A1102 coo -32.42 55.27 46.18 -30.51 54.94 47.67 181.99 133.83 18.01 182.11 135.27 19.93 coo -23.62 58.20 50.84 -23.76 56.14 48.96 174.23 127.42 20.06 171.47 127.09 19.71 coo -23.08 51.44 54.96 -24.43 52.71 52.88 170.58 131.61 12.01 169.84 128.92 11.74 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 28 3 # 28 D 130 SER B 164 SER^? 16.78 N7 ADE A 500 D 166 PHE B 161 PHE^? 22.57 O4 CIT A1102 D 182 PHE B 157 PHE.? 26.46 N7 ADE A 500 coo -32.42 55.27 46.18 -30.51 54.94 47.67 181.99 133.83 18.01 182.11 135.27 19.93 coo -23.62 58.20 50.84 -23.76 56.14 48.96 187.70 125.47 18.98 188.18 126.81 16.59 coo -23.08 51.44 54.96 -24.43 52.71 52.88 189.45 127.38 26.40 186.79 128.09 26.89 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 29 3 # 29 D 130 SER C 17 SER~? 28.78 O3 GOL C1901 D 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 D 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 163.51 133.37 60.38 162.40 135.36 61.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 165.27 130.81 50.33 167.94 131.66 50.23 coo -23.08 51.44 54.96 -24.43 52.71 52.88 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 30 3 # 30 D 130 SER C 29 SER~? 23.88 O1 GOL C1901 D 166 PHE C 157 PHE~? 20.21 O1 GOL C1901 D 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 147.11 140.58 52.92 148.91 141.55 51.57 coo -23.62 58.20 50.84 -23.76 56.14 48.96 154.00 141.12 47.59 151.92 139.65 46.43 coo -23.08 51.44 54.96 -24.43 52.71 52.88 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 31 3 # 31 D 130 SER C 79 SER.? 11.88 O1 GOL C1901 D 166 PHE C 171 PHE.? -4.01 O1 GOL C1901s D 182 PHE C 173 PHE~? 4.81 C3 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 152.54 126.39 26.52 151.63 128.65 26.08 coo -23.62 58.20 50.84 -23.76 56.14 48.96 153.30 120.94 34.06 153.74 119.07 36.11 coo -23.08 51.44 54.96 -24.43 52.71 52.88 151.21 115.28 36.33 149.30 116.99 37.50 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 32 3 # 32 D 130 SER C 90 SER.? 14.02 O3 GOL C1901 D 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 D 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 155.07 128.53 53.12 154.12 126.92 51.57 coo -23.62 58.20 50.84 -23.76 56.14 48.96 165.27 130.81 50.33 167.94 131.66 50.23 coo -23.08 51.44 54.96 -24.43 52.71 52.88 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 33 3 # 33 D 130 SER C 90 SER.? 14.02 O3 GOL C1901 D 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 D 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 155.07 128.53 53.12 154.12 126.92 51.57 coo -23.62 58.20 50.84 -23.76 56.14 48.96 159.14 135.31 45.76 161.07 134.95 43.76 coo -23.08 51.44 54.96 -24.43 52.71 52.88 154.00 141.12 47.59 151.92 139.65 46.43 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 34 3 # 34 D 130 SER C 124 SER^? 23.11 O1 GOL C1901 D 166 PHE C 95 PHE^? 18.35 C1 GOL C1901 D 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 172.32 130.73 43.72 171.22 130.88 45.88 coo -23.62 58.20 50.84 -23.76 56.14 48.96 166.44 121.18 45.60 168.59 122.86 46.18 coo -23.08 51.44 54.96 -24.43 52.71 52.88 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 35 3 # 35 D 130 SER C 124 SER^? 23.11 O1 GOL C1901 D 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 D 182 PHE C 161 PHE^? 16.85 O1 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 172.32 130.73 43.72 171.22 130.88 45.88 coo -23.62 58.20 50.84 -23.76 56.14 48.96 165.27 130.81 50.33 167.94 131.66 50.23 coo -23.08 51.44 54.96 -24.43 52.71 52.88 159.14 135.31 45.76 161.07 134.95 43.76 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 36 3 # 36 D 130 SER C 124 SER^? 23.11 O1 GOL C1901 D 166 PHE C 150 PHE^? 21.92 O1 GOL C1901 D 182 PHE C 199 PHE~? 22.74 O3 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 172.32 130.73 43.72 171.22 130.88 45.88 coo -23.62 58.20 50.84 -23.76 56.14 48.96 165.27 130.81 50.33 167.94 131.66 50.23 coo -23.08 51.44 54.96 -24.43 52.71 52.88 166.87 125.25 54.17 167.82 127.39 52.65 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 37 3 # 37 D 130 SER C 137 SER.? 22.99 O1 GOL C1901 D 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 D 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 163.55 140.21 37.15 163.65 142.66 37.22 coo -23.62 58.20 50.84 -23.76 56.14 48.96 159.14 135.31 45.76 161.07 134.95 43.76 coo -23.08 51.44 54.96 -24.43 52.71 52.88 154.00 141.12 47.59 151.92 139.65 46.43 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 38 3 # 38 D 130 SER C 149 SER^? 14.30 O1 GOL C1901 D 166 PHE C 146 PHE^? 16.71 C1 GOL C1901 D 182 PHE C 178 PHE^? 10.90 O3 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 163.58 128.93 46.04 161.38 129.11 45.07 coo -23.62 58.20 50.84 -23.76 56.14 48.96 167.22 118.61 41.10 166.40 115.95 40.88 coo -23.08 51.44 54.96 -24.43 52.71 52.88 159.27 115.44 43.88 157.53 113.30 44.32 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 39 3 # 39 D 130 SER C 164 SER^? 12.32 O1 GOL C1901 D 166 PHE C 48 PHE^? -4.71 O3 GOL C1901s D 182 PHE C 171 PHE.? -4.01 O1 GOL C1901s coo -32.42 55.27 46.18 -30.51 54.94 47.67 154.76 133.75 36.85 152.97 135.36 36.47 coo -23.62 58.20 50.84 -23.76 56.14 48.96 150.16 125.74 41.77 148.90 123.30 41.28 coo -23.08 51.44 54.96 -24.43 52.71 52.88 153.30 120.94 34.06 153.74 119.07 36.11 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 40 3 # 40 D 130 SER C 164 SER^? 12.32 O1 GOL C1901 D 166 PHE C 161 PHE^? 16.85 O1 GOL C1901 D 182 PHE C 157 PHE~? 20.21 O1 GOL C1901 coo -32.42 55.27 46.18 -30.51 54.94 47.67 154.76 133.75 36.85 152.97 135.36 36.47 coo -23.62 58.20 50.84 -23.76 56.14 48.96 159.14 135.31 45.76 161.07 134.95 43.76 coo -23.08 51.44 54.96 -24.43 52.71 52.88 154.00 141.12 47.59 151.92 139.65 46.43 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 40 hits 2r11_o03 naa= 3 ULMN 4 3ay3_o00 NAD-DEPENDENT EPIMERASE/DEHYDRATASE user 1 4 # 1 A 33 ASP A 89 ASP.? 18.10 N3 ADE A 500 A 50 ASP A 158 ASP.? 25.18 C8 ADE A 500 A 135 TYR A 113 TYR^? 11.47 C8 ADE A 500 A 139 LYS A 126 LYS^? 24.40 C8 ADE A 500 coo 70.97 69.36 47.09 72.37 70.68 46.17 203.02 151.24 21.31 203.43 152.46 19.71 coo 70.64 63.25 38.70 71.64 63.73 36.92 203.27 140.75 25.55 204.24 138.86 25.61 coo 76.54 81.45 36.18 74.68 81.93 38.25 185.14 149.36 25.84 186.22 148.61 23.38 coo 70.40 81.94 33.22 70.32 79.36 37.92 186.22 145.69 31.90 189.62 146.93 37.05 ULMN 4 3ay3_o00 NAD-DEPENDENT EPIMERASE/DEHYDRATASE user 2 4 # 2 A 33 ASP B 89 ASP.? 31.34 O4 CIT A1102 A 50 ASP C 119 ASP.? 26.31 O1 GOL C1901 A 135 TYR B 83 TYR^? 20.46 C8 ADE A 500 A 139 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 70.97 69.36 47.09 72.37 70.68 46.17 181.93 115.70 26.33 180.57 117.33 26.20 coo 70.64 63.25 38.70 71.64 63.73 36.92 178.03 118.40 36.14 177.70 120.46 36.31 coo 76.54 81.45 36.18 74.68 81.93 38.25 179.54 132.93 23.44 180.82 135.06 24.75 coo 70.40 81.94 33.22 70.32 79.36 37.92 174.03 130.60 22.66 171.30 132.48 26.53 3ay3_o00 source 3AY3 NAD-DEPENDENT EPIMERASE/DEHYDRATASE : 2 hits 3ay3_o00 naa= 4 ULMN 4 3ay3_o01 NAD-DEPENDENT EPIMERASE/DEHYDRATASE user 1 4 # 1 B 33 ASP B 89 ASP.? 31.34 O4 CIT A1102 B 50 ASP C 119 ASP.? 26.31 O1 GOL C1901 B 135 TYR B 83 TYR^? 20.46 C8 ADE A 500 B 139 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 74.18 70.35 5.04 72.24 70.85 5.80 181.93 115.70 26.33 180.57 117.33 26.20 coo 77.13 65.83 12.97 75.77 65.81 14.64 178.03 118.40 36.14 177.70 120.46 36.31 coo 62.73 77.36 15.79 63.97 78.80 13.74 179.54 132.93 23.44 180.82 135.06 24.75 coo 67.49 80.95 18.75 69.23 79.00 14.39 174.03 130.60 22.66 171.30 132.48 26.53 3ay3_o01 source 3AY3 NAD-DEPENDENT EPIMERASE/DEHYDRATASE : 1 hits 3ay3_o01 naa= 4 ULMN 4 3ay3_o02 NAD-DEPENDENT EPIMERASE/DEHYDRATASE user 1 4 # 1 C 33 ASP B 89 ASP.? 31.34 O4 CIT A1102 C 50 ASP C 119 ASP.? 26.31 O1 GOL C1901 C 135 TYR B 83 TYR^? 20.46 C8 ADE A 500 C 139 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 86.20 60.28 31.38 86.67 62.15 32.25 181.93 115.70 26.33 180.57 117.33 26.20 coo 81.03 56.94 39.98 80.92 58.13 41.68 178.03 118.40 36.14 177.70 120.46 36.31 coo 93.45 71.06 42.47 95.04 69.99 40.46 179.54 132.93 23.44 180.82 135.06 24.75 coo 97.22 66.11 45.24 94.47 64.68 41.07 174.03 130.60 22.66 171.30 132.48 26.53 3ay3_o02 source 3AY3 NAD-DEPENDENT EPIMERASE/DEHYDRATASE : 1 hits 3ay3_o02 naa= 4 ULMN 4 3ay3_o03 NAD-DEPENDENT EPIMERASE/DEHYDRATASE user 1 4 # 1 D 33 ASP B 89 ASP.? 31.34 O4 CIT A1102 D 50 ASP C 119 ASP.? 26.31 O1 GOL C1901 D 135 TYR B 83 TYR^? 20.46 C8 ADE A 500 D 139 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 85.52 62.84 73.55 86.96 61.48 72.69 181.93 115.70 26.33 180.57 117.33 26.20 coo 79.58 63.22 65.19 80.01 62.49 63.28 178.03 118.40 36.14 177.70 120.46 36.31 coo 97.27 56.92 62.74 97.69 58.80 64.79 179.54 132.93 23.44 180.82 135.06 24.75 coo 98.02 63.02 59.73 95.39 63.19 64.30 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 4 3ay3_o03 NAD-DEPENDENT EPIMERASE/DEHYDRATASE user 2 4 # 2 D 33 ASP B 158 ASP.? 34.51 N7 ADE A 500 D 50 ASP B 89 ASP.? 31.34 O4 CIT A1102 D 135 TYR B 83 TYR^? 20.46 C8 ADE A 500 D 139 LYS B 49 LYS^? 24.07 O1 GOL C1901 coo 85.52 62.84 73.55 86.96 61.48 72.69 190.60 123.10 30.08 190.26 121.25 31.09 coo 79.58 63.22 65.19 80.01 62.49 63.28 181.93 115.70 26.33 180.57 117.33 26.20 coo 97.27 56.92 62.74 97.69 58.80 64.79 179.54 132.93 23.44 180.82 135.06 24.75 coo 98.02 63.02 59.73 95.39 63.19 64.30 174.03 130.60 22.66 171.30 132.48 26.53 ULMN 4 3ay3_o03 NAD-DEPENDENT EPIMERASE/DEHYDRATASE user 3 4 # 3 D 33 ASP C 158 ASP~? 26.27 O1 GOL C1901 D 50 ASP C 89 ASP.? 17.67 O3 GOL C1901 D 135 TYR C 83 TYR^? 12.44 O1 GOL C1901 D 139 LYS C 49 LYS^? 10.29 O2 GOL C1901 coo 85.52 62.84 73.55 86.96 61.48 72.69 152.92 141.67 53.35 151.80 143.42 53.28 coo 79.58 63.22 65.19 80.01 62.49 63.28 152.15 130.32 56.35 151.16 130.16 54.50 coo 97.27 56.92 62.74 97.69 58.80 64.79 149.52 133.95 39.18 148.57 136.34 38.09 coo 98.02 63.02 59.73 95.39 63.19 64.30 147.41 128.03 39.92 142.61 128.90 38.51 3ay3_o03 source 3AY3 NAD-DEPENDENT EPIMERASE/DEHYDRATASE : 3 hits 3ay3_o03 naa= 4 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 44 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 50 THR A 51 THR^? 8.68 N6 ADE A 500 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 185.43 146.45 17.17 186.00 148.48 17.29 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 185.72 140.93 6.30 184.35 140.00 4.99 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 189.89 142.39 7.18 190.42 141.55 9.05 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 165 GLU^? 4.52 C8 ADE A 500 A 44 ASP A 52 ASP^? 9.33 O4 CIT A1102 A 50 THR A 80 THR^? 4.30 N6 ADE A 500 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 185.43 146.45 17.17 186.00 148.48 17.29 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 185.72 140.93 6.30 184.35 140.00 4.99 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 182.84 145.31 7.97 182.66 147.39 7.73 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 44 ASP C 52 ASP^? 12.06 O1 GOL C1901 A 50 THR C 51 THR^? 10.18 O1 GOL C1901 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 157.34 129.59 37.15 157.60 127.69 38.11 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 147.21 130.59 30.19 147.01 130.37 28.08 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 146.36 130.30 34.58 146.96 132.15 35.42 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU C 165 GLU^? 7.74 O1 GOL C1901 A 44 ASP C 52 ASP^? 12.06 O1 GOL C1901 A 50 THR C 80 THR^? 5.30 O1 GOL C1901 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 157.34 129.59 37.15 157.60 127.69 38.11 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 147.21 130.59 30.19 147.01 130.37 28.08 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 151.58 126.43 30.18 151.60 124.76 31.56 3hde_o00 source 3HDE LYSOZYME : 4 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 44 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 50 THR A 51 THR^? 8.68 N6 ADE A 500 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 185.43 146.45 17.17 186.00 148.48 17.29 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 185.72 140.93 6.30 184.35 140.00 4.99 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 189.89 142.39 7.18 190.42 141.55 9.05 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 165 GLU^? 4.52 C8 ADE A 500 B 44 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 50 THR A 80 THR^? 4.30 N6 ADE A 500 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 185.43 146.45 17.17 186.00 148.48 17.29 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 185.72 140.93 6.30 184.35 140.00 4.99 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 182.84 145.31 7.97 182.66 147.39 7.73 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU B 7 GLU.? 17.06 N6 ADE A 500 B 44 ASP A 52 ASP^? 9.33 O4 CIT A1102 B 50 THR A 51 THR^? 8.68 N6 ADE A 500 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 195.60 134.63 1.65 195.26 136.71 1.75 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 185.72 140.93 6.30 184.35 140.00 4.99 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 189.89 142.39 7.18 190.42 141.55 9.05 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 44 ASP B 52 ASP^? 16.07 C8 ADE A 500 B 50 THR B 51 THR^? 19.74 C8 ADE A 500 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 180.17 131.30 14.36 179.09 129.62 13.64 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 173.93 140.35 20.11 173.24 142.10 19.12 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 174.04 136.47 22.40 175.88 136.63 23.40 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU B 165 GLU^? 13.88 O4 CIT A1102 B 44 ASP B 52 ASP^? 16.07 C8 ADE A 500 B 50 THR B 80 THR^? 11.53 O1 CIT A1102 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 180.17 131.30 14.36 179.09 129.62 13.64 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 173.93 140.35 20.11 173.24 142.10 19.12 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 173.05 137.67 14.86 171.74 136.22 13.94 ULMN 3 3hde_o01 LYSOZYME user 6 3 # 6 B 35 GLU C 165 GLU^? 7.74 O1 GOL C1901 B 44 ASP C 52 ASP^? 12.06 O1 GOL C1901 B 50 THR C 51 THR^? 10.18 O1 GOL C1901 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 157.34 129.59 37.15 157.60 127.69 38.11 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 147.21 130.59 30.19 147.01 130.37 28.08 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 146.36 130.30 34.58 146.96 132.15 35.42 ULMN 3 3hde_o01 LYSOZYME user 7 3 # 7 B 35 GLU C 165 GLU^? 7.74 O1 GOL C1901 B 44 ASP C 52 ASP^? 12.06 O1 GOL C1901 B 50 THR C 80 THR^? 5.30 O1 GOL C1901 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 157.34 129.59 37.15 157.60 127.69 38.11 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 147.21 130.59 30.19 147.01 130.37 28.08 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 151.58 126.43 30.18 151.60 124.76 31.56 3hde_o01 source 3HDE LYSOZYME : 7 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 165 GLU^? 4.52 C8 ADE A 500 C 44 ASP A 52 ASP^? 9.33 O4 CIT A1102 C 50 THR A 51 THR^? 8.68 N6 ADE A 500 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 185.43 146.45 17.17 186.00 148.48 17.29 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 185.72 140.93 6.30 184.35 140.00 4.99 coo 25.48 4.87 1.60 23.90 4.95 0.15 189.89 142.39 7.18 190.42 141.55 9.05 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 165 GLU^? 4.52 C8 ADE A 500 C 44 ASP A 52 ASP^? 9.33 O4 CIT A1102 C 50 THR A 80 THR^? 4.30 N6 ADE A 500 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 185.43 146.45 17.17 186.00 148.48 17.29 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 185.72 140.93 6.30 184.35 140.00 4.99 coo 25.48 4.87 1.60 23.90 4.95 0.15 182.84 145.31 7.97 182.66 147.39 7.73 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU B 7 GLU.? 17.06 N6 ADE A 500 C 44 ASP A 52 ASP^? 9.33 O4 CIT A1102 C 50 THR A 51 THR^? 8.68 N6 ADE A 500 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 195.60 134.63 1.65 195.26 136.71 1.75 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 185.72 140.93 6.30 184.35 140.00 4.99 coo 25.48 4.87 1.60 23.90 4.95 0.15 189.89 142.39 7.18 190.42 141.55 9.05 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU B 165 GLU^? 13.88 O4 CIT A1102 C 44 ASP B 52 ASP^? 16.07 C8 ADE A 500 C 50 THR B 51 THR^? 19.74 C8 ADE A 500 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 180.17 131.30 14.36 179.09 129.62 13.64 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 173.93 140.35 20.11 173.24 142.10 19.12 coo 25.48 4.87 1.60 23.90 4.95 0.15 174.04 136.47 22.40 175.88 136.63 23.40 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU B 165 GLU^? 13.88 O4 CIT A1102 C 44 ASP B 52 ASP^? 16.07 C8 ADE A 500 C 50 THR B 80 THR^? 11.53 O1 CIT A1102 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 180.17 131.30 14.36 179.09 129.62 13.64 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 173.93 140.35 20.11 173.24 142.10 19.12 coo 25.48 4.87 1.60 23.90 4.95 0.15 173.05 137.67 14.86 171.74 136.22 13.94 ULMN 3 3hde_o02 LYSOZYME user 6 3 # 6 C 35 GLU C 165 GLU^? 7.74 O1 GOL C1901 C 44 ASP C 52 ASP^? 12.06 O1 GOL C1901 C 50 THR C 80 THR^? 5.30 O1 GOL C1901 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 157.34 129.59 37.15 157.60 127.69 38.11 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 147.21 130.59 30.19 147.01 130.37 28.08 coo 25.48 4.87 1.60 23.90 4.95 0.15 151.58 126.43 30.18 151.60 124.76 31.56 3hde_o02 source 3HDE LYSOZYME : 6 hits 3hde_o02 naa= 3 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 1 3 # 1 A 966 SER A 54 SER.? 4.61 O3 CIT A1102 A 967 ARG A 53 ARG^? 5.21 N6 ADE A 500 A 975 TYR A 56 TYR.? -3.24 O3 CIT A1102s coo 82.02 40.88 31.11 79.88 41.56 30.18 180.68 142.57 2.59 178.38 141.86 2.59 coo 78.94 44.79 33.75 77.86 47.56 32.82 184.38 147.77 2.51 183.90 149.96 4.60 coo 83.57 40.86 25.45 83.15 43.18 26.91 175.94 140.65 -0.34 176.08 138.10 -1.42 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 2 3 # 2 A 966 SER B 54 SER.? 13.70 O5 CIT A1102 A 967 ARG B 53 ARG^? 12.50 O1 CIT A1102 A 975 TYR B 56 TYR.? 17.06 O5 CIT A1102 coo 82.02 40.88 31.11 79.88 41.56 30.18 170.01 143.15 16.19 170.47 144.95 14.66 coo 78.94 44.79 33.75 77.86 47.56 32.82 166.97 137.64 16.68 167.60 135.18 14.95 coo 83.57 40.86 25.45 83.15 43.18 26.91 168.51 148.73 14.38 168.50 150.54 16.52 ULMN 3 4dqk_o00 BIFUNCTIONAL P-450/NADPH-P450 REDUCTuser 3 3 # 3 A 966 SER C 54 SER.? 14.46 O1 GOL C1901 A 967 ARG C 53 ARG^? 4.89 O2 GOL C1901 A 975 TYR C 56 TYR.? 18.89 O2 GOL C1901 coo 82.02 40.88 31.11 79.88 41.56 30.18 147.47 126.83 25.21 148.44 127.11 23.04 coo 78.94 44.79 33.75 77.86 47.56 32.82 146.33 122.48 29.52 148.17 121.33 31.67 coo 83.57 40.86 25.45 83.15 43.18 26.91 147.08 126.92 19.41 145.08 128.68 18.52 4dqk_o00 source 4DQK BIFUNCTIONAL P-450/NADPH-P450 REDUCTASE : 3 hits 4dqk_o00 naa= 3